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Kathryn Wasserman Davis 
(1907–2013)
Kathryn Wasserman Davis was 106 when she died—remarkable in her number of years and how 
she lived every day to the fullest. Her dictum: “I want results in my lifetime.” She certainly made 
things happen. She was best known for passion and philanthropic support of cross-cultural edu-
cation and international relations, but our institution benefi ted greatly from Mrs. Davis’s deep 
appreciation for scientifi c discovery. At CSHL, we remember her fondly for her infi nite curiosity 
and youthful exuberance.
Mrs. Davis once admitted to a journalist that she “always hated science and avoided it like the 
plague.” She explained that this was because “I didn’t understand it and no one ever gave me the 
opportunity to learn.” But when given the opportunity to learn from CSHL’s experts, she grew 
to be a champion of biomedical research. Jim Watson and I were fortunate to get to know Mrs. 
Davis when she was in her 90s, a time when she was exploring new interests including painting, 
kayaking, and saving the Hudson River Valley. Her remarkable oil paintings hung proudly in her 
homes and often dominated our conversations over lunch or tea. Kathryn always maintained her 
leadership role as the widow of one of the United States’ great Ambassadors, Shelby Cullom Davis, 
banker, philanthropist, and US Ambassador to Switzerland from 1969 to 1975.
An undergraduate at Wellesley College, Kathryn later graduated from Columbia University 
with a Master’s and from the University of Geneva with a Ph.D., both in international relations. 
An avid traveler, she continued her passion for travel even through her later years, visiting many 
countries and meeting world leaders. In her own right, she was a very special ambassador for the 
United States.
With encouragement from her daughter Diana, son Shelby, and grandson Christopher, she 
proved an eager student of some of the most complex and cutting-edge technologies being de-
veloped at CSHL. Mrs. Davis became a prized student of RNA interference (RNAi) pioneer and 
CSHL Professor Greg Hannon, who partnered with Mrs. Davis on a research mission to create a 
set of tools to silence every gene in humans and mice, search for new therapeutic targets for cancer 
in the human genome, and implement a genetically based attack on human cancer cells.
Celebrating her 100th, she proudly announced in a birthday letter to friends the founding of 
the Kathryn W. Davis RNAi Research Program here. Headed by Greg Hannon, this program 
pursues the understanding and use of RNAi technology. This technology enables researchers to 
silence genes in cells grown in culture and in animals, allowing for the study of gene functions 
and of roles in cancer and other diseases. The generosity of Kathryn and her family through the 
Shelby Cullom Davis Foundation, which was named for her late husband, has enabled scientists 
throughout the world to use RNAi technology for many diverse experiments.
With two sisters who had suffered from breast cancer, Mrs. Davis was keenly interested in 
CSHL’s multipronged efforts in cancer research. She also spearheaded collaborative efforts be-
tween CSHL and the Jackson Laboratory toward fi nding a cure for glaucoma, a condition that 
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affected her during her last years. In these research areas and in most everything she pursued, Mrs. 
Davis said she always wanted to be “ahead of the curve.” She took a very personal approach to 
philanthropy and it was important to her not only to understand the science that we were doing 
but also to get to know the scientists themselves.
Her friendship with Dr. Hannon, who was honored to serve as the fi rst Davis Chair in Human 
Genetics at CSHL, was special. He called Mrs. Davis the “energizer bunny.” Her friends from 
CSHL were in full force to present her the 2009 Double Helix Medal for Humanitarianism. She 
took the stage at the gala that night in New York City to accept the medal and easily stole the 
hearts of all 400 guests!
I am quite sure that someone like Kathryn Davis comes along but once every 100 years or 
so. To her family, we express our sympathy. In the words of Jim Watson, who in a March 2005 
letter to Diana, wrote, “your mother is an inspiration to us all. Between her ‘Navratilova-genes’ 
and ‘Monet-genes’ she is truly an example of genetics at its best. . . . With your help, we can truly 
change the paradigm of human genetics research and set in motion the paths to stop genetic disease 
from holding back the lives of so many of the world’s peoples.”
Bruce Stillman
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xArthur M. Spiro 
(1925–2013)
As I was writing the president’s essay for this Annual Report on the topic of public science edu-
cation, I remembered Arthur and the deep commitment that he and Joan extended to the Lab’s 
DNA Learning Center (DNALC) programs. I think he would concur with my proposition that 
what we have created with the DNALC can and should be a model for education across this 
 nation. Thank you, Arthur, for your support.
Arthur served on the CSHL Board of Trustees from 1999 until 2006, where he was active on 
many committees, including the executive, audit, and Woodbury Genome Research Center com-
mittees. But he was most passionate about the DNALC Committee that he chaired from 2001 to 
2006. As the trustee liaison to the DNALC and its Corporate Advisory Board, Arthur contributed 
his business savvy and entrepreneurial thinking to the growth of our educational programs and 
facilities.
Arthur and Joan introduced CSHL to Clemson University, where in 1945 Arthur earned a 
B.S. in Chemical and Textile Engineering. Half a century later, he would return to Clemson as 
an adjunct professor in the College of Business and Behavioral Sciences, Trustee of the University 
Foundation, member of the President’s Advisory Council, and, with Joan at his side, founder of 
the Arthur M. Spiro Institute for Entrepreneurial Leadership. The mission of the Spiro Institute 
symbolized Arthur’s own meteoric rise in the global textile industry from technician to designer, 
manufacturer, merchant, and executive manager.
It was his vision that leveraged a scientifi c collaboration between the CSHL plant biology group 
and the Clemson Genomics Institute to establish the DNALC at Clemson University in 2006. He 
and Joan saw this partnership between institutions as a way to enhance public science education 
in South Carolina schools and beyond. Partnering DNALC teaching methodologies and tech-
nologies with university outreach programs has proven very successful. Just this year, we launched 
another such partnership with the University of Notre Dame.
As a tribute, the 100+ seat auditorium at the Dolan DNA Learning Center facility in Cold 
Spring Harbor Village is named the Joan and Arthur M. Spiro Auditorium. It was dedicated on 
September 9, 2003, with the wish that their donation to the DNALC “help provide a better quality 
of life for our families and future generations.” Today, more than 450,000 middle and high school 
students in the tri-state area have experienced hands-on genetics learning experiences as a result.
Arthur and Joan were world travelers, but he was raised in close-by Belle Harbor, Rockaways, 
and they were very dedicated to Long Island. Arthur was an honorary trustee of North Shore-
Long Island Jewish (NSLIJ) Health System and founding Chairman of the Feinstein Institute for 
Medical Research. We have him to thank for the formation of the partnership between NSLIJ and 
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our DNALC that is called DNALC West, a DNALC teaching facility located within the NSLIJ 
facilities at Lake Success. Both the Clemson DNALC and DNALC West set the stage for our later 
partnership with the NYC Department of Education and the Harlem DNA Lab located at the 
John S. Roberts Educational Complex.
2013 was the 25th anniversary year of the DNA Learning Center at CSHL. We have accom-
plished much on the shoulders of great men like Arthur M. Spiro. Our deepest sympathy and 
respect go to Joan and her daughters and grandchildren.
Bruce Stillman
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Colton Packer Wagner (1919–2013)
Former Cold Spring Harbor Laboratory Trustee Colton P. Wagner died this year at the age of 
95. He was born in Seattle and graduated from St. Paul’s School with an honorary scholarship 
to Harvard College, from which he received a B.S. in 1941, magna cum laude, Phi Beta Kappa. 
A distinguished lawyer with an L.L.B. from Harvard Law School, “Colty” helped found the 
community-based law fi rm of Humes & Wagner LLP in 1962. He served on the Board of Trustees 
from 1971 to 1977, a pivotal period in the contemporary history of this institution.
At that time, the Laboratory was the only major scientifi c organization whose Board of Trustees 
was composed almost equally of leaders in the local community and notable scientists. During 
the early 1970s, the staff of CSHL was approximately 100-strong, operating on a budget of just 
about $3 million. It was a diffi cult time fi nancially, and the dedication and support of trustees 
were crucial.
In the year that Colty retired from the board, Jim Watson declared that “our long period of 
emergency is over.” In the 1977 Annual Report, he wrote:
For the past fi fteen years we have had to work very hard—fi rst to survive when the Carnegie 
Institute of Washington began the close-down of its Department of Genetics, and then to 
grow again into a serious body for the advancement of fundamental biology. In the begin-
ning the outcome was in doubt, and only through the efforts of many loyal friends did 
the Participating Institutions come into existence and join forces with our friends in this 
community to see that we kept going as an independent body. . . . Now we are completely 
different.
So much happened during Colty’s term of service. In 1971, the Laboratory received its fi rst 
Cancer Center grant from the National Cancer Institute. To this day, CSHL is one of the nation’s 
leading NCI-designated Cancer Centers.
At the same time, the seeds of our neuroscience research program were being sown. In 1971, 
summer courses in neurobiology began with a view to complementing them with a year-round 
program of research. By 1977, the focus had turned to initiating such a program to investigate the 
way nerve cells grow and form synapses.
During Colty’s tenure, much was also accomplished in the physical growth and moderniza-
tion of the campus. But preservation of the historic and environmental beauty of the Cold Spring 
Harbor shoreline has always been paramount. In 1973, CSHL seized the opportunity to acquire 
the Whaler’s Cove Marina so as not to “lose the tranquility so very essential to our existence and 
become part of the commercial-urban spread that now dominates so much of the north shore 
of Long Island.” We are sure that Colty, an avid fi sherman who was active in local conservation 
organizations  including the Long Island Chapter of the Nature Conservancy, appreciated the 
tranquility of the Harbor that this purchase continues to guarantee.
We will be forever grateful to trustees like Colty who helped to navigate this institution through 
rough and sometimes perilous waters. As a seaman who served for 5 years in the U.S. Navy as 
the Executive Offi cer on a Second World War destroyer escort, Colty was particularly qualifi ed 
for such a mission. He retired from the Navy in 1946 as a Lieutenant Commander. We salute his 
service to CSHL, community, and country. Our condolences go to his children, grandchildren, 
and great grandchildren.
Bruce Stillman
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1PRESIDENT’S REPORT
Cold Spring Harbor Laboratory enjoyed a highly successful year in 2013, despite uncertainty 
about how a political logjam in Washington, D.C., would impact the ability of our scientists to 
obtain federal grants. In the 20 years since I was appointed Director of the Laboratory, our faculty 
has grown from 39 to 52 and our federal grant income has increased more than 2.5-fold. Even so, 
it is clear that federal funding is not keeping pace with the cost of doing science. Federal grants 
now cover only about 40% of our $119 million research budget, down from approximately 60% 
support of the $30 million research budget in 1994. In the past decade, federal R&D funding 
has decreased by about 22% when corrected for infl ation, and the fraction of grant applications 
funded by the National Institutes of Health (NIH) and the National Science Foundation (NSF) 
has declined alarmingly, to about one in seven of all applications. In forging a political compro-
mise in early 2014 to fund government operations through 2015, Congress failed to engage in a 
full-scale budget debate about the role of American science in promoting economic development. 
Although the success rate of CSHL scientists in obtaining NIH grants is more than twice the 
national average, the funding situation is increasingly tight. Cultivating new sources of private 
philanthropy is therefore a high priority.
Uncertainty about funding notwithstanding, laboratories of the principal investigators at 
CSHL made impressive progress in 2013. Elsewhere in these pages are capsule summaries that 
demonstrate the breadth of our scientifi c achievements during the year—in cancer research, re-
search on the brain, and in the genetics of plant development. Basic science discoveries continue to 
drive advances that are increasingly having an impact on medicine and food production.
As our friends and supporters know, CSHL takes pride not only in research achievements, but 
also in our extraordinary educational programs. These serve a unique range of target audiences, 
from professional scientists attending one of the world-famous CSHL Meetings or Courses, to a 
doctoral candidate matriculating in our Watson School of Biological Sciences, to 5th graders at 
the DNA Learning Center (DNALC) getting their fi rst hands-on exposure to the tools that scien-
tists use to study DNA. In this Report, I focus on our programs that reach young people.
The DNALC was founded 26 years ago to help children and their parents and teachers “thrive 
in the genome age.” The vision that guided the founders was notably democratic and pragmatic: 
“We envision a day when all elementary students are exposed to principles of genetics and disease 
risk, when high school students have the opportunity to do hands-on experiments with DNA, 
and when all families have access to genetic information that they need to make informed health 
care choices.”
The central achievement of the DNALC program, as developed by David Micklos, Executive 
Director of the Center since its inception, has been to educate all students, not just those who pro-
fess and display at an early age an interest in science. My main purpose here is to propose that, in 
the coming years, the DNALC’s hands-on learning model be emulated and reproduced across the 
sciences and throughout the nation, to the greatest extent possible. We have a winning formula, 
and it can do much good if scaled up.
What has worked on Long Island and to date has impacted half a million students can work 
in every major American city and in outreach programs organized for children at every major 
American university. The Learning Center concept is one that has legs. The more extensively it 
reaches across the United States, the better prepared Americans will be to make informed health 
care choices and compete internationally in science and technology fi elds.
Scientifi c investigation is a defi ning feature of our civilization and a prime basis of our hopes for 
a better future. There is strong evidence that the American people are well aware of this. Year after 
year, more than 80% of American adults tell pollsters from the University of Chicago’s National 
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Opinion Research Center that “scientifi c research that advances the frontiers of knowledge should 
be supported by the federal government, even if it brings no immediate benefi ts.” But the same 
set of annual surveys, published in Science and Engineering Indicators and available online,1 reveal 
that Americans score poorly when asked nine questions about basic scientifi c facts. Many Ameri-
cans don’t understand what radioactivity is, many don’t understand that antibiotics do not target 
viruses that cause illness, and more than 50% agree when asked if the following statement is true: 
“Ordinary tomatoes don’t contain genes, while genetically modifi ed tomatoes do.”
Adult scientifi c literacy in the United States is far below a level befi tting a nation leading the 
world in scientifi c research and technological development. If we expect to continue leading the 
world in these areas, we must be serious about investing in science education for the rising genera-
tion. The need is all the more acute when one considers the rapid emergence of new centers of 
scientifi c and technological activity, notably in China and other East Asian nations that are devot-
ing an increasing share of their GDP to science and science education while we are reducing our 
share of GDP that supports research. It is worth mentioning that the government of Singapore, 
when planning the city-state’s economic future, chose medical and biotechnology as new areas of 
focus and accordingly came to CSHL for permission to license our model of high school scientifi c 
education. They now teach as many students each year as we do on Long Island, but since the 
population of Singapore is 2 million less than Long Island, one can safely assume that every child 
in Singapore is taught science using DNALC methods.
It is possible that in relative terms, tiny Singapore may benefi t more from our education model 
than we will—unless, that is, American academic and political leaders, as well as leaders in indus-
try, support better hands-on science education throughout the nation. It is ironic that although 
our public schools, with federal and state encouragement, have made commitments to stressing 
education in the so-called STEM fi elds (science, technology, engineering, and math), Congress 
has not seen fi t to increase funding for scientifi c research or for science education. The advance-
ment of science may be one of our highest national priorities, but support of educational programs 
remains stuck in neutral as debates over spending priorities are put off year after year.2
My enthusiasm for the “hands-on” concept central in all DNALC programs—which can be 
adapted to work in every major scientifi c fi eld—is grounded in years of watching it succeed in 
real-world educational situations right here on Long Island and in our satellite facilities, notably in 
our Harlem DNA Learning Center in Manhattan. There, we have been able to serve students and 
teachers across the largest and most complex school district in the United States.
The ability of the DNALC to reach public and private school students in all fi ve boroughs 
of the City from a single Harlem school demonstrates its scalability. The programs are scalable 
by design: Dave Micklos and members of his very talented team have devised various labs and 
modules that are fully compatible with the New York school system’s State-mandated curriculum. 
These modules take students on journeys of discovery that make elements of the curriculum lit-
erally come alive before their eyes. For instance, the DNALC’s pioneering lab on mitochondrial 
DNA has enabled tens of thousands of New York students to learn by doing—by sampling some 
of their own mitochondrial DNA and later learning how to interpret the DNA sequences that 
these generate. The children learn something about themselves—about their own genetic heritage 
and the extent to which it is shared, and not shared, with their fellow students, other members of 
their species, and indeed with distant species. Ostensibly abstract knowledge in this way becomes 
personally relevant.
1http://www.nsf.gov/statistics/seind14/; see especially “Science and Technology: Public Attitudes and Understanding,” 
Chapter 7.
2“Wild Wild Cards Remain After Proposed Reshuffl e of STEM Education,” Science, 19 April 2013, 258–259; “NIH 
Swears Off Science Education,” Science Insider, 27 September 2013; “Congress and NIH Don’t See Eye to Eye on Sci-
ence Education,” ibid., 28 January 2014.
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Another of the DNALC’s great successes is in using the hands-on approach to inculcate the 
single most important take-away skill from any K–12 science class: the ability to understand sci-
entifi c reasoning. In the same respected national survey I have already cited, 58% of American 
adults in 2010 failed to demonstrate a basic understanding of scientifi c inquiry (regarding the use 
of evidence to test theories and the concept of “controls”). The fi gure balloons to 77% among 
those with a high school education or less.
Two years ago, the DNALC introduced an educational program that has worked marvelously 
to demonstrate that high school students are perfectly capable, and often brilliant, at understand-
ing how to use science to ask a question and how to design an experiment using the scientifi c 
method to try to answer it. The new program, called the Urban Barcode Project, or UBP, involves 
teams of competing students, many from ethnic groups underrepresented in science. Importantly, 
these students were not cherry-picked from “gifted” classes; quite the opposite, for many, this 
experience is their fi rst exposure to science. In 2013, 53 teams used DNA barcoding technology 
to identify living things in the local environment. They discovered 35 DNA sequences that did 
not match existing data in GenBank, an international database of DNA information. These new 
sequences were then published to the database with the students as authors. Teams presented their 
results at the American Museum of Natural History, with the grand prize awarded to students 
who investigated ant diversity in the Bronx. In 2012, 65 novel DNA sequences were discovered, 
and winners of the competition proved that many herbal Ginkgo products contained little or no 
Ginkgo biloba DNA—a lesson learned about science as well as marketing practices.
Each of the DNALC programs is scalable. A grant from the Howard Hughes Medical Institute 
(HHMI) enabled Micklos and his team to train 835 New York City teachers in lab techniques 
over a 5-year period. With minimal backup, readily provided by teaching mentors at the DNALC, 
these teachers have gone back to their schools and taught DNALC lab modules, captivated thou-
sands of children with a hands-on approach, and have been able to build upon lab modules with 
some of the DNALC’s prize-winning websites that extend the lessons from the lab setting and 
deepen student involvement during much longer periods of time. There are 22 such websites now 
freely available for use by teachers anywhere who want to use them. The DNALC also has devised 
“DNA Footlocker” kits that can be rented by mail and provide all the needed materials to do any 
of their current offering of six different lab modules. This is another aspect of the approach that is 
infi nitely scalable, given proper organization and funding.
A small contingent of teaching experts from the DNALC thus has succeeded in markedly 
enhancing science education in a school district of more than 1 million students. The multiplier 
effect of each DNALC-trained teacher is hard to measure, but we do know that more than 40% 
of the 835 teachers trained under the HHMI grant and 133 additional teachers trained to lead 
UBP projects have subsequently booked fi eld trips to one of our DNALC facilities; others have 
explicitly indicated that they felt self-suffi cient as a result of their DNALC training and could now 
introduce students to concepts at their own schools, with the help of rented Footlockers. Students 
who take our labs appear to do better as well: Approximately a full letter-grade improvement was 
noted in our most recent attempt to document impact of the labs on students’ grades.3
I want to make a fi nal point about why this model is ready to be replicated across America. 
The DNALC has solved a problem that over decades has befuddled other innovative developers 
of science education curricula. Typically, the creation of programs such as the UBP or the mito-
chondrial DNA lab is supported by an initial government or foundation grant. When the grant 
expires, the program is left to succeed or fail on its own. Usually, funds dry up and programs are 
discontinued. The DNALC has had the insight to charge school districts that can afford to pay a 
nominal amount, typically a few thousand dollars a year, for the services it provides. Rather than 
32011 Annual Report, Cold Spring Harbor Laboratory, “DNA Learning Center Executive Director’s Report,” p. 448.
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hiring a teacher with a Ph.D. in biological science, a high school or middle school knows it can rely 
on our program to reach large numbers of students, at a tiny fraction of the cost of new faculty.
We annually host more than 20,000 students from Long Island schools for laboratory-based 
fi eld-trips to our Cold Spring Harbor DNALC facility and its satellites, each of which has dedi-
cated lab space manned by our instructors. Ten thousand more are reached in other programs, 
including DNA summer camps, a major plus—especially for students in resource-poor urban 
school districts. Separately, we provide training classes for teachers. No school that is unable to 
pay is prevented from benefi ting from our programs. But many can pay a nominal fee, and the 
revenues generated make the entire DNALC enterprise economically sustainable, year after year.
Other cities, if they are motivated to do so, can use a similar model to kindle and sustain 
DNALC-like programs in biology, indeed, all of the physical sciences, as well as engineering. In 
2013, we opened a new DNALC at the University of Notre Dame in Indiana, and we have started 
DNALCs in other areas of the United States, Australia, and Europe. We will open a new, larger 
DNALC in Manhattan and a new center in Suzhou, China in 2015. It is my dream that one day 
there will be as many science, technology, and engineering Learning Centers across this nation as 
there are McDonald’s restaurants. It is a lot to hope for, but such a program will immediately make 
an impact, particularly if we have partners to help. The need is real and, in my view, urgent. By 
the time they graduate high school, we can prepare our young people to know—every student, not 
just the highly motivated—how scientists think, how they approach and answer problems, and a 
bit about how the natural world works. The long-term benefi t is to allow more of our citizens to 
form opinions about subjects grounded in science, including those affecting their own health and 
well-being.
Bruce Stillman, Ph.D., F.R.S.
President and Chief Executive Officer
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Research
How Jumping Genes May Contribute to Age-Related Brain Degeneration
Cognitive decline is often obvious to people as they age. However, corresponding changes in 
the brain, at a molecular level, are not well understood. This year, Associate Professor Joshua 
 Dubnau and his colleagues used the fruit fl y brain as a model to offer insight into a pos-
sible molecular basis of neurodegeneration. They identifi ed a class of DNA elements, 
known as transposons or “jumping genes,” that become more abundant and active as the 
brain ages and cognitive function declines. Transposons are short repetitive sequences of 
DNA that insert themselves into an organism’s genome. When active, transposons copy 
themselves and jump into other locations within the genome. After the initial stages 
of life, transposons are typically inactive, but Dubnau and his team discovered that as 
fl ies age, transposons become more active and move. A protein called Ago2 is important 
for regulating transposon levels. When Ago2 is mutated in young fl ies, transposon lev-
els prematurely increase. At the same time, long-term memory declines, mirroring the 
memory defects seen in much older fl ies. Dubnau’s work suggests that this “transposon 
storm” may be responsible for age-related neurodegeneration—a hypothesis his lab is 
actively working to test.
Healthy Cells Support Tumors with Signals That Spur Growth
When researchers and clinicians think of targeted cancer drugs, they are generally look-
ing for therapies that will directly attack tumor cells and spare nearby healthy cells. But 
new research from Assistant Professor Mikala Egeblad and Associate Professor Scott 
Powers challenges that strategy. They found that tumors rely, at least in part, on mul-
tiple signals from healthy cells in the local environment to promote growth. Egeblad, 
Powers, and their team systematically cataloged the repertoire of interactions between 
breast cancer cells and a type of healthy cell that is commonly found in breast tis-
sue. They used genomic analysis to identify 42 different factors that are released by 
normal cells, the majority of them encouraging cancer growth. They found that each 
factor came with a different set of instructions for the tumor. Looking closely at three 
of these factors, the team discovered that one promoted survival, another signaled for 
greater proliferation, and a third increased infl ammation and the growth of nearby 
blood vessels supporting tumor development. The team blocked these signals, alone 
and in combination, and found that targeting multiple factors did the most to inhibit 
tumor growth. Their work has broad implications for future cancer drug development. 
The most effective cancer therapies, the work suggests, would combine two kinds of 
drugs: those that target tumors and those that block proliferation signals from nearby 
healthy cells.
Natural Mutations Point the Way to Greater Corn Yield
As the global population soars beyond 7 billion, efforts to increase food production have taken on 
new importance. This year, Professor David Jackson and his colleagues made discoveries that offer 
insight into how to naturally boost the production of maize, a staple of the world diet. Known 
commonly as corn kernels, the edible parts of a maize plant are the seeds. These seeds, like all or-
gans in a plant, are derived from a structure known as the meristem. Jackson began with a simple 
hypothesis: Increasing the size of the meristem could create more area for kernels to develop and 
thus lead to an increase in the plant’s yield. To test this hypothesis, Jackson and his team sought 
J. Dubnau
M. Egeblad
S. Powers
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to identify genes that control the size of the meristem. They discovered a mutation in one 
of these genes, known as FASCIATED EAR2 (FEA2), that results in a larger meristem. 
Plants grown with the FEA2 mutation produce ears of corn that have a greater number of 
rows and up to 13% more kernels than their normal counterparts. In other experiments, 
Jackson and colleagues identifi ed another mutant gene, known as COMPACT PLANT2 
(CT2), that also regulates the size of the meristem. The team explored the molecular basis 
of these mutations and discovered that the CT2 gene encodes for a protein known as Gα 
that unexpectedly interacts with FEA2, an unusual type of cell-surface receptor. Detailed 
understanding of these natural mutations and their impact on plant growth points the 
way to higher maize yields—good news if we are to meet the planet’s ever-growing food 
needs.
Brain Uses Disinhibition to Obtain Extremely Precise Control
There are two major classes of neurons in the cerebral cortex: excitatory and inhibi-
tory. Assistant Professor Adam Kepecs and his team are working to understand how 
signaling between these neurons shapes mental processes such as cognition and learning. 
This year, Kepecs and his team identifi ed the role of a special class of inhibitory neu-
rons, known as VIP neurons, in the cortex. In collaboration with CSHL Professor Josh 
Huang, they used a technique known as optogenetics to specifi cally stimulate VIP neu-
rons in the mouse brain. They found that when these neurons are active, signaling from 
certain neurons decreases, whereas the activity of other neurons increases. Upon closer 
investigation, Kepecs and his colleagues discovered that VIP neurons were inhibiting 
other inhibitory neurons in the brain, which allowed the excitatory neurons to become 
more active. This process, known as disinhibition, is something like releasing the brakes 
on a car without stepping on the gas pedal. Excitatory neurons are not directly activated, 
which gives the brain highly precise control over cortical processing. Kepecs and his 
team found that VIP neurons function in the auditory cortex and mediate reward and 
punishment behaviors. In linking neuronal signaling with a behavior, Kepecs has gained 
critical insight that will allow him to further explore the complex networks that control 
cortical function.
First Animal Model of Adult-Onset Motor Neuron Disease, SMA
Spinal muscular atrophy (SMA) is a rare but devastating motor neuron disease. It is caused by a 
defect in a type of genetic editing, known as splicing. The splicing error occurs in a gene, called 
SMN1 (survival of motor neuron 1), that is required for motor neurons to function and low-
ers the amount of SMN protein in the body. In its most severe form, the disease affects infants 
and young children; it is the leading genetic cause of childhood mortality. Patients with more 
SMN protein and, therefore, more mild manifestations of the disease, can live to adulthood, 
but they develop debilitating handicaps such as losing the ability to walk. Professor 
Adrian Krainer, an authority on splicing, has made major contributions to the study of 
the most serious forms of SMA, and he has taken part in work leading to the discovery 
and testing of a promising drug, currently in Phase-2 clinical trials. Yet, the adult-onset 
form of SMA has been challenging to research because scientists have lacked a proper 
animal model. This year, Krainer led a team to develop a mouse model for adult-onset 
SMA, which faithfully reproduced many of the pathologies seen in patients. His team 
was particularly interested in understanding how SMN1 protein levels affect neuronal 
function in adults. They were excited to discover that only moderate levels of the protein 
are needed, suggesting that clinicians will have a broad time window in which to treat 
adult patients with SMA.
D. Jackson
A. Kepecs
J. Huang
A. Krainer
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Mathematical Technique to Declutter Cancer Cell Data
In recent years, next-generation sequencing has brought genome-wide data to clinical 
research, paving the way for major new discoveries in the diagnosis and treatment of 
disease. Despite this promise, there has been some signifi cant challenges. Sequencing 
generates extremely large data sets that cannot easily be interpreted. Advanced com-
puting technology is required to extract meaningful information from the data. This 
year, Assistant Professor Alexander Krasnitz and Professor Michael Wigler developed 
a mathematical method of simplifying and interpreting genome data based on varia-
tions in the sequence. These changes in genomic sequence are common in diseases 
such as cancer, where certain segments of DNA may be amplifi ed or deleted in a 
tumor cell. These mutated regions are called “intervals” and may appear repeatedly 
within a specifi c population of cells. When the intervals are superimposed against a 
map of the full human genome, they form “stacks” at discrete locations. Because of 
the vagaries of collecting genome data and a certain amount of small-scale variation 
in the precise boundaries of the deleted or amplifi ed DNA intervals, these stacks 
are wobbly. This makes them very hard to accurately interpret. Krasnitz and Wigler 
devised a mathematical method called CORE to clean up the stacks of overlapping 
data, revealing a rich structure underlying all of the clutter. Such analysis is a po-
tentially valuable guide to prognosis and can also help to make important treatment 
decisions.
Finding Where Fear Memories Form in the Brain
Fear elicits a similar response in animals and humans: a momentary feeling of paralysis as the 
brain assesses present danger. This past year, Assistant Professor Bo Li examined how this univer-
sal emotion is learned, controlled, and remembered, and how the brain translates fear into action. 
Li and his team trained mice to be afraid of an auditory cue. They used a technique called opto-
genetics to activate specifi c neurons with laser light, directed fi beroptically into the brain 
with pinpoint accuracy. They could then record changes in the behavior of the mouse to 
determine how stimulating a particular area of the brain results in action. Li’s team found 
that fear conditioning alters the release of neurotransmitters in a part of the brain called 
the central amygdala. The central amygdala is associated with emotion, pain processing, 
and reward-based behavior. The team further examined this portion of the brain and dis-
covered that both formation and recall of fear memory requires the activation of a specifi c 
class of neurons, known as somatostatin-positive neurons, within the central amygdala. 
This work demonstrates that specifi c subsets of neurons in the central amygdala have an 
active role in the brain’s fear response, converting fear into action. Li’s lab hopes to build 
on these discoveries to understand the neural circuit changes involved in posttraumatic 
stress disorder (PTSD).
Genetics Explains Variable Severity of Birth Defects 
in EEC Syndrome
Cleft palate can be part of a larger condition known as ectodactyly, ectodermal dysplasia, cleft-
ing syndrome (EEC), that can be debilitating and sometimes fatal. The illness is caused by a 
well-known DNA mutation in the p63 gene, but the birth defects that result range in severity. 
In fact, not all children with the p63 mutation develop EEC. This year, Professor Alea Mills 
and her team discovered a genetic modifi er of the p63 mutation that explains how two people 
with the same mutation can manifest the illness very differently. They engineered a mouse in 
which the normal copy of p63 was replaced with the mutated version seen in EEC. These mice 
developed with birth defects ranging in severity, similar to babies with EEC. A complex series 
A. Krasnitz
M. Wigler
B. Li
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of genetic experiments revealed that the presence or absence of one variant type of the 
p63 protein, called TAp63, determines whether or not a child with the p63 mutation 
will actually develop EEC pathology. Loss of TAp63 alone does not cause EEC. But 
when mice lacking TAp63 also possess the EEC-causing p63 gene mutation, pathology 
always occurs. This work suggests that in children who have inherited the EEC-causing 
mutation from one of their parents, levels of the TAp63 protein determine whether and 
to what extent these children will be born with birth defects. Mills speculates that when 
levels of TAp63 drop beneath a certain threshold, it is no longer protective, opening the 
way to pathology. The next step for researchers in this area is to compare the DNA of 
children only mildly affected by EEC with siblings or other children who have a severe 
form of the disease.
Linking Brain Cell Activity with Smell Recognition and Behavior
An orange and a grapefruit have quite similar odors; at the same time, they are both sweet and 
acidic. Despite the similarity, our brains can readily differentiate between the two. Associate 
Professor Glenn Turner and colleagues have made signifi cant advancements this year 
using the fruit fl y olfaction system to identify how the brain distinguishes one scent 
from another. The fruit fl y brain has a structure called the mushroom body that is re-
sponsible for learning and memory, including olfaction. Within the mushroom body 
are neurons called Kenyon cells that have unique response properties. Signals from 
these neurons are rare and often weak. To determine if and how Kenyon cells function 
in odor memory, Turner and his team used an imaging technique that allowed them 
to monitor and measure the response of more than 100 Kenyon cells at once. They 
found that their sparse responses allow these neurons to integrate multiple signals that 
provide a large amount of information about a particular odor. They discovered that 
as few as 25 neurons are required to distinguish among similar scents. This informa-
tion will help Turner’s team to better understand how the brain combines sensory data to make 
decisions.
Growth Factors Contribute to Drug Resistance in Pancreatic Cancer
Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival 
rate of only 6%. New treatments are urgently needed. This past year, Professor David Tuveson 
uncovered a new avenue for drug development. It is thought that many existing chemo-
therapies fail because they are unable to reach the interior of pancreatic tumors. Tuveson 
and his colleagues tried to address this problem by targeting high amounts of a che-
motherapy drug directly into the tumor. Unfortunately, the response did not improve, 
suggesting that other factors contribute to tumor survival. The team discovered proteins, 
known as growth factors, that promote tumor growth in the pancreatic tumor mass. 
Using an antibody against just one of these factors, called connective tissue growth factor 
(CTGF), the team was able to block nurturing signals in the local tumor environment. 
When mice with pancreatic cancer were treated with both the antibody and standard 
chemotherapy, tumor cells died and mice lived longer. Tuveson’s work suggests that these 
growth signals within the tumor overcome the power of conventional chemotherapies. 
New drugs targeting these survival signals might be used in combination with existing chemo-
therapies to stop cancer growth.
Scientiﬁ c Advisory Committee
We are honored to receive input from scientifi c world leaders who serve on CSHL’s Scientifi c 
 Advisory Council (SAC). The SAC is a nine-member Council that also includes participation 
A. Mills
G. Turner
D. Tuveson
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from CSHL Trustee James M. Stone, Ph.D., and CSHL Scientifi c Trustee Michael R. Botchan, 
Ph.D. Chairing the SAC is Fred Alt, Ph.D., of Harvard University Medical School. Other mem-
bers include Drs. Cori Bargmann, Joanne Chory, Carol Greider, Leonid Kruglyak, Markus Meis-
ter, Kevan Shokat, and Max Wicha.
Technology Transfer
As CSHL’s employee numbers and operating budgets have grown signifi cantly in the fi rst 
decade of the millennium, so have opportunities for commercialization of our research 
discoveries and technologies. This year, CSHL announced the recruitment of Teri Willey 
to the new position of Vice President, Business Development and Technology Transfer. 
Teri brings a wealth of experience from leading transfer and business development for 
Mount Sinai Medical Center and the founding of several ventures including Cambridge 
Enterprise Ltd. and ARCH Development Partners.
John Maroney, who for the past 20 years has helped many CSHL investigators 
launch successful technology start-ups and negotiate licensing agreements, continues in 
his role as the Laboratory’s general counsel. John played a critical part in the establish-
ment of the Broad Hollow Bioscience Park, a collaborative biotech incubator that CSHL 
helps to lead on the campus of SUNY Farmingdale, the original home of the CSHL spin-off and 
cancer drug manufacturer OSI Pharmaceuticals Inc. (now owned by Astellas  Pharma Inc.).
CSHL is engaged in technology transfer as one way of delivering important discoveries to the 
public. We are ramping up support to our scientists in partnering with companies, investors, and 
others to achieve this mission. This support includes identifying science ideal for partnering, fi nd-
ing the best partners, performing good negotiations, managing the corresponding transactions, 
and developing the team to carry out this work. 2013 was a year to take stock and initiate program 
changes in order to move forward with a new approach. 2014 will be a year for evolving the pro-
gram, building the team, and completing new deals with industry.
Cold Spring Harbor Laboratory Board of Trustees
The CSHL Board of Trustees elects members whose academic and professional accomplishments 
reach beyond the boundaries of science, providing well-informed governance in an increasingly 
complex fi scal and regulatory environment. The Board welcomed four new trustees: Cornelia I. 
Bargmann, Ph.D., Jeffrey E. Kelter, Robert W. Lourie, Ph.D., and Thomas A. Saunders III.
The Board congratulated two retiring members, Scientifi c Trustee Dr. David Botstein and 
Alan Seligson. Dr. Botstein was the 2013 recipient of the Breakthrough Prize in Life Sciences and 
donated $100,000 of his prize to CSHL to support its advanced technology courses. Mr. Seligson, 
who was named an Honorary Trustee, established the Andrew Seligson Clinical Fellowship in 
T. Willey
C.I. Bargmann J.E. Kelter R.W. Lourie T.A. Saunders III
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memory of his son who died of cancer, helping to set the stage for CSHL’s Cancer Therapeutics 
Initiative.
The entire community mourned the passing of trustees and friends Colton Packer Wagner, 
Arthur M. Spiro, and Kathryn W. Davis.
Development
Together, the Board, the CSHL Association, the Corporate Advisory Board, and many individual 
foundations and donors raised more than $6.9 million in unrestricted funds for research and 
education programs. Thanks to all those who contributed, especially the Charitable Lead Annuity 
Trust under the Will of Louis Feil and The Simons Foundation for new major gifts.
CSHL is grateful to the Lustgarten Foundation and Roy Zuckerberg for supporting the Cancer 
Therapeutics Initiative (CTI) and its leaders, including Dr. David Tuveson, an M.D./Ph.D. expert 
in pancreatic cancer. Infrastructure for the CTI is essential, and with help from David Koch, New 
York State Empire State Development, and an anonymous donor, construction of the Preclinical 
Experimental Therapeutics Facility began in November. The project is moving forward on the 
strength of a $2 million award from Governor Andrew M. Cuomo’s Regional Council initiative.
The Governor praised the initiative. “This expansion project demonstrates how Long Island is 
becoming a leading hub for scientifi c and medical study,” Cuomo said. “With the support of the 
Regional Council Initiative, CSHL is moving forward with a facility that will enable critical re-
search seeking to advance the quality of healthcare around the globe. I am pleased that the project 
is now under way and look forward to seeing its positive impact on the region for years to come.”
Long Island Regional Economic Development Council Cochairs Kevin Law, President, Long 
Island Association, and Stuart Rabinowitz, President, Hofstra University, said, “This ground-
breaking is a major milestone not only for Cold Spring Harbor Laboratory and Long Island, but 
also for the critical research CSHL conducts to fi nd new and innovative ways to treat cancer and 
improve the quality of life for people around the world.”
With dedicated state-of-the-art facilities and staff, CSHL will accelerate research aimed at 
developing new therapeutics for cancer and neurological disorders. Other signifi cant contributors 
included the estate of Robert B. Gardner, Jr., Lisa Lourie and Dr. Robert Lourie, and the St. Giles 
Foundation.
CSHL Association Board of Directors
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CSHL is extending the reach of its science education programs to urban centers all over the 
world. A new fl agship center in Manhattan will serve as the nucleus for DNA learning in New 
York City. Middle and high school students will have access to hands-on DNA laboratory experi-
ences to gain a greater understanding of their own uniqueness, the implications of personalized 
medicine, and their shared genetic heritage in America’s melting pot. The NYC center has been 
made possible by a lead contribution by CSHL Trustee Laurie L. Landeau and signifi cant gifts by 
the Thompson Family Foundation and the Alfred P. Sloan Foundation.
Unveiled this year was a commemorative wall honoring the major donors, who, under the lead-
ership of Board Chairman Eduardo Mestre, contributed to the Hillside Campaign of 2003–2008. 
This campaign made possible the 2009 opening of six new Hillside Laboratory buildings, rep-
resenting the largest expansion in the history of the Laboratory. With these research buildings, 
CSHL increased its research capacity by 40%.
Supported by our trustees, fund-raising events including the eighth Double Helix Medals Dinner 
(DHMD) in Manhattan opened CSHL’s doors to many new friends in the New York metropolitan 
area. The DHMD honors individuals who have raised public awareness of the signifi cance of bio-
medical and genetics research. We saluted Robin Roberts for her courage and tenacity in using her 
celebrity to share information about breast and blood cancers.
Groundbreaking of Preclinical Experimental Therapeutics facility
Commemorative wall, Hillside campus
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This year’s DHMD also highlighted the impact that 
CSHL has had in leveraging biomedical technology for ap-
plications to benefi t society. Since 1992, the Innocence Proj-
ect has used DNA technology to generate evidence leading 
to the exoneration of 312 wrongfully convicted individuals. 
This is a concept that cofounders (and 2013 DHMD medal 
winners) Peter Neufeld and Barry Scheck advanced after 
attending a conference on the subject organized at CSHL’s 
Banbury Center in 1989. The Banbury Center’s role as a 
think tank bringing science and public policy experts to-
gether is unrivaled.
Research Faculty
Awards
• Professor and Howard Hughes Medical Institute Investigator Gregory Hannon won a MERIT 
(Method to Extend Research in Time) Award from the National Institute of General Medical 
Sciences. This prestigious award recognizes highly productive scientists by extending funding 
for an existing research project grant. A leader in the fi eld of small RNA biology, Hannon 
has sought to understand the biological roles of small RNAs and the underlying mechanisms 
through which they operate.
• Professor Partha Mitra, Crick-Clay Professor of Biomathematics, was honored with two 
awards: the George S. Axelby Outstanding Paper Award of the Control Systems Society of 
the Institute of Electrical and Electronics Engineers (IEEE) and an INSPIRE (Integrated 
NSF Support Promoting Interdisciplinary Research and Education) grant from the National 
Science Foundation (NSF). The INSPIRE grant was established in 2012 to address some of 
the most complicated and pressing scientifi c problems that lie at the intersections of tradi-
tional disciplines. Mitra is weaving together theoretical threads from physics and engineering 
to arrive at a coherent theoretical framework for understanding connectivity and dynamical 
behavior of circuits in the mammalian brain. He is applying insights from his theoretical work 
to the Mouse Brain Architecture Project, with the goal of generating brain-wide maps of inter-
regional neural connectivity.
• Associate Professor Adam Kepecs received the Memory & Cognitive Disorders Award from 
the McKnight Endowment Fund for Neuroscience, which provides support to encourage 
breakthroughs in understanding complex systems involved in neuron signaling.
• Assistant Professor Hongwu Zheng was the recipient of the Distinguished Scientist Award 
from the Sontag Foundation. He is investigating how brain tumors known as malignant gli-
oma emerge from normal neuronal cells and transform into metastatic tumors.
• Four CSHL postdoctoral neuroscientists won NARSAD Young Investigator Awards from the 
Brain and Behavior Research Foundation. This support is intended to facilitate the transition 
for young scientists to ultimately work in laboratories that they themselves direct. Three of 
the CSHL awardees are studying autism spectrum disorder: Guy Horev, Yongsoo Kim, and 
Keerthi Krishnan. Sandra Aherns is conducting research on schizophrenia.
• Cited for her postdoctoral work in genetics and genomics, Research Investigator Emily Hodges 
was named one of fi ve fi nalists in the annual Regional Blavatnik Award for Young Scientists.
• Postdoctoral Fellow Christine Iok In Chio was named a Damon Runyon Fellow in cancer 
research. As part of the Lustgarten Foundation Pancreatic Cancer Research Laboratory at 
CSHL, she is evaluating the biological role of oxidative stress in pancreatic cancer.
Double Helix Medal winners P. Neufeld, R. Roberts, and 
Barry Scheck with Bruce Stillman
001-026_Pres_High.indb   12 8/28/2014   10:34:59 AM
Highlights of the Year   13
New Faculty
Welcome to our new CSHL Fellow Lingbo Zhang, Ph.D., who earned his doctorate 
in 2013 in a joint program of Massachusetts Institute of Technology and the National 
University of Singapore. CSHL Fellows direct their own research programs under the 
guidance of a senior faculty member. They have their own laboratory space and techni-
cian, as well as access to all of the Laboratory’s core facilities. Fellowship appointments 
are for 3 years. Dr. Zhang is interested in understanding the self-renewal mechanism of 
stem and progenitor cells in the blood-forming system, work he hopes will lead to better 
treatments for a broad spectrum of unresponsive anemias associated with certain bone 
marrow failure disorders, myelodysplastic syndrome, and kidney disease. His work can 
also be applied to leukemic cells, a population of malignant cells whose self-renewal ma-
chinery has been hijacked.
Promotions
On January 1, 2013, Alex Gann began his appointment as Dean of the Watson School 
of Biological Sciences. Congratulations to Adam Kepecs, Bo Li, and Zachary Lippman, 
who were promoted to Associate Professor. Michael Ronemus was promoted to Research 
Assistant Professor.
Departures
Professor Lincoln Stein is now Program Director, Informatics and Biocomputing at the 
Ontario Institute for Cancer Research (OICR).
Education Programs
Banbury Center
In its 36th year, the Laboratory’s think tank for science and public policy known as the 
Banbury Center was an exceptionally busy place. A total of 23 meetings were held, invit-
ing more than 700 participants from 40 states and 20 countries. Approximately one-fi fth 
of the attendees were from overseas and about one-third were women.
One of the year’s highlights was a meeting called Redesigning Photosynthesis: Identifying 
Opportunities and Novel Ideas that brought plant biologists together to consider whether 
the effi ciency of solar energy capture by plants might be improved. A fi ne example of a 
meeting on an “emerging topic”—something for which Banbury is known—convened 
a distinguished group to discuss whether transposable genetic elements might be active 
during normal neurogenesis, the process by which new neurons are generated. Until now, 
“jumping genes” have been known for their role in causing pathology.
A 2010 WSBS graduate, Yaniv Erlich, now on the faculty of the Whitehead Insti-
tute, organized a Banbury meeting to discuss strategies for maintaining privacy of data 
gleaned from genomes and other bioscience data sets. Accelerate Genomic Research with 
Privacy Protections included participants across disciplines from science to cryptography 
to ethics.
The Banbury Center also hosted three Watson School of Biological Sciences (WSBS) 
courses and six courses conducted as part of the Laboratory’s Meetings & Courses Pro-
gram. The Center appreciates support from numerous corporate sponsors and underwrit-
ers who helped to make its rich offerings possible.
L. Zhang
A. Gann
Z. Lippman
M. Ronemus
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DNA Learning Center
This past year, some 20,960 students made fi eld trip visits to DNA Learning Center (DNALC) 
facilities in Cold Spring Harbor, Lake Success, and Harlem. An additional 10,200 students were 
reached through in-school instruction by DNALC staff. There were also 1640 in-school lab expo-
sures via mobile “Footlocker Kits” used by teachers in their own schools. These teachers previously 
received specialized DNALC training.
During the summer, 60 week-long biology and genetics summer camps were held in Cold 
Spring Harbor and eight other locations in New York, Massachusetts, and Connecticut, drawing 
a record 1240 students. Monthly Saturday DNA! sessions drew hundreds more children, parents, 
and grandparents.
At its main facility in Cold Spring Harbor, the DNALC this year updated museum space that 
currently features an exhibit on “Our Common Human Origins.” More than 100 classes per year 
take an instructor-guided tour of the museum, which is also open to the public.
In its second year, the Center’s innovative Urban Barcode Project (UBP) 
scored major successes, with teams of motivated NYC high school stu-
dents competing, many from ethnic groups underrepresented in science. 
Fifty-three teams comprising 144 students were accepted into the com-
petition and completed fi eld work, wet labs, and bioinformatics analyses 
with the support of their teachers and UBP staff at Open Labs at Harlem 
DNA Lab. Teams presented their results at symposia at the American Mu-
seum of Natural History, with the grand prize awarded to Hostos-Lincoln 
Academy of Science students Kavita Bhikhi and Hillary Ramirez, who investigated ant diversity 
in the Bronx.
The BioMedia team of the DNALC is award winning and trend setting. Their 3D Brain iPhone 
app, launched in 2009 and available on multiple platforms, has been downloaded more than 2.2 
million times, and it is used not only by teachers and students, as intended, but also by health 
professionals, patients, and the public. A 2013 iOS update provides current information about 29 
primary structures of the human brain.
This year, the BioMedia team introduced live streaming and webinar programs, broadcast 
from the DNALC’s Laurie J. Landeau Multimedia Studio. Altogether, approximately 4.9 million 
visits were recorded to the DNALC’s 22 websites in 2013. DNALC-produced YouTube videos 
drew more than 823,000 views, with apps downloaded 579,163 times. Total visitation therefore 
numbered a record 6.26 million.
Since 1995, more than a dozen programs worldwide have been modeled directly on the DNALC 
experience. These centers, across America and in Europe, Asia, and Australia, provide hands-on ex-
periments to more than 150,000 students annually. The DNALC is the largest provider of teacher 
training in molecular and genomic biology, and it is the only institution capable of offering high-
quality biochemical and bioinformatics instruction 
anywhere in the world. In the fall, a dedication cere-
mony marked the opening of the latest DNA Learn-
ing Center at Notre Dame University. The DNALC 
also continued to develop its relationship with Bei-
jing No. 166 High School in China.
Plans to develop a new full-service DNALC 
teaching facility in Manhattan received a jump 
start with the receipt of a $3 million start-up grant 
from the Alfred P. Sloan Foundation and a $10 mil-
lion endowment grant from the Thompson Family 
Foundation. These add to a lead endowment grant 
of $6 million from CSHL trustee Laurie J. Landeau.
URBAN BARCODEPROJECTNYC
DNA Learning Center dedication, Notre Dame University
001-026_Pres_High.indb   14 8/28/2014   10:35:01 AM
Highlights of the Year   15
Meetings & Courses Program
With its beginnings in the fi rst annual meeting, in 1933, of the Cold Spring Harbor Symposium 
on Quantitative Biology—a scientifi c conference series still going strong—the Meetings & Cours-
es program in the last year attracted more than 11,600 participants. This included upwards of 
7200 individuals who attended scientifi c meetings and more than 1300 
trainees, teaching, and support faculty who took part in courses. An addi-
tional 3000 scientists from the Asia/Pacifi c region attended 17 conferences 
and one summer school held by the Cold Spring Harbor Asia program in 
Suzhou, China.
A major feature of CSHL meetings is that there are very few invited 
speakers. Meeting organizers select talks from abstracts submitted in ad-
vance, ensuring that the latest fi ndings are presented and that young sci-
entists have a chance to describe their work. Several meetings are held an-
nually, including The Biology of Genomes and Retroviruses, but the majority 
of meetings convene every other year.
A total of 27 academic meetings were held in 2013. The 78th ses-
sion of the historic Symposium series addressed Immunity and Tolerance 
and attracted almost 400 participants. The year saw the introduction of 
several successful new meetings: Wiring the Brain, Metabolic Signaling 
and  Disease, and Behavior and Neurogenetics of Nonhuman Primates. Two 
special meetings, Genes & Diagnostics: A Myriad of Issues in Biotech IP 
and the History of Restriction Enzymes, drew rather different audiences of 
lawyers and historians, respectively.
The Courses program covers a diverse array of topics in molecular biology, neurobiology, struc-
tural studies, and bioinformatics. The primary aim is to teach professional scientists the latest ad-
vances that can be immediately applied to their own research. Increasingly, many courses feature 
a strong computational component as biology grows ever more interdisciplinary, incorporating 
methodologies from computer science, physics, and mathematics. Instructors, lecturers, and as-
sistants come from universities, medical schools, research institutes, and companies around the 
world to teach at CSHL.
Grants from a variety of sources support the courses, with core funding provided by the 
 Howard Hughes Medical Institute. The courses are further supported by awards from the 
National Institutes of Health and the National Science Foundation, private foundations, and other 
sources. Equipment and reagents are loaned or donated by companies, ensuring that the courses 
offer training in the latest technologies.
Cold Spring Harbor Laboratory Press
CSHL Press published a single volume in 1933, based on the Laboratory’s fi rst Symposium on 
Quantitative Biology. Since then, the Press has developed a program consisting of seven successful 
journals, 190 books, and two online services. It is now a digital publisher with a capacity for print 
production on demand, and in recent years, its staffi ng, skills, and organizational structure have 
been reshaped to this end.
In the United States and Europe, budgetary restrictions continued to squeeze research depart-
ments and the academic libraries that are the most important purchasers of scientifi c information. 
The Press weathered these pressures by maintaining fi rst-class editorial standards and fi nding 
fresh ways of promoting its publications to scientists and their institutions worldwide. Examples 
include three review journals launched in the past 6 years and growth of subscriptions in emerging 
scientifi c communities abroad.
Widely cited impact-factor measurements place two Press journals, Genes & Development and 
Genome Research, in the top 1% of the 8000 journals in the Science Citation Index. Online usage of 
78th CSH Symposium
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these and their sibling journals continues to climb, exceeding 12 million full-text article downloads 
in 2013, an increase of 25%. Cold Spring Harbor Protocols and Learning & Memory continued to gain 
ground. Cold Spring Harbor Perspectives in Biology had particularly sharp growth, a vote of approval 
for its fresh approach of melding journal and book publishing. Testament to its editorial quality was 
the award of the Nobel Prize in 2013 to three scientists (Drs. Thomas Südhof, Randy Schekman, 
and James Rothman) who have edited recent Perspectives titles.
The Press published 18 new book titles in 2013. Several 
were new editions of past best-sellers, including Antibodies: A 
Laboratory Manual and Lab Math: A Handbook of Measure-
ments, Calculations, and Other Quantitative Skills for Use at 
the Bench. Eleven books were generated from the two online 
Perspectives review journals.
In November, bioRχiv, a new preprint service for the life 
sciences, was launched to permit distribution of scientifi c 
manuscripts not yet published in peer-reviewed journals. This 
enables researchers to establish priority for their work and to 
benefi t from critiques offered by readers as manuscripts are 
honed for conventional publication in a peer-reviewed journal. 
bioRχiv provides an exciting platform on which to build other 
valuable services in future.
Watson School of Biological Sciences
Under the leadership of its new Dean, Dr. Alexander Gann, the Laboratory’s Ph.D.-granting 
program welcomed its 15th incoming class and graduated its 10th. Eight WSBS students were 
awarded Ph.D. degrees, bringing the total since the school’s inception to 66.
Honorary degrees were conferred upon Jack E. Dixon, Ph.D., Howard Hughes Medical Insti-
tute Vice President and Chief Scientifi c Offi cer and Professor at the University of California, San 
Diego; and Brigid L.M. Hogan, Ph.D., F.R.S., Professor and Chair of the Department of Cell 
Biology at Duke University.
bioRχiv.org website
2013 WSBS graduates and honorary degree recipients
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The 19th Annual Gavin Borden Visiting Fellow Lecture, reception, and dinner were held 
on October 28. Sean Carroll, Ph.D., delivered the lecture, titled “Brave Genius: A Scientist’s Jour-
ney from the French Resistance to the Nobel Prize.” Dr. Carroll leads the Department of Science 
Education of the Howard Hughes Medical Institute, the largest private supporter of science edu-
cation activities in the United States, and is the Allan Wilson Professor of Molecular Biology and 
Genetics at the University of Wisconsin.
In August, the WSBS welcomed 10 new students. Members of the Class of 2013 were selected 
from among 274 applicants and represent the United States, Bulgaria, India, Israel, Italy, and 
Mexico. Other new graduate students entered as visitors from other institutions, including seven 
from Long Island’s Stony Brook University; other current visitors hail from more distant institu-
tions, including several in Germany, France, and Spain.
The achievements of the graduate program continued to grow. Scientifi c papers published by 
students appeared in major journals, bringing the cumulative total of WSBS student publications 
to more than 230. Current and former students won prestigious and highly competitive scholar-
ships and fellowships. Watson School students continued to graduate considerably faster than 
students at comparable institutions and demonstrated an ability to secure excellent jobs. Fifteen 
WSBS graduates have thus far secured tenure-track faculty positions.
From June through August, 25 undergraduates 
from across the United States, as well as from Can-
ada, China, France, India, Nepal, and the United 
Kingdom, arrived at CSHL to take part in the 
historic Undergraduate Research Program. These 
“URPs” (chosen from among 738 applicants!) had 
the remarkable opportunity to perform advanced 
research in the laboratory of a CSHL faculty mem-
ber. This immersive experience reaped intellectual 
as well as social rewards for the lucky participants, 
as in past years. The URP Program, along with 
the equally innovative and competitive Partners 
for the Future Program, which brings gifted local 
high school students to CSHL labs for hands-on 
research experience, is managed by the Watson 
School.
Library & Archives
The Institutional Repository is a new on-line resource for 
publications from CSHL researchers. The repository was ini-
tiated this year, with the goal of providing the public with 
direct access to CSHL discoveries throughout its history. 
Through this repository, anyone can access these scholarly 
materials. As an initiative of the Genentech Center for the 
History of Molecular Biology and Biotechnology at CSHL, 
Robert Wargas and Mila Pollock examined the history of 
CSHL’s initial involvement in the Biotechnology revolution 
during the late 1970s/early 1980s, as well as the Lab’s con-
tinuing relationship with the Biotechnology industry.
The Library hosted The History of Restriction Enzymes 
 October 19–21, 2013. Attended by more than 150 scientists, 
history scholars, authors, educators, and students, this was 
Members of the 54th Undergraduate Research Program
Institutional Repository for CSHL authors
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the fi fth meeting in the Genentech Center series on the history of science. Herb Boyer, Stu Linn, 
and Rich Roberts, pioneers in the fi eld of restriction enzymes, were co-organizers, bringing to-
gether scientists involved in the discoveries and research on restriction enzymes dating back to the 
1950s and covering developments to the present time.
The Archives participated in several events, displaying elements from various CSHL col-
lections:
• Alfred Day Hershey Collection. Materials from the Alfred Day Hershey Collection were dis-
played at the Scottish Parliament in an exhibit about the philanthropic legacy of Andrew 
Carnegie, on display from 14 October 2013 until 25 January 2014.
• Extraordinary Women in Science & Medicine. A landmark public exhibition, Extraordinary 
Women in Science & Medicine: Four Centuries of Achievement, held at the prestigious Grolier 
Club in New York City from September 19 to November 13, 2013, showed materials from the 
Barbara McClintock Collection, including photos, landmark papers, and a corn cob from the 
1960s loaned by CSHL Professor Rob Martienssen.
• From Base Pair to Body Plan: Celebrating 60 years of DNA. A display of more than 200 
images related to the Laboratory’s history and its science was a central part of the meeting 
From Base Pair to Body Plan: Celebrating 60 Years of DNA, held at CSHL from February 28 to 
March 3, 2013. This display stayed on exhibit for the entire 2013 meetings season.
CSHL completed the digitization of the archives of James D. Watson and Sydney Brenner, 
as part of the Wellcome Digital Library Pilot Project “Codebreakers: Makers of Modern 
 Genetics.” The result of this multiyear collaborative effort with Churchill Archives  Center 
Cambridge, the University of Glasgow, King’s College London, and University College  London 
is free public access to these and other historic collections from an online portal at www
.wellcomelibrary.org.
Infrastructure
Woodbury Genome Center Addition
The year 2013 saw the groundbreaking of a 7000-square-foot addition to the Woodbury Genome 
Center. This expansion of the Genome Center Animal Facility—the Preclinical Experimental 
Therapeutics Facility—will serve as a vital core facility 
supporting the Laboratory’s Cancer Therapeutics Initia-
tive. The facility will house a number of cancer diagnostic 
and therapeutic resources. Construction is expected to be 
completed by the end of 2014.
Cairns Laboratory Renovation
The Cairns Laboratory was reconstructed during 2013. 
The building was originally used as a sheep shed in the 
early 20th century and was most recently used as a mi-
croscopy laboratory. The completion of the new Hershey 
Building allowed for relocation of microscopy resources 
and renovation of the Cairns Laboratory. The roof was 
raised to make way for improved ventilation systems and 
the building’s infrastructure was brought up to modern 
laboratory standards. The building will be ready for occu-
pancy in 2014 and will house an RNAi Shared Research 
Resource facility.
Woodbury Genome Center addition (proposed)
Renovated Cairns building
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Yellow House Reconstruction: Historic Perspective
The Yellow House was a circa 1830 residence in considerable disrepair. The house had signifi cant 
foundation and structural issues and had suffered a number of unsympathetic renovations and 
additions during its lifetime. Deemed uninhabitable, it was demolished and replaced with a new 
structure.
The Laboratory spent nearly a year working with the State Historic Preservation Offi cer to 
obtain permission to demolish and replace the house. Prior to demolition, the Laboratory photo-
graphed and documented the entire house, and the records were entered into the Laboratory and 
New York State archives. A new Yellow House will be used for faculty housing and be ready for 
occupancy in the spring of 2014.
Syosset Campus
The Laboratory expanded the use of the Syosset Campus in 2013 with the relocation of the 
 Accounting Department from the Nichols Building and the Procurement Department from the 
Woodbury Genome Center to new offi ces on the Syosset Campus.
Information Technology
Completed this year was a campus-wide WiFi upgrade that included replacement of aging infra-
structure to provide better coverage and speed and greatly improved handling of our high-density 
venues, notably the Grace auditorium. This project will continue in 2014, providing a further 
substantial increase in bandwidth.
Information is at the core of our scientifi c activities. Our ability to collect, manage, and safe-
guard large volumes of data is critical. Centrally managed CSHL data storage, currently in excess 
of 3 petabytes, is expected to grow signifi cantly over the coming years. Enterprise-grade data 
storage of this scale is tremendously expensive to procure and maintain, and the adoption of a fi -
nancially sustainable data-handling model is essential. To mitigate escalating storage costs, CSHL 
adopted a new solution, and we are now well positioned to handle current and emerging data stor-
age needs. With the latest expansion, the CSHL system already has a 900-TB disk capacity that 
can scale up to 21 petabytes.
Additional upgrades were performed to the core and data center distribution layer network 
for the Hillside and Grace datacenters. Hardware selection was completed, and vendor selection 
began. To lower maintenance costs and retire aging hardware, we have increased our use of virtual 
servers.
Employees at new Syosset Campus
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Community Outreach
CSHL Public Lectures
February 13–Dr. Richard E. Leakey, Professor, Chair, Turkana Basin Institute; Stony Brook 
 University, Department of Anthropology. Hominid Evolution: How It Has Shaped Human 
 Behavior, Ethics, and Morality. 2012 Lorraine Grace lectureship on societal issues of biomedical 
research (rescheduled from 2012 due to Hurricane Sandy).
June 8–Paul A. Offi t, M.D., Chief, Section of Infectious Diseases and Direc-
tor, Vaccine Education Center at Children’s Hospital of Philadelphia; Maurice 
R. Hilleman Professor of Vaccinology, Professor of Pediatrics at University of 
Pennsylvania School of Medicine. Alternative Medicine: Sense and Nonsense. 
2013 Lorraine Grace lectureship on societal issues of biomedical research.
June 25–Josh Dubnau, Ph.D., CSHL Associate Professor; Peter Davies, Ph.D., Head and 
 Scientifi c Director, Litwin-Zucker Research Center for the Study of Alzheimer’s Disease and 
Memory Disorders, Feinstein Institute for Medical Research; Jill Goldman, M.S., M.Phil., 
 Certifi ed Genetic Counselor, The Center for Parkinson’s Disease and Other Movement 
 Disorders, Columbia University Medical Center. Untangling Dementia–Latest Research and 
Treatments, cosponsored by CSHL; U.S. Trust–Bank of America; North Shore–LIJ; and St. 
Johnland Nursing Center.
July 16–Zachary Lippman, Ph.D., CSHL Associate Professor. Flower Power and the DNA of 
 Feeding the World, hosted by The Secret Science Club, Brooklyn, New York.
July 17–Kevin J. Mitchell, Ph.D., Associate Professor of Neurogenetics, Trinity College Dublin, 
Ireland. The Miswired Brain—How Altered Brain Development Leads to Mental Disorders.
August 20–Anne Churchland, Ph.D., CSHL Assistant Professor; Swinging synapses and decision 
making, hosted by The Secret Science Club, Brooklyn, NY.
October 7–Rob Martienssen, Ph.D., CSHL Professor. Oil Palm and the Rainforest: Genome 
 Sequencing for Sustainability. Public lecture, Grace Auditorium.
CSHL Public Concerts
April 19: Ching-Yun Hu, Piano
April 26: Ying Fang with Ken Noda, Soprano with piano
May 3: DZ4 with David Kaplan, Woodwind quartet with piano
May 17: Hye-Jim Kim, Violin (w/piano)
August 23: Southampton Festival Chamber Orchestra
Sept 12: Andrew Tyson, Piano
October 4: Paul Huang, Violin (w/piano)
October 11: Mikhail Yanovitsky and Galina Sakhnovskaya, Piano and soprano
With help from enthusiastic graduate students and postdoctoral fellows who staff CSHL’s 
public tour program, we conducted 50 campus walking tours throughout the year serving more 
than 800 visitors. Our guests came from near and wide, including Germany, Italy, and China.
On March 23, more than 400 neighbors came to the main campus for an Open House. 
Visitors, including many who had never been to CSHL before, plainly enjoyed learning about 
the spectrum of CSHL research and education programs, as well as ways in which they can be 
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Open House 2013 (Top left, right, and bottom left) J. Ipsarro giving a short science talk
involved, as students, friends, and neighbors. During a continuously running series of 5-Minute 
Science Talks, CSHL postdoctoral researchers engaged audiences throughout the afternoon on 
topics from “Why haven’t we cured cancer?” to “Molecular photography.” Videos of these talks 
are available on YouTube. Free minitours of the campus led by graduate students and Lab postdocs 
were extremely popular. Kids and adults alike crammed a booth where DNA Learning Center 
teachers led hands-on biology demonstrations, featuring DNA extraction.
Local families enjoyed the DNA Day Scavenger Hunt while exploring the history of Cold 
Spring Harbor Village on April 20. Local institutions including the Cold Spring Harbor Library, 
the Cold Spring Harbor Whaling Museum, the Firehouse Museum, and CSHL’s DNA Learning 
Center took part. DNA Day is celebrated across the country, with educational events sponsored 
by the National Human Genome Research Institute (NHGRI), a part of the National Institutes 
of Health. The day commemorates the completion of the Human Genome Project in April 2003 
and the discovery of DNA’s double helix.
In April, fi rst graders from Goosehill Primary and Friends Academy participated in a science 
fair. At six stations, they learned about various scientifi c principles (from chromatography to cell 
structure to brain anatomy) through hands-on activities and instruction conceived, planned, and 
led by graduate students and DNALC instructors; 160 students, 14 teachers, and 120 parents 
participated during the 2 days.
DNALC’s Jason Williams led a team of CSHL graduate student and postdoc ambassadors in 
two iPad app demonstrations at the June 2nd World Science Festival Street Fair in Manhattan’s 
Washington Square Park. CSHL’s ambassadors interacted with Festival participants, demonstrat-
ing how to use the DNALC-developed apps, 3D Brain, and Gene Screen.
CSHL was pleased to participate in the 10th Long Island 2-Day Walk to Fight Breast Cancer, 
in which nearly 400 walkers and an equal number of volunteers raised more than $550,000. Since 
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the Walk started in 2004, CSHL has received more than a quarter of a million dollars for breast 
cancer research from LI2DAY.
This year, CSHL Associate Professor Raffaella Sordella joined in the Swim Across America (SAA) 
“Sound to the Cove Swim” at Morgan Park in Glen Cove. Dr. Sordella received $70,000 from SAA 
for her research aimed at fi nding ways to overcome resistance to targeted therapies for non-small-cell 
lung cancer. Dr. Sordella credited the support she has received from SAA—$420,000 to date—with 
providing critical resources to identify a population of cells in lung tumors that are intrinsically 
resistant to therapy.
CSHL Chief Operating Offi cer Dill Ayres participated in the October 24 Long Island Press 
“The Future of Healthcare on Long Island” summit that brought research institutions, health care 
providers, and vendors together to highlight the region’s assets and challenges.
A member of the New York Academy of Sciences (NYAS), CSHL was pleased to contribute 
to an effort to showcase New York’s research community. The initiative included the landmark 
publication of “New York: A Science State of Mind” and a November 18th gala in Manhattan.
CSHL teamed with Research!America, the Society of Neuroscience, Elsevier, and George Wash-
ington University to organize the “Research Matters Communications Workshop” for early-career 
scientists in Washington, D.C. on October 9. The event included a plenary session led by the Alan 
Alda Center for Communicating Science at Stony Brook University, a panel discussion that included 
journalists from CNN, Reuters, and NPR, and a session with current and former congressional 
staff. CSHL Assistant Professors Mikala Egeblad, Alex Krasnitz, 
and Steve Shea participated as part of the Public Affairs Depart-
ment’s program to help researchers enhance communication with 
nonscientifi c audiences.
Looking Forward
2013 marked the anniversaries of two game-changing events for 
this institution and the world. Sixty years ago, James D.  Watson 
and Francis Crick co-discovered the double helix structure of 
DNA and set off a revolution in biology and medicine. Forty-
fi ve years ago, Jim and his wife Liz came to Cold Spring Harbor 
Laboratory, a time when total staff numbered only 100 and the 
total operating budget was barely $3 million. With their foresight 
and leadership what in 1968 was a fl edgling research institution 
became the modern day powerhouse in molecular biology and 
genetics that is today’s Cold Spring Harbor Laboratory.
Long Island 2-Day Walk R. Sordella (center right) participated in Swim Across America (SAA)
Jim and Liz Watson
001-026_Pres_High.indb   22 8/28/2014   10:35:08 AM
Highlights of the Year   23
“Now we are completely different,” wrote Jim, looking back on what he had accomplished since 
taking on the challenge of leading CSHL in 1968. “The science we do, the demanding excellence 
of our courses and meetings, and the high quality of our publishing program convey to the world 
outside the aura of a quality postgraduate university. We worry not about becoming good, but 
instead on how to ensure that we continue to carry out science at the highest possible level” (1977 
CSHL Annual Report). We thank Jim and Liz for their continuing dedication to the Laboratory 
and its continued success. The CSHL family of faculty, students, and employees feted Jim and Liz 
at a special 1960s-themed picnic on Blackford lawn in summer 2013.
To mark the anniversary of Jim and Francis Crick’s DNA discovery and the fact that Jim was 
invited to CSHL to present the paper for the fi rst time in public at the 1953 Qualitative Biology 
symposium on viruses, the Meetings & Courses Program organized a special 4-day meeting that 
began on the discovery’s anniversary day of February 28. This meeting was called “From Base Pair 
to Body Plan” and was organized by Dean Alex Gann, Professor Rob Martienssen, and Meetings 
& Courses Program Executive Director David Stewart, with guest speakers including Nobel Prize 
winners Christiane Nüsslein-Volhard, Elizabeth Blackburn, Carol Greider, Craig Mello, and Sir 
John Gurdon. Celebration of the anniversary included the redecoration of the CSHL bar to look 
like the famous Cambridge pub, the Eagle, and a gala at Oheka Castle.
Jim and Liz inspired a culture that opened the doors of this institution to participation from 
the local community and beyond—bringing the intellectual expertise and fi nancial generosity of 
private philanthropists who have been invaluable to the evolution of CSHL.
The last 60 years at Cold Spring Harbor have yielded great advances in biology. CSHL is now 
poised for even bigger breakthroughs that will undoubtedly change the world for the better.
Bruce Stillman, Ph.D., F.R.S.
President and Chief Executive Ofﬁ cer
Dr. James Watson
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CHIEF OPERATING OFFICER’S REPORT
As Cold Spring Harbor Laboratory’s lead administrator, my overriding objective 
for the past 15 years has been consistent: to create the structure that a rapidly 
growing enterprise requires to operate effi ciently and deal with increasing regula-
tion, without compromising a uniquely productive academic culture. Although 
not listed on the balance sheet, the Laboratory’s culture is its most valuable asset.
In 1968, Jim Watson began establishing a culture at Cold Spring Harbor 
Laboratory carefully designed to foster collaboration, intensity, entrepreneu-
rism, risk-taking, productivity, and, above all, excellence. In other words, an 
environment ideally suited to doing great science. This culture endures. It has 
been carried forward by Bruce Stillman and is sustained by many “culture car-
riers” here, be they facilities personnel, educators, or elite research investigators. 
We understand what makes the institution special and we work hard to pre-
serve it. This work is not without challenges that sometimes shift unpredictably. 
Initially, my objective was to preserve culture in an environment characterized 
by extraordinary growth—the doubling of the National Institutes of Health (NIH) budget and 
substantial expansion of infrastructure and scientifi c staff here at the Laboratory. Now we face the 
opposite challenge—adjusting to a dramatic decline in federal funding that threatens America’s 
superiority in basic science and biomedical research.
Administratively, we must make diffi cult decisions in response. Aggressive expense manage-
ment has become a constant. Annual cost-of-living increases are no longer a given. For the fi rst 
time, the decision was made to cut back on nonresearch positions at the Laboratory. This causes 
human hardship and puts more pressure on our dedicated staff. Culture preservation becomes an 
issue of maintaining morale and optimism in an increasingly diffi cult environment—a very dif-
ferent kind of managerial challenge.
Fortunately, we are benefi ting from healthy growth in our endowment funds. This results from 
three factors: strong appreciation in public equities since the fi nancial crisis in 2008, a revised in-
vestment strategy implemented by the Laboratory’s Investment Committee during the last several 
years, and generous philanthropic donations to endowment. Return on investment for the 2013 
calendar year was +16.5%, placing us in the upper performance tier of university endowments. 
Year-end market value was $385 million, another all-time high for the Laboratory. In addition, 
we are fortunate to have booked another $80 million in endowment pledges receivable to date 
through fund-raising. The importance to the future of the institution of increasing endowment 
cannot be overstated and remains atop our list of priorities.
Our research and education programs remain strong. We continue to attract the very best fac-
ulty, postdocs, and students. These strengths manifest in higher than average success rates with 
federal grant awards. This, combined with substantial private support and a growing endowment, 
allows the academic programs to move forward unencumbered. We are more excited than ever 
about the quality and progress of our work and its promise for human health.
Our community is a cohesive one. We work hard to maintain the culture that has and contin-
ues to make Cold Spring Harbor Laboratory so productive, and we do so now in the face of some 
daunting challenges. We are fond of saying that “science never sleeps.”
W. Dillaway Ayres, Jr.
Chief Operating Ofﬁ cer
W. Dillaway Ayres, Jr.
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Long-Term Service
The following employees celebrated milestone anniversaries in 2013:
45 years James Watson
35 years Patricia Maroney, Christopher McEvoy, Michael Wigler
30 years Margaret Falkowski, Daniel Jusino
25 years  Maryliz Dickerson, Grigori Enikolopov, Ronnie Packer, Francis Bowdren, Margot 
Bennett, Salvador Henriquez, Margaret Stellabotte, Jeffrey Goldblum, Arne Stenlund
20 years David Stewart, Wayne Pav, Deborah Aufi ero, Patricia Brady
15 years  Paul Edwards, Jesus Magana, Louis Hunter, Amanda McBrien, Michael Riggs, Drew 
Comer, Jeffrey Klaverweiden, Sabrina Boettcher, Thomas McIlvaine, W. Dillaway 
Ayres, Marja Timmermans, Ming Wang, Lari Russo, Susana Roman, Lifang Zhang
Front row (left to right) Maryliz Dickerson, Margaret Falkowski, Ronnie Packer. Second row (left to right) Patricia Maroney, Grigori 
Enikolopov, Christopher McEvoy, Margot Bennett. Third row (left to right) Michael Wigler, Francis Bowdren, Arne Stenlund, James 
Watson. Fourth row (left to right) Salvadore Henriquez, Bruce Stillman, David Spector, Daniel Jusino.
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CANCER: GENE REGULATION AND 
CELL PROLIFERATION
Christopher Hammell’s lab is interested in understanding gene regulatory processes that give rise 
to robust phenotypes associated with normal development in animals (specifi cally, how the tim-
ing of developmental processes is controlled) as well as the alterations in these pathways that 
give rise to diseases such as cancer (as in the alterations in mitogenic pathways in melanoma). 
 Hammell and colleagues approach this elemental problem by using a variety of model organisms 
and patient-derived cancer cell lines. To directly identify the components that function in control-
ling normal developmental timing, they use the small nematode Caenorhabditis elegans, applying 
forward and reverse genetic approaches. In contrast to the extreme robustness of cell-fate lineage 
in C. elegans, in which specifi cation of developmental programs is hard-wired, mutations that 
alter conserved signaling pathways in melanoma create relatively plastic developmental landscapes 
that allow these lesions to become aggressive tumors. Notably, the gene regulatory architecture of 
melanoma cells allows them to acquire resistance to therapeutic agents. Hammell’s team is inter-
ested in epigenetic mechanisms that contribute to resistance, specifi cally dramatic changes in gene 
expression patterns and intracellular signaling pathways. They are performing high-throughput 
screens to identify cellular factors that allow these re-wiring events to occur, with the idea that 
these components would make ideal therapeutic targets to complement existing clinical strategies.
Many of the best cancer drugs are highly toxic chemotherapeutics that kill normal and malignant 
cells alike. In contrast, targeted compounds that recognize cancer-specifi c pathways represent a 
kind of silver bullet that would be able to distinguish tumor cells from their healthy counterparts. 
A few targeted drugs have been identifi ed, such as the BRAF inhibitor vemurafenib for melanoma, 
and initially these agents were highly promising. But patients rapidly relapsed as their cancers 
became resistant to treatment.
Molly Hammell is working to tackle this problem, known as “acquired resistance,” in melanoma. 
Her lab, in collaboration with the Wistar Institute, combines the power of systems-level, high-
throughput data analysis with patient-derived tumor samples. Hammell has developed computa-
tional algorithms for the integration of multiple types of high-throughput sequencing data into 
gene regulatory circuits. She is now applying these methods to explore the global changes in gene 
regulation that enable melanoma cells to bypass inhibitors of the BRAF signaling pathway, in-
cluding DNA mutations and epigenetic modifi cations. Her work will identify the most clinically 
relevant pathways of interest for additional therapeutic approaches to inhibit tumor growth in 
melanoma. In addition to her work on melanoma, Hammell is using her expertise in bioinformatics 
in collaboration with other members of the CSHL community (including Marja Timmermans, 
Josh Dubnau, and Greg Hannon) to understand gene regulation in diverse systems, from maize to 
Drosophila.
In Leemor Joshua-Tor’s lab, researchers study the molecular basis of nucleic acid regulatory pro-
cesses using the tools of structural biology and biochemistry. One such regulatory process is RNA 
interference (RNAi), in which a small double-stranded RNA triggers gene silencing. Joshua-
Tor and her team offered critical insight when they solved the crystal structure of the Argonaute 
protein and identifi ed it as the long-sought Slicer. They then went on to explore the mechanism of 
the slicing event. The structure of human Argonaute 2 (hAgo2) bound to a microRNA (miRNA) 
guide allowed Joshua-Tor and her colleagues to understand how mRNA is cleaved during RNAi. 
This year, members of the Joshua-Tor lab explored the function of a very similar protein, called 
Argonaute 1, that has no slicing ability, even though it is almost identical in structure to the slicing 
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hAgo2. Using biochemical methods and mutational analysis, they were able to identify key parts 
of the protein that are required for slicing activity. The lab also studies the generation of PIWI-
interacting RNAs (piRNAs), which serve to protect the genome of germ cells. With colleagues in 
the Hannon lab, Joshua-Tor’s team also determined the structure and function of Zucchini, a key 
nuclease in the initial generation of piRNAs in fruit fl ies. In other work, the lab is exploring the 
mechanisms of heterochromatin formation and gene silencing through the study of a protein com-
plex called RNA-induced initiation of transcriptional gene silencing (RITS). Joshua-Tor is also 
well known for her work on the E1 helicase enzyme, which acts to unwind DNA strands during 
the DNA replication process.
Adrian Krainer’s lab studies the mechanisms of RNA splicing, ways in which they go awry in 
disease, and the means by which faulty splicing can be corrected. In particular, they study splic-
ing in spinal muscular atrophy (SMA), a neuromuscular disease that is the leading genetic cause 
of death in infants. In SMA, a gene called SMN2 is spliced incorrectly, making it only partially 
functional. The Krainer lab is able to correct this defect using a potentially powerful therapeutic 
approach. It is possible to stimulate protein production by altering mRNA splicing through the 
introduction of chemically modifi ed pieces of RNA called antisense oligonucleotides (ASOs) into 
the spinal cords of mice. Previously, using ASOs in mice carrying a transgene of human SMN2, 
they developed a model for SMA using a technique they called TSUNAMI (shorthand for  targeting 
splicing using negative ASOs to model illness). This year, they used the method to develop a 
mouse model for adult onset SMA, and they are currently working to develop models for the study 
of other diseases caused by splicing defects, including familial dysautonomia. The Krainer lab 
has also worked to shed light on the role of splicing proteins in cancer. They have found that the 
splicing factor SRSF1 functions as an oncogene stimulating the proliferation of immortal cells. This 
year, they were surprised to fi nd that SRSF1 can actually stop cell growth by stabilizing a  powerful 
tumor suppressor protein, called p53—suggesting that the cell is responding to the aberrant 
SRSF1 activity. This discovery offers insight into how tumors arise and the pathways that lead to 
transformation.
David L. Spector’s laboratory studies the spatial organization and regulation of gene expression. 
Their recent studies demonstrated an increase in random monoallelic gene expression upon the 
differentiation of mouse embryonic stem cells (mESCs) to neural progenitor cells (NPCs). These 
data support a model where stochastic gene regulation during differentiation results in monoallelic 
gene expression, and for some genes, the cell is able to compensate transcriptionally to maintain 
the required transcriptional output of these genes. Therefore, random monoallelic gene expres-
sion exemplifi es the stochastic and plastic nature of gene expression in single cells. In addition, 
the Spector lab is characterizing long nuclear retained noncoding RNAs (lncRNAs) that exhibit 
altered levels of expression as mESCs transition from the pluripotent state to NPCs, and they are 
studying lncRNAs that are misregulated in cancer. Their efforts have focused on Malat1 lncRNA, 
which is one of the most abundant noncoding RNAs. The Spector lab previously identifi ed a novel 
mechanism of 3′-end processing of this RNA. Current studies have revealed that altered levels of 
Malat1 lncRNA impact breast cancer initiation and progression. Studies are currently under way 
to elucidate the mechanism of action of this abundant nuclear retained lncRNA.
Arne Stenlund and colleagues have obtained a detailed understanding of processes required for 
initiation of DNA replication from the papillomavirus, using this system to gain a general bio-
chemical understanding applicable in other systems. Papillomaviruses are a large viral family that 
induces cell proliferation at the site of infection, usually giving rise to benign tumors. But cer-
tain types of human papillomaviruses (HPVs) generate tumors that progress toward malignancy. 
Among these are HPVs that cause most cervical cancers. Members of the Stenlund lab also pursue 
studies aimed at developing an effective small-molecule inhibitor of HPVs that might someday be 
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used by women who do not receive the preventive anti-HPV vaccine now available or those already 
infected with HPV who would not be helped by the vaccine.
Bruce Stillman’s lab studies the process by which DNA is copied within cells before they divide 
in two. Working with yeast and human cells, Stillman and colleagues have identifi ed many of the 
 cellular proteins that function at the DNA replication fork during the S phase, the portion of the 
cell-division cycle when DNA synthesis occurs. Among these proteins are those that facilitate 
the assembly of chromatin, the protein–DNA complexes that form the chromosomes. The prime 
focus of current research, however, is the mechanism that initiates the entire process of DNA rep-
lication in eukaryotic cells. At the heart of this mechanism is a protein that binds to “start” sites 
on the chromosomes, called the origin recognition complex, ORC. This year, the Stillman lab 
was part of a collaboration that determined the cryo-EM structure of ORC proteins in complex 
with a group of proteins, called a helicase, that unwind DNA during replication. This image offers 
molecular insight into how the helicase is loaded onto DNA. Stillman’s research also focuses on 
the process by which duplicated chromosomes are segregated during mitosis. The team has found 
ORC at centrosomes and centromeres, structures that orchestrate chromosome separation during 
mitosis. Stillman’s team has discovered that mutations in the largest protein found in this com-
plex, Orc1, alter the ability of ORC to regulate both DNA replication and centrosome duplication. 
These mutations have been linked to Meier–Gorlin syndrome, a condition that results in extreme 
dwarfi sm, small brain size, and related characteristics of abnormal growth.
Acute myeloid leukemia (AML) is a particularly devastating and aggressive blood cancer that is 
currently incurable in 70% of patients. Research in Chris Vakoc’s lab seeks to understand this dis-
ease as well as others, such as lymphoid leukemias and epithelial tumors, by studying them at the 
level of genomic regulation. He is particularly interested in the proteins that regulate chromatin in 
the nucleus of the cell. To identify proteins involved in AML, which may also be targets for drug 
therapy, he deploys large-scale genetic screens using RNA interference (RNAi) as well as geneti-
cally engineered mouse models that display the hallmarks of human cancer. In collaboration with 
Jay Bradner at the Dana-Farber Cancer Institute, Vakoc has shown that the small-molecule drug 
candidate JQ1 has potent anti-AML activity. It works by suppressing the protein Brd4, which is 
a critical regulator of the potent oncogene c-Myc. JQ1 is currently in clinical trials as a therapeu-
tic strategy for AML. Vakoc’s team identifi ed other chromatin regulators, including PRC2 and 
RNF20, that if blocked with small-molecule inhibitors may halt AML. This year, Vakoc’s lab 
gained new insights into the mechanism behind these drug targets when he found that Brd4 and 
other proteins required for AML bind to enhancers, short stretches of DNA more than a mil-
lion bases away from the oncogene c-Myc. When Brd4 binds to the enhancer, it bends the DNA 
within the nucleus so that it touches the c-Myc region of the genome and activates it, causing cells 
to proliferate without restraint. Understanding how these proteins function in AML will allow 
researchers to design more effective and safer therapies to treat this intractable cancer.
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THE COUPLING OF TEMPORAL GENE EXPRESSION AND 
DEVELOPMENTAL CELL-FATE SPECIFICATION
C.M. Hammell C. Aguirre-Chen K. Doerfel
 C. Carlston R. Perales
The overarching goal of our laboratory is to under-
stand how the precise timing of gene expression is 
coordinated throughout development. We are ap-
proaching this problem by using forward genetics 
and the model organism Caenorhabditis elegans. One 
of the main advantages of using this model is that 
these tiny worms have an invariant cell lineage that, 
in wild-type animals, results in the exact production 
of 959 somatic cells. Even more surprising is the fact 
that each of the cell divisions that give rise to the vari-
ous tissues and organs of an adult animal occurs with 
incredible precision and at defi ned times. This sug-
gests that the timing of development events is also 
hardwired and that the proper timing of gene expres-
sion contributes to an organism’s fi tness. We are ex-
ploiting the experimental tractability of this system 
to identify the genes that orchestrate the temporal 
aspects of development.
After embryogenesis, C. elegans larvae hatch from 
their eggs, begin foraging for food, grow in size, and 
develop in a stereotyped fashion. This period of de-
velopment, called the juvenile or larval period, is 
characterized by dramatic organismal growth and the 
production of a variety of new organs that are used 
in adulthood. Larval development is divided into four 
stages that are punctuated by molts. Molting is an es-
sential process, and its importance in coordinating the 
additional cellular aspects of development is under-
scored by the numerous cell divisions that are coupled 
to this process. Importantly, distinct patterns of cell 
division are executed at specifi c stages, and these tem-
poral patterns of cell-fate specifi cation are essential for 
normal morphogenesis and behavior.
Pioneering work from the Ambros and Ruvkun 
laboratories identifi ed a conserved set of genes, called 
heterochronic genes, that are required for establishing 
the normal sequence of stage-specifi c cell-fate deci-
sions. Mutations in heterochronic genes result in tem-
poral cell-fate transformations that include either an 
inappropriate skipping or reiteration of stage-specifi c 
patterns of cell divisions. Many heterochronic genes 
encode transcription factors and RNA-binding pro-
teins that turn on or turn off gene expression patterns 
in a stage-specifi c manner. Several protein-coding 
genes, such as lin-14, lin-28, hbl-1, and lin-41, are 
important for controlling temporal patterning and 
are regulated by microRNAs (miRNAs). In this con-
text, miRNAs are expressed and operate at defi ned 
times during postembryonic development and func-
tion as molecular switches to curtail earlier patterns 
of development and promote the emergence of later 
gene expression profi les (Fig. 1). Throughout post-
embryonic development, the expression of individual 
hetero chronic miRNAs is regulated at both the tran-
scriptional and posttranscriptional levels. Although 
the detailed study of the regulatory requirements of 
individual miRNAs has produced a wealth of infor-
mation, it is not known whether a higher level of orga-
nization coordinates the precise temporal expression 
of all heterochronic genes.
The stringent requirement of normal temporal 
patterning for the precise control of miRNA activity 
Figure 1. (A) The genes regulating the heterochronic pathway 
that control speciﬁ c cell-fate transitions are ordered into a large, 
linear gene-regulatory logic. (B) The ordered down-regulation 
of most heterochronic genes is orchestrated by the sequential 
activity of miRNAs. (C) The transcriptional regulation of miRNAs 
and the subsequent down-regulation of their targets is accom-
plished by three separate families of miRNAs.
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provides a unique genetic context to identify genes 
that regulate this process. We determined that there 
might be a set of genes that normally function to 
dampen miRNA expression in order to maintain 
miRNA levels within strict physiological ranges. 
These genes would be important for maintaining 
the normal robustness of the C. elegans developmen-
tal lineage. This is because mutations in miRNAs 
that control temporal cell fate are dosage dependent: 
Overexpression or underaccumulation of hetero-
chronic miRNAs during development results in re-
ciprocal transformations of cell-fate specifi cation. 
Mutations that alter the function of these genes could 
be identifi ed in forward genetic screens because mu-
tant animals would display precocious heterochronic 
phenotypes due to the overexpression of one or more 
miRNAs. Alternatively, removal of these compo-
nents in genetic backgrounds that underaccumulate 
 miRNAs would alleviate phenotypes associated with 
reduced miRNA target regulation.
lin-42 Negatively Regulates the Biogenesis 
of Postembryonically Expressed miRNAs
In a set of pilot screens geared to identify suppressors 
of hypomorphic miRNA mutants, we identifi ed fi ve 
alleles of the lin-42 gene. When outcrossed, animals 
harboring lin-42 mutations display profound hetero-
chronic phenotypes including the precocious expres-
sion of adult characteristics one stage earlier than 
normal. These phenotypes allowed us to clone the 
mutations in the lin-42 gene that cause these pheno-
types. The lin-42 gene is complex in that it produces 
many alternatively spliced transcripts, and these 
mRNAs are derived from two different promoters. 
Furthermore, both lin-42 promoters are activated in 
an oscillatory fashion once each stage during post-
embryonic development. At the protein level, LIN-42 
encodes the C. elegans homolog of the human and 
Drosophila PERIOD gene involved in circadian gene 
regulation. As with PERIOD, LIN-42 protein os-
cillates in expression and is localized to the nuclear 
compartment. Analysis of miRNA expression levels 
from lin-42 mutant animals suggests that LIN-42 
broadly alters miRNA biogenesis. Surprisingly, mu-
tations in the lin-42 gene lead to the overexpression 
of most postembryonically expressed miRNAs while 
having little or no effect on the expression of other 
small regulatory RNAs (Fig. 2). In fact, we found 
that the precocious phenotypes of lin-42 mutants 
 result from the inappropriate overexpression of het-
erochronic miRNAs.
To determine how lin-42 regulates miRNA ex-
pression, we developed a variety of transcriptional 
reporters for various miRNAs. These reporters are 
unique in that each miRNA promoter drives the ex-
pression of a constitutively destabilized green fl uo-
rescent protein (GFP). These unique tools enabled 
us to determine that the promoters of many miRNAs 
are transcriptionally activated in a pulsatile manner 
and that these patterns are very similar to the expres-
sion of lin-42. We then sought to characterize the 
expression of various miRNAs in lin-42 mutants. 
We focused on characterizing miRNA expression in 
lin-42 mutants that delete the highly conserved PAS 
domain that distinguishes LIN-42 as the C. elegans 
homolog of human and Drosophila PERIOD. Mu-
tation or deletion of this domain in the PERIOD 
protein completely abolishes periodic circadian gene 
expression. Surprisingly, the oscillatory patterns of 
miRNA expression are still maintained in lin-42 
Figure 2. lin-42 mutations lead to the overexpression of sev-
eral miRNAs. (A) Small RNA northern analysis of 20 μg of total 
RNA extracted from morphologically staged, young adult, 
wild-type lin-42(ma206), alg-1(ma192), and lin-42(ma206);alg-
1(ma192) animals. Blots were probed sequentially for the in-
dicated miRNAs. tRNAGly serves as a loading control. (B) The 
results of miR-TaqMan assays to quantify the levels of mature 
miRNAs in wild-type, lin-42(ma206), alg-1(ma192), and lin-
42(ma206);alg-1(ma192) animals. Notice that lin-42(ma206) 
displays the highest levels of miRNAs relative to the other 
genotype backgrounds. Data represent three biological repli-
cates with three technical replicates each. Heat map colors are 
shown as log2 scale as indicated and within each individual 
assay. Red indicates an increase in miRNA expression, and blue 
indicates a reduction in mature miRNA levels. Numbers within 
each box indicate standard fold change when compared to 
wild-type samples.
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mutant animals. Although the temporal patterns 
of miRNA expression are maintained in lin-42 mu-
tants, they were dramatically overexpressed. These 
fi ndings explain why lin-42 mutants display pleio-
tropic heterochronic phenotypes and further suggest 
that the PAS domain of LIN-42 functions to nega-
tively regulate transcription.
Identiﬁ cation of blmp-1, a New 
Heterochronic Gene That Promotes the 
Expression of Heterochronic miRNAs
The precocious developmental phenotypes of lin-42 
mutants are due to elevated transcription of multiple 
miRNA genes and the early down-regulation of spe-
cifi c miRNA targets. We reasoned that lin-42 likely 
antagonizes the function of one or more transcription 
factors that promote the temporal expression of het-
erochronic miRNAs and that reducing the activity 
of this transcription factor could alleviate the preco-
cious phenotypes of lin-42. To identify these candi-
date transcription factors, we systematically depleted 
them via RNA interference (RNAi) and determined 
whether the reduction of their expression could re-
duce the penetrance of lin-42 precocious phenotypes. 
This strategy identifi ed the conserved zinc-fi nger/
SET-domain-containing transcription factor BLMP-1. 
Analysis of these genetic interactions with a deletion 
allele confi rmed these results. Furthermore, blmp-1 
mutants display retarded heterochronic phenotypes 
and strongly enhance the developmental phenotypes 
of mutations that alter miRNA-induced silencing 
complex (miRISC) components (Fig. 3). Future ex-
periments are aimed to determine the direct nature 
of blmp-1-mediated gene regulation and how blmp-1 
expression is coordinated with other heterochronic 
genes.
Figure 3. blmp-1 is a new heterochronic gene. (A) blmp-1 en-
codes an 817AA zinc-ﬁ nger transcription factor. The tm548 al-
lele of blmp-1 deletes a central portion of the blmp-1 gene and 
causes a premature stop in the BLMP-1 protein at amino acid 
237. Therefore, tm548 is a presumptive null allele of this gene. 
(B,C) blmp-1 mutations strongly suppress the precocious alae 
phenotypes of lin-42. Images show the lateral hypodermis of in-
dicated animals and the L4 stage. The cuticles of lin-42(n1089) 
animals have adult-speciﬁ c alae. Removing blmp-1 in the lin-
42(n1089) background completely suppresses these pheno-
types. (D,E) blmp-1(tm549) mutations dramatically enhance the 
heterochronic phenotypes of miRISC mutants. (F,G) Removal of 
blmp-1 function in animals that lack one of the two miRNA-
speciﬁ c argonautes (alg-1) leads to an increase in the number of 
lateral hypodermal stem cells.
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INTEGRATING GENOMIC DATA SETS INTO GENE REGULATORY 
NETWORKS
M. Hammell Y. Hao Y. Jin A. Patel O. Tam
 Y.-J. Ho E. Paniagua J. Regalado Perez
Cellular function is dictated by the complex interplay 
of gene regulatory networks that control gene expres-
sion. These networks are incredibly robust to small or 
temporary fl uctuations in the environment, yet they 
retain the ability to change and rewire themselves in 
response to large-scale or long-term changes in ex-
ternal stimuli. This plasticity in genetic networks is 
mediated by multiple types of regulatory factors, such 
as transcription factors and noncoding RNAs, which 
respond coordinately to changes in cellular signaling. 
Thus, gaining a systems-level view of how these fac-
tors combine to produce a specifi c cellular outcome 
requires distilling multiple types of genomic profi l-
ing data into an integrated model of genetic signaling 
pathways. Our lab uses computational algorithms to 
integrate multiple types of genomic and transcriptom-
ic profi ling data into models of regulatory rewiring 
events in human disease. This includes an emphasis 
on developing novel tools for the statistical analysis 
of high-throughput data, developing novel algorithms 
for modeling the fl ow of signals through genetic path-
ways, and, importantly, testing these models using the 
tools of molecular genetics.
The ultimate goal is to understand how human 
diseases such as cancer take advantage of the cell’s in-
nate propensity for plasticity to rewire these regula-
tory networks into programs that serve the needs of 
the cancer cells.
In particular, members of our lab use a combina-
tion of computational and experimental methods to 
better understand how gene expression is regulated 
in plant and animal genomes. Much of this work in-
volves tight collaborations with other experimental 
groups at CSHL. One example involves a collabora-
tion with Marja Timmermans’ lab to understand the 
diversity of small RNA regulators in the maize ge-
nome and how these small RNAs dictate organ pat-
terning in development. Another collaboration with 
Josh Dubnau’s lab is exploring the contribution of 
transposons to human neurodegenerative diseases, 
such as amyotrophic lateral sclerosis (ALS) and fronto-
temporal dementia (FTD). A collaboration with Greg 
Hannon’s lab probes the molecular mechanisms of 
transposon control in animals. An independent proj-
ect in our lab combines both computational and ex-
perimental techniques to understand how melanoma 
cells develop resistance to targeted inhibitors of the 
melanoma cell growth pathways. Although the exper-
imental systems for each of these projects vary greatly, 
each project seeks to understand how gene regulation 
contributes to maintaining cellular function.
Mechanisms of Acquired Drug Resistance 
in Melanoma
A. Patel, J. Regalado Perez
The genetic basis of melanoma development is fairly 
well understood, with activating mutations in the on-
cogene BRAF occurring in a majority of melanoma 
patients (Hodis et al., [2012]). Specifi c inhibitors 
that target activated BRAF as well as the downstream 
MAP/ERK (mitogen-activated protein kinase/ex-
tracellular signal-related kinase) signaling pathway 
have been developed, which dramatically reduce the 
growth of melanoma cells in patients. However, the 
effects of these drugs typically extend patient life span 
for 6 mo or less, as the tumors rapidly develop resis-
tance to these targeted therapies (Villanueva et al., 
[2011]). Although some tumors resistant to BRAF 
inhibitors acquire additional genetic lesions that el-
evate ERK or AKT signaling (Alcala et al., [2012]), 
an astounding number of therapy-resistant cell lines 
establish resistance without signifi cant alteration of 
the genome (M. Herlyn, pers. comm.). Furthermore, 
serial passage of some of these cell lines in drug-free 
media results in the re-acquisition of sensitivity to the 
targeted therapeutics, suggesting that the resistance 
mechanism in these cases is likely to be due to chang-
es in gene regulation rather than secondary acquired 
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mutations. There are many factors that could be me-
diating this reversible acquired resistance phenotype, 
the most likely of which would involve alterations in 
the expression of small RNAs, alternative splicing of 
key transcripts in the MEK/ERK or AKT signaling 
pathways, or chromatin-modifying enzymes that alter 
DNA methylation or histone modifi cation. Members 
of our lab are using genomic and transcriptomic pro-
fi ling studies to identify the gene regulatory factors 
that accompany acquired resistance to BRAF inhibi-
tors. These experimental data sets are fed into custom 
algorithms designed to integrate these disparate data 
types into a systems-level view of the cellular signaling 
pathways that underlie melanoma growth and BRAF 
inhibitor resistance.
Small RNA Pathways in Maize
O. Tam [in collaboration with M. Timmermans, 
Cold Spring Harbor Laboratory]
The maize genome has remained relatively unexplored 
despite the importance of maize as one of the early 
genetic model organisms. Preliminary characteriza-
tions of the maize genome and transcriptome suggest 
that substantial differences exist, both between maize 
ecotypes as well as the well-characterized plant model 
Arabidopsis (Springer et al., [2009]; Eveland et al., 
[2010]). Furthermore, these maize inbreds exhibit dra-
matic phenotypic differences in response to mutations 
in small RNA biogenesis factors, suggesting extensive 
evolution in both small RNA function and activity. 
In collaboration with the Timmermans lab, my group 
has undertaken a project to characterize the dynamics 
of small RNA expression and activity in a variety of 
maize tissues and inbreds. The focus of this project 
is to determine the small RNA-mediated regulatory 
circuits that give rise to inbred-specifi c phenotypic 
diversity both within the maize species and within 
the larger group of grasses. Our analysis of maize 
trans-acting small interfering RNAs  (tasiRNAs), a 
group of mobile endogenous 21-nucleotide siRNAs, 
has revealed that in maize shoots, tasiRNAs are 
generated through just a single genetic pathway and 
function solely in leaf development. In contrast, the 
many tasiRNAs found in Arabidopsis are processed via 
several distinct biogenesis pathways and function in 
development as well as pathogen defense. This same 
analysis also identifi ed a new class of 22-nucleotide 
phased siRNAs, produced by an unidentifi ed pathway 
that does not overlap with the tasiRNA biogenesis 
pathway. This class of small RNAs is entirely novel, 
with no homologs in other sequenced plants and no 
defi ned mechanism for biogenesis or activity. Finally, 
only 25% of the known microRNAs (miRNAs) from 
Arabidopsis are conserved in maize, leaving a wealth 
of novel miRNAs to explore. Members of our lab are 
collaborating to provide computational analysis of the 
profi les of small RNAs and their targets across maize 
ecotypes. Our lab has developed novel algorithms for 
the identifi cation of phased small RNAs, for miRNA 
gene identifi cation, and for miRNA target interaction 
analysis. These algorithms are being applied to deep 
sequencing data sets of small RNAs and mRNAs iso-
lated from developing maize tissues.
Transposon Control Systems in Animals
Y. Jin, O. Tam [in collaboration with G. Hannon and 
J. Dubnau, Cold Spring Harbor Laboratory]
TDP-43 is an RNA-binding protein that is known to 
control proper splicing and translation of many RNA 
targets in neurons. Mutation of TDP-43 has been as-
sociated with a variety of neurodegenerative diseases 
including ALS, frontotemporal lobar degeneration 
(FTLD), and Alzheimer’s disease (AD) (Cohen et al., 
[2011]). However, the normal function of TDP-43 in 
neuronal development and maintenance has not been 
fully characterized, and few of its mRNA targets have 
been defi nitively associated with the neurodegenera-
tive diseases that result from loss of TDP-43 function 
(Da Cruz et al., [2011]). In collaboration with the 
Dubnau lab, my group has explored the novel hypoth-
esis that TDP-43 normally has a large and hitherto 
uncharacterized role in regulating the expression of 
transposable elements (TEs), mobile genetic elements 
whose unregulated expression leads to genetic insta-
bility as well as cellular toxicity. Members of the Dub-
nau lab have shown that TE transcripts are elevated 
upon expression of mutant, aggregate-prone forms of 
human TDP-43 in the fl y brain and that neurodegen-
eration results from expression of this human TDP- 
43 protein. Members of my group have shown that 
TDP-43 binds widely to TE transcripts in mammals 
and that TDP-43 binding to TEs is lost in human 
patients diagnosed with FTLD (Li et al., [2012]), 
a disease characterized by TDP-43 proteinopathy. 
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Although these studies support a role for TDP-43 in 
regulating TE expression, our future goals are cen-
tered on defi ning a causal role for TDP-43-mediated 
regulation of TEs in neurodegenerative disease. One 
important element of this project will be the identifi -
cation of how TDP-43 interacts with the small RNA 
regulators of TE expression known to be involved in 
controlling TE mobility. The Dubnau lab is currently 
exploring the molecular mechanism behind TDP-
43 function in the fl y and mouse model organisms, 
where many genetic mutants are available to carefully 
describe the factors that mediate TDP-43 involvement 
in TE regulation, biogenesis, and activity. My group 
is pursuing a parallel approach in close collaboration 
with the Dubnau lab to quantify the extent to which 
TDP-43 contributes to TE regulation as compared to 
its other mRNA targets and the potential contribu-
tion of each function to clinical outcomes.
In a separate collaboration, we work closely with 
members of the Hannon lab to better understand the 
biological mechanisms of transposon control in ani-
mals. This basic research into the factors that regu-
late transposon activity sets the foundation for un-
derstanding disease processes affected by transposon 
misregulation. Most families of TEs are highly dis-
tinct at the primary sequence level and use different 
strategies for their propagation, challenging the abil-
ity of host genomes to discriminate transposons from 
endogenous genes (Levin and Moran, [2011]). Several 
recent studies have indicated that a small RNA-based 
innate immune system, the Piwi-interacting RNA 
(piRNA) pathway, addresses the challenge of trans-
poson recognition and silencing. In germ cells, pri-
mary piRNAs are loaded into Piwi and Aubergine 
to control transposons through a posttranscriptional 
mechanism. However, several factors, including Piwi’s 
nuclear localization, have suggested that Piwi might 
also regulate its targets by controlling their transcrip-
tion. We therefore probed the contributions of Piwi to 
transposon silencing in germ cells and in their somatic 
support cells using tissue-specifi c piwi knockdowns.
Integrated analyses of steady-state RNA levels by 
RNA sequencing (RNA-Seq), and measurements of 
nascent RNA synthesis using global run-on sequenc-
ing (GRO-Seq), chromatin marks by chromatin im-
munoprecipitation combined with deep sequencing 
(ChIP-Seq), and small RNA levels indicated multi-
ple roles for Piwi in the piRNA pathway in both the 
germline and the soma. In the soma, our data sup-
port a model where Piwi silences the transcription of 
targeted elements, such that transcriptional gene si-
lencing (TGS) is the dominant form of Piwi activity. 
In germ cells, our data revealed that Piwi both acts 
via TGS and exerts unexpected impacts on piRNAs 
that occupy Aubergine and Ago3, indirectly reducing 
the capacity of the entire piRNA pathway to silence 
transposons via posttranscriptional gene silencing 
(PTGS). These data sets add new complexity to our 
understanding of Piwi function, which has primar-
ily been studied for its direct role in PTGS. Ongoing 
experiments will seek to understand the mechanisms 
by which Piwi contributes to TGS and how Piwi indi-
rectly affects other moderators of PTGS.
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STRUCTURAL BIOLOGY OF NUCLEIC ACID 
REGULATORY PROCESSES
L. Joshua-Tor E. Elkayam S. Goldsmith C.-D. Kuhn M. Morales J. Walleshauser
 A. Epstein J. Ipsaro C. Kuscu A. Tocilj M. Wang
 C. Faehnle M. Jacobs S.-J. Lee D. Wah
We study the molecular basis of nucleic acid regula-
tory processes by using the tools of structural biology, 
biochemistry, and biophysics to examine proteins and 
protein complexes associated with these processes. 
X-ray crystallography enables us to obtain the three-
dimensional structures of these molecular machines. 
Biochemistry, biophysics, and molecular biology 
allow us to study properties that can be correlated to 
their function and biology.
Mechanisms of RNAi
C. Faehnle, E. Elkayam, J. Ipsaro, C. Kuhn, C. Kuscu, 
J. Walleshauser [in collaboration with G.J. Hannon, 
R.A. Martienssen, Cold Spring Harbor Laboratory; 
J. Partridge, St. Jude Children’s Research Hospital]
RNA interference (RNAi) has made an enormous im-
pact on biology in a very short period of time. Not 
only are we still discovering new cellular pathways for 
the regulation of gene expression that use these path-
ways, but RNAi has become an extraordinarily use-
ful and simple tool for gene silencing. Almost from 
its beginnings, people have used genetics, biochem-
istry, molecular biology, and bioinformatics to study 
the mechanism of RNAi and related pathways. We 
argued, however, that to get a true mechanistic un-
derstanding of these pathways, we must understand 
how the components of the RNAi machinery work at 
a molecular level. Therefore, we embarked on struc-
tural, biochemical, and biophysical studies of key pro-
teins in the RNAi pathway.
The Making of a Slicer: Structure and 
Activation of Human Argonaute-1
In humans, Argonaute-2 (hAgo2) is the key effec-
tor protein in the RNA-induced silencing complex 
(RISC) that was identifi ed as Slicer, the endonuclease 
that cleaves a target RNA when the guide and tar-
get are fully complementary. Besides slicer-mediated 
RNAi, hAgos 1–3 are at the heart of nonslicer gene 
repression mechanisms involving translational repres-
sion and mRNA destabilization. In this case, par-
tially mismatched miRNAs guide Argonaute to its 
target, where the recruitment of downstream silenc-
ing factors commences. Because slicing does not take 
place in microRNA (miRNA) silencing pathways, 
several mammalian Argonautes have lost their ability 
to slice, namely, hAgo1 and hAgo3. Most perplex-
ing is the fact that despite an intact catalytic site in 
hAgo3, it still lacks slicer activity. In addition, hAgo2 
can function in both a slicer and nonslicer mode. The 
question arises therefore as to whether a nonslicing 
conformation exists (for hAgo1 and hAgo3, e.g.) or 
is assumed (by hAgo2). To understand what makes 
an active slicer, we set out to characterize the struc-
tural determinants of slicing by comparing structures 
of human Argonaute proteins and to make an active 
slicer enzyme out of the otherwise inactive hAgo1. 
We solved the structure of hAgo1 loaded with endog-
enous Sf9 guide RNA to 1.75 Å and in complex with 
the tumor suppressor let-7 miRNA to 2.1 Å. The 
structure of hAgo1 closely resembles the structures 
of hAgo2 in complex with guide RNAs that we and 
other investigators determined recently. Like hAgo2, 
hAgo1 is composed of the same domain organization 
as that of N, PAZ, Mid, and PIWI domains. The 
PIWI domain is similar to RNase H-like nucleases 
and contains the conserved DEDH catalytic tetrad 
required for endonuclease slicer activity. hAgo1 has 
a mutated DEDR active-site tetrad that, upon resto-
ration to DEDH, remains inactive. Instead, through 
extensive mutagenesis, we found that mutation of a 
leucine to phenylalanine within a loop adjacent to 
the active site of hAgo1 restores slicing activity. We 
mutated this loop in the slicer-active hAgo2 and 
showed that the integrity of this region is essential for 
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target slicing. When we coupled this active mutation 
in hAgo1 with an amino domain swap with hAgo2, 
the target slicing activity was substantially enhanced. 
Conversely, the hAgo1 amino domain, when swapped 
into hAgo2, impaired slicing. Finally, hAgo3, which 
already has an intact DEDH tetrad, becomes an 
active slicer by swapping in the amino domain of 
hAgo2. These domain-swapping experiments point 
to a previously underappreciated function for the 
amino domain in Argonaute slicing activity. Intrigu-
ingly, the elements that make Argonaute an active 
slicer involve a sophisticated interplay between the 
active site and more distant regions of the enzyme. 
We continue to investigate the features of Argonaute 
that arose from our structural and biochemical work 
to further our understanding of Argonaute proteins 
in human development and disease.
RNAi and Heterochromatin Formation
RNAi pathways are also used to repress genes at the 
transcriptional level by guiding heterochromatin for-
mation. Although we are just beginning to discover 
how metazoans use this type of mechanism for tran-
scriptional silencing, these pathways are much better 
characterized in plants and fungi, in particular in 
Schizosaccharomyces pombe, where heterochromatin is 
essential for kinetochore assembly required for proper 
segregation of chromosomes during cell division. The 
complexes involved in heterochromatization in S. 
pombe are fairly well defi ned, and in most cases, only 
one version of each component exists. However, our 
understanding of this pathway has not gone much be-
yond the “blobology” stage either. Assembly of centro-
meric heterochromatin requires the RITS complex, a 
specialized RISC, that physically anchors small RNAs 
to chromatin. It consists of the Argonaute protein 
Ago1, the chromodomain protein Chp1, a GW-like 
protein Tas3, and small interfering RNAs (siRNAs) 
derived from centromeric repeats. We previously char-
acterized Chp1’s high-affi nity binding to chromatin 
and showed it to be critical for establishment of cen-
tromeric heterochromatin. In addition, apart from the 
chromodomain, Chp1 had no recognizable domains. 
Our structure of the carboxy-terminal half of Chp1 
with the Tas3 amino-terminal domain revealed the 
presence of a PIN domain in Chp1 that contributes 
to posttranscriptional gene silencing of subtelomeric 
transcripts independent of RNAi. We also realized 
that Chp1 and Tas3 form a tight complex, and Argo-
naute appears to bind more loosely. We suggested that 
Chp1-Tas3 provides a solid and versatile platform to 
recruit both RNAi-dependent and -independent gene-
silencing pathways for locus-specifi c regulation of het-
erochromatin and that the reach of long and fl exible 
regions in these two proteins might be important for 
contacting other nucleosomes at these loci.
The RITS complex recruits the H3K9 methylase 
Clr4, which is part of a large complex called CLRC. 
CLRC also contains the cullin Cul4 and its interact-
ing protein Pip1, the adaptor Rik1, a WD repeat pro-
tein Dos1, and Dos2. Curiously, CLRC is an active 
E3 ligase in vitro, and this activity is necessary for 
heterochromatin assembly in vivo. Yet, the role of this 
E3 ligase activity is still unknown. We performed a 
pairwise interaction screen of the CLRC components 
revealing a subunit arrangement that is reminiscent of 
CRL4, a different cullin ring ligase complex for which 
a crystal structure is available. Both complexes con-
tain the ubiquitin ligase Cul4, and sequence similari-
ties between two other subunits were already noted. 
We have begun delineating structural and functional 
similarities. In particular, the placement of Dos1 indi-
cated that it might have a role similar to that of DDB2 
in CRL4, as a target-binding factor for the E3 ligase. 
We solved the structure of Dos1 and found it to be 
an eight-bladed β propeller with one face mediating 
interaction with the adaptor protein Rik1. We made a 
series of mutations on the opposite surface and found 
several regions that are required for heterochromatin 
silencing, underscoring the notion that Dos1 is the 
specifi city factor for the ligase.
Figure 1. Structure of human Argonaute-1 in complex with the 
tumor suppressor miRNA let-7.
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The Different Faces of E1: A Replicative 
Hexameric Helicase
S.-J. Lee [in collaboration with A. Stenlund, Cold Spring 
Harbor Laboratory; T. Ha, University of Illinois, 
Urbana-Champaign]
Precise replication of the genome is essential for main-
taining the integrity of genomic information. As a 
prerequisite for DNA replication, two complementary 
DNA strands are separated and each becomes a tem-
plate for the synthesis of a new complementary strand. 
Strand separation is mediated by a helicase enzyme, 
a molecular machine that uses the energy derived 
from ATP hydrolysis while moving along the DNA. 
Our crystal structures of the double-stranded DNA 
(dsDNA)-binding domain (DBD) of the replicative 
helicase E1 from papillomavirus in various stages of 
assembly led us to propose a model in which the tran-
sition from the dimer to the ultimate double hexamer 
results in strand separation. The loading and assem-
bly of this protein separate the double helix, such that 
each hexameric helicase encircles one strand of DNA. 
Once assembled, the helicase uses its ATP-driven 
motor to translocate on the DNA or “pump” the sin-
gle-stranded DNA (ssDNA) through the hexameric 
ring. Several competing mechanisms for helicase un-
winding were proposed. Having determined a struc-
ture of hexameric E1 with ssDNA discretely bound 
in the central channel and nucleotides at the subunit 
interfaces, we showed that only one DNA strand 
passes through the hexamer channel and that the 
DNA-binding hairpins of each subunit form a spiral 
staircase that sequentially tracks the DNA backbone. 
The nucleotide confi gurations at the subunit inter-
faces indicate that each subunit sequentially progresses 
through ATP, ADP, and apo states, whereas its associ-
ated DNA-binding hairpin travels from the top to the 
bottom of the staircase, each escorting one nucleotide 
of ssDNA through the channel, as if six hands grab 
the DNA and upon ATP hydrolysis and ADP release 
pull it through the channel. With this unique look 
into the mechanism of translocation of this molecular 
machine along DNA, we have focused on mechanistic 
aspects of the enzyme in solution.
By taking a multifaceted approach including single-
molecule and ensemble FRET (Förster resonance ener-
gy transfer) methods, we have found that E1 is oriented 
with the amino-terminal side of the helicase facing the 
replication fork, consistent with the crystal structure. 
We also showed that E1 generates strikingly hetero-
geneous unwinding patterns stemming from varying 
degrees of repetitive movements that are modulated by 
the DNA-binding domain. Furthermore, our studies 
found that DNA-binding domain promotes the assem-
bly of E1 helicase onto a forked DNA substrate, acting 
as an allosteric effector of the helicase. Taken together, 
our studies reveal previously unrecognized dynamic 
facets of replicative helicase unwinding mechanisms, 
adding another layer of complexity in the workings 
and regulation of DNA replication.
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RNA SPLICING
A.R. Krainer M. Akerman W.-J. Chen M. Jensen T. Nomakuchi M. Sivaramakrishnan
 O. Anczuków S. Das H.-Y. Jeon J. Novatt R.-Y. Tzeng
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 Y. Basedo X. Hua K.-T. Lin H. Rees M. Walia
 F. Bezirci Y. Hua Y.-H. Liu K. Sahashi J. Wu
 S. Brøner K. Ishida L. Manche J. Scharner
Mechanisms of Constitutive and 
Alternative Pre-mRNA Splicing
RNA splicing is required for expression of most eu-
karyotic protein-coding genes. The spliceosome 
selects authentic splice sites with very high fi del-
ity, relying on limited sequence information present 
throughout introns and exons. In humans, >90% of 
genes are expressed via alternative splicing, giving rise 
to multiple protein isoforms. The choice of alterna-
tive-splice sites is commonly regulated to alter gene 
expression, either tissue-specifi cally or in response to a 
developmental program or to signaling pathways. The 
fact that multiple protein isoforms can be expressed 
from individual genes demonstrates that the classical 
“one gene–one enzyme” paradigm is no longer valid 
and provides an explanation for the unexpectedly 
small number of protein-coding genes uncovered by 
genome-sequencing projects.
Both constitutive and alternative-splicing mecha-
nisms involve numerous protein components, as well 
as fi ve noncoding RNA components that are part of 
small nuclear ribonucleoprotein (snRNP) particles. 
The work in our lab focuses on the identifi cation and 
molecular characterization of protein factors and se-
quence elements that are necessary for the catalysis 
and fi delity of splicing and/or for the regulation of 
alternative-splice-site selection. We are interested in 
how the spliceosome correctly identifi es the exons on 
pre-mRNA, and how certain point mutations in either 
exon or intron sequences cause aberrant splicing, lead-
ing to various human genetic diseases. Related areas of 
interest include the remodeling of mRNP architecture 
as a consequence of splicing, which infl uences down-
stream events, such as nonsense-mediated mRNA 
decay (NMD); the various roles of alternative-splicing 
misregulation in cancer; and the development of ef-
fective methods to correct defective splicing or modu-
late alternative splicing, especially in a disease context. 
A summary of some of our recently published studies 
is provided below.
Alternative Splicing and Cancer
Alternative splicing has an important role in cancer, 
partly by modulating the expression of many onco-
genes and tumor suppressors, and also because inac-
tivating mutations that affect alternative splicing of 
various tumor suppressor genes account for some of 
the inherited and sporadic susceptibility to cancer. 
In addition, alternative splicing controls a metabolic 
switch characteristic of all cancer cells, known as the 
Warburg effect. We have continued to analyze the 
roles of individual members of the SR protein family 
of splicing factors in cancer.
As part of a systematic analysis of the SRSF1–pro-
tein interaction network, we used immunoprecipita-
tion and quantitative mass spectrometry (i-DIRT) and 
found a novel interaction among SRSF1, the ribosom-
al protein RPL5, and the ubiquitin E3 ligase MDM2. 
We demonstrated that SRSF1 stabilizes the tumor 
suppressor protein p53 by abrogating its MDM2-de-
pendent proteasomal degradation. Moreover, SRSF1 
is a necessary component of the complex, which func-
tions in a p53-dependent ribosomal-stress checkpoint 
pathway. Consistent with the stabilization of p53, 
increased SRSF1 expression in primary human fi bro-
blasts decreased cellular proliferation and triggered 
oncogene-induced senescence (OIS). These fi ndings 
underscore the deleterious outcome of SRSF1 overex-
pression and identifi ed a cellular defense mechanism 
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against its aberrant function. Furthermore, they im-
plicated the RPL5-MDM2 complex in OIS and dem-
onstrated a link between spliceosomal and ribosomal 
components, functioning independently of their ca-
nonical roles, to monitor cellular physiology and cell 
cycle progression.
We also collaborated with Frédéric Allain (ETH, 
Zurich), whose group used nuclear magnetic reso-
nance (NMR) to solve the structure of the human 
SRSF1 pseudo-RNA-recognition motif (pseudo-
RRMs) bound to RNA. Although pseudo-RRMs 
are crucial for the activity of SR proteins that have 
one, their mode of action was unknown. The struc-
ture revealed a very unusual and sequence-specifi c 
RNA-binding mode centered on one α-helix, in-
stead of the β-sheet surface, which typically mediates 
RNA binding by RRMs. We found that the isolated 
pseudo-RRM was suffi cient to regulate splicing of 
about half of the SRSF1 target genes tested, and the 
bound α-helix was required for this function. These 
results suggest that SR proteins with a pseudo-RRM 
frequently regulate splicing by competing with, rather 
than recruiting, spliceosome components, binding 
RNA through this unusual RRM.
We also studied another SR protein, SRSF6, and 
identifi ed it as a regulator of wound healing and tissue 
homeostasis in skin (in collaboration with John Erby 
Wilkinson, University of Michigan, Ann Arbor). We 
found that SRSF6 is a proto-oncogene frequently 
overexpressed in human skin cancer, including ma-
lignant melanomas and basal cell and squamous cell 
carcinomas. Overexpressing doxycycline-inducible 
SRSF6 cDNA in transgenic mice induced epithelial 
hyperplasia of sensitized skin (e.g., by shaving) and 
promoted aberrant alternative splicing. We observed 
severe epidermal thickening and hair-follicle lesions, 
which were reversible upon withdrawal of the doxy-
cycline inducer. Skin transplantation experiments to 
nontransgenic donor mice showed that the inducible 
SRSF6 effects are cell autonomous.
Microarray analysis identifi ed 139 target genes with 
SRSF6-induced alternative-splicing changes in skin, 
including many genes associated with wound healing. 
Focusing on the Tnc gene coding for the extracellu-
lar matrix protein tenascin C, we demonstrated that 
SRSF6 binds to alternative exons in its pre-mRNA 
and promotes the expression of isoforms characteristic 
of invasive and metastatic cancer, although this par-
ticular regulatory event is independent of cell type. 
SRSF6 overexpression additionally resulted in deple-
tion of LGR6+ stem cells and excessive keratinocyte 
proliferation and response to injury. Furthermore, we 
showed that the effects of SRSF6 in wound healing 
assayed in vitro depend on the tenascin C isoforms. 
Thus, abnormal expression of this SR protein splicing 
factor can perturb tissue homeostasis in skin.
Targeted Antisense Modulation of 
Alternative Splicing for Therapy and 
Disease Modeling
Spinal muscular atrophy (SMA) is a common, auto-
somal-recessive motor-neuron degeneration disorder 
caused by homozygous deletion or mutation of the 
survival-of-motor-neuron gene SMN1. A closely re-
lated SMN1 paralog, SMN2, is present in all patients 
and differs from SMN1 by a C to T transition in exon 
7 that causes substantial skipping of this exon, such 
that SMN2 expresses only low levels of functional pro-
tein. SMN2 decreases the severity of SMA in a copy 
number–dependent manner. We previously developed 
an antisense method to increase the extent of exon 7 
inclusion during splicing of SMN2 transcripts, for 
therapeutic use in SMA. This translational research is 
being done in collaboration with Isis Pharmaceuticals. 
Phase II open-label clinical trials with the ASO com-
pound, ISIS-SMNRx, are well under way; the drug, 
which was administered to SMA infants and children 
by lumbar puncture, was well tolerated at all doses 
tested, and dose- and time-dependent improvements 
in motor function were observed. Double-blind, 
 placebo-controlled Phase III trials to establish effec-
tiveness are being planned.
We also described the use of another antisense oli-
gonucleotide (ASO) complementary to exon 7 that 
exacerbates SMN2 missplicing to phenocopy SMA 
in a dose-dependent manner when administered to 
SMN2-transgenic Smn−/− mice. Intracerebroventric-
ular ASO injection in neonatal mice recapitulated 
SMA-like progressive motor dysfunction, growth 
impairment, and shortened life span, with α-motor 
neuron loss and abnormal neuromuscular junctions. 
These SMA-like phenotypes were prevented by in-
tracerebroventricular (ICV) injection of the above 
therapeutic ASO. We uncovered starvation-induced 
splicing changes—particularly in SMN2—that likely 
accelerate disease progression. These results constitute 
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proof of principle that ASOs designed to cause sus-
tained splicing defects can be used to induce patho-
genesis and rapidly and accurately model splicing-
associated diseases. This approach, which we dubbed 
TSUNAMI (targeting splicing using negative ASOs 
to model illness), also allows the dissection of patho-
genesis mechanisms, including spatial and temporal 
features of disease onset and progression as well as 
testing of candidate therapeutics. By targeting splic-
ing of endogenous genes, the method can potentially 
be used to phenocopy diseases in wild-type animals.
We have now used the TSUNAMI approach to 
phenocopy adult-onset SMA (known as type IV SMA) 
in mice. We again used the above exon-7 ASO to ex-
acerbate SMN2 missplicing and observed distinctive 
pathological features of adult-onset versus early-onset 
SMA. We demonstrated that ICV ASO injection in 
adult SMN2-transgenic mice phenocopies key as-
pects of adult-onset SMA, including delayed-onset 
motor dysfunction and relevant histopathological 
features. As in the neonate model, SMN2 missplicing 
increased during late-stage disease, likely accelerating 
disease progression. Systemic ASO injection in adult 
mice caused SMN2 missplicing in peripheral tissues 
and affected prognosis, eliciting marked liver and 
heart pathologies, with decreased circulating insulin-
like growth factor 1 (IGF1) levels. ASO dose-response 
and time-course studies suggested that only moderate 
SMN levels are required in the adult central nervous 
system, and treatment with the splicing-correcting 
ASO showed a broad therapeutic time window.
Analyzing Splicing by Next-Generation 
Sequencing
A crucial step in analyzing mRNA-Seq data is to ac-
curately and effi ciently map hundreds of millions of 
reads to the reference genome and to exon junctions. 
In collaboration with Chaolin Zhang (Columbia) and 
Michael Zhang (University of Texas, Dallas), we de-
veloped OLego, an algorithm specifi cally designed for 
de novo mapping of spliced mRNA-Seq reads. OLego 
adopts a multiple-seed-and-extend scheme and does 
not rely on a separate external aligner. It achieves high 
sensitivity of junction detection by strategic searches 
with small seeds (~14 nucleotides for mammalian ge-
nomes). To improve accuracy and resolve ambiguous 
mapping at junctions, OLego uses a built-in statistical 
model to score exon junctions by splice-site strength 
and intron size. Burrows-Wheeler transform is used in 
multiple steps of the algorithm to effi ciently map seeds, 
locate junctions, and identify small exons. OLego is 
implemented in C++ with fully multithreaded execu-
tion, and it allows fast processing of large-scale data. 
We systematically evaluated the performance of 
OLego in comparison with published tools, using both 
simulated and real data. OLego demonstrated better 
sensitivity, higher or comparable accuracy, and sub-
stantially improved speed. It also identifi ed hundreds 
of novel micro-exons (<30 nucleotides) in the mouse 
transcriptome, many of which are phylogenetically 
conserved, and we validated them experimentally.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector G. Arun S. Dai M. Hübner
 J. Bergmann S. Diermeier R. Kumaran
 M. Bodnar M. Eckersley-Maslin J. Li
 K.-C. Chang S. Hearn C. Zepeda-Mendoza
Most cellular processes can trace their beginnings 
to the nucleus, where a gene is activated resulting in 
the production of an RNA molecule—some of which 
encode proteins, whereas others are functional in the 
form of RNA. Although much biochemical informa-
tion is available regarding many of the factors involved 
in gene expression, the spatial and temporal parameters 
that infl uence gene expression and the role of noncod-
ing RNAs in regulating this multifaceted process are 
just beginning to be elucidated. During the past year, 
our research has continued to focus on elucidating 
various mechanisms of regulating gene expression and 
DNA repair and the role of long nuclear retained non-
coding RNAs in development and cancer progression.
Organization and Expression of Genes 
in Embryonic Stem Cells and Neural 
Progenitor Cells
M. Bodnar, M. Eckersley-Maslin, J. Bergmann
Embryonic stem cells (ESCs) undergo dramatic 
changes in transcription, chromatin structure, and 
nuclear architecture as they transition from a pluripo-
tent state to a lineage-specifi c cellular program. To 
better understand how the unique ESC nuclear en-
vironment infl uences pluripotency, and vice versa, we 
have focused on the dynamic movements of the Oct4 
gene locus during the onset of ESC differentiation. 
We have found that the alleles of the Oct4 gene locus 
transiently associate in the nucleus and that the tim-
ing of this allelic association event coincides with the 
transcriptional modulation of the Oct4 gene.
Although differentiating ESCs can partially re-
capitulate embryonic development in vitro, we were 
interested in whether the observed Oct4 allelic asso-
ciations that we previously observed at specifi c time 
points after induction to differentiate would also 
occur in vivo during early mouse embryo develop-
ment. In the postimplantation mouse epiblast, Oct4 
expression in the ectoderm/neuroectoderm is down-
regulated in an anterior to posterior manner concur-
rent with neural lineage specifi cation and loss of pluri-
potency, such that by the 6-somite stage (~E8.5), Oct4 
expression is largely restricted to primordial germ 
cells. We reasoned that if Oct4 allelic pairing was cor-
related with repression of the Oct4 gene, high levels 
of Oct4 allelic pairing should be observed in nuclei of 
the anterior neuroectoderm where the gene was being 
coordinately repressed, whereas lower levels of Oct4 
allelic pairing would be expected more posteriorly 
where Oct4 is still expressed. Thus, we assessed the 
frequency of Oct4 allelic association in sagittal sec-
tions of late head fold (LHF)-stage mouse embryos, 
which were harvested at E7.75 (in collaboration with 
David-Emlyn Parfi t and Michael M. Shen, Columbia 
University Medical Center). Embryos were immuno-
labeled with an OCT4 antibody to identify regions 
of the embryo actively expressing the OCT4 protein, 
and immunostaining was assessed in three embryonic 
regions as indicated: anterior, middle, and posterior. 
Next, multicolor DNA FISH (fl uorescence in situ 
hybridization) was performed, using DNA probes to 
Oct4, Sox2, and Nanog gene loci. Distances between 
homologous alleles were measured in ectoderm/neu-
roectoderm cells in sections taken from three separate 
E7.75 embryos, in at least 100 individual nuclei per 
region in each embryo, and the percentage of nuclei 
with paired homologous loci was calculated for each 
embryonic region. Interestingly, pairing of homolo-
gous Oct4 alleles was observed at roughly equal lev-
els (~25%–30%) in ectoderm/neuroectoderm cells 
of all three regions, regardless of the level of OCT4 
immunofl uorescence observed in each region. When 
distances between Nanog and Sox2 alleles were as-
sessed in the same nuclei, allelic associations were 
not observed. Because Oct4 allelic pairing is observed 
throughout the ectodermal/neuroectodermal layer 
at this stage of development, this suggests that Oct4 
allelic pairing occurs in embryonic cells as they are 
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losing pluripotency and transitioning to a range of 
differentiated cell lineages in the mouse embryo.
On the basis of these data, we propose a model in 
which Oct4 allelic pairing functions to modulate the 
expression of the Oct4 gene, thereby facilitating the 
transition between the pluripotent state and lineage 
commitment. According to our model, in the pluripo-
tent state, Oct4 is transcriptionally active and the Oct4 
alleles are separated in nuclear space. Upon induction 
of differentiation, ESCs enter a transitional state in 
which the alleles of the Oct4 gene transiently colocalize 
in the nucleus, allowing for a transvection-like modu-
lation of Oct4 gene expression levels as the promoter 
and enhancer regions of each Oct4 allele come in close 
proximity with each other. Once the appropriate Oct4 
expression level has been achieved, the cell may exit the 
transitional state and progress to lineage commitment.
Monoallelic gene expression describes the tran-
scription from only one of two homologous alleles of a 
particular gene. We previously performed an unbiased 
RNA-sequencing screen to identify random monoal-
lelically expressed genes taking advantage of a hybrid 
ESC line which is an F1 cross between C57BL/6 and 
CAST/Ei strains, so that the expressed single-nu-
cleotide polymorphisms (SNPs) would refl ect from 
which allele the transcript is derived. We identifi ed 
a 5.6-fold increase from just 67–376 genes exhibiting 
random autosomal monoallelic expression during dif-
ferentiation of mouse ESCs to neural progenitor cells 
(NPCs), indicating that monoallelic expression is ac-
quired upon lineage commitment. These 376 genes 
represented ~3% of expressed genes in NPCs.
During the past year, we examined the impact of 
monoallelic expression on the transcriptional output 
of each of these genes. We performed linear regression 
analysis to compare expression levels of individual 
monoallelically expressed genes across the indepen-
dent NPC clones to determine if there was a correla-
tion between the extent of allelic imbalance and total 
expression level. Using this approach, we identifi ed 30 
monoallelically expressed genes (8%) with evidence 
for transcriptional compensation and 54 genes that 
followed the dosage of active alleles. The remaining 
genes either showed intermediate responses or were 
highly variable and so not able to be confi dently clas-
sifi ed based on data from six independent clones. We 
validated the linear regression analysis by quantitative 
reverse transcriptase–polymerase chain reaction (RT-
PCR), confi rming transcriptional compensation for 
seven out of nine genes (78%) and dosage sensitivity 
for seven out of 11 genes (64%) tested. The identi-
fi cation of transcriptional compensation is intriguing 
because it suggests that for these genes, the exact level 
of transcript is more critical than for others. Further-
more, it supports a model in which the biological con-
sequences of monoallelic expression are not limited to 
reducing transcript levels in the cell, but rather may be 
a refl ection of the stochastic nature of gene regulation 
at independent alleles.
On the basis of our fi ndings, we propose that ran-
dom monoallelic expression exemplifi es a stochastic 
aspect of gene regulation that takes place upon the ini-
tiation of specifi c differentiation programs, resulting 
in global changes in chromatin compaction and gene 
expression. If the probability of gene activation or re-
pression is less than 1 for a particular gene, this would 
result in a mixed population of cells containing 0, 1, 
or 2 active alleles, which, once established and not det-
rimental to the cell, could be subsequently maintained 
across cell generations and propagated clonally. In all 
cases, the two alleles are independently regulated with 
a low activation probability, possibly due to limiting 
accessibility of key activating factors. One outcome of 
this independent regulation is that it results in both 
monoallelic and biallelic cells in a mixed population. 
Indeed, at least one biallelic clone is observed for al-
most all monoallelically expressed genes, consistent 
with an independent stochastic regulation model. The 
outcome of monoallelic expression for some genes may 
be unfavorable if the cell requires a specifi c level of 
transcript that cannot be accommodated for by the 
single active allele, thus resulting in cell death. How-
ever, either for those genes for which the exact level 
of transcript is not critical or for those that are able to 
compensate transcriptionally, monoallelic expression 
represents a viable outcome for the cell.
Long noncoding RNAs (lncRNAs) (>200 nucleo-
tides in length) represent a relatively recently studied 
class of RNAs for which functional insight is current-
ly available for only a few candidates out of potentially 
thousands. The majority of lncRNAs are expressed at 
very low levels, some as low as one copy per cell, and 
these RNAs generally exhibit poor primary sequence 
conservation over evolution. lncRNAs have been im-
plicated in numerous molecular functions, including 
modulating transcriptional patterns, regulating pro-
tein activities, serving structural or organizational 
roles, altering RNA processing events, and serving as 
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precursors to small RNAs. We performed a next-gen-
eration sequencing screen of poly(A)+ RNA to identify 
putative lncRNAs that are differentially expressed in 
mouse ESCs and NPCs. Our goal is to uncover new 
mechanisms by which lncRNAs regulate gene expres-
sion, differentiation, and/or nuclear organization. We 
identifi ed 334 lncRNAs expressed in ESCs and NPCs. 
Of these, 148 were greater than threefold down-regu-
lated and 63 were greater than threefold up-regulated 
during differentiation toward NPCs. Of these tran-
scripts, ~70% are enriched in the nucleus, indicating 
potential roles in the regulation of gene expression or 
nuclear organization. Using stringent criteria, we gen-
erated a short list of 50 presently uncharacterized and 
moderately abundant lncRNAs. We are depleting the 
levels of these lncRNA in a high-throughput approach 
using antisense oligonucleotide (ASO) technology. 
Combined with downstream RNA sequencing, we 
are generating comprehensive and high-resolution 
data of global gene expression patterns in the context 
of aberrant lncRNA expression. We have also begun 
to characterize these lncRNAs with respect to their 
expression in embryonic and adult tissues, as well as 
to examine their subcellular localization by RNA fl uo-
rescence in situ hybridization protocols with single-
molecule sensitivity. We are also optimizing targeted 
lncRNA knock-down in the course of early embryonic 
development to assess the potential impact on normal 
differentiation processes. Finally, we are working on 
establishing ESC-derived cell lines that will allow us 
to track the dynamics of selected candidate lncRNP 
complexes in living cells, as well as to determine the 
composition of specifi c lncRNP complexes at the pro-
tein level. Our overall aim is to provide a thorough 
and comprehensive characterization of individual 
lncRNAs to dissect functional interactions of these 
RNAs with nuclear proteins and their mechanisms of 
action at the molecular level.
Probing the Function of Malat1, an 
Abundant Long Noncoding RNA, 
That Is Overexpressed in Cancer
G. Arun, S. Diermeier, K.-C. Chang (in collaboration with 
M. Egeblad, Cold Spring Harbor Laboratory; J.E. Wilkinson, 
University of Michigan Medical School)
lncRNAs, lacking protein-coding capacity, consti-
tute a huge repertoire of gene regulatory molecules. 
However, there has been limited genetic evidence to 
support the function of lncRNAs in vivo. MALAT1 
(metastasis-associated lung adenocarcinoma tran-
script 1) is among the most abundant nuclear enriched 
lncRNAs. MALAT1 up-regulation has been correlated 
with high metastatic progression and poor prognosis 
of human breast, lung, and prostate cancer. MALAT1 
is highly conserved, and it exhibits an uncommon 3′-
end processing mechanism. In addition to its dysregu-
lation in cancer, its specifi c nuclear localization and 
developmental regulation are suggestive of it having a 
critical biological function.
To characterize the role of Malat1 in primary lu-
minal B breast cancer and its subsequent metastasis, 
we have used the MMTV-PyMT mouse mammary 
tumor model. MMTV-PyMT mice exhibit all stages 
of the disease from premalignant to distant metasta-
sis. Malat1 lncRNA was knocked down in MMTV-
PyMT mice via subcutaneous administration of ASOs 
at a dose of 125 mg/kg/wk during a period of 7 weeks, 
after which animals were sacrifi ced and primary tumors 
and lungs were removed for histological analyses. 
Malat1-ASO treatment resulted in ~60% knock down 
in the primary tumor and a signifi cant reduction in 
tumor progression rate. Detailed histopathologi-
cal analysis of Malat1-ASO-treated tumors showed 
an increase in well-differentiated ductular tumors, 
whereas scrambled-ASO-treated tumors progressed 
to solid carcinomas. There were structurally normally 
organized preinvasive lesions present in the Malat1-
ASO-treated MMTV-PyMT mice, suggesting that 
Malat1 function is required for the conversion from 
the preinvasive to invasive stage. Most interestingly, 
a marked decrease was observed in the incidence of 
lung metastases, with a reduction of 70%–80% in 
the number of metastatic nodules, as compared to an-
imals treated with scrambled ASOs. We are currently 
intercrossing MMTV-PyMT mice with our Malat1 
knockout mice to develop genetic data to support our 
ASO knockdown studies.
To characterize the cellular effects of Malat1 knock-
down on cancer cell invasion, we have also generated 
mammary “organoids” from MMTV-PyMT primary 
tumors. Tumor organoids embedded in Matrigel were 
treated with Malat1-ASOs, and the effects on cellular 
behavior were followed for 3 days using spinning disk 
confocal imaging. In such cultures, Malat1 loss did 
not affect cellular viability, but a marked reduction 
in the invasive properties of the three-dimensional 
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structures was observed. This in vitro assay now al-
lows us to dissect the molecular mechanisms respon-
sible for the effects of Malat1 on cancer cell invasive 
properties. Together, our data indicate that Malat1 
lncRNA represents a promising therapeutic target for 
treatment of metastatic breast cancer.
A Role for JmjD3/Kdm6B in the Induction 
of H3K27me3-Independent Genes
M. Hübner, J. Li
The regulation of gene expression is associated with 
modifi cations at the amino termini of histones associ-
ated with active or silent genes. In particular, silenced 
genes are often enriched in trimethylated lysine 27 of 
histone H3 (H3K27me3) and Polycomb group pro-
teins. Two proteins with H3K27me3 demethylase ac-
tivity have been identifi ed, Jmjd3 and UTX. It has 
been postulated that one or both of these enzymes are 
needed to remove the H3K27 methylation mark prior 
to the activation of silenced genes.
Through live-cell and immunofl uorescence imag-
ing in human cancer cells, we identifi ed the local-
ization of the Jmjd3 protein in heterochromatic foci 
and a soluble nuclear pool. Interestingly, the Jmjd3 
protein is recruited rapidly (within 5 min) to an ac-
tivated gene locus that is not H3K27-methylated and 
it binds transiently to the promoter region of the in-
duced gene. This led us to investigate whether Jmjd3 
has a more general role in transcriptional induction 
that is independent of its catalytic activity. Analysis of 
coimmunoprecipitated proteins by mass spectrometry 
indicated that Jmjd3 is associated with proteins of the 
MLL4 complex, which is involved in the deposition 
of the H3K4 trimethylation mark on activated genes. 
Importantly, small hairpin RNA (shRNA)-mediated 
depletion of the Jmjd3 protein in human breast can-
cer cells leads to an attenuation of the induction of 
estradiol target genes, many of which do not carry the 
H3K27me3 mark. Through a rescue experiment with 
Jmjd3 point mutants and protein fragments as well 
as a small-molecule inhibitor for the catalytic site, we 
found that the carboxy-terminal zinc-fi nger domain 
involved in protein–protein interactions, but not the 
catalytic activity, is involved in the activation of non-
H3K27-methylated genes. A genome-wide RNA-Seq 
experiment in human breast cancer cells revealed two 
classes of estradiol target genes: one class of genes 
whose regulation is independent of Jmjd3 and another 
class that requires Jmjd3 for full activation. Interest-
ingly, a comparison of these genes with genome-wide 
chromatin immunoprecipitation sequencing (ChIP-
Seq) data revealed that most estradiol target genes are 
not H3K27 methylated.
These data suggest that in addition to the role of 
Jmjd3 in the demethylation and activation of H3K27-
methylated genes, it also has a role in the induction of 
non-H3K27-methylated genes. This latter function is 
mediated by a multifunctional complex consisting of 
Jmjd3 and proteins of the MLL4 complex, which is 
involved in chromatin remodeling and transcriptional 
induction.
Evaluation of the Effect of DNA Repair 
Pathway Choice on Zinc-Finger 
Nuclease-Induced Double-Strand Breaks
R.I Kumaran, J. Li
DNA double-strand breaks (DSBs) are the most dan-
gerous class of DNA damage. If DSBs are left unre-
paired, they can result in genomic instability or cell 
death. Therefore, cells have evolved complex DNA-
damage response pathways to repair DSBs. In mam-
malian cells, two major and mechanistically distinct 
DSB repair pathways are nonhomologous end join-
ing (NHEJ) and homologous recombination (HR). 
NHEJ and HR can be regulated by multiple factors 
including cell cycle phase. Although cell cycle regula-
tion of the DSB-repair pathway choice on a single-
copy locus is thought to be restricted to G1 phase 
for NHEJ and to late S/G2 phase for HR, it remains 
unclear for a multicopy locus. We have investigated 
DSB pathway choice by developing and using mul-
ticopy and single-copy DSB reporter cell systems. 
Earlier, we have demonstrated that enhanced yellow 
fl uorescent protein (EYFP)-Rad51 (HR protein) is re-
cruited at a high frequency (90%) to the multicopy 
DSB reporter as compared to the single-copy DSB 
reporter cell line (20%), upon induction of DSBs by 
green  fl uorescent protein–zinc-fi nger nucleases (GFP-
ZFNs). This result strongly suggested that donor copy 
number could be an important determinant that 
could alter pathway choice toward HR. To test this in 
the single-copy DSB reporter cell line, which did not 
have a fl uorescent reporter readout for gene correction, 
we have used a molecular approach, by examining the 
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sequence alterations at the ZFN-induced DSB. In the 
absence of donor and upon induction of DSB, NHEJ-
induced repair will result in indels at the ZFN target 
site. However, in the presence of the donor template 
(which has isogenic codon substitutions, to exhibit a 
fi ve-nucleotide sequence variation at the mutant ZFN 
site), when HR repair occurs, the ZFN site in the 
genome of the reporter cell line will incorporate the 
fi ve-nucleotide variant sequence. For molecular analy-
sis, the reporter cells were electroporated with ZFNs 
in the presence/absence of donor or with increasing 
donor concentrations. Then, genomic DNA was iso-
lated after 24 or 72 h and PCR-amplifi ed to generate 
a 400-bp product fl anking the ZFN target site. The 
PCR products were barcoded and sequenced using 
the PacBio SMRT technology. Initial observation of 
PacBio sequence data indicates that the HR frequency 
increases with increasing donor copy number.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund S. Schuck
The papillomaviruses are a group of viruses that infect 
and transform the basal epithelium, inducing prolif-
eration of the cells at the site of infection. The result-
ing tumors (warts) are in most cases benign and will 
usually regress after some time, but certain types of 
human papillomaviruses (HPVs) give rise to tumors 
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV 
infection appears to be a necessary cause of invasive 
cervical carcinoma and thus represents one of the few 
fi rmly established links between viral infections and 
the development of cancer.
An impediment to the study of papillomaviruses 
has been the inability to defi ne simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These 
viruses normally require specialized differentiating 
cells that only with diffi culty can be generated in cell 
culture. However, for a bovine papillomavirus (BPV-
1) a convenient cell culture system exists where viral 
gene expression, oncogenic transformation, and viral 
DNA replication can be studied. Thus, BPV has be-
come a useful model for these aspects of the viral life 
cycle. The DNA replication properties of the papil-
lomaviruses show some unique and interesting char-
acteristics. As part of their normal life cycle, these vi-
ruses can exist in a state of latency, which is character-
ized by maintenance of the viral DNA as a multicopy 
plasmid in infected cells. The copy number of the 
viral DNA is tightly controlled, and the viral DNA is 
stably inherited under these conditions. Papillomavi-
ruses therefore provide a unique opportunity to study 
plasmid replication in mammalian cells. In addition, 
the viral DNA replication machinery represents one of 
the most promising targets for antiviral therapy.
In previous years, we reported the characterization 
of the papillomavirus replicon and the identifi cation 
of the viral components that are required for viral 
DNA replication. In recent years, we directed our at-
tention toward the biochemical events that are associ-
ated with initiation of DNA replication. We are study-
ing the biochemical properties of the viral E1 and E2 
proteins and how these two proteins interact with the 
viral origin of DNA replication and with the cellular 
replication machinery to generate initiation com-
plexes. Our studies demonstrate that the E1 protein 
has all of the characteristics of an initiator protein, 
including ori recognition, DNA-dependent ATPase 
activity, and DNA helicase activity. The transcription 
factor E2, whose precise function has remained more 
elusive, appears to serve largely as a loading factor for 
E1. Through direct physical interactions with both E1 
and the ori, E2 provides sequence specifi city for the 
formation of the initiation complex.
We are currently attempting to elucidate how the 
E1 and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication 
at the viral ori. These events include binding of the 
initiator to the ori, the initial opening of the DNA du-
plex (melting), and the assembly and loading of the E1 
replicative helicase at the replication fork. Our studies 
so far indicate that these activities are generated in an 
ordered process that involves the sequential assembly 
of E1 molecules on the ori. This sequential assembly 
generates different complexes with different properties 
that in turn recognize ori, destabilize the double helix, 
and function as the replicative DNA helicase.
Phosphorylation by the Protein Kinase CK2 
Regulates the DNA-Binding Activities of the 
Papillomavirus E1 and E2 Proteins
The viral E1 and E2 proteins are site-specifi c DNA-
binding proteins that recognize specifi c binding sites 
in the viral genome and together control viral gene ex-
pression and viral DNA replication. E2 binds to mul-
tiple binding sites in the E2-dependent enhancer and 
activates or represses viral gene expression, whereas E1 
binds to a small cluster of sites in the origin of DNA 
replication (ori) and prepares the ori for initiation of 
DNA replication. E1 also functions as the replicative 
DNA helicase. The viral life cycle consists of at least 
two distinct stages. In the latent stage, the early viral 
genes are expressed and the viral DNA is replicated 
at a low level. In the vegetative stage, the late viral 
genes (such as the capsid proteins) are also expressed, 
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the viral DNA is replicated at a very high level, and 
new virus particles are assembled. It is believed that 
the transition from the latent stage is controlled by 
the differentiation of the infected cells and likely in-
volves changes in cellular gene expression. However, 
the precise signals that trigger the switch to vegetative 
replication are unknown.
We wanted to determine whether phosphorylation 
of the viral E1 protein has a role in the viral life cycle. 
It is well established that E1 can be phosphorylated by 
the protein kinase CK2 in vitro. To determine what 
the effects of such phosphorylation events were, we 
subjected recombinant E1, purifi ed from Escherichia 
coli, to CK2 phosphorylation and tested the protein 
in various in vitro assays related to initiation of DNA 
replication. Interestingly, CK2 phosphorylation of E1 
resulted in loss of sequence-specifi c DNA binding. To 
map the phosphorylation sites responsible for inactiva-
tion, we tested the amino-terminal half of E1 (E11-308), 
which contains the E1 DNA-binding domain (DBD), 
for binding with or without phosphorylation. This 
fragment was also inactivated for DNA binding, dem-
onstrating that the inactivating sites are present in the 
amino-terminal half of E1. In collaboration with Dr. 
C. Ruse (CSHL Proteomics facility), we performed 
mass spectrometric analysis of E1 phosphorylated by 
CK2 in vitro and identifi ed multiple phosphorylation 
sites in the amino-terminal domain, each of which was 
individually capable of inactivating E1 DNA binding. 
Interestingly, no phosphorylation sites were present 
in the E1 DBD, demonstrating that phosphorylation 
events outside the E1 DBD inactivate DNA binding. 
Consistent with this result, the isolated E1 DBD could 
not be inactivated by CK2 phosphorylation. Inspired 
by this result, we next examined the effect of CK2 on 
the E2 protein. Previous studies have indicated that 
CK2 phosphorylation affects the half-life of E2. In-
stead, we found that similar to the effect on E1, CK2 
phosphorylation resulted in complete loss of E2 DNA-
binding activity. Also as in E1, the phosphorylation 
sites responsible for the inactivation of DNA binding 
are located outside the E2 DBD, demonstrating that 
the inactivation of the DBD is not caused by direct 
phosphorylation of the DNA-binding surface.
To determine precisely what role CK2 phosphory-
lation of E1 and E2 has in the viral life cycle, we mu-
tated all of the CK2 sites in the amino terminus of E1 
and the two sites in E2 in the context of the papillo-
mavirus genome. We then tested the mutant genomes 
for viral DNA replication and transformation in a cell 
culture system that represents the latent stage of the 
viral life cycle. The phosphorylation site mutations in 
E2 showed a greatly increased level of viral DNA rep-
lication and also increased the morphological trans-
formation as measured by focus formation, indicating 
that phosphorylation at these sites has an important 
role in the viral life cycle. Surprisingly, however, the 
phosphorylation mutations in the amino terminus of 
E1 had no obvious phenotype. We believe that this 
lack of a phenotype indicates that phosphorylation of 
E1 likely has a role during the vegetative stage of the 
viral life cycle.
A Dynamic Look at DNA Unwinding by the 
E1 Replicative Helicase
Hexameric helicases perform functions conserved 
throughout evolution, including unwinding the DNA 
double helix during replication. Despite their promi-
nent roles in biology, some of the basic aspects of these 
helicases, such as whether they use a strand exclusion 
mechanism or whether they translocate along double-
stranded DNA, have been subjects of considerable de-
bate. Viral replicative helicases, such as SV40 large-T 
antigen (Tag) and papillomavirus E1, have provided 
the opportunity to study some of these basic features 
largely because of their homohexameric architecture. 
These viral helicases form double hexameric (DH) 
structures on their respective origins of DNA replica-
tion and unwind the DNA bidirectionally. It is well 
established that E1 can form hexamers with helicase 
activity on single-stranded DNA (ssDNA), and in the 
structure of the hexameric E1 helicase with ssDNA, 
the orientation is such that the amino-terminal part 
of the polypeptide is closest to the 5′ end of the DNA. 
Given that E1 is a 3′-5′ helicase, this would mean 
that the hexamers translocate with the amino termi-
nus leading and that the two hexamers have to pass 
each other in order to unwind DNA. Although this 
is a very clear result, earlier electron microscopy data 
from Tag has indicated that perhaps the DH unwinds 
DNA in a manner fundamentally different from that 
of the hexamer. These data suggested that the DH 
encircles double-stranded DNA (dsDNA) and uses 
a pumping mechanism for unwinding. In collabora-
tion with L. Joshua-Tor at CSHL and Taekjip Ha at 
the University of Illinois, we set out to distinguish 
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between these possibilities. We fi rst demonstrated, 
using fl uorescence resonance energy transfer (FRET) 
analysis with fl uorescent labels on the DNA and on 
the protein, that the orientation of ssDNA relative to 
E1 is the same in solution as was observed in the E1 
structure. Second, we wanted to distinguish between 
models where one or two strands pass through the 
DH ring. It has been shown that some hexameric he-
licases can displace streptavidin bound to a biotinyl-
ated template in the process of unwinding. We used 
this ability to determine whether one or both strands 
pass through the hexameric ring. We assembled the 
double trimer (DT) on an ori containing a strepta-
vidin on either the 5′ end or 3′ end. The DT can 
be converted to a DH, which then unwinds the ori, 
generating ssDNA. Under these conditions, we could 
observe displacement of the 5′ streptavidin but not 
of the 3′ streptavidin, effectively ruling out a mech-
anism where both strands pass through the central 
channel of the DH and proving that E1 uses a strand 
exclusion mechanism for unwinding by both the E1 
hexamer and DH.
PUBLICATIONS
Schuck S, Ruse C, Stenlund A. 2013. CK2 phosphorylation inacti-
vates DNA binding by the papillomavirus E1 and E2 proteins. J 
Virol 87: 7668–7679. 
In Press
Lee S-J, Syed S, Enemark EJ, Schuck S, Stenlund A, Ha T, Joshua-Tor 
L. 2014. Dynamic look at DNA unwinding by a replicative heli-
case. Proc Natl Acad Sci (in press).
029-058_CancerGeneReg.indb   51 28-10-2014   10:49:33
52
DNA REPLICATION AND CHROMATIN INHERITANCE
B. Stillman W. Gao N. Kara S. Ni
 M. Hossain A. Mazurek Y.-J. Sheu
 J. Jansen S. Nandi P. Wendel
Replication of the genome in eukaryotes has been 
the focus of this laboratory for 35 years at Cold 
Spring Harbor Laboratory. During that time, we 
have progressed from a very superfi cial understand-
ing of how the DNA double helix within each chro-
mosome is duplicated to detailed insights into both 
the mechanism and control of this complex process. 
In particular, studies in recent years have focused 
on understanding the initiation of DNA replication 
that is orchestrated by the origin recognition com-
plex (ORC), an ATPase machine that loads other 
proteins onto DNA prior to actual DNA synthesis. 
ORC and its associated proteins, the Cdc6 ATPase 
and the Mcm2-7 hexamer with its chaperone Cdt1, 
establish a prereplicative complex (pre-RC) at each 
origin of DNA replication during the G1 phase of 
the cell division cycle. We have reconstituted pre-RC 
assembly in vitro with purifi ed proteins and are now 
investigating the structure of various complexes that 
are formed during pre-RC assembly and the next 
steps that load the DNA polymerases and other pro-
teins that actually replicate the DNA. A key event 
during pre-RC assembly is the formation of a double 
hexamer of the Mcm2-7 complex, with each hexamer 
destined to become part of the active DNA helicase 
at the DNA replication fork. We have also studied 
how pre-RC assembly and activation to form two 
replication forks at each origin are regulated during 
the cell division cycle.
Dbf4-Cdc7 Control of Pre-RC Assembly 
and Origin Utilization
During each cell division cycle, DNA synthesis in 
eukaryotic cells starts from multiple replication ori-
gins of DNA replication that are scattered along each 
chromosome. Replication from each origin only oc-
curs once, thereby ensuring uniform duplication of 
DNA across the entire genome. The spatial and tem-
poral control of initiation of DNA replication and 
the subsequent DNA synthesis at replication forks are 
both highly regulated by a number of protein kinases 
that ensure genome integrity. The protein kinases 
include the cyclin-dependent protein kinases cyclin 
E/CDK2 and cyclin A/CdK2 in human cells and the 
related Clb5/Cdc28 in yeast. Other investigators have 
shown that Clb5/Cdc28 phosphorylate two proteins, 
Sld2 and Sld3, that then bind the Dpb11 protein; 
somehow this trimeric complex facilitates activation 
of the Mcm2-7 double hexamer to convert into active 
DNA helicases.
A second protein kinase, the Dbf4-dependent Cdc7 
kinase (DDK), is known to phosphorylate Mcm2-7 
hexamer subunits, particularly Mcm4 and Mcm2. 
Previous studies from this laboratory have shown that 
DDK binds to a domain within the Mcm4 protein and 
phosphorylates an unstructured region of Mcm4 near 
its amino terminus. DDK phosphorylation of Mcm4 
is required for the initiation of DNA replication, and 
removal of the phosphorylation sites in Mcm4 allows 
yeast to proliferate in the absence of DDK. Thus, the 
only essential activity of DDK is to inactivate an in-
trinsic inhibitor of the initiation of DNA replication 
that resides in the Mcm4 subunit, a part of the Mcm2-
7 double-hexamer structure.
In the past year, we have performed a comprehen-
sive analysis of the patterns of origin activation, rep-
lication fork progression, and checkpoint responses 
in cells under replication stress. DNA replication was 
monitored by pulse labeling nascent DNA strands 
and then isolating them and sequencing the entire 
DNA, thereby mapping replicated regions of the ge-
nome. The addition of hydroxyurea, an inhibitor of 
the enzyme ribonucleotide reductase that is essen-
tial for production of the dNTP precursors for DNA 
synthesis, causes replication forks to slow down con-
siderably. At the same time, dNTP depletion trig-
gers Rad53 kinase-mediated checkpoint signaling 
that then prevents the activation of pre-RCs at ori-
gins that have not yet fi red (so-called late origins). 
The studies showed that the Mcm4 amino-terminal 
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domain, which is intrinsic to the replicative heli-
case, integrates multiple kinase signaling pathways 
to control various aspects of the genome duplication 
process. DDK and CDK both target the structurally 
disordered amino-terminal serine/threonine-rich 
domain (NSD) of Mcm4. Using whole-genome rep-
lication profi le analysis and single-molecule DNA 
fi ber analysis, the results suggested that under rep-
lication stress, the temporal pattern of origin acti-
vation and DNA replication fork progression were 
altered in cells with mutations within two separate 
segments of the Mcm4 NSD. The proximal segment 
of NSD (closer to the ATPase domain of Mcm4) re-
siding next to the DDK-docking domain mediated 
repression of late origin fi ring by checkpoint signals, 
because in its absence, late origins were activated de-
spite an elevated DNA-damage checkpoint response. 
In contrast, the distal segment of the NSD at the 
very amino terminus of Mcm4 had no role in the 
temporal pattern of origin fi ring but had a strong 
infl uence on replication fork progression and on 
checkpoint signaling (Fig. 1). Both fork progression 
and checkpoint response were regulated by the phos-
phorylation of the canonical CDK sites at the distal 
NSD. Together, the data suggest that the eukaryotic 
MCM helicase contains an intrinsic regulatory do-
main that integrates multiple signals to coordinate 
origin activation and replication fork progression 
under stress conditions.
The studies suggest mechanisms by which eu-
karyotic cells modulate the pattern of replication in 
response to environmental conditions through the rep-
licative helicase.
In other studies related to the function of the ORC 
and the pre-RC assembly apparatus, we have contin-
ued to investigate the structure and function of the 
ORC subunits in human cells. We have previously 
shown that the Orc2 and Orc3 subunits localize to the 
kinetochores of centromeres during mitosis in human 
cells. More recently, we have shown that both of these 
subunits form a complex with the BubR1 checkpoint 
protein kinase that controls the attachment of micro-
tubule spindles to kinetochores. BubR1 is part of a 
checkpoint process that ensures that the kinetochores 
of all duplicated sister chromatids are attached to 
spindles directed to both poles of the mitotic spindles 
apparatus so that the sister chromatids can be evenly 
segregated to both poles of the dividing cell. The as-
sociation of Orc2 and Orc3 with BubR1 requires the 
protein kinases cyclin B/CDK1 and PLK1, both regu-
lators of progression through mitosis. Current efforts 
are designed to determine the function of the Orc1 
and Orc3 interaction with BubR1.
DDX5, a Regulator of Cell Proliferation 
in Leukemia Cells
Our laboratory has previously demonstrated that the 
DDX5 protein is required for the E2F1-dependent ex-
pression of DNA replication genes in a subset of epithe-
lial cancers, notably 25% of breast cancer cells. DDX5 
was identifi ed via a genetic screen for proteins that are 
required for DNA replication in epithelial cells. Sur-
prisingly, DDX5 was the only one required in a sub-
set of cancer cells and not in normal cells, and in the 
cells in which it is essential, the DDX5 gene was either 
amplifi ed or overexpressed. More recently, in collabo-
ration with Drs. Scott Lowe (formerly at CSHL and 
now at Memorial Sloan-Kettering Cancer Center) and 
Chris Vakoc, a series of human and mouse acute my-
eloid leukemia (AML) cell lines were tested for depen-
dence of AML cell proliferation on DDX5 expression. 
Depletion of DDX5 caused apoptosis in the leukemia 
cells (different from the induced senescence in DDX5-
sensitive breast cancer cells), and examination of the 
mechanism revealed the induction of reactive oxygen 
species (ROS) in these cells. Gene expression (RNA-
Seq) analysis, in collaboration with Dr. Jesse Gillis, 
of the RNA isolated from cells that had either normal 
Figure 1.  The structure of the Mcm4 subunit of the Mcm2-7 
hexameric helicase showing the amino-terminal nonstructured 
domain (NSD) that is a target for multiple protein kinases that 
regulate DNA replication.
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DDX5 expression or DDX5 depletion demonstrated 
that genes associated with metabolism of glucose were 
selectively inhibited in the absence of DDX5. Block-
ing ROS accumulation with the oxygen radical scav-
enger N-acetyl-l-cysteine prevented apoptosis. DDX5-
induced apoptosis was also blocked by overexpression 
of the BCL2 anti-apoptotic regulator, and inhibition 
of BCL2 with the anticancer drug ABT-737 enhanced 
the effect of depleting DDX5, suggesting that combina-
tion therapy might be a valuable approach to treating 
chemotherapy- resis tant AML.
The results with both epithelial breast can-
cer cells and AML in mice showed that inhibiting 
DDX5 might be a good strategy for anticancer therapy, 
particularly in combination with drugs that enhance 
apoptosis. The next question asked was how to deter-
mine the effect of depleting DDX5 in normal cells in 
the body—that is, are there any side effects of depleting 
DDX5 in an adult animal? The reason why this was of 
concern is that DDX5 knockout mice die during early 
embryogenesis, but the effect of depletion in adult 
mice was not determined. Using doxycycline-regulated 
small hairpin RNAs (shRNAs) that were expressed in 
all tissues of mice, it was demonstrated that inhibition 
of DDX5 in normal tissues of the adult mouse did not 
have any phenotypic consequences. Thus, combina-
tion therapy of AML with inhibition of DDX5 may 
be safe and effective. The pathology analysis of these 
mice depended on analysis by Dr. John E. Wilkinson, 
our collaborating pathologist from the University of 
Michigan Cancer Center.
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CHROMATIN AND TRANSCRIPTIONAL REGULATORY 
MACHINERIES AS CANCER DEPENDENCIES
C.R. Vakoc A. Bhagwat S. Kawaoka J. Milazzo K. Palacios-Flores C. Shen E. Wang
 A. Hohmann F. Mercan J. Minder J. Roe J. Shi Y. Xu
Cancer cells exploit the chromatin regulatory ma-
chinery to maintain oncogenic transcriptional pro-
grams. This is particularly evident in leukemia, a he-
matopoietic cancer where genes encoding chromatin 
regulators often function as driver oncogenes and/or 
tumor suppressors. Hence, many forms of leukemia 
can be considered a direct consequence of deregulated 
chromatin signaling. In our laboratory, we investigate 
how chromatin regulatory proteins participate in the 
pathogenesis of cancer.
Mechanistic Studies of Brd4, a Chromatin 
Reader and Drug Target in Leukemia
F. Mercan, K. Palacios-Flores, J. Roe, C. Shen, J. Shi, 
Y. Xu [in collaboration with B. Nelson, Cold Spring 
Harbor Laboratory; R. Young, Massachusetts Institute 
of Technology, Boston; J. Bradner, Harvard Medical 
School, Boston]
Original studies from our laboratory in 2011 identi-
fi ed the BET (bromodomain and extra-terminal) bro-
modomain protein Brd4 as a leukemia dependency 
and drug target in acute myeloid leukemia. In 2013, 
Brd4 inhibitors entered Phase-1 clinical trials in leu-
kemia patients. A major focus of our current work is 
to defi ne the disease-relevant molecular mechanism 
of Brd4 function in leukemia. We have pursued this 
question using a host of genetic and biochemical ap-
proaches and have made substantial progress in defi n-
ing a “Brd4 pathway” composed of critical cis- and 
trans-acting components that fuel uncontrolled cell 
growth in leukemia.
One area of focus has been to defi ne the key cis-
elements used by Brd4 to regulate its important 
target genes in leukemia cells. Using chromatin im-
munoprecipitation followed by deep sequencing, we 
completed a genome-wide survey of Brd4-occupied 
sites along the leukemia genome. One remarkable 
observation from these studies has been the realiza-
tion that a number of Brd4-dependent genes possess 
large clusters of distal enhancer elements that exhibit 
profound occupancy of Brd4. These large clusters of 
enhancers, recently termed superenhancers, appear 
to be the functionally relevant mode of Brd4-depen-
dent gene regulation. For example, the Myc gene is 
among the most Brd4-dependent in its expression 
and the Myc locus possesses one of the largest Brd4 
superenhancers in the leukemia genome. We have 
performed extensive experiments to assign Myc as 
the relevant target gene of this distal superenhancer, 
which required chromosome conformation capture 
technology (3C and 4C). Interestingly, the Myc su-
perenhancer closely corresponds to a region found 
previously as a site of recurrent focal amplifi cation in 
leukemia patients. These experiments substantially 
clarify the mechanism of transcriptional regulation 
performed by Brd4 to support leukemia mainte-
nance.
An additional area of investigation has been to 
identify the critical lysine acetyltransferases that gen-
erate docking sites for Brd4 on chromatin. Through 
a genetic screening approach, we pinpointed the 
acetyltransferase enzyme p300 as the critical up-
stream recruiter of Brd4 at many of its critical target 
genes. Pharmacological inhibition of p300 catalytic 
activity results in severe displacement of Brd4 from 
chromatin. Having pinpointed the catalytic activity 
of p300 as crucial for Brd4 recruitment to chroma-
tin, ongoing studies aim to determine the critical 
substrates of p300 that facilitate Brd4 recruitment. 
On the basis of specifi c patterns of Brd4 chromatin 
immunoprecipitation sequencing (ChIP-Seq), we are 
focusing our analysis on hematopoietic transcription 
factors as potential acetylated factors that support 
Brd4 recruitment.
Another area of mechanistic investigation has been 
the identifi cation of candidate effectors of Brd4 (i.e., 
interacting partners of Brd4 that facilitate transcrip-
tional activation). Through immunoprecipitation 
mass-spectrometry analysis, we have found a litany 
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of Brd4-associated proteins. By fi ltering of candidates 
through genetic criteria of having critical roles in leu-
kemia maintenance, we were led to the Nsd3 protein. 
Nsd3 is a SET-domain-containing histone H3K36 
methyltransferase that is not currently well-studied. 
We found that Nsd3 is recruited to the majority of 
Brd4-occupied enhancers in the genome. In ongoing 
studies, we are trying to dissect the molecular mecha-
nism through which Nsd3 promotes Brd4 function 
at superenhancers.
Currently available small molecules that target 
Brd4, even those in current clinical trials, lack speci-
fi city and inhibit all members of the BET bromodo-
main family (Brd2, Brd3, and Brdt). Furthermore, 
these small molecules also lack selectivity among 
the two Brd4 bromodomains. Hence, it is likely that 
the therapeutic index of Brd4 inhibitors could be 
improved upon by achieving a greater degree of se-
lectivity among the BET family. We have sought to 
explore this question using protein engineering as a 
means to generate highly selective probes that inhibit 
individual bromodomains in the BET family. Using 
phage display, we have generated specifi c short pep-
tides (selected among random libraries) that can se-
lectivity bind to the bromodomains of Brd4 and can 
compete with acetyl-histone binding. Remarkably, 
we have identifi ed specifi c peptides that can discrim-
inate between the two bromodomains of Brd4. We 
will continue to develop these approaches to generate 
highly specifi c probes that be genetically introduced 
into cells to defi ne the ideal means of targeting Brd4 
in vivo to maximize the therapeutic index of this 
approach.
Role of the SWI/SNF Chromatin 
Remodeling Complex in Cancer 
Pathogenesis
A. Hohmann, J. Shi, J. Milazzo, J. Minder [in collaboration 
with D. Spector and L. Joshua-Tor, Cold Spring Harbor 
Laboratory; R. Young, Massachusetts Institute of 
Technology, Boston]
Cancer cells frequently depend on chromatin regu-
latory activities to maintain a malignant phenotype. 
Using nonbiased small hairpin RNA (shRNA) screen-
ing of chromatin regulator dependencies in cancer, we 
have discovered that leukemia cells require the mam-
malian SWI/SNF chromatin remodeling complex 
for their survival and aberrant self-renewal potential. 
Although Brg1, an ATPase subunit of SWI/SNF, is 
known to suppress tumor formation in several cell 
types, we found that leukemia cells instead rely on 
Brg1 to support their oncogenic transcriptional pro-
gram, which includes Myc as one of its key targets. 
To account for this context-specifi c function, we dis-
covered a cluster of lineage-specifi c enhancers located 
1.7 Mb downstream from Myc that are occupied by 
SWI/SNF as well as the BET protein Brd4. Brg1 is re-
quired at these distal elements to maintain transcrip-
tion factor occupancy and for long-range chromatin 
looping interactions with the Myc promoter. Notably, 
these distal Myc enhancers coincide with a region 
that is focally amplifi ed in ~3% of acute myeloid leu-
kemias. Together, these fi ndings defi ne a leukemia 
maintenance function for SWI/SNF that is linked to 
enhancer-mediated gene regulation, providing general 
insights into how cancer cells exploit transcriptional 
coactivators to maintain oncogenic gene expression 
programs.
A major unanswered question raised by our fi nd-
ings is how SWI/SNF can have these dual roles both 
in tumor protection and in tumor formation. We 
hypothesize that the answer lies in the polymor-
phic nature of SWI/SNF complexes, which can 
be formed from a variety of constituent subunits 
to generate highly diverse complex assemblies. We 
are currently performing genetic screens that aim to 
defi ne specifi c SWI/SNF subunits that are linked 
to tumor maintenance, but which lack tumor pro-
tective functions. We aim to direct our therapeutic 
approaches to target such subunits in future drug 
discovery efforts.
A Mediator Complex of Oncogenic 
Signal Transduction
A. Bhagwat
The major focus of this project is to evaluate the 
Mediator complex as a therapeutic target in acute 
myeloid leukemia (AML). Cancer cells are often 
dependent on aberrant transcriptional programs 
to maintain their tumorigenic state. Therefore, 
rationale exists to therapeutically target oncogen-
ic transcription factors. A major obstacle in this 
pursuit arises from the structure of DNA-binding 
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transcription factors, which generally lack the deep 
hydrophobic pockets that are amenable to small-
molecule-based inhibition. As an alternate strategy, 
we have undertaken efforts to target transcriptional 
coactivators, which have already revealed promis-
ing opportunities for drug discovery (e.g., Brd4). 
To advance this idea, we are evaluating the Media-
tor complex, a critical coactivator that relays regu-
latory signals from sequence-specifi c transcription 
factors to the core transcriptional machinery. We 
hypothesize that targeting individual subunits of 
Mediator will provide a means of interrupting the 
function of select oncogenic transcription factors. 
Using a functional genetic approach, we have pin-
pointed the Med12, Med13, Med23, and Med24 
subunits of Mediator as being selectively required 
for leukemia proliferation, whereas other subunits 
are more generally required for cell proliferation. 
This project will focus on evaluating the mecha-
nism of addiction of AML to these Mediator sub-
units. This will entail cellular, transcriptional, and 
epigenomic characterization of Mediator function 
in AML, as well as an in vivo exploration of Med12 
function.
Histone H2B Ubiquitin Ligase RNF20 
as an Oncogenic Cofactor for 
MLL Fusion Proteins
E. Wang [in collaboration with R. Roeder, 
Rockefeller University]
MLL-fusions are potent oncogenes that initiate ag-
gressive forms of acute leukemia. As aberrant tran-
scriptional regulators, MLL-fusion proteins alter gene 
expression in hematopoietic cells through interac-
tions with the histone H3 lysine 79 (H3K79) meth-
yltransferase DOT1L. Notably, interference with 
MLL-fusion cofactors such as DOT1L is an emerging 
therapeutic strategy in this disease. We have identi-
fi ed the histone H2B E3 ubiquitin ligase Rnf20 as an 
additional chromatin regulator that is necessary for 
MLL-fusion-mediated leukemogenesis. Suppressing 
the expression of Rnf20 in diverse models of MLL-
rearranged leukemia leads to inhibition of cell pro-
liferation, under tissue culture conditions as well as 
in vivo. Rnf20 knockdown leads to reduced expres-
sion of MLL-fusion target genes, including Hoxa9 
and Meis1—effects resembling DOT1L inhibition. 
Using ChIP-Seq, we found that H2B ubiquitina-
tion (H2Bub) is enriched in the body of MLL-fusion 
target genes, correlating with sites of H3K79 meth-
ylation and transcription elongation. Furthermore, 
Rnf20 is required to maintain local levels of H3K79 
methylation by DOT1L at Hoxa9 and Meis1. These 
fi ndings support a model whereby cotranscriptional 
recruitment of Rnf20 at MLL-fusion target genes 
leads to amplifi cation of DOT1L-mediated H3K79 
methylation, thereby rendering leukemia cells depen-
dent on Rnf20 to maintain their oncogenic transcrip-
tional program.
Chromatin Reader Protein 
TRIM33 Regulates Cell Survival 
in Therapy-Resistant Acute 
Lymphoblastic Leukemia
S. Kawaoka [in collaboration with Y. Suzuki, 
University of Tokyo]
We have recently extended our epigenetic screening 
platform into the aggressive blood cancer acute lym-
phoblastic leukemia of B-cell origin (B-ALL). This 
disease model is driven by the BCR-ABL oncogene 
and is associated with a dismal prognosis. We evalu-
ated the role of all chromatin regulators in the pro-
liferation of these leukemia cells and have pinpoint-
ed a TRIM domain containing protein (TRIM33) 
in the pathogenesis of this disease. TRIM33 protein 
acts to support survival of B-ALL cells largely by re-
pressing tissue-specifi c enhancer function. Notably, 
knocking down expression of TRIM33 has minimal 
effects on heterologous cell types. We have recently 
completed genome-wide studies evaluating chroma-
tin occupancy of TRIM33 in B-ALL and are ex-
panding these studies into other cell lineages. From 
this work, we hope to gain a general model for how 
TRIM33 governs leukemia-specifi c transcriptional 
regulation.
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Gregory Hannon is a pioneer in the study of RNA interference (RNAi), a process in which 
double-stranded RNA molecules induce gene silencing. Hannon and colleagues have elucidated 
key elements of the RNAi machinery. During the past several years, the Hannon lab has focused 
on the roles of small RNAs in germ cells, which tend to have the most elaborate set of small 
RNA pathways of any cell type. They have discovered an essential role for small RNAs, called 
Piwi-interacting RNAs (piRNAs), that are critical for proper oocyte development and guard the 
genome against transposable elements. This year, the lab conducted two screens, one in the fruit 
fl y germline and another in somatic cells, to search for new components of the pathway that gen-
erates piRNAs. They identifi ed dozens of genes that are required for piRNA production, offering 
insight into how germ cells ensure genomic integrity. The Hannon lab also strives to understand 
the biology of cancer cells, with a focus on breast and pancreatic cancer. They have led the way 
in using RNAi to study cancer biology and genetics, generating libraries of short-hairpin RNAs 
(shRNAs) that have been widely applied in gene-silencing studies. These libraries can then be 
used to identify new therapeutic targets for specifi c disease subtypes. In addition, they are explor-
ing the roles of small RNAs as oncogenes and tumor suppressors and using genetic approaches to 
understand the biology of resistance to currently used cancer therapies. Another research thrust 
of Hannon’s team exploits the power of next-generation sequencing to understand the biology of 
the mammalian genome. Their efforts range from the identifi cation of new classes of small RNAs 
to understanding human evolution and diversity, including an emphasis on the evolution of the 
epigenome and its role in driving cell-fate specifi cation.
Alea Mills is studying genetic pathways important in cancer, aging, and autism, identifying the 
genetic players and determining how aberrations in their functions culminate in human disease. 
Through innovative use of a technique called “chromosome engineering,” the Mills group discov-
ered that one of the most common genetic alterations in autism—deletion of a 27-gene cluster on 
chromosome 16—causes autism-like features in mice. These autism-like movement impairments 
can be identifi ed just days after birth, suggesting that these features could be used to diagnose 
autism. Mills has also used chromosome engineering to identify a tumor suppressor gene that 
had eluded investigators for three decades. The gene, called Chd5, was shown by Mills to regulate 
an extensive cancer-preventing network. This year, the Mills lab uncovered how Chd5 acts as a 
tumor suppressor: It binds to a protein found within chromatin to turn specifi c genes on or off, 
halting cancer progression. The epigenetic role of Chd5 in development, cancer, and stem-cell 
maintenance is currently being investigated. The Mills lab is also studying p63 proteins, which 
regulate development, tumorigenesis, cellular senescence, and aging in vivo. They succeeded in 
halting the growth of malignant tumors by turning on production of one of the proteins encoded 
by the p63 gene, called TAp63. TAp63 also exerts other protective effects. This year, the Mills lab 
generated a mouse model which allowed them to fi nd that TAp63 is required to prevent a genetic 
disorder, known as EEC (ectrodactyly-ectodermal dysplasia cleft lip/palate syndrome), which is 
characterized by a cleft palate and major deformities of the skin and limbs in infants. In addition, 
they recently discovered that a different version of p63, called ΔNp63, reprograms stem cells of the 
skin to cause carcinoma development—the most prevalent form of human cancer. Modulation of 
these proteins may offer new ways to treat human malignancies in the future.
Scott Powers’ work focuses on gene alterations that cause cancer and factors that infl uence re-
sponses to specifi c anticancer drugs. His lab uses technologies that probe the entire genome to 
identify candidate cancer genes and evaluate their functional role in cell transformation and 
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tumor biology. They also use whole-genome technologies to guide development of novel cancer di-
agnostics and therapeutics. Using DNA copy number analysis, the Powers group pinpoints novel 
amplifi ed oncogenes and then applies functional studies to address the mechanisms by which they 
are implicated in oncogenesis. They have successfully applied this approach in breast, liver, colon, 
and lung cancers. Powers has also had an important role in the development of a distinctive CSHL 
approach to functional study of cancer genes. Called integrative oncogenomics, it is a rapid, large-
scale screen for genes that are deleted or amplifi ed in human cancers and suspected of being tumor 
suppressors, in the case of deletions, or oncogenes, in the case of amplifi cations.
Michael Wigler’s work provides a new paradigm for understanding and exploring human disease. 
The Wigler lab studies human cancer and the contribution of new mutation to genetic disorders. 
The cancer effort (with James Hicks, Alex Krasnitz, and Lloyd Trotman) focuses on breast and 
prostate cancers. It involves collaborative clinical studies to discover mutational patterns predict-
ing treatment response and outcome and the development of diagnostics to detect cancer cells in 
bodily fl uids such as blood and urine. The major tools are single-cell DNA and RNA analysis. The 
single-cell methods, which are in development, are also being applied to problems in neurobiol-
ogy (with Josh Huang and Pavel Osten) to characterize neuronal subtypes, somatic mutation, and 
monoallelic expression. The Wigler lab’s genetic efforts are a collaboration with Ivan Iossifov and 
Dan Levy, and this team focuses on determining the role of new mutations in pediatric disorders. 
In a large-scale population sequencing project with W. Richard McCombie and the Genome 
 Sequencing Center at Washington University in St. Louis, and supported by the Simons Founda-
tion, the team has proven the contribution of this mechanism to autism. The work further suggests 
a relationship between the mutational targets in autism and the process of neuroplasticity that lies 
at the heart of learning. Smaller-scale population studies of congenital heart disease and pediat-
ric cancer (collaborations with scientists at Columbia University and Memorial Sloan- Kettering 
 Cancer Center, respectively) also point to new mutation as a causal factor in these disorders.
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RNA INTERFERENCE MECHANISMS AND APPLICATIONS
G. Hannon D. Bressan D. Fagegaltier E. Harrison M. Mosquera E. Seah Jun Wen 
 K. Chang I. Falciatori E. Hodges J. Preall M. Soto Ruiz de la Torre
 B. Czech W.S. Goh M. Keane C. Rebbeck V. Vagin
 M. Delas Vives J. Gu S. Knott N. Rozhkov E. Wagenblast
 C. Dos Santos S. Gutierrez Angel M. Kudla E. Rozhkova K. Wasik
 O. El Demerdash A. Haase E. Lee L. Sabin Y. Yu
 N. Erard C. Hannon A. Maceli S. Sau X. Zhou
Our lab continues to focus on three distinct areas. 
First, we study RNA biology, with a focus on non-
coding RNAs. In particular, we are interested in a 
conserved pathway that protects animal germ cell ge-
nomes against parasitic genetic elements. Second, we 
study the roles of noncoding RNAs in cancer, mainly 
breast cancer, and use small RNAs as tools to uncover 
tumor-specifi c vulnerabilities as potential therapeutic 
targets. Third, we develop technologies, mainly in the 
areas of mammalian genetics and genomics. Histori-
cally, we have had a particular focus on using next-
generation sequencing to study epigenetic regulation, 
to identify disease-associated genes, and to help in the 
establishment of new model organisms.
Fred Rollins left and completed his M.B.A., and 
Stephanie Shaw and Andres Canela moved on to 
greener pastures. Assaf (Gordy) Gordon, who had be-
come a fi xture in the computational world at CSHL, 
decided to leave the world of science; however, after a 
short stint in chilly Canada, he moved back to Boston 
to work with former student Yaniv Erlich. Antoine 
Molaro took his special style of science to the West 
Coast as a postdoc at the Hutch, Poppy Gould moved 
back to the U.K. as a graduate student, and Yicheng 
Luo joined former postdoc Alexei Aravin’s lab. Marte 
Andres Terre became a student in sunny California, 
and we also said good-bye to undergraduates Jorge 
Ruiz and Jessica Oberheim.
We were joined this year by several undergradu-
ates: Eugene Seah, who will remain as a grad student, 
and Elvin’s Spanish helpers Sara Gutierrez Angel 
and Mar Soto Ruiz de la Torre, both of whom will 
join graduate programs in Europe. Jiaqi Gu took on 
the diffi cult job of focusing Yang Yu, and Osama El 
 Demerdash stepped in to fi ll Gordy’s very large shoes. 
A selected set of laboratory projects are described in 
detail below.
A Novel Technology for the Recovery 
of Biomolecules
D. Bressan
This past year, I have been in the process of complet-
ing the development of a novel technology for the re-
covery of biomolecules, namely, proteins and their as-
sociated nucleic acids, from spatially restricted areas in 
heterogeneous tissue samples. The method, which we 
named laserTAG, is based on the interaction between 
a protein tag fused to a cellular protein of interest and 
a light-activatable ligand, specifi c for the tag, that is 
attached to it only following light irradiation. The li-
gand is functionalized with a group allowing the af-
fi nity purifi cation of the labeled complex. We used 
this system to perform chromatin pull-down from 
heterogeneous cell cultures and profi le chromatin 
structure through analysis of the histone-associated 
DNA. Additional work is currently under way to im-
prove the performance of the technique as well as to 
develop additional applications.
RNAi as a Path to Target Discovery 
for Breast Cancer Treatment
K. Chang
Genome-Scale Screening Approach. Breast cancer 
is a heterogeneous disease that can be clinically cat-
egorized into three therapeutic subgroups: estrogen 
receptor (ER) positive, HER2 amplifi ed, and triple 
negative (basal-like). The ER-positive (most diverse 
and numerous) and the Her2-amplifi ed subgroups 
account for 80%–85% of all human breast cancers, 
whereas patients diagnosed with the triple-negative 
subtype have the most aggressive form of the dis-
ease and often have poor prognosis. Our goal is to 
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apply genome-wide, loss-of-function RNA interfer-
ence (RNAi) screens in cell culture to uncover vul-
nerabilities of breast cancer cells in all subtypes and 
discover genes and pathways that modify responses to 
targeted therapies (lapatinib, trastuzumab, tamoxifen, 
and estrogen deprivation) for de novo and acquired 
resistance. We have been using both established and 
novel preclinical models from collaborators (includ-
ing Dennis Slamon, University of California, Los 
 Angeles, and Rachel Schiff, Baylor College of Medi-
cine) to conduct RNAi screens in order to identify 
novel therapeutic targets/drugs that can be translated 
to the clinic. This study is funded by the Stand Up 
to  Cancer (SU2C) foundation and the NWCRA 
(National Women’s Cancer Research Alliance)/EIF 
(Entertainment Industry Foundation).
Through a collaborative effort with Dr. Stephen 
Elledge (Harvard Medical School), we have complet-
ed 34 genome-wide screens (28 screens in the Hannon 
lab and six screens in the Elledge lab) representing all 
three therapeutic treatment classes. To date, 17 of 
the 28 CSHL RNAi screens have been deconvoluted 
(deep sequenced), and sequencing of the remaining 
screens is ongoing. Various vulnerabilities have been 
identifi ed for the Her2-positive and hormone-recep-
tor-positive breast cancer subtypes as well as modifi ers 
of trastuzumab resistance.
Focused RNAi Screens Using an In Vivo Ap-
proach. Three-dimensional culture systems mim-
icking the spherical organization of breast epithelial 
cells recapitulate much of the morphogenetic pro-
grams of mammary development and thus are useful 
tools to address how breast cancer cells survive in a 
more physiological context than in two-dimensional 
cell culture. Although these are valuable tools to gain 
insight into mammary gland biology during normal 
and cancer development, we aim to study the behav-
ior of breast cancer cells in a more natural environ-
ment. To this end, we are developing RNAi screens 
in vivo using cells derived from human primary 
tumors engrafted into immunocompromised mice. 
We have acquired patient tumor-derived  xenografts 
(PDXs) from Dr. Alana Welm (University of Utah) 
and are expanding these PDXs in vivo to obtain suf-
fi cient quantities of tumor cells for in vivo screen-
ing. On the basis of collaborative studies with the 
Dr. Charles Sawyers lab (Memorial Sloan-Ketter-
ing Cancer  Center), data supports the notion that 
 subpopulations of cells within a tumor could enrich 
stochastically during tumorigenesis. This poses a 
problem for RNAi screens in solid tumors by ham-
pering target identifi cation. Thus, we have embarked 
on a study to gain a deeper understanding of tumor 
heterogeneity in breast PDX cells by tracking tagged 
subpopulations of tumor cells during primary tumor 
establishment and metastasis. This study will provide 
the basis for developing a more optimized approach 
to RNAi screening of clinical samples in vivo.
Molecular Characterization of piRNA 
Biogenesis in Drosophila
B. Czech
The Piwi-interacting RNA (piRNA) pathway pro-
vides a sophisticated defense mechanism that protects 
the genetic information of animal germ cells from the 
deleterious effects of molecular parasites such as trans-
posable elements. This conserved small RNA silenc-
ing system consists of Piwi-clade Argonaute proteins 
and their associated 24–28-nucleotide RNA-binding 
partners, the piRNAs. piRNAs typically descend 
from acute transposon mobilization events and from 
piRNA clusters, which provide a genomic memory 
of ancestral transposon activity, through the coordi-
nated activity of several processing factors. Although 
a candidate nuclease, called Zucchini, has been identi-
fi ed, the precise mechanism that converts transposon 
and cluster transcripts into mature piRNAs remains 
largely elusive.
We have recently performed a reverse genetic 
screen that aimed to fi nd all genes that participate 
in piRNA-mediated genomic defense. Follow-up ex-
periments have revealed a number of previously un-
known factors that are crucial for piRNA biogenesis. 
Through genetic experiments combined with high-
throughput sequencing, we identifi ed two proteins, 
termed GASZ and PIMP, that are essential for the 
production of piRNAs from cluster transcripts. In-
terestingly, both proteins share their cellular localiza-
tion on the outer surface of mitochondria with the 
presumed nuclease Zucchini. Using genetic, molecu-
lar, and biochemical approaches, we are currently 
dissecting the specifi c roles of each of these factors 
individually, as well as their interplay, in order to fully 
understand the molecular mechanism of the piRNA 
processing machinery.
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Mouse Mammary Glands
C. Dos Santos
During the past few years, we have sought to defi ne 
the changes in DNA methylation and gene expression 
that are induced by pregnancy in the mouse mam-
mary gland. We investigated how pregnancy-induced 
changes control normal mammary gland development 
and how these modifi cations could protect from breast 
cancer development. We have found that pregnancy 
brings about profound epigenetic remodeling, alter-
ing the character of well-defi ned cell types within the 
mammary gland. Most relevant is that these epigen-
etic modifi cations persist as a long-term memory in 
the mammary epithelium, even after the signals from 
pregnancy are long gone. Many of the pregnancy-asso-
ciated changes in DNA methylation encompass STAT-
binding sites. Thus, changes in STAT transcription-
factor-regulated gene expression might contribute to 
long-term changes in cancer risk. We are currently 
validating genes that presented pregnancy-associated 
changes at DNA methylation levels and expression lev-
els with regard to their ability to prevent mammary 
gland cell transformation in vitro and in vivo.
A Role of Germline PIWI Proteins and 
piRNAs in Cancer
D. Fagegaltier
PIWI proteins are detected in several human and 
mouse tumors, yet no direct link has been established 
between cancer and a piRNA response to genome insta-
bility. In a STARR Cancer Consortium collaboration, 
we have derived a large collection of immortalized cell 
lines from Drosophila embryos expressing an activated 
oncogene or mutant for a tumor suppressor gene. The 
comparison of their transcriptomes provides a com-
prehensive view of how genomes coordinate their ge-
netic and epigenetic responses to acquire a transformed 
state under the stress of specifi c oncogene and tumor 
suppressor-activated signaling pathways. We identifi ed 
cell lines expressing a complete piRNA machinery in-
cluding Aubergine (AUB) and Argonaute3 (AGO3), 
proteins known to amplify the piRNA response ex-
clusively in ovarian germ cells. The piRNA pathway 
in these cell lines is fully functional: Long transcripts 
derived from the major somatic piRNA cluster fl a-
menco are processed into characteristic piRNAs that 
eliminate transcripts made from transposable elements 
(TEs). Similar to the situation in germ cells, piRNA 
production is abolished, and TE transcripts are affect-
ed following the depletion of the major RNA nucleases 
and cofactors of PIWI (Zucchini or Armitage), but 
not AUB or AGO3. However PIWI-bound piRNAs 
present signatures that distinguish these fl y cancer 
cells from both somatic follicle cells (OSS) and germ 
cells: The piRNAs originate in part from clusters not 
active in OSS cells, and the bidirectionally transcribed 
piRNA cluster at 42AB, typical of germ cells, remains 
inactive. This work suggests the exciting possibility of 
a functional role for the piRNA pathway in cancer and 
identifi es Ras and Hippo as two major signaling path-
ways upstream of the response. The in vitro system 
will be an invaluable tool to characterize the role of the 
piRNAs in cancer and in the long term may provide a 
therapeutic target.
Role of Small RNAs in Mouse 
Spermatogenesis
I. Falciatori
Small RNAs are particularly important during mouse 
spermatogenesis. Both microRNAs (miRNAs) and 
piRNAs are expressed in the male germline, and sper-
matogenesis is defective in any situation in which one 
of these pathways is affected.
We identifi ed an X-linked miRNA cluster highly 
and specifi cally expressed in the male germline. To 
determine its role during different stages of spermato-
genesis, we aim to produce a conditional knockout and 
several Cre transgenic mouse lines. We engineered a 
bacterial artifi cial chromosome (BAC)-targeting con-
struct in which the miRNA cluster is surrounded by 
LoxP sites. However, our attempts to produce targeted 
embryonic stem cells (ESCs) by regular homologous 
recombination have so far failed. We therefore turned 
to the recently developed CRISPR engineering tech-
nology, which harbors the potential to improve target-
ing effi ciency. We are currently trying to target the 
cluster in mouse ESCs using this technology. We have 
already produced transgenic lines expressing the Cre 
recombinase in different stages of germ cell develop-
ment, and are currently testing the specifi city of Cre 
expression using a fl uorescent reporter mouse line. Ex-
periments to test the effect of overexpression of this 
miRNA cluster in ESCs are also under way.
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piRNAs and piwi proteins are part of a defense 
mechanism that acts during embryonic development 
to limit the mobility of TEs in the germline. As part 
of this mechanism, Miwi2 regulates TE expression 
level by inducing DNA methylation of their promot-
ers. However, the precise molecular and biochemical 
mechanism by which Miwi2 is able to direct the DNA 
methylation is currently unknown. Miwi2 is only ex-
pressed in germ cells during a very short window of 
embryonic development, making biochemical studies 
in this system particularly challenging. To overcome 
this hurdle, we are taking two different approaches. 
First, we are trying to develop an in vitro system to 
produce high numbers of embryonic germ cells by dif-
ferentiation from mouse or human ESCs. This will 
allow us not only to have ready access to a high num-
ber of embryonic germ cells, but also to use shRNA 
technologies to pinpoint possible intermediate players 
in the DNA methylation mechanism. As an alterna-
tive strategy, we produced transgenic mouse lines in 
which a Miwi2-GFP (green fl uorescent protein) fusion 
is expressed under the control of the Miwi promoter. 
Miwi is expressed starting at meiosis and is associated 
with a class of piRNAs (meiotic piRNAs) that differ 
in origin and sequence from those usually associated 
with miwi2. The ectopic expression of miwi2 in mei-
otic and postmeiotic germ cells increases the number 
and accessibility of cells expressing miwi2. It can also 
give insights into the targeting mechanism for DNA 
methylation because miwi2 should now be directed 
to ectopic locations by its association with the meiotic 
piRNA. So far, for all the lines we produced, the mice 
look healthy and fertile. We are currently testing the 
distribution of miwi2-GFP in the different transgenic 
lines. We will select two different lines to confi rm 
the association with meiotic piRNAs and analyze the 
genome-wide DNA methylation to establish whether 
methylation gets introduced in unusual locations 
under the direction of the meiotic piRNAs.
Asterix Is Essential for Transcriptional 
Silencing of Transposons in the 
Drosophila Germline
P.M. Guzzardo, F. Muerdter
piRNAs, together with Piwi-clade Argonaute pro-
teins, constitute an evolutionary conserved, germline-
specifi c small RNA silencing system. The piRNA 
pathway is implicated in gene silencing, particularly of 
repetitive elements, as well as germline differentiation 
and maintenance of germline stem cells. Accordingly, 
mutations in Piwi almost universally lead to steril-
ity and germ cell loss. In our current understanding, 
nuclear Piwi silences transposable elements at the level 
of transcription by inducing formation of repressive 
chromatin over transposon loci. However, it is unclear 
what other factors are involved in this process.
In a genome-wide RNAi screen in Drosophila ovar-
ian cells, we identifi ed asterix, a gene that is indis-
pensable for repression of endogenous retroelements. 
In vivo follow-up experiments revealed that knock-
down of asterix (CG3893) led to elevated transpo-
son transcript levels that were only paralleled by dis-
ruption of core components of the piRNA pathway. 
Nevertheless, mature piRNA populations remained 
unchanged, hinting toward a specifi c role in the ef-
fector step of the piRNA pathway. Indeed, disruption 
of asterix function leads to loss of repressive histone 
marks over transposon loci and massive up-regulation 
of their transcriptional activity. This points toward a 
central role of asterix in the Piwi-associated silencing 
complex.
Functional Analysis of Ectopic Germline 
Gene Expression in Cancer
A.D. Haase
Considerable similarities between germ cell develop-
ment and tumor progression have long been observed: 
Cancer cells, like germ cells, struggle in a complicated 
balance between genomic stability and fl exibility; 
both are considered immortal, and analogous to the 
migration of germ cells, cancer cells metastasize. To 
ensure genomic stability, germ cells use specialized 
RNAi pathways that silence transposons. At the core 
of these pathways are PIWI proteins and their associ-
ated small RNAs. Recent studies revealed expression 
of PIWI pathway components outside of the germline 
in various cancers, strengthening earlier observations 
of ectopic germline gene expression in cancer. Such 
germline genes are potentially ideal targets for diagno-
sis, therapy, and vaccination because of their restricted 
physiological expression and unique immunogenic 
properties. In collaboration with the laboratories of 
Dr. Gurinder Atwal (CSHL) and Dr. Robert Darnell, 
we initiated a project with the aim of systematically 
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investigating ectopic germline signatures and their 
functions in oncogenesis, through a multidisciplinary 
approach combining computational, molecular and 
biomedical methodologies. First, we will assemble a 
compendium of functional germline gene networks 
and characterize cancer/germline signatures compu-
tationally. Second, we will investigate the function 
and molecular mechanisms of piRNA pathways in 
cancer. Based on the importance of small RNA silenc-
ing pathways in development and disease and the vital 
function of piRNA pathways in the germline, we an-
ticipate uncovering a novel layer of gene regulation in 
cancer. Third, we will elucidate the function of germ-
line signatures in glioblastoma in vivo and evaluate 
their clinical potential. Overall, this work will provide 
comprehensive identifi cation and characterization of 
functional germline signatures in cancer with the aim 
of identifying candidate vaccine antigens, diagnostic 
markers, and therapeutic targets.
The Role of miRNAs in Mouse Embryonic 
Stem Cell Differentiation
M. Kudla
miRNAs are part of the posttranscriptional control 
mechanism inhibiting protein synthesis. The roles of 
particular miRNAs in the regulation of developmen-
tal processes have been studied extensively; however, 
the global image encompassing all interactions is still 
elusive. We focused our efforts on the embryonic stem 
cell differentiation process in a widely studied model 
of differentiation toward the neuronal progenitor cells. 
Thanks to the novel HITS-CLIP (high-throughput 
sequencing–cross-linking immunoprecipitation) tech-
nology applied to our research problem, we were able 
to obtain snapshots of the miRNAs acting on their 
transcriptome targets during key differentiation steps. 
Strict and conservative statistics provides backing to 
our list of candidate sites located in many embryonic 
stem cell transcripts. Functional analysis of the gene 
targets provides evidence for neuronal function-specif-
ic miRNA targeting. Validation of the gene list against 
the external coexpression data set confi rms progression 
of the miRNA targeting from nonspecifi c to highly 
brain-specifi c in neuronal progenitor cells. The unrav-
eled extent of this functional regulation shows the im-
portance of miRNA activity that forms a complex layer 
of regulation through its network-like effects.
Designation of piRNA Cluster Transcripts 
in the Drosophila Ovary
J. Preall
Transposon silencing in the Drosophila germline is a 
function of a specialized genomic immune system 
called the piRNA pathway that utilizes small RNAs 
to program a gene-silencing response targeted at harm-
ful genetic elements. piRNA production is fueled by 
genomically encoded piRNA clusters that are tran-
scribed and converted into 23–29-nucleotide short 
RNAs incorporated into PIWI-family proteins. Thus 
far, three proteins have been implicated in the produc-
tion of piRNAs specifi cally from a specialized family 
of dual-stranded clusters: Rhino, Cutoff, and Dead-
lock. I have shown that the collapse of dual-strand 
cluster-derived piRNAs caused by the loss of any of 
these factors is accompanied by a dramatic decline in 
the fi delity of the piRNA biogenesis machinery. In 
these backgrounds, piRNA production is still robust, 
but it shifts to use aberrant precursors, including a sub-
set of ovarian mRNAs and endo-siRNA loci. In addi-
tion, I have identifi ed a novel factor that participates in 
this process and exhibits phenotypes similar to Rhino, 
Cutoff, and Deadlock. Cytological evidence suggests 
that these four proteins function as a complex that sits 
directly atop piRNA clusters in the nucleus, where they 
facilitate the channeling of nascent transcripts into the 
cytoplasmic piRNA production machinery.
The Role of Long Noncoding RNAs in 
Normal Hematopoiesis and Malignant 
Transformation
L. Sabin, M.J. Delas Vives
Precise control of gene expression is achieved through 
multiple layers of regulation that infl uence the tran-
scriptional and epigenetic states of genomic loci. Long 
noncoding RNAs (lncRNAs) have recently emerged 
as a novel class of molecules with regulatory potential. 
However, ascribing clear functional and biological 
roles to these noncoding transcripts has been chal-
lenging. Although the function of most lncRNAs 
remains unknown, many of the lncRNAs that have 
been characterized have roles in transcriptional and 
epigenetic regulation of gene expression and may act 
by physically recruiting epigenetic modifi ers and other 
protein complexes to target genomic loci.
055-075_CancerGenet.indb   61 27-08-2014   16:03:41
62  Research
One developmental process that requires coor-
dinated regulation of gene expression is hematopoi-
esis. During hematopoiesis, hematopoietic stem cells 
(HSCs) differentiate to generate both the myeloid and 
lymphoid lineages of blood cells. Importantly, the ma-
lignant transformation of various hematopoietic lin-
eages leads to the development of several forms of leu-
kemia and lymphoma, and the disruption or misregu-
lation of epigenetic modifi cations is a common feature 
of cancer cells. Therefore, we are studying the func-
tion of lncRNAs in the murine hematopoietic system, 
with the aim of identifying lncRNAs that have critical 
roles in the epigenetic control of gene regulation. In 
particular, we hope to uncover lncRNAs responsible 
for regulating the processes of tumorigenesis, stem cell 
self-renewal, and differentiation. To this end, we have 
used high-throughput sequencing of various cell types 
within the murine hematopoietic lineage. In total, 
we have performed transcriptome sequencing of 26 
samples, which include HSCs, as well as normal and 
transformed cells from both myeloid and lymphoid 
lineages.
To identify lncRNAs important in the mainte-
nance or progression of leukemia, we are using a 
mouse model of AML, which is driven by the onco-
gene MLL-AF9, a common fusion protein found in 
human AML. MLL-AF9 leukemia cells can be ma-
nipulated and studied in culture, but they can also 
be injected into recipient animals to induce leukemo-
genesis. Therefore, we are using short hairpin RNA 
(shRNA) knockdown technology to determine which 
candidate lncRNAs have important biological roles in 
leukemia both in vitro and in vivo. We have verifi ed 
that lncRNAs can be depleted by shRNA-mediated 
RNAi and have developed competitive proliferation 
assays with MLL-AF9 leukemia cells in vitro and in 
vivo. These assays are amenable to large-scale screen-
ing efforts. Therefore, we have compiled a catalog of 
the lncRNAs that are expressed most abundantly in 
MLL-AF9 leukemia cells (859 candidates) and are 
building an shRNA library that individually targets 
each of these candidates. While the comprehensive 
shRNA library is being sequence-verifi ed, we are cur-
rently performing a smaller-scale in vivo screen of 
the top 120 highest-priority candidates. Using RNAi 
knockdowns of candidate lncRNAs in our in vivo 
competitive proliferation assay, we aim to identify 
lncRNAs that are important in leukemogenesis and 
will validate hits both in vitro and in vivo. We hope 
that this work will provide important insights into 
 lncRNA function in the epigenetic control of gene ex-
pression during normal hematopoiesis and malignant 
transformation.
In addition to our studies of AML, we also aim to 
uncover novel lncRNAs involved in HSC self-renewal 
and differentiation. Despite having been studied for 
decades, the low abundance and complex physiologi-
cal niche of HSCs in animals make these stem cells a 
challenging experimental model. We have established 
in the lab a unique in vitro culture system that al-
lows us to expand HSCs for several weeks by cocul-
turing them with endothelial cells, one of the essential 
cell types present in their physiological niche. These 
HSCs are able to fully reconstitute hematopoiesis 
when injected into lethally irradiated mice, which 
provides ultimate proof of their functionality. We can 
use this coculture system to study the role of lncRNAs 
in HSC self-renewal and differentiation using an in 
vitro assay, which reduces the experimental time. The 
candidate lncRNAs that will be tested in this loss-
of-function assay are currently being selected using 
the transcriptome sequencing data, and we are test-
ing several shRNA delivery vectors to obtain optimal 
lncRNA knockdown in HSCs. To further character-
ize the functionality of promising candidates, we can 
quickly transition to the in vivo model using bone 
marrow reconstitution assays. We hope to understand 
how these molecules participate in the regulation of 
gene expression during hematopoietic regeneration.
RNF17 Prevents Promiscuous Activity 
of PIWI Proteins in Mouse Testes
V.V. Vagin, K.A. Wasik
PIWI proteins and their associated piRNAs protect 
germ cells from the activity of mobile genetic elements. 
Two classes of piRNAs—primary and secondary—
are defi ned by their mechanisms of biogenesis. Pri-
mary piRNAs are processed directly from transcripts 
of piRNA cluster loci, whereas secondary  piRNAs 
are generated in an adaptive amplifi cation loop, 
termed the ping-pong cycle. In mammals, piRNA 
populations are dynamic, shifting as male germ cells 
develop. Embryonic piRNAs consist of both primary 
and secondary species and are mainly directed toward 
transposons. In meiotic cells, the piRNA population 
is transposon-poor and restricted to primary piRNAs 
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derived from pachytene piRNA clusters. The transi-
tion from the embryonic to the adult piRNA pathway 
is not well understood. Here we show that RNF17 
shapes adult meiotic piRNA content by suppressing 
the production of secondary piRNAs. In the absence 
of RNF17, ping-pong occurs inappropriately in meiot-
ic cells. Ping-pong initiates piRNA responses not only 
against transposons, but also against protein-coding 
genes. Thus, the sterility of RNF17 mutants may be a 
manifestation of a small RNA-based autoimmune re-
action. Our data indicate that RNF17 constitutes one 
component of a licensing mechanism that prevents 
deleterious activity of the meiotic piRNA pathway, re-
stricting the loading of PIWI proteins to products of 
meiotic piRNA clusters.
A Molecular Framework for 
Understanding DCIS
E. Wagenblast
Ductal carcinoma in situ (DCIS) is the most common 
type of noninvasive pre-breast cancer in women. It re-
fers to regions of proliferating cancer cells within the 
milk ducts of the breast and is believed to be the pre-
cursor of invasive ductal carcinoma (IDC). The aim of 
this study is to evaluate the biology of human DCIS 
through transcriptome sequencing (RNA-Seq). We 
are using our next-generation sequencing expertise to 
generate gene expression profi les from single DCIS and 
IDC lesions and assay them for oncogenic signaling 
and adaptive immune responses. We are also analyzing 
the gene expression signature from the  surrounding 
stroma, which may hold the key to determining 
whether disease progresses to invasive  carcinoma.
We have established a collaboration with the Duke 
SPORE breast tumor bank, which contains core 
needle samples from 1700 patients including cases of 
pure DCIS tumors. These tissue samples are cut into 
10-μm-thick sections, and individual lesions and stro-
mal compartments are dissected and collected using a 
laser-capture microscope. Total RNA from dissected 
individual DCIS lesions are converted to double-
stranded cDNA and sequenced using the Illumina 
next-generation sequencing platform.
We obtained preliminary transcriptomes for ~100 
samples derived from normal tissues, stromal tissues, 
DCIS, and IDC lesions. Each of these samples was 
prepared from ~50–100 cells. Hierarchical clustering 
revealed that nearly all DCIS samples in our data set 
clustered closely together. As we are increasing the 
number of samples, we are confi dent that we will be 
able to identify molecular subtypes of DCIS, includ-
ing benign DCIS lesions.
Exploring the Functions of Thermus 
Thermophilus Argonaute Protein
X. Zhou
Argonaute proteins are essential components in eu-
karyotic RNAi pathways. They are also found in a 
large number of prokaryotic organisms. However, the 
functions of prokaryotic Argonaute remain unclear. 
My goal is to understand the function of argonaute 
protein in the thermophile Thermus Thermophilus. In 
the absence of Ago, plasmid transformation and inte-
gration effi ciency increases by ~10-fold, suggesting the 
important role of Ago in defense against foreign genetic 
invasion. Characterization of small nucleic acids shows 
global reduction of small RNA, including small RNA 
from the invading DNA sequence. Interestingly, we 
observe enrichment of sequences from invading DNA. 
Besides, another defense system in the CRISPR system, 
is differentially expressed as the expression level of Ago 
is altered. Further examination is required to under-
stand the link between Ago and CRISPR.
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TRACKING DOWN CANCER CELL BY CELL
J. Hicks J. Alexander N. Anaparthy H. Cox A. Stepansky
 F. Ambrosio T. Baslan M. Riggs
Our laboratory is focused on developing technolo-
gies for the rapid molecular profi ling of clinical can-
cer samples, with the primary goal of understand-
ing the cellular complexity of cancer initiation and 
progression, and through these studies to discover 
and implement molecular biomarkers into clinical 
practice. The ultimate goal of this work, the achieve-
ment of “precision medicine,” will match the right 
therapies with the right patients at the right time. 
To this end, our group has established collaborations 
with oncologists and pathologists at clinical cancer 
centers across the country in order to apply molecu-
lar analysis, in particular, next-generation DNA se-
quencing (NGS) and copy number variation (CNV) 
analysis, to profi le cancer at its most fundamental 
level, the single cell.
NGS technologies have revolutionized the study 
of human cancer genetics. The ability to characterize 
complete cancer genomes has led to the identifi cation 
of a rogues’ gallery of frequently mutated cancer genes 
and previously unknown genomic rearrangements, 
both of which can be used in combination to identify 
patients for response to new families of targeted can-
cer therapies. Although many large consortium stud-
ies designed to identify the specifi c mutations in thou-
sands of cancer samples are under way world-wide, 
our application of NGS has been focused on a related 
but separate property: the genomic heterogeneity of 
cancer. Once cancer is initiated, it begins to evolve 
through rapid and random reorganization of the genes 
and chromosomes, making each individual cancer a 
nearly unique disease. Using an NGS technique de-
veloped through our close collaboration with Mike 
Wigler’s laboratory (Navin et al., [2011]; Baslan et al., 
[2012]), we have created the opportunity to track ge-
netic evolution in tumors at the single-cell level and to 
use genetic markers to track cancer cells as they move 
through the body. Moreover, we have the opportunity 
to apply this approach not only to tumors, but also to 
tissues where only a very small number of cancer cells 
might be hiding, as in the bloodstream, bone marrow, 
urine, or lymphatic fl uid.
Single-Cell Proﬁ ling of Circulating 
Tumor Cells
Nearly all patients suffering from advanced cancer 
have a small number of cancer cells in their circula-
tion that are apparently shed from the primary or 
metastatic sites. These rare “circulating tumor cells” 
or CTCs can be detected by differential staining for 
specifi c protein markers that distinguish them from 
tens of millions of white blood cells in a typical blood 
sample. Once detected and isolated, the genetic pro-
fi les of these cells provide a novel window into the 
deep recesses of metastatic cancer and a noninvasive 
means to understand how cancer evolves and becomes 
resistant to anticancer drugs in real time in patients 
undergoing treatment. It is our long-term goal to iden-
tify key biomarkers that would direct oncologists to 
apply the most effective targeted therapy to each pa-
tient and to provide an early warning of cancer recur-
rence or treatment resistance.
In the past year, we have successfully applied our 
single-cell NGS profi ling method to cells isolated in 
multiple ways from multiple types of cancer. We are 
now working to make this process faster and cheaper 
so that it can be widely applied to larger numbers of 
patients, especially in clinical trials for drug approval. 
Although one method of simply counting potential 
CTCs in a blood sample, the Janssen Cell Search pro-
cess, is currently in clinical use, it has not been pos-
sible until now to go beyond enumeration and begin 
to detect the genetic changes that occur in the can-
cer during treatment. This year, we have successfully 
gone beyond enumeration of CTCs by applying of our 
single-cell profi ling technology to genomic profi ling 
of large numbers of CTCs from metastatic breast and 
prostate cancer patients, comparing the spectrum of 
genetic events across many cases and following the 
sequential changes that occur over time in a single 
patient. This work was done in collaboration with 
clinical colleagues at Memorial Sloan-Kettering Can-
cer Center (MSKCC), Scripps Research Institute, and 
the University of Southern California Cancer Center.
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In one project supported by a grant from the 
STARR Foundation, we sequenced CTCs isolated 
by fl uorescence-activated cell sorting (FACS) from 
20 patient samples undergoing treatment by Dr. 
Howard Scher and colleagues at MSKCC. This work 
revealed the great differences in genetic makeup of 
CTCs from patients at different stages of disease 
and further revealed a novel genetic marker for the 
onset of resistance to abiraterone, one of the newly 
approved targeted drugs against metastatic prostate 
cancer.
In the second project in collaboration with Dr. 
Peter Kuhn of Scripps Research Institute, we ap-
plied our single-cell technology to a very different 
method of capturing CTCs, where the cells can be 
identifi ed and phenotyped for protein markers on 
microscope slides and then stored for many months, 
after which CTCs can be retrieved one at a time as 
needed. This method was appropriate for following 
a single patient through four rounds of therapy and 
tracking the changes in the genome through that 
15-mo time course. Our data showed that during 
treatment, genetically defi ned clones of cells could 
disappear from the bloodstream and new popula-
tions of cells could arise within a few weeks of the 
onset of treatment. After only a few weeks, a third 
population arose, now with new genetic markers 
and resistant to the treatment, and the patient suf-
fered a relapse. The rapid time course has put new 
emphasis on monitoring patients repeatedly through 
the course of therapy.
The success of these projects has led our group to 
be recruited, along with Dr. Kuhn, to perform the 
“translational science” component of an 800-person 
clinical trial, S1222, for treatment of metastatic breast 
cancer sponsored by the Southwest Oncology Group 
(SWOG), a clinical trial organization that CSHL 
joined in 2011. This trial will open in May 2014.
Proﬁ ling Single Cells from Prostate 
Cancer Biopsies
Another very important clinical issue in prostate 
cancer is centered on the question of who should be 
subjected to trans-rectal, multisite biopsies, and fur-
thermore, which patients should have radical prostate 
removal when cancerous cells are discovered. Both bi-
opsies and prostatectomies carry signifi cant risk to the 
patient, and therefore, any less invasive means to make 
such determinations will be of great value to  patients 
and physicians alike. In a joint project with Michael 
Wigler here at CSHL, we have begun to attack this 
problem in collaboration with Dr. Herbert Lepor of 
Langone Medical Center at New York University 
(NYU). Using our single-cell DNA-profi ling meth-
ods, we are establishing the “molecular landscape” of 
early-stage prostate cancer and directly comparing our 
observations with traditional histopathology on speci-
mens from the same patient.
To retrieve cells from biopsy tissue, our groups 
jointly devised a nondestructive method in which the 
freshly extracted biopsy tissue is washed in cell culture 
medium prior to the biopsy being fi xed and treated 
for standard histopathology. Thousands of cells are 
exfoliated from the biopsy during the washing step 
and these cells are then transferred to our laboratory 
for sorting by FACS, DNA extraction, and single-cell 
genetic sequencing at CSHL by next-generation DNA 
sequencing. The biopsy then goes through standard 
histopathology at NYU. Comparing the results from 
single-cell sequencing with the clinical Gleason scor-
ing for cancer, we have been able to correlate the pro-
gression from benign tissue, showing minimal genetic 
aberrations, through progression to cancer, with the 
acquisition of random genetic alterations until one 
cell begins to replicate rapidly. At that point, corre-
sponding to the Gleason 7 grade by histology, the tis-
sue exhibits a distinct clone of cancer cells that carry 
the same genetic changes and is clearly cancerous. We 
therefore believe that “clonality” is a measurable pa-
rameter than can be used, in conjunction with stan-
dard pathology, as a prognostic marker with enhanced 
sensitivity for making critical treatment decisions.
These results are consistent with a parallel project 
being directed by Dr. Wigler (described in his con-
tribution to this Annual Report) on samples taken 
from radical prostatectomy samples supplied by Dr. 
Ashutosh Tewari of Weill-Cornell Medical Center.
Single-Cell Proﬁ ling of Breast 
Cancer Biopsies
Building on our earlier results, we have adapted the 
single-cell sequencing method to a high-throughput 
platform where we now routinely sequence hundreds 
of single cells at a relatively low cost. We have since 
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utilized this platform in a collaborative project with 
Dr. Lyndsay Harris of Case-Western Reserve Medical 
Center in Cleveland, as part of a neo-adjuvant clini-
cal trial for the treatment of breast cancer. By profi l-
ing hundreds of single cells from pretreated biopsies 
from all major subtypes of breast cancer (luminal, 
Her2-amplifi ed, and basal tumors), we are detail-
ing the landscape of tumor heterogeneity across all 
major breast cancer subtypes. Among the many ob-
servations we have made are differing amplifi cations 
of driver cancer genes among clonal populations and 
differing levels of amplifi cation in the same driver 
oncogene among discrete subclones. Furthermore, 
for some tumors, we have profi led posttreatment bi-
opsies from the same patients. By analyzing hundreds 
of single cells from pre- and posttreatment biopsies, 
we are observing the clonal adaptive response of tu-
mors to therapeutic intervention. Already in some pa-
tients, we observed major dynamic restructuring of 
clonal populations in response to therapy. By relating 
distinct genomic alterations among sensitive, as op-
posed to resistant, clones we hope to identify predic-
tive biomarkers of sensitivity to targeted drugs. We 
are validating our fi ndings using different molecular 
techniques such as DNA-FISH and exome sequenc-
ing of these tumors.
Biomarker Discovery: Retrospective 
CNV Analysis of Clinical Trial Samples
The DNA copy number method that we used for sin-
gle cells was originally applied by us to another prob-
lematic type of cancer sample: tumor tissue preserved 
by chemical fi xation and embedding in paraffi n. This 
is the type of sample most often available from clini-
cal trials that were completed long enough in the past, 
often 5–10 years, that there are data available on the 
patients’ outcome. Having outcome data makes these 
samples valuable for retrospective analysis using newer 
molecular methods, in order to search for molecular 
biomarkers that stratify patient groups and identify 
those that do particularly well or poorly on a specifi c 
treatment.
This year, we completed a retrospective analysis of 
250 preserved samples from a clinical trial of the drug 
epirubicin, a member of the anthracycline class of 
chemotherapy agents, in breast cancer patients. An-
thracyclines are effective chemotherapeutic agents in 
some cases, but they have signifi cant cardiotoxicity, 
and so identifying a prospective biomarker for those 
cancers in which the drug will work would have sig-
nifi cant clinical value. The BR9601 trial was begun 
in 1996 and completed in 2008, and preserved sam-
ples were provided by Dr. John Bartlett of the On-
tario Cancer Research Institute (OCRI) in Toronto. 
The goal of our work on these samples was to use 
copy number profi ling to locate potential biomarkers 
for high sensitivity to anthracyclines. Genomic copy 
number profi ling was successful for more than 200 
of the samples, and the profi les were analyzed by our 
collaborator, Dr. Alex Krasnitz, who has developed 
a novel method for reducing complex genome-wide 
data to a series of discrete, scorable “cores” of activ-
ity. Using this method, Dr. Krasnitz reduced the ge-
nome-wide copy number profi les of all of the tumor 
samples to ~250 major “cores” which were then tested 
against time to relapse and overall survival data from 
the trial. Through this method, we have identifi ed 
a common amplicon of hitherto unknown function, 
occurring in up to 20% of advanced breast cancers, 
as a potential biomarker for sensitivity to epirubicin. 
This project is now in the validation phase with an 
additional 600 patient samples from a parallel Cana-
dian clinical trial that was undertaken by the OCRI 
during a similar time period.
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills Y. Chang D.-W. Hwang Y.-E. Son
 G. Horev W. Li A. Vestin
Our research is focused on elucidating the genetic/
epigenetic basis of cancer. We have discovered new 
cancer genes, have revealed mechanisms for how the 
encoded proteins normally work, and determined 
what goes wrong during the process of oncogenesis. 
These fi ndings have had a major impact in the sci-
entifi c community and have affected how clinicians 
analyze and treat patients with cancer.
Major discoveries:
• Identifying p63 as a gene affecting development, 
aging, and cancer.
• Establishing mouse models of EEC syndrome.
• Identifying TAp63 as a modifi er of disease pa-
thology.
• Discovering CHD5 as a gene that prevents cancer.
• Determining that Chd5’s ability to bind histone 
H3 is essential for tumor suppression.
Identifying p63 as a Gene Affecting 
Development, Cancer, and Aging
We discovered p63, a gene that looked very similar 
to p53—a well-studied gene known to be defective 
in over half of all human cancers. Besides looking 
similar to p53, it was not clear how p63 worked. My 
group discovered that a lack of p63 leads to aging. 
We found that p63 is needed for stem cell renewal 
and that when p63 is depleted, rapid aging features 
take place, including curvature of the spine, hair loss, 
and severe skin lesions. Yet, there is a fi ne balance, as 
an excess of one version of p63 (ΔNp63α) causes car-
cinoma—the most prevalent type of human cancer. 
In contrast, we found that a different version of p63 
(TAp63) prevents cancer. We showed that TAp63 
inhibits tumor growth and that it can do so even 
when p53 is absent. This work was surprising, as it 
had always been believed that p53 was absolutely es-
sential for inhibiting cancer. Instead, we found that 
TAp63 can do the job alone. We are currently work-
ing on strategies to turn p63 on, which might be use-
ful in the clinic.
When we fi rst identifi ed p63, we found that it was 
needed for development, as its loss in mice causes mal-
formations of the limbs, skin, and palate. This work 
provided a clue to clinicians seeking causes of human 
syndromes in which children have birth defects in-
cluding anomalies of the hands and feet, abnormal 
skin, and severe cleft palate. Our discovery that p63 
is needed for development had a major impact, as it 
is now known that p63 mutations cause seven dif-
ferent human syndromes involving birth defects af-
fecting the limbs, skin, and palate. Within the past 
year, we generated the fi rst mouse models for one of 
these syndromes, ectrodactyly, ectodermal dyspla-
sia, clefting (EEC) syndrome (Vernersson Lindahl 
et al. 2013). These mice had anomalies of the limbs, 
skin (as well as defects in related structures such as 
hair, tear ducts, sweat glands, nails, and teeth), and 
cleft palate; these features are analogous to those of 
children with EEC syndrome. Remarkably, these 
mice recapitulated a curious feature of EEC that had 
long been a mystery: Why some children with EEC 
syndrome have symptoms that are very severe and 
even life threatening, whereas other children with 
EEC—even those in the same family that carry the 
same exact p63 mutation—have symptoms that are 
barely noticeable. We discovered a “modifi er” gene 
that controls just how severe the clinical features are 
in different individuals. We identifi ed TAp63, one of 
the two major kinds of proteins manufactured from 
the p63 gene, as being responsible for the range of 
severity characteristic of EEC. Mice that have the 
EEC-causing mutation that also have TAp63 have 
very subtle defects, whereas those that have the very 
same EEC-causing mutation but that are also miss-
ing TAp63 are very severely affected. This shows 
that TAp63 normally prevents the adverse effects 
of the EEC mutation, allowing the fetus to develop 
quite normally, but when TAp63 is not present, the 
fetus is not able to develop as it should, resulting 
in severe EEC features. These EEC models provide 
functional evidence for the genetic basis of EEC and 
paved the way for defi ning TAp63 as a rheostat that 
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controls EEC-like features in mice. We are currently 
working to understand how a single-amino-acid mu-
tation such as that found in human EEC perturbs 
p63’s ability to regulate gene expression, leading to 
abnormal development and cancer.
Discovering CHD5 as a New 
Cancer-Preventing Gene
My laboratory discovered CHD5 as a tumor sup-
pressor mapping to human 1p36—a region of our 
genomes that is often deleted in cancer cells. 1p36 
deletions occur in many different types of human 
cancers, including those of the epithelia, brain, and 
blood. Although this suggested that a cancer-sup-
pressing gene resided in this region, its identity re-
mained a mystery. To tackle this problem, my group 
generated mice with mice with deletions and dupli-
cations of the genomic region corresponding to 1p36 
using chromosome engineering technology—a strat-
egy with which we can generate precise chromosome 
rearrangements in the mouse—and we pinpointed a 
region of the genome with potent tumor suppressive 
activity. Using genetic and molecular approaches, 
we identifi ed CHD5 as the tumor suppressor gene 
in the region and found that its product worked as 
a “circuit breaker” for a cancer-preventing network. 
In addition, we discovered that CHD5 was frequent-
ly deleted in human glioma. Within the past year, 
we discovered that CHD5 uses its plant homeodo-
mains to bind histone 3 and that this interaction is 
essential for Chd5 to function as a tumor suppressor 
(Paul 2013). Our work has had a major impact in 
the cancer fi eld, as it is now known that CHD5 is 
mutated in human cancers of the breast, ovary, and 
prostate, as well as in melanoma, glioma, and neuro-
blastoma. Furthermore, recent reports indicate that 
CHD5 status predicts whether anticancer therapy 
will be effective; indeed, patients with high levels of 
CHD5 have much better overall survival than those 
with low levels. We are currently delving deeper into 
the mechanism whereby Chd5-mediated regulation 
of chromatin affects gene expression cascades that 
regulate stem cells and cancer.
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My fi rst visit to Cold Spring Harbor Laboratory was 
in 1980 during the symposium on DNA tumor vi-
ruses. I was a graduate student at Columbia and had 
not left the grime and grit of Manhattan in about 2 
years, and so CSHL appeared as an incredible oasis 
of trees and picturesque buildings and water and 
brilliant people. At that meeting, a postdoc from 
Columbia taught me to sail—kind of; however, my 
fi rst time at the helm I screwed up by sailing into 
the roped-off area for swimmers and scattered sev-
eral children. No one came close to being hurt but 
I was really embarrassed. Just at that moment I saw 
Jim Watson for the fi rst time. I knew him by sight 
because I had seen his pictures in the Double Helix 
and The Eighth Day of Creation. He was standing 
on the beach, surveying his domain, seeming quite 
content, and either oblivious or totally unconcerned 
about the mild mishap. This made a very favorable 
impression on me, and it was one of the fi rst of many 
interesting encounters I’ve had over the years here at 
CSHL. The specialness of this place—in addition to 
its scientifi c excellence—has induced in me a type 
of loyalty that other people have for favorite sports 
teams. I am very grateful to be continuing my asso-
ciation with the Laboratory after I move the base of 
my operations to Stony Brook in 2014. What follows 
is a report of projects completed in 2013.
Identiﬁ cation of Tumor Suppressor 
Genes in Hepatocellular Carcinoma by 
Genome-Wide Methylation Analysis 
and Epigenetic Unmasking
K. Revill, J. Li
To identify clinically relevant tumor suppressor genes 
silenced by DNA methylation in hepatocellular carci-
noma (HCC), we integrated DNA methylation data 
from human primary HCC samples with data on 
up-regulation of gene expression after epigenetic un-
masking. We performed genome-wide methylation 
analysis of 71 human HCC samples using the Illumina 
HumanBeadchip27 K array; data were combined with 
those from microarray analysis of gene reexpression 
in four liver cancer cell lines after their exposure to 
reagents that reverse DNA methylation (epigenetic 
unmasking). We identifi ed 13 candidate tumor sup-
pressor genes. Subsequent validation led us to focus 
on functionally characterizing two candidates, sphin-
gomyelin phosphodiesterase 3 (SMPD3) and neuro-
fi lament, heavy polypeptide (NEFH) that we found 
to behave as tumor suppressor genes in HCC. Over-
expression of SMPD3 and NEFH by stable transfec-
tion of inducible constructs into an HCC cell line re-
duced cell proliferation by 50% and 20%, respectively 
(SMPD3, P = .003 and NEFH, P = .003). Conversely, 
knocking down expression of these genes with short 
hairpin RNA (shRNA) promoted cell invasion and 
migration in vitro (SMPD3, P = .0001 and NEFH, 
P = .022) and increased their ability to form tumors 
after subcutaneous injection or orthotopic transplanta-
tion into mice, confi rming their role as tumor suppres-
sor genes in HCC (Fig. 1). Low levels of SMPD3 were 
associated with early recurrence of HCC after curative 
 surgery in an independent patient cohort (P = .001; 
hazard ratio = 3.22; 95% confi dence interval: 1.6−6.5 
in multivariate analysis). Thus, SMPD3 is a potent 
tumor suppressor gene that could affect tumor aggres-
siveness; a reduced level of SMPD3 is an independent 
prognostic factor for early recurrence of HCC.
System-Wide Analysis Reveals a Complex 
Network of Tumor–Fibroblast Interactions 
Involved in Tumorigenicity
M. Rajaram, J. Li
Many fi broblast-secreted proteins promote tumorige-
nicity and several factors secreted by cancer cells have 
in turn been proposed to induce these proteins. It is 
not clear whether there are single dominant pathways 
underlying these interactions or whether they involve 
multiple pathways acting in parallel. We identifi ed 42 
fi broblast-secreted factors induced by breast cancer 
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cells using comparative genomic analysis. To deter-
mine what fraction was active in promoting tumorige-
nicity, we chose fi ve representative fi broblast-secreted 
factors for in vivo analysis. We found that the majority 
(three out of fi ve) had equally major roles in promoting 
tumorigenicity, and intriguingly, each one had distinct 
effects on the tumor microenvironment. Specifi cally, fi -
broblast-secreted amphiregulin promoted breast cancer 
cell survival, whereas the chemokine CCL7 stimulated 
tumor cell proliferation and CCL2 promoted innate 
immune cell infi ltration and angiogenesis. The other 
two factors tested had minor (CCL8) or minimally 
(STC1) signifi cant effects on the ability of fi broblasts 
to promote tumor growth. The importance of parallel 
interactions between fi broblasts and cancer cells was 
tested by simultaneously targeting fi broblast-secreted 
amphiregulin and the CCL7 receptor on cancer cells, 
and this was signifi cantly more effi cacious than block-
ing either pathway alone. We further explored the 
concept of parallel interactions by testing the extent to 
which induction of critical fi broblast-secreted proteins 
could be achieved by single, previously identifi ed, fac-
tors produced by breast cancer cells. We found that 
although single factors could induce a subset of genes, 
even combinations of factors failed to induce the full 
repertoire of functionally important fi broblast-secreted 
proteins. Together, these results delineate a complex 
network of tumor–fi broblast interactions that act in 
parallel to promote tumorigenicity and suggest that ef-
fective antistromal therapeutic strategies will need to 
be multitargeted.
Two Distinct Categories of Focal Deletions 
in Cancer Genomes
M. Rajaram, J. Li
One of the key questions about genomic alterations 
in cancer is whether they are functional in the sense 
of contributing to the selective advantage of tumor 
cells. The frequency with which an alteration occurs 
might refl ect its ability to increase cancer cell growth, 
or alternatively, enhanced instability of a locus may 
increase the frequency with which it is found to be 
aberrant in tumors, regardless of oncogenic impact. 
We addressed this on a genome-wide scale for cancer-
associated focal deletions that are known to pinpoint 
both tumor suppressor genes (tumor suppressors) and 
unstable loci. On the basis of DNA copy number 
Figure 1. Depletion of Smpd3 and Nefh promotes liver carcinoma 
formation. (A) Subcutaneous growth of tumor protein p53 (p53) –/–; 
Myc hepatoblasts infected with either nontargeting shRNA, shRNA 
4, shRNA 6, or shRNA 1 to Smpd3 (n = 6 injections; asterisks in-
dicate that the indicated tumor group is signiﬁ cantly different than 
controls, error bars denote ±S.D., *P < .05; **P < .01; ***P < .001). 
Tumor volumes were determined from 2 to 7 wk postinjection. (B) 
Subcutaneous growth of p53−/–; Myc hepatoblasts infected with 
either nontargeting shRNA or shRNA2 or shRNA 5 to Nefh (n = 6 
injections, asterisks indicate that the indicated tumor group is sig-
niﬁ cantly different than controls, error bars denote ±S.D., *P < .05; 
**P < .01; ***P < .001). Tumor volumes were determined from 5 to 
8 wk postinjection. (C) Images of mouse livers and sections taken 
6 wk after transplantation of p53−/–; Myc mouse hepatoblasts with 
knockdown of either Smpd3 or Nefh. (Panel columns from left 
to right): Intact livers; ﬂ uorescent imaging of intact liver for green 
ﬂ uorescent protein (GFP)−positive transplanted cells; H&E stain-
ing of liver tissue sections showing the border between normal 
liver and carcinoma (arrows); immunohistochemical detection 
of GFP; and immunohistochemical detection of proliferating cell 
nuclear antigen (PCNA). The last three columns are from the same 
tissue block. Scale bars: 100 μm. (D) Association of SMPD3 ex-
pression with time to early and late recurrence after surgery: early 
recurrence in patients from HCC Genomic Consortium. SMPD3 
high-expressing patients are indicated in blue and SMPD3 low-
expressing patients are indicated in red. (E) Early recurrence in 
patients from validation cohort. SMPD3 high-expressing patients 
are indicated in blue and SMPD3 low-expressing patients are in-
dicated in red.
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analysis of more than 1000 human cancers represent-
ing 10 different tumor types, we observed fi ve loci 
with focal deletion frequencies above 5%, includ-
ing the A2BP1 gene at 16p13.3 and the MACROD2 
gene at 20p12.1. However, neither RNA expression 
nor functional studies support a tumor suppressor 
role for either gene. Further analyses suggest instead 
that these are sites of increased genomic instability 
and that they resemble common fragile sites (CFS). 
Genome-wide analysis revealed properties of CFS-
like recurrent deletions that distinguish them from 
deletions affecting tumor suppressor genes, including 
their isolation at specifi c loci away from other genom-
ic deletion sites, a considerably smaller deletion size, 
and dispersal throughout the affected locus rather 
than assembly at a common site of overlap. Addition-
ally, CFS-like deletions have less impact on gene ex-
pression and are enriched in cell lines compared to 
primary tumors. We found that loci affected by CFS-
like deletions are often distinct from known common 
fragile sites. Indeed, we fi nd that each tumor tissue 
type has its own spectrum of CFS-like deletions and 
that colon cancers have many more CFS-like dele-
tions than other tumor types.
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 D. Esposito J. Kendall J. McIndoo J. Troge Z. Zhu
In collaboration with James Hicks and Alex Krasnitz, 
among others, we study human cancer and genetic 
disorders from a population genomics perspective. The 
cancer effort focuses on breast and prostate cancer 
(the latter jointly with Lloyd Trotman) and involves 
collaborative clinical studies (with local, national, and 
international collaborators) to discover mutational 
patterns predicting treatment response and outcome. 
The lab also develops methodology for single-cell 
genomic and RNA analysis, to detect cancer cells in 
bodily fl uids such as blood and urine. This last has 
major potential applications to the early detection of 
cancer and monitoring its recurrence and response to 
therapy during and after treatment. Single-cell analy-
sis has also led to insights about the clonal evolution 
and heterogeneity of cancers and may lead to a  better 
understanding of initiation, progression, and metasta-
sis. In collaboration with Scott Lowe, now at Memorial 
Sloan-Kettering Cancer Center, we recently showed 
that tumor suppressor genes are often clustered in 
large regions that are deleted in common cancers. The 
single-cell methods are also being applied to problems 
in neurobiology (with Josh Huang and Pavel Osten) 
and differentiation (with Chris Vakoc).
Our lab’s genetic efforts are a collaboration with 
Ivan Iossifov and Dan Levy of Quantitative Biology at 
CSHL and largely focus on determining the role of de 
novo mutation in pediatric disorders. They participate 
in a large study of autism organized by the Simons 
Foundation and also study congenital heart disease 
and pediatric cancers with collaborators at Colum-
bia University and Memorial Sloan-Kettering Cancer 
Center, respectively. Recent work has confi rmed and 
extended the team’s previous observations on the role 
of de novo copy number variation in autism, with sim-
ilar results in the other disorders. A large-scale exome 
sequencing project with our team and the  Genome 
Sequencing Center at Washington University in St. 
Louis has proven the contribution of small-scale de 
novo mutations to autism. Overall, results confi rm 
their previous genetic models for autism incidence. In 
collaboration with Robert Darnell of the Rockefeller 
University, they have also uncovered a striking link 
between autism and the genes regulated by the gene 
that causes fragile-X syndrome, FMR1.
The Genetics of Autism
We are examining the genetic basis of autism spec-
trum disorders (ASD) by studying de novo mutations 
occurring in affected individuals and comparing 
rates of different types of mutations with the unaf-
fected siblings. We are in the process of compiling the 
efforts of three teams studying nearly 2700 families 
from the Simons Simplex Collection (SSC). Iossifov 
et al. (Neuron 74: 285 [2012]) summarizes earlier 
fi ndings based on nearly 350 simplex families drawn 
from the collection, and the major conclusions of that 
study remain intact. There is a statistically signifi cant 
increased incidence of de novo mutations of func-
tional consequences (copy number changes, nonsense 
mutations, splice site mutations, and frameshifts) in 
affected children compared to siblings, whereas de 
novo mutations that are likely without effect (syn-
onymous mutation) show no difference between the 
groups. Mutation incidence is higher in affected girls 
and increases with the age of the parents. Target 
analysis indicates a strong overlap of autism candi-
dates with genes expressing mRNAs that are associ-
ated with the fragile-X mental retardation protein 
(FMRP) (collaboration with Robert Darnell at the 
Rockefeller University). Recurrence analysis suggests 
that there are on the order of 300–400 target genes. 
The overall incidence of new mutation, observed and 
projected, is consistent with new mutation being the 
major source of autism risk in simplex autism, espe-
cially for females.
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De Novo Mutation in Sporadic 
Human Disease
De novo mutations of varying classes have been con-
clusively linked to neuropsychiatric diseases such as 
autism, but the overall contribution to sporadic dis-
eases of other types has not been studied in equal 
depth. To better understand the relationship bet-
ween rare, de novo copy number variants (CNVs) 
and sporadic diseases with strong genetic compo-
nents, we have participated in several smaller-scale 
studies. In collaboration with Dr. Kenneth Offi t of 
the Memorial Sloan-Kettering Cancer Center, we an-
alyzed copy number variants in 116 families in which 
a child or young adult was diagnosed with sporadic 
cancer. Among the patients with testicular cancer, 
7% had germline de novo events—a level similar 
to that seen in autistic individuals and indicating a 
strong likelihood that de novo mutations underlie at 
least some types of cancer. Building on this effort, we 
have begun to perform whole-exome sequencing of 
these families to detect additional mutations of other 
classes, such as single-nucleotide variants and small 
insertions and deletions. The study on copy number 
variation is now published (Stadler et al., Am J Hum 
Genet 91: 379 [2012]).
Congenital heart disease (CHD) is one of the most 
common malformations in humans—found in nearly 
1% of live births—and is largely sporadic, with evi-
dence of a signifi cant genetic component. Using the 
same approach as that used in our autism and cancer 
studies, we studied 213 families in collaboration with 
Dr. Dorothy Warburton at Columbia University Med-
ical Center. As in the other studies, we found strong 
evidence that de novo CNVs may cause CHD, with 
greater than 10% of affected children having a germ-
line variant—a rate fi ve times higher than was seen 
in a control population. This study is now published 
(Warburton et al., Hum Genet 133: 11 [2014]). These 
studies suggest that rare de novo mutation contributes 
too many types of sporadic disorders in humans.
Algorithms for Genomic Analysis
We develop tools for genome analysis by refi ning exist-
ing methods and creating novel algorithms when “off-
the-shelf” software is inadequate. Insertions and dele-
tions (indels), as well as other genome rearrangements, 
contribute signifi cantly to genetic variation and 
disease. Many small indels can be detected by exist-
ing software, but in some genomic contexts—such 
as within microsatellites—indels can be diffi cult to 
discern. To address this need, we have developed our 
own software. As concrete results, we have identifi ed 
de novo mutations in microsatellite loci as contribu-
tory in perhaps 2%–3% of autism cases. Many of the 
observations were made using unconventional tools.
Molecular Methods
We have continuously worked on developing methods 
to perform measurements with greater resolution, or 
more effi ciently, or to make new types of measure-
ments. In the area of genomics, this includes not only 
algorithm development as described above, but also 
bench methods. In this regard, we have efforts in 
three projects. First, we are developing copy  number 
measurements based on sequencing and are driv-
ing down experimental costs using sample barcodes, 
pooled samples, and genome fragmentation. This 
work is still ongoing. Second, we are developing meth-
ods for single-cell DNA and RNA analysis. The latter 
incorporates the idea of varietal tagging to reduce the 
distortion caused by polymerase chain reaction (PCR) 
amplifi cation.
Single-Cell Analysis of Mouse Brain 
Neurons
Neuronal cells of the brain are the most function-
ally diverse of any organ in the human body, but 
the totality of that diversity is not fully understood. 
Moreover, the diversity of neurons in the brain may 
be increased by somatic mutational mechanisms oc-
curring during the last few cycles of neuronal dif-
ferentiation—before the neuronal fate is fi xed. With 
recent advances in single-cell sequencing technology, 
it is possible to sequence DNA and RNA from single 
neurons of a given subtype in the brain. In collabora-
tion with Josh Huang and Pavel Osten at CSHL, we 
are exploring the roles of somatic mutation in mice, 
categorizing subtypes and specifi c transcription 
 patterns, and exploring the contribution of monoal-
lelic expression to neuronal diversity and cognitive– 
behavioral variation.
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Genomic Landscape of Prostate Cancer
Prostate cancer (PCa) is the most common genitouri-
nary malignancy among men. It often presents as a 
multifocal disease characterized by tremendous bio-
logic heterogeneity with a variable clinical course rang-
ing from indolent to lethal disease. Current guidelines 
for prognostication and treatment strategies rely on 
clinic pathological parameters such as serum PSA lev-
els and histological appearance. Developing genomic 
parameters such as copy number variation, genome 
instability, and clonality will enhance current meth-
ods for prognostication and disease management. We 
are using a single-cell DNA and RNA genomics ap-
proach to obtain high-resolution profi les of the genetic 
alterations that occur in single prostatic cancer cells. 
Our methods are very general and are applicable to 
many kinds of cancer and many types of biological 
sampling, including body fl uids.
In collaboration with the laboratory of Dr. 
Ashutosh Tewari of the Weill-Cornell Medical Col-
lege and Herbert Lepor at New York University Med-
ical School, we have shown that analysis of the ge-
nomes of a few hundred cells can provide a landscape 
of the evolution of prostatic neoplasia. Comparison to 
Gleason scores suggests that early stages of the disease 
comprise cells with unstable genotypes, with little if 
any clustering into emergent clones with consensus 
genotypic markers. In contrast, advanced stage dis-
ease displays not only cells with divergent and unsta-
ble genotypes, but also emergent clones of cells with 
common chromosomal deletions and amplifi cations 
that spread throughout the organ. Efforts are under 
way to determine whether genome scores derived 
from single-cell genomic analysis may improve risk 
stratifi cation in PCa.
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Mikala Egeblad and colleagues study tumors and, in particular, the contributions of the mi-
croenvironment in which the cancer cells arise and live. Solid tumors are abnormally organized 
tissues that contain not only cancer cells, but also various stromal cell types and the extracellular 
matrix, and these latter components constitute the microenvironment. Communications between 
the different components of the tumor infl uence its growth, its response to therapy, and its ability 
to metastasize. Among the tumor-associated stromal cells, the lab’s main focus is on myeloid-
derived immune cells, a diverse group of cells that can enhance angiogenesis and metastasis and 
suppress the cytotoxic immune response against tumors. Egeblad is interested in how different 
types of myeloid cells are recruited to tumors and how their behaviors—for example, their physi-
cal interactions with cancer cells and other immune cells—infl uence cancer progression, includ-
ing metastasis. The Egeblad lab studies the importance of the myeloid cells using mouse models 
of breast and pancreatic cancer and real-time imaging of cells in tumors in live mice. This enables 
them to follow the behaviors of and the interactions between cancer and myeloid cells in tumors 
during progression or treatment. This technique was instrumental when the lab recently showed 
that cancer drug therapy can be boosted by altering components of the tumor microenviron-
ments, specifi cally reducing either matrix metalloproteinases (enzymes secreted by myeloid cells) 
or chemokine receptors (signal receptors on myeloid cells). This year, the Egeblad lab collaborated 
with Scott Powers’ group to understand how normal cells surrounding a tumor promote cancer 
growth. They found that normal cells signal to tumors through multiple pathways, and blocking 
these signals together has the greatest effect on inhibiting tumor growth—offering a new strategy 
to fi ght cancer.
Changes in tissue architecture and cell differentiation are often the early signs of cancer, but little 
is known about the pathways that regulate them. Senthil Muthuswamy has developed a novel 
paradigm for thinking about this aspect of cancer biology. Using sophisticated model systems 
such as three-dimensional cell culture platforms and transgenic mice, his team found that proteins 
which regulate cell polarity are involved in both initiation and progression of cancer. Because cell 
polarity is found to be altered in multiple human cancers, understanding the pathways regulated 
by them can identify novel molecules and pathways that can be used either as drug targets or as 
biomarkers for cancer. In addition, Muthuswamy’s lab collaborates actively with multiple research 
teams at CSHL. For example, lab members collaborated with the Mills lab to demonstrate a role 
for p63 protein in stem cells of the skin and with the Krainer lab to investigate the role that the 
splicing factor SF2 has in breast cancer. Muthuswamy’s lab has ongoing collaborations with the 
Tonks lab to investigate and identify novel opportunities for targeting tyrosine phosphatases in 
HER2-positive breast cancers and with the Spector lab to study the role noncoding RNAs have 
in breast cancer.
Darryl Pappin’s lab develops chemical and computational methods for analysis of proteins and 
peptides. These are fundamental tools for proteomics, and they are vital in many fi elds of biologi-
cal investigation. Proteins and peptides are typically analyzed via mass spectrometry, a method 
that involves fragmenting samples by colliding them with gas atoms in a vacuum. Masses of the 
resulting fragments are measured, and computer algorithms match the results with known or 
predicted molecules whose amino acid sequences are either known or inferred. Pappin has de-
veloped search engines for mass spectrometry data that enable investigators to sift hundreds of 
thousands of experimental spectra at a time for database matches. He also seeks to reduce sample 
complexity via an approach he calls chemical sorting. This includes the use of chelation to enrich 
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phosphopeptides from the total peptide pool and the use of specifi c affi nity-tagged small-molecule 
inhibitors to segregate classes of kinases or phosphatases for more specifi c mass spectroscopic 
analysis.
Despite their large variety of genetic abnormalities, cancer cells have been found to be extremely 
sensitive to the reversal of certain mutations. Raffaella Sordella and colleagues study why cells 
in certain cancers are responsive to the inhibition of one particular gene or gene product. Why, 
for instance, do non-small-cell lung cancer (NSCLC) cells that have a particular mutation in 
the epidermal growth factor receptor (EGFR) respond dramatically to its inhibition by the drug 
Tarceva? This occurs in 15%–20% of patients, the great majority of whom, within 1–3 years, 
develop resistance. Various mutations have been implicated in about half of resistant patients. Sor-
della and colleagues have discovered a new resistance mechanism in a subpopulation of NSCLC 
cells that are intrinsically resistant to Tarceva. These tumor cells were observed to secrete elevated 
amounts of a growth factor called transforming growth factor-β (TGF-β), which in turn increases 
secretion of interleukin-6 (IL-6), an immune signaling molecule. Signifi cantly, these effects were 
independent of the EGFR pathway. The team therefore hypothesizes that infl ammation is one of 
the factors that can render a tumor cell resistant to treatment with Tarceva. In other work, Sordella 
collaborates with the Krainer lab to study whether alternative splicing has a role in the failure of 
p53-mediated senescence to halt oncogenesis in certain lung cancers.
Nicholas Tonks and colleagues study a family of enzymes called protein tyrosine phosphatases, or 
PTPs, which remove phosphate groups from proteins and other signaling molecules, such as lipids, 
in cells. Disruption of PTP function is a cause of major human diseases, and several of the PTPs 
are potential therapeutic targets for such diseases. Tonks’ group seeks to fully characterize the PTP 
family, understanding how PTP activity is controlled and how PTPs modify signaling pathways. 
In addition, they are working to determine how those pathways are abrogated in serious illnesses, 
including cancer, diabetes, and Parkinson’s disease. The overall goal is to identify new targets and 
strategies for therapeutic intervention in human disease. Tonks and colleagues have defi ned new 
roles for PTPs in regulating signaling events in breast cancer, identifying three PTPs as novel 
potential tumor suppressors. They have characterized the regulation of PTP1B by reversible oxi-
dation, demonstrating that it is regulated by covalent modifi cation of the active site by hydrogen 
sulfi de (H2S) under conditions of ER stress that are linked to protein-folding-related pathologies, 
such as Parkinson’s and Alzheimer’s. In addition, they have generated recombinant antibodies that 
selectively recognize the oxidized conformation of PTP1B; these antibodies display the ability to 
promote insulin signaling in cells and suggest novel approaches to therapy for diabetes. Finally, 
they have also discovered a novel mechanism for allosteric regulation of PTP1B activity, offering 
the possibility of developing small-molecule drugs that could inhibit the phosphatase and thereby 
modulate signaling by insulin and the oncoprotein tyrosine kinase HER2, potentially offering 
new ways to treat insulin resistance in type-2 diabetes and breast cancer.
Lloyd Trotman’s recent research path begins at his discovery some years ago that the loss of a 
single copy of a master tumor suppressing gene called PTEN is suffi cient to permit tumors to de-
velop in animal models of prostate cancer. His team later found that complete loss of PTEN para-
doxically triggers senescence, an arrested state that delays or blocks cancer development in affected 
cells. These fi ndings explained why many patients only display partial loss of this tumor suppres-
sor when diagnosed with prostate cancer. Now the team is researching ways to restore the PTEN 
protein levels in these patients. This therapeutic approach could slow disease progression and thus 
greatly reduce the need for surgical removal of the prostate or similar drastic interventions that 
carry the risks of incontinence and impotence. Their second approach to combat prostate cancer is 
to model the lethal metastatic disease in genetically engineered mice. They are developing a novel 
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approach that allows for quick generation and visualization of metastatic disease. The effi cacy of 
existing and novel late-stage therapies, such as antihormonal therapy, can then be tested and op-
timized in these animals. At the same time, the Trotman lab is exploring the genome alterations 
associated with metastatic disease and with resistance to therapy. To this end, they use single- and 
multicell genome sequencing techniques developed at CSHL by Drs. Wigler and Hicks.
David Tuveson’s lab uses mouse and human tissue models of neoplasia to explore the funda-
mental biology of these diseases and thereby identify new diagnostic and treatment strategies. 
His team’s main focus is pancreatic cancer, a lethal malignancy that has eluded clinical solutions 
despite intensive study. The lab’s approaches at CSHL run the gamut from designing new model 
systems of disease to inventing new therapeutic and diagnostic platforms for rapid evaluation in 
preclinical and clinical settings. For example, they have adopted a new method of culturing tissue 
fragments indefi nitely in cell culture, enabling deep analysis with genetic and pharmacological 
probes. In addition, therapeutic experiments in mouse models have revealed an important role 
of redox metabolism and stromal interactions on infl uencing therapeutic response. This year, 
they used the mouse model system to identify the mechanism of a promising drug treatment for 
pancreatic cancer. The lab found that using the drug in combination with more standard chemo-
therapeutic drugs stopped the tumor growth and lengthened life span for the mice, suggesting 
that the combination therapy may help overcome the drug resistance that is so commonly found 
in cancers. Tuveson’s lab also has a strong link to clinical trials locally and internationally, with 
confi rmation in early-phase trials the ultimate goal. Collectively, their strategy in the preclinical 
and clinical arena is codifi ed as the “Cancer Therapeutics Initiative,” and this initiative will pro-
vide these same approaches to the entire CSHL cancer community.
Linda Van Aelst’s lab studies how aberrations in intracellular signaling involving enzymes 
called small GTPases can result in disease. They are particularly interested in Ras and Rho 
 GTPases, which help control cellular growth, differentiation, and morphogenesis. Alterations af-
fecting Ras and Rho functions are involved in cancer and various neurodevelopmental disorders. 
Van Aelst’s team has extended its prior study of mutations in a Rho-linked gene called oligo-
phrenin-1 (OPHN1), part of an effort to connect the genetic abnormalities associated with mental 
retardation to biological processes that establish and modify the function of neuronal circuits. In 
addition to a role for OPHN1 in activity-driven glutamatergic synapse development, lab members 
have obtained evidence that OPHN1 has a critical role in mediating mGluR-LTD (long-term 
depression), a form of long-term synaptic plasticity, in CA1 hippocampal neurons. Their fi nd-
ings provide novel insight not only into the mechanism and function of mGluR-dependent LTD, 
but also into the cellular basis by which mutations in OPHN1 could contribute to the cognitive 
defi cits observed in patients. Defects in cortical neurogenesis have been associated with cerebral 
malformations and disorders of cortical organization. The Van Aelst team discovered that in-
terfering with the function of the Rho activator DOCK7 in neuronal progenitors in embryonic 
cerebral cortices results in an increase in the number of proliferating neuronal progenitors and 
defects in the genesis of neurons. In an extension of these studies, the Van Aelst team this year 
showed that DOCK7 has a central regulatory role in the process that determines how and when 
a radial glial cell progenitor “decides” to either proliferate, i.e., make more progenitor cells like 
itself, or give rise to cells that will mature, or “differentiate,” into pyramidal neurons. These lines 
of research provide novel insight into mechanisms that coordinate the maintenance of the neural 
progenitor pool and neurogenesis.
Hongwu Zheng’s lab aims to defi ne the complex biology of malignant glioma pathogenesis, 
with the ultimate goal of translating the developed knowledge into patient benefi ts. Although 
eerily similar in terms of their self-renewal capacity and distinct phenotypic plasticity, malig-
nant glioma cells conspicuously lack the terminal differentiation traits possessed by their normal 
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counterparts—neural progenitors. With the use of multiple approaches combining human cancer 
genomics, animal modeling, and stem cell biology, Zheng has unraveled the causal relationship 
between aberrant differentiation and ensuing gliomagenesis. Perhaps more importantly, his team 
has demonstrated that forced restoration of differentiation capacity within glioma cells can drasti-
cally attenuate their tumorigenic potential. This fi nding fi ts well with the team’s overall strategy, 
which is to target differentiation control pathways as a novel avenue for malignant glioma treat-
ment. To this end, they have sought (1) to develop various animal models to recapitulate the 
human glioma pathogenesis and utilize them to trace and investigate in vivo tumor initiation/
progression and (2) to identify key pathways/players controlling normal and neoplastic neural 
progenitor cell renewal and fate determination.
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THE INFLUENCE OF THE TUMOR MICROENVIRONMENT 
ON DRUG RESISTANCE AND METASTASIS
M. Egeblad A. Almeida Y. Kinugasa M. Shields
 J. Cappellani J. Park R. Wysocki
 M. Fein J.-H. Park
Solid tumors are aberrant tissues that are composed of 
cancer cells and stroma. The stroma is the supportive 
framework of the organs and includes the extracellu-
lar matrix (ECM) and fi broblasts, adipocytes, cells of 
the vascular system, and immune cells. Interactions 
between epithelium and stroma are essential for nor-
mal organ development as well as for tumor progres-
sion. In solid tumors, the stroma is also known as the 
tumor microenvironment.
We study how the tumor microenvironment infl u-
ences cancer cells in the context of drug resistance and 
metastasis. We use mouse models of breast and pan-
creatic cancer together with real-time spinning-disk 
microscopy in living mice (intravital imaging). This 
allows us to study how cancer cell proliferation, mi-
gration, and survival are infl uenced by stromal com-
ponents in real time.
Functional Genomic Approaches Reveal 
That Multiple, Parallel Interactions 
Occur between Cancer Cells and 
Stromal Cells
This work was done in collaboration with Scott  Powers 
at CSHL. Fibroblasts are one of the most prevalent 
stromal cell types in solid tumors. They have been 
shown to promote cancer cell proliferation, angiogen-
esis, ECM remodeling, infl ammation, invasion, and 
metastasis. Tumors containing a high percentage of 
fi broblasts tend to be higher grade and are associated 
with poor prognosis.
With Scott Powers, we have undertaken a genome-
wide approach to identify important functional genes 
that are induced in fi broblasts in basal breast can-
cer. We identifi ed genes up-regulated in fi broblasts 
upon interaction with breast cancer cells in cocul-
tures and compared the identifi ed genes with those 
up-regulated in stroma from primary human breast 
cancers (Fig. 1). Many of the up-regulated genes 
encode secreted growth factors or cytokines. Using 
RNA interference (RNAi) with a co-injection tumor 
formation assay, three of fi ve tested fi broblast-secreted 
factors were found to have major roles in promoting 
tumorigenicity. Interestingly, the fi broblast-secreted 
factors had functionally diverse effects on tumori-
genicity, such as stimulation of tumor cell prolifera-
tion, infl ammatory cell infi ltration, and angiogenesis. 
These results indicate that there likely is no single 
major mediator of tumor–fi broblast interactions that 
can be targeted. Instead, there are multiple points of 
intervention to prevent fi broblasts from supporting 
breast cancer.
Through intravital imaging, we recently discov-
ered that fi broblasts and breast cancer cells exchange 
microvesicles. Currently, we are determining the con-
tents of these microvesicles to allow us to compare the 
effects of tumor–fi broblast communication that occur 
through microvesicles with those mediated by classi-
cal peptide factors.
The Inﬂ uence of the Tumor 
Microenvironment on Response 
to Therapy
R. Wysocki, M. Fein, J. Cappellani
Breast cancer will recur in 20% of patients within 
10 years after apparently successful treatment with 
chemotherapy. When resistance to chemotherapy 
develops, no other effective treatment options are 
available. How resistance develops is still an open 
question, with three main theories proposed for the 
origin of the resistant cells (1) from subpopulations 
of cells already within the tumor, (2) from cells with 
stem-cell-like properties, or (3) through mutations 
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or epigenetic changes. Understanding which of these 
mechanisms drive resistance is critical to reducing 
recurrence.
Surprisingly, little is known about how cancer 
cells in intact tumors respond to classical chemo-
therapy, although these drugs have been used for 
decades. Most knowledge of the responses has been 
obtained from cell culture or xenograft animal ex-
periments, but such experiments are often not pre-
dictive of drug responses in patients. We previously 
used intravital imaging to show that monocytes are 
recruited to tumors ~30 h after chemotherapeutic 
treatment with doxorubicin, after cancer cell death 
was observed. We determined that monocytes were 
recruited to tumors through activation of the che-
mokine receptor CCR2. We further determined 
that the infi ltration of these monocytes contributed 
to chemoresistance, as the effect of doxorubicin and 
cisplatin on tumors transplanted to mice lacking 
CCR2 was signifi cantly better than that of tumors 
in normal mice.
We noted that when tumors recurred in mice 
lacking CCR2, they were of lower histological grade 
than tumors relapsing in wild-type mice. We have 
now found that the tumors relapsing in mice where 
host cells lack CCR2 are more differentiated toward 
a luminal epithelial cell type than the rapidly relaps-
ing tumors in wild-type mice. We are currently in-
vestigating how CCR2 expressed by the tumor mi-
croenvironment can cause not just a delay in relapse, 
but also an altered phenotype of the cells that recur. 
To identify the cellular and molecular mechanisms, 
we are using lineage tracing with intravital imaging 
over weeks, using our newly developed mammary 
imaging windows, together with microgenomics 
 approaches.
Figure 1. Using imaging and genomics approaches to analyze tumor–stroma interactions. (Left) Fibroblasts and can-
cer cells intermingle in a breast tumor model. A still image (acquired through our new mammary imaging windows) is 
shown from a tumor in a live mouse. Cancer cells and ﬁ broblasts were co-injected. (Right) Gene expression changes 
induced by culturing ﬁ broblasts with cancer cells lead to promotion of cancer. The separate ﬂ uorescent labeling of 
cancer cells and ﬁ broblasts allowed us to separate the two cell populations and determine how gene expression was 
changed in ﬁ broblasts after they had been exposed to cancer cells. From the 320 genes identiﬁ ed, ﬁ ve genes coding 
for proteins that can be pharmacologically targeted were tested for functional relevance, and three of the ﬁ ve genes 
had major effects on tumor growth.
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Effects of Myeloid Cells on Breast 
Cancer Metastasis
J. Park, M. Fein, R. Wysocki, Y. Kinugasa
The prognosis of metastatic breast cancer is poor. 
More than a century ago, Dr. Stephen Paget observed 
that metastases develop preferentially in certain or-
gans, suggesting that factors external to cancer cells 
infl uence metastasis and that targeting such factors 
might reduce the ability of cancer cells to take seed. It 
is now recognized that communication between can-
cer cells through growth factors and cytokines has an 
important role in the formation of metastases.
Traditionally, studies of metastasis have relied pri-
marily on measurements made at the endpoint of the 
process, the establishment of micro- or macrometas-
tases. However, the metastatic process is dynamic and 
characterized by the ability of cancer cells to move 
from one part of the body to another: Cells exit the 
primary tumor, invade the local tissue, enter blood or 
lymphatic vessels, and are transported to a distant site 
where they exit the vessels and move into the tissue. 
Thus, a different level of understanding of metastasis 
might be achieved using technologies that can follow 
these dynamic processes in vivo.
We use intravital imaging with mouse models 
of breast cancer and classical genetic manipulation 
to determine how interactions between cancer cells 
and stromal cells infl uence metastasis. We have com-
pared the microenvironment of tumors formed from 
the metastatic 4T1 and the nonmetastatic 4T07 cell 
lines, isolated from the same breast tumor. We have 
identifi ed signifi cant differences in the types and 
amount of chemokines that are secreted by the cancer 
cells and in the nature of the myeloid cell infi ltrate 
between the metastatic and nonmetastatic tumors. 
Strikingly, tumors grow more slowly and metastasis 
is greatly reduced in mice that lack the receptor for 
one of the chemokines that specifi cally is secreted by 
metastatic cancer cells and acts on neutrophils, one 
of the least-studied infl ammatory cell types in can-
cer metastasis. Ongoing studies are addressing how 
the chemokine–chemokine receptor signaling axis 
regulates invasion and promotes metastasis. Prelimi-
nary data strongly suggest that cancer cells activate 
an unusual cell death mechanism in the neutrophils, 
leading to the release of strong proteolytic enzymes. 
We have determined that pharmacological inhibitors 
against both the cell death pathways and proteolysis 
are effective at reducing neutrophil-promoted inva-
sion in vitro and metastasis in vivo.
Collagen Architecture in Pancreatic 
Cancer Progression
M. Shields, J. Cappellani
Tumors are often discovered as nodules that are harder 
than the surrounding tissue. This refl ects the changes 
in ECM stiffening and architecture. The interstitial 
ECM consists of macromolecules such as fi brillar col-
lagens, fi bronectin, and proteoglycans. Type I colla-
gen is the major fi brillar collagen in many tissues and 
forms a scaffold that provides stability. It also has sig-
naling functions mediated by, for example, integrins 
and discoidin domain receptors. The synthesis and 
proteolytic remodeling of the fi brillar type I collagen 
increases in many tumors, most notably in pancreatic 
tumors.
In collaboration with Dr. Weaver’s lab at the Uni-
versity of California, San Francisco, we previously re-
ported that inhibiting collagen cross-linking in mouse 
models of mammary carcinoma delays tumor onset 
and slows tumor progression. We also found that the 
collagen architectural structure became abnormal 
with progression of breast cancer: Whereas collagen 
fi bers are curly and oriented in parallel to normal or 
hyperplastic epithelium, there is a progressive change 
in the fi bers so that they are straighter and mostly 
perpendicular to the tumor border in the late stages. 
This changed architecture promoted cell invasion by 
enabling cells to migrate along the collagen fi bers or 
by enhancing integrin signaling. Enzymes of the lysyl 
oxidase (LOX) family are important for the collagen 
cross-linking that results in straighter fi bers, and these 
enzymes have been shown to promote cancer progres-
sion and metastasis of breast cancer.
Pancreatic cancer has higher levels of type I collagen 
and of the LOX-like 2 enzyme than breast cancer, and 
we therefore hypothesized that collagen cross-linking 
would have a signifi cant effect on reducing tumor ini-
tiation and metastatic spread. However, using both 
pharmacological inhibitors and genetic approaches, we 
instead found an increase in the growth of pancreatic 
tumors and in metastatic spread. Intravital imaging in 
mice showed that pancreatic cancer cells also migrate 
along collagen fi bers and that collagen architecture is 
altered by cross-linking inhibitors in pancreatic cancer. 
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This suggests that collagen architecture or the cancer 
cells’ response to collagen is fundamentally different 
between breast and pancreatic cancer. Currently, we are 
determining the effects of the altered collagen architec-
ture on growth, migration, and intracellular signaling.
Employing Tumoricidal Activities 
of Macrophages
A. Almeida, M. Shields
Tumor-associated macrophages have tumor-support-
ing activities, and their infi ltration is associated with 
poor patient prognosis. However, macrophages are ca-
pable of killing tumor cells if they are activated with 
interferon-γ (IFN-γ) and agonists of receptors for 
pathogen-associated molecular patterns. We are using 
live cell imaging of cocultures between macrophages 
and breast or pancreatic cancer cells to understand the 
mechanisms responsible for the tumoricidal activities. 
We have determined that activated macrophage-medi-
ated cancer cell killing is highly effective and requires 
direct cell–cell contact between macrophages and 
cancer cells. A mediator of cancer cell killing has been 
identifi ed and is under further investigation. Live im-
aging has also revealed that a small number of cancer 
cells survive the tumoricidal activities of macrophages. 
Because such a macrophage-evading mechanism used 
by cancer cells would hinder therapeutic use of macro-
phage activation, we used RNA sequencing to identify 
candidate genes involved in the evasion. Several can-
didates are under further investigation.
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PROTEOMICS AND MASS SPECTROMETRY
D. Pappin G. Bencze S. Peacock 
 C. M. Gauss K. Rivera 
 T. Hassan J. Wilson
Role of N-Acetyltransferases 
in Neurological Disorders
This work was done in collaboration with M. Doerfel 
and G. Lyon here at CSHL.
More than 85% of human proteins are acetylated 
at their amino-terminal amino group, and thus 
N(α)-terminal acetylation is the most abundant 
posttranslational modifi cation known. Despite 
its discovery more than 30 years ago, very little is 
known about the cellular effects or functions of this 
modifi cation. In humans, six distinct amino-termi-
nal amino-acetyltransferases (NATs) catalyze the 
transfer of an acetyl group from acetyl-CoA to the 
N(α)-terminal amino group of their specifi c target 
proteins.
The major human acetyltransferase, NatA, consists 
of an auxiliary subunit (Naa15) and a catalytically ac-
tive subunit (Naa10). Recently, the Lyon laboratory 
described two families with a lethal X-linked disorder 
of infancy called the Ogden syndrome. This disor-
der comprises a distinct combination of an aged ap-
pearance, craniofacial anomalies, hypotonia, global 
developmental delays, cryptorchidism, and cardiac 
arrhythmias. Using X chromosome exon sequencing 
and a recently developed variant annotation, analysis, 
and selection tool (VAAST), the Lyon lab identifi ed 
a c.109T > C (p.Ser37Pro) variant in Naa10 as the 
probable disease-causing variant.
To characterize the effects of this mutation, they 
have generated a yeast knockout NatA cell line and 
rescue strains ectopically expressing the human 
Naa15/Naa10 wild type as well as the human Naa15/
Naa10 S37P mutant, respectively. Total proteins of 
these strains were extracted, labeled with distinct 
iTRAQ reagents, and analyzed by liquid chromatog-
raphy-mass spectrometry (LC-MS). Analysis of the 
generated data set revealed specifi c changes in the 
expression within ribosomal proteins, indicating an 
impaired ribosomal function of the NatA knockout 
and S37P mutants.
Role of Nrf2 in Pancreatic Cancer
This work was done in collaboration with C. Chio and 
D. Tuveson here at CSHL.
Drug resistance is a major cause of pancreatic cancer 
lethality, and this has been ascribed to augmented cell 
survival pathways and poor drug delivery. Nrf2 is a tran-
scription factor that promotes both pancreatic ductal ad-
enocarcinoma (PDAC) progression and drug resistance, 
and antagonizing the Nrf2 pathway may be clinically 
advantageous. Because transcription factors are diffi cult 
to target therapeutically, the Tuveson laboratory has 
sought to comprehensively characterize the mechanisms 
used by Nrf2 to promote PDAC so that more feasible 
approaches to counter the effects of Nrf2 in PDA may 
be developed. In pursuit of this goal, we aim to deter-
mine the Nrf2-dependent “cysteine proteome” to iden-
tify pathways impacting PDA biology and therapy.
Activation of the Nrf2 program is known to elicit a 
more reducing intracellular environment. Protein oxi-
dation can infl uence protein activity and stability, and 
thus, one hypothesis is that certain mediators of Nrf2 
function may be “redox sensor” proteins that contain 
labile cysteine thiol groups. Accordingly, we are using 
pancreatic ductal organoids to develop a highly sen-
sitive proteomic method that identifi es proteins con-
taining cysteines that undergo selective reduction due 
to the Nrf2 antioxidant program.
We have developed a novel proteomics workfl ow 
that uses selective capture of cysteine peptides in 
conjunction with iTRAQ (isobaric tagging for rela-
tive and absolute quantitation) labeling to determine 
quantitative changes in free (reduced) cysteine resi-
dues on a proteome-wide scale that also normalizes 
these changes to expression levels of the respective 
proteins. Using this approach, we performed a proof-
of-concept experiment using mouse embryonic fi bro-
blasts treated with BSO (buthionine sulfoximine) or 
DEM (diethyl maleate), two oxidizing agents known 
to induce Nrf2 target genes; 98% of ICAT (isotope-
coded affi nity tags)-enriched peptides contained 
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cysteines, demonstrating the specifi city of the ICAT-
labeling reagent. We found 349 cysteine-containing 
peptides modifi ed by both of these treatments from 
a total of 3662 proteins and 4572 measured cysteine-
containing peptides, showing that the approach is 
effective in quantifying free cysteine changes upon 
redox alterations. Notably, proteins oxidized by both 
agents included those previously reported to contain 
redox sensitive sites, such as Pkm1/2, thioredoxin, 
and galectin-1. These and other oxidation-sensitive 
proteins (and the biochemical pathways they impact) 
will be assessed for the ability to promote PDAC bi-
ology and drug resistance, potentially informing new 
therapeutic strategies.
Oil Production in Duckweed
This work was done in collaboration with S.C. Li and 
R. Martienssen here at CSHL.
Duckweeds are potential bioenergy crops because of 
their fast growth and reproduction. Duckweed plants 
propagate mainly via vegetative reproduction, so main-
taining clonal populations is also possible. The Mar-
tienssen laboratory aims to increase oil production in 
duckweeds in order to provide an alternative diesel re-
source. Because their genome sequencing has already 
been completed, the target species are Lemna minor 
and Lemna gibba. The methods of plant transforma-
tion with L. minor have also been improved as well as 
the development of an artifi cial microRNA system, so 
genetic engineering for overexpression or knockdown 
lines is now feasible.
Plant oils are mostly composed of triacylglycer-
ols stored in lipid droplets. Multiple enzymes such as 
PDAT (phospholipid diacylglycerol) and DGAT (dia-
cylglycerol acyltransferase) are involved in their bio-
synthesis from glycerols and fatty acids. Overexpres-
sion and knockdown duckweed mutants are being de-
veloped, both to promote production of specifi c fatty 
acids and triacylglycerols and to inhibit degradation to 
increase overall yield. In addition to these genetic en-
gineering approaches, nutrient stress (such as nitrogen 
defi ciency) has been shown to increase triacylglycerol 
production in L. gibba. To support this project, we have 
developed a set of quantitative multiple reaction moni-
toring (MRM) assays to measure several key triacyl- 
and diacylglycerol species, allowing for rapid screening 
of lipid composition. Using this technique, we will be 
able to screen different mutant and stressed plant sam-
ples for high accumulation of target triacylglycerols.
Glycopeptide Markers for Pancreatic Cancer
This work was done in collaboration with D. Engle and 
D. Tuveson here at CSHL.
Pancreatic cancer is the most lethal of the common 
carcinomas, and by the time it is detected, the disease 
has usually disseminated to multiple sites. Pancreatic 
ductal adenocarcinoma (PDAC) presents insidiously 
with nonspecifi c symptoms such as vague abdominal 
discomfort and weight loss, and as a result, it is often 
not recognized as a developing cancer. But, although 
this disease is often diagnosed late, its long latency 
presents an opportunity for early detection and inter-
vention. Ideally, a simple blood test would be able to 
identify patients at risk of developing cancer, diagnose 
and stage the type of cancer, and monitor disease pro-
gression and treatment effi cacy.
Pancreas cancer burden can be followed longitu-
dinally in many patients by measuring the level of 
circulating tumor antigen CA19-9; however, this bio-
marker is insuffi cient for the early diagnosis of pancre-
as cancer (PDAC) because it lacks the necessary sen-
sitivity and specifi city. Thus, there is currently a great 
need for effective diagnostic tools that enable early de-
tection and quantitative measurement of disease pro-
gression. The Tuveson group has produced accurate 
mouse models of early and advanced PDAC that have 
accelerated basic and applied research for this disease. 
Unfortunately, the evaluation of novel diagnostics 
in mouse models has been hampered by the lack of 
CA19-9 production in mice due to the absence of cer-
tain enzymes that catalyze the production of sialylated 
Lewis A antigens. The Tuveson laboratory is attempt-
ing to generate the fi rst GEMM of pancreas cancer 
that produces CA19-9 antigens, enabling facile and 
high-throughput discovery, evaluation, and validation 
of new diagnostics. This will provide an important 
preclinical tool for the rigorous analysis of candidate 
biomarkers before the onset of clinical trials.
We performed immunoprecipitation of CA19-9- 
labeled proteins that are secreted or shed in monolayer 
cultures of mouse PDAC cell lines engineered to pro-
duce CA19-9. The immunoprecipitated proteins were 
labeled with amine reactive isobaric mass tags (iTRAQ), 
and proteins that were present in higher abundance in 
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the CA19-9-positive samples were identifi ed by LC-MS. 
We confi rmed the pulldown of known CA19-9-bearing 
proteins, including Mucin 1 (western blot) and Mucin 
5ac (IP/mass spectrometry), as well as other proteins 
that have known O-glycosylation sites but that had not 
been previously annotated as CA19-9 carriers in human 
cells. Upon transplantation of these cell lines into the 
pancreas of C57BL/6 J mice, CA19-9 was detected in 
the tumors and metastases from the cell lines engineered 
to produce CA19-9, whereas none were detected in the 
control, pBabe-neo tumors. Furthermore, high levels of 
CA19-9 were detected in both the plasma and ascites 
of mice inoculated with CA19-9-positive human and 
mouse cells. Using these plasma and ascites samples, 
we have further optimized the immunoprecipitation of 
CA19-9 carrier proteins for LC-MS analysis and have 
identifi ed the known carrier of CA19-9 (Mucin 1) in 
the ascites of mice transplanted with mouse PDAC cells. 
Mass spectrometric analyses of the transplants with 
human cell lines is currently ongoing.
Characterization of BAF Complexes
This work was done in collaboration with J. Shi and 
C. Vakoc here at CSHL.
ATP-dependent remodeling enzymes are a major cat-
egory of chromatin regulators that regulate transcrip-
tion programs underlying a variety of biological pro-
cesses. The SWI/SNF complex (also known as BAF in 
mammals) is one of the most studied. In mammalian 
cells, BAF complexes are composed of ~11 subunits that 
are encoded by ~19 distinct genes, and the diversity of 
confi guration of BAF subunit assemblies is thought to 
confer distinct, specialized functions. Recently, the core 
catalytic subunit of the BAF complex, Brg1, has been 
shown to have a critical role in leukemia maintenance 
through sustained expression of oncogenic Myc. How-
ever, little is known about BAF complex assemblies 
in leukemia cells. To investigate the BAF complex in 
leukemia, we immunoprecipitated endogenous Brg1 to 
pull down BAF complexes from human leukemia cell 
lines (NOMO-1) and quantifi ed the protein contents 
by iTRAQ LC-MS (Fig. 1) We identifi ed numerous 
Brg1-associated proteins, which included almost all 
well-known BAF subunits, and some additional pro-
tein factors. Currently, we are using immunoprecipita-
tion (IP)-western blotting to confi rm the MS results 
and trying to pinpoint the leukemia-biology functional 
relevance of these Brg1-associated proteins through ge-
netic and biochemical experiments.
Discovery and Characterization 
of a Lys/Arg-N Protease
D. Pappin, J. Wilson
Directed peptide fragmentation can generate specifi c 
ion fragment series that simplify MS/MS spectra. 
This is achieved by controlling where the charge is 
Figure 1. (Left) Silver staining of endogenous BAF complex in human leukemia cell line (NOMO-1) that 
was subjected to iTRAQ mass spectrometry. (Right) Two biological replicates of the iTRAQ data quan-
titatively comparing proteins enriched from Brg1 IP and control IgG IP in human leukemia cell line. 
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located on the peptide, either enzymatically or, with 
extra steps, by chemical modifi cation. To produce pre-
dominantly amino-terminal ions, the charge must be 
placed at or near the amino termini of peptides. This 
can be most elegantly achieved using a proteolytic en-
zyme with amino-terminal cleavage specifi city at basic 
amino acids. We have discovered a novel thermostable 
protease with amino-terminal arginine and lysine 
specifi city. The enzyme can be used as a substitute 
for trypsin, generates predominantly amino-terminal 
ions, and completes digestions in ≤1 h at 60°C.
The enzyme exhibits a temperature optimum of 
~60°C and a broad pH specifi city around neutral. 
The protease is most active in low ionic strength and 
MS compatible acetate buffers, and activity requires 
calcium and zinc. In contrast to trypsin, MS compat-
ible or selectively cleavable detergents did not increase 
the number of identifi ed peptides or proteins. Speci-
fi city for amino-terminal cleavage at arginine and 
lysine was ≳95%, with the remaining 5% amino-
terminal to larger aliphatic residues. In whole-cell ly-
sates, the numbers of identifi ed peptides and proteins 
were similar to trypsin, yet generated in nearly 20× 
shorter digestion times. As expected, the b-ion series 
in MS/MS spectra were signifi cantly more intense 
than y ions. In complex mixtures, a shift to lower 
peptide charge states was also observed, likely due to 
close physical proximity of basic centers. This pref-
erence was abrogated by modifi cation with iTRAQ, 
probably due to the increased distance between posi-
tive charges. The effi ciency of iTRAQ labeling was 
unchanged.
This highly active metalloprotease is suitable for 
extremely rapid (≤1 h) digestion of samples for im-
mediate MS analysis. The peptides produced by this 
enzyme always have major basic centers at the peptide 
amino termini, producing more easily interpretable 
MS/MS fragmentation spectra by generating a domi-
nant b-ion series. In contrast to trypsin, the ion cur-
rent is not diluted between b and y ions, thus simul-
taneously increasing detection sensitivity. The speed, 
specifi city, ease of use, and overall effectiveness of this 
protease, combined with its ability to provide more 
interpretable spectra, make it a valuable component of 
the proteomics toolkit.
PUBLICATION
Ruse CI, Peacock S, Ghiban C, Rivera K, Pappin DJ, Leopold P. 
2013. A tool to evaluate correspondence between extraction ion 
chromatographic peaks and peptide-spectrum matches in shot-
gun proteomics experiments. Proteomics 16: 2386–2397.
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MOLECULAR TARGETED THERAPY OF LUNG CANCER EGFR 
MUTATIONS AND RESPONSE OF EGFR INHIBITORS
R. Sordella M. Camiolo M. Pineda
 P. Debjani S. Senturk
 V. Himenez N. Shirole
 T. Lindsted Z. Yao
Recent technological advances in genomic and se-
quencing technologies have revolutionized the way in 
which we understand tumorigenesis and have led to 
the identifi cation of cancer mutations with diagnos-
tic, prognostic, or therapeutic implications. The use of 
drugs that precisely target such mutations has shown a 
defi nitive impact in the management and treatment of 
cancer patients. It is nonetheless evident that at pres-
ent, major obstacles still need to be overcome in order 
to achieve the goal of developing truly curative thera-
pies. Among these hurdles, drug resistance continues 
to be a major factor in reducing the effectiveness of 
cancer treatments at large.
Cancer was fi rst described as an evolutionary pro-
cess by Nowell, who hypothesized that natural selec-
tion occurs in tumors in the form of clonal selection 
leading to constant evolutionary change and possibly 
to drug resistance. Evolutionary processes in cancer 
development and progression have since been stud-
ied, which has provided remarkable insights into the 
biology of cancer. It has now become clear that by 
the time a cancer is detected, it is composed of bil-
lions of malignant cells. Although all share somatic 
mutations that were present in the founder cell, they 
also carry additional mutations acquired during the 
natural evolution of the tumor. Thus, although most 
cancers are monoclonal at their origin, the acquisi-
tion of additional mutations and the expansion of 
the population size result in a dramatic increase in 
genetic tumor heterogeneity. Somatic mutation anal-
yses of tumors and phylogenetic trees constructed 
from these data provided evidence for the Darwin-
ian evolution model based on positive selection. As 
Darwinian evolution is fueled by this population 
heterogeneity, the study of the origin and the mea-
surement of the extent of genetic heterogeneity are 
key steps to gaining an understanding of how cancer 
drug resistance develops.
NRSF Modulates Cancer Cell-State 
Plasticity by Epigenetically Regulating 
miR-335 Expression
In recent studies, we found that in addition to the ac-
quisition of genetic mutations, epigenetic changes can 
also contribute to the observed intramural tumor het-
erogeneity. In particular, we observed a critical role for 
NRSF (neuron-restrictive silencer factor) and miR-
335 in epigenetic reprogramming of cells. Our data 
indicate that NRSF and miR-335 can act as “pegs and 
guy ropes” to shape the cell epigenetic landscape, and 
by doing so, they can contribute to restraining epi-
thelial cell differentiation and promoting the acquisi-
tion of a cell state characterized by the acquisition of 
mesenchymal-like features, increased metastatic po-
tential, expression of a specifi c immunotype (CD44+/
CD24−), and distinct drug sensitivity.
This conclusion is based on multiple observations. 
First, miR-335 expression is signifi cantly decreased 
in CD44+/CD24− tumor cells, and its inhibition 
in CD44+/CD24− cells was suffi cient to activate 
a composite program that resulted in the acquisi-
tion of molecular and phenotypic features typical of 
a CD44+/CD24− cell state (i.e., decrease in features 
associated with epithelial differentiation, acquisition 
of a specifi c immunotype, and increased resistance to 
EGFR-mediated signaling). Second, miR-335 expres-
sion is regulated by NRSF recruitment to the MEST 
(mesoderm-specifi c transcript) isoform-2  promoter. 
Inhibition of NRSF expression caused a decrease in 
DNA methylation of the MEST isoform-2 promoter 
and rapid reactivation of MEST and miR-335 expres-
sion. This was accompanied by decreased expression 
of genes characteristic of a CD44+/CD24− state 
such as transforming growth factor-β (TGF-β), in-
terferon-6 (IL-6), WNT5a, ECAD (E-cadherin), 
and vimentin.
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miR-335 and NRSF are ideal players for coupling 
epigenetic inheritance and dynamic interconversion 
among cell states. Expression of miR-335 can swiftly 
activate complex molecular circuitries and limit fl uc-
tuation among cell states by restricting the expression 
of a plethora of genes controlling traits that typify the 
CD44+/CD24− cells (i.e., TGF-β, IL-6, WNT-5a, 
Sox9, CD44, CD24, ECAD, and vimentin). Of par-
ticular interest is the regulation of TGF-β, IL-6, and 
WNT-5a by miR-335 as these cytokines have been 
shown to be necessary and suffi cient to induce and 
maintain a CD44+/CD24− state. 
miR-335 can also regulate multiple miRNAs 
through silencing of TGF-β-mediated signaling: 
Many of these miRNAs have been associated with key 
aspects of CD44+/CD24− cells such as self-renewal, 
metastatic capacity, cell reprogramming, and drug 
resistance. For example, miR-200c and miR-183 clus-
ters are down-regulated in human and murine breast 
cancer stem cells and in mammary gland stem cells. 
miR-200c has also been shown to restrain epithelial-
to-mesenchymal transition (EMT) by mediating the 
degradation of ZEB1. Moreover, miR-34a, miR-92a, 
miR-99, and miR-192 expression is negatively corre-
lated with an increased risk of metastasis. Interesting-
ly, miR-34a was recently shown to be involved in the 
reprogramming of somatic cells and in the inhibition 
of growth and metastasis of prostate cancer stem cells 
by directly repressing CD44 expression.
NRSF, on the other hand, is a well-characterized 
transcriptional repressor involved in heterochromatin-
mediated silencing and in restriction of cell-fate de-
termination. By interacting with corepressors such as 
co-REST and Sin3a, NRSF mediates several histone 
modifi cations that are part of a “histone code” thought 
to be essential in gene silencing. These modifi cations 
include H3K9 trimethylation, a histone modifi cation 
associated with heterochromatin structures that poises 
promoters for DNA methylation.
Intriguingly, NRSF is best known for its roles in 
repressing neuronal gene expression and restricting 
neurogenesis in nonneuronal tissues and in undif-
ferentiated neuronal progenitors. Hence, the obser-
vation that NRSF also regulates the CD44+/CD24− 
cell-state transition supports a broader role of NRSF 
in cell-fate determination and in maintaining an un-
differentiated state that is not restricted to neuronal 
differentiation.
Our studies also imply that the interconversion 
among cell states relies on a few events. As a conse-
quence, the system can be easily perturbed not only 
by inter- and intracellular signals, but also by non-
deterministic distribution of Prickle1/NRSF/miR-
335 activity. This is particularly interesting in light 
of recent work by Gupta et al. suggesting that the 
capability of cancer cell populations to retain pheno-
typic equilibrium over extended periods of time can 
be described through the stochastic interconversion 
of cancer cell states. Hence, in principle, stochastic 
differences in NRSF binding and/or Prickle1/miR-
335 expression could explain the nondeterministic 
cell transition between cell states.
The dependence of the CD44+/CD24− cell state 
on a nearly singular perturbation can, in principle, 
also increase cell-state plasticity and, hence, cellular 
adaptability to environmental changes. This can be of 
extreme importance in the case of drug treatment. As 
a corollary, we anticipate that as opposed to anticancer 
therapies that exclusively target one cell population in 
tumors, the use of a combination of agents that are 
selectively toxic to multiple cell states (e.g., EGFR 
and IL-6) or the concomitant use of these drugs with 
agents that can reshape the epigenetic landscape, for 
example, by blocking cells in defi ned cell states or by 
shifting drug-resistant cells into a drug-sensitive state, 
will be more effective.
CD44+/CD24− Cells Are Characterized 
by Deﬁ cient Homology-Directed Repair 
and Increased Adaptability Triggered 
by TGF-β Down-Regulation of DNA 
Damage-Response Genes
The emergence of RNA interference (RNAi) as a 
mechanism to silence gene expression has enabled 
loss-of-function analysis in mammalian cells in a po-
tentially genome-wide manner. We have utilized such 
an RNAi-based, forward genetic approach to identify 
genes that are selectively required for the survival of 
CD44+/CD24− cells. We identifi ed 135 shRNAs that 
target genes that are selectively required for the surviv-
al of CD44+/CD24− cells. Strikingly, among them, 
we also observed shRNAs silencing genes involved in 
DNA repair/replication pathways. In follow-up stud-
ies, we found that the selective sensitivity of these cells 
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to the inactivation of this particular class of genes 
was due to a decreased expression of genes that play a 
critical role in homology-direct DNA repair that was 
dependent upon the activation of TGF-β signaling. 
This observation is of particular interest because in 
addition to sensitizing cells to inactivation of DNA 
repair pathway components, a decreased expression of 
genes involved in DDR could also lead to an increased 
rate of DNA double-strand breaks (DSBs). Consistent 
with this idea, we observed an increased number of 
γH2AX-foci-positive cells and larger mean comet tail 
movement in CD44+/CD24− cells sorted from A549 
compared to cells with any other immune type and 
parental cells, as well as in H1650-M3 cells compared 
to H1650 cells.
In 1943, Luria and Delbrück showed that genetic 
diversity generated as a consequence of random muta-
tions in each generation of bacteria resulted in a sub-
population that was able to survive T1 phage infec-
tion. Thus, in a similar fashion, the defects in DDR 
that we observed in CD44+/CD24− cells could result 
in an increased phenotypic diversity of cells. Although 
intratumor heterogeneity is most likely not critical 
when growth conditions are stable, it could have an 
important role in the survival and adaptability of a 
cell population upon drastic environmental changes. 
In particular, similar to the case of the fl uctuation ex-
periment of Luria and Delbrück, it could contribute to 
acquired resistance upon drug treatment. Indeed, our 
data reveal that the transition into a cell state charac-
terized by a CD44+/CD24− immune type can result 
in a greater phenotypic diversity and adaptability.
The observed inverse correlation between the ex-
pression of these genes and TGF-β in tumors indi-
cates that our fi ndings could be highly relevant to the 
human disease. In principle, they could explain why 
tumors characterized by a high content of CD44+/
CD24− cells, although initially sensitive to drug treat-
ment, rapidly become drug resistant. In addition, be-
cause TGF-β is one of the main cytokines produced 
during infl ammation, our data could provide a novel 
nexus between infl ammatory conditions, tumorigen-
esis (tumor initiation and progression), and acquired 
drug resistance. The observation that the CD44+/
CD24− state is particularly sensitive to the inacti-
vation of BRCA1, NEK9, ORC5L, RFC3, POLS, 
ERCC8, and RPA2 also points to novel actionable 
drug targets for the treatment of tumors characterized 
by this phenotype.
One interesting aspect of CD44+/CD24− cells is 
their transient nature. In fact, it has been shown that 
they can be generated by stochastic fl uctuation and/
or exposure to paracrine TGF-β. Given that cells in a 
CD44+/CD24− state are intrinsically more genetically 
unstable, our model predicts a “quanta” evolution of 
tumors. Fascinatingly, although it was initially as-
sumed that all tumors evolve in a linear mode, recent 
observations in prostate cancers indicate that certain 
tumors also progress in a punctuate manner.
On the other hand, defects in the expression of 
DDR genes have been shown to induce DNA dam-
age responses that could result in cell cycle arrest and/
or senescence/apoptosis. The tumor suppressor TP53, 
often referred to as the “guardian of the genome,” has 
a major role in coordinating DNA-damage responses 
in cells. Thus, the fact that p53 tumor suppressor ac-
tivities are often disabled in CD44+/CD24− suggests 
the intriguing possibility that inactivation of p53 is a 
cardinal feature that empowers TGF-β to accelerate 
genetic instability and cancer evolution. 
P53Ψ Is a Transcriptionally Inactive 
P53 Isoform Able to Reprogram Cells 
toward a Metastatic-Like State
CD44+/CD24− cells can also be generated stochasti-
cally/epigenetically in cells bearing a tp53 wild-type 
allele, implying that the p53 network in CD44+/
CD24− cells must be compromised. Interestingly, we 
uncovered in these cells a novel mode of p53 regu-
lation that involves alternative splicing of the TP53 
gene. We found that the use of an alternative 3′ splice 
site in intron 6 generates a previously uncharacter-
ized p53 isoform that we named p53Ψ. Intriguingly, 
this isoform is highly expressed in cells character-
ized by a CD44+/CD24− immune type. At the mo-
lecular level, p53Ψ lacks major portions of the DNA 
binding domain, the nuclear-localization sequence, 
and the tetramerization domain, features that are 
normally present in full-length p53 (p53FL). Con-
sequently, this isoform proved to be incapable of se-
quence-specifi c DNA binding and trans-activation 
of canonical p53 target genes. However, expression 
of the p53Ψ isoform attenuated the expression of 
E-cadherin, induced expression of markers asso-
ciated with EMT, and enhanced the motility and 
invasive capacity of normal and malignant cells. 
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Consistent with a role of these features in enhancing 
the prometastatic capabilities of cells, we observed 
that in patients with early-stage NSCLC, expres-
sion of p53Ψ correlated with increased probability 
of relapse following surgical tumor resection. Such 
characteristics are similar to certain p53 gain-of-
function missense mutants.
We also found that reprogramming of cells to-
ward acquisition of mesenchymal-like features, 
induced by either expressing p53Ψ or p53 with 
gain-of-function mutations, is contingent upon in-
creased production of reactive oxygen species (ROS) 
by virtue of interaction with cyclophilin D (CypD), 
a mitochondrial matrix peptidyl-prolyl isomerase 
known to modulate opening of the mitochondrial 
permeability transition pore (mPTP). Hence, we pro-
pose that p53Ψ encodes a “separation-of-function” 
isoform that lacks canonical p53 tumor suppressor/
transcriptional activities, but is capable of reprogram-
ming cells toward acquisition of mesenchymal-like 
features in a transcriptionally independent manner. 
The remarkably similar activities of p53Ψ and certain 
p53 mutants also suggest that the latter “highjack” a 
regulated and reversible program (i.e., p53Ψ alterna-
tive splicing) that contributes to the biology of p53 
mutations during tumorigenesis. Thus, in principle, 
this implies a possible physiological origin for certain 
p53 mutations.
Debjani Pal
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL 
OF SIGNAL TRANSDUCTION
N.K. Tonks S. Akshinthala N. Krishnan M. Yang
 G. Bencze L. Li S. Zhang
 F. Chaudhary M. Ramesh
 G. Fang I. Rus
An important aspect of the work of the Tonks lab is to 
devise creative new approaches to exploiting the protein 
tyrosine phosphatase (PTP) family of enzymes as targets 
for therapeutic intervention in major human diseases, 
including diabetes, obesity, and cancer. At the core of 
this effort is the study of PTP1B, the prototypic protein 
tyrosine phosphatase, which Nick Tonks fi rst discovered 
25 years ago. It is now established that PTP1B not only 
plays a role in attenuating insulin signaling, but also 
plays a positive role in promoting signaling events associ-
ated with breast tumorigenesis. This suggests that inhi-
bition of PTP1B function may represent a novel thera-
peutic strategy to address not only diabetes and obesity, 
but also mammary tumorigenesis and malignancy.
The reversible addition and removal of phosphate 
to proteins, which is termed protein phosphoryla-
tion, is the central feature of the mechanism of sig-
nal transduction—the process by which cells respond 
to stimuli in their environment. The activities of the 
enzymes that mediate the addition (kinases) and re-
moval (phosphatases) of phosphate groups are coordi-
nated in signal transduction pathways to mediate the 
cellular response to environmental stimuli, and the 
function of these enzymes is frequently disrupted in 
human diseases, including diabetes and cancer. The 
ability to modulate such signal transduction pathways 
selectively with drugs holds enormous therapeutic po-
tential. Drugs that target the protein kinases represent 
breakthroughs in cancer therapy. For example, HER2 
is a member of the family of kinases and is amplifi ed 
and/or overexpressed in several cancers, in particular 
in ~25% of breast cancer, where it is associated with 
poor prognosis. The humanized HER2-directed an-
tibody, Herceptin (trastuzumab), is an example of 
a “rational cancer therapy” for treatment of HER2-
positive metastatic breast tumors. It targets HER2 
as a unique marker of the cancer cell. Although Her-
ceptin is used frequently and is being presented as a 
treatment of choice, the overall success rate is low and 
patients develop resistance to the therapy. The prob-
lem of acquired resistance has become an obstacle to 
the successful application of kinase-directed therapies 
in general. Therefore, despite the obvious potential, it 
is anticipated that new alternative therapies, admin-
istered alone or in combination with kinase-directed 
drugs, will represent the way forward. The challenge is 
to identify such alternative therapies. Considering the 
intimate cooperation between kinases and phospha-
tases in the regulation of signal transduction under 
normal and pathophysiological conditions, the Tonks 
lab focuses on the PTPs, which have been garnering 
attention as potential therapeutic targets, but remain a 
largely untapped resource for drug development.
In following established approaches to developing 
small-molecule drugs that bind to the active site of 
an enzyme, industry has found PTPs to be challeng-
ing targets for therapeutic development. Although it 
was possible to generate potent, specifi c, and revers-
ible inhibitors of PTP1B, such molecules were highly 
charged, due to the chemistry underlying PTP-medi-
ated catalysis, and thus of limited drug development 
potential. Consequently, new approaches are required 
to exploit this important target effectively and reinvig-
orate drug discovery efforts. One strategy that would 
avoid targeting the active site of PTP1B would be to 
look for allosteric inhibitors, which bind at a site re-
mote from the catalytic center, but induce conforma-
tional changes in the enzyme that result in inhibition. 
The Tonks lab has characterized a small-molecule nat-
ural product, TRODUSQUEMINE, as such an allo-
steric inhibitor of PTP1B. This is a unique mechanism 
of inhibition that will have been missed in the efforts 
to target PTP1B that have been conducted to date in 
industry. They have demonstrated that this inhibitor 
antagonizes the function of HER2 in cell and animal 
models of breast cancer. In particular, it essentially ab-
rogates metastasis of HER2-positive tumor cells in the 
NDL2 mouse model of breast cancer.
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It is important also to note that TRODUSQ UE-
MINE (also known as MSI-1436) has already been 
tested in a Phase 1 study that involved 88 obese pa-
tients and was found to be extremely well tolerated. 
Of particular signifi cance is the fact that the effects 
observed in mice by the Tonks lab were achieved at 
~20% of the maximum dose that has been admin-
istered to patients. During the last year, discussions 
have been initiated with the FDA, and a collaboration 
between the Tonks lab and the Monter Cancer Cen-
ter at North Shore LIJ has been set up to take TRO-
DUSQUEMINE/MSI-1436 into clinical trials for 
HER2-positive cancer. In an initial meeting with the 
FDA, it was indicated that a Phase 1 study of safety 
and tolerability of TRODUSQUEMINE/MSI-1436 
as a single agent in metastatic breast cancer patients 
would have to be performed. The preparations for this 
clinical trial are now under way and will represent a 
focus of effort in 2014.
Although TRODUSQUEMINE/MSI-1436 dem-
onstrates effi cacy in an injectable format, it also has 
limited oral bioavailability. Industry has set oral bio-
availability as a hurdle for the next generation of thera-
pies for diabetes. During the last year, the Tonks lab has 
identifi ed a derivative of TRODUSQUEMINE/MSI-
1436 for which they have demonstrated oral bioavail-
ability in a weight loss study in a high-fat diet-induced 
mouse model of obesity. At this time, they are defi ning 
the mechanism of action of this inhibitor. Furthermore, 
they have identifi ed novel chemical entities that display 
properties similar to those of TRODUSQUEMINE/
MSI-1436, which are currently being validated as inhib-
itors of PTP1B to identify further new drug candidates.
The Tonks lab is also trying to harness a physi-
ological mechanism for regulation of PTP1B func-
tion as a distinct approach to development of thera-
peutics, particularly in the context of diabetes and 
obesity. PTP1B is a major regulator of the signaling 
pathways initiated by insulin and leptin, which con-
trols appetite. Gene-targeting studies demonstrated 
that PTP1B-null mice are healthy, display enhanced 
insulin sensitivity, do not develop type-2 diabetes, and 
are resistant to obesity when fed with a high-fat diet. 
Furthermore, depletion of PTP1B expression with an-
tisense oligonucleotides elicits anti-diabetic and anti-
obesity effects in rodents, as well as human subjects. 
The Tonks lab discovered that the activity of PTP1B 
is attenuated by reversible oxidation of an essential 
cysteinyl residue at the active site of the enzyme. The 
architecture of the PTP-active site is such that this 
essential cysteinyl residue displays unique properties 
that favor its role in catalysis but also render it prone 
to oxidation. Insulin stimulation of mammalian cells 
leads to enhanced production of intracellular H2O2, 
which causes reversible oxidation of PTP1B and in-
hibition of its enzymatic activity, which in turn con-
comitantly promotes the signaling response to insulin. 
They have shown that mild oxidation of PTP1B, such 
as occurs in response to insulin, results in profound 
conformational changes in the active site of the en-
zyme that transiently inhibit substrate binding and 
catalysis. These structural changes, however, are re-
versible and the enzyme can be reduced back to its 
active state. Therefore, reversible oxidation of PTP1B 
in response to insulin provides a mechanism for fi ne-
tuning the signaling response to the hormone. They 
hypothesized that a conformation-sensor antibody 
that recognizes the reversibly oxidized form of PTP1B 
selectively may stabilize the inactive state, inhibit its 
reactivation by reducing agents, and thereby inhibit 
phosphatase activity. Using antibody phage display, 
they generated such conformation-sensor antibodies 
and demonstrated that expression of these antibodies 
in cells enhanced insulin-induced signal transduc-
tion. Their data provide proof-of-concept that stabi-
lization of the oxidized, inactive form of PTP1B with 
appropriate therapeutic molecules may offer a novel 
paradigm for phosphatase drug development. This 
has the additional advantage that, if one assumes that 
in responding to insulin the cell targets for oxidation 
the pool of PTP1B that is important for physiological 
regulation of the signaling response, then this strategy 
Figure 1. Structure model for PTP1B (residues 1–405) with two 
molecules of the allosteric inhibitor MSI-1436 (marked with ar-
rows) docked to the two putative binding sites. Important struc-
tural features within PTP1B are highlighted.
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will target that pool specifi cally, possibly also reduc-
ing complications of side effects that may accompany 
inhibition of the native enzyme as a whole.
The antibodies themselves are unlikely to be of 
use as therapeutics; however, the Tonks lab has now 
developed an assay that will permit screening of a 
small-molecule library on an industrial scale to iden-
tify drug-like molecules that mimic the effects of the 
antibodies. A pilot-scale screen has already been com-
pleted, demonstrating the feasibility of this strategy 
and identifying candidate small molecules that stabi-
lize specifi cally the oxidized form of PTP1B. During 
the last year, this approach has led to the initiation of 
a collaboration with a large pharmaceutical company. 
Studies are under way to test the potential for con-
formation-sensor antibodies that recognize selectively 
the oxidized form of PTP1B to promote the signaling 
response to leptin. If these antibodies are shown also 
to potentiate leptin signaling, it is anticipated that a 
full-scale screen of the company’s small-molecule col-
lection will be initiated to exploit fully this unique ap-
proach to development of PTP inhibitors, thus open-
ing a new strategy for therapeutic intervention in a 
major disease.
Efforts in the Tonks lab to defi ne PTP function, 
and wherever possible establish links to human dis-
ease, are not restricted to PTP1B. Examples of prog-
ress in additional areas include the following.
Characterization of PTP Function 
in the Control of Migration and Invasion 
of Mammary Epithelial Cells
The Tonks lab has characterized missing in metasta-
sis (MIM), which is a scaffold protein that is down-
regulated in multiple metastatic cancer cell lines com-
pared to nonmetastatic counterparts. MIM regulates 
cytoskeletal dynamics and actin polymerization and 
has been implicated in the control of cell motility and 
invasion. MIM has also been shown to bind to a re-
ceptor PTP (PTPδ), an interaction that may provide 
a link between tyrosine phosphorylation-dependent 
signaling and metastasis. They used small hairpin 
RNA (shRNA)-mediated gene silencing to investigate 
the consequences of loss of MIM for the migration 
and invasion of the MCF10A mammary epithelial cell 
model of breast cancer. They observed that suppres-
sion of MIM by RNA interference (RNAi) enhanced 
migration and invasion of MCF10A cells, effects that 
were mediated by enhancing the stability and quan-
tity of PTPδ. Furthermore, analysis of human clinical 
data indicated that PTPδ was elevated in breast cancer 
samples when compared to normal tissue. They dem-
onstrated that SRC is a direct substrate of PTPδ, and, 
upon suppression of MIM, they observed changes in 
the phosphorylation status of the SRC protein tyro-
sine kinase: The inhibitory site (Y527) was hypophos-
phorylated, whereas the activating autophosphoryla-
tion site (Y416) was hyperphosphorylated. Thus, the 
absence of MIM led to PTPδ-mediated activation of 
SRC. Finally, the SRC inhibitor SU6656 counteracted 
the effects of MIM suppression on cell motility and 
invasion. This demonstration of PTPδ-dependent ac-
tivation of SRC in cells depleted of MIM suggests a 
new therapeutic strategy for targeting metastasis.
Investigation of the Role of Thioredoxin 
in Reversible PTP Oxidation
Despite great progress in defi ning the mechanism of 
reactive oxygen species (ROS) production, the con-
trols over the levels of ROS in cells, and the scope of 
potential targets of this modifi cation, the mechanisms 
underlying reduction and reactivation of the oxidized 
PTPs have remained relatively underexplored. It is es-
sential that PTPs recover their active form when ROS 
concentrations decrease so as to limit the response to 
growth factors/hormones and prevent uncontrolled 
stimulation of signaling pathways. For the PTPs, 
redox-active enzymes and small molecules, such as 
thioredoxin (TRX), glutaredoxin, or glutathione, have 
been implicated in reduction and reactivation. In a col-
laborative study with Arne Östman’s lab, they dem-
onstrated that TRX was important for reduction and 
reactivation of PTP1B in the context of PDGF signal-
ing. In a separate study, they used a combination of 
biochemical analysis, mechanism-based trapping and 
RNAi-induced suppression to demonstrate the impor-
tance of TRX1 for the reduction and reactivation of 
PTP1B and PTEN. Although TRX is best known as 
a disulfi de reductase, they demonstrated that it has an 
important role in the reduction and reactivation of the 
oxidized form of PTP1B, which features a cyclic sul-
phenamide modifi cation of the active-site cysteine res-
idue. Furthermore, they have shown that these effects 
of TRX have the potential to fi ne-tune the signaling 
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response to insulin. Finally, in addition to highlight-
ing the important role of TRX in reduction and reac-
tivation of PTPs, the TRX trapping mutants illustrate 
another approach to defi ning the importance of re-
versible oxidation in the regulation of PTP function 
in general and tyrosine phosphorylation-dependent 
signaling in a broad array of signaling contexts.
Identiﬁ cation of the Anti-Inﬂ ammatory 
Compound BAY 11-7082 as a 
Potent Inhibitor of PTPs
BAY 11-7082 is an anti-infl ammatory compound that 
has been reported to inhibit IκB kinase activity. The 
compound has an α,β-unsaturated electrophilic cen-
ter, which confers the property of being a Michael 
acceptor; this suggests that it may react with nucleo-
philic cysteine-containing proteins, such as PTPs. 
In this study, the Tonks lab demonstrated that BAY 
11-7082 was a potent, irreversible inhibitor of PTPs. 
Using mass spectrometry, they demonstrated that 
BAY 11-7082 inactivated PTPs by forming a covalent 
adduct with the active-site cysteine. Administration of 
the compound caused an increase in protein tyrosine 
phosphorylation in RAW 264 macrophages, similar 
to the effects of the generic PTP inhibitor sodium or-
thovanadate. These data illustrate that BAY 11-7082 
is an effective pan-PTP inhibitor with cell permeabil-
ity, revealing its potential as a new probe for chemi-
cal biology approaches to the study of PTP function. 
Furthermore, the data suggest that inhibition of PTP 
function may contribute to the many biological effects 
of BAY 11-7082 that have been reported to date.
Investigation of the Regulation 
and Function of Receptor PTPα 
in Breast Cancer Models
HER2/ERBB2 is a member of the epidermal growth 
factor (EGF) receptor family of protein tyrosine ki-
nases (PTKs) and is amplifi ed and/or overexpressed in 
~25% of breast cancer and associated with poor prog-
nosis. Using MCF10A mammary epithelial cells that 
ectopically express an “activatable” ErbB2 chimera as 
a model, they demonstrated that NOX-dependent pro-
duction of hydrogen peroxide occurs rapidly following 
ERBB2 activation, leading to reversible oxidation 
of the transmembrane receptor phosphatase PTPα. 
This inhibited the activity of PTPα, contributing to 
increased ERBB2 signaling. Furthermore, the suppres-
sion of PTPα by shRNA led to ERBB2-dependent 
increased cell migration, which was characterized 
by prolonged interaction of GRB7 with ERBB2, in-
creased association of ERBB2 with a β1 integrin-rich 
complex, and was dependent on GRB7-SH2 domain 
interactions. Interestingly, the human GRB7 gene is 
commonly co-amplifi ed with ERBB2 in breast cancer, 
and GRB7 has been implicated in cell migration. Sup-
porting this concept, the ERBB2-dependent migration 
in PTPα-knockdown cells was suppressed by a GRB7-
SH2 domain inhibitor. They demonstrated that PTPα 
dephosphorylated FAK specifi cally on Tyr407, and FAK 
Tyr407 phosphorylation was enhanced in cells follow-
ing ERBB2 activation when PTPα was suppressed, 
which contributed to the recruitment of vinculin to 
FAK. Collectively, these data support a role for PTPα 
in regulating motility of mammary epithelial cells in 
response to ERBB2 signaling, consistent with a role for 
the phosphatase in breast cancer.
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UNDERSTANDING PROSTATE CANCER METASTASIS
L. Trotman M. Chen T. Herzka D. Nowak
 H. Cho A. Naguib W. Zheng
We study the mechanisms behind the transition from 
indolent to lethal metastatic prostate cancer. Our 
aim is to recreate the lethal disease in fast and faith-
ful mouse models that can be studied and used for 
preclinical trials that help us develop better therapies. 
PTEN is a haploinsuffi cient tumor suppressor: Par-
tial loss or degradation results in growth advantage, 
and in contrast, we found that complete loss triggers 
senescence arrest. Studying human prostate cancer 
genomes showed that loss of PTEN and p53 genes 
was strongly associated with metastatic disease, sug-
gesting that overcoming the senescence brakes leads 
to disease progression in some 50% of patients. Clas-
sic mouse models of this genotype, however, failed to 
recapitulate metastasis. We are developing a new ap-
proach for modeling prostate cancer in mouse, termed 
RapidCaP. It allows us to generate loss of Pten and 
p53 genes without the need for breeding and suggests 
that widespread metastasis is found when the genes 
are co-deleted. This approach could serve as the fi rst 
platform for therapy of endogenous metastatic pros-
tate cancer in a preclinical animal model.
At the same time, we study regulation of the PTEN 
protein because many patients show reduced protein 
in spite of intact DNA and RNA function.
Molecular and Genetic Analysis of Prostate 
Cancer Evolution
H. Cho, D. Nowak, T. Herzka, W. Zheng [in collaboration 
with J. Hicks and M. Wigler, Cold Spring Harbor Laboratory; 
B. Robinson, Weill Cornell Medical College, New York]
Understanding the progression from indolent to le-
thal prostate cancer remains the major challenge in 
the fi eld. Hyperactivation of the phosphoinositol-3 
kinase (PI3K)/AKT pathway is common in many 
cancer types. Our work demonstrated that loss of the 
capacity to mount a senescence response is critical for 
the lethal progression event. To defi ne the molecular 
changes that occur in this transition, we have reca-
pitulated the pre- and postsenescence genetics in vitro 
using primary cells and analyzed the signatures that 
are an immediate consequence of breaking the senes-
cence response by loss of p53. Comprehensive analy-
ses of changes in transcription, proteome, and secre-
tome have led to identifi cation of signature responses, 
which are being validated in human prostate cancer 
specimens (in collaboration with Dr. Robinson).
In a collaboration with scientists at McGill Uni-
versity, Montreal, we found that amplifi cation of an 
androgen receptor (AR) target locus is associated with 
amplifi cation of AR itself, suggesting that enhanced 
transcription at these sites may promote amplifi cation. 
Because the region has previously been implicated 
as an inherited locus for prostate cancer risk, it may 
emerge as a critical region for genome analysis and 
prediction of a patient’s disease progression.
To validate alterations and key genetic events that 
are found in the human samples, we are developing 
more fl exible mouse modeling techniques. RNA-in-
terference (RNAi) has been shown to recapitulate key 
features of gene knockout models, especially given the 
fact that the majority of tumor suppressors are found 
in hemizygous deletions in cancer. RNAi-based mod-
els of Pten/p53 loss have been generated and followed 
up for disease initiation and progression character-
istics. Most notably, our approach of direct viral in-
jection into prostate has shown highly effi cient gene 
transduction of cancer genes, cre-recombinase, as well 
as reporter genes, resulting in highly penetrant metas-
tasis. Thus, our approach introduces a fast and fl exible 
method for the generation of prostate cancer and its 
metastasis that can be tracked in live animals.
Living with Lethal Genes
M. Chen, A. Naguib, T. Herzka, W. Zheng
PTEN is the major negative regulator of PI3K signal-
ing with cell-specifi c functions that go beyond tumor 
suppression. In fact, it is surprising that a gene that pre-
vents cells from growing and can cause them to die is 
constitutively expressed in most healthy tissues. This 
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raises the fundamental question of how the PTEN gene 
is suppressed to allow for normal growth, tissue repair, 
and development. We are interested in this question be-
cause many cancer types reveal degradation of PTEN 
protein while the gene remains intact. Our hypothesis 
is that such cancers indirectly target PTEN by loss of 
genes that are essential for PTEN maintenance. Thus, 
understanding the normal processes behind PTEN 
regulation may unearth critical cancer genes.
Ischemic injury results from insuffi cient blood 
fl ow to organs or tissues, examples of which include 
stroke and myocardial infarction. PTEN, under nor-
mal physiological conditions, acts to antagonize 
PI3K/AKT-mediated signaling and thereby promotes 
growth arrest and can trigger apoptosis. However, 
subsequent to ischemic injury, limiting the ability 
of wounded tissue to renew or promoting cell death 
would be detrimental to the healing effort. To our 
surprise, we learned that nuclear seclusion of PTEN is 
one mechanism to temporarily suppress its function: 
In collaboration with experts in mouse models for 
stroke, we have demonstrated that cytoplasmic Pten 
is translocated into the nucleus of neurons following 
cerebral ischemia. Critically, this transport event 
is dependent on the surge in the Ndfi p1 protein, as 
neurons in Ndfi p1-defi cient mice fail to import Pten. 
Ndfi p1 binds Pten, resulting in enhanced ubiquitina-
tion by Nedd4 E3 ligases, an event that we previously 
showed to control import.
These fi ndings highlight the intersection of PTEN 
nuclear import and degradation, and we are currently 
testing the role of nuclear import receptors in regulat-
ing PTEN stability and transport.
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CANCER MEDICINE LABORATORY/CANCER 
THERAPEUTICS INITIATIVE
D. Tuveson B. Alagesan E. Elyada T. Oni
 T. Ardito D. Engle Y. Park
 L. Baker M. Feigin M. Ponz-Sarvise
 C. Chio A. Handly-Santana H. Tiriac
 V. Corbo C. Hwang K. Wright
 B. Creighton M. Ludwig K. Yu
 B. Delcuze D. Ohlund
The Tuveson laboratory uses cancer models and 
human clinical trials to explore fundamental biology 
questions and to identify new diagnostic and treat-
ment strategies. Our main focus is pancreatic can-
cer, a lethal malignancy despite intensive study. For 
example, we have adapted a new method to culture 
primary human and mouse pancreatic tissue indefi -
nitely as ductal organoids, enabling deep molecular 
and therapeutic analyses. Second, therapeutic experi-
ments in mouse models have revealed an important 
role for stromal interactions on infl uencing therapeu-
tic response. We are initiating our fi rst clinical trial 
shared between CSHL and Memorial Sloan-Kettering 
Cancer Center to investigate a drug delivery approach 
for pancreatic cancer patients. Collectively, our strat-
egy in the preclinical and clinical arena represents the 
“Cancer Therapeutics Initiative” at CSHL, a resource 
that should enable many investigators to do similar 
work.
Cancer Diagnostics
This work was done in collaboration with D. Pappin 
(Cold Spring Harbor Laboratory), J. Lewis (Memorial 
Sloan-Kettering Cancer Center), and R. Hynes 
(Massachusetts Institute of Technology).
The diagnosis of early-stage cancers in most patients 
is challenging and usually based on a tissue biopsy. 
Indeed, our failure to detect nascent malignancies 
when anatomically localized and potentially surgi-
cally curable refl ects the lethality of many cancers for 
which insuffi cient systemic therapies exist. Cervical 
cancer best exemplifi es this principle, where the in-
troduction of gynecological examinations with histo-
logical screening led to a marked decrease in the previ-
ously main cause of female cancer deaths worldwide. 
Additionally, the direct visualization of incipient tu-
mors with a variety of radiological and endoscopic 
modalities also reduces lung and colon cancer mor-
tality, respectively. These recent advances have estab-
lished standards for preventive medicine in the United 
States, although most patients who are ultimately 
diagnosed with lung, bowel, and other malignancies 
are missed. Investigational approaches include the de-
velopment of blood-based biomarkers such as circu-
lating nucleic acids, proteins, cancer cells, exosomes, 
and immune response biomarkers. These exploratory 
efforts are still under way, and other than biomarkers 
for uncommon cancers (e.g., b-HCG for choriocar-
cinoma, AFP for testicular cancer), they have not yet 
provided an effective approach that can be utilized in 
a general or selected population of otherwise healthy 
individuals. The major barriers to the development of 
cancer biomarkers are the lack of sensitivity (limits of 
detection) and specifi city (due to similarities to non-
malignant diseases). Accordingly, we have initiated a 
new research program to develop methods for tumor 
detection in mice by taking advantage of genetic dif-
ferences between mice and humans, in efforts to fi nd 
biomarkers of early-stage, pancreatic preneoplasms. 
These methods include a combination of biochemical 
and radiological approaches.
Cancer Therapeutics
This work was done in collaboration with K. Yu (Cold 
Spring Harbor Laboratory/Memorial Sloan-Kettering 
Cancer Center) and A. Krainer (Cold Spring Harbor 
Laboratory).
Pancreatic cancer is refractory to conventional and 
targeted agents. Although the drug resistance of pan-
creatic ductal adenocarcinoma (PDA) may represent 
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unique cell-intrinsic drug resistance mechanisms such 
as cellular differentiation states and drug exporters, 
we have shown that the stromal-rich PDA tumors lack 
a functional vasculature-limiting drug delivery, thus 
contributing to drug resistance. Hedgehog inhibition 
and stromal digestion with pegylated hyaluronidase 
(PEG-PH20) both led to increased perfusion and 
chemotherapy delivery in PDA tumor tissues, and 
transient increases in mouse survival. These fi ndings 
became the basis of a clinical trial using the hedgehog 
inhibitor IPI926 in combination with gemcitabine for 
patients with metastatic PDAC, but unfortunately, the 
fi rst randomized trial was negative and the analysis is 
ongoing. Early-phase clinical trials with gemcitabine 
in combination with PEG-PH20 are under way, with 
interim results expected shortly. Interestingly, PEG-
PH20 treatment also specifi cally increased the deliv-
ery of high-molecular-weight agents, providing the 
opportunity to evaluate novel high-molecular-weight 
therapeutic agents that are otherwise diffi cult to deliv-
er to PDAC tissues, including antibodies and nucleic 
acids.
Dr. Ken Yu, working with the Tuveson laboratory 
as a CSHL clinical fellow and a medical oncologist at 
MSKCC, has written a proof-of-concept clinical trial 
to assess whether PEG-PH20 and related stromal dis-
ruption approaches will increase the effectiveness of 
biological therapeutics in pancreatic cancer patients. 
His trial will be conducted to establish whether PEG-
PH20 can increase the delivery of an FDA-approved 
anti-EGFR (epidermal growth factor receptor) anti-
body cetuximab in patients scheduled to undergo sur-
gery for resectable pancreatic cancer. The design will 
be to administer PEG-PH20 2 d before surgery and 
treat with therapeutic antibody 24 h later, with surgery 
following 24 h later. Comparisons will be made to pa-
tients who do not receive PEG-PH20, and resected tu-
mors will be assessed for the delivery of the antibody 
and any biochemical alterations by IHC. Cetu ximab 
is the fi rst antibody to be considered because it binds 
to EGFR, which is expressed by the majority of PDAC 
cells and can be easily detected through the chimeric 
murine portion of the antibody. Cetuximab was not 
shown to alter the effects of gemcitabine treatment in 
PDAC patients in a recent SWOG trial, potentially 
because it is not delivered optimally. Positive fi ndings 
will motivate the assessment of additional agents in 
more advanced preclinical and clinical trials, includ-
ing neoadjuvant trials in locally advanced pancreatic 
cancer patients and mice to improve resectability and 
survival.
Besides the limitations in drug delivery observed 
in pancreatic tumors, we recently reported that the 
matricellular protein connective tissue growth factor 
(CTGF) promotes drug resistance in mice with PDA 
(Neesse et al. 2013a). Our analysis has determined 
that CTGF promotes cell survival in neoplastic cells 
by up-regulating the survival factor XIAP. This sug-
gests that multiple matricellular proteins may serve 
such a role in preventing a response to therapies in 
PDA. Our organoid approach below is currently being 
used to establish the mechanism of CTGF function.
Development of Pancreatic Ductal 
Organoids as a Novel In Vitro Cancer 
Model for Biological Exploration and 
Medical Applications
This work was done in collaboration with H. Clevers, 
Hubrecht Institute, The Netherlands.
To accelerate our molecular and therapeutic work, 
we established a method to indefi nitely culture nor-
mal, preneoplastic, and frankly malignant murine 
and human pancreatic ductal cells in semisolid media 
(Fig. 1). This approach was based on the pioneering 
work of Dr. Hans Clevers (Hubrecht Institute, The 
Netherlands), who demonstrated that intestinal villi 
could be indefi nitely propagated in three-dimensional 
cultures, and he termed these cultures organoids be-
cause they formed normal tissues upon transplanta-
tion into murine intestines. Our pancreatic ductal 
organoid structures obtained from normal and malig-
Figure 1. Mouse pancreatic tissues from normal (A) PanIN (B) 
and tumors (C) were used to isolate the corresponding organoid 
lines (D–F). Scale bar, 200 μm. n > 3 samples each.
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nant mouse pancreata resumed their original morpho-
logical appearances following orthotopic transplanta-
tion, confi rming that they represent distinct stages of 
tumorigenesis (Fig. 2). These cultures will enable the 
less costly, high-throughput assessment of small mol-
ecule and shRNA screens in cell culture, prior to char-
acterization in vivo. Additionally, they can be directly 
characterized at the genomic, transcriptomic, and pro-
teomic levels to determine the molecular correlates of 
therapeutic response. This approach will be compared 
to routine two-dimensional tissue culture systems, 
and in parallel, they will be compared to the tradi-
tional PDX models. If organoids offer advantages to 
PDX models, we will determine how to extend this to 
other organ types and how to best utilize this technol-
ogy for patient benefi t. For example, serial organoids 
from patients under therapy may reveal a model sys-
tem for interrogating drug resistance and identifying 
new targets of drug sensitivity, perhaps more robustly 
than circulating tumor cells (CTCs) as it is challeng-
ing to propagate these cells in culture. We also have 
found that cancer cell lines readily adapt to growth in 
organoid conditions, suggesting that this approach for 
CTCs may work.
PUBLICATIONS
Feig C, Jones JO, Kraman M, Wells RJ, Deonarine A, Chan DS, Con-
nell CM, Roberts EW, Zhao Q, Caballero OL, et al. 2013. Tar-
geting CXCL12 from FAP-expressing carcinoma-associated fi bro-
blasts synergizes with anti-PD-L1 immunotherapy in pancreatic 
cancer. Proc Natl Acad Sci 110: 20212–20217.
Neesse A, Frese KK, Bapiro TE, Nakagawa T, Sternlicht MD, See-
ley TW, Pilarsky C, Jodrell DI, Spong SM, Tuveson DA. 2013a. 
CTGF antagonism with mAb FG-3019 enhances chemotherapy 
response without increasing drug delivery in murine ductal pan-
creas cancer. Proc Natl Acad Sci 110: 12325–12330.
Neesse A, Frese KK, Chan DS, Bapiro TE, Howat WJ, Richards 
FM, Ellenrieder V, Jodrell DI, Tuveson DA. 2013b. SPARC in-
dependent drug delivery and antitumour effects of nab-paclitaxel 
in genetically engineered mice. Gut doi: 10.1136/gutjnl-2013-
305559.
Figure 2. Orthotopic, syngeneic transplantation of GFP-express-
ing organoids evaluated 1 mo later by H&E and IHC. (Bottom) 
Mucin production (Alcian blue) and Muc5ac expression in trans-
plants from P organoids. Scale bar, 300 μm. n > 3 cases each.
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RAS AND RHO GTPASES AND THE CONTROL 
OF SIGNAL TRANSDUCTION
L. Van Aelst B. Elmer M. Wang
 Y. Tai Y.-T. Yang
 C.-L. Wang J.-R. Yu
Research in my laboratory is focused on the role of 
Ras and Rho GTPase family members in signal trans-
duction. Ras and Rho family members have key roles 
in cellular activities controlling cell growth control, 
differentiation, and morphogenesis. Alterations in Ras 
and Rho functions have been causally linked to both 
cancer and brain disorders, including mental retarda-
tion, schizophrenia, and epilepsy. Our interests lie in 
understanding how defects in Ras- and Rho-linked 
proteins contribute to the development of these dis-
ease processes. Toward this end, my lab has contin-
ued to defi ne the functions of selected GTPases and 
their regulators and effectors in models of cancer and 
neurodevelopmental disorders. Below are highlighted 
selected key projects that have been performed during 
the past year.
Regulation of Chandelier Cell Cartridge and 
Bouton Development via DOCK7-Mediated 
ErbB4 Activation
DOCK7 is a member of the evolutionarily con-
served DOCK180-related protein superfamily. The 
DOCK180 family emerged as a distinct class of Rac 
and/or Cdc42 GTPase guanine nucleotide exchange 
factors (GEFs), which have diverse cell-type-specifi c 
functions. We initially identifi ed DOCK7 as a novel 
activator of Rac that is highly expressed in the de-
veloping brain. Signifi cantly, sequence variations in 
DOCK7 have been reported in schizophrenia pa-
tients; however, the role(s) of DOCK7 in neuronal 
development and/or function has remained largely 
elusive.
We previously reported that DOCK7 has a critical 
role in the polarization and genesis of newborn pyra-
midal neurons and that it does so by promoting Rac 
activity and antagonizing TACC3 (transforming acid-
ic coiled-coil-containing protein 3) function, respec-
tively. Interestingly, in more recent studies examining 
the expression patterns of members of the DOCK180 
family in GABAergic interneurons, we intriguingly 
observed the presence of DOCK7, among other par-
valbumin (PV)-expressing interneurons, in chande-
lier cells (ChCs) of adolescent/adult mouse brains. 
ChCs, typifi ed by their unique axonal morphology, 
are the most distinct interneurons present in cortical 
circuits. Via their distinctive axonal terminals, called 
cartridges, these cells selectively target the axon initial 
segment of pyramidal cells and control action poten-
tial initiation; yet, the mechanisms that govern the 
characteristic ChC axonal structure have remained 
elusive. The main obstacles have been a lack of unique 
biochemical ChC markers and versatile methods to 
target and manipulate gene expression in these cells. 
This prompted us to develop a method to manipu-
late gene expression in ChCs so that DOCK7’s role 
in their development could be assessed. On the basis 
of recent evidence indicating that progenitors in the 
ventral medial ganglionic eminence (vMGE) provide 
a source of ChCs, we reasoned it should be possible to 
target gene expression in nascent ChCs by means of in 
utero electroporation directed toward the vMGE and 
found that this is indeed the case. Using this tech-
nique, we demonstrated a critical role for DOCK7 in 
ChC cartridge/bouton development. In particular, 
knockdown of DOCK7 caused a disorganization of 
ChC cartridges and a decrease in the density and size 
of ChC boutons. DOCK7 overexpression elicited es-
sentially the opposite phenotypes. An organized net-
work of ChC cartridges was formed, and both the 
density and size of boutons were increased. We fur-
ther found that DOCK7 functions as a cytoplasmic 
activator of the schizophrenia-associated ErbB4 re-
ceptor tyrosine kinase, and importantly that DOCK7 
modulates ErbB4 activity to control ChC cartridge/
bouton development. Indeed, an ErbB4 mutant with 
enhanced kinase activity was able to overcome the 
phenotypes associated with DOCK7 knockdown, 
whereas silencing of ErbB4 prevented the phenotypes 
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elicited by DOCK7 overexpression. Thus, our fi nd-
ings defi ne DOCK7 and ErbB4 as key components of 
a pathway that controls the morphological differentia-
tion of ChCs, with implications for the pathogenesis 
of schizophrenia.
Multifunctional Role of the X-Linked 
Mental Retardation Protein OPHN1 
at the Hippocampal CA1 Synapse
Oligophrenin-1 (OPHN1), encoding a Rho- GTPase-
activating protein, was the fi rst identifi ed Rho-linked 
mental retardation (MR) gene. It was initially identi-
fi ed by the analysis of a balanced translocation t(X;12) 
observed in a female patient with mild MR. Subse-
quent studies revealed the presence of OPHN1 muta-
tions in families with MR associated with cerebellar 
hypoplasia, lateral ventricle enlargement, and/or epi-
lepsy. Most of the OPHN1 mutations identifi ed to date 
have been shown, or predicted, to result in OPHN1 
loss of function; however, the pathophysiological role 
of OPHN1 has remained poorly understood.
We have begun to unveil the function of OPHN1 
both at the pre- and postsynaptic site of the hippo-
campal CA3-CA1 synapse. We previously reported 
that during early development, presynaptic OPHN1 
is important for effi cient retrieval of synaptic vesicles, 
whereas postsynaptic OPHN1 has a key role in activ-
ity-dependent maturation and plasticity of excitatory 
synapses, suggesting the involvement of OPHN1 in 
normal activity-driven glutamatergic synapse devel-
opment. Interestingly, we more recently found that 
postsynaptic OPHN1 also has a critical role in me-
diating a form of plasticity (mGluR-LTD) that relies 
on the activation of group I metabotropic glutamate 
receptors, which consist of mGluR1 and mGluR5 
in CA1 hippocampal neurons. Alterations in this 
form of plasticity have been linked to drug addic-
tion and cognitive disorders. A key characteristic of 
mGluR-LTD is its dependence on rapid protein syn-
thesis; however, the identities of the proteins mediat-
ing LTD have remained largely elusive. We obtained 
evidence that OPHN1 expression is translationally 
induced in dendrites of CA1 neurons within 10 min 
of mGluR activation and that this response is essen-
tial for mGluR-dependent LTD. Specifi cally, acute 
blockade of new OPHN1 synthesis impedes mGluR-
LTD and the associated long-term decreases in surface 
 AMPARs (α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid receptors). Interestingly, the rapid in-
duction of OPHN1 expression is primarily dependent 
on mGluR1 activation and is independent of fragile-X 
mental retardation protein (FMRP).
We further demonstrated that OPHN1’s role in 
mediating mGluR-LTD is dissociable from its role in 
basal synaptic transmission. mGluR-LTD and the as-
sociated long-term decreases in surface AMPARs are 
dependent on OPHN1’s interaction with endophilin 
A2/3, whereas regulation of basal synaptic strength 
requires OPHN1’s Rho-GAP activity and association 
with Homer 1b/c proteins. As to how OPHN1 could 
mediate the strengthening of synapses via interactions 
with Homer 1b/c and RhoA, we previously showed 
that OPHN1 becomes enriched in spines in response 
to synaptic activity and NMDAR (N-methyl-d-
aspartate) activation, where by locally modulating 
RhoA/Rho kinase activities (i.e., in the proximity 
of AMPARs), it contributes to the stabilization of 
AMPARs. Homer 1b/c proteins, on the other hand, 
were shown to participate in the positioning of the 
endocytic zone (EZ) near the postsynaptic density 
(PSD). The close juxtaposition of the EZ and the 
PSD enables localized endocytosis and recycling of 
 AMPARs, thereby maintaining a mobile pool of sur-
face AMPARs required for synaptic potentiation. In-
terestingly, we recently found that a physical interac-
tion between OPHN1 and Homer 1b/c is crucial for 
the positioning of the EZ adjacent to the PSD, and we 
obtained evidence that this interaction is important 
for OPHN1’s role in controlling activity-dependent 
strengthening of excitatory synapses. Disruption of 
the OPHN1-Homer 1b/c interaction caused a dis-
placement of EZs from the PSD, along with impaired 
AMPAR recycling and reduced AMPAR accumula-
tion at synapses, under both basal conditions and con-
ditions that can induce synaptic potentiation. Thus, 
these data indicate that OPHN1 exerts its effects on 
synapse strengthening by serving at least two distinct 
roles. Via its interaction with Homer 1b/c, OPHN1 
facilitates the recycling and thereby maintenance of a 
mobile pool of surface AMPARs, whereas via its Rho-
GAP activity, OPHN1 contributes to the stabilization 
of synaptic AMPARs.
Collectively, our fi ndings point to a multifunc-
tional role for OPHN1 at CA1 synapses. Independent 
of its role in activity-driven glutamatergic synapse de-
velopment, regulated OPHN1 synthesis has a critical 
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role in mGluR-dependent LTD. Thus, it is conceiv-
able that, on the one hand, OPHN1 might have an 
important role in synapse maturation and circuit wir-
ing during early development, and, on the other hand, 
the regulated OPHN1 synthesis could operate during 
adulthood to weaken synapses in response to behav-
iorally relevant stimuli.
DOK2 Inhibits EGFR-Mutated 
Lung Adenosarcoma
Members of the Dok family of adaptor proteins have 
emerged as key modulators of protein tyrosine kinase 
(PTK) signaling. Dok1, also known as p62dok, is the 
prototypical family member. It was fi rst identifi ed as a 
substrate of oncogenic tyrosine kinases, p210bcr-abl and 
v-Abl, and found to be a substrate of many endogenous 
PTKs; hence, it was termed Dok, for downstream from 
kinases. Since the identifi cation of Dok1, six addition-
al Dok family members have been identifi ed: Dok1 to 
Dok7. Among them, Dok1 and Dok2 share the ability 
to bind to Ras-GAP, a negative regulator of Ras. We 
reported previously that Dok1 attenuates growth-fac-
tor-induced cell proliferation and that Dok1 as well as 
Dok2 possess tumor suppressive activity in the context 
of myeloid leukemia. Indeed, in collaboration with 
Dr. Pandolfi ’s group, we found that mice lacking both 
Dok1 and Dok2 spontaneously develop a CML-like 
myeloproliferative disease. Signifi cantly, Dok family 
members do not act only as “tumor suppressors” in the 
hematopoietic compartment, but also in solid tissues, 
such as the lung. Single, double, or triple compound 
loss of Dok1, Dok2, and Dok3 in mice results in lung 
adenocarcinoma with penetrance and latency depen-
dent on the number of lost Dok family members.
In more recent collaborative studies with the Pan-
dolfi  lab, we examined in more depth the role of Dok2 
in suppressing EGFR-driven lung tumorigenesis, es-
pecially since DOK2 was identifi ed as a candidate 
human lung tumor suppressor gene. Of note, somat-
ic mutations in the EGFR proto-oncogene occur in 
~15% of human lung adenocarcinomas, and the im-
portance of EGFR mutations for the initiation and 
maintenance of lung cancer is well established from 
mouse models and cancer therapy trials in human 
lung cancer patients. Interestingly, we found that ge-
nomic loss of DOK2 is associated with EGFR muta-
tions in human lung adenocarcinoma. These fi ndings 
led us to postulate that loss of DOK2 could combine 
with EGFR mutations to promote lung tumorigenesis. 
We tested this hypothesis using genetically engineered 
mouse models and found that loss of Dok2 in mice 
accelerates lung tumorigenesis initiated by oncogenic 
EGFR, but not by mutated Kras. Moreover, we found 
that DOK2 participates in a negative feedback loop 
that opposes mutated EGFR; EGFR mutation leads to 
recruitment of DOK2 to the EGFR and DOK2-me-
diated inhibition of downstream activation of RAS. 
Thus, these data identify DOK2 as a tumor suppres-
sor in EGFR-mutant lung adenocarcinoma.
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REGULATION OF MALIGNANT GLIOMA HETEROGENEITY 
AND LINEAGE DEVELOPMENT
H. Zheng B. Guo L. Zhang
 L. Klingler 
Malignant glioma is the most common and lethal type of 
brain tumor in adult patients. The current standard care 
for malignant glioma includes maximal surgical resec-
tion, followed by radiation with adjuvant chemotherapy 
for the residual infi ltrative tumor component. Despite 
these aggressive treatment efforts, the disease invariably 
returns. In its most aggressive form, glioblastoma (GBM) 
has a median survival of only 12–15 mo with a 5-yr sur-
vival rate of <5% after initial diagnosis. Unfortunately, 
refi nements of available therapeutic modalities including 
microneurosurgery, radiation, and chemotherapy in the 
last several decades have not substantially improved pa-
tient survival. The long-term goal of our research is to 
defi ne the complex biology of malignant glioma patho-
genesis with the aim of translating the developed knowl-
edge into patient benefi ts. Along this line, the research in 
our group has been focused on two major areas: (1) de-
veloping various genetically engineered animal models 
to recapitulate the process of human glioma pathogen-
esis and using these animal models as tools to investigate 
in vivo tumor initiation, progression, and their response 
to various therapeutic treatments and (2) applying an 
integrated approach combining model systems, neural 
stem cell biology, and RNA interference (RNAi) to iden-
tify molecular and developmental programs relevant to 
glioma pathogenesis and treatment. Particularly, we are 
interested in genetic and epigenetic pathways involved in 
controlling neural precursor cell fate determination. We 
believe that an improved understanding of the develop-
mental programs governing the self-renewal and differ-
entiation processes along the neural progenitor–glial axis 
and, by extension, the glioma stem cells–progeny axis, 
will serve instrumentally in guiding future development 
of effi cient treatments targeting this dreadful disease.
Characterizing EGFR-Targeted Therapeutic 
Resistance
The epidermal growth factor receptor (EGFR) is a 
transmembrane protein that belongs to a family of 
receptor tyrosine kinases. In human malignant gli-
oma, amplifi cation and mutation of EGFR represent 
the signature genetic abnormalities encountered in 
~40%–50% of patients, a fact that makes EGFR a 
compelling candidate for targeting therapy. A range 
of potential target therapies, particularly small mo-
lecular inhibitors of its tyrosine kinase activity, are 
currently in development or in clinical trials for the 
treatment of malignant gliomas. Despite their no-
table therapeutic impact for treating other types of 
cancers, effi cacy of these clinically approved small-
molecule EGFR inhibitors in malignant glioma 
trials has so far been limited by both upfront and 
acquired drug resistance, and any responses have 
been unrelated to EGFR amplifi cation status. These 
clinical observations question whether EGFR is a vi-
able therapeutic target for malignant gliomas. There 
are three potential causes of the clinically observed 
EGFR inhibitor resistance in glioma: (1) EGFR 
might not be essential for glioma cell survival, and 
therefore the EGFR cannot be targeted for glioma 
treatment, (2) the drugs may not penetrate the 
blood brain barrier, a general concern for drugs tar-
geting central nervous system diseases, and (3) the 
brain-cancer-specifi c EGFR and mutant may not be 
particularly sensitive to the current small-molecular 
EGFR kinase inhibitor. To address these questions, 
we developed a malignant glioma animal model 
driven by the tetracycline-induced overexpression of 
a malignant glioma-specifi c EGFR mutant with con-
current brain-specifi c inactivation of Ink4a/Arf and 
Pten tumor suppressors. The tightly tetracycline-
controlled mutant EGFR expression in this case 
ensures a faithful model system to mirror clinically 
EGFR targeting therapy and provides us with an 
opportunity to dissect the resistance mechanism(s) 
in vivo. By using both genetic and pharmacologic 
approaches, we demonstrated that genetic abla-
tion of mutant EGFR protein expression leads to 
acute glioma regression, confi rming that EGFR 
and its mutants are indeed therapeutic targets for 
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malignant glioma treatment. Importantly, the acute 
response caused by genetically suppressing EGFR 
protein expression is in stark contrast to the poor 
outcome from EGFR kinase inhibitor treatment, 
which only marginally decelerated tumor growth 
despite the displayed potency of inhibiting EGFR 
phosphorylation. Our fi ndings strongly suggest that 
EGFR kinase activity is not an absolute indicator 
of overall EGFR oncogenic functions in malignant 
gliomas as had been thought. Therefore, we believe 
the next generation of therapies will need to target 
both EGFR kinase-dependent and -independent ac-
tivities in order to achieve optimal effi cacy against 
malignant gliomas carrying EGFR amplifi cation 
and/or mutations. We currently are focusing on de-
ciphering the EGFR kinase-independent activities 
and analyzing their contribution to glioma progres-
sion and drug resistance.
Epigenetic Regulation during Glioma 
Pathogenesis
Epigenetic regulation is developmentally defi ned as 
heritable changes in cellular and organismal pheno-
types without altering the underlying genetic infor-
mation and is best exemplifi ed by cell fate determi-
nation. During development, epigenetic programs 
work in concert with genetic mechanisms to regulate 
transcription and control cell fate determination. As 
one key event in glioma pathogenesis is corruption of 
cell lineage differentiation programs, we reason that 
glioma cells, particularly the G-TICs, are dependent 
on distinct epigenetic networks to sustain their aber-
rant differentiation state and therefore are sensitive 
to perturbations of certain epigenetic structures. In 
collaboration with Scott Lowe and Chris Vakoc’s 
groups here at CSHL, we previously had initiated 
a project to probe the epigenetic networks essential 
for maintaining glioma cell differentiation state. In 
a comprehensive epigenetic screen of a customized 
small hairpin RNA (shRNA) library targeting epi-
genetic regulators, we had identifi ed multiple chro-
matin modulators including bromodomain contain-
ing 4 (Brd4) that are important for glioma cell self-
renewal. Starting from this small panel of chromatin 
modulators, we used an assortment of genetic and 
pharmacological assays to narrow down candidates 
to those whose suppression sensitizes glioma cells to 
differentiation. Interestingly, we found that not all 
glioma cells respond the same to individual candi-
date suppression. For example, although Brd4 inhi-
bition did in general slow down glioma cell growth, 
we noticed that different lineages of glioma cell lines 
present very different sensitivities to the Brd4 inhibi-
tor. In particular, we observed that the glioma cells 
with high neuronal lineage marker expression were 
generally more sensitive to Brd4 inhibition. Consis-
tently, Brd4 inhibition preferentially eliminates neu-
ronal lineage cells during differentiation of cultured 
neural stem cells. These fi ndings indicate that dif-
ferent subtype of gliomas may depend on distinctive 
sets of chromatin modulators to maintain their prop-
agation. In addition, identifi cation of the unique de-
pendencies with different subtypes of gliomas will 
likely provide insight into mechanistic actions of 
these specifi c candidates, possibly forming a basis for 
future patient stratifi cation.
In another effort to probe chromatin modulators 
for tumor suppressor genes whose suppression dis-
rupts neural progenitor cell differentiation, we have 
identifi ed multiple interesting candidates, including 
alpha thalassemia/mental retardation syndrome X-
linked (ATRX ). ATRX is a Rad54-like ATP-driven 
DNA translocase belonging to the SWI/SNF family 
of chromatin remodulators, and its germline muta-
tion causes a form of syndromal mental retardation 
with multiple developmental abnormalities. Recently, 
frequent ATRX somatic frameshift and nonsense mu-
tations that completely abolish protein function have 
been identifi ed in human pediatric and adult glio-
mas, pancreatic neuroendocrine tumors (PanNETs), 
as well as other cancers of the central nervous system 
(CNS), suggesting a tumor suppressor role of ATRX. 
But despite some evidence suggesting that Atrx might 
be involved in facilitating a replication-independent 
histone variant incorporation into chromatin, in large 
part, its molecular functions remain unclear. In our 
current studies, we found that suppression of Atrx 
expression can signifi cantly promote glioma initia-
tion from murine NSC cells deleted of p53 and Pten 
tumor suppressor genes. Functionally, we demon-
strated that Atrx has an important role modulating 
neuronal differentiation, although not their lineage 
determination. By using chromatin immunoprecipi-
tation and sequencing technologies, we further estab-
lished the genome-wide distribution of Atrx protein 
in mouse neural stem cells. Our data reveal that Atrx 
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protein targets tandem repeat sequences and likely 
regulates expression of the genes associated with these 
tandem repeats during the process of neural stem cell 
lineage differentiation. Currently, we are character-
izing Atrx molecular targets responsible for its roles 
in neural stem cell lineage differentiation and glioma 
pathogenesis.
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How does the brain encode stimuli from the outside world, within and across sensory modali-
ties, to generate specifi c perceptions that trigger complex behaviors? How is the brain shaped by 
sensory experience, and what modifi cations occur in neuronal circuits that allow us to learn and 
remember? These are the questions guiding the work of Florin Albeanu, who is using the olfac-
tory bulb and olfactory cortex of mice as the subject of his current studies. Airborne chemicals, 
translated into neuronal signals by specifi c receptors in the nose, are sent directly to the olfactory 
bulb. Advances in optical imaging and optogenetics combined with electrophysiological record-
ings enable Albeanu and colleagues to monitor and/or alter patterns of activity at unprecedented 
synaptic and millisecond resolution, in real time, as animals are engaged in various behaviors. 
For survival, rodents need to identify the smells of objects of interest such as food, mates, and 
predators, across their recurring appearances in the surroundings, despite apparent variations 
in their features. Furthermore, animals aptly extract relevant information about environment 
across different sensory modalities, combining olfactory, visual, or auditory cues. By recording 
neuronal activity in the input and output layers of the olfactory bulb, as well as feedback from 
olfactory cortical areas and neuromodulatory signals, Albeanu and his team aim to understand 
computations the bulb performs and how this information is decoded deeper in the brain. They 
have recently published evidence suggesting that the mouse olfactory bulb is not merely a relay 
station between the nose and cortex, as many have supposed. Using optogenetic tools and a novel 
patterned illumination technique, they discovered that there are many more information output 
channels leaving the olfactory bulb for the cortex than there are inputs received from the nose. 
They are currently investigating how this diversity of bulb outputs is generated, as well as how 
downstream areas, such as the piriform and parietal cortex, make use of such information during 
behaviors.
The study of decision-making provides a window into the family of brain functions that constitute 
cognition. It intervenes between perception and action and can link one to the other. Although 
much is known about sensory processing and motor control, much less is known about the cir-
cuitry connecting them. Some of the most interesting circuits are those that make it possible to de-
liberate among different interpretations of sensory information before making a choice about what 
to do. Anne Churchland’s lab investigates the neural machinery underlying decision-making. Lab 
members use carefully designed paradigms that encourage experimental subjects to deliberate over 
incoming sensory evidence before making a decision. Recent results show that rats and humans 
have a statistically similar decision-making ability. To connect this behavior to its underlying neu-
ral circuitry, the researchers measure electrophysiological responses of cortical neurons in rodents 
as they perform designated tasks. The lab’s current focus is on parietal cortex, which appears to be 
at the midpoint between sensory processing and motor planning. Churchland and colleagues also 
use theoretical models of varying complexity to further constrain how observed neural responses 
might drive behavior. This approach generates insights into sensory processing, motor planning, 
and complex cognitive function.
Research in Josh Dubnau’s lab is concentrated on two different questions. First, Dubnau and his 
team are investigating mechanisms of memory using Drosophila as a model system. A second area 
of research is focused on uncovering mechanisms of neurodegeneration that underlie amyotrophic 
lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Work in the Dubnau lab 
has suggested a novel hypothesis to explain neurodegeneration in these disorders. They discov-
ered that awakening retrotransposons in the genome of some brain cells might be responsible for 
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causing cell death. Retrotransposons are virus-like repetitive elements that are encoded in the 
genome and are capable of replicating and inserting into new chromosomal positions. This can 
lead to DNA damage and cell death by a process known as apoptosis. The lab is investigating 
this hypothesis for ALS/FTLD using a multidisciplinary approach that includes experimental 
work with fl y, mouse, cell culture, and human postmortem tissue. Computational analyses of 
genomic data are performed in collaboration with Molly Hammell’s group. If the retrotransposon 
hypothesis is correct, it will change the trajectory of neurodegeneration research and have obvious 
clinical impact. Retrotransposon RNAs and proteins are promising new diagnostic markers and 
potentially important therapeutic targets.
Grigori Enikolopov and colleagues study stem cells in the adult brain. They have generated sev-
eral models to account for how stem cells give rise to progenitors and, ultimately, to neurons, 
and they are using these models to determine the targets of antidepressant therapies, to identify 
signaling pathways that control generation of new neurons, and to search for neuronal and neu-
roendocrine circuits involved in mood regulation. Recent experiments suggest a new model of 
how stem cells are regulated in the adult brain, with a focus on stem cells’ decision on whether to 
divide—and embark on a path of differentiation—or remain quiescent. This model explains why 
the number of new neurons decreases with advancing age and may lead to impairments in memory 
and depressed mood. It also explains why multiple brain trauma and prolonged neurodegenera-
tive disease may lead to accelerated decrease of cognitive abilities. In other research, the team has 
identifi ed stem cell targets of various therapies used for treating depression and developed a gen-
eral platform to determine the effect of drugs and therapies and predict their action. The team 
is now focusing on the signaling landscape of neural stem cells and on their interaction with the 
surrounding niche. Enikolopov’s group is also focusing on other types of stem cells in the organ-
ism. Their latest discovery, with a team at Cornell University, relates to a new type of stem cell in 
the ovary that normally heals the ovarian tissue after an oocyte is released, but easily transforms 
to become malignant and generate tumors. The team is now using these discoveries to reveal how 
stem cells relate to neural and oncological disorders.
Hiro Furukawa’s lab studies receptor molecules involved in neurotransmission. Its members 
mainly focus on the structure and function of NMDA (N-methyl-d-aspartate) receptors—ion 
channels that mediate excitatory transmission. Dysfunctional NMDA receptors cause neuro-
logical disorders and diseases including Alzheimer’s disease, Parkinson’s disease, schizophrenia, 
depression, and stroke-related ischemic injuries. The Furukawa lab is working to solve the three-
dimensional structure of the very large NMDA receptor by dividing it into several domains. 
They seek to understand the pharmacological specifi city of neurotransmitter ligands and allo-
steric modulators in different subtypes of NMDA receptors at the molecular level. Toward this 
end, they use cutting-edge techniques in X-ray crystallography to obtain crystal structures of the 
NMDA receptor domains and validate structure-based functional hypotheses by a combination 
of biophysical techniques including electrophysiology, fl uorescence analysis, isothermal titration 
calorimetry, and analytical centrifugation. Crystal structures of NMDA receptors serve as a 
blueprint for creating and improving the design of therapeutic compounds with minimal side 
effects for treating neurological disorders and diseases. During the last several years, the team 
discovered and mapped several regulatory sites in specifi c classes of NMDA receptors, progress 
that now opens the way to the development of a new potential class of drugs to modulate the 
receptor activity.
To better understand neuronal circuits, Josh Huang and colleagues have developed novel means 
of visualizing the structure and connectivity of different cell types at high resolution in living 
animals, and they are able to manipulate the function of specifi c cell types with remarkable preci-
sion. Huang is particularly interested in circuits that use GABA, the brain’s primary inhibitory 
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neurotransmitter. The lab’s work has direct implications in neurological and psychiatric illness 
such as autism and schizophrenia, which involve altered development and function of GABAergic 
circuits. Huang’s team also previously developed 20 different mouse lines, each of which is engi-
neered to express markers of specifi c cell types, and demonstrated the exquisite specifi city of this 
technology by imaging GABA cells. This has been used to shed new light on synapse validation, 
which is at the heart of the process by which neural circuits self-assemble and is directly impli-
cated in neurodevelopmental pathologies. Huang’s team looked closely at neurexins, proteins that 
interact with neuroligins to form the “zipper” that holds synapses together. They discovered that 
α and β neurexins respond in different ways to neural activity—the α molecules searching out 
compatible connection partners and the β molecules securing preliminary connections that prove 
to be strong. The team’s most recent observations show that GABA also regulates the process by 
which synapses are pruned after they have been formed. The lab has also made good progress in 
studying perturbations in the developing GABAergic system in a mouse model of Rett syndrome, 
one of the autism spectrum disorders. In a recent landmark study, the team also made a major 
breakthrough in determining the origin of (and the genetic mechanisms that specify) the cortex’s 
powerful and enigmatic chandelier cells. This is a critical class of inhibitory brain cells, and the 
team showed that chandelier cells are born in a previously unrecognized portion of the embryonic 
brain, which they have named the VGZ (ventral germinal zone).
Adam Kepecs and colleagues are interested in identifying the neurobiological principles underly-
ing cognition and decision-making. They use a reductionist approach, distilling behavioral ques-
tions to quantitative behavioral tasks for rats and mice that enable the monitoring and manipula-
tion of neural circuits supporting behavior. Using state-of-the-art electrophysiological techniques, 
they fi rst seek to establish the neural correlates of behavior and then use molecular and optoge-
netic manipulations to systematically dissect the underlying neural circuits. Given the complexity 
of animal behavior and the dynamics of neural networks that produce it, their studies require 
quantitative analysis and make regular use of computational models. The team also has begun 
to incorporate human psychophysics to validate its behavioral observations in rodents by linking 
them with analogous behaviors in human subjects. Currently, the team’s research encompasses 
study of (1) the roles of uncertainty in decision-making, (2) the division of labor among cell types 
in prefrontal cortex, (3) how the cholinergic system supports learning and attention, and (4) social 
decisions that rely on stereotyped circuits. A unifying theme is the use of precisely timed cell-
type- and pathway-specifi c perturbations to effect gain and loss of function for specifi c behavioral 
abilities. This year, the Kepecs lab was able to link foraging decisions—the choice between staying 
or going—to a neural circuit and specifi c cell types in the prefrontal cortex. In other work, they 
identifi ed a class of inhibitory neurons that specializes in inhibiting other inhibitory neurons in 
the cerebral cortex and conveys information about rewards and punishment. Through manipula-
tions of genetically and anatomically defi ned neuronal elements, the team hopes to identify funda-
mental principles of neural circuit function that will be useful for developing therapies for diseases 
such as schizophrenia, Alzheimer’s disease, and autism spectrum disorder.
Alexei Koulakov and colleagues are trying to determine the mathematical rules by which the 
brain assembles itself, with particular focus on the formation of sensory circuits such as those in-
volved in visual perception and olfaction. The visual system of the mouse was chosen for study in 
part because its components, in neuroanatomical terms, are well understood. What is not known 
is how projections are generated that lead from the eye through the thalamus and into the visual 
cortex, how an individual’s experience infl uences the confi guration of the network, and what 
parameters for the process are set by genetic factors. Even less is known about the assembly of the 
neural net within the mouse olfactory system, which, in the end, enables the individual to distin-
guish one smell from another with astonishing specifi city and to remember such distinctions over 
time. These are among the challenges that engage Koulakov and his team.
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Dysfunction of synapses in the brain is thought to have an important role in the pathogenesis of 
major psychiatric disorders, including depression, anxiety, and schizophrenia. But what are the 
causes? Where in the brain does the dysfunction occur? How does it result in the behavioral symp-
toms of illness? To address these issues, Bo Li and colleagues are studying, in animals, normal 
synaptic plasticity underlying adaptive behaviors and synaptic aberrations responsible for mal-
adaptive behaviors that are related to depression, anxiety, and schizophrenia. Their long-term goal 
is to develop methods allowing the manipulation of activity in specifi c brain circuits in order 
to change disease-related behaviors. Li’s group uses a variety of methodologies, including patch-
clamp recording and calcium imaging of labeled neurons, two-photon imaging of spine morphol-
ogy and tagged receptors, in vivo stereotaxic virus injection, RNA interference (RNAi)-based 
gene silencing, activation of specifi c axon terminals using light-gated cation channels, activation 
or silencing of specifi c brain regions using transgenes, and assessment of the behavioral conse-
quences of certain manipulations. A project focusing initially on a gene called ErbB4 seeks to de-
termine the genetic causes of attention defi cit, a cognitive impairment that is consistently observed 
in schizophrenia. This year, Li and his lab members demonstrated that neurons in a tiny area of 
the mammalian brain called the central amygdala encode fear memory and control fear expres-
sion. These fi ndings laid the foundation for future work aimed at understanding the circuit mech-
anisms of anxiety disorders, in particular post-traumatic stress disorder (PTSD).
Partha Mitra seeks to develop an integrative picture of brain function, incorporating theory, in-
formatics, and experimental work. In the ongoing Mouse Brain Architecture Project, Mitra and 
colleagues are generating a brain-wide connectivity map for the mouse using a shotgun approach, 
where neuronal tracer substances are injected systematically on a grid in the brain. Currently, 
~500 tracer-injected mouse brains may be viewed through a virtual online digital microscope 
on the project portal (http://mouse.brainarchitecture.org). The project requires a petabyte of 
data, posing big-data computational challenges that the lab is fi nding novel ways of meeting. In 
another application of whole-brain digital neuroanatomy, Mitra is collaborating with Josh Huang 
to characterize the distribution of the cell bodies and processes of subtypes of GABAergic neu-
rons in mouse brains, to understand the differences between a normal mouse and mouse models 
of autism spectrum disorders. In parallel, Mitra is undertaking theoretical work at the interface 
between physics, engineering, and biology by bringing methods from statistical physics to bear on 
problems in network control theory and multivariable statistics. Biological networks involve large 
numbers of variables, and it is expected that insights and analytical methods derived from this 
work will apply to biological networks such as the whole-brain network being determined in the 
Mouse Brain Architecture Project.
Pavel Osten’s lab works on identifi cation and analysis of brain regions, neural circuits, and con-
nectivity pathways that are disrupted in genetic mouse models of autism and schizophrenia. Osten 
hypothesizes that (1) systematic comparison of multiple genetic mouse models will allow deter-
mination of overlaps in pathology—neural circuit endophenotypes—responsible for the mani-
festation of neuropsychiatric disorders and (2) neural circuit-based classifi cation of autism and 
schizophrenia will provide key circuit targets for detailed mechanistic studies and therapeutic 
development. Osten and colleagues have developed the fi rst systematic approach to the study 
of neural circuits in mouse models of psychiatric diseases, based on a pipeline of anatomical 
and functional methods for analysis of mouse brain circuits. An important part of this pipeline 
is high-throughput microscopy for whole-mouse brain imaging, called serial two-photon (STP) 
tomography. This year, they used this method to describe the fi rst whole-brain activation map 
representing social behavior in normal mice. They are currently focusing on using this approach 
to study brain activation changes in two mouse models of autism: the 16p11.2 df/+ mouse model, 
which shows an increased propensity to seizures and hyperactivity, and the CNTNAP2 knockout 
mouse model, which shows abnormal social behavior.
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Stephen Shea’s lab studies the neural circuitry underlying social communication and deci-
sions. He uses natural social communication behavior in mice as a model to understand circuits 
and processes that are evolutionarily conserved and therefore shared broadly across species, likely 
contributing to disorders such as autism. Shea and colleagues have examined how emotion and 
arousal enable mice, via their olfactory systems, to store memories of other individuals and of 
related social signals. The team has exploited the intimate relationship between memory and emo-
tion to effectively create memories in anesthetized mice, allowing them unprecedented access to 
neurobiological processes that typically only occur during behavior. The lab has been making 
a detailed analysis of the changes in neural connections that underlie odor memory. The team is 
particularly focused on an enigmatic cell type (granule cells or GCs) that has long been hypoth-
esized to be crucial for memories, but has resisted direct study. They have developed methods for 
recording, giving them the fi rst glimpse of the dynamics of these cells while the animal is learn-
ing an odor. The results show unexpectedly complex population dynamics among the GCs that 
were independently predicted by a model of odor learning developed in Alexei Koulakov’s lab. 
The two labs are collaborating to discern how GC population activity gets integrated by olfactory 
bulb output neurons and to pinpoint the synaptic circuit that underlies this form of learning. In 
parallel, another member of the lab is using imaging techniques to determine how memories are 
stored among broad neuronal ensembles, at a different level of the system. Recently, the lab made 
a key breakthrough, developing the ability to record from GCs in awake animals and discovering 
that their activity is dramatically modulated by state of consciousness. Finally, the Shea lab com-
pleted a series of studies of a different form of social recognition: auditory recognition of pup vo-
calizations by their mothers. Through this research, they have shown that a mouse model of Rett 
syndrome exhibits defi cits in communication and learning not unlike those in human patients. 
Grants from the Simons and Whitehall Foundations are allowing the lab to extend this work by 
directly linking these defi cits to the action of the gene MeCP2 in the auditory cortex.
What is a memory? When we learn an association, information from two different sensory streams 
somehow becomes linked together. What is this link in terms of neural activity? For example, after 
a few bad experiences, we learn that the “green” smell of an unripe banana predicts its starchy 
taste. How has the neural response to that green smell changed so it becomes linked to that taste? 
What are the underlying mechanisms—what synapses change strength, what ion channel proper-
ties change? These are the questions that drive research in Glenn Turner’s laboratory. His team 
addresses these questions by tracking neural activity using a combination of different techniques. 
Using electrophysiological methods, they can examine individual neurons with very high reso-
lution, monitoring synaptic strength and spiking output. They have also developed functional 
imaging techniques to monitor the activity of the entire set of cells in the learning and memory 
center of the fl y brain. This comprehensive view of neural activity patterns enables them to actu-
ally predict the accuracy of memory formation in separate behavioral experiments. This year, the 
Turner lab was able to map the activity of a particular region of the brain that is associated with 
learning and memory. They found that a remarkably small number of neurons are required for 
fl ies to distinguish between odors. The Turner lab also studied the role of a specifi c type of cells, 
known as Kenyon cells, that receive input via several large claw-like protrusions. These neurons 
use their claws to recognize multiple individual chemicals in combination in order to remember 
a single scent. By examining the effects of learning-related genes on these processes, they can in 
the future connect their network-level view of memory formation to the underlying molecular 
mechanisms that govern the basic cellular and synaptic changes that drive learning.
Anthony Zador and colleagues study how brain circuitry gives rise to complex behavior. Work 
in the lab is focused on two main areas. First, they ask how the cortex processes sound, how that 
processing is modulated by attention, and how it is disrupted in neuropsychiatric disorders such as 
autism. Recently, the lab found that when a rat makes a decision about a sound, the information 
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needed to make the decision is passed to a particular subset of neurons in the auditory cortex 
whose axons project to a structure called the striatum. In the second major line of work in the 
Zador lab, they are developing new methods for determining the complete wiring instructions of 
the mouse brain at single-neuron resolution, which they term the “Connectome.” In contrast to 
previous methods, which make use of microscopy, these methods exploit high-throughput DNA 
sequencing. Because the costs of DNA sequencing are plummeting so rapidly, these methods have 
the potential to yield the complete wiring diagram of an entire brain for just thousands of dollars.
Yi Zhong’s lab studies the neural basis of learning and memory. The team works with fruit fl y mod-
els to study genes involved in human cognitive disorders, including neurofi bromatosis,  Noonan 
syndrome (NS), and Alzheimer’s disease. Mutations leading to a lack of function of the neurofi -
bromatosis 1 (NF1) gene cause noncancerous tumors of the peripheral nervous system as well as 
learning defects. The lab’s analyses of Drosophila NF1 mutants have revealed how expression of the 
mutant gene affects a pathway crucial for learning and memory formation. The NF1 gene and a 
gene called corkscrew, implicated in NS, share a biochemical pathway. Recently, the lab succeeded 
in linking changes in this pathway due to specifi c genetic defects in NS with long-term memory 
defi ciencies. In fl y models, they discovered the molecular underpinnings of the “spacing effect”—
the fact that memory is improved when learning sessions are spaced out between rest intervals. 
Zhong’s team also has succeeded in reversing memory defi cits in mutant fl ies, work suggesting 
longer resting intervals for NS patients might reverse their memory defi cits. They also identifi ed 
a means of reversing memory loss in fruit fl ies while suppressing brain plaques similar to those 
implicated in Alzheimer’s disease by blocking epidermal growth factor receptor (EGFR) signal-
ing, a pathway commonly targeted in cancer. Separately, having discovered that memory decay is 
an active process, regulated by the Rac protein, the team has proposed that Rac’s role in erasing 
memory is related to its infl uence on downstream cytoskeleton remodeling agents. This year, the 
Zhong lab explored how neurons control our response to different scents, offering insight into 
how the brain distinguishes between food odors that are attractive and repulsive. They discovered 
that neurons expressing a particular peptide were only activated by food odors, and the amount of 
activation predicted how much a fl y was attracted to a particular odor.
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UNDERSTANDING NEURONAL CIRCUITS IN THE 
MAMMALIAN OLFACTORY BULB
F. Albeanu F. Anselmi H.G. Chae P. Alexandre Garcia Da Silva M. Koh G. Otazu Aldana
 A. Banerjee M. Davis P. Gupta F. Marbach B. Rebouillat
The focus of our research group is to understand 
how neuronal circuits encode and interpret inputs 
from the environment and lead to meaningful be-
haviors. Toward this end, we use optogenetic meth-
ods (such as fast multiphoton laser-scanning imag-
ing of genetically encoded neuronal activity report-
ers or patterned illumination of light-gated neuronal 
activity switches) coupled with electrophysiological 
measurements (extracellular and intracellular re-
cordings). We want to understand (1) how inputs 
get processed at different synapses of the underly-
ing neuronal circuits, (2) how these representations 
change with the state of the system and its circuits 
(awake vs. anesthetized; naïve vs. behaving, learn-
ing), and (3) what changes in the activity patterns of 
well-defi ned neuronal circuits contribute to specifi c 
behaviors. The broad scope of this effort is observing 
how perceptions arise.
We use the rodent olfactory system as a model 
and monitor neuronal inputs, outputs, and feedback 
loops in different layers of the circuit. We modulate 
activity of select neuronal populations in a reversible 
manner in awake animals to understand how funda-
mental sensory encoding problems are solved by the 
olfactory bulb (OB) and olfactory (piriform) cortex 
networks.
Characterizing the Input-Output 
Transform of the Olfactory Bulb
In the OB, sensory neurons expressing the same type 
of olfactory receptor converge in tight focus, form-
ing ~2000 clusters of synapses called glomeruli. The 
layout of glomeruli on the OB is highly reproducible 
across individuals with a precision of 1 part in 1000. 
However, nearby glomeruli are as diverse in their re-
sponses to odors as distant ones, lacking an apparent 
chemotopic arrangement (Soucy et al., Nat Neurosci 
12: 210 [2009]). From each glomerulus, a few dozen 
mitral cells (principal output neurons of the OB) 
carry the output further to the olfactory cortex and 
several other brain areas. Such “sister” mitral cells 
typically have only one primary dendrite that proj-
ects to a single glomerulus, but they can sample in-
puts on their primary and secondary dendrites from 
functionally diverse glomeruli via several types of 
interneurons (Fig. 1). Using optogenetic manipula-
tions and digital micromirror device (DMD)-based 
patterned photostimulation (Fig. 2), we found that 
sister cells carry different information to the cortex: 
Average activity represents shared glomerular input, 
and phase-specifi c information refi nes odor repre-
sentations and is substantially independent across 
sister cells (Dhawale et al., Nat Neurosci 13: 1404 
[2010]).
Activity in the OB is a rich mix of excitation and 
inhibition, via both direct inputs and feedback con-
nections. Many different classes of interneurons in-
teract with the sensory afferents and/or the output 
neurons via both short- and long-range connections. 
Their connectivity patterns and roles in olfactory 
processing, however, remain largely unknown. We 
use a Cre-loxP approach to express reporters (i.e., 
synaptopHluorin, GCaMP6) and light-gated switch-
es of neuronal activity (ChR2, Halorhodopsin, Arch) 
in different bulbar neuronal types. We monitor the 
Figure 1. Main olfactory bulb wiring schematics.
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inputs (glomerular activity patterns) and the outputs 
(mitral cell fi ring) in response to numerous odorants 
across a wide range of concentrations (fi ve orders of 
magnitude), as we systematically perturb the activity 
of the input nodes (glomeruli) and of different inter-
neuron types. Patterned photostimulation allows us 
to bypass odor stimulation and gain precise spatio-
temporal control over the inputs by directly activat-
ing glomerular patterns of choice. We record bulbar 
outputs via multitetrode recordings and patch clamp, 
or we use optical imaging readouts via multiphoton 
microscopy in vivo to understand what computations 
the OB performs.
We are currently investigating the roles of two 
classes of interneurons: short axon cells (SAs) that 
broadcast long-range signals in the glomerular layer 
and granule cells (GCs) that establish reciprocal 
synapses with mitral/tufted (M/T) cells and receive 
rich cortical feedback input.
Long-Range Interactions between SAs and 
External Tufted Cells Gate the Output 
of the Glomerular Layer of the OB
Odors elicit distributed activation of input nodes 
(glomeruli) on the OB. This necessitates long-range 
interactions among coactive glomeruli. Long-range 
projecting SA cells provide the earliest opportunity 
for such cross-talk. SA cells, in the glomerular layer, 
receive inputs from olfactory sensory neurons (OSNs) 
and/or external tufted (ET) cells and release both 
GABA and dopamine, synapsing onto ET cells as far 
as tens of glomeruli away (Kiyokage et al., J Neurosci 
30: 1185 [2010]). Computational models (Cleland 
et al., Trends Neurosci 33: 130 [2007]) have suggested 
that SA cells may be involved in long-range normal-
ization of bulb outputs, but to date, their function in 
the intact brain has not been investigated. We imaged 
GCaMP3 responses to odor stimulation by wide-fi eld 
microscopy across a broad range of concentrations. 
Odorants induced transient, yet widespread, SA re-
sponses, in contrast to focal glomerular patterns ob-
served via intrinsic optical imaging.
To understand the roles played by the SA network 
with respect to the OB output dynamics, we record-
ed extracellularly from M/T cells using tetrodes in 
anesthetized mice. In conjunction, we selectively ac-
tivated/inactivated SA cells by shining blue/yellow 
light either throughout the dorsal bulb surface or in 
specifi c spatial patterns in mice expressing ChR2 and 
Halorhodopsin, respectively. In parallel, we developed 
complementary tools to silence SA cells pharmaco-
genetically using inhibitory designer receptors exclu-
sively activated by designer drugs (DREADDs) and to 
monitor mitral cell activity at the population level by 
retrograde expression of GCaMP3.
Using optogenetic and pharmacogenetic approa-
ches, we fi nd that SA cells infl uence distant M/T cells 
by modulating local excitatory interneurons (ET cells). 
Synaptic SA action enables long-range suppression of 
ET cells. In addition, we fi nd electrical coupling be-
tween SA and ET cells that may facilitate local syn-
chronization of ET-SA responses. Our results indicate 
that ET cells are the gatekeepers of glomerular output 
and prime determinants of M/T responsiveness. We 
Figure 2. DLP patterned illumination in ORC mice maps the 
parent glomeruli of mitral cells in vivo. (A, left) A DLP projec-
tor coupled to a system of three lenses delivered light patterns 
to activate individual glomeruli on the dorsal surface of the 
bulb. A CCD camera was used to visualize the bulb surface 
and record the position of the light stimulus. (Top panel, right) 
Dorsal surface of the bulb with a tetrode positioned in the 
mitral cell layer. One square light spot is being projected onto 
the surface of the bulb. (Inset) Cartoon schematic of glomeruli 
on the bulb, a subglomerular-size light spot and dual tetrodes 
positioned in the mitral cell layer. (a) A DLP projector, with 
color wheel removed from optical path, (b) focusing lens, 
(c) blue excitation ﬁ lter, (d) dichroic mirror, (e) emission ﬁ lter, 
(f ) CCD camera, (g) dual-tetrode, (h) olfactory bulb. (B, Top) 
Raw voltage traces corresponding to the four  channels of 
a tetrode showing light-induced changes in ﬁ ring patterns 
of the units recorded. (Center) Raster plot shows changes in 
spiking activity of a single isolated unit across 25 light stimula-
tion trials, each 200-msec long; dots mark spike occurrence 
times. (Bottom) Peristimulus time histogram (PSTH) with 
25-msec time bins, summing spikes over the trials shown in 
the center panel.
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propose that long-range SA-ET action is fundamental 
for gain control and contrast enhancement by allow-
ing multiple co-active inputs to alter the output of any 
given glomerulus, before reaching M/T cells.
Characterization of Granule Cell Odor 
Responses in Awake Head-Fixed Mice
GCs mediate both lateral and recurrent inhibition by 
forming reciprocal synapses with M/T cells, the prin-
cipal output neurons of the OB. GCs receive glutama-
tergic inputs both from MT cells and from feedback 
axons originating in the olfactory cortex. GCs are the 
most numerous cells in the OB (~90%), outnumber-
ing the M/T cells by two orders of magnitude, and 
further represent the main target of direct feedback 
from the olfactory cortex.
Computational models and behavioral studies have 
suggested critical roles for these cells in olfactory pro-
cessing and learning. However, very little is known 
about their response properties in vivo, because of 
technical diffi culties in electrophysiological record-
ings from these small-sized neurons.
To begin characterizing the odor response proper-
ties of GCs, we used a Cre-LoxP approach to express 
a genetically encoded calcium indicator (GCaMP6f) 
in the GCs (CST-Cre) and multiphoton imaging to 
monitor the odor-evoked responses of GCs (250–350-
μm deep) in awake head-fi xed mice. GCs showed ro-
bust spontaneous activity and were sparsely activated 
upon odor presentation, displaying a diverse range of 
enhanced and suppressed, ON, OFF, and ON-OFF 
responses. Enhanced responses were more common 
than suppressed responses (65% vs. 35%). Further-
more, a signifi cant fraction (~25%) of GCs exhibited 
characteristic enhanced OFF responses, independent 
of stimulus duration. Pairwise analysis of GCs moni-
tored simultaneously indicates that neighboring GCs 
are as diverse in their odor responses as are pairs of 
distant cells. No spatial clustering of similarly odor- 
responding GCs was apparent within a 350-μm 
range. Enhanced responsive GCs increased monotoni-
cally in number across concentrations. Suppressed and 
OFF-responsive GCs varied in a complex fashion with 
concentration.
To dissect the contribution of the corticobulbar 
feedback to GC activity, we are using pharmacological 
and optogenetic manipulations of the cortical input in 
tandem with multiphoton imaging of GCs and M/Ts. 
Furthermore, we are currently monitoring how GC 
responses evolve during learning and performing of 
olfactory detection and discrimination tasks.
Dissecting the Spatial and Temporal 
Features of the Glomerular Code in 
Awake Behaving Animals via 
Optogenetics Strategies
Odorants activate precise spatiotemporal glomeru-
lar activity patterns on the OB surface. These pat-
terns constitute the fi rst representation of odor input 
into the olfactory system and hence must contain all 
meaningful attributes of the incoming odor stimulus, 
such as odor identity, intensity, and temporal dynam-
ics. Different odors activate distinct overlapping and 
nonoverlapping glomerular maps. In principle, these 
odor maps can vary in several possible features, such 
as number (how many glomeruli are activated), space 
(which glomeruli), intensity (absolute and relative 
levels of activity of individual glomeruli), and timing 
(onset with respect to each other and the order of their 
activation). Previous experiments suggest that present-
ing different odorants (A vs. B), mixtures (A and B), 
or different concentrations of the same odorant (A) 
may all result in modulation of odor maps along many 
(if not all) of these features. It is unknown how the 
downstream circuitry (M/T cells, olfactory cortex) in-
terprets these variations and assigns meaning to them, 
in order to segregate odor identity from changes in 
concentration or components within/from a mixture.
One way to understand how the circuit makes 
sense of changes in the glomerular activity patterns 
to extract relevant information is to systematically 
alter features of odor maps and study the concurrent 
changes in neuronal outputs and olfactory behavior. 
Hitherto, however, this has not been possible, primar-
ily because of the inability to activate and modulate 
individual glomeruli in a controlled manner using 
odorants. We are using optogenetic tools to bypass 
odorant stimulation and simulate odor-like glomeru-
lar activity patterns, or alter them, by directly acti-
vating/inhibiting glomeruli using light in transgenic 
mice that express ChR2 or Arch in all OSNs or in 
a single type of OSN (Olf151). Furthermore, using 
patterned illumination, we are activating/inhibiting 
select subsets of glomeruli with single-glomerulus 
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precision in terms of intensity, onset time, or dura-
tion. This approach confers unprecedented ability to 
make feature-specifi c perturbations in a glomerular 
pattern of choice. We aim to understand what features 
of an odor map are used by a behaving mouse under 
naturalistic conditions to identify odors and their at-
tributes, such as concentration, temporal fl uctuations, 
and spatial location. Furthermore, we are testing the 
resolution at which mice can in principle detect varia-
tions within specifi c features of odor maps in a strictly 
controlled artifi cial regime. While doing so, we will 
also monitor neuronal responses at multiple layers in 
the olfactory system to compare the behavioral and 
neuronal detection thresholds and to understand the 
neuronal correlates of olfactory behavior.
To this end, we are training head-fi xed and water-
restricted mice to identify a target stimulus (“A”) as 
being unique from other nontarget (“not A”) stimuli 
by licking a “Left” versus “Right” water reward port 
placed on either side of the mouth (Fig. 3). Animals 
are reinforced with water reward for correct choices 
and a mild air puff as punishment upon licking of the 
wrong port (Fig. 3). We are using wide-fi eld imag-
ing (intrinsic, fl uorescence) and two-photon micros-
copy to monitor the glomerular input maps evoked 
by the target (“A”) and the non-target stimuli (“not 
A”) as mice learn and perform the task. These activity 
patterns are further used as templates to design pho-
tostimulation masks for perturbation of stimulus-in-
duced activity patterns during behavior. Once the task 
has been learned to >85% accuracy, we reversibly per-
turb the stimulus “A” activity pattern and determine 
the behavioral threshold at which an altered activity 
pattern is classifi ed as “not A.”
Investigating the Roles of Cortical Feedback 
in Invariant Odor Perception
Invariant perception refers to the identifi cation of a 
sensory stimulus or an object of interest in a general-
ized fashion across its variable and recurring presen-
tations. This is a common feature across all sensory 
modalities and becomes particularly preeminent in 
olfaction. Natural odor scenes are composed of odor 
plumes originating from multiple sources and travel-
ing at fl uctuating intensities that span several orders 
of magnitude. Despite this turbulent nature of the 
stimulus, rodents readily identify odors essential for 
their survival against varying odor-rich backgrounds 
and faithfully track a fl uctuating odor stream to its 
source. Several models have attempted to explain 
invariant perception in different sensory modalities. 
Some of these models are based on the conventional 
view of sensory processing that relies solely on feed-
forward information fl ow, whereas others argue that 
feed-forward mechanisms are insuffi cient and suggest 
the involvement of feedback among different neuro-
nal layers. Anatomical studies show massive feedback 
projections from higher brain areas to the sensory pe-
riphery that often outnumber direct sensory inputs. 
The interplay of feed-forward and feedback signals 
has been proposed to be fundamental for learning 
and memory recall. Although rich cortical feedback 
projections innervate the OB, to date, little is known 
about their contribution to olfactory processing. Cor-
ticobulbar feedback innervates multiple bulb layers, 
but it primarily targets the granule cells that form 
extensive dendrodendritic synapses with M/T cells.
Our approach is to understand the role of corti-
cobulbar feedback (Fig. 4) in the identifi cation of an 
odor, invariant of fl uctuations in its concentration 
and/or timing and presence of background odors. We 
are taking advantage of optogenetic tools and pat-
terned illumination techniques recently developed in 
our group to reversibly manipulate the activity of cor-
tical feedback fi bers and their targets in awake head-
fi xed mice as they learn and perform invariant odor 
perception tasks. To mimic naturalistic odor condi-
tions, we are making use of custom-designed odor de-
livery systems that reproducibly deliver arbitrary time-
varying patterns of individual odors and mixtures. To 
understand the underlying neuronal mechanisms, we 
monitor the activity of feedback inputs and their tar-
gets via high-speed scanning multiphoton microscopy 
and multitetrode recordings.
To date, little is known about the contribution of 
cortical feedback to olfactory processing in the OB in 
response to novel or previously encountered odors. To 
examine how cortical feedback shapes input process-
ing in the OB, we use GCaMP5 and GCaMP6 signals 
to monitor the odor-evoked responses of feedback fi -
bers in awake head-fi xed mice. Feedback fi bers showed 
rich, locally diverse, and brief (<1 sec) spontaneous ac-
tivity in the majority of imaged boutons. Individual 
boutons were sparsely activated across odors, resulting 
in both enhancement and suppression compared to 
baseline activity. Strikingly, we observed roughly two 
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Figure 3. Pharmacogenetic silencing of SA cells suppresses odor-evoked M/T excitation and inhibition. (A) Images 
from the olfactory bulb of a DAT-Cre × Ai38 mouse injected with DIO-DREADDi-mCherry AAV2.9 virus in the 
glomerular layer and with PRV-Cre in the piriform cortex. (Top, left) Wideﬁ eld image showing mCherry expression 
in the exposed olfactory bulb. (Top, right) In vivo multiphoton image of resting ﬂ uorescence showing GCaMP3.0 
expression in M/T cells. (Bottom) Confocal image showing selective expression of mCherry expression only in the 
glomerular layer. (B) Baseline-subtracted, normalized GCaMP3.0 signals from an example imaging session of SA cell 
responses to increasing concentrations of heptanal before (control, top) and after CNO (clozapine-N-oxide) injection 
(bottom). Stimulus concentrations are reported as nominal dilution in mineral oil. Each row represents an individual 
SA cell (ROI) in the same ﬁ eld of view. Color indicates normalized change in ﬂ uorescence with respect to pre-odor 
baseline (dF/F). Dotted lines indicate odor presentation (4 sec). Images were acquired at a frame rate of 5 Hz. (C, i) 
Average odor-evoked response (dF/F) of all SA cells (20 ROIs) shown in B, across ﬁ ve odors as a function of increas-
ing odor concentration. Dotted lines show responses before and after CNO injection. Error bars indicate standard 
error of mean. (ii) Average odor-evoked response (dF/F) of all responsive SA cells (110 cells, three mice), across ﬁ ve 
odors as a function of increasing odor concentration. Dotted lines show responses before and after CNO addition. 
Error bars indicate standard error of mean. (D) Baseline-subtracted, normalized GCaMP3.0 signals from an example 
imaging session of M/T cells to increasing concentrations of isoamyl acetate (i) and valeraldehyde (ii) before (control, 
top) and after (CNO, bottom) CNO injection. Stimulus concentrations are reported as nominal dilution in mineral 
oil. Each row represents an individual M/T cell (ROI). Color indicates relative change in ﬂ uorescence with respect 
to pre-odor baseline (dF/F). Dotted lines indicate odor presentation. Images were acquired at a frame rate of 5 Hz. 
(E) Average normalized odor-evoked response (two to three repeats) of four example M/T cells (ROIs) shown in D, 
to ﬁ ve odors, as a function of increasing odor concentration, before (control, solid lines, top) and after (CNO, dotted 
lines, bottom) CNO injection. Colors indicate individual odors (same as Fig. 2g). (F) Summary histogram (left) and 
cumulative distribution (right) of M/T odor responses as a function of normalized response strength (dF/F) before 
(black) and after (red) CNO addition. 49 cells, 842 cell-odor pairs, three mice.
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types of bouton responses suggestive of distinct piri-
form cortex output channels. Approximately 40% of 
the imaged boutons showed purely enhanced respons-
es, whereas ~55% of boutons were consistently sup-
pressed by odors. Only ~5% responded through both 
enhancement and suppression to different odors. The 
enhanced and suppressed responses to odors were not 
just mirror images of each other: Suppressed bouton 
responses maintained their suppression for several sec-
onds following odor presentation, whereas enhanced 
bouton responses tracked the temporal dynamics of 
odors more faithfully. These observations suggest that 
transient odor input can trigger long-lasting activity 
(suppression or enhancement) that may further im-
pact bulbar dynamics. This long-lasting activity may 
originate in the bulb itself, or it may result from local 
inhibitory interactions in the piriform cortex. To dis-
tinguish between these possibilities, we are currently 
combining cortical feedback imaging to varying odor 
pulse durations with pharmacological blocking of in-
tracortical interactions.
The enhanced and suppressed bouton responses to 
a particular odor appeared to be clustered in spatial 
domains. However, pairwise analysis of simultaneous-
ly imaged boutons revealed functional local diversity 
across our panel of 20 odors. No spatial organization 
was apparent in bouton responses across odors within 
the imaged fi eld of view (<150 μm). Enhanced and 
suppressed boutons also had different population re-
sponses to increases in odor concentration; the num-
ber of enhanced boutons that responded to an odor 
increased on average with odor concentration, where-
as the number of suppressed boutons followed a non-
monotonic trajectory.
To directly determine the effect of cortical feed-
back on the dynamics of the OB output, we are sup-
pressing piriform cortex activity using pharmacologi-
cal and optogenetic methods, in conjunction with 
simultaneous monitoring of granule and mitral cell 
activity via multiphoton microscopy. Preliminary 
results show that suppressing corticofeedback bidi-
rectionally alters spontaneous activity and decreases 
the responsiveness of granule cells to odors and across 
concentrations, diminishing both enhanced and sup-
pressed responses.
We propose that cortical feedback modulates the 
dynamics of OB output such as to sharpen odor re-
sponses and maintain diverse neuronal representa-
tions across different stimuli. We are currently test-
ing this hypothesis in behaving mice engaged in odor 
discrimination tasks.
Monitoring Cholinergic Input in the 
Olfactory Bulb in Mice Engaged 
in Attention Tasks
Cholinergic inputs from the basal forebrain have been 
shown to enhance encoding and discrimination of vi-
sual, auditory, and somatosensory cues by modulating 
attention and learning processes. Although rich cho-
linergic projections innervate the mouse olfactory bulb 
(MOB), to date, little is known about their contribu-
tion to olfactory behaviors. Pharmacological block-
ade of acetylcholine (ACh) action has been shown to 
impair olfactory behavior, whereas augmenting ACh 
levels improved odor discrimination. A clear under-
standing of the underlying mechanisms of ACh ac-
tion and their spatiotemporal statistics, however, has 
been limited by the low yield of recordings from the 
basal forebrain, as well as diffi culties in ascertaining 
the downstream targets of the recorded neurons, given 
the widespread and long-range nature of cholinergic 
projections.
Figure 4. Odor-evoked responses in cortico-bulbar feedback ﬁ -
bers. (A) Cortico-bulbar feedback ﬁ bers labeled with GCaMP5; 
(B) feedback ﬁ ber boutons in an optical plane 230-μm below 
the surface; (C) example responses to three different odors  (ethyl 
tiglate, 2-heptanone, and p-anis aldehyde) for six synaptic bou-
tons from the imaged ﬁ eld of view.
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Behavioral Readout
We are using behavioral tasks that require the sub-
jects to identify a stimulus of interest in two different 
contexts and investigating cholinergic fi ber dynamics.
• Sustained attention task. In this task, water-deprived 
mice are trained to discriminate a target odor cue 
from a nontarget odor to obtain a water reward 
(Fig. 5A,i). Both the target and nontarget odors 
are presented at diff erent intensities and timing 
and, more importantly, in the presence of a vary-
ing background odor. To maintain a high success 
rate, the animals are required to learn to maintain 
attention after the background odor is presented 
and detect the onset of the target odor, despite the 
fl uctuating signal to noise across trials. In this con-
text, we are monitoring whether cholinergic activity 
is time-locked to the background presentation and 
persists until target/nontarget presentation. Further-
more, we analyzed whether the levels of cholinergic 
input correlate with trial-to-trial success. Informed 
by these results, we aim to manipulate cholinergic 
inputs (optically and reversibly), selectively, in either 
the OB or medial prefrontal cortex (mPFC) to ver-
ify the causal mechanisms that underlie attentional 
strategies in this behavioral paradigm.
• Selective attention task. In this task, mice are trained 
to discriminate between a target and nontarget 
odor, as well as a target and nontarget sound stim-
ulus (tone). After this basic learning phase, both 
olfactory and auditory cues are presented simul-
taneously, but the availability of reward is locked 
only to one pair of cues. Th is reward contingency 
is switched randomly across blocks of contiguous 
trials (odor block, sound block) (Fig. 5A,ii). In this 
Figure 5. (A) (i) Sustained attention and (ii) selective attention tasks. (B) 1-mon-old cranial window over MOB, 
cholinergic axons expressing GCaMP5 imaged at 100-μm depth (150 × 150-μm ﬁ eld of view). (C) Recorded traces 
spontaneous activity of cholinergic axons form three different ROIs (4 min, mean dF/F0 = 200%). (D) Two examples 
of cue-evoked (white lines) transients of cholinergic axon activity in awake animals. Rows represent different axon 
boutons. (Bottom) Mean (black line) and standard deviation (gray line) of all responsive axon boutons (mean dF/F 
for transients = 200%). (E) Spread of cholinergic axons expressing GCaMP5 in different layers of the MOB, injection 
site showing cholinergic cell bodies. (F) Diagram of the ﬁ ber-optic imaging setup. (G) Two proof-of-principle odor-
evoked responses acquired with optical ﬁ bers from cortical feedback axons expressing GCaMp3 (left, 6-sec odor 
[black bar], mean dF/F0 = 3%, four repeats each) recorded in the main olfactory bulb.
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context, we are investigating if and how the cholin-
ergic system enables the subject to selectively direct 
attention to odor or sound cues. Th is will allow us 
to understand the general principles that under-
lie ACh-mediated attentional processes, whether 
attention signals are broadcasted as global “up-
states” throughout the brain, or whether, depend-
ing on the task requirement, only selective brain 
areas receive modulatory inputs. Th e latter analysis 
will provide critical insight into whether excess/def-
icit of cholinergic activity impairs brain function, 
particularly under conditions of sensory overfl ow.
To circumvent low yield of electrophysiological re-
cordings, we are taking advantage of genetically en-
gineered mice (Chat-Cre) and viral strategies to tar-
get expression of calcium indicators (GCaMP5 and 
GCaMP6) in cholinergic neurons and optically moni-
tor the activity patterns of the projection fi bers to the 
MOB in behaving animals (Fig. 5). We are pursuing 
two complementary strategies to gain access to the ac-
tivity of ensembles of cholinergic neurons: (1) multi-
photon imaging in awake head-fi xed mice (Fig. 5B–E), 
which allows observation of a large number of choliner-
gic projections in the MOB, with axonal resolution, en-
abling precise spatiotemporal characterization of their 
activity patterns within, as well as across, different cir-
cuit layers (glomerular versus mitral cell layer), and (2) 
fi ber-optic imaging in freely moving mice (Fig. 5F,G). 
Although limited to assessment of average population 
activity of cholinergic inputs, this approach can be eas-
ily coupled with electrophysiological means to simulta-
neously monitor the OB output (M/T cells).
Combining insights obtained via these two ap-
proaches will reveal how ACh action in the OB is linked 
to the timing and nature of olfactory stimuli across dif-
ferent behavioral states. In addition, it will further aid 
informed optogenetic manipulations of ACh signals to 
Figure 6. Combined imaging and photostimulation setup. (Left) Experimental conﬁ guration, combining scanning 
two-photon imaging (red), DMD photo-stimulation (blue), and holographic photo-stimulation (brown). (Right) Sche-
matic of the experimental microscope. DMD stimulation is used to create spatiotemporal light patterns on the sur-
face (<100 μm). Digital holography is used to photo-stimulate deeper (<500 μm) in the brain with cellular resolution. 
Calcium activity is monitored in an independent optical plane by two-photon imaging and by electrodes in down-
stream brain regions. (BE) Beam expander; (SM) scan mirrors; (O) objective; (PMT) photo-multiplier; (SLR) camera 
lens; (DMD) digital micro-mirror device; (SLM) spatial light modulator; (CCD) charged coupled device. 
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elucidate the relevance of cholinergic inputs in shaping 
mitral cell output and olfactory behaviors.
Implementing Digital Holography Methods 
to Investigate in a Closed-Loop Fashion 
the Spatiotemporal Integration Rules 
in the Olfactory Bulb and Cortex
We are implementing strategies that will enable non-
invasive functional dissection of neuronal networks, 
with cellular resolution, in behaving animals. This 
will be brought about via a closed-loop strategy involv-
ing real-time control of activity of select neurons with 
simultaneous monitoring of the concomitant effects 
of these manipulations on neuronal outputs within 
the circuit, and elsewhere in the brain. Briefl y, we 
are using digital holography methods via spatial light 
modulators to optogenetically control neurons of in-
terest at the single-cell level and DMD-based methods 
to control cell-type-specifi c populations across large 
brain regions (Fig. 6). This allows us to both replicate 
and systematically manipulate stimulus-evoked activ-
ity patterns in a circuit. We are simultaneously using 
two-photon calcium imaging and electrophysiology 
within the same and different brain regions (olfactory 
bulb vs. olfactory cortex) to dissect how the alteration 
of select circuit elements, or their specifi c properties, 
affects the output of the network. This closed-loop ap-
proach will make it possible to determine the spatio-
temporal integration rules within the bulb and the ol-
factory cortex, investigate the relevance of spike-time 
codes, and reveal underlying decoding schemes.
Other Collaborative Projects with 
CSHL Groups
We are collaborating with other fellow CSHL scien-
tists on the following projects: multisensory integra-
tion of olfactory and visual information in the mouse 
brain (A. Churchland); sequencing the OB—bridg-
ing the gap between glomerular odor responses and 
odor receptor sequences by identifying the molecular 
identity of glomeruli (A. Koulakov, G. Hannon, and 
A. Zador); a fi ber-optic-based approach to monitor 
neuronal activity in punishment and reward neu-
ronal circuits during behavior (B. Li) (we will focus 
on monitoring activity in the insula cortex and basal 
layer); developing light-sheet-based approaches for fast 
optical reconstruction of neuronal circuits (P. Osten); 
and optical monitoring and manipulation of neuronal 
activity in genetically and anatomically defi ned corti-
cal circuits in animal models of cognition (A. Zador).
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INVESTIGATING NEURAL CIRCUITS FOR SENSORY 
INTEGRATION AND DECISION-MAKING
A. Churchland A. Brown O. Odoemene
 M. Kaufman M. Ryan
 D. Nunes Raposo J. Sheppard
Making use of sensory information requires more 
than simply relaying incoming signals from the sen-
sory organs. It requires interpreting information, 
classifying it, drawing inferences, and ultimately 
using the context of behavioral goals to make a deci-
sion about its meaning. A decision is a commitment 
to a particular choice or proposition at the expense of 
competing alternatives. In some situations, decisions 
involve integration of evidence (i.e., they make use 
of multiple pieces of information from the environ-
ment or from memory). These decisions can provide a 
framework in which to investigate complex cognitive 
processes and open a window into higher brain func-
tion in general.
Although previous experiments have begun to re-
veal how neural systems combine evidence to make 
decisions, they have left a critical gap in our under-
standing. Specifi cally, very little is currently known 
about the neural mechanisms that make it possible to 
combine information from multiple sensory modali-
ties for decisions. The gap is apparent, although it is 
clear from behavioral observations that neural sys-
tems can combine multisensory information: When 
parsing speech in a crowded room, for example, the 
listener makes use of both auditory information 
(the speaker’s vocal sounds) and visual information 
(the speaker’s lip movements). Understanding the 
neural mechanisms of multisensory integration is crit-
ical for two reasons. First, it is essential for a complete 
understanding of sensory perception because real-
world stimuli rarely affect a single sense in isolation. 
Therefore, understanding how the brain  interprets 
incoming information requires understanding how 
the brain merges information from different senses. 
Second, it is likely of clinical importance that sev-
eral developmental abnormalities appear to be related 
to diffi culties in integrating sensory information. For 
example, abnormalities in multisensory processing 
are a hallmark of subjects with autism spectrum dis-
order. Impairments in multisensory processing are 
also observed in subjects with a collection of sen-
sory abnormalities known together as sensory pro-
cessing disorder and may also be evident in patients 
with Rett syndrome and dyslexia. Understanding 
the neural mechanisms of multisensory integration 
could inform treatment of those conditions. Our 
long-term goal is to understand how the brain can 
make decisions that integrate inputs from our mul-
tiple senses, stored memories, and innate impulses. 
Our projects in previous years constituted the very 
fi rst steps toward achieving this goal: We developed 
a multisensory behavior that could be carefully mea-
sured in both humans and rodents. A second publi-
cation about this foundational work was published 
this year (Sheppard et al. 2013a). In addition, we 
built on this foundation by measuring the responses 
of neurons in rodents engaged in the behavior, af-
fording insight into the neural circuits underlying 
multisensory  decisions.
The Role of Parietal Cortex in Multisensory 
Decision-Making
This work was done in collaboration with D. Raposo 
(Champalimaud Neuroscience Program, Lisbon, Portugal), 
M. Kaufman (Stanford University), and J. Sheppard 
(Watson School).
The goal of this project is to gain a deeper understand-
ing of the neural circuits that enable integration of vi-
sual and auditory inputs for decision-making. David 
Raposo has been a leader in the lab in two techniques 
this year: He measures electrophysiological responses 
from neurons in the posterior parietal cortex (PPC) 
of rats engaged in decision-making behavior. He pre-
sented this work at two conferences (Raposo et al. 
2013). In addition, he inactivated those same neu-
rons and measured the effect on behavior (Raposo 
and Churchland 2013). Matt Kaufman has worked 
alongside David to develop sophisticated analyses of 
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the data. John Sheppard has also contributed to the 
project by recording additional neurons that are in-
cluded in our growing population of cells. John, 
David, and Matt are working as a group; their main 
fi nding is that PPC neurons refl ect random combina-
tions of stimulus features, but they can be decoded at 
the population level to provide the animal with ongo-
ing estimates of incoming sensory stimuli. The three 
are working collectively to write up the exciting results 
from these experiments for publication.
Population Dynamics Across Cortex
This work was done in collaboration with M. Kaufman 
(Stanford University).
The goal of this project is to understand how popula-
tion activity changes from one neural structure to the 
next to support behavior. To tackle this question, Matt 
has brought a new technique to the lab: two-photon 
imaging. Using this technique, we can measure the 
responses of 80 to 100 neurons simultaneously. This 
approach will revolutionize the kinds of questions we 
can address about decision-making, especially when 
used in conjunctions with emerging mathematical 
techniques for analysis. We have benefi ted greatly in 
this project from technical support from the Albeanu 
lab, our neighbors in the Marks building, and valued 
collaborators.
Probabilistic Representation in the Brain: 
Insights about Neural Mechanisms That 
Allow Organisms to Cope with Stimulus 
Uncertainty
This work was done in collaboration with J. Sheppard 
(Watson School of Biological Sciences).
The goal of this project is to understand how the brain 
estimates the reliability of sensory stimuli and uses that 
estimate to guide decision-making. John published a 
paper on his behavioral data relevant to this question 
this year (Sheppard et al. 2013a), demonstrating to 
the fi eld that rats are capable of optimally weighting 
sensory information to guide behavior. John’s results 
were a surprise to many skeptics who doubted that ro-
dents were capable of such sophisticated behavior. He 
has also led the lab in using an optogenetic approach 
to understand how the posterior parietal cortex (PPC) 
drives behavior. He presented this work at the Society 
for Neuroscience Annual Meeting (Sheppard et al. 
2013b) and is continuing to collect data.
Decision-Making in Mice
This work was done in collaboration with O. Odoemene 
(Watson School of Biological Sciences).
We have developed a decision-making paradigm 
using mice that will allow us to take advantage of 
genetic tools. These tools will also allow us to probe 
the neural circuitry that underlies decision-making. 
In the past year, Onyekachi Odoemene has sought to 
establish which neural structures in mice are critical 
for  decision-making. He is using cutting-edge tech-
niques to inactivate different structures and examine 
the effect on behavior. By using different strains of 
transgenic mice, Odoemene is able to target particu-
lar cell types within each area and examine how they 
contribute to behavior. This project had benefi ted 
greatly from our collaborator Dr. Z. Josh Huang, who 
has provided us with materials for experiments, as 
well as invaluable advice on understanding inhibitory 
circuitry.
Bayesian Number Estimation
A. Brown
This project aims to understand whether humans use 
a probabilistic approach to number estimation, and 
it is part of an international collaboration with Dr. 
Alexandre Pouget (University of Geneva). This work 
challenges a long-standing assumption of human 
number estimation—that numbers are estimated as 
scalar quantities. Our experiments suggest that the 
assumption is not correct. Instead, humans appear to 
represent numbers probabilistically, and a signature 
of this representation is evident when they combine 
number estimates from two modalities. Amanda 
copresented this work at the Society for Neuroscience 
Annual Meeting (Kanitscheider et al. 2013), and we 
are writing up this work for publication now.
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MECHANISMS OF NEURODEGENERATION 
AND MEMORY FORMATION
J. Dubnau R. Borges Monroy W. Donovan L. Prazak
 N. Chatterjee L. Krug H. Qin
 M. Cressy W. Li M.-F. Shih
There are two main areas of research in my lab. First, 
we are using neurogenetic and genomics approaches 
to investigate a novel hypothesis to explain neurode-
generative disorders such as frontotemporal lobar de-
generation and amyotrophic lateral sclerosis. Second, 
we are investigating the genetic and neuronal mecha-
nisms of memory formation using Drosophila as a 
model system.
Impact of Retrotransposons on Aging 
and Neurodegeneration Underlying 
Frontotemporal Lobar Degeneration and 
Amyotrophic Lateral Sclerosis
R. Borges, N. Chatterjee, W. Donovan, L. Krug, L. Prazak, 
J. Dubnau [in collaboration with M. Hammell, Y. Jin, 
T. Zador, Cold Spring Harbor Laboratory]
Transposable elements (TEs) are mobile genetic ele-
ments that provide a massive reservoir of potential 
genetic instability and toxicity. We have advanced 
the novel hypothesis that deregulated TE/ERV (en-
dogenous retrovirus) expression may contribute to 
TDP-43-mediated neurodegenerative disorders (Li 
et al. 2013). We have found that TE transcripts are 
derepressed during the normal aging process and that 
this leads to active mobilization of transposons, re-
sulting in new insertions in the genome of neurons 
(Fig. 1). We used mutations in Drosophila Argonaute 
2 (dAgo2) to create a situation in which TEs are de-
repressed in the brain. Such mutants exhibit preco-
cious TE elevation in young animals and exacerbated 
age-dependent derepression. This is accompanied by 
rapid age-dependent memory impairment and short-
ened lifespan. These fi ndings support the hypothesis 
that protracted loss of TE silencing contributes to age-
dependent decline in neuronal physiological function.
To investigate the hypothesis that TE derepres-
sion contributes to neurodegenerative disorders, we 
focused (in collaboration with Molly Hammell and 
Ying Jin) on TDP-43, an RNA-binding  protein 
 involved in a broad spectrum of neurodegenerative 
 disorders including amyotrophic lateral sclerosis 
(ALS) and frontotemporal lobar degeneration (FTLD). 
By mining a series of deep sequencing data sets of 
protein–RNA interactions and of gene expression 
profi les, we uncovered broad and extensive binding 
of TE transcripts to TDP-43 (Li et al., PloS One 7: 
e44099 [2012]). We also fi nd that association be-
tween TDP-43 and many of its TE targets is reduced 
in FTLD patients (Fig. 2). Finally, we discovered 
that a large fraction of the TEs to which TDP-43 
binds become derepressed in mouse TDP-43 disease 
models. We propose the hypothesis that TE misregu-
lation contributes to TDP-43-related neurodegenera-
tive disease. Current efforts are focused on dissection 
of the underlying mechanisms of transposon control 
in the brain and the role of unregulated transposon 
expression in these disorders. Efforts involve work in 
Drosophila and mouse models of TDP-43 pathology, 
in human cell culture and in postmortem tissue from 
human subjects with FTLD or ALS.
Age-Dependent Memory Impairment 
and Retrotransposon Activation
L. Prazak
On the basis of our observation that certain retro-
transposons become highly active during normal 
brain aging, we are investigating the hypothesis that 
retrotransposon-generated DNA damage contributes 
to age-related memory impairment. Using the toolbox 
for genetic manipulations that are available in Drosoph-
ila, we are (1) investigating the normal mechanisms 
of retrotransposon silencing in the brain, (2) testing 
the impacts of age on these cellular mechanisms, and 
(3) testing whether retrotransposon activation has a 
causal role in age-related cognitive impairment.
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Neurogenetic Mechanisms of Olfactory 
Memory
L. Prazak, M.F. Shih
An understanding of memory, indeed of all behav-
ioral phenotypes, will require a multidisciplinary ap-
proach to forge conceptual links between the relevant 
genetic/cell signaling pathways and neural circuits. 
Work in genetic model systems such as Drosophila can 
contribute to our understanding in several ways. First, 
by enabling discovery of genes and genetic pathways 
underlying normal memory as well as pathological or 
degenerative cognitive disorders, model systems pro-
vide entry points for dissection of cellular mechanisms 
that are often conserved. Second, systematic manipu-
lation of gene function within relevant anatomical cir-
cuits allows a conceptual integration of fi ndings from 
cellular, neuroanatomical, and behavioral levels.
Figure 1.  “Gypsy-TRAP” reporter detects de novo integration in neurons in aged animals. (A,B) Illustration of the 
design of “gypsy-TRAP.” An ~500-bp fragment from the ovo regulatory region containing ﬁ ve Ovo-binding sites is 
inserted between the Tub promoter and GAL80 gene (A). A mutated “gypsy-TRAP” construct contains mutations 
that disrupt each of the ﬁ ve Ovo-binding sites. (B) In the absence of gypsy insertions, GAL80 expression suppresses 
GAL4, and UAS::mCD8::GFP expression does not occur. In the presence of gypsy integration into the “gypsy-TRAP,” 
GAL80 expression is blocked, and UAS::mCD8::GFP is turned on. (C) Approximately 800 MB Kenyon cell neurons 
per brain hemisphere are labeled by MB247-GAL4-driven UAS::mCD8::GFP. (D) An example brain from 2–4-day-old 
mutated “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. No green ﬂ uorescent protein (GFP)-labeled neurons were 
seen. (E) An example brain from ~28-day-old mutated “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. No GFP-la-
beled neurons were seen. (F) An example brain from ~2–4-day-old “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. 
No GFP-labeled neurons were seen. (G) Example brains from ~28-day-old “gypsy-TRAP”; UAS::mCD8::GFP/+; 
MB247/+. Several GFP-labeled MB neurons were seen in each brain.
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A MicroRNA–Dopamine Receptor Genetic 
Module in Distinct Neural Circuits for 
Olfactory Arousal and Olfactory Memory
W. Li, M. Cressy, H. Qin
microRNAs (miRNAs) are ~21–23 nucleotide-non-
coding RNA transcripts that regulate gene expres-
sion at the posttranscriptional level. miRNAs regu-
late gene expression by binding to complementary 
sequences in the 3′-untranslated regions of target 
mRNAs. A growing number of studies demon-
strate that miRNA biogenesis and function, broadly 
speaking, are important for virtually all aspects of 
cell function, including neuronal function. But there 
still are relatively few examples where individual 
miRNA genes have been shown to function acutely 
in the brain in the context of behavior. We have dem-
onstrated that miR276a expression is required acute-
ly in the Drosophila melanogaster brain within two 
different neural cell types (Li et al. 2013b). In both 
circuits, the miR appears to target a DA1-type do-
pamine receptor, but the circuits subserve different 
aspects of olfactory behavior. This miR276a–dopa-
mine receptor interaction is required in mushroom 
body neurons to support long-term olfactory mem-
ory and in ellipsoid body R4 neurons in the central 
complex to modulate olfactory arousal. This may 
reveal a conserved functional dissection of memory 
and arousal in the mushroom body (MB) and central 
complex.
Figure 2.  TDP-43 binding to TEs is selectively lost in FTLD patients. (A) In the human CLIP-Seq data from FTLD ver-
sus healthy control, 38 repeat elements showed signiﬁ cant (p-value ≤ 1e-5 and fold changes ≥ 2) differential binding. 
Log2-fold binding differences are shown for signiﬁ cantly enriched/depleted elements. (B,C,D) Peaks are shown in 
genome browser for one RefGene control (B) and two differentially targeted TEs (C,D) in healthy (top) versus FTLD 
(bottom).
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Cell-Type-Speciﬁ c Expression Proﬁ ling 
to Identify Memory-Related Targets 
of miR276a
M.F. Shih
We have demonstrated a role for a miRNA gene, 
 miR276a, in olfactory memory in Drosophila. Our 
fi ndings implicate this miRNA in two different neu-
ronal cell types (mushroom body Kenyon cells and a 
subset of the so-called ellipsoid body neurons). We are 
using methods for cell-type-specifi c expression profi l-
ing to identify the relevant targets of miR276a within 
each of these neuronal cell types.
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STEM CELLS, SIGNAL TRANSDUCTION, AND BRAIN FUNCTION
G. Enikolopov Z. Glass T. Michurina J.-H. Park O. Podgorny
 R. Makayus O. Mineyeva N. Peunova
Our main focus is on stem cells of the adult organism. 
Our research aims to identify stem cells in different 
tissues, understand the molecular logic of their main-
tenance and differentiation, and apply this knowledge 
for human therapy. Our main approach is generating 
animal models that would allow visualization of stem 
cells and their environment and monitoring changes 
in their signaling landscape. Although most of our 
work is related to adult neural stem cells, we are also 
investigating stem cells and regulatory signals in non-
neural tissues, particularly those that are involved in 
complex physiological circuits of the organism.
Neural Stem Cells, Aging, and Brain 
Disorders
The key focus of our group is on adult neurogenesis, 
maintenance of adult neural stem cells, and signals 
that control them. Emerging evidence indicates that 
adult neurogenesis is important for behavior, patho-
physiology, aging, and neural tissue repair; there-
fore, a clear understanding of the rules that govern 
the maintenance, division, and differentiation of 
adult neural stem cells may have direct implications 
for human aging, disease, and therapy. We recently 
showed that age-related decrease in hippocampal neu-
rogenesis under normal conditions is driven by the 
disappearance of neural stem cells via their conversion 
into mature hippocampal astrocytes. We described 
the life cycle of an adult neural stem cell and proposed 
a “disposable stem cell” model which posits that an 
adult hippocampal stem cell is quiescent throughout 
the entire postnatal life, but, when activated, it un-
dergoes several rapid asymmetric divisions (eventu-
ally producing a neuron) and then exits the pool of 
stem cells by converting into an astrocyte. Our model 
reconciles observations on the age-related decrease in 
new neurons and age-related increase in astrocytes, the 
disappearance of hippocampal neural stem cells, and 
the remodeling of the neurogenic niche. These con-
tinuous changes underlie age-dependent diminished 
production of new neurons and may contribute to age-
related cognitive impairment.
We also used our reporter lines and our model to 
determine the classes of stem and progenitor cells in 
the hippocampus that are affected by various pro- and 
antineurogenic factors and stimuli. This included fac-
tors that increase hippocampal neurogenesis, such as 
SSRI and SNRI (selective serotonin and norepineph-
rine reuptake inhibitors) antidepressants, electrocon-
vulsive shock, deep brain stimulation of the anterior 
thalamic nucleus and cingulate gyrus, and physical 
exercise. Our model of adult hippocampal neurogen-
esis predicts that specifi c treatments may accelerate 
production of new neurons by various means (e.g., via 
increased division of stem cell progeny, increased sym-
metric or asymmetric division of stem cells, increased 
recruitment of quiescent stem cells, or suppression of 
cell death) and that each mode of augmented produc-
tion of new neurons may have different effects on the 
pool of stem cells. Indeed, we found examples of each 
of the different modes of activation of neurogenesis 
in response to specifi c stimuli (so far, except for sym-
metric division of stem cells). Importantly, we found 
examples of increased recruitment of normally quies-
cent stem cells in division induced by a widely used 
therapeutic drug; accompanied by astrocytic differen-
tiation, such recruitment would lead to an increased 
number of new neurons but at the expense of prema-
ture exhaustion of the stem cell pool. In contrast, we 
found that electroconvulsive shock increases the num-
ber of asymmetric divisions of stem cells without re-
cruiting additional stem cells, therefore leading to an 
increased number of new neurons without additional 
loss of stem cells. Thus, these experimental studies 
of adult neurogenesis may have direct relevance to 
human therapy.
Much of our interest is related to the effect of aging 
on stem cells. Lifespan of a diverse range of species 
can be signifi cantly extended by restricting the calorie 
intake or by treatment with the mTOR (mammalian 
target of rapamycin) pathway inhibitor rapamycin. 
Both calorie restriction (CR) and rapamycin have also 
107-169_Neurosci.indb   129 8/28/2014   10:39:01 AM
130  Research
been shown to affect adult neurogenesis. These treat-
ments are usually applied for a limited period of time, 
and it is not clear whether prolonged treatment with 
CR or rapamycin has similar benefi ts and whether 
such benefi ts are observed in old animals. It is also 
not clear which specifi c subclasses of neural stem and 
progenitor cells and which steps of the neuronal dif-
ferentiation cascade are targeted by CR or rapamycin. 
We used our reporter mouse lines to investigate the 
effects of CR and rapamycin on hippocampal stem 
and progenitor cells in aging animals and found that 
prolonged (12- or 18-mo) exposure of animals to CR 
(but not to rapamycin) alleviates age-related decrease 
in neural progenitor cell division in the aging brain; 
the increase in the number of dividing cells was par-
ticularly evident in the hippocampus of female mice. 
Our results indicate that the majority of the dividing 
cells correspond to neural stem and progenitor cells 
and that CR may increase the number of divisions 
that neural stem and progenitor cells undergo in the 
aging brain of female animals.
Much of our effort is related to developing new 
methods to study adult neurogenesis. One such proj-
ect concerns three-dimensional representation of 
neural stem cells in the adult brain. There have been 
several attempts to obtain a three-dimensional repre-
sentation of the stem cell compartments in the adult 
brain; however, they were either too labor-intensive 
or imprecise. We have applied a new method of serial 
two-photon tomography to our reporter mouse lines 
to produce a quantitative three-dimensional atlas of 
stem and progenitor cells in the adult brain (in col-
laboration with Dr. Pavel Osten, CSHL). The result-
ing image shows active stem and progenitor cells, as 
well as cells with stem cell potential, in the regions 
of robust neurogenesis, the circumventricular organs, 
and the central canal; importantly, such imaging is 
quantitative by the nature of the technique. This ap-
proach may become a powerful tool to analyze stem 
cells upon aging, in behavioral paradigms, or in the 
context of disease.
Another project concerns triple S-phase labeling to 
increase the resolution of the cell cycle analysis. La-
beling cells undergoing the S phase of the cell cycle 
with a nucleotide analogue, such as bromodeoxyuri-
dine (BrdU) or ethyldeoxyuridine (EdU), became 
the main approach to analyze cell division, stem cell 
division in particular. This method has been greatly 
improved by the ability to double-label the S phase 
using pairs of modifi ed nucleotides, e.g., chlorodeoxy-
uridine (CldU) and iododeoxyuridine (IdU) or BrdU 
and EdU. We have now developed a new method for 
labeling dividing stem and progenitor cells, based on 
sequential labeling with three different nucleotide 
analogues on the background of green fl uorescent 
protein (GFP)-labeled cells (i.e., quadruple labeling). 
Our method allows a qualitatively new level of resolu-
tion of cell division kinetics: tracing of multiple cell 
populations in a normal, transformed, damaged, or 
regenerating tissue and tracing of progeny of multiple 
stem and progenitor cell subpopulations. We are cur-
rently applying this new approach to determine the 
changes in neural stem cell maintenance, division, 
and differentiation in the aging hippocampus and in 
response to drugs.
We also continue our collaboration with Dr. He-
lene Benveniste (Stony Brook University) on meta-
bolic profi ling of dividing cells in the live rodent 
brain using proton magnetic resonance spectroscopy. 
We apply a widely used spectral fi tting algorithm 
 (LCModel) to characterize the effect of increased pro-
genitor cell division in the model of electroconvulsive 
therapy and in a mouse model of glioblastoma. Our 
results indicate that this method can detect character-
istic lipid signatures at high concentrations of dividing 
neural progenitor-like cells in live animals.
Stem Cells in Nonneural Tissues
Much of our effort is based on using engineered re-
porter mouse lines to visualize, track, and isolate stem 
cells. We originated this approach more than 15 years 
ago, and some of our reporter lines (e.g., Nestin-GFP 
mice) became popular and useful genetic tools used 
by many laboratories to study stem cells. Although 
these lines were originally designed to identify stem 
cells in the nervous system, we soon found that the 
same reporter lines highlight stem and progenitor cells 
in a range of other tissues. These tissues are as diverse 
as anterior pituitary, skeletal muscle, testis, hair fol-
licles, liver, pancreas, and bone marrow.
We have been expanding on the reporter approach 
by generating double- and triple-reporter lines, based 
on various regulatory elements, including those that 
use pro moters of Sox2, Gli1, or Lgr5 genes (e.g., Sox2-
GFP/Nestin-mCherry or Lgr5-mCherry/Nestin-GFP). 
Using this approach, we discovered a new population 
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of stem cells in the ovary that normally act to repair 
the epithelial surface of the ovary but that can be eas-
ily transformed and become cells of origin of ovarian 
tumors (a collaboration with Dr. Alex Nikitin from 
Cornell University). When an oocyte leaves the ovary 
during ovulation, the ovarian surface epithelium is 
ruptured and has to be repaired. We found a small 
population of epithelial cells in the mouse ovary that 
have the main characteristics of stem cells: They ex-
press several characteristic markers of stem cells, they 
are mainly quiescent, and their progeny can differen-
tiate and repair the surface epithelium after the oocyte 
exits. These stem cells show increased propensity to 
be transformed after inactivation of tumor suppressor 
genes p53 and Rb1, whose pathways are altered fre-
quently in the most aggressive and common type of 
human ovarian cancer, high-grade serous adenocarci-
noma. Thus, we found a new type of stem cells and 
extended support for the often discussed notion that 
susceptibility of transitional zones between different 
types of epithelia (of which the epithelial cells of the 
ovarian hilum are an example) to malignant transfor-
mation may be explained by the presence of stem cell 
niches in those areas.
Signaling in the Stem Cell Niche
One of the our new directions is elucidating the sig-
naling landscape of the neurogenic regions in the 
adult brain. Our current focus is on redox signaling, 
which emerges as an important regulator of stem cell 
maintenance. The changes in the redox status and 
production of reactive oxygen and nitrogen species 
(ROS) change the proliferation and differentiation of 
various classes of stem and progenitor cells, including 
neural cells. Aging correlates with increased produc-
tion of ROS, and this increase may be crucial for vari-
ous manifestation of aging. We develop genetically 
encoded sensors that report different aspects of redox 
signaling and apply them to visualize signaling pro-
cesses in and around aging neural stem cells and their 
subcellular compartments, with a larger goal of tying 
these processes to normal aging or disease (much of 
this work is carried out in collaboration with Dr. 
Vsevolod Belousov, a Visiting Scientist in the group). 
Among other results, we have (1) generated and vali-
dated a new sensor for imaging changes in the NAD+/
NADH ratio in various cellular compartments (e.g., 
mitochondria); (2) developed a method for controlled 
production of ROS in mammalian cells and parallel 
measuring the levels of produced ROS and demon-
strated that the effi ciency of redox-sensitive oxidation 
of cysteine residues depends on the proximity to the 
source of H2O2; and (3) generated and validated a red 
recombinant redox sensor. We are now working on ex-
panding the panel of sensors and reporters for parallel 
visualization of multiple signaling events controlling 
the stem cell niche.
NO, Development, and Differentiation
During the last decade, we discovered an essential role 
of nitric oxide (NO) in development and in stem cell 
regulation. We continue to uncover the diversity of 
biological functions mediated by NO. For instance, 
we found that NO is an important mediator of activi-
ty-dependent neuronal development in the hippocam-
pus, promoting local activity-dependent spine growth 
(collaboration with Dr. Dominique Muller, Univer-
sity of Geneva). Ablation of activity of neuronal NO 
synthase (NOS) interferes with the development of 
excitatory synapses and prevents structural adaptation 
of hippocampal excitatory synapses to environmental 
enrichment.
We found yet another important function of NO: 
its critical role in the multiciliated cells of the mu-
cociliary epithelium. Cilia of these cells beat in con-
cert to generate directed fl ow of fl uid across tissue; 
in the trachea and bronchi, this fl ow helps to clear 
pathogens, foreign particles, and toxic chemicals 
from the airways. We found that this role of NO is 
conserved, and its basic features are highly similar 
in such diverse settings as skin of the frog embryo 
and mammalian airways. We identifi ed distinct NO- 
dependent signaling pathways that control the cilia 
distribution, cilia polarity, and cilia length. Our re-
sults suggest that some of the inborn and acquired 
human ciliopathies and related disorders may also be 
associated with inadequate activity of NOS and de-
creased availability of NO and may thus benefi t from 
NO-based therapies.
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MOLECULAR ANALYSIS OF NEURONAL RECEPTORS 
AND ION CHANNELS
H. Furukawa E. Karakas N. Simorowski
 T. Malinauskas N. Tajima
 A. Romero Hernandez 
The research program in our lab attempts to under-
stand the molecular basis of the functions of the cell 
surface receptors or membrane proteins that initiate 
cellular signal transductions involved in neurotrans-
mission in the mammalian brain, in order to develop 
compounds with therapeutic value for treating neuro-
logical diseases and disorders including schizophrenia, 
depression, stroke, and Alzheimer’s disease. Toward 
this end, we are conducting structural and functional 
studies on ion channels that control intracellular cal-
cium signaling upon stimulation by voltage and/or 
neurotransmitters. These ion channels regulate the 
strength of neurotransmission, the fundamental pro-
cess whereby multiple neurons communicate with one 
another. Dysfunction of the ion channel studied in 
our group is strongly implicated in neurotoxicity that 
results in various neurological disorders and diseases 
described above. To achieve our goals, we use X-ray 
crystallography to determine three-dimensional atomic 
structures of target proteins and test structure-based 
mechanistic hypotheses by site-directed mutagenesis 
in combination with biochemical and biophysical tech-
niques. The main accomplishment in 2013 was the 
completion of high-resolution structures of the ligand-
binding domain (LBD) of a ligand-gated ion channel, 
N-methyl-d-aspartate receptor (NMDAR) in complex 
with antagonists and validation of the crystal structures 
by electrophysiological techniques. The crystal struc-
ture shows the overall change in protein conformation 
within LBD upon binding to two types of antagonists 
compared to the agonist-bound form. The electrophysi-
ological experiments pinpointed elements possibly re-
sponsible for subtype-specifi c inhibition of NMDARs.
Structural Studies on the Ligand Binding 
Domain of NMDAR
NMDARs belong to the family of ionotropic gluta-
mate receptors (iGluRs) that mediate the majority 
of excitatory synaptic transmissions in the mam-
malian brain. They are voltage-sensitive calcium 
ion channels composed mainly of two copies each 
of the GluN1 and GluN2 subunits, which bind gly-
cine and glutamate, respectively. The calcium sig-
nals triggered by NMDARs facilitate cellular signal 
transduction, resulting in neuroplasticity essential 
for learning and memory formation. Dysfunctional 
NMDARs are implicated in various neurological 
disorders and diseases. For example, hypofunction of 
NMDAR is a well-known paradigm for schizophre-
nia. Overactivation of NMDARs causes depression 
and neurodegenerative responses associated with Al-
zheimer’s disease and stroke-induced ischemic inju-
ries. The four distinct GluN2 subunits (A–D) con-
trol the pharmacological properties of the NMDAR 
ion channels and show different spatial and tempo-
ral expression patterns; thus, there has been great 
interest in creating subtype-specifi c compounds that 
can target specifi c neuronal circuits. The NMDAR 
subunits are modular and are composed of distinct 
protein domains including the amino-terminal do-
main (ATD), ligand-binding domain (LBD), trans-
membrane domain (TMD), and carboxy-terminal 
domain (CTD) (Fig. 1). Our group has obtained the 
fi rst crystal structures of GluN1/GluN2 ATD and 
LBD and provided the fi eld with important struc-
tural insights into how subunits may be arranged 
in those domains in the context of the tetrameric 
NMDAR ion channels. However, there has not been 
any detailed information on the binding modes of 
various inhibitors and competitive antagonists. In 
2013, we completed structure/function studies on 
competitive antagonism on NMDARs mediated by 
LBD.
Structural information on the antagonist-bound 
form of NMDAR has thus far been restricted to 
that of GluN1 LBD. Thus, despite the historical 
importance, the molecular mechanism underly-
ing inhibition of NMDARs by D-AP5 at GluN2 
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LBD has remained enigmatic. Furthermore, how 
the phenanthrene-based compounds such as PPDA, 
with a chemical structure highly distinct from that 
of D-AP5, can function as an antagonist has been 
a mystery (Fig. 1). These questions have been dif-
fi cult to answer because of the technical diffi culties 
associated with crystallization of the antagonist-
bound GluN2 subunit. We overcame this techni-
cal barrier by developing a crystallographic method 
that involved soaking, which resulted in two crystal 
structures bound to (1) glycine and D-AP5 and (2) 
glycine and PPDA.
The study shows that D-AP5 and PPDA bind to 
the ligand-binding site within the GluN2A LBD in 
distinct modes and result in “opening” of the bilobed 
LBD structure to different extents (Fig. 2). Addition-
ally, the study demonstrated that the phenanthrene 
ring of PPDA forming van der Waals interactions with 
the hydrophobic pocket and sulfur–aromatic interac-
tion with a methionine residue present in GluN2B-D 
in Site-II is responsible for the moderate subtype spec-
ifi city within NMDARs. The work also established 
an effective method for obtaining crystals that permit 
visualization of antagonist-bound GluN1/GluN2A 
LBD structures at high resolution.
Validating Binding Modes of Antagonists
Inspection of the ligand-binding site shows distinct 
binding modes between D-AP5 and (-)-PPDA involv-
ing different residues in the GluN2A ligand-binding 
site. To validate the physiological relevance of this 
structural observation and to further understand the 
chemical nature of the ligand-binding site, we carried 
out mutational analysis of residues involved in an-
tagonist binding by measuring current inhibition via 
two-electrode voltage clamp (TEVC). The normalized 
potencies of D-AP5 and (-)-PPDA were calculated 
by determining EC50 values of l-glutamate and IC50 
values for D-AP5 and (-)-PPDA at fi xed l-glutamate 
concentrations, and by converting EC50 and IC50 into 
Ki values using the Cheng–Prusoff equation for every 
Figure 1. NMDAR subunit organization and ligands. NMDAR 
subunits are modular protein composed of an amino-terminal 
domain (ATD), a ligand-binding domain (LBD), a transmembrane 
domain (TMD), and a cytosolic domain (CTD). The domains are 
oriented such that the amino terminus (NT) and the carboxyl ter-
minus (CT) are located at the extracellular and cytoplasmic re-
gions, respectively. LBDs from GluN1 and GluN2A are isolated 
(scissors) by tethering two peptide fragments between TMD M1 
and M3 by a Gly-Thr dipeptide linker (dashed line). (B) Ligands 
for GluN2 subunits. L-glutamate and NMDA bind GluN2 LBD. 
(2R)-amino-5-phosphonovaleric acid (D-AP5) and 1-(phenan-
threne-2-carbonyl )piperazine-2,3-dicarboxylic acid (PPDA) with 
distinct chemical structures both act as competitive antagonists 
at the GluN2 LBD.
Figure 2. Crystal structures of GluN1/GluN2A LBD in complex 
with GluN2-antagonists. The GluN1 and GluN2A LBDs form 
physiological heterodimers in the crystal. Each subunit has bi-
lobed structures composed of upper (D1) and lower (D2) do-
mains. Ligands such as D-AP5 (A) and PPDA (B) bind at the inter-
cleft between D1 and D2. Stereoview of the binding sites for 
D-AP5 (C) and PPDA (D). (Right panel) Fo-Fc electron density 
contoured at 4σ. LIG-PLOT presentation of the binding residues 
for D-AP5 (E) and PPDA (F). The antagonist binding sites are 
composed of two subsites called Site-I and Site-II.
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mutant tested (Fig. 3). Mutational analysis indeed 
verifi ed the involvement of distinct residues in binding 
of D-AP5 and (-)-PPDA and thus validates the physi-
ological relevance of the crystal structures obtained 
in our current study. In general, mutation of residues 
surrounding the phenanthrene rings of (-)-PPDA 
(Fig. 2 in Site-II) affects the potency of (-)-PPDA with 
little or no effect on the potency of D-AP5. Among 
these mutations, GluN2A Val734Ala, Tyr737Ala, 
and Lys738Met have signifi cant effects on (-)-PPDA 
potency but only minor effects on D-AP5 potency 
(Fig. 3). An intriguing observation is that although 
 Val734Ala and Tyr737Ala both decrease (-)-PPDA 
sensitivity by reduction of van der Waals interaction 
with the phenanthrene ring, Lys738Met increases 
(-)-PPDA sensitivity by strengthening the interaction 
(likely via aromatic–sulfur interaction). Among all the 
GluN2 subunits, GluN2A is the only one with lysine 
at the 738 position, whereas the other three subunits 
(GluN2B-D) contain methionine at the equivalent po-
sition. GluN1/GluN2A NMDAR is the subtype that 
is consistently least sensitive to (-)-PPDA. Based on the 
structural observation above, we propose that the pref-
erential binding of (-)-PPDA toward GluN2B/C/D 
over GluN2A-containing NMDARs derives from dif-
ferent modes of interaction with the phenanthrene ring 
at the 738 position. Mutations on the other residues 
surrounding the phenanthrene ring, Phe416Ala and 
Val713Ala, have minor effects on sensitivity to both 
(-)-PPDA and D-AP5, consistent with the structural 
observation that those residues are farther away from 
the phenanthrene ring compared to Val734, Tyr737, or 
Lys738 and, therefore, not at the ideal position to form 
a strong van der Waals interaction. Tyr730 partici-
pates in binding of D-AP5 through polar interaction 
with the phosphono group and, to a minor extent, of 
(-)-PPDA through Van der Waals interaction with the 
piperazine ring. The Tyr730Phe mutation results in a 
fi vefold decrease in sensitivity of D-AP5 by reduction 
in the number of polar interactions, whereas it results 
in an increase in (-)-PPDA sensitivity—likely by the 
strengthening of hydrophobic interactions due to the 
absence of the hydroxyl group (Fig. 3).
Binding Speciﬁ city between NMDARs 
and Non-NMDARs
Specifi c inhibition of NMDA-induced currents by 
antagonists was crucial to confi rm the existence of 
the iGluRs. D-AP5 was one of the fi rst antagonists 
discovered to specifi cally inhibit the NMDA-in-
duced current, whereas (-)-PPDA was later reported 
to inhibit NMDARs with subtype specifi city toward 
GluN2C/GluN2D-containing NMDARs. Structural 
comparisons between GluN1/GluN2A LBD and 
non-NMDAR LBDs show elements that may have a 
role in distinguishing NMDARs and non-NMDARs 
such as AMPA (α-amino-3-hydroxy-5-methyl-4-is-
o xazole propionic acid) and kainate receptors. The 
residues from D1 in direct contact with or in vicin-
ity of D-AP5 are mostly conserved in non-NMDARs 
except that the equivalent residue to GluN2A His484 
is tyrosine in AMPA and kainate receptors (Fig. 4). 
As described above, direct and indirect polar interac-
tions in D2 are mediated by side chains of Ser689, 
Thr690, and Tyr730, and nitrogen and oxygen atoms 
from the main chain. Although GluN2A Ser689 
and Thr690 are conserved in all of the l-glutamate-
binding subunits in iGluRs, Tyr730 is unique to the 
GluN2 subunits in NMDAR family (Fig. 4). The 
equivalent residues of GluN2A Tyr730 are GluA2 
Leu704 and GluK1 Met722, which cannot form 
direct polar interaction or “cap” the binding site as 
GluN2A Tyr730 does. Consistent with the structural 
and primary sequence analyses, mutating GluN2A 
Tyr730 to leucine or methionine dramatically reduces 
D-AP5 sensitivity (~20-fold and ~80-fold increase in 
Ki values in Tyr730Leu and Tyr730Met, respectively), 
although it causes little or no change in sensitivity to 
(-)-PPDA. However, mutating GluA2 Leu704 and 
GluK1 Met722 to tyrosine does not confer sensitivity 
Figure 3. Site-directed mutagenesis of the antagonist binding 
sites. Residues in Site-I and Site-II (Fig. 2) are mutated in the 
context of the full-length GluN1/GluN2A NMDARs, expressed 
in Xenopus oocytes, and analyzed for potency. Ki values are cal-
culated based on the EC50 values for glutamate and IC50 values 
for antagonists.
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to D-AP5 in these non-NMDARs, indicating that 
specifi c binding of D-AP5 to NMDARs is not deter-
mined solely by the tyrosine residue in the binding 
pocket (data not shown). Overall, Tyr730 is a critical 
factor, but not the only one that facilitates specifi c in-
hibition of NMDAR by D-AP5.
Contrary to D-AP5, structural comparison be-
tween GluN1/GluN2A LBD and GluA2 or GluK1 
LBD shows no apparent molecular feature that may 
interfere with binding of (-)-PPDA in non-NMDARs, 
but instead, it indicates a possibility that (-)-PPDA 
binding will occur (Fig. 4). To validate this struc-
tural observation, we assessed the inhibition pattern 
of (-)-PPDA on l-glutamate-induced currents pro-
duced by non-desensitizing mutants of GluA2 Leu-
483Tyr fl ip (Stern-Bach et al., [1998]) and GluK1 
Tyr506Cys Leu768Cys (Weston et al., [2006]) using 
TEVC. The application of 100 μm (-)-PPDA in the 
presence of agonists completely inhibited not only 
GluN1/GluN2A NMDARs, but also GluA2 AMPA 
receptors, and GluK1 kainate receptors (Fig. 4). In-
deed, both GluA2 and GluK1 respond to (-)-PPDA 
with Ki values of 7.85 μm and 1.17 μm, respectively, 
which are comparable to Ki of 0.82 μm in GluN1/
GluN2A receptors. These results are consistent with 
the recent report that some piperazine-2,3-dicar-
boxylate derivatives can act on both kainate and 
NMDARs. The current study clearly shows that (-)-
PPDA is a general antagonist that acts on all of the 
l-glutamate-binding iGluR subunits. Unlike PPDA, 
D-AP5 has no effect on non-NMDARs in similar 
experiments. This indicates that the interaction be-
tween the phosphono group of D-AP5 and Site-I 
is the crucial determinant for NMDAR specifi city 
over non-NMDARs. Although Site-II does not de-
fi ne NMDAR specifi city, it distinguishes different 
subtypes within the NMDAR families (e.g., GluN1/
GluN2A vs. GluN1/GluN2D). Thus, a compound 
that interacts with both Site-I and Site-II would 
be a good lead for development of subtype-specifi c 
antagonists.
Overall, our work shows the detailed molecular 
mechanism of antagonist binding in NMDARs and 
suggests a strategy to develop compounds specifi c for 
GluN1/GluN2A subtypes. There has been enthusi-
asm for such compounds in recent years because of 
the involvement of GluN1/GluN2A NMDARs in 
neuropathic pains, fear, and early onset epileptic en-
cephalopathy.
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Figure 4. PPDA is capable of recognizing both NMDARs and 
non-NMDARs. The structural comparison between the GluN1/
GluN2A LBD with AMPA receptor (A) or kainate receptor (B) im-
plicates possible binding of PPDA. Electrophysiological record-
ings show that every subfamily member of ionotropic glutamate 
receptors is inhibited by PPDA. Shown here are recordings done 
in the presence of saturating glycine and glutamate. The current 
is inhibited by 100 μM of PPDA.
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ASSEMBLY AND FUNCTION OF NEURAL CIRCUITS 
IN THE NEOCORTEX
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 D. Huilgol J. Levine P. Wu
 S. Kelly J. Lu 
We aim to understand the developmental assembly 
and functional organization of neural circuits in the 
cerebral cortex. We have pioneered the use of mouse 
engineering toward a genetic dissection of GABA-
ergic inhibitory circuitry in the neocortex. In the 
past year, we extended this effort to targeting dis-
tinct classes of excitatory glutamatergic pyramidal 
neurons. Genetic targeting of distinct neuron types 
establishes entry points for studying cortical circuits 
and builds a solid middle ground that coherently 
connects to system neuroscience, on the one hand, 
and molecular and developmental neuroscience, on 
the other hand. In addition, we have been develop-
ing strategies for cell-type-based genomic analysis 
in brain tissues. Our goal is to discover the genetic 
principles underlying the assembly and organization 
of cortical circuits and provide insight into how al-
tered development of these circuits contributes to 
mental disorders.
Genetic Targeting of Pyramidal Neuron 
Subtypes in the Mouse Neocortex
A key obstacle to studying the development, orga-
nization, and function of neural circuits in the cere-
bral cortex is the stunning diversity of neuron types 
and a lack of comprehensive knowledge about their 
basic biology. The problem of neuronal diversity and 
identity in the cortex is fundamental, transcending 
developmental and systems neuroscience, and lies at 
the heart of defi ning the biology of cognition and 
psychiatric disorders. Glutamatergic pyramidal neu-
rons (PyNs) constitute ~80% of cortical neurons, 
are endowed with large capacity for information 
coding, storage, and plasticity, and carry the out-
put of cortical computation. PyNs consist of diverse 
subtypes based on their specifi c laminar locations, 
axonal projection patterns, and gene expression 
profi les. Subsets of PyNs form multiple and hierar-
chical subnetworks of information processing, with 
distinct output channels to cortical and subcortical 
targets that subserve sensory, motor, cognitive, and 
emotional functions. Importantly, PyN subtypes 
are differentially affected in various neuropsychiat-
ric and neurodegenerative disorders. However, the 
serious lack of specifi c and effective genetic tools 
for studying PyNs has hampered progress in under-
standing cortical circuits. We have begun to build a 
comprehensive genetic tool set for major PyN sub-
types in the mouse through a joint project led by my 
laboratory and Dr. Paola Arlotta at Harvard Univer-
sity, with key collaboration from Dr. Hongkui Zeng 
at the Allen Institute for Brain Science. We have dis-
covered a set of specifi c and combinatorial markers 
that distinguish major PyN subtypes. We are using 
intersection, subtraction, and inducible strategies to 
target PyN subtypes.
The Progenitor Origin of Chandelier Cells
Diverse GABAergic interneurons regulate the func-
tional organization of cortical circuits and derive from 
multiple embryonic sources. It remains unclear to 
what extent embryonic origin infl uences interneuron 
specifi cation and cortical integration due to diffi cul-
ties in tracking defi ned cell types. Using genetic fate 
mapping, we followed the developmental trajectory of 
chandelier cells (ChCs), the most distinct interneu-
rons that innervate the axon initial segment of pyra-
midal neurons and control action potential initiation. 
A single ChC innervates hundreds of pyramidal neu-
rons and might exert decisive infl uence on their fi ring, 
but the developmental origin and cortical organiza-
tion of ChCs have been unclear. We recently discov-
ered that the specifi cation of ChC identity is medi-
ated through lineage and birth timing mechanisms in 
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the embryonic subpallium, and young ChCs navigate 
over long distances with stereotyped route and sched-
ule to achieve characteristic laminar and areal distri-
bution in the cortex by the end of fi rst postnatal week. 
The developmental specifi cation of this bona fi de in-
terneuron type likely contributes to the assembly of a 
cortical circuit motif. We have been using combinato-
rial genetic fate mapping to explore whether there are 
designated ChC progenitor pools that give rise to this 
distinct cell type.
Distinct DNA Methylation Signatures in 
Glutamatergic and GABAergic Neurons 
of the Cerebral Cortex
Epigenetic regulation at 5-methylcytosine (5mC) in 
the mammalian genome is essential for numerous 
biological processes, including brain development, 
function, and plasticity. A key obstacle in genomic 
and epigenomic analysis of the brain is cellular het-
erogeneity—genomes of distinct yet highly intermin-
gled cell types are largely inaccessible to sequencing 
technology. To address this issue, we have developed 
an integrated genetic targeting and molecular tag-
ging system that establishes “genetic access” to the 
methylomes and transcriptomes of specifi c cell types. 
This is achieved by cell-type-specifi c expression of an 
epitope-tagged histone protein (H2B-GFP fusion pro-
tein) through mouse engineering. Using fl uorescence-
assisted cell sorting (FACS) of dissociated cortices and 
whole-genome bisulfi te sequencing, we have analyzed 
the DNA methylomes of two cardinal neuron types, 
the glutamatergic and GABAergic neurons. In col-
laboration with the Michael Wigler lab, we achieved 
10× whole-genome coverage per cell type, allowing us 
to interrogate ~90% of the CpG sites in the mouse 
genome. These results identify extensive genome-wide 
methylation differences in two cardinal neuron types 
in the postnatal cortex. Furthermore, we have demon-
strated, to our knowledge for the fi rst time, develop-
mental dynamics in methylation in a defi ned cell type 
during cortical maturation.
Our approach establishes a cell-type-based experi-
mental paradigm for epigenomic analysis in complex 
tissues and sets the stage for analysis of neuronal sub-
types during both brain development and behavioral 
plasticity.
MeCP2 Regulates the Maturation of GABA 
Signaling and Critical Period Plasticity 
That Shape Experience-Dependent 
Functional Connectivity in the Primary 
Visual Cortex
A major challenge is to explain the cellular, devel-
opmental, and neural circuitry mechanisms that 
link gene mutations to functional and behavioral 
defi cits. Rett syndrome (RTT) in several ways epit-
omizes this challenge: RTT is caused by mutations 
in the MeCP2 gene that encodes a broadly expressed 
chromatin and transcription regulatory protein, 
and yet it is characterized by postnatal language 
and cognitive defi cits, stereotyped behaviors, and a 
myriad of sensory and neurological symptoms. Al-
though numerous mouse models of RTT have been 
established, it has been diffi cult to identify primary 
molecular and cellular changes and trace their im-
pact on circuit alterations that underlie behavior-
al defi cits. Using MeCP2-null mice, we examined 
 experience-dependent development of neural cir cuits 
in the primary visual cortex where GABA ergic inter-
neurons regulate a critical period of plasticity. The 
functional maturation of parvalbumin interneurons 
was accelerated upon vision onset, as indicated by 
the elevated GABA synthetic enzyme GAD67 and 
perineuronal net formation. These are correlated 
with an early enhancement of GABA transmission 
within the parvalbumin interneuron network and 
an accelerated maturation of cortical activity propa-
gation patterns. We further demonstrate an early 
onset and closure of the critical period and defi cient 
visual function: Binocular neurons in mature V1 
remain mismatched with regard to inputs from the 
two eyes. Importantly, a reduction of GAD67 level 
is suffi cient to rescue precocious onset of the criti-
cal period, suggesting a causal role for GAD67 in 
MECP2-mediated regulation of experience-driven 
V1 circuit development. Taken together, our study 
establishes a coherent link, to our knowledge for 
the fi rst time, from specifi c molecular changes in 
defi ned cell types to circuit development and plas-
ticity, and to a functional alteration with behavior 
 implications, in a mouse model of RTT. Our fi nd-
ings thus begin to elucidate the circuit pathogenesis 
by  “connecting the dots” across levels from neural 
development to function.
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Input-Speciﬁ c Maturation of Synaptic 
Recruitment of Parvalbumin Interneurons 
in the Primary Visual Cortex
Cortical networks consist of local recurrent circuits 
and long-range pathways from other brain areas. Parv-
albumin inhibitory interneurons (PVNs) regulate the 
dynamic operation of local ensembles as well as the 
temporal precision of afferent signals. The synaptic 
recruitment of PVNs that support these circuit op-
erations is not well understood. Here, we demonstrate 
that the synaptic dynamics of PVN recruitment in 
mouse visual cortex are customized according to input 
source with distinct maturation profi les. Although the 
long-range inputs to PVNs show strong short-term 
depression throughout postnatal maturation, local 
inputs from nearby pyramidal neurons progressively 
lose such depression. This enhanced local recruitment 
depends on PVN-mediated reciprocal inhibition and 
results from both pre- and postsynaptic mechanisms, 
including calcium-permeable AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid) recep-
tors at PVN postsynaptic sites. Whereas short-term 
depression of long-range inputs is well-suited for af-
ferent signal detection, the robust dynamics of local 
inputs may facilitate rapid and proportional PVN re-
cruitment in regulating local circuit operations.
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NEUROBIOLOGY OF COGNITION AND DECISION-MAKING
A. Kepecs L. Calcaterra J. Hirokawa H.J. Pi
 E. Demir D. Kvitsiani S. Ranade
 L. Desban M. Lorenc J. Sanders
 B. Hangya P. Masset A. Vaughan
Understanding the mysteries of cognition has been 
an age-old aspiration of humankind. Our laboratory 
engages this question by studying the neurobiologi-
cal basis of cognitive tasks in rodents. We use a re-
ductionist approach to translate psychological ques-
tions into the language of neuroscience by develop-
ing quantifi able, well-controlled behavioral tasks for 
rodents. We then couple these tasks with targeted, 
high-resolution, and high-throughput monitoring 
and manipulation of neural circuits mediating cog-
nitive behaviors. Given the complexity of animal 
behavior and the dynamics of neural networks pro-
ducing it, our studies rely on computational models 
to guide and sharpen the neurobiological questions. 
Finally, we use human psychophysics to validate our 
behavioral observations in rodents by linking them 
with analogous behaviors in humans. Using this in-
tegrated approach, our long-term goal is to “reverse 
engineer” the computational and neurobiologi-
cal principles underlying cognition and decision- 
making.
In terms of topics, our approach is multifaceted: 
We study (1) the roles of uncertainty and confi -
dence in decision-making, (2) foraging decisions about 
whether to stay or to switch, (3) the division of labor 
between different cell types in the prefrontal cortex, 
(4) how the cholinergic system supports sustained at-
tention, and (5) social decisions that rely on shallow, 
stereotyped circuits. A unifying theme is the use of 
cell-type- and pathway-specifi c perturbations to ef-
fect gain and loss of function for specifi c behavioral 
abilities. Through such manipulations of genetically 
and anatomically defi ned neuronal elements, we hope 
to identify fundamental principles of neural circuit 
function that will be ultimately useful for developing 
therapies for diseases such as addiction, major depres-
sion, schizophrenia, Alzheimer’s disease, and autism 
spectrum disorder.
Neural Basis of Decision Conﬁ dence
J. Hirokawa, J. Sanders [in collaboration with A. Lak, 
University of Cambridge; G. Costa and Z.F. Mainen, 
Champalimaud Neuroscience Program, Portugal]
Natural events in the world, and the likely conse-
quences of our actions, are both fraught with ambigu-
ity. In the face of pervasive uncertainty, one’s degree of 
confi dence in a belief is a critical component of cogni-
tion. This can confer benefi ts for a broad range of ac-
tivities from the sophisticated to the mundane to the 
essential: managing a stock portfolio, deciding wheth-
er to carry an umbrella, or deciding between fi ght and 
fl ight. An essential use of confi dence estimates is to 
guide information-seeking behaviors, learning, and 
attention so as to reduce the level of uncertainty. Con-
versely, the pathological misevaluation of confi dence 
contributes to a wide range of neuropsychiatric condi-
tions, including anxiety, obsessive-compulsive disor-
der, and addiction.
What is the neural basis for such judgments? Previ-
ously, we discovered neurons in orbitofrontal cortex 
(OFC) that signal decision confi dence, and we are 
pursuing these observations by trying to establish the 
causal neural circuit basis for estimating and acting on 
decision confi dence.
As a fi rst step, we designed a new behavioral task 
for rats, in which we could measure confi dence behav-
iorally on a trial-by-trial basis. Briefl y, rats are trained 
on a simple olfactory decision task and by delaying 
reward, we found that the time they are willing to 
wait for an uncertain reward is proportional to deci-
sion confi dence, as predicted by theory. To further 
refi ne the role OFC in confi dence, we are trying to 
“read out” confi dence reports (i.e., predict the timing 
of leaving decisions on a trial-by-trial basis based on 
neural activity [establish correlation]). To demonstrate 
that OFC is necessary for confi dence reports, we used 
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both excitotoxic lesions and pharmacological inacti-
vation techniques and found that confi dence reports 
were  disrupted without changing decision accuracy. To 
establish the suffi ciency of OFC for confi dence report-
ing, we are preparing gain-of-function experiments. 
Because there is no obvious map in the prefrontal cor-
tex, we cannot use electrical microstimulation. Instead, 
we will use optogenetic activation of neurons defi ned 
by projection target using retrograde viruses and will 
attempt to inject extra “uncertainty” into the brain by 
activating the appropriate population of neurons. Our 
ultimate aim is to defi ne a precise neural circuit for 
computing and using decision confi dence.
From Metacognition to Statistics: 
Conﬁ dence Judgments in Humans
J. Sanders, B. Hangya, P. Masset
In our rodent studies of confi dence, we use a com-
putational framework to interpret behavioral and 
neural data. We are also interested in understanding 
the degree to which the theoretical concept of deci-
sion confi dence corresponds to the human notion of 
subjective confi dence. Human confi dence judgments 
are thought to originate from metacognitive processes 
that provide a subjective assessment about one’s be-
liefs. Confi dence can be alternatively framed as an 
objective statistical quantity, an estimate of the prob-
ability that a chosen hypothesis was correct. Despite 
similar usage of this term, it remains unclear whether 
the objective, statistical notion of confi dence is related 
to the subjective human feeling of confi dence.
To address this issue, we developed a normative 
statistical framework to mathematically derive predic-
tions relating a statistical measure of decision confi -
dence to observable measures of decisions. We found 
that human confi dence reports in both sensory and 
general knowledge decision tasks followed the nor-
mative statistical predictions, defying several naïve 
intuitions about confi dence. In addition, by fi tting a 
model to choice behavior within this framework, we 
could quantitatively predict confi dence reports. On 
the basis of these results, we suggest that the compu-
tation underlying the human sense of confi dence is 
consistent with a mental implementation of statistical 
decision confi dence.
Next, we developed a new confi dence-reporting 
task that provides both implicit and explicit measures 
of decision confi dence and is suitable for both rodents 
and humans in order to make direct comparisons. 
We designed a perceptual discrimination task where 
subjects choose which of two Poisson click streams 
is clicking faster and rate their confi dence in their 
choices. On each trial, we store the precise time of 
each click the subject heard in each ear and acquire 
three measures: a reaction time (how long the subject 
collected evidence before choosing), a choice (which 
side they thought was faster), and a confi dence re-
port (how much they believe in the hypothesis that 
their choice was correct). We used several previously 
described models of choice and confi dence to try to 
design a computer program that could “listen” to the 
same click trains and respond with the same reac-
tion time, choice, and confi dence. To our surprise, 
we discovered that standard models of perceptual 
 decision-making failed to reproduce the basic pat-
terns from our normative model, that confi dence re-
fl ects the strength of perceived evidence. Currently, 
we are examining a broader range of models to fi t our 
psychophysical data.
We fi nd that all of these confi dence-reporting tasks 
share the basic patterns of confi dence that is predicted 
by statistical confi dence. On the basis of these results, 
we are now in a position to use these quantitative 
measures of decision confi dence in humans, through 
collaborations and with neuroimaging and genetic ap-
proaches. Moreover, by showing that a single confi -
dence measure is applicable to humans and rodents, 
our results strengthen the case for using the rat as a 
model system for studying decision confi dence.
The Representational Content 
of Orbitofrontal Cortex during 
Outcome Anticipation
J. Hirokawa, A. Vaughan
OFC is strongly implicated in decision-making under 
uncertainty, especially when decisions require the 
evaluation of predicted outcomes. Neurophysiological 
studies conceptualize OFC as a hub for the integration 
of different variables into unifi ed value signals. Using 
model-based approaches, previous studies have iden-
tifi ed a number of critical outcome-related variables 
in OFC, such as reward value, risk, and confi dence. 
However, such model-based approaches are limited in 
their ability to characterize neuronal representations 
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because it is diffi cult to address all potentially encoded 
variables. Here, we address the representational content 
of OFC using both model-based and model-free (i.e., 
unsupervised) approaches. First, we assessed whether 
and how different decision variables are integrated 
in OFC using a model-based approach. Second, we 
sought to uncover the content of OFC representations 
using unsupervised techniques to assess whether deci-
sion variables arise naturally and whether they are rep-
resented separately or as a continuum.
To address this, we trained rats in a two-alternative 
forced-choice (2AFC) perceptual decision-making 
task with block-wise changes in reward size and re-
corded 481 neurons in ventrolateral OFC. We focused 
our analysis on the period after choice/before feedback 
(i.e., while the animal is anticipating the outcome of 
its choice). First, we constructed a normative model to 
account for the behavioral data. Our model combines 
reward value and perceptual decision confi dence in a 
Bayesian way to yield integrated value, which is then 
used to make choices. The model correctly predicted 
the behavioral choices and reaction times observed in 
each animal. From neuronal data, analysis of single 
units revealed that individual OFC neurons can repre-
sent identifi able decision variables separately, includ-
ing reward size and confi dence, as well as their com-
bination into integrated reward value. Analysis across 
the population of OFC neurons revealed the separable 
representation of a variety of decision variables pre-
dicted by the model. Importantly, the largest fraction 
of neuronal variance in the OFC population (the fi rst 
principal component) was explained by a variable, 
which represents coherently integrated value (deci-
sion confi dence multiplied by reward size). Moreover, 
cluster analysis suggests nonrandom, structured repre-
sentations of these decision variables in OFC. Taken 
together, we demonstrated that OFC representations 
of task variables are fundamentally linked to model-
based decision variables such as reward value and deci-
sion confi dence.
Microtraits in Rodent Models of 
Psychiatric Diseases
L. Desban, J. Hirokawa [in collaboration with 
F. Henn, Cold Spring Harbor Laboratory]
Basic research on psychiatric disorders relies on the 
use of animal models. Usually, animal models are 
validated mainly on the basis of genetic insights and 
simple behavioral measures. However, in the case of 
cognitive diseases, this has become challenging be-
cause it is unclear how to map human behavioral 
defi cits to animal models. To overcome these issues, 
we are taking a different approach to this challenge, 
based on the emerging fi eld of computational psychia-
try. We focus on microtraits that can be easily quanti-
fi ed using psychometric tasks and that can be directly 
related to humans (e.g., reward sensitivity, learning 
rate, and decision confi dence).
We attempted to use such a dimensional approach 
to identify microtraits that may be quantitatively dif-
ferent between our model rats and their controls. We 
studied major depressive disorder (MDD), a hetero-
geneous condition whose pathophysiology remains 
unclear, with a commonly used rodent model, the 
congenital learned-helplessness (cLH) rat. Using dif-
ferent behavioral paradigms, we tested two major 
hypotheses about depression: anhedonia, a blunted 
sensitivity to reinforcers, and depressive realism, the 
improved calibration of the sense of confi dence. We 
fi rst manipulated reward contingencies by introduc-
ing a bias in either reward size or reward probability. 
Our results showed no signifi cant difference between 
cLH and cNLH rats, which suggested that cLH rats 
did not display any imbalance in reward evaluation. 
Then, we assessed confi dence based on their willing-
ness to invest waiting time for uncertain outcomes. 
When they were most confi dent, the optimal strategy 
was to wait longer, and indeed, this is what we ob-
served. Moreover, we observed greater differences in 
cLHs’ waiting times with confi dence, suggesting that 
they had more insight into their choices than controls 
during the task. These preliminary results highlight 
how a computational phenotyping approach can be 
used to relate animal models of psychopathologies to 
human behavior.
Impact of Drugs of Abuse on Decision-
Making and Orbitofrontal Cortex
Y. Wu, J. Hirokawa
Drug abuse and addiction result in and are com-
pounded by compromised decision-making pro-
cesses. OFC has emerged as one important region of 
structural and functional alterations resulting from 
chronic drug exposure. Although opioids are widely 
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used for treatment of chronic pain conditions, their 
long-term effects on cognitive functions have not 
been well characterized. Morphine is a potent opi-
ate drug that has been shown to directly affect OFC, 
along with other prefrontal regions with strong dopa-
minergic projections. Addiction to morphine renders 
subjects unable to make good judgments and fl exible 
choices, which mimics the effects of OFC lesions. 
Therefore, we sought to fi nd out whether the previ-
ously unexplained behavioral aspects of drug addic-
tion could be due to defects in integration of decision 
confi dence and reward value in the decision-making 
process.
In our preliminary experiments, we used daily 
sessions of morphine injections to disrupt choice be-
havior or saline controls. We found that acute effects 
of morphine involve a decrease in choice accuracy 
and increase in impulsivity and reaction time. In 
addition, although saline-treated rats show a strong 
tendency to pick a bigger reward when the evidence 
level is low, this tendency is decreased in morphine-
treated rats, and the severity of this tendency is cor-
related with the amount of morphine animals re-
ceived. These results are consistent with morphine 
causing defects in the integration of reward value 
and sensory evidence. On the basis of this evidence, 
we are pursuing the hypothesis that morphine self-
administration leads to suboptimal decision-making 
by disrupting integration and distribution of deci-
sion variables in OFC.
Foraging Decisions, Anterior Cingulate 
Cortex, and Inhibitory Neuron Types
D. Kvitsiani, S. Ranade, B. Hangya [in collaboration with 
Z.J. Huang, Cold Spring Harbor Laboratory]
Making decisions about when to engage with op-
tions as they are encountered and when to disengage 
and switch behavior are fundamental problems for 
all decision makers. Such decisions about whether to 
stay and exploit an opportunity or leave and explore 
alternatives, presented in the language of behavioral 
ecology, are called foraging decisions. It is critical to 
appreciate that foraging decisions are not binary ones 
between currently available options (such as two-
alternative forced choice), but are instead decisions 
about when and how to engage with the available 
options.
We have been studying the anterior cingulate cortex 
(ACC) during a simple foraging task. In both humans 
and rodents, ACC has been implicated in variety of 
goal-directed behaviors including reward processing, 
inhibitory response control, and confl ict monitor-
ing. Electrophysiological recordings from ACC show 
great diversity of neuronal responses to a range of be-
havioral variables. At the same time, the neocortex 
is composed of a variety of cell types, among which 
GABAergic interneurons exhibit the largest diversity 
in connectivity, morphology, and intrinsic physiology. 
Does the anatomical and molecular variety of inter-
neuron subtypes map onto the diversity of neuronal 
responses in behaving animals? To address this issue, 
we used optogenetics as a means of identifying extra-
cellularly recorded neurons in freely moving mice, 
 focusing on inhibitory interneurons, which exhibit the 
largest diversity of cell types in cortex. We tested 
the overarching hypothesis that neurons belonging to 
the same subtype share fundamental commonalities 
in response properties during behavior, whereas dis-
tinct subtypes specialize in distinct functional roles.
We showed that parvalbumin-expressing (Pv) and 
a subtype of somatostatin-expressing (Som) neu-
rons form functionally homogeneous populations 
showing a double dissociation between both their 
inhibitory impact and their behavioral correlates. 
Out of a number of events pertaining to behavior, 
a subtype of Som neurons selectively responded at 
reward approach, whereas Pv neurons responded at 
reward leaving, encoding preceding stay duration. 
These behavioral correlates of Pv and Som neurons 
defi ned a behavioral epoch and a decision variable 
important for foraging (whether to stay or to leave), 
a crucial function attributed to ACC. Furthermore, 
Pv neurons could fi re in millisecond synchrony, ex-
erting fast and powerful inhibition on principal cell 
fi ring, whereas the inhibitory impact of Som neurons 
on fi ring output was weak and more variable, consis-
tent with the idea that they respectively control the 
outputs of and inputs to principal neurons. These 
results suggest a connection between the circuit-level 
function of different interneuron types in regulating 
the fl ow of information and the behavioral functions 
served by the cortical circuits. Our results also point 
to a new view of inhibition that sees interneurons 
as encoding behaviorally relevant variables and serv-
ing to control the fl ow of information on behavioral 
timescales.
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Cortical VIP Interneurons and 
Disinhibitory Control
H.J. Pi, B. Hangya [in collaboration with Z.J. Huang, 
Cold Spring Harbor Laboratory]
We are interested in understanding how the diversity 
of cortical inhibitory interneurons underlies distinct 
neural circuit dynamics that direct perception and 
behavior. As part of this broader project, we studied 
vasoactive intestinal peptide-expressing (VIP) inter-
neurons. VIP neurons are mostly bipolar, and their 
processes are vertically oriented and constitute less 
than 2% of all cortical neurons. Interestingly, these 
neurons specifi cally target other inhibitory neurons 
and avoid pyramidal cells. Therefore, we hypothesized 
that VIP neurons regulate a disinhibitory circuit and 
tested it in two functionally different cortical regions: 
auditory and medial prefrontal cortices.
Using a combination of in vivo and in vitro physi-
ology, we showed that VIP interneurons mediate 
disinhibitory control in multiple areas of neocortex. 
By combining optogenetic activation with single-cell 
recordings, we examined the functional role of VIP 
interneurons in awake mice and investigated the un-
derlying circuit mechanisms in vitro in auditory and 
medial prefrontal cortices. We identifi ed a basic disin-
hibitory circuit module in which activation of VIP in-
terneurons transiently suppresses most somatostatin-
expressing and a fraction of parvalbumin-expressing 
inhibitory interneurons—specialized to control the 
input and output of principal cells, respectively. In 
the auditory cortex, we found that reinforcement sig-
nals (punishment and reward) strongly activated VIP 
neurons, and in turn, VIP recruitment modulated the 
tone-responsiveness of a functional subpopulation of 
principal neurons. We propose that this disynaptic 
disinhibitory mechanism represents a cortical circuit 
motif that enables long-range inputs to modulate the 
gain of local circuits.
What are the mechanisms by which VIP neurons 
are recruited at specifi c moments in behavior? Pre-
vious studies suggest that VIP neurons may act as a 
conduit for fast neuromodulatory control and thereby 
acquire behaviorally relevant responses. To identify 
which neuromodulatory systems recruit a VIP-con-
trolled disinhibitory circuit, we took advantage of a ra-
bies-virus-assisted retrograde tracing system that only 
labels monosynaptic input neurons fl uorescently. We 
identifi ed direct projections from cholinergic neurons 
in the basal forebrain and serotonergic neurons in the 
raphe nuclei. Moreover, it is known that VIP neurons 
express ionotropic nicotinic acetylcholine and seroto-
nergic 5-HT3A receptors. On the basis of these results, 
we are pursuing the hypothesis that VIP neurons 
transform fast neuromodulatory signals into cortical 
disinhibitory output.
Neural Representation of Social Decisions 
and Rewards
E. Demir, L. Calcaterra [in collaboration with 
R. Axel, Columbia University]
Social behavior is integral to animals’ survival and re-
production. Social defi cits are at the heart of cognitive 
disorders such as autism spectrum disorder that have 
proven to be profoundly diffi cult to study in model or-
ganisms. Mice, like humans, are social animals. To in-
teract, cooperate, and compete with others, mice have 
to collect information about each others’ identity, fer-
tility, and likely intent. We would like to understand 
how social information is represented, computed, and 
used by mice. In rodents, a main source of informa-
tion for social decision-making and reward valuation 
is the chemosensory system. The neural circuits sup-
porting these tend to be shallow, from sensory input 
to motor actions, and highly stereotyped, enabling the 
systematic dissection of this system.
We started our studies by recording from part of 
the amygdala that processes information from the 
vomeronasal system, detecting behaviorally signifi -
cant chemical cues such as pheromones. We have de-
signed a behavioral task that presents different urinary 
proteins to our mice while we are performing electro-
physiology in medial amygdala. Moreover, we char-
acterized molecular markers that enable us to further 
dissect the social amygdalar circuit. Currently, we are 
doing optogenetic experiments as well as electrophysi-
ological recordings to map behavioral relevance onto 
specifi c medial amygdala neurons.
We are also interested in understanding the basic 
rules that mice use to choose their partners. For this 
purpose, we have developed a psychophysical social 
behavior task, the “social carousel,” inspired by per-
ceptual psychophysics and game theoretic traditions 
that have been instrumental in studying other facets of 
cognition. Our task enables the reliable, quantitative, 
and high-throughput analysis of social interactions in 
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mice. This task contrasts appetitive rewards with op-
portunities for social interaction. Water-deprived ani-
mals are trained to alternate between two platforms: 
One platform provides a small water reward and the 
other allows for social interaction with caged mice 
drawn at random from a revolving magazine. Sub-
jects can engage in extended social interactions with 
these mice, but at the expense of delaying the water 
reward. This task allows us to infer the “social value” 
of a mouse based on the trade-off between social in-
teractions and appetitive rewards. In addition, this 
task is compatible with our electrophysiological stud-
ies because it is devised for precise stimulus delivery 
and reproducible behavioral contingencies. Currently, 
we are characterizing social preferences of individual 
mice of different strains and subspecies.
Role of Nucleus Basalis in Reinforcement 
and Sustained Attention
B. Hangya, S. Ranade, M. Lorenc
The nucleus basalis (NB) is a vitally important yet 
poorly understood neuromodulatory system that is 
thought to have signifi cant roles in cognitive func-
tions, including learning, memory, and attention. 
Cognitive defi cits in Alzheimer’s disease, Parkinson’s 
dementia, age-related dementias, and normal aging 
are correlated with the extent of deterioration of NB 
cholinergic neurons. Yet, despite the association of 
NB with higher cognitive functions and a host of dis-
ease states in humans, it is surprising how little we 
understand about its function during behavior. Pre-
vious research, mostly using lesions, pharmacology, 
and microdialysis, revealed that NB can have strong 
and confusingly diverse effects on downstream tar-
gets and behavior. However, it is not known when 
cholinergic neurons are recruited during behavior 
and how their activity might support different aspects 
of cognition.
To overcome these challenges, we combine opto-
genetic and electrophysiological approaches to record 
from identifi ed cholinergic projection neurons in NB 
during behavior. We have successfully developed vi-
sual and auditory versions of sustained attention tasks 
for mice. In these tasks, mice report target stimuli oc-
curring at uncertain times. Performance and reaction 
time are used as indicators of attention. We manipu-
late temporal expectancy by using specifi c distribu-
tions for stimulus timing, thus modulating attention 
in a temporally precise, graded manner, also refl ected 
in the reaction times of the animals. We recorded 
single-neuron activity from the NB while mice were 
performing the auditory sustained attention task and 
identifi ed cholinergic neurons by using an optogenetic 
approach. We found that tonic changes in cholinergic 
fi ring are correlated with brain states but not with be-
havioral measures of attention on a trial-to-trial basis. 
On the other hand, cholinergic neurons were phasi-
cally activated following delivery of the reinforcer, ei-
ther air puff or water reward. Surprisingly, almost all 
cholinergic neurons recorded during the task showed 
a similar fast response to the air puff with a median 
latency of 17.5 msec and a very low jitter (median jit-
ter = 2.2 msec), whereas responses to reward were 
more variable. These results suggest that cholinergic 
neurons have dual functions, with tonic fi ring mediat-
ing vigilance and phasic fi ring rapidly signaling rein-
forcement feedback.
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THEORETICAL AND COMPUTATIONAL NEUROSCIENCE
A. Koulakov D. Ferrante Y. Wei
Our laboratory develops theories of neural compu-
tation. We work in parallel on three topics. First, 
we formulate mathematical models for combining 
genetic information and experience (nature and 
nurture) during formation of connections between 
neurons. Our models describe how genes can help 
build neural networks and how neural activity adds 
a layer of plasticity to the network topology that re-
fl ects learning and experience. These models have 
been tested on circuits that are formed in the visual 
system and can be rewired through genetic, surgical, 
and pharmacological manipulations. We have ap-
plied our theory to the visual maps of ocular domi-
nance observed in visual cortices of many higher 
vertebrates, such as humans. We were able to relate 
the orientation of ocular dominance patterns to the 
distribution of molecular labels that control estab-
lishing connectivity between the cortex and thala-
mus. Second, we have been developing the neural 
network theory for olfactory processing. We previ-
ously argued that information about smells can be 
represented in the olfactory system in the form of 
temporal sequences. We proposed a model for learn-
ing odorant representations in the olfactory bulb. Fi-
nally, this year, we have developed a model for deci-
sion confi dence estimation within cortical networks 
forming perceptual decisions.
The Molecular Basis for the Development 
of Neural Maps
Y. Wei, A.A. Koulakov
Neural development leads to the establishment of 
precise connectivity in the nervous system. By con-
trasting the information capacities of cortical con-
nectivity and the genome, we suggest that simpli-
fying rules are necessary in order to create cortical 
connections from the limited set of instructions con-
tained in the genome. One of these rules may be used 
by the visual system, where connections are formed 
on the basis of the interplay of molecular gradients 
and activity-dependent synaptic plasticity. We show 
how a simple model that accounts for such interplay 
can create both neural topographic maps and more 
complex patterns of ocular dominance (i.e., the seg-
regated binary mixture of projections from two eyes 
converging in the same visual area). With regard to 
the ocular dominance patterns, we show that pattern 
orientation may be instructed by the direction of the 
gradients of molecular labels. We also show that the 
periodicity of ocular dominance patterns may result 
from the interplay of the effects of molecular gra-
dients and correlated neural activity. Overall, we 
propose that simple mechanisms can account for the 
formation of apparently complex features of neuro-
nal connections (Fig. 1).
Figure 1. The geometry of the ocular dominance stripe orienta-
tion predicted by our computational model. (A) The orientation 
of ocular dominance stripes in the middle of the eye is predicted 
to be horizontal, whereas at the periphery, this orientation is 
circular. (B) This is a picture of orientation projected into the 
primary visual cortex.
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Sparse Learning of Odorant Representations 
in the Olfactory Bulb
A. Koulakov [in collaboration with S. Shea, Cold Spring 
Harbor Laboratory]
The olfactory bulb is the fi rst brain region in the neural 
network dedicated to odor perception. Mitral cells in 
the olfactory bulb receive odor information from nasal 
epithelial receptor neurons and process and transmit 
this information to the cortex. Activity at this crucial 
processing step is steeply dependent on behavioral state 
and experience. For example, sustained mitral cell 
odor responses under anesthesia disappear in wakeful-
ness. Yet, aligning spikes to respiration revealed brief 
and precise transient activity, suggesting that odor in-
formation is transmitted as sparse temporal sequences 
of activation. Mitral cell output is likely shaped in part 
by local inhibitory neurons called granule cells, but the 
signifi cance of granule cells for sensory coding and per-
ception is unclear. Recently, we proposed that granule 
cells form inverse representations of odorants that are 
subtracted from the responses of mitral cells to elimi-
nate redundancies and enforce temporal structure. The 
responses of cells in the olfactory bulb circuit display 
rich dynamical repertoire including state-dependent 
activity, temporal coding, and experience-dependent 
plasticity. Here, we extended our theoretical model 
and derived the learning rules for granule cell connec-
tions that facilitate sparse, temporally patterned mitral 
cell output that reduce the redundancy of odorant 
representations by the mitral cells. In parallel, we used 
experimental data to rigorously test our model’s pre-
dictions. Understanding how redundancy gets reduced 
in the mitral-granule cell network is especially relevant 
for the human olfactory system because according to 
recent data, it contains a greater number of mitral cells 
receiving redundant inputs from fewer types of olfac-
tory receptor neurons. Moreover, sparsened sensory 
coding is observed in a wide range of systems during 
wakefulness. Our studies help us to understand how 
this computation is achieved by experience-dependent 
plasticity and learning in a population of olfactory 
 inhibitory neurons.
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THE FUNCTION AND PLASTICITY OF CENTRAL SYNAPSES 
IN ADAPTIVE AND MALADAPTIVE BEHAVIORS RELATED 
TO PSYCHIATRIC DISORDERS
B. Li S. Ahrens G.-R. Hwang M. Stephenson-Jones
 K. Delevich  M. Penzo K. Yu
Understanding the relationship among synapse, cir-
cuit, and behavior has been the focus of research in 
my lab. We are particularly interested in understand-
ing the synaptic and circuit mechanisms underlying 
cognitive functions, as well as synaptic and circuit 
dysfunction that may underlie mental disorders, in-
cluding anxiety, depression, schizophrenia, and au-
tism. To address these questions, we use in vitro and 
in vivo electrophysiology, two-photon imaging, and 
molecular, genetic, optogenetic, and chemical-genetic 
methodologies to probe and manipulate the function 
of specifi c neural circuits in the rodent brain and to 
determine their role in behaviors, such as learning and 
expression of fear, learned helplessness, and attention. 
We are currently undertaking three major lines of re-
search, which are summarized below.
The Central Amygdala Fear Circuits 
and Fear Regulation
The amygdala is essential for fear learning and ex-
pression. The central amygdala (CeA), once viewed 
as a passive relay between the amygdala complex and 
downstream fear effectors, has emerged as an active 
participant in fear conditioning. However, how CeA 
contributes to the learning and expression of fear is 
unclear. We recently discovered in mice that fear 
conditioning induces robust plasticity of excitatory 
synapses onto inhibitory neurons in the lateral sub-
division of CeA (CeL). This experience-dependent 
plasticity is cell-specifi c and expressed by inputs from 
the lateral amygdala. Furthermore, we demonstrated 
that this CeL plasticity is required for the storage of 
fear memories.
The CeL also controls fear expression by gating the 
activity of the medial subdivision of the central amyg-
dala (CeM), the canonical amygdala output to areas 
that mediate defensive responses. In addition to the 
connection with CeM, the CeL sends long-range pro-
jections to innervate extra-amygdala areas. However, 
the long-range projection CeL neurons have not been 
well-characterized, and their role in fear regulation 
is unknown. Our recent studies in mice show that a 
subset of CeL neurons directly project to the midbrain 
periaqueductal gray (PAG) and the paraventricular 
nucleus of the thalamus, two brain areas implicated 
in defensive behavior. These long-range projection 
CeL neurons are predominantly somatostatin-positive 
(SOM+) neurons, which can directly inhibit PAG 
neurons, and some of which innervate both the PAG 
and the paraventricular nucleus of the thalamus. No-
tably, fear conditioning potentiates excitatory synaptic 
transmission onto these long-range projection CeL 
neurons. Thus, our study identifi es a subpopulation of 
SOM+ CeL neurons that may contribute to fear learn-
ing and regulate fear expression independent of CeM.
The Habenula Circuitry in the Learned 
Helplessness Model of Depression
The cellular basis of depressive disorders is poorly 
understood. Recent studies in monkeys indicate that 
neurons in the lateral habenula (LHb), a nucleus that 
mediates communication between forebrain and mid-
brain structures, can increase their activity when an 
animal fails to receive an expected positive reward or 
receives a stimulus that predicts aversive conditions 
(i.e., disappointment or anticipation of a negative 
outcome). LHb neurons project to, and modulate, 
dopamine-rich regions, such as the ventral tegmen-
tal area (VTA), that control reward-seeking behavior 
and participate in depressive disorders. We have found 
that in two learned helplessness models of depression, 
excitatory synapses onto LHb neurons projecting to 
the VTA are potentiated. Synaptic potentiation cor-
relates with an animal’s helplessness behavior and is 
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due to an enhanced presynaptic release probability. 
Depleting transmitter release by repeated electrical 
stimulation of LHb afferents, using a protocol that 
can be effective for patients who are depressed, mark-
edly suppresses synaptic drive onto VTA-projecting 
LHb neurons in brain slices and can signifi cantly re-
duce learned helplessness behavior in rats. Our results 
indicate that increased presynaptic action onto LHb 
neurons contributes to the rodent learned helplessness 
model of depression.
This study provides insights into cellular mecha-
nisms that may explain previously reported phenom-
ena—the increase in LHb metabolic activity observed 
in humans who are depressed and in animal models 
of depression—and that lesion or pharmacological 
silencing of the LHb can modulate depression-like 
symptoms in animal models. Our fi ndings suggest an 
aberrant cellular process that has not previously been 
examined in the context of mood disorders and that 
may be crucial in the etiology of depression. Future 
studies aimed at determining the changes in molecu-
lar signaling that underlie the synaptic hyperactivity 
onto LHb neurons may lead to novel and effective 
treatments able to reverse some forms of depressive 
disorders.
The Schizophrenia-Linked ErbB4 
Controls Attention through the 
Thalamic Reticular Nucleus
Considerable evidence supports a role of the tha-
lamic reticular nucleus (TRN) in sensory processing 
and cognitive functions such as attention. Dysfunc-
tion of TRN has been implicated in schizophrenia, 
a mental disorder in which cognitive defi cit is a core 
feature; however, the mechanisms by which TRN 
dysfunction occurs and leads to disease symptoms 
are unclear. We have probed and manipulated the 
somatostatin (SOM+) class of TRN neurons, which 
express ErbB4, a gene that has been linked to schizo-
phrenia. We found that ErbB4 defi ciency in these 
neurons selectively strengthened excitatory synapses 
driven by cortical inputs, thereby enhancing the 
feedforward modulation of thalamic neurons, and 
specifi cally impaired behavioral performance in a 
task that engages rule selection but not input selec-
tion, attentional processes dependent on activity of 
SOM+ TRN neurons.
Rule selection and input selection represent distinct 
attentional processes that likely require the coordinat-
ed action of cortical and subcortical structures. We 
found that suppression of SOM+ TRN neurons (by 
the chemical-genetic method) impaired performance 
in both the input-selection and rule-selection tasks, 
indicating that these neurons are indispensable. On 
the other hand, increasing cortical drive onto SOM+ 
TRN neurons (caused by ErbB4 defi ciency) markedly 
improved input selection, but severely impaired rule 
selection. These results, although paradoxical at fi rst 
glance, are in fact consistent with Francis Crick’s at-
tentional searchlight hypothesis, in which TRN neu-
rons act as the “beam” of the searchlight to enhance 
the activity of thalamocortical neurons. Indeed, acti-
vation of TRN neurons promotes the generation of 
bursting activity in the thalamus, which may facili-
tate information processing and improve behavioral 
performance. Through this mechanism, the increased 
cortical drive onto TRN neurons may improve perfor-
mance in the input-selection task, in which distractors 
may interfere with information processing in the thal-
amus through a bottom-up process. In contrast, in the 
rule-selection tasks, both auditory and visual stimuli 
have been learned to be associated with reward, and 
therefore, either stimulus can be voluntarily attended 
through a top-down process. In a given trial, attend-
ing to the inappropriate stimulus (under the current 
rule) results in performance error. This problem be-
comes exaggerated in the ErbB4 mutant mice, in 
which the aberrantly enhanced cortical-TRN inputs 
might render the TRN neurons more responsive to 
false signals originating from the cortex.
These results uncover a critical role of a cortico–
TRN synaptic circuitry in goal-directed attention and 
provide insights on cellular and circuit mechanisms by 
which TRN dysfunction may occur and contribute to 
a consistently observed cognitive impairment in major 
psychiatric disorders. Our results suggest that either 
aberrantly increased or decreased TRN neuronal ac-
tivity can result in impairment in rule selection, a key 
aspect of executive control. The rule-selection task 
used in our study mimics, to some extent, the Stroop 
task, a test commonly used to assess cognitive defi cit 
in schizophrenia. The fi nding that ErbB4 defi ciency 
selectively impairs rule selection, but not input selec-
tion, parallels a clinical observation that schizophre-
nia specifi cally affects performance in the Stroop task 
and does not impair attentional functions in general. 
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Deletion of a single copy of ErbB4 is suffi cient to pro-
duce a robust effect, suggesting that ErbB4 signaling 
is exquisitely regulated in SOM+ TRN neurons in 
order to properly maintain TRN function. Thus, our 
fi ndings reveal circuitry and cellular mechanisms that 
may underlie a form of cognitive defi cit observed in 
mental disorders.
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INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra N. Baltera  N. Franciotti G. Havkin S. Michelsen C. Powell K. Weber
 C. Bergano P. Grange J. Jones A. Mukherjee S. Savoia C. Wu
 A. Field-Pollatou H. Greene F. Mechler  V. Pinskiy A. Tolpygo Y. Zhang
We study complex neurobiological systems using a 
combination of experimental and computational ap-
proaches. The primary area of experimental work 
in our laboratory is the Mouse Brain Architecture 
(MBA) project, with a goal to generate a brainwide 
mesoscale connectivity map in the mouse. In collab-
orative studies, we also apply the methods developed 
for the MBA project to multiple other species, includ-
ing the zebra fi nch, marmoset, macaque monkey, 
and human. Our neuroinformatics research involves 
the development and application of analytical tools 
to large volumes of neurobiological data. A specifi c 
area where we have concerted our efforts is the de-
velopment of informatics infrastructures for data and 
knowledge integration for various brain connectivity 
projects. We have major ongoing collaborations with 
research groups, both inside and outside CSHL. At 
CSHL, we collaborate with Josh Huang on a project 
on GABAergic interneuron expression in mouse mod-
els of autism. The Brain Architecture Project has col-
laborators at multiple institutions, including Harvey 
Karten (University of  California, San Diego), Michael 
Hawrylycz (Allen Institute of Brain Research), Jin 
Hyung Lee (Stanford), and Mihail Bota (University 
of Southern California). We began a joint effort with 
Allan Johnson’s team (Duke University) to develop 
a high-resolution Nissl atlas for the MR-based Wax-
holm space of the mouse brain. We collaborate with 
Bijan Pesaran (New York University) on mapping 
connectivity in the macaque brain, and with Naoshige 
Uchida (Harvard) on mapping the afferent inputs to 
the dopaminergic system of the mouse brain. We have 
completed the pilot phase of a collaborative effort with 
Kirk Wilhelmsen (University of North Carolina) to 
link brainwide neuroanatomy with genetics using the 
Collaborative Cross project mouse lines. We have also 
been working with Randal Burns and his team (Johns 
Hopkins University) on integrated hardware/software 
solutions to storage and computing tasks posed by the 
massive imaging data in our projects.
Continuing in the Mitra laboratory in 2014 are 
Sandra Michelsen (Administrator), Vadim Pins-
kiy (Computational Science Analyst), Alex Tolpygo 
(Laboratory Manager), Gregor Havkin (Computa-
tional Science Manager), Kevin Weber (Laboratory 
Technician), Neil Franciotti (Laboratory Techni-
cian), Amit Mukherjee (Postdoctoral Fellow), and 
Ferenc Mechler (Computational Science Analyst, 
Project Manager). Jamie Jones (Laboratory Tech-
nician), Caitlin Powell (Laboratory Technician), 
Christin Bergano (Laboratory Technician), Harri-
son Greene (Laboratory Technician), Pascal Grange 
(Postdoctoral Fellow), Caizhi Wu (Research Asso-
ciate), and Yingbin Zhang (Computational Science 
Manager) have recently left to further pursue their 
careers. Angeliki Field-Pollatou (Visiting Graduate 
Student), Nicholas Baltera (Laboratory Technician), 
and Stephen Savoia (Laboratory Technician) joined 
us during the last year.
Mouse Brain Architecture Project
V. Pinskiy, A. Tolpygo, C. Wu, J. Jones, K. Weber, 
C. Bergano, N. Franciotti, G. Havkin, Y. Zhang, 
A. Mukherjee, F. Mechler
The function of the brain is served and constrained 
by its wiring and our knowledge of a comprehensive 
wiring map of the mammalian brain. Our knowledge 
of the wiring map remains highly incomplete. The 
MBA project, now running in its fourth year, is de-
signed to address this knowledge gap. We use a pair 
of anterograde tracing and a pair of retrograde tracing 
methods and make computer-guided precision injec-
tions targeting one of 262+ predetermined sites sys-
tematically mapped on a three-dimensional grid that 
covers the entire brain volume. Using this approach, 
we map brain connectivity in the adult (p56) mouse 
(C57BL/6J) in four different ways and align these re-
sults to the Allen Brain Atlas.
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To date, we have processed and released more than 
540 brains for public access on the MBA web por-
tal (http://mouse.brainarchitecture.org/), and more 
brains are being processed and posted on a continuing 
basis. Although the whole brain still remains to be tar-
geted with injections, some areas are now well-covered 
(including the somato-motor system). The Mathers 
Foundation agreed to provide support to allow the 
continuation and completion of the MBA project.
Much of the current effort deployed in the MBA 
project is developing hardware and software tools 
to cope with challenges posed by the very large 
(~TB size) image data sets. We need to move, store, 
and process hundreds of these data sets securely and 
effi ciently. Furthermore, the computationally in-
tensive analyses (such as volume registration) of the 
MBA brains require specialized software solutions to 
be feasible on these sets that we address in the Johns 
Hopkins University collaboration. In addition, we 
continue to work to improve the portal interface and 
user experience. We have added new browser capa-
bilities and started to add a video to each brain that 
animates the coronal image stack as a virtual rostro-
caudal fl y-through.
Regarding future directions, we started a pilot 
 collaboration with Mihail Bota (University of  Southern 
California) in which he manually annotates the la-
beled monosynaptic afferent and efferent connec-
tions of primary motor cortex (MOp) revealed in 
tracer- injected MBA project brains. This study aims 
for a comparison with the BAMS database (that Dr. 
Bota helps curate) and will help validate project data 
against literature results and highlight new fi ndings.
Most recently, in collaboration with Professor 
Guenter Giese at the Max-Planck Institute (Heidel-
berg), we have started to explore the utility of a novel 
tissue clearing technology he has recently pioneered. 
Professor Giese’s clearing method, unlike many of his 
competitors’, manages to preserve the fl uorescent label 
with high signal-to-noise ratio and thus presents a fea-
sible and faster alternative to our current technology 
of mapping whole-brain connectivity. Pilot studies 
using motor cortical injections produced some good 
three-dimensional data sets (Fig. 1), and we are look-
ing into ways to incorporate this methodology into 
our pipeline.
With the use of retrograde tracing methods and 
the high spatial resolution attained in our data, we 
expect that the MBA project will complement and 
signifi cantly refi ne our knowledge of brain connec-
tivity currently available in the literature or from 
other projects (in particular, the Allen Institutes’ 
parallel project, which is focused on cell-type-spe-
cifi c projection mapping but only uses anterograde 
neuronal tracers).
Outreach. We continue to work to highlight the 
MBA project to the scientifi c public. I have participat-
ed in the U.S. BRAIN initiative related discussions, 
through online articles and other media listed below:
Scientifi c American
http://www.scientificamerican.com/article/whats-
wrong-with-the-brain-activity-map-proposal/; http://
www.scientifi camerican.com/article/neuroscientists-
weigh-in-obamas-brain-initiative/
Th e Washington Post
http://www.washingtonpost.com/blogs/wonkblog/
wp/2013/04/03/obama-braaaaaains-partha-mitra-
whoa-there-buddy/
Live Radio
http://www.kqed.org/a/forum/R201304030900
Published Opinion Papers
Devor et al. (2013); Mitra et al. (2013)
Organizational activity with the National Science 
Foundation for BRAINI workshops
http://physicsofl ivingsystems.org/brainstructureand
function/
Control Systems Theory Applied 
to Complex Brain Circuits
P. Mitra
I have continued to pursue theoretical work. I am cur-
rently engaged with collaborators Dr. Bassam Bamieh 
(University of California, Santa Barbara) and Dr. 
Anirvan Sengupta (Rutgers University) in an inves-
tigation that aims to apply novel insights from the 
theory of distributed control in statistical physics and 
engineering to biological systems of large numbers of 
heavily interacting components. The study is motivat-
ed by recent discoveries of sharp transitions between 
states with qualitatively different behaviors that can 
emerge due to small changes in parameters, analogous 
to the transitions, for example, between solid and 
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liquid states. Drawing on National Science Founda-
tion support through the prestigious Inspire Award, 
we aim to apply these new ideas to help unravel the 
complex dynamics of the interconnected brain net-
works. In particular, this novel approach could bring 
new simplifying insights into the function (and limi-
tations) of the mouse brain from the underpinnings of 
the connectivity patterns revealed in the MBA project 
in our lab. For a related groundbreaking theoretical 
study (Bamieh et al., IEEE Trans Automat Control 
57: 2235 [2012]), my co-authors and I have received 
the George S. Axelby Outstanding Paper Award of 
the Control Systems Society (CSS) of the Institute of 
Electrical and Electronics Engineers (IEEE). Further 
information can be found on these theoretical efforts 
in a recent CSHL press report (http://www.cshl.edu/
Article-Mitra/cshls-partha-mitra-receives-two-honors-
for-theoretical-work-with-implications-for-brain- 
circuitry) and links therein.
A High-Resolution Nissl-Based 
Mouse Brain Reference Atlas
V. Pinskiy, A. Tolpygo, A. Mukherjee, F. Mechler
A classical segmentation of reference atlas brains uses 
information on cell size and density revealed by Nissl 
stain. However, the quality and spatial resolution of 
the Nissl material associated with the available best 
reference atlases of the mouse brain is limited. To 
Figure 1. Monosynaptic efferent connections of mouse primary motor cortex (MOp) revealed in a mouse brain 
microinjected in the left MOp with the GFP-expressing anterograde virus tracer, AAV. The whole brain was scanned 
via light-sheet microscopy (Giese lab), producing a z-stack of 3.1-μm-thick optical horizontal slices; here two layers 
of interest in the left hemisphere are shown in gray level rendition. GFP-labeled axons of AAV-infected MOp neurons 
make MOp projection ﬁ elds appear bright. (A) z-level ~1.8 mm below bregma; (B) z-level ~2.4 mm below bregma. 
MOs, ipsilateral secondary motor area; SSp, SSs, ipsilateral primary and secondary somatosensory area; STRd, dorsal 
striatum, descending projection passing through; cc, corpus callosum, projections to the contralateral motor cortex.
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improve on this, we have begun a collaboration with 
Professor Allan G. Johnson’s team at Duke Univer-
sity to develop a digital high-resolution Nissl-based 
whole-brain atlas for the adult (p56) C57BL/6J 
mouse. The Duke team took high-resolution MRI 
scans (uniform 22-μm voxels) of the brains in the 
skull shortly after perfusion. The fi xated brain-in-
skull specimens were processed in the MBA pipeline 
to acquire high-resolution (0.5 μm/pxl, in-plane) 
light-microscopic scans of contiguous 10-μm-thick 
Nissl-stained coronal sections. For each brain, the 
Nissl image stack was computationally registered to 
its MR scan and segmented (Fig. 2). A high-quality 
segmented Nissl brain obtained by averaging several 
similarly processed mice will update the histological 
component of the digital Waxholm reference space 
for multimodal mouse brain images, providing the 
higher spatial resolution suitable for MBA brains.
Alterations in Brain-Wide GABAergic 
Neuroanatomy in Autism Mouse Models
V. Pinskiy, A. Tolpygo, A. Mukherjee, F. Mechler
In an ongoing collaboration with Josh Huang, funded 
by the Simons Foundation Autism Research Initiative 
(SFARI), we address the developmental neuroanatomy 
of dysfunctional inhibition implicated in autism spec-
trum disorders (ASDs). In a systematic brain-wide ap-
proach, we generate whole-brain maps of genetically 
targeted key subpopulations of inhibitory neurons that 
have distinct physiological function refl ected in their 
specialized cellular morphology. We quantify and com-
pare the distribution and long-range projection pat-
terns of these GABAergic neurons in an ASD mouse 
model (the 16p(df/+) heterozygous copy number– 
defi cit mutant) and the “wild type” (C57BL/6). Last 
year, we reported on baseline data obtained in the wild 
type; since then, we have bred ASD mutants and start-
ed to process them. Figure 3 compares the brainwide 
distribution of the somatostatin-expressing (SOM+) 
GABAergic bitufted neurons in one ASD animal and 
its littermate (wild type) control. Data sets like these 
are analyzed using software tools we have developed 
for the MBA computational pipeline. Aligned whole-
brain image stacks are registered to a reference atlas, 
and the normalized cell counts obtained with auto-
matic cell detection within annotated anatomical com-
partments are compared across genotypes.
Figure 2. (A) The MRI scan of a mouse brain. (B) The Nissl 
stack of the same brain. (C) The alignment of the two volumes 
shown for a sagittal slice through a checkerboard aperture that 
alternates visibility of the two image modalities to aid visual as-
sessment of their alignment. (D) Segmentation of the same Nissl 
brain is obtained via alignment with the annotated reference 
brain. (The latter was developed by Dr. Pavel Osten from brains 
scanned by block-face tomography and registered to the Allen 
Reference Atlas.) Inset is a cartoon of the deformation ﬁ eld of the 
warping operation that achieves alignment.
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Figure 3.  Comparison of the brainwide distribution of genetically targeted somatostatin+ (SOM) GABAergic bi-
tufted neurons in an animal of the ASD model genotype, 16p(df/+), (right) and its wild-type (C57BL/6) littermate (left). 
In these animals, the SOM neurons selectively express nuclear green ﬂ uorescent protein by design. The SOM-Cre 
and HG alleles are heterozygous in both animals. Coronal levels, indicated by arrows in the sagittal sections above, 
are selected for representative SOM-density patterns: (A) ~ Bregma + 1.0 mm; (B) ~ bregma − 2.0 mm. Locally el-
evated densities seen in, for example, the lateral septal nucleus (LS), the reticular nucleus of the thalamus (RT), and 
the amygdala (AMY). HG expression appears to be less concentrated and obtains lower levels overall in the ASD 
animal than in the control, but this remains a hypothesis to be subjected to quantitative testing on more animals.
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IDENTIFICATION OF DISRUPTED BRAIN CIRCUITS IN MOUSE 
MODELS OF AUTISM AND SCHIZOPHRENIA
P. Osten H. Ederle Y. Kim A. Narasimhan E. Szelenyi J. Taranda
 G. Fitzgerald C. Mende R. Palaniswamy N. Takada K.U. Venkataraju
We are interested in studying how brain circuits as-
semble during development and give rise to behavior 
in the juvenile and adult mouse, both under normal 
conditions and in genetic mouse models of autism.
Mapping Mouse Brain Activation
For the past several years, we have been developing a 
largely automated and highly quantitative approach 
to mapping neuronal activation in the mouse brain 
at cellular resolution. We have introduced a novel 
microscopy, called serial two-photon (STP) tomog-
raphy, which achieves high-throughput fl uorescence 
imaging of whole mouse brains by integrating two-
photon microscopy and tissue sectioning (Ragan 
et al., Nat Methods 9: 255 [2012]; Osten and Margrie 
2013). More recently, we have established a pipeline 
of computational methods that allows the visualiza-
tion of the immediate-early gene c-fos, a molecular 
marker of neuronal activation, by STP tomography 
in transgenic c-fos-GFP mice. The c-fos-GFP-positive 
neurons are computationally detected, their distri-
bution is warped to a reference brain registered to 
the Allen Mouse Brain Atlas (ABA), and the acti-
vated brain regions are identifi ed by rigorous statis-
tical tests comparing c-fos-GFP cell counts in more 
than 600 anatomical ABA regions (Fig. 1). We have 
Figure 1. Mapping mouse brain activation by STP tomography. (A) Brain activation causes the induction of c-fos-GFP. 
(B–C) The brain is imaged by STP tomography. (D) c-fos-GFP cells are computationally detected. (E) The data sets 
are warped to a “reference” brain and Allen Mouse Brain Atlas. (F) The distribution of c-Fos-GFP cells is compared 
by statistical analyses, and the results are tabulated in a spreadsheet of brain regions. (G) Activated brain regions are 
plotted in circuits based on their known anatomical connectivity.
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demonstrated the power of these methods by gener-
ating whole-brain activation maps for two complex 
behaviors: a brief social interaction between a male 
and a female mouse and an odor-driven novelty ex-
ploration (manuscript submitted for publication; see 
Fig. 2). We anticipate that our methods will enable 
routine quantitative generation of whole-brain activa-
tion maps representing different complex behaviors, 
including other innate behaviors (e.g., sex, aggres-
sion, and fear) and higher cognitive behaviors (e.g., 
decision-making). We predict that such maps will 
become a valuable resource for the systems neuro-
science community. Furthermore, the application of 
our methods to the screening of brain activation in 
genetic mouse models of autism may reveal brain cir-
cuit defi cits common to multiple susceptibility genes, 
which could serve as clinically relevant brain-circuit-
based targets (or biomarkers) for the development of 
novel therapeutics.
Toward Quantitative Cell-Type-Based 
Mapping of the Mouse Brain
The mouse brain comprises ~70 million neurons 
and ~30 million glia and other cells. In addition to 
the method for mapping brain activation described 
above, we have also developed an assay for quantita-
tive mapping of the many neuronal and glia cell types 
present in the mouse brain (see example in Fig. 3). 
This work aims to provide a complete picture of cell 
type distribution in the mouse brain during develop-
ment, in the adult, and during aging. The study of 
the developing brain will shed light on the temporal 
sequence of cell-type- and region-specifi c circuit as-
semblies that give rise to emerging motor, sensory-
perceptual, and cognitive specializations in the young 
brain. The experiments in the adult brain will focus 
primarily on the questions of gender differences in 
cell numbers that have been described for several 
Figure 2. Mapping social behavior in the mouse brain. Brain areas activated selectively during social behavior are 
visualized in color according to statistical signiﬁ cance (right side in panel A) overlay on the reference brain volume 
(gray). The social brain circuit includes areas of the prefrontal cortex (A–B), regions of the ventral striatum and dopa-
minergic areas linked to reward processing (C,I), and areas linked to emotional processing, such as amygdala (E–H) 
and bed nuclei of the stria terminalis (D).
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Figure 3. Whole-brain SOM+ interneuron distribution. Shown 
is an example of cell type distribution, speciﬁ cally of the soma-
tostatin-positive (SOM+) interneurons, in the adult mouse brain. 
The view shows a registration to the Allen Mouse Brain Atlas 
visualized in a single coronal plane.
brain areas but have not been examined at a whole-
brain level. And, fi nally, the studies in older animals 
will aim to determine whether a loss of specifi c cell 
types may contribute to the decline in certain brain 
functions during aging.
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NEURAL CIRCUITRY FOR SOCIAL COMMUNICATION
S. Shea B. Cazakoff B. Lau
 D. Eckmeier B. Schuman
 G. Ewall K. Tranchina
The overarching research goal in our laboratory is to 
understand how processing in specifi c brain circuits 
works to support natural communication behaviors. 
We aim to reveal neural mechanisms that allow or-
ganisms to detect and recognize familiar individuals, 
to gather information about their identity and social 
status, and to select appropriate behaviors. Mice are 
capable of acquiring detailed profi les on one another 
from the smells and sounds experienced during their 
social encounters. These dossiers may include infor-
mation on a mouse’s sex, genetic identity, reproduc-
tive state, levels of distress or sexual interest, or even 
recently consumed foods, details that are indispens-
able for survival and mating success. Initially, we are 
working to understand the neuronal activities and 
mechanisms in primary sensory brain areas that sup-
port these forms of communication. In the future, we 
anticipate moving deeper into the brain to ascertain 
where the sensory data from those regions are col-
lected and integrated into hormonal and electrical 
signals that promote appropriate behavioral choices. 
We are particularly interested in how all stages of this 
decision arc are fl exible according to experience and 
behavioral state.
The scientifi c benefi t of this approach is twofold. 
First, we want to identify fundamental principles 
for how the circuitry of the brain adaptively controls 
complex behavior. In our pursuit of this goal, innate 
social behaviors are advantageous because they allow 
us to study neural circuits in light of problems they 
are exquisitely adapted to solve. Second, it is also our 
goal to pinpoint disturbances in the circuits that im-
pair appropriate use of social information. Diffi culty 
with social perception and cognition are core features 
of the autism spectrum disorders (ASD); for example, 
patients may have trouble perceiving and interpret-
ing communication gestures such as speech, facial 
expressions, and “body language.” This broad fea-
ture is recapitulated in many mouse models of ASD 
that carry genetic variants identifi ed in human ASD 
populations. Therefore, if we can ascertain the neural 
circuit substrates of social behavior in normal mice, 
we can make and test predictions for how the circuitry 
is affected in the mouse models. The results are likely 
to tell us more about the synaptic modifi cations that 
occur in human autism.
There are two broad areas of research in the lab. 
The primary arm of the lab’s efforts is focused on 
neural circuits that facilitate detection, discrimina-
tion, and memories for olfactory cues. In particular, 
we are interested in how these circuits help an animal 
fl exibly select appropriate behavioral decisions toward 
potential mates, rivals, offspring, predators, and food 
sources. Our approaches range from detailed in vivo 
synaptic physiology in anesthetized animals, to func-
tional imaging and physiology in head-fi xed mice, to 
recording and manipulating neural activity in awake, 
freely behaving animals. We ultimately hope to un-
cover the neural encoding of social cues during a live 
encounter with another mouse. The secondary arm of 
our research program is aimed at understanding the 
plasticity of cortical circuits that enable vocal com-
munication between mice. Specifi cally, we have been 
working on how this circuitry and the attendant be-
havior are altered in mice that have impaired function 
of the gene MeCP2, which is mutated in humans with 
Rett syndrome.
State-Dependent Neuronal Coding 
in Granule Cells of the Olfactory Bulb
B. Cazakoff, B. Lau, K. Crump, H. Demmer
Arguably, the most critical and fi nely tuned instru-
ment providing a mouse with information about its 
social world is its sense of smell. Detection and in-
terpretation of olfactory stimuli in the brain begin at 
the olfactory bulb. Odor signals passing through the 
olfactory bulb are subject to processing and modifi ca-
tion by the intrinsic neuronal circuitry of the bulb. 
Among these intrinsic neurons, inhibitory granule 
cells are certainly the most numerous, arguably the 
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most important, and yet somehow the most mysteri-
ous. These cells are the primary conduit for the olfac-
tory bulb to integrate odor information with signals 
originating deep in the brain. Furthermore, granule 
cell anatomy along with a handful of functional stud-
ies suggests that they are crucial for olfactory dis-
crimination and learning. Nonetheless, their activity 
patterns in vivo are poorly understood, and their elec-
trophysiological properties in awake animals are com-
pletely unknown. This is because granule cells do not 
yield to conventional recording techniques. Former 
lab postdoc Dr. Heike Demmer therefore developed 
reliable methods for recording and labeling olfactory 
bulb granule cells. In a tour de force series of experi-
ments, WSBS student Brittany Cazakoff, postdoctoral 
fellow Dr. Billy Lau, and CSHL URP Kerensa Crump 
applied these methods to mice that were awake with 
their heads fi xed, but running freely on a foam ball 
and receiving water rewards from a lick tube. Their re-
cordings represent the fi rst reported view of the activ-
ity of this important cell type during wakeful behav-
ior. The team’s results conclusively show that granule 
cells become much more active during wakefulness 
and surprisingly uncouple from the animal’s breathing 
and sniffi ng pattern. This seems to suggest that upon 
waking, granule cell activity becomes dominated by 
internal signals from the brain rather than the sen-
sory properties of odors. If so, we have functionally 
identifi ed a pathway central to the remarkably labile 
processing of odor stimuli. Ms. Cazakoff ’s thesis will 
be focused on expanding this paradigm to include dis-
crimination of odors and associative learning to study 
how the granule cells’ fi ring patterns refl ect experience 
with and behavioral signifi cance of an odor.
Noradrenaline Stores Olfactory Memories 
through Dynamic Regulation of Inhibition
H. Demmer, D. Eckmeier, B. Cazakoff [in collaboration 
with A. Koulakov, Cold Spring Harbor Laboratory]
How do we remember individuals that we have pre-
viously encountered? Substantial evidence indicates 
that many animals remember each other based on 
olfactory cues. Memories are especially strong for in-
dividuals encountered during key life events such as 
mating with a new partner or the birth of a litter of 
young. These important events typically evoke mas-
sive release of the neurochemical noradrenaline (NA), 
initiating a heightened state of emotion and arousal. 
This surge appears to cause long-lasting modifi cations 
of the responses to odorants in the olfactory bulb, 
Figure 1. (A) Recording from identiﬁ ed MOB granule cells in the awake and anesthetized mouse. Representative 
recording from a GC in an anesthetized mouse showing a neuronal spiking trace and respiratory signal above. Scale 
bar, 2.5 mV/1 sec. (Lower panel) Photomicrograph of the corresponding neurobiotin-ﬁ lled cell exhibiting hallmark 
GC features. Scale bar, 40 μm. (GCL) Granule cell layer; (MCL) mitral cell layer; (EPL) external plexiform layer; (GL) 
glomerular layer. (B) Representative traces showing the heterogeneity of odor responses in the awake state. In contrast 
to anesthetized state GCs, cells in the awake animals variably responded with activation (awake trace 1), delayed 
onset activation (awake trace 2), and inhibition (awake trace 4) in response to different odors. Scale bar anesthetized, 
5 mV/1 sec. Scale bar awake, 2 mV/1 sec. (C) Distribution of spontaneous ﬁ ring rates during anesthetized (black bars, 
mean ± S.D. = 1.90 ± 1.9 spikes/sec) and awake states (gray bars, mean ± S.D. = 7.41 ± 7.1 spikes/sec). Spontaneous ac-
tivity of GCs is signiﬁ cantly increased in awake animals (Mann–Whitney U test, p = 0.00012). (D) In select cases, indi-
vidual cells were recorded during both anesthesia and wakefulness. Spontaneous ﬁ ring decreases when isoﬂ urane is 
administered (unshaded trace) and returns to preanesthesia level when anesthesia is turned off. Scale bar, 1 mV/1 sec.
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which is the fi rst processing station for scent in the 
mammalian brain. Indeed, it was hypothesized that 
the coincidence of an odor stimulus with a surge of 
NA is minimally suffi cient to store a memory. We have 
been exploiting the intimate relationship among NA, 
olfactory bulb activity, and behavior to trigger and 
observe olfactory memories in mice. We discovered 
that indeed, when NA release is evoked by stimulat-
ing locus coeruleus, the source of most NA, while the 
sleeping mouse sniffed an odorant, neural responses 
to that odor underwent specifi c long-term alterations. 
Remarkably, once awake, the mouse’s subsequent be-
havior toward the odorant was also changed. In other 
words, the mouse seemed to remember the odor and 
treat it as though it were familiar. This fi nding has 
motivated several of our studies into how NA causes 
lasting changes to odor processing circuitry.
Memories are widely believed to be stored as 
changes to the synaptic connections among the neu-
rons in our brains. How are olfactory memories for 
individuals stored mechanistically among the specifi c 
synaptic connections of the various neuronal types in 
the olfactory bulb? In one set of experiments aimed at 
answering this question, Dr. Heike Demmer used her 
techniques for recording granule cells to observe their 
activity during the induction of NA-dependent plas-
ticity. She found that naturalistic stimulation of NA 
release such as occurs in social encounters suppresses 
granule cells. Suppression of granule cells transiently 
increases the excitability of mitral cells by relieving 
them from inhibition. This transient release of mitral 
cells from granule cell control is a key trigger for the 
synaptic plasticity that likely underlies memory. In-
deed, this disinhibitory event triggers selective long-
term changes to mitral cells that signal the presence 
of the learned odor. We have therefore pinpointed the 
synaptic connections between granule cells and mitral 
cells as an important synaptic substrate of individual 
recognition memories.
Dr. Dennis Eckmeier has been taking a different 
approach to observe population mechanisms of NA-
dependent memory formation with functional neural 
imaging. He uses a technique in which the sensory 
neurons that provide input to the olfactory bulb are la-
beled with a fl uorescent activity sensor that allows him 
to monitor the strength of activation in foci called 
“glomeruli.” By comparing the response strength 
of each of these glomeruli before and after NA re-
lease, Dr. Eckmeier has shown that NA weakens the 
response to paired odors. This effect is only observed 
in cases where NA is released during the odor by stim-
ulation of a brainstem structure called locus coeruleus 
(LC). These data establish the synaptic input to the 
MOB as a target of noradrenergic modulation, thus 
revealing that the effects of learning and plasticity in 
the olfactory system extend to remarkably early sen-
sory signaling events.
Vocal Communication Is Impaired 
in a Mouse Model of Rett Syndrome
B. Lau, G. Ewall [in collaboration with J. Huang and 
K. Krishnan, Cold Spring Harbor Laboratory]
Far outside the range of our hearing, in the ultrasound 
range, mice are constantly holding conversations with 
one another in a language that is poorly understood 
at best. Many types of vocalizations are emitted by 
males and females, juveniles and adults, in a variety 
of behavioral contexts. We would like to better un-
derstand the perceptual signifi cance of these calls to 
the mice and how they are used to guide behavioral 
choices. One form of vocalization that is reasonably 
well understood is the ultrasonic distress vocalization 
(USV). Young mice prior to vision and full mobil-
ity will occasionally become separated from the nest. 
This is stressful for them and they will therefore call 
out to their mother with a very high frequency peep. 
New mothers develop sensitivity to these cries and re-
spond by moving toward their source (phonotaxis) to 
retrieve the pup. Moreover, females who have never 
given birth do not innately show approach responses 
to pups or their calls; however, they can learn to per-
form the behavior with experience.
Dr. Billy Lau is collaborating with CSHL profes-
sor Dr. Josh Huang and his postdoctoral fellow Dr. 
Keerthi Krishnan to examine how vocal percep-
tion of pup calls is affected in mice that are miss-
ing one copy of a gene called MeCP2. Impairments 
in the function of this gene are understood to cause 
the autism spectrum disorder Rett syndrome, and the 
Huang lab’s fi ndings regarding mutations in MeCP2 
suggest that they may affect inhibitory networks in 
the auditory cortex important for development of pup 
call sensitivity. Indeed, we fi nd that females which 
possess only a single copy of MeCP2 are not able to 
develop profi ciency at gathering pups. This is an im-
portant fi nding because we describe the fi rst robust 
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behavioral phenotype to be observed in mice that 
most closely genetically resembles humans with Rett 
syndrome. It is also signifi cant that this phenotype 
is a social communication defi cit. Ongoing studies 
are exploring the molecular and neurophysiological 
effects of MeCP2 mutations on circuits in the audi-
tory cortex that facilitate detection of pup calls. Fur-
thermore, we are using this novel behavioral assay to 
assess strategies for ameliorating the effects of Rett 
syndrome.
Neural Activity during Social Encounters
D. Eckmeier
We have begun experiments that are ultimately aimed 
at recording individual neurons during social encoun-
ters and other behavioral assays involving the percep-
tion of social and nonsocial information. There are 
two broad related goals to this approach. The fi rst 
goal is to examine the encoding of social informa-
tion such as body odors and vocalizations in primary 
sensory structures of awake animals. We hypothesize 
that activity in response to these signals may be labile 
to associative learning, attention, and arousal, which 
we may be able to manipulate in the context of social 
encounters. The second goal is to record from neurons 
in deep brain neuromodulatory centers during these 
encounters as well. Neurons that release noradrena-
line and dopamine are likely responsive to social 
signals and may modulate encoding of sensory data 
and associative plasticity. Understanding the context-
dependent activity patterns of these neurotransmitters 
is therefore critical to developing models for how they 
affect behavior.
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NEURAL CODING AND MEMORY FORMATION IN THE 
DROSOPHILA OLFACTORY SYSTEM
G. Turner R. Campbell T. Hige
 E. Gruntman K. Honegger
The brain has a tremendous capacity to form differ-
ent memories. These memories are, under normal 
circumstances, highly accurate for particular stimuli 
and situations. This is precisely the facility that is lost 
in diseases such as Alzheimer’s and other dementias. 
Our overall goal is to understand how the brain forms 
such precise memories: How does the specifi city arise? 
How does the brain derive such tremendous capacity 
for forming different memories?
We address these questions by studying olfactory 
memory formation in Drosophila. Just like Pavlov’s 
dogs, Drosophila learn to form associations between 
smells and reward or punishment. A specifi c area of 
the fl y brain, known as the mushroom body (MB), 
is essential for the fl ies to form olfactory memories. 
We are investigating how the neural activity patterns 
in this brain area are used to form specifi c olfactory 
memories. To achieve this, we monitor activity using 
both electrophysiological and functional imaging 
techniques. We have found that MB neurons exhibit 
highly odor-specifi c responses and that activity pat-
terns are relatively sparse across the population of MB 
neurons. This specifi city is thought to underlie the ac-
curacy of memory: modifying the synapses of highly 
odor-specifi c neurons would lead to relatively precise 
memories. Sparse representations by highly stimulus-
specifi c neurons are a general feature of brain areas 
involved in learning and memory, including hippo-
campus and cerebellum in humans.
Using the simplicity and genetic manipulability of 
Drosophila, our goal is to understand several funda-
mental properties of neural responses in learning and 
memory-related brain areas: What mechanisms give 
rise to the stimulus-specifi city? What exactly is mean-
ingful about the activity patterns? Is it simply which 
cells respond, or does the precise timing of activity 
matter? How are these response patterns modifi ed by 
learning? Ultimately, what are the roles of the many 
genes implicated in learning on network-level activity 
in the brain?
A Population Code for Odor Identity 
in the Drosophila Mushroom Body
R. Campbell K. Honegger, E. Demir, H. Qin, W. Li
Do the neuronal response patterns in the MB convey the 
specifi city of memory formation? If so, what features of 
neural activity underlie that specifi city? To address these 
fundamental questions, we tested whether we could use 
the activity patterns we measure in the MB to predict 
the odor specifi city of fl ies’ memories. We examined this 
in the following contexts: (1) when fl ies learn fi ne dis-
criminations between highly similar odors and (2) when 
they learn an association with one odor, and then gen-
eralize that association to a different, but related odor.
To assess the odor specifi city of the memories, we 
used the standard Pavlovian conditioning protocol, 
training fl ies to form an association with one odor and 
testing the specifi city of those memories by giving fl ies 
a choice between that odor and a second odor. We 
compared this behavioral measure with the specifi city 
of the response pattern of ~150 MB neurons to these 
odors. We found that we could use the MB activity 
patterns to accurately predict the specifi city of mem-
ory formation subsequently measured in behavioral 
experiments.
To evaluate the features of neural activity that un-
derlie accurate memory formation, we developed tech-
niques to track activity of ~80% of the 2000 neurons 
in the MB. The unprecedented scope of these experi-
ments enabled us to fi nd the small differences between 
different odor representations. We found that, even 
when fl ies are forced to choose between two odors 
that are near the limit of their discrimination ability, 
there are neurons that respond to only one odor of the 
pair, so that binary differences are present between the 
two odor representations. These differences are suf-
fi cient to train a biologically realistic model network 
to respond specifi cally to different odors. We have also 
used the activity patterns we measured in the MB to 
predict generalization of odor memories.
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There are two important conclusions from this 
study: (1) Analog differences between odor represen-
tations in the olfactory receptor neurons are convert-
ed to binary differences in the MB, and (2) a simple 
learning scheme of changing synaptic strength of all 
neurons that respond to an odor is suffi cient to ac-
curately determine odor identity. These results show 
how a simple coding scheme can enable accurate but 
generalizable memory formation.
Dendritic Claws of Mushroom Body 
Neurons Integrate the Olfactory Code
E. Gruntman
How is it possible to recognize an odor as a unifi ed smell 
(e.g., coffee) when it has a large number of different 
components, which in turn have many different chemi-
cal features? One idea is that olfactory receptor neurons 
(ORNs) in the nose (fl y’s antennae) each recognize a 
particular feature of an odor, and the overall combina-
tion of activated ORNs conveys the identity of the odor. 
But are there neurons at deeper layers of the brain that 
read this combinatorial code and respond to specifi c 
combinations of co-active inputs? In this work, we show 
that the integration of these different inputs in the fl y 
occurs on the dendritic trees of individual MB neurons.
We addressed this issue by examining odor re-
sponses of individual dendritic input sites, making 
this one of a handful of studies to examine sensory 
responses of dendrites in vivo. To achieve this, we ex-
pressed a calcium-sensitive fl uorescent protein in sin-
gle MB neurons and then used two-photon imaging 
to construct an odor tuning curve for each dendritic 
input site. By comparing tuning curves for different 
dendritic sites, we directly showed that some MB neu-
rons integrate combinations of different inputs.
To evaluate how these inputs are integrated, we used 
optogenetic techniques to control the activity of the 
input neurons. Our results provide an elegant expla-
nation for why MB neurons are so odor-selective. Not 
only do they receive different types of inputs, but they 
require those different inputs to be co-active in order 
for the MB neuron to spike. Examining the time course 
of synaptic summation showed a rapid initial depolar-
ization, which quickly plateaued at a level well below 
spike threshold. Summation of inputs from different 
dendritic sites is also strongly sublinear. Nevertheless, if 
suffi cient numbers of different input sites are activated, 
membrane potential can reach spike threshold. Con-
trary to prevailing models for generating stimulus-spe-
cifi c responses, which rely mainly on supralinear sum-
mation of coincident inputs, our results show a surpris-
ing variant: a demand for strong multiple concurrent 
inputs due to sublinear summation.
Dopamine Controls the Signal-to-Noise 
Ratio of Transmission through 
the Mushroom Body
T. Hige, K. Honegger
Neuromodulators such as dopamine and octopamine 
are essential for learning, but how they act and what 
their precise role is during the learning process has not 
been established. We examined the effects of these 
neuromodulators on activity in the MB. Surprisingly, 
we found that dopamine affects the signal-to-noise 
ratio of odor representations in the MB. Preliminary 
results suggest that dopamine increases the reliability 
of MB responses. Reliability is diffi cult to achieve in 
sparse representations, because neurons typically re-
spond with small numbers of spikes. Thus, it seems 
particularly useful for the circuit to use neuromod-
ulators to increase signal to noise depending on the 
behavioral context the animal is in; essentially, dopa-
mine could control the salience of a stimulus.
In addition, we have shown that dopamine dimin-
ishes odor responses in the neurons that are downstream 
from the MB. Together, these results suggest a model 
where the dopamine acts to make the circuit a selective 
fi lter, increasing the signal-to-noise ratio of responses in 
the MB while decreasing signal transmission through 
the MB. These results may be an excellent entry point 
for studying the fundamental cognitive process of at-
tention, which is essentially a process of fi ltering out 
distracting information to focus on pertinent inputs. 
We are now testing this possibility and investigating the 
precise mechanisms of the dopamine effects.
Mushroom Body Output Neurons and 
Odor Categorization
T. Hige
Almost no studies have examined what happens to sen-
sory information downstream from areas with sparse rep-
resentations. So what happens to odor information after 
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it leaves the MB? In collaboration with Gerry Rubin’s lab 
at Janelia Farm, we have functionally characterized odor 
coding in the complete set of 34 MB output neurons 
(MBONs). The following are our main fi ndings:
1. Synaptic plasticity diversifi es MBON tuning 
properties. We found that uniquely identifi able 
MBONs have strikingly different odor response 
properties across different fl ies. To test whether 
these individual differences are experience-
dependent, we examined odor tuning of the same 
neuron across the two hemispheres of the brain. 
Identical MBONs in the two hemispheres have 
identical odor tuning properties; however, the 
tuning of this neuron is very different across dif-
ferent individual fl ies. This result suggested that 
MBON tuning in each fl y is partly a product of 
that individual’s developmental and experiential 
history. We tested this by showing that a cen-
tral gene in learning and memory, rutabaga, is 
required for these individual differences to arise. 
This experiment is one of the fi rst to show that 
the odor tuning properties of MBONs are shaped 
by synaptic plasticity.
2. MBONs represent categories/groups of odors. We 
examined odor responses across the entire popu-
lation of MBONs and found that MBONs do a 
poor job of representing odor identity, especially 
in comparison to the upstream neurons that con-
stitute the MB itself. This is because certain odors 
evoke extremely similar patterns of response across 
the MBON population. In fact, only three main 
groups of odors were identifi ed based on the pat-
tern of activity in the MBONs. Interestingly, one 
group was composed of odors that are repellent 
to fl ies, whereas another group contained food-
based odors. This is an exciting result because 
few investigators have considered how different 
sensory inputs can be categorized into behavior-
ally meaningful classes. These results suggest that 
olfactory information is shaped into behaviorally 
relevant neuronal signals at this layer, an impor-
tant step in the process of connecting sensory 
input to motor output.
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CIRCUITRY OF UNDERLYING CORTICAL PROCESSING 
AND DECISION-MAKING
A. Zador B. Burbach S.-G. Koh A. Reid
 W. Donovan U. Livneh Q. Xiong
 D. Gizatullina F. Marbach H. Zhan
 S. Jaramillo H. Oyibo P. Znamenskiy
 J. Kebschull I. Peikon
My laboratory is interested in how neural circuits un-
derlie cognition, with a focus on the cortical circuits 
underlying auditory processing and decision-making. 
To address these questions, we use a combination of 
molecular, electrophysiological, imaging, and behav-
ioral approaches.
Characterizing Transposable Element 
Activity in TDP-43-Pathology 
Neurodegenerative Disorders
W. Donovan [in collaboration with J. Dubnau,
Cold Spring Harbor Laboratory]
Mutations of the TAR DNA-binding protein 43 
(TDP-43) have been linked to both amyotropic 
lateral sclerosis (ALS) and frontotemporal lobar 
degeneration (FTLD), debilitating neurodegenera-
tive diseases for which there are no cures, effective 
treatments, or even diagnostic biomarkers. The 
mechanism by which TDP-43 proteinopathy causes 
neurotoxicity is not known. The main goal of this 
project is to test the hypothesis that retrotransposons 
are induced by TDP-43 pathology. To accomplish 
this, we are using the CRISPR (clustered regularly 
interspaced short palindromic repeats) genome edit-
ing system to generate a new mouse model in which 
the endogenous mouse gene contains disease-causing 
amino acid substitutions. We will validate the rel-
evance of our hypothesis by examining TE expres-
sion in human postmortem tissue. Finally, we will 
use cell-culture-based assays to test whether TDP-
43 has an impact on retrotransposon replication and 
whether this involves non-cell-autonomous effects 
that might explain the focality and spread of neuro-
degenerative disorders.
Circuits Underlying Auditory 
Representations and Decisions
S. Jaramillo, U. Livneh, F. Marbach
We are studying the circuits underlying auditory rep-
resentations and how these representations give rise to 
decisions. We train rats and mice to perform well-con-
trolled auditory tasks and then use electrical and opto-
genetic methods to monitor and perturb neural activity. 
We use this approach to study the role of the auditory 
thalamus, cortex, and striatum in these behavioral pro-
cesses. Using tasks in which the stimulus–action associ-
ations vary within a behavioral session, we have uncov-
ered striking similarities in how thalamic and cortical 
neurons are modulated by the animals’ choices.
Sequencing the Connectome
I. Peikon, D. Gizatullina, J. Kebschull, H. Oyibo
We are developing an entirely novel approach to map-
ping neural connectivity which harnesses the high-
throughput power of next-generation sequencing. We 
have engineered a suite of molecular tools to barcode 
individual neuronal connections (BOINC) for read-out 
via DNA sequencing. By mapping neural connectivity 
onto DNA sequencing, we have rendered neural circuit 
reconstruction tractable with current techniques.
Interhemispheric Connections in the 
Auditory Cortex
S. Koh
The callosal projection is a long-range connection be-
tween the left and right auditory cortex, and it is one 
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of the major corticocortical projections in the auditory 
cortex. However, its role in auditory coding is unclear. 
We are studying how manipulating callosal projec-
tion affects auditory representations in the cortex. We 
found that silencing the auditory cortex in one hemi-
sphere suppresses sound-evoked activity in the other 
hemisphere. The suppression effect was stronger for 
late response with latency longer than 40 msec and 
also for the response to sound coming from ipsilateral 
locations. Our results suggest that the callosal projec-
tion is well suited for slow interhemispheric integra-
tion of location-relevant information.
Role of Inhibitory Interneurons 
in Auditory Cortex Function
A. Reid
Fast synaptic inputs to neurons in the auditory cor-
tex are either inhibitory or excitatory. Cortical in-
terneurons are tremendously diverse. One inhibitory 
interneuron subclass, defi ned molecularly by the ex-
pression of parvalbumin (“PV+”), seems to be ide-
ally positioned to mediate the fast component of the 
characteristic barrage of inhibition elicited by a sound. 
We are testing the hypothesis that PV+ inhibitory in-
terneurons mediate fast sound-evoked inhibitory syn-
aptic currents in the auditory cortex. Our proposal 
seeks to establish a causal link between a physiological 
property—the fast sound-evoked inhibition that con-
tributes to receptive fi eld dynamics—and a compo-
nent of the underlying cortical circuitry. We approach 
the problem at three different levels, from brain slices 
through in vivo physiology to behavior. Although we 
are currently focusing on the role of one particular 
interneuron subclass (PV+), our approach combining 
electrophysiological and molecular tools can readily 
be generalized to other subclasses and can be extended 
to probe the circuitry underlying other sensory- and 
behaviorally elicited neuronal responses.
Role of Corticostriatal Plasticity 
in Auditory Decisions
Q. Xiong, P. Znamenskiy
Corticostriatal plasticity has a key role in reinforce-
ment learning, but how associations between stimuli 
and motor responses are established remains unclear. 
Recent work from our group demonstrated a causal 
role of corticostriatal neurons in driving choices dur-
ing an auditory discrimination task, inspired by the 
classic random dot motion task used by Newsome 
and colleagues in macaques, in which subjects were 
required to choose the left or the right response port 
depending on the perceived frequency of a sound. We 
are testing the hypothesis that changes in the strength 
of corticostriatal synapses underlie the association be-
tween sound and action required to perform this task. 
Our results indicate that changes in the strength of a 
specifi c subset of corticostriatal synapses encode the 
arbitrary association between stimulus and motor re-
sponse. Because all sensory cortical areas send projec-
tions to the striatum, our fi ndings suggest a general 
mechanism for the formation of arbitrary sensorimo-
tor transformations.
Labeling Speciﬁ c Neuronal Subtypes by 
Ribozyme Mediated Trans-Splicing
H. Zhan, I. Peikon
We are developing a novel strategy to label specifi c 
neuronal subtypes by using ribozyme-mediated 
trans-splicing to couple recombinase (e.g., Cre) 
mRNAs into endogenous target genes (e.g., soma-
tostatin or parvalbumin), mRNA and the expres-
sion of recombinase in specifi c neuronal cells being 
switched into the expression of an exogenous trans-
gene such as green fl uorescent protein (GFP) or red 
fl uorescent protein (RFP). Our approach, if suc-
cessful, has the potential to allow monitoring and 
manipulation of specifi c cell types even in model 
systems, such as rats and primates, that are not as 
genetically tractable as mice.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong J. Beshel Y. Shuai
 S. Khurana C. Xu
Food Odor Value Coding in the Fly Brain 
via Neuropeptide Y Homolog
J. Beshel
Chemosensation is a critical regulator of food-seek-
ing behaviors across animal species. Food odor alone 
can trigger the appropriate approach for investiga-
tive behaviors essential for survival. Yet very little is 
known about how the brain determines odor value, 
let alone of potential food sources specifi cally. Our 
analysis of the Drosophila brain extends the role of a 
small number of hunger-sensing neurons to include 
food-odor value representation. In vivo two-photon 
calcium imaging shows that the amplitude of food 
odor-evoked activity in neurons expressing Drosophila 
neuropeptide F (dNPF), the neuropeptide Y homo-
log, strongly correlates with food-odor attractiveness. 
Hunger elevates neural and behavioral responses to 
food odors only, although heightened responses also 
exist for some food odors when fed. Inactivation of a 
subset of dNPF-expressing neurons or silencing dNPF 
receptors abolishes food-odor attractiveness, whereas 
genetically enhanced dNPF activity not only increases 
food-odor attractiveness, but also promotes attraction 
to aversive odors. Varying the amount of presented 
odor produces matching graded neural and behavioral 
curves that can function to predict preference between 
odors. We thus demonstrate a possible motivationally 
scaled neural “value signal” accessible from uniquely 
identifi able cells.
The Mushroom Body Circuit Underlying 
Fruit Fly Forgetfulness
Y. Shuai, A. Hirokawa
Like memorization, forgetting is also a delicately orga-
nized process at both the molecular and neural circuit 
levels. We have been studying forgetting mechanisms 
using a relatively simple model organism, the fruit fl y. 
Although fl ies readily learn to avoid odorants paired 
with a mild foot shock punishment, the learned aver-
sion declines substantially in a few hours. We previ-
ously showed that this rapid early memory forgetting 
is tuned by a cytoskeleton-regulating molecular cas-
cade headed by small G protein Rac. Rac function was 
mapped to the mushroom body (MB) γ lobe neurons. 
This subset of MB intrinsic neurons comprises ~700 
cells in each hemisphere and sends parallel axons to 
the MB medial lobes, where they are intersected by a 
few dozen of the so-called extrinsic (MBex) neurons 
from heterogeneous sources. How these MBex neu-
rons are involved in forgetting is not clear. We thus 
screened ~40 MBex Gal4 drivers, which together shall 
cover most types of the MBex neurons connected to 
the medial lobes. A few of them, when coupled with 
neuron-silencing genetic tools, showed memory en-
hancement, indicating that they are part of the MB 
forgetting circuit. In particular, three of these Gal4s 
label a common single pair of neurons, which we 
named the MB-M9 neurons. MB-M9 appear to be 
feedback neurons that receive input from one specifi c 
axonal compartment of the γ lobe, γ4, and project 
back to other axonal compartments of the γ lobe and 
to areas outside the MB as well. We are in the process 
of detailing the anatomy of MB-M9 and evaluating 
their interactions with other MB neurons. We hope 
that these efforts will shed light on the organization of 
the MB circuit underlying fruit fl y forgetting.
NF1 and Memory in Drosophila
C. Xu
Neurofi bromatosis type 1 (NF1) is a genetic disorder 
affecting one in 3500 people in the population. Af-
fected individuals manifest overgrowth of various 
types of tissue and some patients show cognitive de-
fects. The mutated gene responsible for NF1 disorder 
is called neurofi bromin and it is conserved among 
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species. When the neurofi bromin gene is deleted, the 
Drosophila animal model has both learning and long-
term memory defects in olfactory aversive condition-
ing. In contrast to the aversive conditioning, the ap-
petitive conditioning is more effective in forming long-
term memory by single training trails, whereas aversive 
conditioning needs multiple training trails. Here, we 
showed that neurofi bromin is also required for nor-
mal appetitive memory performance. We are currently 
mapping the circuits in which neurofi bromin is in-
volved to maintain normal appetitive memory.
Decision-Making in Drosophila Larvae
S. Khurana
In the previous year, we initiated the development of 
an image acquisition, tracking, and analysis system to 
measure the behavioral responses of animals. We have 
specifi cally focused on the larvae of Drosophila mela-
nogaster because of the genetic toolkit of the fruit fl y. 
The two-dimensional locomotion of larvae, compared 
with the three-dimensional movement of an adult fl y, 
makes the tracking relatively straightforward. Addi-
tionally, larvae have a much smaller number of neu-
rons than the adult fl y, making the problem of neu-
ral mapping of behavior potentially more tractable. 
This year, we completed the development of the fi rst 
iteration of the tool and are working to make it an 
online-accessible package that can be easily modifi ed 
for many other tracking and analysis purposes. The 
advances of our analysis compared to other contem-
porary such methods was our ability to look at the 
sequence of patterns in behavior, instead of simply 
looking at the isolated features. Additionally, we can 
track multiple animals at the same time, increasing 
the effi ciency of measures. Using this method, we 
have looked at the conditioned behavior of larvae to 
ask if there is a difference in behavioral sequences be-
tween innate and acquired responses to odors. Our 
results show a severalfold increase in the frequency 
and duration in the slow phases (when animals slow 
down and frequently change the direction of their lo-
comotion) when animals make a choice to approach 
or avoid the conditioned odor over such decisions in 
innate response. Whether this is entirely capturing the 
sequence of the decision-making behavioral pheno-
type in larvae or whether our measurements contain 
some noise arising from stimulus concentration issues 
currently remains to be settled. The long-term goals 
of this line of work are to create a more effi cient drug 
and more mutant screens and to improve behavioral 
measurements in general.
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PLANT BIOLOGY
David Jackson and colleagues study genes and signals that regulate plant growth and architec-
ture. They are investigating a unique way in which plant cells communicate, by transporting 
regulatory proteins via small channels called plasmodesmata. These channels, which direct the 
fl ow of nutrients and signals through growing tissues, are regulated during development. The 
team discovered a gene encoding a chaperonin, CCT8, that controls the transport of a transcrip-
tion factor SHOOTMERISTEMLESS (STM) between cells in the plant stem cell niche, or 
meristem. STM is critical for stem cell maintenance, and studies of the CCT8 gene indicate that 
movement of STM between cells is required for this function. The lab also continues to identify 
other genes that control plant architecture through effects on stem cell maintenance and identity, 
and their work has implications for crop yields. Recent examples include discovery of a subunit 
of a heterotrimeric G protein that is conserved throughout animals and plants, and their studies 
indicate that this gene controls stem cell proliferation. They have found that in plants, the G 
protein interacts with a completely different class of receptors than in animals. Their discovery 
helps to explain how signaling from diverse receptors is achieved in plants. This year, they also 
demonstrated that weak mutations in one of the receptor proteins can enhance seed produc-
tion in maize, which could lead to yield increases. Separately, the lab has characterized system-
wide networks of gene expression, using “next-gen” profi ling and chromatin immunoprecipita-
tion methods that have revealed many new hypotheses in developmental networks controlling 
infl orescence development. They are also developing a collection of maize lines that can drive 
expression of any reporter or experimental gene in any tissue type—tools of great interest to 
maize researchers that are being made available to the broader scientifi c community, enabling 
experiments never before possible in crop plants.
Zachary Lippman’s research focuses on the process of fl owering and fl ower production, which is 
a major contributor to plant reproductive success and agricultural yield. By identifying genes that 
control how tomato plants produce their fl owers in their characteristic repeated zigzag arrange-
ment (e.g., tomatoes on a vine), Lippman’s lab is addressing when and how fl owering branches 
known as infl orescences develop on plants, particularly fruit-bearing plants. Of particular interest 
is how these “reproductive phase transitions” have contributed to the evolution of diverse infl ores-
cence branching patterns in tomato’s larger Solanaceae family, which includes plants that make 
just one fl ower, such as pepper and petunia, in each infl orescence, to plants whose infl orescences 
produce dozens of branches and hundreds of fl owers, such as many wild species of tomato. Using 
a combination of genetic, genomic, and molecular approaches, Lippman is dissecting the gene 
networks that are responsible for the variation in infl orescence branching found in nature. He 
hopes to leverage these discoveries to improve crop yields. Already, his work on genes that are re-
sponsible for the production and activity of a universal fl owering hormone known as fl origen has 
resulted in novel approaches to fi ne-tune plant architecture and fl ower production, boosting yield 
beyond leading commercial varieties. To continue hunting for new genes, Lippman has adopted 
a systems-biology approach and next-generation sequencing technology to capture those genes 
that are active as stem cells mature from a vegetative to a reproductive state. Nearly 4000 genes 
were found to refl ect the existence of a “maturation clock,” and one of the clock genes known as 
Terminating Flower acts as a key regulator to maintain a progressive pace to fl owering—which in 
turn, dictates how many fl owers are produced on each tomato infl orescence. Finally, the Lippman 
lab determined the genome sequence of the “currant tomato,” the wild ancestor of larger-fruited 
cultivated tomatoes, in order to better understand how fl ower and fruit production changed dur-
ing the process of crop domestication.
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Epigenetic mechanisms of gene regulation—chemical and conformational changes to DNA and 
the chromatin that bundles it—have had an important impact on genome organization and in-
heritance and on cell fate. These mechanisms are conserved in eukaryotes and provide an addi-
tional layer of information superimposed on the genetic code. Robert Martienssen, a pioneer in 
the study of epigenetics, investigates mechanisms involved in gene regulation and stem cell fate in 
yeast and model plants including Arabidopsis and maize. He and his colleagues have shed light 
on a phenomenon called position-effect variegation, caused by inactivation of a gene positioned 
near densely packed chromosomal material called heterochromatin. They have discovered that 
small RNA molecules arising from repeating genetic sequences program that heterochromatin. 
Martienssen and colleagues have described a remarkable process by which “companion cells” to 
sperm in plant pollen grains provide them with instructions that protect sperm DNA from trans-
poson damage. They found that some of these instructions, or epigenetic marks, could be inher-
ited in the next generation. With collaborators in Mexico, Martienssen has also coaxed Arabidop-
sis, a fl owering plant, to produce egg cells without meiosis, an important step toward a long-time 
goal of plant breeding: generating clonal offspring to perpetuate hybrid vigor. The lab has also 
shown that when RNA polymerase II has transcribed a stretch of DNA, the RNA interference 
mechanism causes the enzyme to release its hold on the DNA and fall away. This allows the repli-
cation fork to progress smoothly and the DNA strands to be copied; histone-modifying proteins, 
which follow right along, establish heterochromatin. Martienssen’s group also continues to work 
on problems related to the creation of plant-based biofuels. This year, as part of a collaborative 
project to generate a high-quality full genome map of the oil palm plant, Martienssen and his col-
leagues identifi ed a single gene that controls the yield of oil palm trees. This discovery will increase 
yields and should lessen the environmental burden of oil palm production, which often threatens 
already endangered rainforest lands.
The growing tips of plants, called meristems, contain a population of stem cells that serve as a 
persistent source of daughter cells from which new organs, such as leaves, arise. Marja Timmer-
mans and colleagues are studying the genetic networks that regulate plant stem cell activity. Using 
genomic approaches, they have defi ned gene expression signatures that distinguish indeterminate 
stem cells from their differentiating derivatives. They have also worked out the mechanism that 
suppresses stem cell fate to allow cells to differentiate and have shown that this process requires 
a highly conserved epigenetic gene silencing mechanism. In particular, Timmermans’ group has 
shown that specifi c DNA-binding proteins mediate the recruitment of Polycomb repressive com-
plexes to stem cell factors, an action that stably represses their expression in differentiating organs. 
This work addresses a major unresolved question in the fi eld of epigenetics: how Polycomb pro-
teins, which do not bind DNA themselves, recognize defi ned targets. Plant stem cells also produce 
signals important for the patterning of lateral organs. The lab has discovered that small RNAs can 
traffi c from cell to cell and are among the stem-cell-derived signals. They have found that polarity 
in leaves is established via opposing gradients of mobile small RNAs that act as morphogen-like 
signals. Their most recent fi ndings identifi ed a third small RNA gradient involved in maintenance 
of organ polarity. These fi ndings illustrate the complexity with which small RNAs generate devel-
opmental patterns. Currently, they are investigating parameters of small RNA mobility and the 
unique patterning properties of resulting small RNA gradients. Mathematical modeling predicts 
that such gradients might serve to generate robustness during development.
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DEVELOPMENTAL BIOLOGY: STEM CELLS, SIGNALING, 
AND CONTROL OF PLANT ARCHITECTURE
D. Jackson R. Balkunde I. Liao K. Vera
 A. Eveland A. Masson S. Vi
 S. Hiraga A. McGarry R. Willen
 B. Il Je M. Pautler Y.G. Wolfenson
 T. La Rue E. Shea Q. Wu
 S. Lee H. Thanh Bui T. Zadrozny
Our research aims to identify genes, signals, and path-
ways that regulate plant growth and development. All 
organisms develop by carefully controlling the fl ow of 
information that passes between cells and tissues. We 
are particularly interested in discovering the signals 
that carry this information, in fi nding out how the 
signals are transmitted, and how they function. In one 
project, we are investigating a unique way in which 
plant cells communicate, by transporting regulatory 
proteins via small channels called plasmodesmata. 
These channels, which direct the fl ow of nutrients and 
signals through growing tissues, are regulated during 
development. We are using genetic screens to iden-
tify novel factors that control the transport of a tran-
scription factor, SHOOTMERISTEMLESS (STM), 
between cells in the plant stem cell niche, or meri-
stem. STM is critical for stem cell maintenance, and 
our studies indicate that movement of STM between 
cells is required for this function. We also continue 
to identify other genes that control plant architecture 
through effects on stem cell maintenance and identity.
Recent examples include discovery of a subunit of a 
heterotrimeric G protein that is conserved throughout 
animals and plants, and our studies indicate that this 
gene controls stem cell proliferation. In animal sys-
tems, the G protein interacts with a class of receptors 
that are called GPCRs (G-protein-coupled receptors), 
but we have found that in plants, the same protein 
interacts with a completely different class of receptors. 
Our discovery helps explain how signaling from di-
verse receptors is achieved in plants. This past year, 
we also demonstrated that weak mutations in one of 
the receptor proteins can enhance seed production in 
maize, which could lead to yield increases. We have 
also identifi ed new genes that control maize ear de-
velopment and are busy fi guring out their mode of ac-
tion. Separately, our lab has characterized system-wide 
networks of gene expression in infl orescence develop-
ment, using “next-gen” profi ling methods, and we 
are developing a collection of maize lines that can 
drive expression of any reporter or experimental gene 
in any tissue type. These tools are of great interest to 
maize researchers and are being made available to the 
broader scientifi c community, enabling experiments 
never before possible in crop plants.
Regulation of Cell-To-Cell Trafﬁ cking 
of the KNOTTED1 Transcription Factor
R. Balkunde, H. Bui
Cell-to-cell communication functions in specifying 
cell fate and coordinating development in all multi-
cellular organisms. However, unlike animal cells, 
plant cells have cell walls that could limit exchange 
of signal molecules between neighboring cells. Plants 
have therefore developed symplasmic connections 
by means of special structures called plasmodesmata 
(PDs). PDs allow the selective traffi cking of signal-
ing macromolecules, such as transcription factors and 
RNAs. In addition to cell-fate specifi cation, PDs are 
involved in viral movement, transport of metabolites, 
and cell-to-cell spread of RNA interference (RNAi), 
which points to their fundamental importance in co-
ordinating plant defense, metabolism, and develop-
ment. Despite the discovery of PDs more than 100 
years ago, the underlying components and mecha-
nisms of PD traffi cking remain poorly understood. 
Hence, we are taking an unbiased genetic strategy to 
dissect these molecular mechanisms, using a reporter 
system involving Arabidopsis leaf trichomes as an easi-
ly scorable phenotype and the developmentally impor-
tant mobile proteins KNOTTED1 and its Arabidopsis 
homolog SHOOTMERISTEMLESS.
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The trichome rescue system designed by our lab 
is widely used to characterize the mobility of a pro-
tein. Briefl y, GL1 is required for trichome formation 
in the Arabidopsis leaf epidermis, and it is cell au-
tonomous. Therefore, GL1, when expressed in me-
sophyll in gl1 mutants, does not rescue trichomes. 
However, when fused to KN1 (GL1-KN1), it now 
results in trichome rescue, as the mobile KN1 brings 
GL1 into the epidermis. Ethylmethanesulfonate 
(EMS) mutagenesis screening using this system, fol-
lowed by Illumina high-throughput sequencing, has 
previously resulted in identifi cation of a mutation 
in a gene encoding CCT8, a chaperonin subunit. 
This led to an exciting discovery that chaperonin 
facilitates KN1 cell-to-cell traffi cking and stem cell 
maintenance in Arabidopsis, which clearly supports 
the functional relevance of chaperonin-mediated 
traffi cking through PD. These results highlight the 
importance of protein conformational changes for 
PD traffi cking.
Current efforts are focused on understanding the 
mechanism of CCT8 action and identifying new 
traffi cking regulators. Our efforts have resulted in 
the identifi cation of potential mutants with interest-
ing developmental defects, in addition to loss of tri-
chome rescue. For example, mutant 1058 has leaf-
shape  defects, and mutant 1066 has narrow and 
elongated leaves and an enlarged vegetative meristem 
(Fig. 1). We have mapped these mutants to a region of 
~0.7 Mb on the upper arm of chromosome 3 (1058) 
and lower arm of chromosome 4 (1066) using clas-
sical marker-based mapping. We next identifi ed po-
tential candidates within these mapping regions using 
next-generation sequencing. We found four novel 
single-nucleotide polymorphisms (SNPs) in coding 
regions within the mapping region for each mutant. 
Interestingly, some of the putative candidates have 
been reported in the PD proteome. The putative can-
didates also include genes in families that have been 
implicated in traffi cking through PD. Currently, we 
are confi rming the causal mutations using T-DNA 
insertional mutants and by rescue experiments using 
transformation compatible bacterial artifi cial chro-
mosomes (BACs) (TAC) clones. Once we have identi-
fi ed the candidates, we will proceed with the detailed 
characterization of the mechanisms and their biologi-
cal signifi cance in plant growth and development in 
the context of developmental defects observed in our 
mutants.
Role of PDLPs in Cell-To-Cell 
Communication and Meristem 
Development
H. Bui, K. Vera
PDs are channels connecting adjacent plant cells. 
These channels are formed during cell division, 
when strands of endoplasmic reticulum are trapped 
in the cell wall formed between daughter cells. 
Many development regulatory proteins, including 
transcription factors (TFs), are found to act non-
cell autonomously by moving through PDs. Clas-
sic examples included the homeobox TF KN1, the 
GRAS TF SHORTROOT (SHR), the myeloblasto-
sis (MYB) TF CAPRICE (CPC), the WD40 protein 
TRANSPARENT TESTA GLABRA1 (TTG1), and 
FLOWERING LOCUS T (FT). Although KN1 
and SHR are required for proper development and 
morphogenesis in the shoot and root. respectively, 
TTG1 is important for trichome and root hair pat-
terning, and FT regulates fl owering induction. Inter-
cellular traffi cking of these proteins is required for 
their function.
Despite the importance of targeted PD traffi ck-
ing in plant development, little is known about the 
Figure 1. Trafﬁ cking mutant 1066 has developmental pheno-
types and loss of trichomes (A). (A’) Enlarged image of inset 
marked in A, showing enlarged meristem.
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mechanism of this process. PD resident proteins and 
PD traffi cking regulators have been identifi ed in ge-
netic and proteomic screens. Our research focuses 
on studying a family of eight PD-localized proteins 
(PDLP 1–8) identifi ed in a proteomic study of the 
PD-enriched membrane fraction. Interestingly, 
PDLP2 and PDLP3 are expressed in specifi c domains 
in the shoot meristem, raising a question about their 
roles in traffi cking of stem-cell regulators, especially 
KN1 and STM. Moreover, we found that the triple 
pdlp mutant (pdlp1/pdlp2/pdlp3) exhibits interesting 
petal number phenotype (Fig. 2), suggesting that 
PDLPs are also important for fl oral development. 
We aim to elucidate the role of PDLPs in regulating 
protein traffi cking in the plant stem cell population. 
This study, along with genetic screen using the tri-
chome rescue system, will provide insight in to the 
general mechanism of intercellular traffi cking and, 
more specifi cally, in to its role in stem cell develop-
ment, which will have broad signifi cance and rel-
evance to all multicellular systems.
Generation of a pOp-LhG4 trans-Activation 
System for High-Throughput Protein 
Localization and Functional Studies in Maize
Q. Wu, T. Zadrozny [in collaboration with A. Chan, J. Craig 
Venter Institute; A. Sylvester, University of Wyoming]
Recent advances in sequencing technology have gener-
ated genome sequences from nearly all groups of organ-
isms. These massive data sets have revolutionized the 
types of biological questions that can now be address ed. 
Despite the ability to predict the function of some pro-
teins by comparative bioinformatics, experimental vali-
dation remains necessary to assign function defi nitively. 
One effective approach to validate gene function is to 
express the gene tissue or cell specifi cally. Currently, we 
are developing a pOp-LhG4 trans-activation system in 
maize that allows researchers to express genes of interest 
in different tissue or cell types.
The pOp-LhG4 system includes (1) a chimeric 
promoter, pOp, that consists of lac operators cloned 
upstream of a minimal CaMV promoter and (2) a 
transcription activator, LhG4, which is a fusion be-
tween a high-affi nity DNA-binding mutant of lac 
repressor, LacIHis17, and transcription activation do-
main II of GAL4 from Saccharomyces cerevisiae. The 
pOp promoter is not activated in the reporter lines 
until crossed with activator lines that express LhG4 
driven by appropriate tissue-specifi c promoters. Thus, 
the pOp-LhG4 trans-activation system allows specifi c 
expression or missexpression of any gene of interest. 
Using our experience in maize promoters, we are now 
developing different driver and reporter lines in maize 
that enable precise experimental intervention to study 
gene function. We have already generated several con-
stitutive, meristem, embryo, root, and leaf-specifi c 
LhG4 drivers, including pEF1A, pUBIQUITIN, 
pRAMOSA3, pWUSCHEL, pCRWAQ81, pSUT1, 
pSH1, pGBL1, and pYABBY14 (Fig. 3), as well as a 
pOp responder line, pOp-ZCN8::YFP (maize ho-
molog of fl owering inducer, FT), as a means to test 
the specifi city of the system with a readout in fl ow-
ering time. We found that neither the driver plants, 
pEF1A::LhG4, nor the responder plants, pOp::ZCN8-
YFP, showed an early-fl owering phenotype, whereas 
the F1 plants containing both pEF1A::LhG4 and 
pOp::ZCN8-YFP showed early fl owering (Fig. 3). We 
are now working to create additional tissue- specifi c 
LhG4 driver lines and responder lines. Our goal is to 
pro duce an array of cell- and tissue-specifi c LhG4 lines, 
Figure 2.  Abnormal ﬂ oral developmental phenotype in pdlp mutants. Col-0, 
wild type. pdlp triple mutants have additional ﬂ oral organs, suggesting a mer-
istem defect.
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which we will use to (1) isolate specifi c cell types by 
fl uorescence-activated cell sorting (FACS) for tran-
scriptional profi ling and (2) drive the missexpression of 
developmentally regulated genes in order to better un-
derstand the changes that occur within stem cell niches 
during differentiation and development. Data on the 
characterization of our FP and LhG4 transgenic lines, 
including confocal micrographs, movies, and recent 
publications, can be found on our website http://maize.
jcvi.org/cellgenomics/ index.php
Control of Shoot Meristem Size and 
Phyllotaxy by the Maize Glutaredoxin 
Abphyl2
F. Yang, H. Thanh Bui, M. Pautler [in collaboration with 
V. Llaca and H. Sakai, DuPont Crop Genetics, Wilmington, 
Delaware]
Phyllotaxy is a major taxonomic indicator and it affects 
plant architecture and light capture effi ciency. Maize 
abphyl (abph) mutants change phyllotaxy from alter-
nate to decussate and develop an enlarged shoot apical 
meristem (SAM). We describe here a new dominant 
phyllotaxy mutant, Abph2. Abph2 mutants have an en-
larged SAM and a decussate leaf pattern that becomes 
visible at leaf ~4–5 stage. Map-based cloning brought 
Abph2 into a region of ~20 kb on chromosome 7, con-
taining fi ve predicted genes in the reference B73 ge-
nome. However, direct sequencing, as well as transcript 
analysis by reverse transcriptase–polymerase chain re-
action (RT-PCR), did not give any obvious clues as 
to the identity of the gene. Therefore, a BAC library 
generated from the Abph2 mutant was screened using 
probes located within the 20-kb mapping interval. 
BAC sequencing revealed a 4.5-kb fragment inserted 
into the mapping interval. This inserted fragment con-
tained a predicted glutaredoxin gene identical to a gene 
(named MSCA1) located ~800 kb upstream. A trans-
genic line containing this 4.5-kb fragment fused with 
yellow fl uorescent protein (YFP) tag phenocopied the 
dominant Abph2 phyllotaxy defect, showing that the 
inserted glutaredoxin gene (named Abph2 hereafter) is 
the cause of the decussate leaf phenotype. Meanwhile, 
putative knockout lines of the dominant Abph2 muta-
tion were screened by EMS mutagenesis. Sequencing 
the Abph2 gene in these knockout lines found point 
mutations leading to conserved amino acid changes 
in each line, further pinpointing the inserted glutare-
doxin gene as Abph2. RNA in situ hybridization indi-
cated that the Abph2 transcripts accumulate in P0 leaf 
primordia and vasculature. However, this expression 
pattern was unaltered in Abph2 mutants. More care-
ful investigation showed that Abph2 transcripts start 
to accumulate in embryos from 12 days after pollina-
tion (DAP), but we detected a missexpression of Abph2 
at 18 DAP, when ~4 leaves have been initiated. This 
altered expression pattern likely explains the altered 
phenotype in the mutant.
The Abph2 gene is identical to MSCA1. Loss of 
MSCA1 leads to male sterility but a normal phyllotaxy. 
A detailed meristem size comparison revealed a signifi -
cant decrease in msca1 mutants. This fi nding demon-
strates that MSCA1 normally functions to promote 
meristem growth. Abph2/MSCA1 encodes a CC-type 
glutaredoxin protein, similar to Arabidopsis ROXY1 
and ROXY2 genes. Recently, ROXY1 and ROXY2 were 
found to interact with basic leucine zipper (bZIP) tran-
scription factors, including PERIANTHIA (PAN), 
which is related to the FASCIATED EAR4 (FEA4) 
recently cloned in our lab. Loss of FEA4 function re-
sults in a larger meristem, as well as altered phyllotaxy, 
Figure 3.  Maize transactivation system. (Left-most panel) pYabby14::LhG4//pOp::TagRFP-T speciﬁ cally 
expresses in leaf primordia (LP, white dots = nuclei) and not in the shoot apical meristem (SAM). (Right 
panels) A plant containing both pEF1A::LhG4 and pOp::ZCN8-YFP constructs showed an early-ﬂ ower-
ing phenotype (arrowhead points to tassel).
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similar to Abph2. Using yeast two-hybrid and bimolec-
ular fl uorescence complementation (BiFC) assays, we 
confi rmed that ABPH2 and FEA4 interact, suggesting 
that these genes may defi ne a new pathway in meristem 
proliferation control.
The Regulation of Meristem Size in Maize
B. Il Je, Q. Wu, M. Pautler, T. La Rue, A. Masson, 
P. Bommert, S. Lee, A. Eveland [in collaboration with 
M. Komatsu and H. Sakai, DuPont Crop Genetics]
All plant organs derive from populations of stem cells 
called meristems. These stem cells have two purposes: to 
divide to replace themselves and to give rise to daughter 
cells, which will differentiate into lateral organs. Con-
sequently, meristems must precisely control the size of 
the stem cell niche via a network of positive and nega-
tive feedback signals. A loss of function in a negative 
regulator of stem cell fate can result in an enlarged or 
fasciated meristem phenotype and a dramatic alteration 
in the morphology of the maize ear and tassel.
Maize is an excellent genetic model system because 
of a large collection of developmental mutants and a 
sequenced reference genome. Our lab has undertaken 
a forward genetic approach to identify key regulators 
of stem-cell homeostasis and meristem size. Two pre-
viously cloned mutants, fasciated ear2 and thick-tassel 
dwarf1, encode orthologs of the Arabidopsis thaliana 
genes  CLAVATA1 and CLAVATA2, indicating the well-
known CLAVATA-WUSCHEL regulatory feedback 
loop is conserved from dicots to monocots. However, 
little else is known about the control of this important 
developmental process in maize. Here, we describe 
our progress in identifying additional genes contrib-
uting to stem-cell niche homeostasis.
ct2 is a classical mutant of maize that exhibits a fas-
ciated infl orescence phenotype as well as semidwarfi sm. 
Using a map-based cloning approach, we found that ct2 
encodes the α subunit of a heterotrimeric  GTPase, a mem-
brane-associated protein involved in the transduction of 
extracellular signals to induce specifi c cellular responses 
by activating downstream effectors. ct2 is epistatic to fea2 
with respect to spikelet density and meristem size, sug-
gesting that they act in a common pathway. We made a 
CT2 fusion with YFP driven by its endogenous promot-
er and found localization to the plasma membrane. In 
coimmunoprecipitation experiments (Co-IPs), we found 
that FEA2 and CT2 interact, implicating heterotrimeric 
G-protein signaling in the CLAVATA signaling pathway. 
To gain a better understanding of the cross-talk between 
G-protein signaling and the CLAVATA pathway, we 
need to determine whether CT2 directly interacts with 
FEA2 or if other proteins mediate their interaction. Our 
Co-IP experiments in Nicotiana benthamiana suggested 
that removing the intracellular tail of FEA2 did not af-
fect the FEA2–CT2 interaction, indicating that their 
interaction may require other mediators. Additionally, 
our Co-IP results showed that the pseudokinase 
 CORYNE interacts with FEA2, but not CT2, indicat-
ing that CORYNE is not the mediator of FEA2 and 
CT2 interactions. Using immunoprecipitation (IP)-
mass spectrometry, we have identifi ed an LRR-RLK 
protein that interacts with both FEA2 and CT2. This 
interaction has been further confi rmed using Co-IP ap-
proaches. Currently, we are trying to fi gure out if this 
LRR-RLK is required for FEA2–CT2  interactions. This 
research introduces a new paradigm in G-protein signal-
ing, because G proteins interact exclusively with seven 
pass trans-membrane receptors in mammals and fungi.
Another fasciated ear mutant that we have cloned 
is fasciated ear 3 ( fea3), which was derived from a ra-
diation mutagenesis screen in Russia. fea3 shows an 
overproliferation of the infl orescence meristem. We 
cloned this gene using map-based cloning, and the 
mutant results from the insertion of a partial ret-
rotransposon into an exon of the FEA3 locus. We con-
fi rmed this identity by isolation of new alleles from an 
EMS-targeted mutagenesis. fea3 encodes a predicted 
leucine-rich repeat receptor-like protein, related to 
fea2. In situ hybridization and RFP-tagged transgenic 
plants show that FEA3 is expressed in the organizing 
center of the SAM, as well as in the root apical meri-
stem (Fig. 4). FEA3 is localized in the plasma mem-
brane and intracellular vesicles. To determine whether 
FEA3 responds to a CLV3-related (CLE) peptide, we 
tested its sensitivity to different peptides. fea3 mutants 
showed reduced peptide sensitivity, but interestingly, 
they responded to a different CLE peptide compared 
to fea2. Double mutants of fea2/fea3 and td1/fea3 have 
additive and synergistic fasciated phenotypes, indicat-
ing that they may act in independent pathways that 
converge on the same downstream target to control 
meristem size. The CLAVATA receptors restrict WUS 
expression to the organizing center (OC) and prevent 
its spread to the overlying central (CZ) and peripheral 
zone (PZ). However, the mechanism restricting WUS 
expression from the rib zone (RZ) below is poorly 
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understood. Comparing FEA3-RFP and WUS-RFP, 
we fi nd that FEA3 is expressed in the RZ just below 
the region of WUS expression, and WUS expression 
spreads downward in fea3 mutants. fea3 ortholog mu-
tants in Arabidopsis resemble CLAVATA mutants in 
having fasciated infl orescence stems, but they do not 
show abnormal fl ower structure like CLAVATA mu-
tants. These results indicate that FEA3 is a receptor 
protein that functions in a new pathway distinct from 
that of known CLAVATA receptors.
Another mutant, fasciated ear4, is a semidwarfed 
maize mutant that also has fasciated ears and tassels. 
These phenotypes are caused by enlarged vegetative and 
infl orescence meristems, which have lost control of the 
pathways normally regulating meristem size. We mapped 
fea4 to a bZIP transcription factor with an EMS-induced 
base transition causing a premature stop codon. Two ad-
ditional alleles also contained mutations in the gene, and 
we obtained a series of transposon-induced mutant al-
leles through collaboration with  DuPont  Pioneer, con-
fi rming that we have identifi ed a novel gene required 
for the control of meristem size in maize.
We have subsequently investigated the function of 
fea4 through several parallel approaches. We used in 
situ hybridization to determine its expression pattern 
during different stages of development. During vegeta-
tive development, fea4 is expressed in the peripheral 
zone of the SAM and is dramatically excluded from 
the stem cell niche and the site of leaf initiation. This 
unique expression pattern suggests that fea4 does not 
act by directly infl uencing the stem cells in the cen-
tral zone of the SAM, but rather by infl uencing the 
process of differentiation in the peripheral zone. We 
have generated plants expressing a translational fusion 
of YFP with FEA4 under the control of its native pro-
moter. These plants express the fusion protein in the 
nucleus of cells in the expected domain, closely match-
ing the mRNA expression pattern. We used these lines 
for chromatin immunoprecipitation followed by high-
throughput sequencing (ChIP-Seq) experiments to 
determine genome-wide binding of FEA4 to its target 
loci. The YFP-tagged transgenic lines will also be used 
for IP-mass spectrometry experiments in the future. We 
have also obtained a global picture of transcriptional 
changes in the mutant by mRNA sequencing, and are 
beginning to follow up on downstream genes that may 
mediate fea4 action. A number of genes that showed 
signifi cant expression differences in fea4 mutants com-
pared to wild-type siblings were involved in determi-
nacy and differentiation, including key developmental 
regulators of maize infl orescence architecture, and in 
auxin-based signaling and transport. The majority of 
genes in these categories were down-regulated in the 
fea4 mutant, suggesting that FEA4 promotes their ex-
pression, whereas genes that were up-regulated in the 
mutant tended to be related to metabolic processes. 
Additional approaches include making double-mutant 
combinations between fea4 and other meristem regula-
tion mutants. So far, these analyses have suggested that 
fea4 acts outside of the canonical meristem size regula-
tion pathways, consistent with a role in buffering the 
balance between division and differentiation.
Beyond these advances, we are in the process of 
mapping additional fasciated ear mutants from EMS 
mutagenesis screens. We have determined approximate 
positions for several of these mutants and are proceed-
ing with fi ne mapping and molecular cloning.
Deﬁ ning the Regulatory Networks 
Controlling Inﬂ orescence Architecture 
in Maize
A.L. Eveland, M. Pautler, T. La Rue, A. Goldshmidt [in 
collaboration with D. Ware and S. Kumari, CSHL/USDA-
ARS; S. Hake and M. Lewis, PGEC/USDA-ARS, University of 
California, Berkeley; E. Vollbrecht, Iowa State University]
Infl orescences bear the fruits and grains that we eat, and 
thus understanding the genetic and regulatory basis 
Figure 4.  RFP-tagged FEA3 is expressed in the organizing center 
of inﬂ orescence meristems of ear and tassel and in vascular ini-
tial cells of the root apical meristem (RAM).
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for how these structures are formed has agronomic 
importance in determining yield. Infl orescence archi-
tecture among cereal crops is diverse, yet characterized 
by a unique morphology, where fl owers are borne on 
short, determinate branches called spikelets. In maize, 
these spikelets are paired, an exclusive feature of the 
tribe Andropogoneae, which includes other important 
cereal and bioenergy crops. Variations in infl orescence 
branching patterns arise from position and develop-
mental fate of differentiating stem-cell populations 
called meristems. The coordinated actions of key de-
velopmental regulators, as well as genetic interactions 
between them, modulate meristem initiation, size, and 
determinacy during maize infl orescence development. 
Our goal is to understand the mechanisms by which 
these regulators act to control infl orescence architec-
ture, what other factors and/or biological processes are 
involved in this regulation, and how these regulatory 
networks coordinate development in space and time.
Our approach integrates large-scale genomics data 
sets, such as gene expression profi les achieved by high-
throughput RNA sequencing, with discrete morpho-
logical features in development. Here, we character-
ized precise timing of developmental transitions at 
the molecular level in maize infl orescences, by asso-
ciating spatiotemporal dynamics in gene expression 
with morphological changes resulting from genetic 
perturbations. For the latter, we used loss-of-function 
mutants in three important regulators of the ramosa 
(ra) pathway, which controls stem-cell fate and the 
decision to branch.
In a recently published study (Eveland et al. 2014), 
we identifi ed discrete developmental modules that 
contribute to identity and determinacy of grass-specif-
ic meristem types. Notably, we defi ned a module for 
spikelet pair meristem determinacy consisting of co-
expressed genes that were largely misexpressed in ra1 
mutants, including known determinacy factors co-
opted from other developmental contexts, along with 
genes of unknown function. In situ hybridizations 
for candidate genes in this module showed that they 
shared largely overlapping and/or adjacent expression 
domains during development. To elucidate additional 
factors that may act upstream in the control of this 
determinacy module, we mined for enrichment of 
known cis-regulatory elements within the promoters 
of coexpressed genes. We identifi ed experimentally de-
fi ned binding sites for bZIP transcription factors (TFs) 
and KNOTTED1 among the most highly enriched 
regulatory elements associated with this module. Con-
sistent with this fi nding, many of the coexpressed genes 
within this module were identifi ed as putative targets 
of KN1 and FEA4, a bZIP TF, based on ChIP-Seq pro-
fi les. We are currently integrating TF occupancy maps 
from different ChIP-Seq experiments, and by associat-
ing cobound targets with RNA-Seq-based transcript 
profi les from respective loss-of-function mutants, we 
are beginning to elucidate combinatorial gene regula-
tion on a genome-wide scale. For example, we found 
that ~50% of the high-confi dence FEA4-binding sites 
overlapped directly with those of KN1. Differential 
expression analysis of genes proximal to shared bind-
ing sites suggested that KN1 and FEA4 acted either 
together or in opposition to regulate a number of genes 
involved in organ differentiation and auxin-related 
processes, suggesting interfaces between meristem 
maintenance and size pathways. FEA4 also bound and 
modulated ramosa1, indicating a link between meri-
stem size and determinacy pathways. Furthermore, 
fea4 gene expression is signifi cantly down-regulated in 
ra1, ra2, and ra3 loss-of-function mutants, suggesting 
feed-forward regulation.
Our RA1 ChIP-Seq experiment identifi ed ~1000 
high-confi dence target genes in proximity to sites 
bound by RA1. Of these, approximately one-fourth 
showed altered expression in the ra1 mutant back-
ground, suggesting that they are modulated targets 
of RA1. We also showed that RA1 acts as both an 
activator and a repressor of gene expression, and the 
mechanism of RA1 action is dependent on spatio-
temporal context. One of the more interesting RA1 
target genes is liguleless1 (lg1), which appears to be di-
rectly repressed by RA1 in determinate spikelet pair 
meristems. We further showed that in the absence of 
RA1, lg1 is expressed at the base of long infl orescence 
branches, for example, in ra1 mutant ears and long 
tassel branches. This fi nding is consistent with recent 
work that identifi ed lg1 as a key candidate locus in an 
association study for infl orescence architecture traits. 
One hypothesis is that lg1 may be promoting branch 
identity by initiating a boundary, similar to its veg-
etative role in specifying the blade-sheath boundary. 
To test conserved and divergent mechanisms of LG1 
function in the leaf versus the infl orescence, we are 
using ChIP-Seq to identify LG1 targets in both tis-
sue types. We are also further investigating potential 
regulatory motifs that are enriched within the binding 
sites of RA1 to resolve consensus TF-binding sites for 
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RA1 and/or cofactors that may be involved in regula-
tion of its downstream targets.
Functional characterization of candidate genes 
from these networks is currently under way, includ-
ing in situ hybridizations, analysis of loss-of-function 
mutant alleles, and crosses to ra mutants to reveal 
potential genetic interactions. Because ra1 has been 
implicated as an important locus in the domestication 
of maize and is found only in Panicoid grasses, these 
data are being used in comparative analyses with other 
grasses to further understand RA1 function and the 
evolution of grass infl orescence architecture. We are 
also now trying to understand the effects of environ-
mental perturbation, specifi cally drought stress, on 
these developmental networks.
Control of Branching and Determinacy 
in Plant Shoots
Y.G. Wolfenson, T. Zadrozny, R. Willen, S. Hiraga
The RAMOSA (RA) genes in maize function to im-
pose determinacy on axillary meristem growth, and 
consequently, ra loss-of-function mutants (ra1, ra2, 
and ra3) have more highly branched infl orescences. 
RA3 encodes a predicted metabolic enzyme, a tre-
halose phosphate phosphatase. The disaccharide tre-
halose is not abundant in plant tissues, and it may 
have a regulatory role because it has been implicated 
in stress protection, control of sugar signaling, and 
regulation of photosynthetic rate. Ours is the fi rst 
indication that trehalose has a specifi c developmen-
tal function. RA3 is expressed in a localized domain 
at the base of axillary infl orescence meristems, and 
it localizes to nuclear and cytoplasmic compart-
ments, suggesting that its effect on development is 
not simply metabolic. The RAMOSA (RA) genes de-
fi ne a boundary domain that surrounds the develop-
ing branch meristem, rather than being deployed in 
the meristem itself. These data support the hypoth-
esis that RA genes may serve as mediators of signals, 
maybe a sugar signal, originated at the boundary 
domain and regulating determinacy. RA3 itself may 
have a transcriptional regulatory function, since it af-
fects the expression of specifi c genes.
To further investigate the mechanism of RA3 ac-
tion, we searched for mutants in Arabidopsis orthologs. 
One of them has an interesting phenotype that is relat-
ed to development and determinacy. Its late-fl owering 
phenotype is accompanied by reduced size and shorter 
roots and fusion of cauline leaves to the main stem. 
Furthermore, double mutants with an additional TPP 
paralog show indeterminate fl oral phenotype of the ra3 
maize phenotypes. A YFP fusion of one of the TPP 
genes shows nuclear localization in roots, supporting 
the idea that it has regulatory functions (Fig. 5B).
Additionally, we are taking genetic approaches to 
identify factors that act in the same pathway with 
RA3 to control spikelet pair meristem determinacy, 
by screening for enhancer/suppressor modifi ers of 
the ra3 phenotype. Typically, ra3 mutants in a B73 
background have three to eight branches only at the 
base of the ear; we mutagenized ra3 mutants and 
looked for plants that have more branches and/or 
have branches at the upper part of the ear. So far, we 
have identifi ed several enhancers and have mapped 
two of them. One maps to an ra3 paralog and the 
second to a giberellic acid metabolic gene, suggest-
ing that GA hormone signaling may interface with 
branching regulation.
Natural Variation and Inﬂ orescence 
Architectures
S. Vi, I. Liao, P. Bommert
Maize infl orescence architectures have been a target 
for extensive selection by breeders since domestication; 
hence, different maize inbreds vary greatly in these 
traits. The genetic basis underlying this diversity is 
Figure 5.  (A) tpp mutants make extra ﬂ oral organs. (B) A TPP-YFP 
fusion shows expression in the root elongation zone (EZ) and is 
nuclear (inset).
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largely unknown and is of great interest for both fun-
damental and applied science. Now with the wealth of 
genomic data, we are equipped to study them. To iden-
tify natural variation relevant to infl orescence traits, 
we looked for inbred backgrounds that can enhance/
suppress the phenotypes of the mutants on which we 
work. We focused on the 25 NAM (nested association 
mapping) founder inbreds because they were selected to 
capture the diversity of maize germplasm and because 
of the genetic tools available for these inbreds. We have 
been crossing these 25 inbreds to our collection of mu-
tants (often in B73 background) and screen the F2 for 
plants with suppressed/enhanced phenotype compared 
to the mutant in the original inbred background.
We have identifi ed a suppressor of ramosa3 (ra3) 
coming from the Mo17 inbred, an enhancer coming 
from the Ki11 inbred, and an enhancer of fea2 coming 
from the NC350 inbred. Segregation ratios suggest one 
semidominant locus for the Mo17-derived suppressor, 
two or more loci for the Ki11-derived enhancer, and 
one recessive locus for NC350-derived enhancer. We 
are now in the process of rough mapping by bulked seg-
regant analysis. Additionally, because the natural modi-
fi ers are often results of quantitative trait loci (QTL) 
rather than single-gene effects, we crossed the mutants 
to the corresponding NAM-founder/B73 RILs, in 
order to identify and map potential modifying QTL.
PUBLICATIONS
Bommert P, Nagasawa NS, Jackson D. 2013. Quantitative variation 
in maize kernel row number is controlled by the FASCIATED 
EAR2 locus. Nature Genet 45: 334–337.
Bommert P, Je B, Goldshmidt A, Jackson D. 2013. The maize Gα 
gene COMPACT PLANT2 functions in CLAVATA signalling to 
control shoot meristem size. Nature 502: 555–558.
Carillo P, Feil R, Gibon Y, Satoh-Nagasawa N, Jackson D, Bläsing O, 
Stitt M, Lunn JE. 2013. A fl uorometric assay for trehalose in the 
picomole range. Plant Methods 9: 21.
Christensen SA, Nemchenko A, Borrego E, Murray I, Sobhy IS, 
Bosak L, Deblasio S, Erb M, Robert CA, Vaughn KA, et al. 2013. 
The maize lipoxygenase, ZmLOX10, mediates green leaf volatile, 
jasmonate and herbivore-induced plant volatile production for de-
fense against insect attack. Plant J 74: 59–73.
Lituiev DS, Krohn DG, Müller B, Jackson D, Hellriegel B, Dres-
selhaus T, Grossniklaus U. 2013. Theoretical and experimental 
evidence indicates that there is no auxin gradient patterning 
the angiosperm female gametophyte. Development 140: 4544–
4553.
Pautler M, Tanaka W, Hirano HY, Jackson D. 2013. Grass Meristems 
I: Shoot apical meristem maintenance, axillary meristem deter-
minacy, and the fl oral transition. Plant Cell Physiol 54: 302–312.
Tanaka W, Pautler M, Jackson D, Hirano HY. 2013. Grass meristems 
II: Infl orescence architecture, fl ower development and meristem 
fate. Plant Cell Physiol 54: 313–324.
In Press
Eveland A, Goldshmidt A, Pautler M, Morohashi K, Liseron-Monfi ls 
C, Lewis M, Kumari S, Hiraga S, Yang F, Unger-Wallace E, et al. 
2014. Regulatory modules controlling maize infl orescence archi-
tecture. Genome Res 24: 431–443.
Huyen Bui and Rachappa Balkunde
170-197_PlantBiol.indb   180 19-08-2014   08:34:28
181
PLANT DEVELOPMENTAL BIOLOGY, STEM CELLS, AND FLORAL 
BRANCHING SYSTEMS
Z.B. Lippman C. Brooks S.J. Park
 K. Jiang S. Thomain
 K. Liberatore C. Xu
 C. MacAlister
Developmental Origins of Plant Shoot 
Architecture
In plants, populations of stem cells called apical meri-
stems (AMs) give rise to all above-ground organs and 
guide shoot architecture. After a seed germinates, an 
AM from the embryo produces a primary shoot with 
lateral leaves that give rise to AMs in their axils. AMs 
formed early in a plant’s life are initially small and fl at 
and maintain a relatively constant number of cells, 
enabling persistent growth. Upon perceiving environ-
mental cues that stimulate genetically encoded sig-
nals, AMs undergo reproductive transitions, marked 
by increasing size and becoming a dome. During this 
transition, leaf shape and size can be altered, internode 
length can change, and apical dominance is released to 
promote branching.
Although useful for understanding principles of 
meristem activity and potential, this framework fails 
to explain the remarkable architectural diversity of 
plants, especially variation in the number and ar-
rangement of branches (Park et al. 2014). Branch-
ing variation traces back to differences in when and 
where meristems form, whether they begin growing 
immediately or experience dormancy, how long they 
grow, how large they become, and the number of ad-
ditional meristems they generate. At the center of this 
diversity lie two processes: (1) meristem maturation, 
during which AMs repeatedly experience a reduction 
of a vegetative promoting program and an increase of 
a fl oral promoting program, and (2) meristem main-
tenance, which is responsible for controlling stem-cell 
proliferation and meristem size. Our research aims to 
elucidate and understand the mechanisms control-
ling meristem maturation and maintenance, focusing 
on the fl oral branching systems (infl orescences) of 
tomato and related Solanaceae (e.g., pepper and to-
bacco). Using the virtues of Solanaceae development, 
including readily accessible meristems for molecular 
analysis, we are addressing the hypothesis that diver-
sity in shoot and infl orescence architecture is deter-
mined by evolutionary differences in rates of meristem 
maturation and meristem size.
Tomato Architecture and Flower Production
Tomato plants generate hundreds of multifl owered 
infl orescences due to sympodial growth, the defi n-
ing feature of which is that each meristem terminates 
in a fl ower and new growth originates from axillary 
meristems that also terminate, but at varying rates 
of maturation to control shoot architecture (Fig. 1). 
In tomato, the primary shoot meristem (PSM) ma-
tures gradually to typically produce eight leaves before 
Figure 1.  Tomato meristems and sympodial plant architecture in 
normal and tmf mutant plants. (A–C) Wild-type shoot architec-
ture (A,B) and tmf mutant phenotypes (C). (D–F) TMF expression 
and localization in situ showing expression at periphery of veg-
etative meristem (D), 35S:TMF-GFP leaves showing localization 
in nuclei (E). RNA-Seq showing expression is highest in vegeta-
tive meristems (F).
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terminating in the fi rst fl ower of the primary infl ores-
cence. This gradual maturation leads the PSM into a 
full reproductive state, which is required to initiate two 
types of axillary “sympodial” meristems. Just below 
the terminating PSM, a sympodial infl orescence meri-
stem (SIM) develops and gives rise to one new SIM 
before quickly terminating with no intervening leaves. 
Several iterations of this process produce a compound 
multifl owered infl orescence composed of fused short 
fl oral branches. Later infl orescences likewise originate 
from sympodial meristems; in the axil of the last PSM 
leaf, a sympodial vegetative meristem (SYM) matures 
at an intermediate rate to develop three leaves before 
terminating in the fi rst fl ower of the second infl ores-
cence. This process repeats to produce a compound 
vegetative shoot with equally spaced infl orescences. 
Axillary meristems from lower leaves repeat the PSM. 
Our research aims to elucidate the mechanisms con-
trolling meristem maturation and maintenance in 
order to gain an understanding of the diversity of 
Solanaceae infl orescences ranging from single fl owers 
(e.g., pepper) to highly branched with dozens of fl ow-
ers (e.g., wild tomatoes).
The Role of TERMINATING FLOWER 
in Inﬂ orescence Architecture
C. MacAlister, C. Xu
Our prior work has shown that mutations in COM-
POUND INFLORESCENCE (S, homolog of WUS-
CHEL HOMEOBOX 9), ANANTHA (AN, homolog 
of UNUSUAL FLORAL ORGANS), and FALSIFLO-
RA (FA, homolog of LEAFY ) cause more SIMs, and 
thus branches and fl owers, to develop, because termi-
nation is delayed (s mutants) or never achieved (an, fa) 
(Jiang et al. 2013). S is expressed late in maturation 
just before activation of AN, which encodes an F-box 
protein that interacts with its transcription factor partner 
FA to form a fl oral specifi cation complex. Thus, one 
mechanism promoting maturation and multifl ow-
ered infl orescences involves S leading meristems to a 
 reproductive stage when AN can activate to trigger fl o-
ral termination, which, in turn, is required for the ini-
tiation and proper maturation of SIMs. Given a mech-
anism promoting maturation, we wondered whether a 
mechanism also exists to repress maturation, or main-
tain a vegetative meristem state. Compromising such a 
mechanism might lead to more rapid termination and 
infl orescences with fewer fl owers. We therefore turned 
to the tmf mutant, which fl owers early and produces 
a single fl ower infl orescence on the primary shoot 
(Fig. 1). We found that TMF encodes a member of 
the ALOG (Arabidopsis LSH1 and Oryza G1) protein 
family, of which there are 12 members in tomato. TMF 
expression peaks in vegetative meristems in a bound-
ary domain, then drops when AN is activated. ALOGs 
contain a DNA-binding domain, suggesting transcrip-
tion factor function; indeed, TMF is in the nucleus 
and can activate transcription in yeast, but native tar-
gets are unknown. In a yeast two-hybrid (Y2H) screen 
using TMF as bait, we identifi ed several transcription-
al regulators, the most prominent being homologs of 
the Arabidopsis BTB/POZ domain-containing BOP1 
and BOP2 proteins, which are expressed in boundary 
domains like TMF and are best known for roles in leaf 
development, fl oral patterning, and organ abscission. 
Tomato has three BOP genes (tBOP1/2/3), and based 
on bimolecular fl uorescence complementation (BiFC) 
confi rming all three tBOP proteins interact with TMF 
in tomato nuclei, we have begun generating RNA inter-
ference (RNAi) knockdown (tbop-kd) plants. Pheno-
typic and molecular analyses of our fi rst tbop-kd plants 
suggest that tBOP genes function with TMF to control 
infl orescence architecture by preventing precocious ac-
tivation of AN transcription during the vegetative phase 
of meristem growth. We are now developing resources 
to identify transcriptional targets of TMF and will also 
perform detailed developmental and molecular analysis 
of tBOP genes to understand their roles in fl owering 
and other aspects of tomato  development.
Divergent Evolution of Genes and 
Gene Expression Programs Underlies 
Solanaceae Inﬂ orescence Diversity
K. Jiang, S.J. Park
Evolution of phenotypic diversity traces to divergent 
evolution of genes and proteins by changes in the 
regulatory networks that lead to differential execu-
tion of conserved developmental programs. One hy-
pothesis for the range of diverse infl orescence forms 
in the Solanaceae family ranging from a single fl ower 
to highly branched multifl ower infl orescences is that 
meristems mature at different rates to guide fi nal infl o-
rescence form. To test this idea and investigate if and 
to what extent there is evolutionary variation in rates of 
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maturation, we used deep sequencing to capture tran-
scriptome dynamics of meristem maturation from fi ve 
Solanaceae species representing the range of infl ores-
cence architecture. Transcriptomes across species are 
more similar at both early (vegetative) and late (fl o-
ral) meristem maturation stages, but more divergent at 
the intermediate stage when the transition from veg-
etative to reproductive growth occurs. Interestingly, 
genes that peak in expression in early and late stages 
are evolutionarily more conserved at the protein level 
compared to genes that peak during the transition. By 
comparing expression dynamics of orthologous genes, 
we established a Solanaceae Transcriptome Maturation 
Index (TMI), defi ned by gene expression weighted by 
their “earliness” in expression during meristem matu-
ration. Using the TMI, we found that greater branch-
ing is associated with a pronounced delay in meristem 
maturation compared to tomato, whereas production 
of simple infl orescences, such as the single fl ower in-
fl orescences of pepper, is associated with a more rapid 
maturation. Our work has led us to propose a “bubble” 
model of Solanaceae meristem maturation, in which 
greater divergence in gene expression dynamics and 
protein similarities during the reproductive transition 
compared to vegetative and fl oral stages is responsible 
for modulating infl orescence diversity.
Inﬂ orescence Architecture and the 
Control of Meristem Size
K. Liberatore, C. MacAlister, S. Thomain
In many plants, infl orescence branching is infl uenced 
by meristem size. Meristem size is tightly controlled 
through a process of “meristem maintenance,” in 
which stem cells lost to lateral organ formation are 
continuously replenished through cell division. Work 
in Arabidopsis, maize, and rice has shown that con-
served components of the CLAVATA (CLV ) signaling 
pathway control meristem maintenance by restrict-
ing stem cell proliferation, but how meristem size is 
regulated in other plants remains poorly understood. 
By studying tomato mutants showing “fasciated” 
phenotypes of infl orescence branching and enlarged 
fl owers and fruits, we isolated a mutation in FASCI-
ATED AND BRANCHED (FAB, ortholog of the Ara-
bidopsis receptor kinase gene CLV1), indicating that 
the CLV pathway is conserved in tomato (Fig. 2). We 
also discovered fasciated infl orescence (fi n) and fasci-
ated and necrotic ( fan), both of which are defective in 
genes encoding glycosyltransferases (GTs), specifi cally 
a hydrox yproline O-arabinosyltransferase and arabino-
syltransferase, respectively. Arabinosyltransferases are 
enzymes that transfer arabinoside moieties to diverse 
Figure 2.  ﬁ n and fab mutant phenotypes. (A–H) Images and quantiﬁ cation of mature inﬂ orescence 
(IF), ﬂ ower, and fruit phenotypes. Representative secondary inﬂ orescences of wild type (A), fab (B), 
and ﬁ n (C) and the primary IF of ﬁ n (D). (D) The ﬁ n-polyopha2 mutant from Solanum pimpinel-
lifolium. Floral image insets within each panel show the increased number of sepals and petals in 
both fab and ﬁ n mutants. The base of each IF is marked with an arrow, and points of IF branching 
are marked with arrows; bars, 1 cm. (E–G) Mature fruits showing increased locule number and 
fruit size in fab and ﬁ n mutants that converts the wild-type M82 roma-sized tomatoes to beefsteak-
sized; bars, 1 cm. (H) Quantiﬁ cation of ﬂ oral organ number (mean ± S.D.).
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proteins, including a three-arabinoside chain on the 
small signaling peptide CLV3 whose biological rel-
evance has been unclear. Thus, our discovery of FIN 
and FAN suggests that GTs have critical roles in stem-
cell proliferation and that glycosylation of tomato 
CLV3 might be required for activity. Interestingly, fan 
mutants also senesce prematurely, leading to necrosis 
and death, which might result from a failure to prop-
erly glycosylate other important signaling peptides, 
such as PSY1, recently shown in Arabidopsis to regu-
late hormonal balance and defense. We are now aim-
ing to integrate genetic, molecular, and biochemical 
approaches to study FIN and FAN in order to under-
stand the roles of glycosylation in the signaling path-
ways that regulate stem-cell proliferation, senescence, 
and defense signaling in tomato.
Diverse Developmental Roles 
for the FIN Family
C. MacAlister
FIN is a member of a deeply conserved GT family. To 
compare developmental roles of FIN genes in diverse 
species, we analyzed mutations in the three FIN-like 
family members in Arabidopsis. Surprisingly, no mu-
tant phenotypes were observed in the single mutants, 
but double mutants of fi nl1;fi nl2 showed severe pollen 
tube growth defects. Although double-mutant pollen 
can germinate, pollen tubes arrest in the transmit-
ting tract of the ovary and fail to target ovules. Such 
striking phenotypic consequences between mutations 
in tomato and Arabidopsis FIN genes is surprising 
considering the deep conservation of this GT family. 
To further explore FIN family function, we created 
mutations in two paralogous FIN genes in the moss 
Physcomitrella patens. Moss development involves ger-
mination of a haploid spore followed by formation 
of a vegetative body (colony) composed of fi lamen-
tous protonemal network containing two cell types: 
slower-growing chloronema for photosynthesis and 
faster-growing caulonema to colonize the surround-
ing substrate. Interestingly, knocking out the more 
highly expressed FIN gene (PpFINLa) results in larger 
and faster colonizing colonies, owing to enhanced 
caulonema production relative to chloronema. Im-
portantly, although pollen tubes and caulonema are 
both tip-growing cells, the process of tip growth itself 
is unaffected in both systems. These results point to 
an exciting link between glycosylation and meristem 
size regulation, pollen tube guidance, and the balance 
between fi lament types in moss. We are currently in-
vestigating whether FIN proteins target distinct sets 
of proteins for glycosylation in different systems and 
developmental contexts.
Improving Flower Production and 
Yield through Dosage Sensitivity 
of the Florigen Pathway
S.J. Park, K. Jiang, K. Liberatore
For more than a century, it has been known that in-
breeding harms plant and animal fi tness, whereas in-
terbreeding between genetically distinct individuals 
can lead to more robust offspring in a phenomenon 
known as heterosis.
Although heterosis has been harnessed to boost ag-
ricultural productivity, its causes are not understood. 
Especially controversial is a model called “overdomi-
nance,” which states in its simplest form that a single 
gene can drive heterosis. In tomato, a mutation in 
just one of two copies of the gene SINGLE FLOWER 
TRUSS (SFT ) encoding the fl owering hormone called 
fl origen causes remarkable increases in yield, but it is 
not known why. One clue is that overdominance is 
only observed in the background of “determinate” 
plants, in which the continuous production of side 
shoots and infl orescences gradually halts due to a de-
fect in the fl owering repressor SELF PRUNING (SP). 
One possibility we have explored is that sft overdomi-
nance is based on epistatic interactions between SFT 
and SP, which have opposing roles in fl owering time 
and shoot architecture. Using transcriptome sequenc-
ing of shoot meristems, we have found that sft mutant 
heterozygosity causes weak semidominant delays in 
fl owering of both primary and side shoots, which ex-
tends the period of fl ower and fruit production. Thus, 
sft heterozygosity triggers a yield improvement by op-
timizing plant architecture via its dosage response in 
the fl origen pathway.
Our fi ndings suggest that dosage sensitivity of 
fl origen and potentially other genes in the fl origen 
pathway could be exploited to further improve to-
mato architecture and yield. Given that heterozy-
gous mutations in SFT partially relieve sp-imposed 
determinacy, we screened for new suppressors of de-
terminacy and isolated a weak allele of sft and two 
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mutations in SUPPRESSOR OF SP (SSP), the latter 
resulting in a highly desirable indeterminate form 
in which fl ower clusters (infl orescences) continu-
ously develop every two leaves instead of the typi-
cal three (Fig. 3). We show that the SSP mutations 
disrupt a critical motif in a bZIP transcription factor 
required to establish a “fl origen activation complex.” 
By generating all combinations of sft and ssp mutant 
heterozygotes in the sp background, we created a 
quantitative range of determinate architectures and 
found that specifi c combinations of ssp and sft double 
heterozygotes provide a new architectural optimum 
that leads to the highest yields. Our fi ndings show 
the power of using fl origen pathway mutations to 
customize tomato architecture, fl ower production, 
and yield, and they suggest that creating similar ge-
netic toolkits in other crops could broadly benefi t 
future breeding.
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Figure 3.  Mutations that suppress sp. (A) Diagrams show left-to-right architectures of wild-type, 
sp mutants, sft sp double mutants, and sft/+ sp plants. The latter two genotypes suppress the sp 
determinate phenotype, and sft/+ mutant heterozygosity leads to increased ﬂ ower production and 
yield. (B) Images show new suppressor of sp (ssp) mutants that restore indeterminacy and result in a 
desirable form of sympodial growth, in which inﬂ orescences form every two leaves instead of every 
three (ssp-2129).
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EPIGENETIC INHERITANCE IN PLANTS AND FISSION YEAST
R. Martienssen S. Bhattacharjee H.S. Kim A. Shimada
 S. Castel C. LeBlanc J. Simorowski
 A.-Y. Chang S.C. Lee R. Tirado-Magallanes
 K. Creasey A. Molla-Morales U. Umamaheswari
 F. de Sousa Borges J.-S. Parent C. Underwood
 M. Donoghue A.C. Pastor
 E. Ernst M. Regulski
 J.-J. Han J. Ren
 R. Herridge B. Roche
 Y. Jacob A. Schorn
Plants and fi ssion yeast provide excellent model or-
ganisms to address the question of how epigenetic 
information is propagated, including transposon 
regulation, heterochromatic silencing, and gene im-
printing, important both for plant breeding and for 
human health. We are investigating the role of RNA 
interference (RNAi) in heterochromatic silencing in 
the fi ssion yeast Schizosaccharomyces pombe and in the 
plant Arabidopsis thaliana, as well as continuing our 
work on Zea mays. In fi ssion yeast, we have found 
additional evidence that DNA replication promotes 
spreading of heterochromatin and that RNAi pro-
motes replication by releasing RNA polymerase II. In 
plants, we have found that the genome undergoes lim-
ited reprogramming of DNA methylation in pollen, 
guided by DNA glycosylases and small RNA. Using 
mutants defi cient in histone and DNA methylation, 
we have found that histone variants and microRNA 
(miRNA) contribute to reprogramming by targeting 
transposons. Our results suggest a model for imprint-
ing, transposon control, and the origin of epialleles. 
We continue to develop duckweeds as a source of bio-
fuel and have developed an effi cient transformation 
and gene control system in Lemna minor. Sequencing 
of the oil palm genome has provided some important 
clues as to how to increase oil yields and reduce tropi-
cal deforestation.
This year, we said good-bye to Fred vanEx, Joe Ca-
larco, and Alex Canto Pastor, who left for positions 
in Gent, Stanford, and Cambridge, respectively. We 
welcomed postdocs Rowan Herridge (University of 
Otago), Sonali Bhattacharjee (Oxford University), 
and Jean Sebastien Parent (INRA Versailles, Paris) 
and student Roberto Tirado-Magallanes (UNAM, 
Mexico).
Reprogramming the Epigenome 
in Arabidopsis Pollen
F. Borges, J.P. Calarco, Y. Jacob, C. LeBlanc, F. Van Ex 
[in collaboration with F. Berger, Temasek Life Sciences 
Laboratory Singapore; T. Kenoshita, Nara Institute of 
Science, Japan; T. Higashiyama, Nagoya University, Japan]
Germline reprogramming of DNA methylation is 
important for transposon silencing and epigenetic in-
heritance. In plants, the male gametophyte is derived 
from haploid microspores via two postmeiotic cell di-
visions to give rise to the gametes (sperm cells, SC) 
and the vegetative cell (VC). The purifi cation of these 
three individual cell types, coupled with genome-wide 
DNA methylation analysis and small RNA sequenc-
ing, has revealed a dynamic regulation of the epig-
enome during gametogenesis. In Arabidopsis, the fre-
quency of single-base variation of DNA methylation 
is much higher than genetic mutation, and, interest-
ingly, variable epialleles are premethylated in the male 
germline. However, these same alleles are targeted for 
demethylation in the pollen vegetative nucleus, by a 
mechanism that seems to contribute to the accumula-
tion of small RNAs that reinforce transcriptional gene 
silencing in the gametes. In mammals and plants, pa-
rental genomic imprinting restricts the expression of 
specifi c loci to one parental allele. Interestingly, im-
printed loci are also demethylated in the vegetative 
nucleus (VN) resembling variable epialleles in accu-
mulating small RNA in sperm. We have found that 
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de novo RNA-directed DNA methylation (RdDM) 
regulates imprinting at some of these loci when they 
are expressed in the endosperm. RdDM in somatic tis-
sues is required to silence expression of the paternal 
allele. In contrast, the repression of RdDM in female 
gametes participates with or without the DME re-
quirement in the activation of the maternal allele. The 
contrasted activity of DNA methylation between male 
and female gametes appears to be suffi cient to prime 
imprinted maternal expression. After fertilization, 
MET1 maintains differential expression between the 
parental alleles. RdDM depends on small interfer-
ing RNAs (siRNAs). The involvement of RdDM in 
imprinting supports the idea that sources of siRNAs 
such as transposons and de novo DNA methylation 
were recruited in a convergent manner in plants and 
mammals in the evolutionary process leading to selec-
tion of imprinted loci.
Selective Methylation of Histone H3 
Variant H3.1 Regulates Heterochromatin 
Replication
Y. Jacob, M.T.A. Donoghue, C. LeBlanc, C.J. Underwood, 
[in collaboration with S. Michaels, Indiana University; 
D. Reinberg, New York University Medical School; and 
J.-F. Couture, University of Ottawa]
Histone variants have been proposed to act as deter-
minants for posttranslational modifi cations (PTM) 
with widespread regulatory functions. We have found a 
histone-modifying enzyme that selectively methylates 
the replication-dependent histone H3 variant H3.1. 
The crystal structure of the SET domain of the his-
tone H3 lysine 27 (H3K27) methyltransferase ARA-
BIDOPSIS TRITHORAX-RELATED PROTEIN 
5 (ATXR5) in complex with an H3.1 peptide shows 
that ATXR5 contains a bipartite catalytic domain 
that specifi cally “reads” alanine 31 of H3.1. Variation 
at position 31 between H3.1 and replication-indepen-
dent H3.3 is conserved in plants and animals, and 
threonine 31 in H3.3 is responsible for inhibiting the 
activity of ATXR5 and its paralog ATXR6 (Fig. 1). 
Our results suggest a simple model for the mitotic 
inheritance of the heterochromatic mark H3K27me1 
and the protection of H3.3-enriched genes against 
heterochromatization during DNA replication. Un-
modifi ed histone H3.1 may trigger overreplication of 
heterochromatin and contribute to reprogramming in 
pollen that lacks H3.1 in the VN.
miRNAs Trigger Widespread Epigenetically 
Activated siRNAs from Transposons in 
Arabidopsis
K.M. Creasey, M. Regulski, F. Borges, F. Van Ex [in 
collaboration with B.C. Meyers, University of Delaware]
Transposons in Arabidopsis give rise to abundant 
21- nucleotide “epigenetically activated” small interfer-
ing RNAs (easiRNAs) in DECREASE IN DNA METH-
YLATION1 (ddm1) and DNA METHYLTRANSFER-
ASE1 (met1) mutants, as well as in pollen from wild-
type plants, in which heterochromatin is lost during 
reprogramming. easiRNA biogenesis is dependent on 
ARGONAUTE1 (AGO1), DICER-LIKE4 (DCL4), and 
RNA-DEPENDENT RNA POLYMERASE6 (RDR6), 
resembling 21-nucleotide trans-acting (ta)siRNAs and 
other secondary siRNA in this respect. However, the fac-
tor that triggers easiRNA biogenesis from transposons 
Figure 1.  The selectivity pocket and safety belt of ATXR5/6-type 
H3K27 methyltransferases are responsible for histone H3.1 prefer-
ence over histone H3.3. (A) Alignment of the amino-terminal tails 
of the canonical histone H3 variants H3.1 and H3.3 from A. thali-
ana highlighting residue 31A or T. (B) In vitro histone lysine meth-
yltransferase assay using recombinant chromatin containing plant 
histone H3.1, plant histone H3.3 or plant histone H3.3 T31A. (C) 
The structure of the ATXR5-H3.1-SAH complex in electrostatic 
potential surface representation with the selectivity pocket and 
safety belt highlighted. Positive and negative potentials are in gray 
and dark gray, respectively. (Inset) Enlarged view of the residues 
forming the surface of the selectivity pocket (three-letter code re-
fers to histone H3.1 residues; one-letter code refers to RcATXR5). 
Hydrogen bonds are shown as dashed red lines.
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has remained elusive. We have found that specifi city is 
provided by targeted cleavage of thousands of transpo-
son transcripts by at least 50 miRNAs, some of which 
are themselves encoded by transposons, but most of 
which are highly conserved and have well-known roles 
in plant development (Fig. 2). Interestingly, the loss of 
easiRNAs in ddm1 rdr6 is compensated by the gain of 
24-nucleotide heterochromatic (het)siRNAs that can 
guide RNA-directed DNA methylation (RdDM). This 
suggests that RDR6-directed easiRNA production acts 
antagonistically to RDR2-directed hetsiRNA produc-
tion, thereby inhibiting transcriptional gene silencing. 
Widespread targeting of transposons may refl ect the 
evolutionary origin of miRNA in genome surveillance.
The Maize Methylome Inﬂ uences mRNA 
Splice Sites and Reveals Widespread 
Paramutation-Like Switches Guided by 
Small RNA
M. Regulski, M.T. Donoghue [in collaboration with 
W.R. McCombie, J. Hicks, and D. Ware, Cold Spring 
Harbor Laboratory; J. Reinders, S. Tingey, and A. Rafalski, 
DuPont Pioneer; A. Smith, University of Southern 
California, Los Angeles]
The maize genome, with its large complement of 
transposons and repeats, is a paradigm for the study 
of epigenetic mechanisms such as paramutation and 
imprinting. We have determined the genome-wide 
map of cytosine methylation for two maize inbred 
lines, B73 and Mo17. CG (65%) and CHG (50%) 
methylation (where H = A, C, or T) is highest in 
transposons, whereas CHH (5%) methylation is like-
ly guided by 24-nucleotide, but not 21-nucleotide, 
siRNAs. Correlations with methylation patterns sug-
gest that CG methylation in exons (8%) may deter 
insertion of Mutator transposon insertion, whereas 
CHG methylation at splice acceptor sites may inhibit 
RNA splicing. Using the methylation map as a guide, 
we used low-coverage sequencing to show that paren-
tal methylation differences are inherited by recom-
binant inbred lines. However, frequent methylation 
switches, guided by siRNA, persist for up to eight 
generations, suggesting that epigenetic inheritance 
resembling paramutation is much more common 
than previously supposed. The methylation map will 
provide an invaluable resource for epigenetic studies 
in maize.
Tunicate 1 and the Origin of PodCorn
J.-J. Han, M. Regulski [in collaboration with D. Jackson, 
Cold Spring Harbor Laboratory and the National Park 
Service, Navajo]
Podcorn was once regarded as ancestral to culti-
vated maize, and it was prized by pre-Columbian 
cultures for its magical properties. Tunicate1 (Tu1) 
is a dominant podcorn mutation in which kernels 
are completely enclosed in leaf-like glumes. We 
reported last year that Tu1 encodes a MADS-box 
gene expressed in leaves whose 5′ regulatory region 
is fused by a 1.8-Mb chromosomal inversion to the 
3′ region of a gene expressed in the infl orescence. 
Both genes are further duplicated, accounting for 
classical derivative alleles isolated by recombina-
tion. In young ear primordia, TU1 proteins are 
nuclearly localized in specifi c cells at the base of 
spikelet pair meristems. Tu1 branch determination 
defects resemble those in ramosa mutants, which 
encode regulatory proteins expressed in these same 
cells, accounting for synergism in double mutants. 
In an effort to trace the origin of podcorn in North 
America, we are sequencing the genome from sam-
ples of ancient corn found at the Betatakin Pueblo 
in Northern Arizona, which were reported to dis-
play the podcorn phenotype.
Figure 2.  microRNA (miRNA) triggers epigenetically activated 
small interfering RNA (easiRNA) from transposons in Arabidop-
sis. miRNA such as miR845, which is expressed in pollen, targets 
transposon transcripts for cleavage and processing by Argonaute 
1 (AGO1), RDR6, and DCl4 to generate 21-nucleotide easiRNA 
(A). This process occurs in decrease in DNA methylation 1 (ddm1) 
mutants, which lose transcriptional silencing but resemble wild-
type plants (B). Failure to generate easiRNA in ddm1rdr6 double 
mutants results in severe epigenetic defects and infertility (C).
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Large-Scale Identiﬁ cation of 
Sequence-Indexed Mu Insertion Sites 
in the Maize-Targeted Mutagenesis 
MTM Population
J.-J. Han, M. Regulski [in collaboration with D. Ware, Cold 
Spring Harbor Laboratory; P. Ferreira, University of Rio de 
Janeiro; B. Meeley, Pioneer Hi-bred International]
In maize, the Robertson’s Mutator (Mu) multicopy 
transposon family has been selected for saturation 
mutagenesis to produce myriad novel mutant alleles 
in the maize-targeted mutagenesis (MTM) collec-
tion. We have sequenced insertions in MTM lines 
and found that the position of newly transmitted 
germinal insertions in the genome can be identifi ed 
on a large scale. More than 50,000 target sites were 
detected over all 10 maize chromosomes distributed 
into hypomethylated genic regions. We detected two 
parental insertions for each germinal insertion in 
each plant, which is somewhat higher than expected 
and likely includes Pack-MULEs that are preferen-
tially located upstream from 5′ termini of genes. We 
sequenced 96 DNA pools from one grid (48 × 48) 
containing 2304 plants, and further bioinformatic 
analysis will create a sequence-indexed MTM Mu 
FST database that will contain up to 100,000 Mu 
insertion sites.
Duckweeds: Genetic Study for Biofuel 
Production
E. Ernst, A. Molla-Morales, A. Canto Pastor, S.C. Lee 
[in collaboration with J. Shanklin and J. Schwender, 
Brookhaven National Laboratories; D. Pappin, Cold 
Spring Harbor Laboratory; Blake Meyers, University of 
Delaware]
Petroleum availability and atmospheric carbon ac-
cumulation are among the main concerns of our era. 
Currently, biofuels produced from corn grain and 
sugarcane are predominant alternatives, but they di-
rectly compete for land with food production, raising 
sustainability concerns. Lemnaceae species (aquatic 
duckweeds) include the smallest fl owering plants, 
and they have considerable potential as biofuel feed 
stocks because of their extreme growth rates and 
clonal propagation. Our goal is to engineer duck-
weeds to increase their oil levels for biofuel produc-
tion. In order to do so, we aim to increase the ex-
pression of genes related to the production of TAG, 
silence the genes that have a role in the oxidation 
of lipid bodies, or redirect the starch metabolism to 
oil production by silencing the key genes that lead 
to starch accumulation. We have sequenced the ge-
nome of Lemna gibba DWC131, and gene annotation 
is currently under way. We have also developed a fast 
and effi cient method for producing stable transgenic 
fronds in Lemna minor via agrobacterium-mediated 
transformation and regeneration from tissue culture. 
Additionally, we engineered an artifi cial miRNA 
(amiRNA) gene silencing system. We identifi ed the 
endogenous Lemna miR166 precursor and used it 
as a backbone to produce amiRNAs. As a proof of 
concept, we induced the silencing of CH42, a mag-
nesium chelatase subunit, using our amiRNA plat-
form. These techniques will enable tackling future 
challenges in the biology and biotechnology of Lem-
naceae. For example, nitrogen defi ciency is an envi-
ronmental stress that can enhance biosynthesis and 
storage of starch and triacylglycerol (TAG) in vegeta-
tive tissues of plant species such as A. thaliana and 
Chlamydomonas reinhardtii, and TAG is a precursor 
of biodiesel. Based on transmission electron micros-
copy, we have found that L. gibba plants grown on 
nitrate-lacking media increased the numbers of lipid 
droplets in the chloroplast, and liquid chromatog-
raphy–mass spectrometry identifi ed increases in 
saturated and monounsaturated fatty acids such as 
palmitic acid (16:0) and palmitoleic acid (16:10). We 
are currently using our transformation system to en-
hance oil yields further.
The Oil Palm Shell Gene Controls 
Oil Yield and Encodes a Homolog 
of SEEDSTICK
R. Martienssen [in collaboration with R. Singh, M. Ong-
Abdullah, E.L. Low, R. Nookiah, and R. Sambanthamurthi, 
Malaysian Palm Oil Board, Kuala Lumpur, Malaysia; E. Lee 
and R. Desalle, American Museum of Natural History, 
New York; J. Ordway, S. Smith, M. Budiman, and N. Lakey, 
Orion Genomics LLC, St. Louis Missouri]
A key event in the domestication and breeding of 
the oil palm, Elaeis guineensis, was loss of the thick 
coconut-like shell surrounding the kernel. Modern E. 
guineensis has three fruit forms: dura (thick-shelled), 
pisifera (shell-less), and tenera (thin-shelled), a hybrid 
between dura and pisifera. The pisifera palm is usually 
female-sterile, but the tenera yields far more oil than 
170-197_PlantBiol.indb   189 19-08-2014   08:34:31
190  Research
dura and is the basis for commercial palm oil produc-
tion in all of Southeast Asia. Here, we describe the 
mapping and identifi cation of the Shell gene respon-
sible for the different fruit forms. Using homozygosity 
mapping by sequencing, we found two independent 
mutations in the DNA-binding domain of a homolog 
of the MADS-box gene SEEDSTICK (STK), which 
controls ovule identity and seed development in Ara-
bidopsis. The Shell gene is responsible for the tenera 
phenotype in both cultivated and wild palms from 
sub-Saharan Africa, and our fi ndings provide a genetic 
explanation for the single-gene heterosis attributed to 
Shell, via heterodimerization. This gene mutation ex-
plains the single most important economic trait in oil 
palm and has implications for the competing interests 
of global edible oil production, biofuels, and rainforest 
conservation.
RNAi Promotes Heterochromatic Silencing 
through Replication-Coupled Release of 
RNA Polymerase II
J. Ren, S. Castel, A.-Y. Chang, R. Martienssen [in 
collaboration with W.Z. Cande, University of California, 
Berkeley; F. Antequera, Universidad de Salamanca, Spain; 
B. Arcangioli, Institut Pasteur, Paris]
Heterochromatin comprises tightly compacted re-
petitive regions of eukaryotic chromosomes and has 
widespread roles in chromosome integrity, stability, 
and silencing. The inheritance of heterochromatin 
requires RNAi, which guides histone modifi cation 
on the two daughter strands upon DNA replication. 
However, the underlying mechanism is poorly un-
derstood. In S. pombe, the alternating arrangement 
of origins of replication and noncoding RNA tran-
scribed during S phase in the heterochromatic peri-
centromeric region provokes the collision of RNA 
polymerase with replication machinery. We propose 
that it is resolved by cotranscriptional RNAi, allow-
ing replication to complete and couple the spreading 
of heterochromatin with fork progression. In the ab-
sence of RNAi, stalled forks are repaired by homolo-
gous recombination without histone modifi cation. 
The molecular basis of this model and its genome-
wide impact is being further investigated and may ex-
plain the participation of RNAi and DNA replication 
in S. pombe and many other systems of heterochro-
matin inheritance.
Transposon Small RNA Expression in the 
Embryonic and Trophectoderm Lineage
A. Schorn [in collaboration with W. Reik, Babraham 
Institute, Cambridge, United Kingdom; Scott Lowe, 
Memorial Sloan-Kettering Cancer Center, New York]
Epigenetic reprogramming is essential to regain plu-
ripotency during reproduction, but it also results in 
transient release of transposable elements (TE) from 
heterochromatin repression. In plants, transposon re-
lease in neighboring tissues triggers the production of 
mobile small RNA in the generative sperm cells. We 
wondered whether, similarly, nurse tissues in mam-
mals express transposon-targeting small RNAs that 
could ensure genome integrity in the offspring. We 
profi led small RNA expression from mouse embry-
onic (ES) and trophectoderm stem (TS) cells and 
found that TEs, which produce small RNAs in ES or 
TS cells, are younger than the average transposon age 
genome-wide. Endogenous retroviruses (ERV) were 
particularly overexpressed in TS cells. Overexpression 
seems not simply due to loss of methylation in TS cells 
because Dnmt1−/− ES cells do not exhibit ERV-derived 
small RNAs. Interestingly, ERV elements are still ac-
tive in mice and have contributed to placenta evolu-
tion. Therefore, small RNA expression in the trophec-
toderm lineage might refl ect a trade-off between the 
benefi ts of transposon domestication during eutherian 
evolution and the necessity of protecting the concep-
tus from active transposition.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans A. Benkovics A. Husbands K. Petsch
 M. Dotto M. Javelle E. Plavskin
 C. Fernandez-Marco M. Lodha D. Skopelitis
Specifi cation of adaxial–abaxial (upper/lower) po-
larity in the developing leaf drives the fl attened out-
growth of the leaf blade and directs the differentiation 
of distinct cell types within the leaf ’s adaxial/top and 
abaxial/bottom domains. Both are important innova-
tions in the evolution of land plants that maximize 
photosynthesis while minimizing water loss to the en-
vironment. In addition to being a key developmental pro-
cess, adaxial–abaxial patterning is of particular inter-
est from a mechanistic point of view and has proven to 
be an excellent model to study small RNA-mediated 
gene regulation. We previously showed that pattern-
ing of this developmental axis involves a cascade of 
opposing small RNAs, in which microRNA (miRNA) 
miR390 triggers the biogenesis of the TAS3-derived 
21-nucleotide tasiR-ARF on the adaxial side of devel-
oping leaves. These confi ne the accumulation of ab-
axial determinants, including AUXIN RESPONSE 
FACTOR3 (ARF3) and miR166, to the lower side of 
leaves. miR166, in turn, demarcates the abaxial side 
by repressing expression of class III homeodomain 
leucine zipper (HD-ZIPIII) transcription factors that 
specify adaxial fate.
Importantly, our analysis of the TAS3 trans-
acting short interfering RNA (tasiRNA) pathway 
in Arabidopsis demonstrated that tasiR-ARF func-
tions as a mobile positional signal in adaxial–abaxial 
patterning. Movement of this small RNA from its 
defi ned source of biogenesis in the two upper-most 
cell layers of leaves creates a gradient of accumula-
tion that dissipates abaxially. The tasiR-ARF gradi-
ent generates a sharply defi ned expression domain 
of the abaxial determinant ARF3 on the bottom 
side of leaf primordia, suggesting that small RNAs 
can establish pattern through a morphogen-like ac-
tivity. This work provided the fi rst direct evidence 
that small RNAs are mobile and can function as 
instructive signals in development, thereby reveal-
ing a novel patterning activity of small RNAs. We 
are currently studying the role of this specifi c small 
RNA pathway and the properties of mobile small 
RNAs in general in maize, Arabidopsis, and the moss 
Physcomitrella patens.
Small RNA Gradients Create Stable 
Developmental Boundaries
A. Benkovics, D. Skopelitis, C. Fernandez-Marco
Mathematical modeling of the tasiR-ARF–ARF3 in-
teraction predicts that small RNA gradients resulting 
from mobility are uniquely suited to generate sharply 
defi ned boundaries of target gene expression. To test 
this, we are taking advantage of the pARF3:ARF3-
GUS reporter generated previously. In an rdr6 mutant 
background, which blocks tasiR-ARF production, 
this reporter is expressed throughout the develop-
ing leaf. In this background, we express an artifi cial 
miRNA targeting ARF3 (miR-ARF3) from different 
leaf-specifi c promoters and in an inducible manner to 
modulate the position, direction, and steepness of this 
small RNA gradient. Target gene expression is being 
monitored by GUS histochemistry, and miR-ARF3 
expression patterns will be determined by in situ hy-
bridizations. The fi rst observations suggest that small 
RNA gradients indeed generate sharply defi ned do-
mains of target gene expression and provide evidence 
for dose-dependence in the miRNA gradient–target 
gene interaction.
Patterning via small RNA gradients is also being 
addressed using a reporter system that monitors the 
readout of a miR166 gradient. An miR166-insensi-
tive HD-ZIPIII reporter (PHB*-YFP) that is active 
throughout the leaf induces an adaxialized leaf phe-
notype. In this background, we express a modifi ed 
version of miR166 (miR166*) that specifi cally cleaves 
the PHB*-YFP transcripts. Given the importance of 
miRNA dosage to gene silencing, we are expressing 
miR166* in an inducible manner in the adaxial or 
abaxial epidermis. This allows us to quantitatively 
measure the relationship between miRNA gradients 
and the spatial patterning of their targets. The fi rst 
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results show that miR166* expression from the abaxial 
epidermis is suffi cient to suppress the PHB*-YFP leaf 
defects, indicative of movement of this small RNA. 
Efforts to visualize the PHB*-YFP and miR166* ex-
pression domains are ongoing.
Considering that patterning of the adaxial–abax-
ial axis involves two opposing small RNA gradients, 
these might serve to confer robustness onto the leaf 
development program by stabilizing the adaxial–ab-
axial boundary throughout organogenesis and under 
a range of environmental conditions. Our preliminary 
results suggest that the adaxial–abaxial boundary as 
visualized by an abaxial reporter is less sharp in sgs3 
mutants, which lack the tasiR-ARF gradient, than 
in wild-type plants. We are also comparing variabil-
ity in leaf parameters under normal and mild stress 
conditions between wild-type and sgs3 mutant plants. 
The outcome of these experiments will reveal whether 
small RNA gradients provide robustness to the leaf 
developmental program under a range of environmen-
tal conditions.
Dissecting Small RNA Mobility in Plants
D. Skopelitis, C. Fernandez-Marco
Given the scope of miRNA-regulated gene networks, 
the cell-to-cell movement of small RNAs has impor-
tant implications with respect to their potential as 
instructive signals in development or in response to 
physiological and stress stimuli. We are using artifi -
cial miRNAs targeting easy-to-score reporter genes to 
study parameters of miRNA movement, such as tissue 
specifi city, directionality, dose-dependence, and the 
kinetics of movement. To investigate miRNA mobil-
ity in multiple distinct developmental contexts, we are 
expressing an artifi cial miRNA targeting a cell-auton-
omous green fl uorescent protein (GFP) reporter (miR-
GFP) from a number of promoters with distinct spa-
tiotemporal patterns of expression. Expression of miR-
GFP from the epidermis-specifi c ATML1 promoter, 
mesophyll-specifi c RBCS promoter, or vasculature 
companion cell-specifi c SUC2 promoter showed that 
miRNAs move bidirectionally between all three cell 
layers and that the number of cells across which a small 
RNA moves is determined in part by its abundance. 
Moreover, analysis of GFP fl uorescence in the vascu-
lature supports the idea that miRNA-mediated gene 
regulation is a dose-dependent process and depends on 
the relative abundance of the miRNA versus the target 
mRNA. No GFP silencing was observed in the sym-
plastically isolated stomata, suggesting that miRNA 
movement occurs via plasmodesmata, small channels 
that connect most plant cells.
Interestingly, production of miR-GFP in young 
leaf primordia surrounding the shoot apical meristem 
(SAM) resulted in silencing of GFP inside the SAM, 
demonstrating that miRNAs traffi c from determi-
nate organs into the shoot stem-cell niche. In addi-
tion, miR-GFP was able to move from the vasculature 
below the SAM into the niche. These fi ndings suggest 
that miRNAs may function as mobile signals between 
differentiated tissues and stem cells, possibly inte-
grating environmental/physiological cues and plant 
development. Analyses of miRNA mobility in other 
developmental contexts are still ongoing, but the data 
obtained thus far suggests that small RNA mobility is 
developmentally regulated and follows rules that are 
distinct from those that govern protein traffi cking. In 
addition, with the knowledge that miRNAs can traf-
fi c from the epidermis into underlying tissue layers, 
we are carrying out forward genetic screens to identify 
factors infl uencing this process.
The START Domain Regulates HD-ZIPIII 
Activity and Organ Polarity
A. Husbands [in collaboration with V. Yong and 
H. Djaballah, Memorial Sloan-Kettering Cancer 
Center, New York]
On the basis of our previous observations regarding 
the expression and function of miR166 and tasiR-
ARF, it is evident that adaxial–abaxial patterning 
involves a cascade of positional signals. The mobile 
signals that pattern the newly formed leaf are distinct 
from those that maintain polarity during subsequent 
development. This project aims to identify additional 
signals in adaxial–abaxial patterning. The adaxial 
promoting HD-ZIPIII transcription factors contain 
a predicted START lipid-binding domain (Fig. 1). 
Modeling of the START domain of the HD-ZIPIII 
member PHABULOSA (PHB) suggests structural 
similarity to human PC-TP, a phosphatidylcholine-
binding START domain. This model and sequence 
conservation with other START domains was used 
to predict amino acids in PHB critical for START 
domain ligand binding. Analysis of Arabidopsis lines 
that express PHB-YFP (yellow fl uorescent protein) 
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fusion proteins with mutations in key residues lining 
the START ligand-binding pocket indicates that the 
START domain is required for proper HD-ZIPIII 
function. Such mutations block PHB-mediated target 
gene expression, indicating positive regulation of HD-
ZIPIII activity by an unknown ligand.
Experiments to determine the mechanism through 
which the START domain controls HD-ZIPIII func-
tion are ongoing. Ligand binding does not appear to 
affect the subcellular localization of these transcrip-
tion factors, as confocal imaging showed that the 
PHB-YFP derivatives correctly localize to the nucle-
us. Likewise, ligand binding is not essential for PHB 
dimerization. However, ligand binding does affect 
PHB’s ability to bind DNA and possibly the inter-
action with protein partners. As part of these analy-
ses, we developed a yeast-based assay and conducted 
a high-throughput screen for chemical compounds 
that bind the HD-ZIPIII START domain and modu-
late protein activity. Using yeast growth as readout, 
we identifi ed compounds that reduced yeast growth 
(antagonists) and others that promoted growth (ago-
nists). Validation experiments in yeast and plants are 
under way to eliminate false positives and demonstrate 
that these chemicals act via modulation of HD-ZIPIII 
activity. In a parallel approach, we have generated 
plants expressing a biotin-tagged form of the START 
domain and will be performing immunoprecipitations 
and mass spectrometry to identify the endogenous 
ligand bound by HD-ZIPIII proteins. These latter 
experiments are under way in collaboration with the 
CSHL proteomics facility.
tasiRNA Pathways in Maize and New Players 
in Leaf Polarity
M. Dotto [in collaboration with M. Hammell, Cold 
Spring Harbor Laboratory; M. Aukerman, M. Beatty, 
and R. Meeley, DuPont-Pioneer]
Small RNAs control the activities of a wide variety 
of genetic elements, including protein-coding genes, 
transposons, and viruses. These diverse functions are 
achieved by distinct classes of small RNAs generated 
through discrete genetic pathways. tasiRNA biogen-
esis is triggered when TAS transcripts are targeted by 
either a single 22-nucleotide miRNA (one-hit model) 
or two 21-nucleotide miRNAs (two-hit model). 
These miRNA-guided cleavage events trigger con-
version of the tasiRNA precursor transcript into long 
Figure 1.  Activity of the HD-ZIPIII transcription factors is regulated by the START lipid-binding domain. (A) Schematic rep-
resentation of the domain structure of HD-ZIPIII proteins. (HD) Homeodomain; (LZ) leucine zipper; (START) START lipid-
binding domain; (MEHKLA) MEKHLA/PAS transcription regulatory domain. (B) Representation of the structure of the human 
PC-TP START domain modeled in SwissExpasy. (C) Predicted fold of the PHB START domain modeled in SwissExpasy. Amino 
acids mutated in the PHB-YFP derivative are highlighted in black arrows. (D) Distribution of phenotypes observed in plants 
transformed with various PHB derivatives that either remain under control of miR166 (left) or carry mutations that render the 
transcripts resistant to miR166 (right). (PHB) Full-length PHB protein; (PHB*) PHB derivative with critical amino acids in the 
START ligand-binding pocket mutated; (PHB-Δ) PHB derivative with the START domain deleted; (N) number of transformants 
analyzed. (E–G) Phenotypes in the transformants were grouped into three categories: (E) Severely adaxialized, indicated in 
black; (F) weakly adaxialized, indicated in light grey; (G) largely normal, indicated in dark grey. Mutation or deletion of the 
START domain suppresses the ability of miR166-resistant PHB to adaxialize developing leaves.
170-197_PlantBiol.indb   194 19-08-2014   08:34:32
Plant Biology  195
double-stranded RNAs (dsRNAs) by RDR6 and 
SGS3/LBL1 and set the register for the subsequent 
production of phased 21-nucleotide tasiRNAs by 
DCL4. Only the TAS3 pathway is conserved across 
land plant evolution. The binding of two miR390-
loaded AGO7 complexes triggers the biogenesis of 
TAS3-derived tasiRNAs, a subset of which are the 
tasiARFs. We previously identifi ed four TAS3 loci in 
the maize genome; however, additional TAS loci de-
scribed in other species are not conserved in maize. 
We used a deep-sequencing and bioinformatics ap-
proach to perform a genome-wide search for clusters 
of phased small RNA in combination with a com-
parison of the small RNA content between wild-type 
and lbl1 mutant apices. This identifi ed fi ve novel TAS 
loci, all belonging to the TAS3 family. No TAS loci 
triggered by 22-nucleotide miRNAs were identifi ed. 
In-depth target analyses indicate that the tasiARFs 
are the only functional tasiRNAs in the maize veg-
etative apex, where they regulate expression of ARF3 
homologs. This study also revealed unexpected con-
tributions for LBL1 in the regulation of miRNAs and 
24-nucleotide transposon- and retrotransposon-de-
rived small interfering RNAs (siRNAs), illustrating 
substantial cross-talk between small RNA pathways. 
The mechanisms underlying these regulatory net-
works remain to be elucidated.
In a separate approach, we are characterizing small 
RNAs associated with diverse AGO proteins. Using 
a specifi c peptide antibody, we analyzed the small 
RNAs associated with ZmAGO10 by deep sequenc-
ing the small RNAs present in immunoprecipitates. 
We found that the immunoprecipitation fraction was 
enriched for just a subset of small RNAs: miR394, 
miR166, and tasiARFs. We had previously shown 
the function of the latter two in the specifi cation 
of maize leaf polarity. However, miR394 remains 
poorly characterized thus far. In situ hybridization 
showed that this miRNA also accumulates in a polar 
pattern, establishing a gradient on the adaxial side of 
developing leaves. This presents the possibility that 
organ polarity is regulated also by a fourth small 
RNA signal. We are currently characterizing the 
maize single and double mutants in components of 
this pathway: mir394a and mir394b, the two F-BOX 
proteins predicted as targets, and both ZmAGO10 
genes. It was reported that AGO10 in Arabidopsis as-
sociates exclusively with miR166. We are currently 
analyzing how structural differences between these 
miRNA precursors and the AGO10 proteins in both 
species account for the differential AGO10/miR394 
binding in maize.
Effects of Natural Variation Present in 
Maize Inbreds on the tasiRNA Pathway
K. Petsch
Mutants that disrupt tasiRNA biogenesis exhibit de-
fects in adaxial–abaxial patterning. Interestingly, the 
severity of these phenotypes is greatly dependent on 
the inbred background. tasiRNA pathway mutants, 
as well as other small RNA biogenesis mutants, typi-
cally exhibit weaker phenotypes when introgressed 
into B73 as opposed to other inbred backgrounds, 
such as W22, Mo17, and A619. To understand how 
inbred background infl uences expressivity of tasiRNA 
pathway mutants, we are using the severe ragged1 
allele of leafbladeless1 (lbl1-rgd1). In the B73 inbred 
background, lbl1-rgd1 conditions a classical leaf po-
larity phenotype with most leaves developing as ra-
dial, abaxialized organs. In W22, however, lbl1-rgd1 
embryos lack a shoot meristem and germinate with 
just a root. We have generated an F2 population to 
map loci that contribute to the variable expressivity of 
lbl1-rgd1 in the two inbreds. This identifi ed a major 
modifi er locus on chromosome 8, which we are fi ne-
mapping in collaboration with DuPont. In addition, 
we are generating NIL populations to further defi ne 
the effect of this locus on the lbl1-rgd1 phenotype and 
to identify the causative gene.
In a complementary approach, we performed a tran-
scriptome analysis of lbl1-rgd1 embryos and nonmutant 
siblings in B73 and W22. This identifi ed 214 genes 
that are differentially expressed in lbl1-rgd1 embryos 
in both backgrounds. These include known tasiRNA 
targets and genes showing differential expression across 
the adaxial–abaxial axis, as well as genes predicted to 
function in the embryonic shoot meristem. Most no-
tably, ~30% of genes that are down-regulated in W22 
mutant embryos have “meristem-associated” functions. 
Further investigation into specifi c genes is ongoing. 
Importantly, this study identifi ed 40 genes within the 
chromosome-8 modifi er region that are expressed in 
the developing embryo and show differential expres-
sion between the inbreds or between lbl1-rgd1 and 
nonmutant siblings. By combining these approaches, 
we hope to gain a better understanding of the factors 
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contributing to natural variation in  tasiRNA pathway 
function.
Ancestral Role of the tasiRNA Pathway
E. Plavskin [in collaboration with R. Quatrano, Washington 
University, St Louis, Missouri; M. Hasebe, National 
Institute for Basic Biology, Okazaki, Japan]
The diversity of multicellular organisms raises the 
question of how so many varied morphologies evolved. 
A number of studies have demonstrated that novel 
structures often arise through the hijacking of exist-
ing developmental pathways for new functions. The 
pathways controlling leaf development seem to be no 
exception, because many of these have been shown to 
be conserved in the moss P. patens, whose ancestors 
diverged from the lineage of fl owering plants ~100 
million years before leaves fi rst evolved in the latter. 
Thus, studying the role of leaf polarity pathways in 
moss provides a unique opportunity to explore the 
evolution of complex novel structures.
We are focusing on the miR390-dependent ta-
siRNA pathway. The genes involved in biogenesis of 
tasiRNAs as well as the tasiRNA targets are conserved 
between maize, Arabidopsis, and P. patens. Elucidat-
ing the function of this pathway in Physcomitrella 
may lead to an understanding of its ancestral role in 
plant development. For this, we are taking advantage 
of the unique ability of this moss to be transformed 
by homologous recombination and characterizing 
knockouts of genes involved in tasiRNA biogenesis, as 
well as the targets of the moss tasiR-ARFs. Our results 
indicate a role for tasiRNA regulation in plant archi-
tecture during the fi lamentous stage of growth. sgs3 
loss-of-function mutants display increased branching 
and decreased formation of caulonema, long runners 
that allow the moss plants to rapidly spread. These 
phenotypes are consistent with a defective response 
to the plant hormone auxin, which is evolutionarily 
more ancient than the land plant lineage itself. Fur-
ther experiments demonstrated that tasiRNAs are im-
portant for setting a threshold for auxin response and 
that deregulation of their targets results in a perturbed 
response to nitrogen deprivation.
Much like fi lamentous runners in moss, forma-
tion of lateral roots in dicots is regulated by auxin 
and modulated by nitrogen levels in the substrate; in 
addition, a link between lateral root outgrowth and 
tasiRNA biogenesis has recently been demonstrated. 
It is exciting to hypothesize that tasiRNAs and their 
targets may be part of an ancient mechanism for regu-
lating plant architecture in response to auxin signal-
ing and environmental inputs such as soil nutrient 
content. To address this experimentally, we are now 
exploring lateral root formation in Arabidopsis mu-
tants with perturbed tasiRNA biogenesis.
High-Resolution Gene Expression Atlas 
for the Maize Shoot Apex
M. Javelle [in collaboration with M. Scanlon, Cornell 
University, Ithaca, New York; G. Muehlbauer, University 
of Minnesota, Minneapolis; J. Yu, Kansas State University, 
Manhattan; P. Schnable, Iowa State University, Ames]
Plants have the distinctive ability to form new or-
gans throughout their lifetime, which can span hun-
dreds or even thousands of years. The growing tip of 
a plant contains a population of stem cells that are 
located within a specialized niche, termed the shoot 
apical meristem (SAM). These stem cells divide to 
maintain the SAM and to generate daughter cells 
from which lateral organs, such as leaves and fl ow-
ers, arise. The gene regulatory networks controlling 
meristem indeterminacy and organogenesis remain 
largely obscure. To gain insight into such networks, 
we have generated a high-resolution gene expression 
atlas for the maize shoot apex. Functional domains 
of the meristem were isolated by laser microdissec-
tion and analyzed by RNA deep sequencing. These 
include the whole meristem, the stem cell contain-
ing SAM tip, the newly initiating leaf (P0), the epi-
dermal layer of the SAM (L1), and the subepider-
mal region (L2). Because gene networks controlling 
meristem maintenance and leaf development are 
largely interconnected, we further compared expres-
sion profi les in an ontogenic series of leaf primordia, 
P1, P2, and P3. We identifi ed 502 genes that show 
strong differential expression between the L1 and 
the L2. Using CAST clustering, we further identi-
fi ed genes that specifi cally mark the meristem, the 
P0, or developing leaf primordia. Most notably, this 
analysis identifi ed 177 genes that specifi cally mark 
the stem cell domain of the meristem, and several 
genes that mark the presumptive organizing center. 
This comprehensive data set allows us to precisely 
predict genes involved in meristem maintenance, leaf 
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initiation, and/or leaf patterning and to assess the 
distinct contributions of the L1 and L2 to these pro-
cesses. Reverse genetic resources available for maize 
are being used to directly test the function of select 
genes in these processes. This has identifi ed several 
new mutations affecting meristem maintenance and 
leaf morphology.
Establishment of Determinacy during 
Lateral Organ Development
M. Lodha
Stem cell activity in the SAM is maintained in part 
by the class I KNOX homeobox genes. To give rise 
to differentiating structures, such as leaves, KNOX 
expression needs to be maintained in a stable “off” 
state throughout lateral organ development. We had 
previously shown that this process is mediated by 
the transcription factors AS1 and AS2, which form 
heterodimers that bind specifi c sites in the KNOX 
promoters. We have now uncovered the mechanism 
through which AS1-AS2 maintain the stable repres-
sion of KNOX genes during leaf development.
We found that KNOX gene silencing also requires 
the activities of the Polycomb repressive complexes, 
PRC2 and PRC1. PRC2 has histone H3K27 trimeth-
ylation (H3K27me3) activity, and we have shown that 
this repressive chromatin mark is enriched at the BP 
and KNAT2 loci in leaves of Arabidopsis. Mutations 
in the PRC2 component CURLY LEAF (CLF) led 
to reduced levels of this repressive H3K27me3 mark 
at the KNOX loci and to ectopic KNOX expression in 
developing leaves. PRC1 is a downstream component 
in the Polycomb pathway that maintains long-term si-
lencing. In plants, this complex contains LIKE HET-
EROCHROMATIN PROTEIN1 (LHP1), which rec-
ognizes the H3K27me3 signature deposited by PRC2. 
We found that LHP1 is present at the silenced KNOX 
loci and that mutations in LHP1 lead to KNOX mis-
expression in developing leaves. Importantly, levels of 
H3K27me3 and LHP1 at the KNOX loci are dramati-
cally reduced in as1 and as2 mutants, identifying these 
DNA-binding proteins as upstream components in 
the KNOX silencing pathway. We were further able to 
show that AS1 and AS2 interact physically with PRC2 
and that the AS1-AS2 complex mediates the recruit-
ment of PRC2 to the KNOX promoters.
Genome-wide H3K27me3 profi ling studies predict 
that as many as 20% of Arabidopsis genes are marked 
with H3K27me3 and regulated by PRC2. However, 
how PRC2, which does not bind DNA specifi cally, 
recognizes defi ned targets remained a major outstand-
ing question in the fi eld. This work showed that PRC2 
is recruited to select targets by the sequence-specifi c 
DNA-binding factors AS1 and AS2. This recruitment 
mechanism resembles the Polycomb response element 
(PRE)-based recruitment of PRC2 originally defi ned 
in fl ies and provides the fi rst such example in plants. 
Moreover, these data provide a framework for the cellu-
lar memory system underlying the somatically heritable 
repression of stem-cell-promoting homeobox genes that 
is required for cellular differentiation in leaves.
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Thomas Gingeras and colleagues study where and how functional information is stored in genomes. 
These efforts help explain the biological and clinical effects of disease-causing gene mutations in hu-
mans and other organisms. Gingeras is a leader of the ENCODE (ENCyclopedia of DNA Elements) 
and the mouseENCODE and modENCODE (model genome ENCODE) projects of the National 
Institutes of Health. His research has altered our understanding of the traditional boundaries of 
genes, revealing that almost the entire lengths of genomes in organisms ranging from bacteria to hu-
mans can be transcribed into RNA (pervasive transcription) and that most RNA products made by 
a cell are not destined to be translated into proteins (noncoding, or ncRNAs). In fact, ncRNAs are 
proving to be involved in a variety of other important biological functions. Some have been shown 
to be critical components in the pre- and posttranscriptional and translational processes, as scaffolds 
upon which large protein complexes are assembled and as extracellular signals. The initial studies 
that led to these observations have been extended to cover the entire human genome.
There has been a growing appreciation in recent years that gene function is frequently context-
dependent, with a large part of that context provided by the activities of other genes. But trying 
to understand how genes interact to produce function is a hugely complicated problem and one 
that appears likely to become more so as genomic information becomes more detailed. Jesse Gillis 
and colleagues are computational biologists who are presently challenging an oft-taken approach 
to the problem in which the functions of genes are interpreted in the context of networks derived 
from gene association data. Such networks consist of millions of interactions across thousands of 
genes, derived from protein-binding assays, RNA coexpression analysis, and other sources. His-
torically, many attempts to understand gene function through networks have leveraged a biologi-
cal principle known as “guilt by association.” It suggests that genes with related functions tend 
to share properties (e.g., physical interactions). In the past decade, this approach has been scaled 
up for application to large gene networks, becoming a favored way to grapple with the complex 
interdependencies of gene functions in the face of fl oods of genomics and proteomics data. Gillis’ 
work centers on identifying the limits of the approach and making fundamental improvements 
to its operation, as well as applying those improvements to neuropsychiatric gene network data.
Gholson Lyon’s lab focuses on analyzing human genetic variation and its role in severe neuropsy-
chiatric disorders and rare diseases, including Tourette syndrome, attention-defi cit hyperactivity 
disorder (ADHD), obsessive compulsive disorder (OCD), intellectual disability, autism, and schizo-
phrenia. By recruiting large groups of related individuals living in the same geographic location (e.g., 
Utah), Lyon’s lab can study the breadth and depth of genetic variants in a similar environmental 
background. Using the exome—the parts of the genome that code for protein—and whole-genome 
sequencing, his lab looks for mutations that segregate with syndromes in the various populations. 
A second focus of the Lyon lab is to study the mechanistic basis of a new rare disease that they de-
scribed in 2011. This is the fi rst human disease involving a defect in the amino-terminal acetylation 
of proteins, a common modifi cation of eukaryotic proteins carried out by amino-terminal acetyl-
transferases (NATs). The team has been using several different cellular model systems to better un-
derstand the disease pathophysiology and the basic process of amino-terminal acetylation. This year, 
Lyon collaborated with a team of researchers from other universities and companies to use precision 
medicine to successfully treat a patient with severe OCD. His symptoms were treated with deep 
brain stimulation, and the team used whole-genome sequencing to try to understand the molecular 
basis of his disease. The patient experienced signifi cant relief from his symptoms and his quality of 
life returned, suggesting that similar methods may hold tremendous promise in the future.
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The insights of W. Richard McCombie and colleagues have led to the introduction and optimiza-
tion of novel methods of high-throughput genome sequencing. His team has made it possible to 
catalog variation among individual organisms in a way that would have been unthinkable 5 years 
ago. They have brought online a new generation of Illumina sequencers and optimized their func-
tion to a level at which eight to 10 trillion DNA bases can be sequenced in a month. McCombie’s 
team has been involved in international efforts culminating in genome sequences for maize, rice, 
and this year for bread wheat—three of the world’s most important food crops. They have also 
had an important role in projects to sequence the fl owering plant Arabidopsis thaliana, the fi s-
sion yeast Schizosaccharomyces pombe, as well as Homo sapiens and other important genomes. Mc-
Combie’s group is currently involved in several important projects to resequence genes in patient 
samples that are of special interest to human health, including DISC1 (a strong candidate gene 
for schizophrenia), looking for genetic variants implicated in bipolar illness and major recurrent 
depression. With Memorial Sloan-Kettering Cancer Center, they are using a method called hybrid 
selection, developed with Greg Hannon, to look at mutations in samples collected from patients 
with prostate cancer.
Using multidisciplinary approaches that combine computational analysis, modeling, and predic-
tion with experimental verifi cation, Doreen Ware’s lab seeks a deeper understanding of the evo-
lution of genome sequences in plants and their implications for agricultural improvement. By 
looking comparatively across the genomes of plants in the same lineage, they seek answers to the 
following questions: How are genes conserved and lost over time? What are the fates of duplicated 
genes? What is the impact of structural variation on phenotypic variation? Ware’s team also stud-
ies gene regulation in plants, focusing on gene regulatory networks, targeting transcription factors 
and microRNA genes with the objective of understanding how these parts of the plant genome 
work together in determining spatial and temporal expression of genes. The lab had an important 
role in the project to produce a haplotype map reference genome of maize, spearheading the most 
comprehensive analysis of the crop yet. This has provided important information on the variation 
of the reference genome, as well as comparative data showing changes in the genome acquired 
through domestication and breeding. They have devoted special attention to examining diversity 
within maize, grape, and tomato, aiming to accelerate the development of strategies to introduce 
new germplasm that is needed to meet demands of increasing population and a changing environ-
ment. The lab also has brought fully sequenced genomes into an integrated data framework, to 
enhance the power of their comparative studies. This past year, Ware was named as its principal 
investigator for the National Science Foundation-funded Gramene project, a comparative genom-
ics resource for agriculturally important crops and models to support sustainable food and fuel 
production. Ware, as principal investigator for plants, has also helped lead an effort funded by 
the Department of Energy to create—out of many separate streams of biological information—a 
single, integrated cyber-“knowledgebase” for plants and microbial life.
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GENOME ORGANIZATION AND REGULATION 
AND FUNCTIONAL ROLES OF NONCODING RNAs
T.R. Gingeras P. Batut J. Drenkow F. Schlesinger
 S. Chakrabortty G. Nechooshtan L.-H. See
 C. Davis A. Prakash H. Xue
 A. Dobin A. Scavelli C. Zaleski
Human ENCODE Project
P. Batut, C. Davis, A. Dobin, J. Drenkow, A. Scavelli, 
L.-H. See, C. Xue, C. Zaleski
Our laboratory is currently involved in phase 3 of the 
Encyclopedia of DNA Elements (ENCODE3) project 
that began in July of 2012. This project endeavors to 
identify and characterize the functional elements pres-
ent in the human genome sequence. Our contribution 
to this effort has been and continues to be the cataloging 
of the sites of long (>200 nucleotides) and short (<200 
nucleotides) RNA transcription, the positions of 5′ and 
3′ termini, as well as the splice sites present in human 
cells/tissues. In previous phases of the ENCODE proj-
ect, the biological materials that served as a source for 
analyses were mostly cancer cell lines, whereas in this 
phase, the project has sought to analyze both human 
primary cell lines and tissues. This year, long RNAs 
were sequenced (RNA-Seq) from more than 30 pri-
mary cells, and a similar collection of human tissues 
was analyzed. A signifi cant proportion of the year has 
been spent in attempting to centralize the analyses 
of the RNA-Seq data sets to the Data Coordination 
Center (DCC) established by the ENCODE project 
at Stanford University. To accomplish this, an evalu-
ation of the available software tools that are needed in 
an analysis pipeline to map, quantify, and model data 
obtained from the RNA-Seq is currently being carried 
out by the DCC. Related to this evaluation effort was 
our participation this year in two independent evalua-
tions carried out by the RGASP (RNA-Seq Genome 
Annotation Assessment Project) consortium of various 
RNA-Seq data-mapping software as well as transcript 
modeling/quantifi cation tools. To assess the perfor-
mance of current mapping software, we were invited 
as a developer of the STAR RNA-Seq mapping pro-
gram to process four large human and mouse RNA-Seq 
data sets as part of the RGASP evaluation. A total of 26 
mapping protocols based on 11 programs and pipelines 
were evaluated (Engström et al. 2013). STAR (spliced 
transcripts’ alignment to a reference; created in our lab-
oratory by Dobin et al. 2013) was determined to be one 
of the best performing mapping tools tested.
Model Genome (mod)ENCODE: 
Human-Fly-Worm Comparative 
Analyses of Transcriptomes
C. Davis, A. Dobin, C. Zaleski
Both the ENCODE and modENCODE consortia have 
generated a community resource containing large 
amounts of RNA-Seq data from a wide variety of 
samples, resulting in a comprehensive annotation for 
the human, worm, and fl y genomes. Extensive data 
integration reveals fundamental principles of transcrip-
tion, conserved across highly divergent animals. In par-
ticular, by clustering expression profi les, we discovered 
conserved coexpression modules shared between the or-
ganisms, many of which are enriched in developmental 
genes. We used these to align the stages in worm and fl y 
development, fi nding the expected embryo-to-embryo 
and larvae-to-larvae pairings in addition to a novel pair-
ing between worm embryo and fl y pupae. Furthermore, 
we found that the extent of per-base-pair noncanonical 
noncoding transcription is similar between the organ-
isms. Finally, we found that the gene expression levels 
in the organisms, both coding and noncoding, can be 
consistently predicted by their upstream histone marks 
using a common “universal model.”
Mouse-ENCODE Project: Human–Mouse 
Comparative Analyses of Transcriptomes
C. Davis, A. Dobin, C. Xue, C. Zaleski
Mammalian genomes are pervasively transcribed, 
with much of the transcribed regions appearing to 
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lack the associated signatures of selective constraint 
often considered indicative of biological function. 
However, by analyzing the transcriptomes of a large 
and diverse panel of human cell lines and mouse tis-
sues, we have observed that many of the transcrip-
tional features associated with pervasive transcription, 
specifi cally intergenic, antisense, and chimeric tran-
scription, are conserved between human and mouse 
even in genomic regions that lack signatures of evolu-
tionary constraint. We also observed that the degree 
of conservation of the levels of expression and splicing 
is independent from the conservation of promoter and 
splicing sequences. These results reveal an evolution-
ary tendency to maintain transcriptional levels and 
organization that are not easily traceable to the con-
servation of primary sequence.
Database and Software Development
A. Dobin, C. Xue, C. Zaleski
Database Development
The infrastructure of our laboratory’s analysis  programs 
is used for the continued development and mainte-
nance of the large databases collected as part of the 
human–mouse and model genome (mod)ENCODE 
projects. The notable achievements in this area include 
the following:
• Continued management and organization of se-
quencing data consisting of fastq fi les (raw data) 
and genome-mapped data fi les (bam, bigwig, con-
tig). During this year, we have added ~30 TB (tera-
bytes) of sequencing data.
• Continued improvement and development of the 
RNA sequencing production pipeline. This con-
sists of sequence mapping into multiple formats, 
generation of “contigs” and “splice junctions,” 
several new multiple QC steps, and fi le transfer of 
data fi les to outside locations (DCC and our Bar-
celona collaborators).
• Implementation of an ENCODE data submission 
client to interface with the primary repository at 
the University of California, Santa Cruz. A set of 
web-based forms connects to a server at CSHL, 
which translates the information to schema-com-
pliant structure. The data are then submitted to a 
REST (representational state transfer) service and 
are viewable via the DCC’s public interface.
• Integrated our lab experimental processes with a 
new CSHL sequencing LIMS (laboratory informa-
tion management system). Data tracking, process-
ing of unique IDs, and management of complet-
ed sequencing runs were all migrated to the new 
 system.
• Continued coordination with the CSHL IT de-
partment to manage our primary storage hardware 
migration. More than 40 TB of data will be mi-
grated to a new hardware system and connected to 
the shared computing cluster as well as our own 
lab’s servers. Code migration, testing, and QC are 
ongoing processes.
Software Development
• STAR development and user support: STAR is the 
RNA-Seq aligner developed and published in 2013 
by Dobin et al. This paper has been cited 40 times 
(Google Scholar) in the less than 1 year and the 
software has been downloaded more than 3000 
times in this period. Efforts were concentrated on 
improving the algorithm, introducing new fea-
tures, and fi xing bugs, with 26 patches, and the 
paper was publicly released. Extensive user support 
is provided by e-mail and through the STAR user 
group.
• Circular RNA (circRNA): Interest in circRNAs 
has been re-ignited by recent publications dem-
onstrating that circRNAs are present in various 
species and cell types, as well as their possible 
role as microRNA sponges. A. Dobin, a member 
of our lab, has developed an accurate and effi cient 
method of circRNA discovery in high-throughput 
RNA-Seq data, based on the chimeric detection 
algorithm of our RNA-Seq aligner STAR. The 
method does not rely on annotations or intronic 
motifs and thus allows for unbiased “de novo” 
detection of circRNAs. Using this algorithm, we 
analyzed the circRNA repertoire in hundreds of 
human cell lines of the ENCODE transcriptome 
data set. Thousands of circRNAs are reproducibly 
detected in each of the samples. We demonstrate 
that circRNAs are signifi cantly enriched in non-
polyadenylated RNA populations compared to the 
polyadenylated RNAs, corroborating the circular 
nature of the molecules. Most of the detected cir-
cRNAs possess canonical intron motifs and con-
nect protein-coding exons, implicating the stan-
dard splicing machinery in the biogenesis of the 
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circRNAs. Some but not all of the circular mol-
ecules appear to correspond to alternatively spliced 
exons and can be attributed to the “lariat model.” 
By comparing the circRNA and linear RNA abun-
dances across a variety of cell types, we show that 
many circular RNAs are strongly regulated.
De Novo DNA Demethylation and 
Noncoding Transcription Deﬁ ne Active 
Intergenic Regulatory Elements
F. Schlesinger
Deep sequencing of mammalian DNA methylomes 
has uncovered a previously unpredicted number of 
discrete hypomethylated regions in intergenic space 
(iHMRs). In collaboration with the Hannon labora-
tory at CSHL, we combined whole-genome bisulfi te 
sequencing data with extensive gene expression and 
chromatin-state data to defi ne functional classes of 
iHMRs and to reconstruct the dynamics of their 
establishment in a developmental setting. Compar-
ing HMR profi les in embryonic stem and primary 
blood cells, we show that iHMRs mark an exclusive 
subset of active DNase-hypersensitive sites (DHS) 
and that both developmentally constitutive and cell-
type-specifi c iHMRs display chromatin states typi-
cal of distinct regulatory elements. We also observe 
that iHMR changes are more predictive of nearby 
gene activity than the promoter HMR itself and that 
expression of noncoding RNAs within the iHMR 
accompanies full activation and complete demeth-
ylation of mature B-cell enhancers. Conserved se-
quence features corresponding to iHMR transcript 
start sites, including a discernible TATA motif, sug-
gest a conserved, functional role for transcription in 
these regions. Similarly, we explored both primate-
specifi c and human population variation at iHMRs, 
fi nding that although enhancer iHMRs are more 
variable in sequence and methylation status than any 
other functional class, conservation of the TATA box 
is highly predictive of iHMR maintenance, refl ecting 
the impact of sequence plasticity and transcriptional 
signals on iHMR establishment. Overall, our analysis 
allowed us to construct a three-step timeline in which 
(1) intergenic DHS are preestablished in the stem 
cell, (2) partial demethylation of blood-specifi c inter-
genic DHS occurs in blood progenitors, and (3) com-
plete iHMR formation and transcription coincide 
with enhancer activation in lymphoid-specifi ed cells 
(Schlesinger et al. 2013).
High-Fidelity Promoter Proﬁ ling Reveals 
Widespread Alternative Promoter Usage 
and Transposon-Driven Developmental 
Gene Expression
P. Batut, A. Dobin
Many eukaryotic genes possess multiple  alternative pro-
moters with distinct expression specifi cities. Therefore, 
comprehensively annotating promoters and decipher-
ing their individual regulatory dynamics are critical 
for gene expression profi ling applications and for our 
understanding of regulatory complexity. We intro-
duce RAMPAGE (RNA annotation and mapping of 
promoters for the analysis of gene expression), a novel 
promoter activity profi ling approach that combines 
extremely specifi c 5′-complete cDNA sequencing with 
an integrated data analysis workfl ow, to address the 
limitations of current techniques. RAMPAGE fea-
tures a streamlined protocol for fast and easy genera-
tion of highly multiplexed sequencing libraries, offers 
very high transcription start site specifi city, generates 
accurate and reproducible promoter expression mea-
surements, and yields extensive transcript connectiv-
ity information through paired-end cDNA sequenc-
ing. We used RAMPAGE in a genome-wide study 
of promoter activity throughout 36 stages of the life 
cycle of Drosophila melanogaster and describe here a 
comprehensive data set that represents the fi rst avail-
able developmental time course of promoter usage. 
We found that >40% of developmentally expressed 
genes have at least two promoters and that alterna-
tive promoters generally implement distinct regula-
tory programs. Transposable elements, long proposed 
to have a central role in the evolution of their host 
genomes through their ability to regulate gene ex-
pression, contribute at least 1300 promoters shaping 
the developmental transcriptome of D. melanogaster. 
Hundreds of these promoters drive the expression of 
annotated genes, and transposons often impart their 
own expression specifi city upon the genes they regu-
late. These observations provide support for the the-
ory that transposons may drive regulatory innovation 
through the distribution of stereotyped cis-regulatory 
modules throughout their host genomes (Batut et al. 
2013).
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RNA-Mediated Intercellular Signaling 
and the Use of Extracellular Vesicle RNAs 
as Possible Cancer Biomarkers
S. Chakrabortty, A. Dobin, A. Prakash
Currently, two distinct populations of extracellular 
vesicles (EVs)–exosomes (<100 nm) and microvesicles 
(100–1000 nm) have been classifi ed. These two types 
of EVs are believed to possess key differences in their 
mode of release from host cells. However, the qualita-
tive and quantitative differences in the cargo RNAs 
between these two subpopulations of EVs have been 
relatively unexplored.
EV RNAs as Possible Cancer Biomarkers
The repertoire of EVs released by four cancer cell lines 
(K562, HELA, MCF7, and U2OS) and two primary 
cell lines (BJ and HUVEC) were studied. These pri-
mary cell lines are frequently the cell types most likely 
to be present in the tumor microenvironment. Using 
previously published protocols, we isolated separately 
the two families of EVs. Using nanoparticle tracking 
analysis, we quantifi ed and analyzed the size distri-
bution of the two families; we found that the exo-
somes had a size distribution ranging from 10 nm to 
300 nm, with a median of 135 nm, and were released 
at an average across cell lines from 10 to 100 exo-
somes per cell. We found that microvesicles had a size 
distribution ranging from 50 nm to 400 nm with a 
median of 225 nm, but that they were less numerous 
than exosomes. A very large degree of overlap in size 
between these two subgroups, as well as all present 
techniques being unable to clearly separate out the 
two populations solely defi ned by their difference in 
size, led us to ask the question of whether the two 
subgroups were just an artifi cial construct or whether 
they were really two physiologically and biochemi-
cally distinct vesicles being released by cells. To an-
swer this question, we used RNA-Seq to investigate 
the transcriptomes of both the EV subgroups. Un-
expectedly, there was a very low correlation between 
the transcript types composing the contents of the 
two EV subgroups. This result is consistent with the 
likelihood that there are two distinct populations of 
EVs that are not merely different in their size distri-
bution but are also distinct in their RNA content. A 
comparison of the RNA transcripts of exosomes to 
source cells in both cancer and primary-cell-derived 
exosomes showed that there were mainly two families 
of RNAs that were enriched in the exosomes when 
compared to source cell,  microRNA (miRNA), and 
Y-RNA. Of the Y-RNA family, RNY5 was found 
to be the predominant molecule. Other interesting 
molecules that were seen to be enriched in exosomes 
were miRNA-17-92a, miRNA-93, and miRNA-103b. 
Comparison of exosomal and microvesicle RNA con-
tents derived from different cell types revealed that 
the contents were cell-type specifi c, increasing the 
likelihood of identifying specifi c disease cell-derived 
exosomes within human body fl uids.
Intercellular Signaling
The intercellular transfer of exosomes and their RNA 
contents have been investigated by light and electron 
microscopy, and their contents were studied using 
RNA-Seq. To demonstrate the release of exosomes in 
the extracellular environment, K562 cells were labeled 
with membrane lipid dye PKH26. Live cell imaging 
was performed and demonstrated the release of la-
beled vesicles from the cells to the extracellular envi-
ronment followed by the uptake of the exosomes by 
different recipient cells using a transwell cell-culture 
system. The labeled exosomes have also been directly 
incubated with multiple human and mouse recipient 
cell types (K562, BJ, 3T3) that were labeled with lipid 
dye PKH67 and Hoechst 33342. In both scenarios, 
live imaging on the recipient cells clearly revealed the 
uptake of labeled exosomes by the recipient cells.
To investigate the subcellular localization of the 
exosomes upon uptake in the recipient cells, multiple 
subcellular organelles in the recipient cells were labeled 
before being incubated with prelabeled exosomes, and 
live imaging was performed. Live imaging revealed 
that (1) the exosomes are primarily localized in the 
cytoplasm in the recipient cells upon uptake and do 
not colocalize with any particular organelle, (2) the 
exosomes do not cross the nuclear membrane in the 
recipient cells, but occupy a characteristic perinuclear 
localization, and (3) the exosomes, upon uptake, are 
not fused with lysosomes or P bodies. To demonstrate 
the uptake of exosomal RNA cargo in recipient cells, 
metabolic labeling of RNA with ethynyl-uridine (EU) 
was performed. Briefl y, donor K562 cells were incu-
bated with EU for 24 h, and exosomes were isolated 
from the conditioned medium. The isolated exosomes 
were then added to recipient cells (NIH-3T3) and 
incubated for 2 h. The exosomal RNA was then de-
tected using click chemistry in the recipient cells and 
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imaged by fl uorescent microscopy. Actinomycin D 
was used to block the endogenous transcription from 
any EU carry over during the exosome preparation.
The transfer of RNA through exosomes among 
cells was also investigated by another orthogonal tech-
nique, namely, RNA-Seq. One member of the Y-RNA 
small noncoding gene RNY5 is expressed abundant-
ly in humans as well as in many lower evolutionary 
organisms, but it is genetically missing in rodents. 
Human RNY5 RNA transcripts are particularly abun-
dant in exosomes secreted by K562 cells and thus can 
serve as excellent genetic markers for intercellular (and 
interspecies) RNA transfer through exosomes. K562 
exosomes were isolated and incubated with mouse 
HB-4 cells for various durations (0, 6, 12, 24, and 
48 h). Small RNA was isolated from recipient mouse 
cells, and the presence of RNY5 transcripts in mouse 
HB-4 cells was detected using RNA-Seq. Interesting-
ly, the time-course experiment revealed the stability of 
RNY5 in mouse cells. Maximum expression of RNY5 
was detected at a 12-h incubation period in the recipi-
ent cells.
One of the most well-known and studied functions of 
tumor-derived exosomes is its role in inducing apoptosis 
upon transfer in the recipient immune cells. The ability 
of tumor exosomes to induce apoptosis in immune cells 
is generally regarded as a mechanism of immune eva-
sion for the tumor cells. The mechanism through which 
apoptosis is induced is thought to be protein mediated 
(Fas-Ligand pathway). In this project, we decided to 
investigate the role of RNA cargo of tumor exosomes 
upon transfer in two other important primary cells of 
the tumor microenvironment, namely, primary fi bro-
blast (BJ) and endothelial (HUVEC) cells.
K562 and BJ cells were incubated with K562 exo-
somes for 24 h, and live-dead cell counting was per-
formed using Hoechst 33342 (live) and Yo-pro1 (dead) 
dye. Surprisingly, we discovered K562 exosomes also 
induce apoptosis in primary fi broblast cells (BJ) but 
not in the tumor cells (K562) themselves. Thus, the 
ability to induce apoptosis by tumor exosomes is not 
restricted to immune cell lineage alone. To investigate 
whether the observed phenotype is caused by exo-
somal RNA or exosomal proteins/lipids, RNA was 
isolated from K562 exosomes and lipofected into BJ 
and K562 cells using Lipofectamine 2000. Consis-
tent with previous experiment, apoptosis was detected 
again in BJ cells alone but not in K562 cells, thus sug-
gesting that apoptosis is caused by exosomal RNA 
and not exosomal proteins/lipids. Scrambled RNA 
and mock lipofectamine treatment were performed as 
negative controls—neither of which caused apoptosis 
in any of the cells.
One of the most abundant transcripts present in 
K562 exosomes is a 32-mer 5′ fragment of a small 
noncoding RNA, RNY5. RNY5 is a Polymerase-III-
transcribed gene of the Y-RNA family (Y1, Y3, Y4, and 
Y5) and is thought to have a role in DNA replication 
and RNA degradation (when bound with protein Ro). 
To investigate whether RNY5 transcripts in exosomal 
cargo are responsible for causing apoptosis, K562 and 
BJ cells were transfected with a synthetic RNY5 frag-
ment (32-mer) with Lipofectamine 2000. Consistent 
with previous experiments with K562 exosomes and 
exosomal RNA, transfection of the synthetic RNY5 
fragment alone resulted in apoptosis in BJ cells but 
not in K562 cells. Mock lipofectamine treatment and 
nonspecifi c scrambled sequences (Allstate negative 
control RNA) were used as negative controls; neither 
of which caused cell death in any cells.
Full-length RNY5 has a characteristic secondary 
structure of two double-stranded RNA stem struc-
tures called lower and upper stem, separated by an 
inner loop that is conserved among all Y-RNA genes. 
Exosomes carry a 5′ 32-nucleotide fragment of RNY5 
only, and thus, only the 5′ side of the lower and upper 
stem and inner loop is present in exosomes. The 
double-stranded upper stem in full-length RNY5 is 
considered to be the motif responsible for its role in 
DNA replication. Because exosomes contain only the 
5′ side of the stem structures, the 5′ side of the upper 
stem (8-mer sequence GUUGUGGG) from nucleo-
tides 14–21 was investigated for its role in apoptosis. 
K562 and BJ cells were transfected with a normal 
synthetic y5 fragment (32-mer, synthetic Y5 fragment 
with 8-mer deleted; Hy5-δ-us) and 8-mer-scrambled 
(Hy5-us-scram). Neither hy5-δ-us nor hy5-us-scram 
was able to induce cell death in either of the cells any-
more, thus suggesting that the 8-mer sequence is the 
motif in RNY5 responsible for causing apoptosis in 
primary cells.
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GENE NETWORK ANALYSIS
J. Gillis S. Ballouz W. Verleyen
Research in my lab centers on using computational 
methods to understand gene function. Computation-
al biology has taken up the challenge of determining 
gene function mainly by attempting to interpret the 
activities of genes in the context of networks derived 
from gene association data. As data sets characteriz-
ing genes grow in size and complexity, it seems self-
evident that computation can assist in inference as 
to gene function. Gene network analysis intended to 
provide insight into complex disorders is a  dominant 
interest in the fi eld. Gene associations (of various 
sorts) are believed to encode functional interaction, 
and this interaction is frequently shown to be able to 
substantially predict gene function across all func-
tions. This approach, commonly called “guilt by as-
sociation” (GBA), is embedded in everything from 
prioritization of de novo variants to uncovering novel 
molecular phenotypes or mechanisms of disease. Our 
research focuses on identifying limitations in the GBA 
approach and making fundamental improvements 
to its operation for the interpretation of neuropsychi-
atric genomics data. Postdocs Sara Ballouz and Wim 
Verleyen joined my lab in early 2013.
Analysis of RNA-Seq Coexpression 
Networks
RNA-Seq offers profound biological and technical 
advantages over microarray technologies, such as 
detecting the whole transcriptome and an improved 
dynamic range. However, as was once the case for 
microarrays, RNA-Seq’s utility is hobbled by our in-
ability to determine sound consensus standards. One 
major reason is that RNA-Seq data have statistical 
properties quite different from those of microarray 
data, and thus the same principles do not apply for 
differential expression. Important questions about 
data quality, such as the role of biological noise in 
experimental design, are not readily addressed. A 
broader characterization of RNA-Seq data through 
meta-analysis offers one avenue to investigate prob-
lems of this nature.
Although differential expression analysis is a more 
common means for interpreting transcriptomic data, 
coexpression analysis is far more routine in the con-
text of meta-analysis, with thousands of expression 
profi les aggregated to generate robust signatures using 
repurposed data. One advantage of coexpression meth-
ods is that they already tend to require meta-analysis 
of disparate data sets with quite different properties, 
so approaches for aggregating across data are already 
common. We have developed a series of methods ap-
propriate for RNA-Seq meta-analysis and have pro-
duced reference networks for general use. RNA-Seq 
coexpression poses novel statistical and bioinformatics 
challenges. We have identifi ed major confounds and 
developed appropriate control experiments necessary 
for network construction, laying the groundwork for 
functional analyses into RNA-Seq coexpression; we 
are particularly focusing on functional inference in 
noncoding RNA.
Bias Tradeoffs in the Creation and Analysis 
of Protein–Protein Interaction Networks
Networks constructed from aggregated protein–pro-
tein interaction data are commonplace in biology. But 
the studies these data are derived from were conducted 
with their own hypotheses and foci. Focusing on data 
from budding yeast present in BioGRID, we deter-
mine that many of the downstream signals present in 
network data are signifi cantly impacted by biases in 
the original data. We determine the degree to which 
selection bias in favor of biologically interesting bait 
proteins goes down with study size, and we also fi nd 
that promiscuity in prey contributes more substantial-
ly in larger studies. We analyze interaction studies over 
time with respect to data in gene ontology and fi nd 
that reproducibly observed interactions are less likely 
to favor multifunctional proteins. We fi nd that strong 
alignment between coexpression and protein–protein 
interaction data occurs only for extreme coexpression 
values and use these data to suggest candidates for tar-
gets likely to reveal novel biology in follow-up studies.
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Assessing Identity, Redundancy, 
and Confounds in Gene Ontology 
Annotations Over Time
Gene ontology (GO) is a key means by which systems 
biologists operationalize gene function, making it a 
heavily relied upon tool in innumerable analyses and 
data interpretation exercises. GO annotations are often 
used as a gold standard, but it has widely appreciated 
imperfections. Ironically, it is very diffi cult to assess 
the properties of GO itself because there is no other 
comprehensive gold standard against which to hold it. 
Broadly speaking, assessment of GO has focused on 
three distinct attributes: the accuracy of annotations 
assigned to GO, GO’s structure  independent of an-
notation, and the utility of GO and its annotations for 
the interpretation of data. Despite misgivings about 
the incompleteness of GO annotations, the use of GO 
“sets” as representing “functions” is now endemic. 
This is put to use in numerous applications such as 
“gene group enrichment,” gene network analysis, and 
gene function prediction. It is essential to understand 
the extent to which such applications are valid.
The statement “the differentially expressed genes 
were enriched for genes with functions in cell growth” 
does not necessarily mean the same thing today as it 
did 5 years ago, because the defi nition of “cell growth 
genes” has changed in GO. Valid experimental results 
often become obsolete over time, but the reported 
facts of the experiment should not. But that is what 
happens when the gene ontology changes. This is of 
course to be expected, and the problem can be ame-
liorated by reporting which version of the gene an-
notations was used. We fi nd that genes can alter their 
“functional identity” over time, with 20% of genes 
not matching to themselves (by semantic similarity) 
after 2 years. We consider ensuring independence of 
GO from the data sets to which it is being applied as 
an absolute minimum standard, and our results show 
that at least some protein interaction data do not meet 
this standard. We discovered that many entries in pro-
tein interaction databases are due to the same pub-
lished reports that are used for GO annotations, with 
66% of assessed GO groups exhibiting this confound. 
In our experience, among systems biologists, there 
seems to be a broadly appreciated disjunction between 
the true utility of GO and how often it is used, even 
if this is rarely acknowledged in the peer-reviewed lit-
erature. The use of GO annotations is often regarded 
as a minimally interesting validation of results, but 
not safe to use for discovery purposes. We believe the 
problems we have identifi ed are among the underly-
ing sources of these mixed feelings about GO. If it is 
“too easy” to obtain interesting results using GO, and 
those results do not consistently hold up, then GO’s 
utility for such purposes is limited.
Meta-Analysis across Computational 
Approaches Predicting Gene Function
The use of our burgeoning genomics data to character-
ize gene function has been one of the central research 
objectives of computational biology in the postgen-
omics era. Despite this intense focus, the abundance 
of public data, and methods development in machine 
learning and “big data” analysis, progress has been 
surprisingly uncertain. Attaching novel functions to 
genes based on prior data remains diffi cult, and a large 
number of genes still have comparatively little infor-
mation attached to them.
To better understand the forces driving algorith-
mic and data performance, developers have focused 
on comparative assessment. Despite some important 
progress enabled by these assessments, the underlying 
mechanisms driving methods performance are poorly 
understood. Each developer may use separate data re-
sources, different algorithms, and quite specifi c means 
for parsing the data in combination, making it quite 
hard to explore factors affecting performance. Field-
wide progress is hampered by our inability to know 
why a specifi c algorithm worked on a particular data 
set for a potentially narrow task.
To overcome this lack of detail in assessment, we 
implemented representative samples of cutting-edge 
“default” machine learning algorithms and obtained 
performances across our set comparable to those of 
previous critical assessments at identical tasks with 
well-characterized data and fully motivated parameter 
choices. Because we now have in-house versions of 
multiple algorithms, we can explore variance and data 
dependencies in a way not typically possible.
We focused on data based on networks derived 
from protein–protein interaction, sequence similarity, 
aggregated coexpression, and semantic similarity to 
study underlying patterns of performance. Our infra-
structure allows us to characterize in detail why aggre-
gation improves performance, where results are robust 
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and reproducible, and what artifacts are potentially 
problematic in data interpretation. We plan to make 
this replication across methods available as a public 
resource, allowing geneticists using function predic-
tion methods to better assess reproducibility and data 
dependencies in target genes of interest.
Assessing the First Computational Gene 
Function Prediction Assessment
The computational assignment of gene function re-
mains a diffi cult but important task in bioinformat-
ics. The establishment of the fi rst critical assessment of 
functional annotation (CAFA) was aimed at increas-
ing progress in the fi eld. We demonstrated an inde-
pendent assessment of the results of CAFA, aimed at 
identifying challenges in assessment and at under-
standing trends in prediction performance. We found 
that well-accepted methods based on sequence similar-
ity (i.e., BLAST) have a dominant effect. Many of the 
most informative predictions turned out to be either 
recovering existing knowledge about sequence similar-
ity or were “postdictions” already documented in the 
literature. These results indicate that deep challenges 
remain in even defi ning the task of function assign-
ment, with a particular diffi culty posed by the problem 
of defi ning function in a way that is not dependent on 
either fl awed gold standards or the input data itself. 
In particular, we suggest that using the gene ontology 
(or other similar systematizations of function) as a gold 
standard is unlikely to be the way forward.
Schizophrenia Coexpression to Prioritize 
Candidate Variants
RNA coexpression data are commonly used to con-
struct gene networks, but it is often considered to be 
more diffi cult to interpret than protein interactions. 
This is in part due to the lack of consensus on meth-
ods for constructing networks from expression profi les 
and the relatively poor performance of coexpression 
for function prediction, as measured by its ability to 
recapitulate data with GO, KEGG, or other databas-
es. On the other hand, coexpression affords a major 
advantage over current large-scale protein interaction 
databases: It can be used to create “condition-specifi c” 
networks. In our preliminary results, we show that 
by appropriate consideration of data pretreatment, 
aggregation, and network construction, coexpression 
networks become a powerful tool for gene function 
analysis, on par with or better than protein interaction 
networks in terms of overall properties, while provid-
ing condition specifi city. We leverage these properties 
to examine the role of de novo schizophrenia variants 
in the most comprehensive analysis to date of coex-
pression patterns in schizophrenia, combining seven 
studies of prefrontal cortex in affected individuals and 
unaffected controls.
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HUMAN GENETICS AND GENOMIC MEDICINE
G. Lyon M. Doerfel P. Kota
 H. Fang J. O’Rawe
 L. Jimenez Y. Wu
Our laboratory focuses on analyzing human genetic 
variation and understanding how genetic mutations 
contribute to severe idiopathic neuropsychiatric disor-
ders. We do this by studying large pedigrees living in 
the same geographic location, where one can study the 
expressivity and segregation of variants in a similar en-
vironmental background and with fewer population 
stratifi cation concerns. Toward this end, we collect 
pedigrees in Utah and elsewhere and then use exome 
and whole-genome sequencing to fi nd mutations that 
segregate with syndromes in the pedigrees. We focus 
on the discovery of families with rare diseases and/
or increased prevalence for syndromes such as intel-
lectual disability, autism, and schizophrenia. Once we 
identify mutations that likely contribute to a disease, 
we undertake detailed functional studies of these mu-
tations and the biological processes affected. Several 
projects are still at an early stage, but some of the proj-
ects that are suffi ciently far along to discuss publicly 
are listed below.
Ogden Syndrome and the Amino-Terminal 
Acetylation of Proteins
M. Doerfel, Y. Wu [in collaboration with R. Marmorstein, 
Philadelphia, Pennsylvania; T. Arnesen and N. Reuter, 
Norway; P. van Damme, Belgium]
We have previously identifi ed a lethal X-linked dis-
order of infancy comprising a distinct combination 
of particular craniofacial features producing an aged 
appearance, growth failure, hypotonia, global devel-
opmental delays, cryptorchidism, and acquired car-
diac arrhythmias. The fi rst family was identifi ed in 
Ogden, Utah, with fi ve affected boys in two genera-
tions of family members. A mutation was identifi ed as 
a c.109T> C (p.Ser37Pro) variant in NAA10, a gene 
encoding the catalytic subunit of the major human 
amino-terminal acetyltransferase (NatA). This same 
mutation was identifi ed in a second unrelated fam-
ily, with three affected boys in two generations. This 
X-linked malformation and infantile lethality syn-
drome has been named Ogden syndrome, in honor 
of the hometown where the fi rst family resides. This 
is the fi rst human disease involving a defect in the 
amino-terminal acetylation of proteins, a common 
(yet vastly understudied) modifi cation of eukaryotic 
proteins carried out by amino-terminal acetyltrans-
ferases (NATs). There is signifi cantly impaired bio-
chemical activity of the mutant hNaa10p, suggesting 
that a reduction in acetylation of some unidentifi ed 
proteins by hNaa10p might lead to this disease. There 
is currently very limited knowledge of the functional 
importance of Nt acetylation at the protein level and 
at the organismal level.
To understand the detrimental impact of the Naa10 
S37P mutation, we performed structural, molecular, 
and cellular investigations. The recently determined 
Schizosaccharomyces pombe NatA complex crystal struc-
ture was used as a template to generate a model of 
human NatA, revealing a highly conserved complex. 
The model allowed for comparison of Naa10 wild 
type and Naa10 S37P within the NatA complex and 
suggested a decreased fl exibility for Naa10 S37P in re-
gions involved in catalysis and at the interface with 
the auxiliary subunit Naa15. The hydrogen bonding 
network between Naa10 and Naa15 was also rear-
ranged. In vitro enzyme kinetics of Naa10 S37P dem-
onstrated a reduced catalytic capacity, probably due 
to impaired peptide substrate binding. In agreement 
with the structural model, Naa10 S37P displayed a 
reduced capacity to form a stable NatA complex. 
Amino-terminal acetylome analyses of patient B cells 
and fi broblasts provided a survey of Nt acetylation in 
human noncancer cells. In line with previous NatA 
knockdown data, patient-derived S37P B cells and fi -
broblasts have reduced Nt acetylation for a subset of 
NatA-type substrates compared to cells from healthy 
family members, demonstrating in vivo perturba-
tion of Naa10 (NatA)-mediated Nt acetylation in 
Ogden syndrome males. THOC7, one of the affect-
ed proteins, was shown to depend on Nt acetylation 
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for its stability. Ogden syndrome fi broblasts further 
displayed abnormal cell proliferation and migration 
capacity. Therefore, the Ogden syndrome mutant 
Naa10 is impaired in NatA complex formation and 
catalytic capacity, and patient cells display reduced in 
vivo Nt acetylation and cellular phenotypes potential-
ly linked to the defects observed in the males suffering 
from this disease.
Low Concordance of Multiple Variant-
Calling Pipelines: Practical Implications 
for Exome and Genome Sequencing
J. O’Rawe [in collaboration with K. Wang, Los Angeles, 
California]
To facilitate the clinical implementation of genomic 
medicine by next-generation sequencing, it will be 
critically important to obtain accurate and consistent 
variant calls on personal genomes. Multiple software 
tools for variant calling are available, but it is unclear 
how comparable these tools are or what their relative 
merits in real-world scenarios might be. We sequenced 
15 exomes from four families using commercial kits 
(Illumina HiSeq 2000 platform and Agilent Sure-
Select version 2 capture kit), with ~120× mean cov-
erage. We analyzed the raw data using near-default 
parameters with fi ve different alignment and variant-
calling pipelines (SOAP, BWA-GATK, BWA-SNVer, 
GNUMAP, and BWA-SAMtools). We additionally 
sequenced a single whole genome using the sequenc-
ing and analysis pipeline from Complete Genomics 
(CG), with 95% of the exome region being covered 
by 20 or more reads per base. Finally, we validated 
919 single-nucleotide variations (SNVs) and 841 in-
sertions and deletions (indels), including similar frac-
tions of GATK-only, SOAP-only, and shared calls, 
on the MiSeq platform by amplicon sequencing with 
~5000× mean coverage. SNV concordance between 
fi ve Illumina pipelines across all 15 exomes was 57.4%, 
whereas 0.5%–5.1% of variants were called as unique 
to each pipeline. Indel concordance was only 26.8% 
between three indel-calling pipelines, even after left-
normalizing and intervalizing genomic coordinates by 
20 base pairs. Of CG variants that fall within targeted 
regions in exome sequencing, 11% were not called by 
any of the Illumina-based exome analysis pipelines. 
On the basis of targeted amplicon sequencing on the 
MiSeq platform, 97.1%, 60.2%, and 99.1% of the 
GATK-only, SOAP-only, and shared SNVs could be 
validated, but only 54.0%, 44.6%, and 78.1% of the 
GATK-only, SOAP-only, and shared indels could be 
validated. Additionally, our analysis of two families 
(one with four individuals and the other family with 
seven), demonstrated additional accuracy gained in 
variant discovery by having access to genetic data from 
a multigenerational family. Our results suggest that 
more caution should be exercised in genomic medi-
cine settings when analyzing individual genomes, 
including interpreting positive and negative fi ndings 
with scrutiny, especially for indels. We advocate for re-
newed collection and sequencing of multigenerational 
families to increase the overall accuracy of whole ge-
nomes.
Advancing Precision Medicine through 
Clinical Grade Whole-Genome Sequencing, 
Return of Results, and Neuromodulation
J. O’Rawe, H. Fang [in collaboration with M. Reese, 
California; G. Higgins, Washington, D.C.; K. Eilbeck and 
R. Robison, Utah]
For widespread precision medicine to become a reality, 
many things must be optimized, including clinical-
grade sample collection, high-quality sequencing data 
acquisition, digitalized phenotyping, rigorous genera-
tion of variant calls, and online sharing of medical 
history and genomic data with research participants 
and others. We report the detailed phenotypic char-
acterization, clinical-grade whole-genome sequencing 
(WGS), as well as the 2-year outcome of a man with 
severe obsessive compulsive disorder (OCD) treated 
with deep brain stimulation (DBS) of the nucleus 
accumbens/anterior limb of the internal capsule. As 
part of his integrated medical care, his genome was 
sequenced, and variants were detected in the Illumina 
WGS Clinical Laboratory Improvement Amendments 
(CLIA)-certifi ed laboratory. It is increasingly appar-
ent that mental illness results from a constellation of 
 genetic and environmental factors. Consistent with 
this, WGS did not reveal any one mutation of large 
effect, but instead showed that he carries several alleles 
that have been shown to elevate risk for mental illness. 
This includes the p.Val66Met variant in brain-derived 
neurotrophic factor (BDNF), the p.Glu429Ala allele 
in methylenetetrahydrofolate reductase (MTHFR), 
and the p.Asp7Asn allele in choline O-acetyltransferase 
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(ChAT). We identifi ed thousands of other variants in 
his genome, including pharmacogenetic variants, and 
one mutation led to the discovery that he has untreated 
bilateral cataracts and other visual disturbances. We ar-
chived all data in the GVFclin format and also returned 
many results to this person. Since implantation of the 
deep-brain stimulator, this man has reported steady im-
provement, highlighted by a decline in his Yale-Brown 
obsessive compulsive scale (YBOCS) score from ~38 
to a score of ~25. A rechargeable Activa RC neuro-
stimulator battery has been of major benefi t in terms 
of facilitating a degree of stability and control over the 
stimulation. His psychiatric symptoms reliably become 
worse within hours of the battery becoming depleted, 
thus providing confi rmatory evidence for the effi cacy of 
DBS for OCD in this person. To our knowledge, this 
was the fi rst study in the clinical neurosciences that in-
tegrates detailed neuropsychiatric phenotyping, deep-
brain stimulation for OCD, and clinical-grade WGS, 
with management and the fi rst return of WGS results 
to a person with severe mental illness.
The Characterization and Analysis of an 
Idiopathic Intellectual Disability Syndrome 
via Whole-Genome Sequencing Analysis
J. O’Rawe, Y. Wu [in collaboration with A. Rope and 
J. Swensen, University of Utah]
We continued this year to study a new idiopathic syn-
drome with intellectual disability and distinctive facial 
dysmorphology. The propositi are two affected male 
brothers, aged 10 and 12, respectively, with severe 
intellectual disability, autism-like behavior, attention 
defi cit issues, and very distinctive facial features, in-
cluding broad, upturned nose, sagging cheeks, down-
ward sloping palpebral fi ssures, relative hypertelorism, 
high-arched palate, and prominent ears. Their parents 
are nonconsanguineous and are both healthy, and the 
family history does not demonstrate any other mem-
bers with anything resembling this current syndrome. 
X-chromosome inactivation assays reveal skewing in 
the mother, suggesting the possibility of an X-linked 
disorder. High-density genotyping arrays in the moth-
er, father, and two sons have not revealed previously 
known copy number variants (CNVs) that might con-
tribute to the phenotype. Whole-genome sequencing 
has led to the identifi cation of several rare variants that 
are currently being characterized further, including in 
other unaffected members of the extended family.
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DEVELOPMENT OF NEXT-GENERATION SEQUENCING TECHNOLOGY
W.R. McCombie E. Antoniou A. DeSantis M. Kramer P. Mocombe
 N. Azamy P. Deshpande D. Lewis S. Muller
 M. Bell S. Ethe-Sayers S. Mavruk-Eskipehlivan J. Parla
 Y. Berstein E. Ghiban S. McCarthy S. Teng
 G. Cheang S. Goodwin O. Mendivil Ramos 
In 2013, we completed important phases of several 
projects and began new initiatives. A paper done in 
collaboration with colleagues at the University of 
Edinburgh on the role of the Disrupted-In-Schizophrenia 
(DISC1) gene and psychiatric disorders was published in 
2013. We continued and expanded that project to study 
the role of DISC1 by continuing the analysis of ~260 
genes that interact with DISC1 in more than 1500 in-
dividuals. We further expanded this project under new 
funding from the National Institute of Mental Health 
(NIMH) by beginning whole-genome sequence analysis 
on 39 members of the translocation family.
In collaboration with colleagues at Trinity Univer-
sity, Dublin, we refi ned our analysis of the data ob-
tained the previous year from sequencing parent-child 
trios with a child affl icted by schizophrenia. The re-
sults showed a link to autism and implicated a class of 
genes involved in chromatin remodeling. A paper de-
scribing this work was submitted in December 2013.
In collaboration with the University of Iowa and 
Johns Hopkins University, we also completed the se-
quencing for our ongoing synaptome project. Ap-
proximately twice as many exomes as we were funded 
for were completed. We published a paper on a new 
analysis method as part of this project and will com-
plete the analyses of these data in the coming year.
In 2013, we initiated the remaining step that we 
believe to be necessary for a comprehensive, overall 
plan to understand the genetics of psychiatric disor-
ders by implementing high-throughput functional 
studies in Caenorhabditis elegans in collaboration with 
the  Hammell lab at CSHL. We also moved ahead our 
targeting technology to better enable us to sequence 
small regions of the genome in very large numbers of 
people. Thus, we now have in place initial genetic stud-
ies on exomes or whole genomes to broadly identify 
possible candidate genes, as well as dual  follow-up ap-
proaches of ultra-high-throughput-targeted resequenc-
ing of these candidates in much larger sample sizes and 
high-throughput functional tests to further character-
ize candidates. Although this “pipeline” needs further 
refi nement, with it in place, we look forward to apply-
ing it to our many candidates in 2014.
In the area of cancer genetics, we began collabora-
tion on colon cancer with colleagues at Stony Brook 
University. This initially focused on RNA sequencing 
and methylation analysis.
Finally, we made considerable progress in our 
plant genomics and de novo assembly research. This 
is being driven mostly by adapting new methods to 
take advantage of the increasing read lengths on the 
Pacifi c Biosciences instrument. In collaboration with 
the Schatz lab at CSHL, we have been working on 
both pure Pacifi c Biosciences assemblies and hybrid 
assemblies with Illumina data included.
Investigating the Biology of DISC1
S. Teng, S.E. McCarthy, M. Kramer, W.R. McCombie 
[in collaboration with D. Blackwood, D. Porteous, 
P. Thompson, and I. Deary, University of Edinburgh; 
A. McRae, University of Queensland]
The DISC1 gene has been implicated in psychiatric 
disorders such as major depression (UP), bipolar dis-
order (BD), and schizophrenia (SZ). This gene was 
originally identifi ed in a Scottish family with a high 
burden of mental disorders (St Clair et al., Lancet 336: 
12–16 [1990]). We have undertaken several projects to 
study the genetics of DISC1. We previously described 
targeted sequencing of the 528-kb DISC1 gene region 
in more than 1500 individuals (221 BP, 240 SZ, 192 
UP, and 889 controls). We found a nominal association 
of noncoding single-nucleotide polymorphisms (SNPs) 
(rs16856199) with major depression, as well as several 
extremely rare variants that seem to be present only (or 
almost only) in affected patients. We believe that the 
DISC1 locus represents a microcosm of the complexity 
that has made a better understanding of the genetics of 
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major psychiatric disorders so diffi cult to unravel. There 
are multiple types of variants at this one locus. Some of 
these are common variants that provide a slight increase 
in risk for a disorder (depression, in this case). Other 
variants in the same gene are extraordinarily rare in 
the population, but they appear to confer an extremely 
high risk for a disorder, probably approaching 100%. 
In addition, there are probably interactions among mul-
tiple variants in the DISC1 gene and among variants in 
DISC1 and other genes. This genetic complexity is then 
amplifi ed across hundreds or even thousands of genes 
contributing to the disorders. In 2013, we published 
this work in Molecular Psychiatry (Thomson et al., Mol 
Psych doi 10.1038/mp.2013.68 [2013]).
To better understand the potential interaction be-
tween DISC1 and other genes, we have been detecting 
variants in genes thought to interact with DISC1. Last 
year, we reported on the targeted resequencing of the 
DISC1 interactome, a network of genes that converge 
on pathways critical for neuronal signaling and genes 
important in the treatment of SZ, BD, and UP. Using 
a custom Nimblegen solution capture of a ~13-Mb tar-
get, we resequenced in 1543 samples (using the same 
sample set as those sequenced in the study above) the 
exons, promoters, and conserved regions of 264 genes 
that are known to directly interact with DISC1. In 
2013, we performed data quality control analysis to 
reduce the numbers of false associations in the case-
control study. Samples with high missing genotypes, 
outlying heterozygosity rate, or discordant sex infor-
mation were removed and individuals of divergent an-
cestry were identifi ed. We fi ltered the single-nucleotide 
variants (SNVs) with excessive missing genotypes or 
a signifi cant deviation from Hardy–Weinberg equi-
librium. The fi nal data set included 1453 samples and 
284,699 SNVs. Among the SNVs with high quality, 
78% have a minor allele frequency of less than 1%, and 
67% of the SNVs have not been previously reported in 
the 1000 Genomes Project European subset. To detect 
the statistical associations between the single SNV and 
psychiatric disorders, we performed a Fisher’s exact test 
across all SNVs on combined diagnoses: SZ, BP, and 
UP, respectively. To assess the associations at the genic 
level, we performed two gene-based association meth-
ods including the basic burden test and the sequence 
kernel association test. In 2014, we aim to expand the 
analysis to analyze epistatic interactions between genes 
and to further investigate and prioritize variants and 
genes for functional follow-up.
We also began a project to analyze the complete 
genomes of 39 members of the DISC1 family in which 
the original translocation was found in order to search 
for independently segregating variants that may ex-
plain why many of the translocation carriers develop 
SZ or recurrent UP but others have only minor or no 
psychiatric diagnoses. We will then be able to com-
pare these potential variants with the variants ob-
served in the DISC1 interactome. On completion of 
whole-genome sequencing, we were able to produce 
high-quality libraries with >33× mean coverage and 
>93% of bases covered at 20× or higher depth for 
each sample. The data were processed through our 
standard analysis pipeline that uses Burrows–Wheeler 
aligner (BWA) mapping (Li et al., Bioinformatics 25: 
1754 [2009]), SAMtools (Li et al., Bioinformatics 25: 
2078 [2009]), BamTools (Barnett et al., Bioinformat-
ics 27: 1691 [2001]), and Picard for alignment process-
ing, and QC and GATK (DePristo et al., Nat Genet 
43: 491 [2011]) for variant calling. Recently, the vari-
ants were recalled using GATK’s multisample calling 
feature in order to obtain more accurate genotyping 
across samples. In 2013, we received a grant from the 
NIMH to continue the study of this important locus.
In 2014, we plan to further investigate the variants 
and to use analysis methods and software such as the 
GEMINI software suite and Ingenuity Variant Anal-
ysis (www.ingenuity.com) to classify and prioritize 
variants (Paila et al., PLoS Comput Biol 9: e1003153 
[2013]). We will expand the analysis from SNPs and 
small indels to include copy number variants (CNVs) 
and structural variants. In addition, we plan to per-
form methylation analysis to scan for differentially 
methylated regions and to follow up on our fi ndings 
in a larger Scottish and NIMH case control set.
Exome-Based Sequencing 
of Parent–Offspring Trios 
with Schizophrenia
S.E. McCarthy, M. Kramer, Y. Berstein, E. Ghiban, 
E. Antoniou, W.R. McCombie [in collaboration with 
J. Gillis and S. Yoon, Cold Spring Harbor Laboratory; 
M. Mistry and P. Pavlidis, The University of British 
Columbia; E. Kelleher, C. O’Brien, G. Donohoe, M. Gill, 
D.W. Morris, and A. Corvin, Trinity College Dublin]
In collaboration with Trinity College Dublin, our data 
analysis of de novo mutations in 57 parent–offspring 
trios with schizophrenia (42 trios with no family  history 
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of psychosis [sporadic] and 15 trios with a family history 
of psychosis [familial]) was fi nalized and submitted for 
publication at Molecular Psychiatry in December 2013. 
The fi ne-tuning of this work improved the signifi cance 
of our fi ndings summarized below.
In addition to the analysis we reported in 2012, we 
found in our sporadic trios that de novo mutations 
likely to be disrupting or damaging to protein func-
tion in genes were less tolerant to new or rare muta-
tions (P = 2 × 10−5) (Petrovski et al., PLoS Genet 9: 
e1003709 [2013]). We also refi ned our disease ontol-
ogy analysis to improve the specifi city of the gene– 
phenotype relationships. Following this revised analysis 
using 72 fi ne-tuned Neurocarta (Portales-Casamar 
et al., BMC Genomics 129: doi 10.1186/1471-2164-
14-129 [2013]) phenotypes (defi ned by 10 or more 
quality-fi ltered associated genes), the overlap between 
genes with de novo mutations (DNMs) and genes im-
plicated in autism and intellectual disability remained. 
The overlap with autism was the greatest of DNMs in 
genes such as CHD8, MECP2, AUTS2, and MLL2, 
which supports previous genetic and epidemiological 
studies that suggest a shared genetic component be-
tween schizophrenia and autism.
We also improved our analysis of DNMs in po-
tential chromatin modifi er genes. First, we found a 
signifi cant enrichment of DNMs in genes coding for 
chromatin modifi ers that have been implicated in the 
etiology of mental illnesses. Second, we expanded the 
analysis to epigenetic modifying genes based on pro-
tein domain specifi city and observed a signifi cant en-
richment overall of DNMs in these genes.
An important addition to this analysis was deter-
mining the consistency of our fi ndings using data 
from nine exome-sequencing studies of trios with 
neurodevelopmental disorders, including schizophre-
nia (n = 3) and autism (n = 4), ID (n = 2), as well as 
six unaffected cohorts. With our data set included, an 
increase in nonsense mutations was observed in 40% 
of the neurodevelopmental data sets compared to just 
one control data set (de Ligt et al., J Med 367: 1921 
[2012]; Gulsuner et al., Cell 154: 518 [2013];  Iossifov 
et al., Neuron 74: 285 [2012]; Neale et al., Nature 485: 
242 [2012]; O’Roak et al., Nature 485: 246 [2012]; 
Rauch et al., Lancet 380: 1674 [2012]; Sanders et al., 
Nature 485: 237 [2012]; Xu et al., Nat Genet 44: 1365 
[2012]). More than 66% of the neurodevelopmental 
data sets had functional de novo mutations affecting 
protein function in haploinsuffi cient genes or genes 
intolerant to novel mutations, in contrast to two con-
trol cohorts. No unaffected cohort had an enrich-
ment in genes implicated in autism spectrum disorder 
(ASD) or intellectual disability (ID). Finally, genes 
involved in chromatin regulation of gene transcrip-
tion were enriched in ~60% of the neurodevelopmen-
tal data sets, whereas enrichment was only observed in 
one control data set.
Finally, our submission included work combining 
the power of orthogonal and complementary genomic 
analysis to understand the function of genes about 
which little is known. Using gene expression data, 
genes with DNMs in our schizophrenia trios presented 
reduced coexpression with other genes in the prefrontal 
cortex, in contrast to other brain and nonbrain regions, 
supporting hypotheses suggesting that genes with loss-
of-function mutations express lower connectivity.
We aim to expand this study of de novo variants in 
more trios with schizophrenia. However, given the role 
of chromatin remodeling and epigenetic regulation of 
gene transcription during brain development and in 
the adult brain, we aim to study how perturbations of 
genes implicated in chromatin remodeling affect neu-
ronal development and function of the PVD (peripher-
al vascular disease) neuron in C. elegans and in neurons 
derived from patient-specifi c induced pluripotent stem 
cells, shedding light on the pathogenesis of neurode-
velopmental disorders. We also aim to explore the role 
of chromatin remodeling in the adult mouse amygdala 
in response to fear conditioning, which may provide 
insight into the molecular mechanisms of anxiety and 
posttraumatic stress disorder (PTSD) that could be 
used to develop novel treatments for these conditions.
Investigation of Bipolar Disorder Genetics 
Using Exome Capture and Resequencing
J.S. Parla, S. Muller, G. Cheang, M. Kramer, E. Ghiban, 
S. Goodwin, W.R. McCombie [in collaboration with 
J. Potash, University of Iowa; P. Zandi, F. Goes, R. Karchin, 
and A. Chakravarti, Johns Hopkins School of Medicine]
Bipolar disorder (BP) is a complex psychiatric disease 
for which previous studies have failed to fi nd signifi -
cant causative variants of large effect. In 2010, we 
began using exome capture and next-generation se-
quencing to study bipolar disorder using family sam-
ples as well as case-control analysis. By 2012, we had 
successfully sequenced more than 60 family samples 
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and ~1000 case-control samples. Although this work 
allowed us to develop and streamline high-through-
put capture and data-processing pipelines, it became 
quite clear that we would need a much larger sample 
set in order to investigate this likely polygenic pheno-
type. In 2013, we scaled up sequencing and brought 
the total samples completed for the project to 2329. 
This basically doubled our goal for the project and 
matched the output of the previous 3 years of the 
project combined. In 2013, we focused the analysis 
on variants that were predicted to be damaging by 
several software tools—SIFT (Ng PC1 et al., Nucleic 
Acid Res 13: 3812 [2003]), PolyPhen (Adzhubei et al., 
Nat Methods 7: 248 [2010]), and VEST (Carter et al., 
BMC Genomics 14: 1–16 [2013]), which is a tool de-
veloped by our collaborators—and that segregated 
with disease in the family samples. We then assessed 
whether there was any increased burden in case versus 
control samples for those genes. This analysis led us to 
focus on 10 possibly signifi cant genes. We then used 
Sanger sequencing to genotype family members of the 
probands who were affected cases in the case-control 
sample set; however, we did not fi nd any further evi-
dence of segregation. In 2014, we plan to further re-
fi ne our analysis techniques and to focus more on vari-
ant analysis in the larger case-control data set.
Additionally, on the analysis front, our collabora-
tor Rachel Karchin proposed a new hybrid likelihood 
model to assess functional variants. The method is 
called BOMP (burden or mutation position test) and 
is a combination of a burden test with a test of the 
positional distribution of variants. This work was 
published in PLoS Genetics in 2013 (Chen et al., PLoS 
Genet 9: e1003224 [2013]). In 2013, we also submit-
ted a paper to the Journal of Human Genetics describ-
ing our work comparing data-processing techniques, 
quality fi lters, and variant detection software tools in 
order to produce an accurate call set.
Functional Screening in the PVD Neuron 
of C. elegans to Unravel Neuropsychiatric 
Disorders
O. Mendivil Ramos, S.E. McCarthy, M. Kramer, 
W.R. McCombie [in collaboration with C. Aguirre-Chen 
and C. Hammell, Cold Spring Harbor Laboratory]
C. elegans is an important model system for the iden-
tifi cation and functional mapping of genes involved in 
complex biological processes, including those of the 
nervous system. In particular, it has been a useful 
model for a variety of neuropsychiatric disorders in-
cluding schizophrenia, Alzheimer’s disease, and neu-
rodegeneration. The number of neurons in the C. 
 elegans nervous system is known. Moreover, most of 
the connections among neurons are known, as well as 
the lineage of every cell from a fertilized embryo to the 
adult animal. The PVD neuron forms several levels of 
well-characterized dendrites and is competent for bac-
terial ingestion-mediated RNA interference (RNAi). 
This unique feature enables functional testing for a 
neural developmental phenotype at high throughput.
Late in 2013, we established a collaboration with 
the Hammell lab at CSHL to functionally assess some 
of the most prominent variants that we have identifi ed 
in human genetics studies as being likely associated 
with neuropsychiatric disorders. We assembled a list 
of 117 human candidate genes identifi ed in various 
ongoing genetic studies and found that 47 of them 
had good homologs in C. elegans. The Hammell lab 
performed a preliminary screen of these genes, ob-
taining six phenotypes of altered branching of the 
PVD neuron. In 2014, both labs will be expanding 
this research line by extending the list of homologs 
to additional candidates, as well as doing controlled 
studies to better estimate the effi cacy of this model in 
assessing the large number of genetic variants being 
identifi ed for major psychiatric disorders.
Highly Multiplexed Targeted Resequencing 
of Submillion Base Genomic Targets
J.S. Parla, P. Deshpande, S. Ethe-Sayers, M. Kramer, 
E. Ghiban, S. Goodwin, W.R. McCombie [in collaboration 
with R. Karchin, Johns Hopkins School of Medicine]
Improvements in next-generation sequencing technol-
ogy allow users to produce enormous amounts of se-
quencing data in increasingly short times, but this is pre-
dominantly directed at a large amount of sequence from 
each sample (such as the entire genome). There remains 
a signifi cant and growing need to effi ciently sample 
small genomic regions (on the order of 0.5 Mb) in ex-
tremely large cohorts of samples. In 2012, we worked to 
establish a technique using Nimblegen solution capture 
probes to barcode and capture highly multiplexed sam-
ples. We created a custom Nimblegen probe set targeting 
fi ve genes that cover ~637 kb of the genome. We then 
successfully validated multiplexing up to 96 samples per 
capture, followed by sequencing of the 96plex set on one 
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Illumina HiSeq lane. We were able to achieve ~90% 
of target coverage at ≥20× sequence depth and ~200× 
mean target coverage with this method.
In 2013, we began testing methods to increase the 
level of sample multiplexing to take advantage of the 
high mean coverage that we were getting on the 96 
individually barcoded samples along with increased 
sequence output from the Illumina instruments. We 
investigated sample-pooling techniques where fi ve or 
10 individuals were pooled together, and that entire 
pool was subsequently barcoded and sequenced up 
to a 96plex of 10 samples per pool (960plex). These 
pools were then run across three HiSeq lanes. We 
began testing a modifi ed GATK pipeline (DePristo 
et al., Nat Genet 43: 491 [2011]) for variant calling in 
the anonymous pools. We found that we were able to 
detect the correct variants for the individuals within 
those pools to a high degree (only ~1%–3% of vari-
ants that were called in the samples when they were 
sequenced individually were not found in the pools 
on average); however, we found we also call a large 
number of extraneous false-positive variants with this 
method of ascertainment. This led as to begin study-
ing the effect of modifying several sequence quality 
fi lters to obtain a high degree of sensitivity while re-
ducing the number of false positives. More work is 
needed to refi ne the fi lters and methods used to call 
variants accurately in these anonymous pools.
Further investigation to explore complex pooling 
designs will be performed in 2014. These investiga-
tions will include simulations and bench work to eval-
uate the performance of various pooling designs for 
identifying rare and common variants. In particular, 
we will begin testing sample pooling using a two-di-
mensional matrix such that individuals will be pooled 
by a unique row/column location before barcoding.
Genomics of Colorectal Cancer
E. Antoniou, W.R. McCombie [in collaboration with E. Li 
and J. Williams, Stony Brook University]
Colorectal cancer (CRC) is the third most commonly 
diagnosed cancer and is the second leading cause of 
cancer-related deaths in the Western world. The mor-
tality from colorectal cancer in Caucasian Americans 
(CAs) has been declining, but, in contrast, it has been 
rising in African Americans (AAs). The response to 
chemopreventive agents differs in terms of the biologi-
cal/genetic heterogeneity of the tumors of AAs and 
CAs. Because chemopreventive agents exert their ef-
fect through a molecular target, this disparity would 
suggest differences at the genetic level. This project 
aims to determine the attribution of genetic and epi-
genetic differences to the racial/ethnic health disparity 
of colon cancer.
In 2012, to validate our laboratory and analysis pipe-
lines, we used RNA-Seq on a cell line (HT29) treat ed 
with 5-aza-deoxy-cytidine. In 2013, we compared our 
results to the data from previous microarray studies. 
We published an article on this comparison, showing 
the superiority of the RNA-Seq technique (Xu et al., 
BMC Bioinformatics 14; S1: doi 10.1186/1471-2105-
14-S9-S1 [2013]). We also used RNA-Seq to obtain 
gene expression measurements on 18 tumor/normal 
paired AA tissue samples and as many samples from 
CA patients. Analysis is ongoing.
In addition, we prepared 57 reduced representa-
tional bisulfi te sequencing (RRBS) libraries, 52 of 
them from paired tumor/normal tissues. In 2014, 
we will prepare another 30 RRBS libraries and more 
RNA-Seq libraries from the same paired samples. We 
will then proceed with the combined analysis of gene 
expression and DNA methylation. Additional biopsies 
are also being collected on an ongoing basis at Stony 
Brook University Hospital.
Plant Genomics
M. Kramer, E. Antoniou, E. Ghiban, W.R. McCombie 
[in collaboration with M.C. Schatz, J. Stein, A. Hernandez 
Wences, J. Gurtowski, E. Biggers, H.Y. Lee, J. Chia, and 
D. Ware, Cold Spring Harbor Laboratory; L.G. Maron, 
M.H. Wright, and S.R. McCouch, Cornell University]
Rice (Oryza sativa) is one of the most important food 
crops in the world, especially in the developing world. 
Relatively little effort has been made to explore the na-
ture of structural variation within and between sub-
populations of domesticated O. sativa. The best way 
to fully understand the genomic diversity of rice is to 
perform whole-genome shotgun sequencing and de 
novo assembly. The diffi culties in assembling the short 
reads initially provided by next-generation sequencing 
have resulted in efforts to sequence other strains of rice 
that rely on mapping the sequence read back to a refer-
ence sequence. This results in the loss of information 
where there are structural differences between the two 
strains. Often, these differences constitute biologically 
salient information. Recent advances in sequencing 
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technology and in computational approaches to se-
quence assembly have signifi cantly improved the power 
and reliability of de novo assembly. In this project, we 
used these new tools to develop de novo assemblies of 
three divergent rice genomes representing the indica 
(IR64), aus (DJ123), and japonica (Nipponbare) sub-
populations and to determine the extent and distribu-
tion of structural variation among them.
During the last quarter of 2012, Pacifi c Biosci-
ences Inc. (PacBio) released a new polymerase and as-
sociated chemistry (P4/C2) that greatly increased the 
read length on this machine, up to an average of 4.5 
kbp. A hardware upgrade also doubled the through-
put of the instrument in mid 2013. Taking advantage 
of these improvements, we produced 19× coverage 
of the  Nipponbare genome using the new P4/C2 
 enzyme/chemistry combination. We also obtained 
28× genome coverage of longer Illumina MiSeq reads 
(paired end 250 bp). A new assembly of the Nippon-
bare genome was made using the PacBio and Illumina 
250-bp reads. The N50 contig size doubled from 21 
kbp to 58 kbp. Furthermore, a new error-correction 
algorithm for the PacBio sequences was written by 
Mike Schatz’s group. After applying this new error-
correction pipeline, the N50 contig size grew to 155 
kbp. In conclusion, we can now generate a de novo 
assembly of a complex genome such as rice using next-
generation sequencing platforms at a fraction of the 
cost and time that it took to make the bacterial artifi -
cial chromosome (BAC)-based rice reference genome.
In the last quarter of 2013, Pacifi c Biosciences in-
troduced yet another polymerase and chemistry as 
well as new library preparation protocols that have 
doubled the average read length on this platform. We 
are planning to generate enough coverage of at least 
one rice genome with these new reagents to assemble 
a de novo rice genome using only PacBio sequences, 
with the hope of achieving even larger contig sizes.
De Novo Assembly of Yeast Genomes 
Using Long Insert Libraries and the Paciﬁ c 
Biosciences RS II Instrument
P. Deshpande, S.M. Eskipehlivan, M. Kramer, S. Goodwin, 
E. Antoniou, W.R. McCombie [in collaboration with J. 
Gurtowski, H.Y. Lee, and M.C. Schatz, Cold Spring Harbor 
Laboratory; C. Heiner and G. Khitrov, Paciﬁ c Bioscience]
Next-generation sequencing has proven to be an invalu-
able tool for the understanding of genetics. However, 
the relatively short reads generated by instruments such 
as the Illumina HiSeq pose a limitation to the de novo 
assembly of larger genomes. Pacifi c Biosciences pro-
vides an instrument that can generate reads that are 
thousands of bases in length. These long reads provide 
the architecture required for de novo assembly and also 
provide superior retention of structural elements im-
portant to the understanding of genetic variation.
In 2013, we began exploring the use of long read 
sequencing for the de novo assembly of yeast strains. 
We selected a large fragment (>7 kb) library from the 
Saccharomyces cerevisiae W303 genome using a Blue-
Pippin from Sage Sciences. Sequences were generated 
using the Pacifi c Biosciences RS II instrument with 
p5-c3 chemistry. The results yielded >75× coverage 
across the genome with reads in excess of 10 kb. These 
sequences were assembled with HGAP and the Celera 
Assembler (Chin et al., Nat Methods 10: 563 [2013]; 
Myers et al., Science 287: 2196 [2014]). The result-
ing contig N50 length approached one million bases, 
essentially only limited by the chromosome lengths 
of the organism. Only one chromosome, containing 
a very long tandem repeat, was not represented by a 
single contig. In 2014, we plan to continue to opti-
mize these protocols and test them on additional yeast 
genomes.
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PLANT GENOME ORGANIZATION, EVOLUTION, AND FUNCTION
D. Ware A. Eveland C. Liseron-Monﬁ ls F. Qiu L. Wang
 Y. Jiao Z. Lu J. Stein S. Wei
 M. Karey Monaco C. Noutsos J. Thomason K. Youens-Clark
 S. Kumari A. Olson P. Van Buren L. Zhang
 Y.K. Lee S. Pasternak B. Wang Z. Zhang
Our lab has two goals: (1) research into plant genom-
ics and (2) developing tools and resources for use 
by the genomics research community. Our research 
 includes a broad range of physical, statistical, and 
functional genomics in model plant systems and ag-
riculturally important crop plants. We also contrib-
ute to two large-scale, multi-institutional, cyberin-
frastructure collaboratives that are designed to serve 
broad  research and educational communities. Dur-
ing the past year, we were joined by visiting scientist 
Fazhan Qi and postdoctoral researcher Bo Wang. Shiran 
 Pasternak has advanced his career, taking a position in 
the industry sector.
Gramene
Y. Jiao, S. Kumari, M. Karey Monaco, A. Olson, S. Pasternak, 
J. Stein, J. Thomason, S. Wei, K. Youens-Clark [in 
collaboration with P. Jaiswal, Oregon State University; 
P. Kersey and H. Parkinson, EMBL–European Bioinformatics 
Institute; L. Stein, Ontario Institute of Cancer Research; 
C. Taylor, American Society of Plant Biologists]
The Gramene project provides online reference re-
sources for plant genomes and curated pathways to 
aid functional genomics research in crops and model 
plant species. Our website, www.gramene.org, allows 
the study of gene function by combining genome an-
notation and experimental data with cross-species 
comparisons. This past year witnessed remarkable 
growth of the website as the project accomplished sev-
eral major milestones culminating in our 40th release 
since the inception of this project. Highlights include 
the addition of six new species, the premiere of the 
Plant Reactome database, and a total redesign of 
Gramene webpages and search functions.
The Gramene team develops comparative genom-
ics databases in collaboration with the Ensembl Plants 
project at the European Bioinformatics Institute (EBI). 
Thanks to this teamwork, we added six new complete 
reference genomes to the collection, bringing the total 
to 28. Perhaps the most signifi cant of these was the 
genome of bread wheat, Triticum aestivum, released by 
the International Wheat Genome Sequencing Con-
sortium. This hexaploid genome is the largest (~17 
Gbp) and most complex angiosperm genome ever se-
quenced. The fi rst draft, although gene-rich, is still a 
highly fragmented assembly; nevertheless, its addition 
to Gramene completes the triumvirate of major cereal 
grains in our collection: wheat, rice, and maize. These 
three crops constitute 90% of world-wide grain pro-
duction and are keystones to future agricultural sus-
tainability. Bread wheat’s unusually large genome can 
be attributed in part to allohexaploidy (AABBDD), 
which arose during domestication. Understanding the 
evolution and interaction among subgenomes will be 
aided greatly by study of its diploid progenitors. Two of 
these, Triticum uartu (AA) and Aegilops tauschii (DD), 
were also added this past year to the Gramene/ Ensembl 
Plants collection, following their release by the Beijing 
Genomics Institute (BGI). These, along with the bar-
ley genome (Hordeum vulgare), make Gramene a pre-
eminent site for study of Triticeae genomes.
Gramene continues to build a genus-level phyloge-
nomics resource for rice and related Oryza species. 
Rice emerged ~15 million years ago. The Oryza genus 
includes two cultivated species (Asian and African 
rice) and 21 wild species adapted to a broad range of 
tropical and subtropical habitats around the world. 
The genomics research wishing to exploit such diver-
sity for crop improvement is also establishing Oryza 
as a model system for genus-level study of trait evolu-
tion, speciation, and domestication. Working with the 
 National Science Foundation (NSF)-funded Oryza 
Genome Evolution (OGE) project (principal inves-
tigator: Rod Wing, University of Arizona) and with 
the international consortium known as I-OMAP, 
Gramene will soon host high-quality genome assem-
blies for more than half of these species. Last year, 
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Gramene added complete reference assemblies for two 
new species and will include six additional genomes 
in the coming release, bringing the total to 12. One 
of the challenges of comparative genomics research 
is that different genome projects apply different pro-
tocols to identify genes, leading to methodological 
bias that confounds comparative analysis. To remedy 
this, Gramene staff worked with the OGE project to 
develop a consistent annotation protocol (using the 
MAKER-P pipeline) that was applied both to the 
new genomes and to the Oryza genomes previously 
sequenced and annotated by other projects. Gramene 
will continue to support both sets of annotations by 
creating a new website to represent I-OMAP genomes 
and phylogenetic trees.
PLANT GENOME RESEARCH
In the last decade, the decoding of complete plant ge-
nomes has helped scientists understand plant function 
and evolution and how to alter economically impor-
tant traits. Many disciplines are required to generate 
reference genomes. This starts with laboratory scien-
tists who generate the raw sequence data and goes to 
computational biologists and bioinformaticians, such 
as those in our lab, who interpret the output. This 
interpretation includes the assembly of raw sequence 
reads into overlapping segments (“contigs”) that are 
used to create a scaffold to discern their order and 
orientation within chromosomes. Another step is an-
notation—the discovery and description of genes and 
other functional elements, as well homologies to other 
genomes. In addition, this information must be faith-
fully communicated and visualized, such as in web-
based platforms like Gramene.
All of these activities are rapidly evolving with the 
advent of new sequencing technologies, algorithms, 
and data-handling requirements. For example, high-
depth sequencing of RNA transcripts at low cost is 
providing new evidence that informs genome annota-
tion and is spurring the development of new software 
to model and perform this task. Low-cost sequencing 
is also transforming the types of questions that can be 
asked, moving beyond the generation of a single refer-
ence for a given species. Ongoing projects within the 
maize, rice, and Arabidopsis research communities are 
now sequencing hundreds or thousands of genotypic 
backgrounds within species, gathered from carefully 
constructed populations, wild populations, and breed-
ing germplasms. Information on genetic variation is 
 helping scientists to understand the genetic basis of phe-
notypic traits and the origins of domesticated crop spe-
cies. New technologies are also driving research in epi-
genetics, the study of heritable traits that are not caused 
by changes in underlying genome sequence. Epigenetic 
mechanisms include modifi cation of DNA by methyla-
tion and various forms of histone modifi cation that can 
cause changes in gene expression and other phenotypes. 
Both of these modifi cation types can be studied with 
new sequence technologies and analysis methods.
Updating the Maize B73 Reference 
Genome and Developing Pan-Genome 
Variation Pipelines
This work was done in collaboration with J. Glaubitz, 
Cornell University; E. Buckler, Cornell University; 
R. Fulton, Washington University; R. Wilson, Wash-
ington University; and the Maize Genome Sequencing 
Consortium. Work continues on refi ning the assembly 
and annotation of the maize B73 reference sequence. 
The third version (“RefGen_v3”) of the B73 assembly 
and annotations is hosted on Gramene and has been de-
posited in GenBank along with contigs assembled from 
Roche/454 sequencing of a whole-genome shotgun li-
brary. RefGen_v3 incorporates some of these contigs in 
order to increase coverage of missing gene space. The 
contigs were selected based on alignment to FLcDNA 
sequences and inserted into gaps in the RefGen_v2 
 assembly guided by a genetic map combined with syn-
teny to rice and sorghum. Approximately 500 genes 
were added or improved with this method, and many 
unplaced physical map contigs were also anchored on 
the basis of these maps. The RefGen_v3 assembly was 
released following acceptance by GenBank.
Work on RefGen_v4 is under way. To improve 
the maize genome sequence, we are adding addi-
tional depth to the existing capillary sequence using 
the Illumina 2000 platform, as well as generating 
long reads with PacBio to span repeats. We have re-
sequenced 17,173 bacterial artifi cial chromosomes 
(BACs) that constituted the minimal BAC tiling path 
from the original B73 sequencing project by pooling 
the BACs in pools of 96 and are generating Illumina 
data to greater than 150× coverage per clone. This in-
creased depth, density of read pairs, and differential 
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bias compared to capillary sequencing will serve as 
an excellent resource to further improve the maize 
sequence. Long reads from PacBio will be used to im-
prove the order and orientation of assembled contigs 
and close gaps wherever possible. These data, once 
completed, will be made available through public da-
tabases before completion of the RefGen_v4 assembly.
In Zea mays, it is estimated that only 50% of ge-
nomic content is held in common between lines due 
to tremendous haplotype diversity. A single reference 
assembly for maize cannot serve as a suffi cient back-
bone to capture and describe this variation and is a 
limiting factor in understanding the genetic variation 
controlling traits. The maize pan-genome under de-
velopment will be composed of the B73 reference as-
sembly and novel sequences from other maize inbred 
lines. Our initial efforts are to identify novel haplo-
types among a broad sampling of sequenced germ-
plasms by conducting whole-genome assembly of 30× 
Illumina reads. At this depth, high-repeat content in 
maize will challenge existing methods for de novo as-
sembly. Simulations using the ALLPATHS-LG recipe 
to assemble 30× reads sampled from the B73 refer-
ence resulted in ~82% coverage of annotated genes. We 
are using sequence data for the inbred B97 to further 
prototype pipeline construction. Because different as-
sembly algorithms have different advantages, we have 
adopted a meta-assembly strategy. Using this strategy, 
~30% of the genome could be assembled with ~72% 
of genic space covered in scaffolds. After aligning to 
the BAC-based B73 reference, ~19.78 Mb of novel se-
quences was identifi ed. We also used a genetic map-
ping method to anchor novel sequences relative to the 
B73 physical map. The accuracy rate of this genetic 
mapping method was tested by anchoring 1000 B73 
genes, and the results demonstrated 77.6% accuracy. 
As for B73, PacBio long reads will be generated and 
used for scaffolding and gap closing.
Discovery and Application of Epigenetic 
Variation in Sorghum and Maize
Z. Lu, A. Olson [in collaboration with R. Martienssen, 
J. Hicks, W.R. McCombie, M. Regulski, and J. Kendall, 
Cold Spring Harbor Laboratory; S. Tingey and A. Rafalski, 
Pioneer DuPont Pioneer; D. Dugas, R. Klein, and P. Klein, 
USDA/Texas A&M University]
DNA methylation has an important role in the regu-
lation of gene expression and control of transposable 
elements. The patterns of DNA methylation, referred 
to as the “methylome,” must be faithfully propagated 
for proper development in plants and animals. In 
collaboration with the Martienssen lab and DuPont 
Pioneer, we sequenced the methylome of two maize 
inbred lines, B73 and Mo17. The genomic DNA is 
treated with bisulfi te, which converts unmethyl-
ated cytosine to thymine. Sequencing using next-
generation Illumina GA2 paired-end reads, followed 
by mapping back to the maize genome, resulted in 
identifi cation of the methylome in single-base resolu-
tion. We have generated 20×–30× coverage over the 
mappable portion of the maize genome. Alignment 
with RNA sequences indicates that the methylation 
patterns are correlated with gene expression, small 
RNA, and alternate splicing. Diversity in cytosine 
methylation patterns was observed in transposable 
elements and especially in genes and was found to be 
largely heritable in recombinant inbred lines (RILs); 
however, signifi cant deviations from heritability were 
observed, many of which were conserved in different 
RILs. This will help us to reveal the roles of DNA 
methylation in gene regulation and other biological 
functions in the future.
In Sorghum, we used shallow sequencing (2×–4×) 
of bisulfi te-treated root tissues in order to identify re-
gions of open chromatin and patterns of methylation 
associated with high-confi dence gene models. These 
patterns, together with measures of gene expression 
and sequence conservation, were used to train a clas-
sifi er to predict functional gene models. A new set 
of gene models was produced using the Gramene/
EnsEMBL GeneBuilder by combining transcript frag-
ments assembled from RNA-sequencing data with 
alignments of protein, expressed sequence tags (ESTs), 
and cDNA sequences from sorghum and other mono-
cots. The classifi er, trained on Sbi1.4 gene models, was 
run on the new set of gene models and predicted a 
total of 56,128 functional genes and transcriptionally 
active regions in sorghum.
Characterization and Analysis of Core 
Promoter Elements in Plant Genomes
S. Kumari
Where and when a plant will express or transcribe a gene 
is controlled by information in the plant genome and 
is infl uenced by environmental signals. Transcription 
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initiation involves the recruitment of the basal tran-
scription factors to the core promoter elements (CPEs) 
of genes. Very little is known about CPEs in plants, and 
this study offers a new insight in the fi eld. To better 
understand the core promoter architecture in plant ge-
nomes, we studied a comprehensive set of known CPEs 
in various monocot and dicot plant genomes.
We developed high-throughput in silico meth-
ods for motif prediction using the publicly available 
CREAD (comprehensive regulatory element analysis 
and discovery) suite of tools. Our computational pipe-
line systematically identifi ed transcription regulation 
motifs at the whole-genome level including TATA-
box, CCAAT, INR, BRE, GC-box, DPE, MTE, and 
Y-Patch motifs containing genes across eight plant ge-
nomes. This is the fi rst large-scale genome-wide com-
putational study that has compared and contrasted 
the distribution profi les of known CPEs across four 
monocots (Brachypodium distachyon, Oryza sativa 
japonica, Sorghum bicolor, Zea mays) and four dicots 
(Arabidopsis thaliana, Populus trichocarpa, Vitis  vinifera, 
Glycine max). The relative abundance signal of CPEs 
with respect to transcription start sites (TSSs) was 
found to be conserved within monocots and dicots 
with slight differences across monocots and dicots. 
The TATA-box motif was found to be present in 
16%–22% of the plant promoters, whereas the GC-
box, XCPE1, and Y-patch motifs were found to be the 
most prevalent CPEs across all eight genomes.
The structural properties in the regulatory part of ge-
nomes distinctly differ from those of the nonregulatory 
part. The core promoter region’s free-energy profi les 
(Fig. 1) segregate into two distinct clusters: one clus-
tering monocots together and the other clustering di-
cots together. Free-energy profi les have the potential 
to be used for delineating the promoter region as well 
as for computational TSS identifi cation. It could help 
build better computational models for predicting the 
TSS in the promoter region, which remains a chal-
lenging problem.
We classifi ed core promoters into three types 
(TATA-containing, TATA-less, and Core-less) and 
looked at the functional enrichment of genes as-
sociated with these types. TATA-containing genes 
showed signifi cant overrepresentation of biological 
processes that included response to abiotic and biotic 
stress, hormonal stimuli, and regulation of carbohy-
drate and nucleic acid metabolic processes. TATA-less 
genes were mainly involved in housekeeping, includ-
ing transferase activities, hydrolase activities, and vari-
ous nucleotide-related binding activities. These genes 
were mainly enriched in biological processes related 
to nitrogen and phosphorous metabolism, which are 
key genes involved in plant-yield-associated traits. The 
Core-less genes showed evidence of unique enrichment 
in genes involved in ATP binding, signal transduction 
activities, apoptosis, etc. Our study expands the CPE 
repertoire in plants, providing impetus for future ge-
nome annotation projects and inspiring research ef-
forts aimed at better understanding transcriptional 
regulation mechanisms and the relationship for crop 
yield improvement.
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Figure 1. Free-energy proﬁ le of the promoter region genes from eight plant genomes.
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PLANT SYSTEMS BIOLOGY
Exploring the Gene Regulatory Network 
Guiding Arabidopsis Stele miRNA Expression
L. Zhang, Y. Koung Lee, C. Liseron-Monﬁ ls, C. Noutsos, 
B. Wang [in collaboration with S. Brady, University of 
California, Davis, and DuPont Pioneer.]
Plant roots not only serve to physically anchor plants to 
the soil but are also responsible for uptake of water and 
critical nutrients; therefore, they must respond quick-
ly to various environmental stresses such as drought, 
waterlogging, and heavy metal pollution. microRNAs 
(miRNAs) have a central role in plant development 
and response to environmental stress. We are inter-
ested in studying the gene regulatory network (GRN) 
that regulates miRNA expression in the root. Most 
miRNAs are transcribed by RNA polymerase II, and 
their transcription process is regulated by transcrip-
tion factors (TFs). To systematically resolve points of 
cross-talk among TFs, miRNAs, and their targets in a 
comprehensive GRN, we make use of a gene-centered 
yeast one-hybrid (Y1H) experimental system that al-
lows us to monitor protein binding to DNA in yeast. 
We have extended the library that initially focused 
on transcription factors from the root stele (657), the 
central part of the root important for nutrient trans-
fer, to the complete root (952). Using this system, we 
screened 172 promoters of stele- expressed  miRNAs, 
their targets, and some highly connected TFs. We 
have obtained 3768 protein–DNA interactions (PDIs). 
The resulting network was analyzed with publicly 
available spatiotemporal expression data in the root 
that allowed us to examine whether the TFs act as 
activators or inhibitors of expression. To validate the 
PDIs found in our yeast work, we screened more than 
250 genetic insertion mutants from Arabidopsis and 
obtained 80 lines for TFs, miRNAs, and miRNA 
targets in our network. From these, we characterized 
their molecular phenotype by quantifying TF expres-
sion. Our results showed that perturbation in planta 
of ~80% of TFs and 70% of miRNAs tested displayed 
molecular phenotypes in the Arabidopsis root.
In addition to molecular phenotypes, the plants 
were also scored for observable morphological differ-
ences, and two mutants with a short-root phenotype 
were identifi ed. To understand the genes that were 
bound by one transcription factor, we used a chroma-
tin immunoprecipitation sequencing (ChIP-Seq) ap-
proach that allows us to identify plant DNA that is 
bound by a transcription factor. Using this approach, 
we identifi ed both genic and intergenic regions bound 
by the transcription factor and used this to predict a 
DNA motif that is likely bound by the transcription 
factor. Further genetic investigation of this transcrip-
tion factor suggested that it may be involved in stem 
cell maintenance in the root.
We have begun to use the network to predict 
genes that may be important in development based 
on the topology of the network. Within the network, 
some genes are more highly connected, which sug-
gested that these genes may have an important role 
in the network. The zinc fi nger homeodomain (ZF-
HD) TFs were found to be highly connected in our 
network. These genes are conserved across the plant 
kingdom. We have managed to identify them in more 
than 300 species. The number of ZF-HD varies from 
species to species. In Arabidopsis, there are a total of 
16 members. Genetic analysis of these TF families in-
dicates that their functions are not restricted to the 
root and that they are important in fl ower develop-
ment. Although our network was focused on root-
expressed genes, more than 80% of these genes are 
expressed in other tissues and will be more broadly 
applicable beyond root development and response to 
stress. The GRN provides a framework for modeling 
adaptive responses to environmental conditions at the 
whole-plant level. We can use this network to identify 
candidate genes for improving germplasm that can 
withstand more detrimental conditions, thus address-
ing global food security and growing demand for re-
newable energy resources.
Developmental Networks Controlling 
Inﬂ orescence Architecture in Maize
A.L. Eveland, S. Kumari, C. Liseron, Y. Jiao [in collaboration 
with D. Jackson, Cold Spring Harbor Laboratory; Z. Xin and 
J. Burke, USDA Agricultural Research Service]
The goal of this work is to integrate genetics and ge-
nomics data sets to fi nd molecular networks that infl u-
ence the morphology (architecture) of maize infl ores-
cences (fl owers). Because infl orescences bear the fruits 
and grains that we eat, understanding the genetic and 
regulatory basis for how these structures are formed 
has clear relevance to important agronomic traits such 
as grain yield and harvesting ability. Our data sets rep-
resent maize infl orescence primordia sampled during 
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key developmental transitions and in perturbed genet-
ic backgrounds. The latter includes loss-of-function 
mutants in three important regulators of the RAMOSA 
(RA) pathway, which controls stem-cell-fate decisions 
and ultimately the decision to branch. We have estab-
lished a robust system to investigate the networks that 
modulate branching, including characterization of 
precise timing of developmental events and associated 
spatiotemporal changes in gene expression. We inte-
grated genome-wide mRNA-Seq data to resolve coex-
pression networks during key stages of maize infl ores-
cence development and are working to expand these 
networks by incorporating additional data sets, such 
as genome-wide transcription factor (TF) occupancy 
profi les and cis-regulatory information.
The primary objectives for this project included 
the following: (1) Establish a comprehensive pipeline 
for mRNA-Seq and ChIP-Seq data analysis in maize 
by evaluating and optimizing available software for 
mapping and quantifi cation. This also included test-
ing various statistical methods to extract biological 
relevance. (2) Characterize genome-wide expression 
signatures specifi c to a given developmental event or 
branching phenotype. We made use of known de-
velopmental marker genes and their spatiotemporal 
transcriptional responses to genetic perturbation in 
order to test our experimental system and establish a 
proxy for developmental staging. (3) Evaluate and im-
plement clustering approaches to identify candidate 
genes that are coexpressed with key regulators and/
or coincide with specifi c developmental events. Our 
results from this included identifi cation of candidate 
genes, specifi cally developmentally regulated TFs, and 
novel genes of unknown function that are potentially 
involved in stem-cell maintenance and determinacy. 
We continue to examine coexpression clusters for en-
richment of functional processes and cis-regulatory 
motifs that lie within proximity of the transcriptional 
start site of coexpressed genes (with Sunita Kumari). 
(4) Identify targets of the RA1 TF using ChIP-Seq 
and integrate results with data from parallel mRNA-
Seq experiments. On the basis of this approach, we 
showed that one-third of the genes with altered ex-
pression levels in the ra1 mutant are also bound by 
RA1. We are incorporating additional ChIP-Seq data 
sets as they become available to investigate combi-
natorial binding of TFs associated with the branch-
ing pathway. The ChIP-Seq data also provide in 
vivo confi rmation for binding sites of developmental 
regulators in maize, information that is being lever-
aged in efforts to resolve cis-regulatory modules across 
the maize genome.
In addition to maize, we have begun work on sor-
ghum, which is an important emergent bioenergy crop 
used for human consumption in sub-Sahara Africa. 
We are using next-generation sequencing approaches 
to identify the single-nucleotide mutations that are 
associated with an increase in seed of the sorghum 
plants in a sorghum EMS (ethylmethanesulfonate) 
population. Using this approach, we have identifi ed 
two genes that can change the structure of fl owers and 
generate more seeds. We intend to apply this strategy 
to perform a large-scale sorghum mutant study to sup-
port candidate genes associated with developmental 
traits in the roots, shoots, and fl owers.
In the next phase, we will further prioritize candi-
dates from this work by overlaying the Arabidopsis reg-
ulatory network information (see previous  section). 
The resulting hypotheses can be tested in Arabidopsis, 
for example, for responses to stress, and ultimately 
translated to agronomic systems. Additionally, can-
didate genes that are maize and/or grass specifi c are 
of high priority because they may contribute to the 
unique morphology of maize infl orescences and/or 
features shared among other grasses. We will further 
use comparative genomics approaches, including both 
computational and integration of analogous RNA-
Seq data sets from closely related grasses, such as sor-
ghum, to identify candidate genes that may contribute 
to grass-specifi c aspects of infl orescence architecture.
CYBERINFRASTRUCTURE PROJECTS
The iPlant Collaborative
L. Wang, J. Lu, C. Noutsos, J. Stein, Y.K. Lee
This project was done in collaboration with Cold 
Spring Harbor Laboratory and employs more than 
100 staff. It is headquartered at the University of 
Arizona under the direction of principal investigator 
Stephen Goff and director Dan Stanzione. Dozens of 
collaborators are located at more than 20 institutions.
The iPlant Collaborative (http://iplantcollaborative
.org) is an NSF-funded cyberinfrastructure project 
that provides public access to high-performance com-
puting, data storage, and tools via customized web-
based interfaces. Having completed the fi rst fi ve-year 
grant, the iPlant Collaborative has made extensive 
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progress toward meeting these goals and has been rec-
ommended for renewal for another fi ve years. Work 
in the last year has culminated in the development of 
multiple platforms that are now being used by the re-
search and educational communities. Staff at CSHL 
directly contributed to some of these cyberinfrastruc-
ture platforms or have built upon them to provide 
ready access to needed software and analysis tools by 
scientists and educators. Within the Ware lab, these 
platforms include the Discovery Environment (DE), 
Atmosphere, and the Taxonomic Name Resolution 
Service (TNRS).
The DE is the most visible portal to iPlant tools 
and services. This web-based platform supports an 
“app store” model of user-extensible tools, automated 
workfl ows, and data storage. Users can take advantage 
of existing tools integrated by iPlant staff and user 
community or add their own tools to use privately 
or share. Users may not be aware that the underlying 
infrastructure provides access to iPlant’s massive data 
store at the University of Arizona and the Texas Ad-
vanced Computing Center (TACC). Computationally 
intensive tasks are handled by supercomputers located 
at TACC and other centers within the Extreme Science 
and Engineering Discovery Environment (XSEDE). 
So far, well over 400 tools have been integrated into 
the DE that enable a broad range of research activi-
ties, including genome/transcriptome assembly, an-
notation, RNA-Seq quantifi cation, variant detection, 
genome-wide association studies (GWAS), and phyloge-
netics. Members of our lab have had important roles 
in  contributing to workfl ow design, tool integration, 
validation, science tutorial, and documentation.
Atmosphere is iPlant’s confi gurable and cloud-
enabled computational resource for the plant research 
community. From Atmosphere’s web interface, users 
can launch a virtual machine (VM) with preconfi g-
ured working environments and ready-to-use software 
precustomized. Users can also create their own appli-
cations and environments as VMs and share with oth-
ers via Atmosphere. As with the DE, Atmosphere is a 
gateway to access iPlant’s core infrastructure resourc-
es, such as the high-performance and grid-computing 
environment and big data-storage system. Using the 
Atmosphere platform, we created a VM to be used 
in the fi elds of ecological and functional genomics. 
The VM includes various binary tools and R statistics 
packages used in ecology and genetics research and for 
plotting complex data in graphs.
The success of genome research depends on our 
ability to accurately assemble, annotate, and derive 
meaning from sequence data; however, extremes of 
genome size, polyploidy, diversity, and repeat con-
tent push the limits on current algorithms, exper-
tise, and computational power needed by today’s 
researchers. In response, iPlant is fostering a com-
munity effort to identify best practices and state-of-
the-art tools, install and optimize their performance 
on the nation’s most powerful supercomputers, and 
make these available as a free online resource. Dur-
ing the last two years, the iPlant Discovery Environ-
ment has matured to provide a comprehensive set of 
tools and services for sequence handling, performing 
read alignments, RNA-Seq profi ling, and de novo 
genome and transcriptome assembly. To extend these 
capabilities, we are working to incorporate MAKER-
P, a standardized, portable, and easy-to-use plant- 
genome annotation engine with built-in methods 
for quality control. As part of this effort, MAKER-P 
was specifi cally optimized to take advantage of the 
parallel computing environment of the TACC Lon-
estar cluster and is now a supported module. Perfor-
mance testing showed that MAKER-P can perform 
high-quality, full-fl edged annotation pipelines on 
even the largest plant genomes in a matter of hours. 
Incorporation of this resource into the DE fi ts into 
an overall strategy that includes downstream func-
tional annotation of protein-coding genes and visu-
alization. MAKER-P is currently available for use as 
an Atmosphere image.
Our lab contributed directly to the development of 
the Taxonomic Name Resolution Service (TNRS), a 
platform to help standardize taxonomic names for all 
plant species—a nontrivial task. Erroneous and syn-
onymous taxonomic names are a major challenge for 
virtually every fi eld of plant biology. Large organismal 
databases (GBIF, SpeciesLink, VegBank, SALVIAS, 
TraitNet, GenBank, TreeBASE) are plagued by taxo-
nomic error and uncertainty. In some databases, up 
to 30% of names do not match any published name; 
furthermore, 5%–20% of published names may be 
synonymous. Correcting and harmonizing taxonomy 
are usually the time-consuming and ad hoc respon-
sibility of the individual researcher. The TNRS tool 
overcomes this barrier, enabling higher-quality com-
parative biodiversity science. The TNRS is available to 
other investigators who wish to perform similar taxo-
nomic name resolutions on their data sets, enabling 
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a wider community to expand the public scientifi c 
knowledge base. The TNRS is currently available at 
http://tnrs.iplantcollaborative.org and is described in 
a recent publication in BMC Bioinformatics.
A major mission of iPlant is to promote adoption 
of the cyberinfrastructure through training work-
shops and outreach at academic institutions and sci-
entifi c meetings. In 2013, members of the Ware lab 
participated as instructors in several tools and services 
workshops focused on transcriptomics, annotation, 
GWAS, and phylogenetics using the DE, Atmosphere, 
and Data Store platforms.
KBase, the Department of Energy Systems 
Biology Knowledgebase
S. Kumari, S. Pasternak, J. Thomason
This project was done in collaboration with the 
 Department of Energy national laboratories and is 
led by principal investigator Adam Arkin of Law-
rence Berkeley National Laboratory (LBNL), with co- 
principal investigators Rick Stevens, Argonne National 
 Laboratory (ANL); Robert Cottingham, Oak Ridge 
National Laboratory (ORNL); and Sergei Maslov, 
Brookhaven National Laboratory (BNL). In addition to 
Doreen Ware at CSHL, participating investigators in-
cluded Mike Schatz, CSHL; Pamela Ronald, University 
of California, Davis; Matthew DeJongh, Hope College, 
Michigan; Gary Olsen, University of Illinois, Urbana-
Champaign; and Mark Gerstein, Yale University.
The DOE Systems Biology Knowledgebase (KBase, 
www.kbase.us) has two central goals. The scientifi c 
goal is to produce predictive models, reference data 
sets and analytical tools, and to demonstrate their 
utility in DOE biological research relating to bioen-
ergy, the carbon cycle, and the study of subsurface mi-
crobial communities. The operational goal is to create 
the integrated software and hardware infrastructure 
needed to support the creation, maintenance, and use 
of predictive models and methods in the study of mi-
crobes, microbial communities, and plants.
Doreen Ware serves as the Plants Science Team 
Lead for KBase. In addition to providing domain ex-
pertise in plant genomics, members of the Ware lab are 
making signifi cant contributions to software develop-
ment for this project. The Plant component of KBase 
allows users to model genotype-to-phenotype rela-
tionships using metabolic and functional networks as 
well as phenotype measurements and high- throughput 
experiment data. It also supports the reconstruction of 
new metabolic and functional networks based on ex-
pression profi les, protein–DNA, and protein–protein 
interactions. To accomplish this, we have provided in-
teractive, data-driven analysis and exploration across 
multiple experiments and diverse data types. We have 
built narratives that can capture analyses,  including 
rich annotations, visualization widgets, reusable work-
fl ows, and custom scripts.
Through KBase resources and infrastructure, users 
have access to workfl ows for analyzing data such as 
those from genotyping assays and expression pro-
fi les as well as metabolic models. Users can integrate 
these with public resources for plant genomes. Using 
the KBase application programming interface (API), 
users can create complex queries across disparate data 
sources and types.
PUBLICATIONS
Boyle B, Hopkins N, Lu Z, Raygoza G, Antonio J, Mozzherin D, Rees 
T, Matasci N, Narro LM, Piel HW, et al. 2013. The taxonomic 
name resolution service: An online tool for automated standard-
ization of plant names. BMC Bioinformatics 14: 16.
Dharmawardhana P, Ren L, Amarasinghe V, Monaco M, Thomason 
J, Ravenscroft D, McCouch S, Ware D, Jaiswal P. 2013. A ge-
nome scale metabolic network for rice and accompanying analysis 
of tryptophan, auxin and serotonin biosynthesis regulation under 
biotic stress. Rice 6: 15.
Kumari S, Ware D. 2013. Genome-wide computational prediction 
and analysis of core promoter elements across plant monocots and 
dicots. PLoS One 8: e79011.
Luo MC, Gu YQ, You FM, Deal KR, Ma Y, Hu Y, Huo N, Wang Y, 
Wang J, Chen S, et al. 2013. A 4-gigabase physical map unlocks 
the structure and evolution of the complex genome of Aegilops 
tauschii, the wheat D-genome progenitor. Proc Natl Acad Sci 110: 
7940–7945.
Monaco MK, Stein J, Naithani S, Wei S, Dharmawardhana P, Ku-
mari S, Amarasinghe V, Youens-Clark K, Thomason J, Preece J, 
et al. 2013. Gramene 2013: Comparative plant genomics resourc-
es. Nucleic Acids Res 42: 1193–1199.
Regulski M, Lu Z, Kendall J, Donoghue MT, Reinders J, Llaca V, 
Deschamps S, Smith A, Levy D, McCombie WR, et al. 2013. The 
maize methylome infl uences mRNA splice sites and reveals wide-
spread paramutation-like switches guided by small RNA. Genome 
Res 23: 1651.
Sen TZ, Monaco M, Chae L, Dharmawardhana P, Schaeffer ML, 
Dreher K, Zhang P, Naithani S, Thomason J, Harper EC, et al. 
2013. Metabolic pathway resources at MaizeGDB. In Proceedings 
of Maize Genetics Conference, p. 3. St. Charles, IL.
In Press
Campbell M, Law M, Holt C, Stein J, Moghe G, Hufnagel D, Lei J, 
Achawanantakun R, Jiao D, Lawrence C, Ware D, et al. 2014. 
198-227_Genomics.indb   226 8/28/2014   10:42:43 AM
Genomics  227
MAKER-P: A tool-kit for the rapid creation, management, and 
quality control of plant genome annotations. Plant Physiol 164: 
513–524.
Eveland AL, Goldshmidt A, Pautler M, Morohashi K, Liseron-
Monfi ls C, Lewis MW, Kumari S, Hiraga S, Yang F, Unger-
Wallace E, et al. 2014. Regulatory modules controlling maize 
infl orescence architecture. Genome Res [Epub ahead of print] 
PubMed PMID: 24307553; PubMed Central PMCID: 
PMC3941108.
Kersey PJ, Allen JE, Christensen M, Davis P, Falin LJ, Grabmuel-
ler C, Hughes DS, Humphrey J, Kerhornou A, Khobova J, et al. 
2014. Ensembl Genomes 2013: Scaling up access to genome-wide 
data. Nucleic Acids Res [Epub ahead of print] PubMed PMID: 
24163254; PubMed Central PMCID: PMC3965094.
Olson A, Klein RR, Dugas DV, Lu Z, Regulski R, Klein PE, Ware D. 
2014. Expanding and vetting Sorghum bicolor gene annotations 
through transcriptome and methylome sequencing. Plant Genome 
doi: 10.3835/plantgenome2013.08.0025.
Christophe Liseron-Monﬁ ls
198-227_Genomics.indb   227 8/28/2014   10:42:43 AM
228
QUANTITATIVE BIOLOGY
Gurinder S. “Mickey” Atwal and colleagues are applying insights from the physical and com-
putational sciences to the study of population genetics and human disease. The Atwal lab has 
modeled the process by which genetic variants, or alleles, have evolved in the last 100,000 years of 
human history. This has recently led to surprising insights about the role of p53, a master tumor 
suppressor gene, in female fertility and furthered our understanding of how complex gene net-
works evolve. The lab has analyzed the comparative genomics and physical organization of cancer-
related genes and their role in mediating tumorigenesis across numerous tissue types. Recently, 
they have begun to focus efforts on understanding cancer genome evolution on shorter time scales 
by analyzing nucleotide sequences from single cells.
Ivan Iossifov focuses on the development of new methods and tools for genomic sequence analy-
sis and for building and using molecular networks, and he applies them to specifi c biomedical 
problems. He studies the genetics of common diseases in humans using two main tools: next-
generation sequencing and molecular networks representing functional relationships among ge-
netic loci. These approaches in combination enable the kind of large-scale studies necessary for 
furthering our understanding of the complex etiology of disorders such as autism, bipolar disorder, 
and cancer.
Alexander Krasnitz and colleagues use mathematical and statistical tools to discover key genetic 
elements involved in cancer and to understand how cancer cells evolve. Array-based comparative 
genome hybridization, a technique honed in the Wigler lab, and, more recently, sequencing ex-
periments, have revealed subtle patterns of frequent and widespread aberration in cancer genomes. 
Krasnitz hypothesizes that recurrent, aberrant genomic loci observed in a range of cancer types are 
under selection and therefore are enriched in important cancer genes. He has developed a novel, 
comprehensive methodology to discover such “cores” and has used it to analyze multiple genome 
data sets in breast, liver, ovarian, and prostate cancer. The results have been shared with cancer 
biology labs across CSHL, and they have been a key enabling agent of functional studies using 
mouse models and RNA interference. Krasnitz has begun to apply these novel statistical tools to 
the latest generation of experimental data, which have characterized tumor samples down to the 
level of single cells. By interpreting single-cell genomes, he and colleagues seek to learn how spe-
cifi c tumors evolve and how cancer cells migrate to invade adjacent tissues and metastasize.
There is increasing evidence that rare and unique mutations have a signifi cant role in the etiology 
of many diseases such as autism, congenital heart disease, and cancer. Dan Levy’s group develops 
algorithms to identify these mutations from large, high-throughput data sets comprising thou-
sands of nuclear families. After earlier working with high-resolution CGH arrays, Levy’s group 
now uses targeted sequence data. Levy has developed methods for identifying de novo mutations 
(i.e., those seen in a child but not in his or her parents) by simultaneously genotyping the entire 
family; the team is currently focused on building algorithms to detect copy-number variants and 
multiscale genomic rearrangements. Although their copy-number methods are based on “read” 
density, there are classes of mutations that require analysis at the level of the read. Thus, they 
are developing algorithms to identify insertions, deletions, inversions, transpositions, and other 
complex events. Other projects in the Levy lab include analysis of single-cell RNA, phylogenetic 
reconstruction from sparse data sets, and disentangling haplotypes from sperm and subgenomic 
sequence data.
Michael Schatz is a computational biologist and an expert at large-scale computational examina-
tion of DNA sequencing data, including the alignment, assembly, and analysis of next-generation 
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sequencing reads. These methods have been used to reconstruct the genomes of previously un-
sequenced organisms, probe sequence variations, and explore a host of biological features across 
the tree of life. Recent improvements in sequencing technologies are challenging our capacity to 
store and analyze the huge volume of DNA sequence data being generated. Consequently, Schatz 
is particularly interested in capitalizing on the latest advances in distributed and parallel comput-
ing, especially cloud computing technologies, to advance the state of the art in bioinformatics and 
genomics. In a recent breakthrough, Schatz was able to create a hybrid software-based solution 
to eliminate errors in so-called third-generation sequencing. This makes it remarkably easier to 
compile, align, and analyze full-genome sequences.
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QUANTITATIVE BIOLOGY
G.S. Atwal R. Aboukhalil R. Korff
 Y. Cai W. Liao
 B. Fendler
Fueled by data generated from recent technological 
developments in DNA sequencing, our lab is primar-
ily focused on population genetics, cancer biology, 
and high-performance computing. We often tackle 
scientifi c questions analytically and computationally 
by invoking theoretical concepts from statistical phys-
ics and machine learning.
Previous work in our lab, in collaboration with 
colleagues at the Cancer Institute of New Jersey and 
Weill Cornell Medical College, has established the 
 association between single-nucleotide polymorphisms 
(SNPs) in the p53 tumor suppressor pathway and fe-
male infertility in mice and humans. This hypothesis 
was fi rst generated through computational investiga-
tions of haplotypic diversity and positive selection in 
genes in the TP53 pathway where we detected sig-
natures of recent positive selection in SNPs present 
at high frequencies in various human populations. 
Selected alleles in SNPs in LIF, Mdm2, Mdm4, and 
Hausp genes, each of which lies in the p53 molecular 
network, were found to be enriched in women under-
going IVF (in vitro fertilization) treatment. More-
over, some of these SNPs have been demonstrated to 
be associated with estrogen-driven cancer risk, high-
lighting the pleiotropic character of genetic variants 
in the p53 pathway. More recently, we have begun to 
investigate the association of SNPs in p63 and p73 
and initial results are encouraging, although we await 
an increase in sample numbers before the results can 
be deemed to be statistically signifi cant.
Following up on these earlier investigations, we 
have begun exploring the contribution of multiple 
alleles from both a population genetics and human 
disease perspective. In addition, we have begun refo-
cusing efforts applying the tools of population genet-
ics to understand single-cell evolution from tumors. 
This systems biology approach has led to the devel-
opment of new computational tools, addressing the 
vast complexity of genomics data. In addition, our 
lab has continued research in the use of information 
theory and other machine learning tools in addressing 
the tsunami of data generated by next-generation se-
q uencing.
Suyash Shringapure, a former visiting researcher 
from Carnegie Mellon, now at Stanford University, 
continues to collaborate with us and Bud Mishra 
(New York University). Bernard Fendler, a postdoc-
toral associate with training in theoretical physics, ob-
tained a computational biologist position at Brigham 
and Women’s Hospital. Willey Liao and Ying Cai are 
graduate students from the Applied Mathematics and 
Statistics department at Stony Brook. Willey Liao 
graduated in May and took a bioinformatician posi-
tion at the New York Genome Center. Ricki Korff was 
an URP student during the summer of 2013 and con-
tinues to work with us remotely. Robert Aboukhalil is 
a graduate student from the Watson School. In addi-
tion, two fi rst-year students from the Watson School 
graduate program, Talitha Forcier and Abram Handly-
Santana, joined the lab for rotation projects.
Web Tool for Multispecies Gene 
Colocalization Analysis
R. Aboukhalil, B. Fendler [with technical assistance from 
P. Andrews, Cold Spring Harbor Laboratory]
The evolutionary pressures that underlie the large-
scale functional organization of the genome are not 
well understood in eukaryotes. Recent evidence sug-
gests that functionally similar genes may colocalize 
(cluster) in the eukaryotic genome, suggesting the 
role of chromatin-level gene regulation in shaping 
the physical distribution of coordinated genes. How-
ever, few of the bioinformatic tools currently available 
allow for a systematic study of gene colocalization 
across several evolutionarily distant species. Further-
more, most tools require the user to input manually 
curated lists of gene position information, DNA se-
quence, or gene homology relations between species. 
With the growing number of sequenced genomes, 
there is a need to provide new comparative genomics 
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tools that can address the analysis of multispecies gene 
colocalization. We built Kerfuffl e, a web tool designed 
to help discover, visualize, and quantify the physical 
organization of genomes by identifying signifi cant 
gene colocalization and conservation across the as-
sembled genomes of available species (currently up to 
47, from humans to worms). This is the fi rst such web 
tool from the newly installed web server set up in the 
Quantitative Biology group. Kerfuffl e only requires 
the user to specify a list of human genes and the names 
of other species of interest. Without further input 
from the user, the software queries the e!Ensembl 
BioMart server to obtain positional information and 
discovers homology relations in all genes and species 
specifi ed. Using this information, Kerfuffl e performs 
a multispecies clustering analysis, presents download-
able lists of clustered genes, performs Monte Carlo 
statistical signifi cance calculations, estimates how 
conserved gene clusters are across species, plots histo-
grams and interactive graphs, allows users to save their 
queries, and generates a downloadable visualization 
of the clusters using Circos software. These analyses 
may be used to further explore the functional roles of 
gene clusters by interrogating the enriched molecular 
pathways associated with each cluster. Kerfuffl e can 
be found at http://www.atwallab.org/kerfuffl e/ and 
runs on a new dedicated web server that we purposed 
for the entire Quantitative Biology program.
Parametric Inference in the Large Data Limit 
Using Maximally Informative Models
[This work was done in collaboration with J. Kinney, 
Cold Spring Harbor Laboratory]
Motivated by data-rich experiments in transcription-
al regulation and sensory neuroscience, we consider 
the following general problem in statistical infer-
ence: When exposed to a high-dimensional signal S, 
a system of interest computes a representation R of 
that signal, which is then observed through a noisy 
measurement M. From a large number of signals and 
measurements, we wish to infer the “fi lter” that maps 
S to R. However, the standard method for solving 
such problems, likelihood-based inference, requires 
perfect a priori knowledge of the “noise function” 
mapping R to M. In practice, such noise functions are 
usually known only approximately, if at all, and using 
an incorrect noise function will typically bias the in-
ferred fi lter. Here, we show that in the large data limit, 
this need for a precharacterized noise function can 
be circumvented by searching for fi lters that instead 
maximize the mutual information I[M;R] between 
observed measurements and predicted representa-
tions. Moreover, if the correct fi lter lies within the 
space of fi lters being explored, maximizing mutual 
information becomes equivalent to simultaneously 
maximizing every dependence measure that satisfi es 
the data processing inequality. It is important to note 
that maximizing mutual information will typically 
leave a small number of directions in parameter space 
unconstrained. We term these directions “diffeo-
morphic modes” and present an equation that allows 
these modes to be derived systematically. The pres-
ence of diffeomorphic modes refl ects a fundamental 
and nontrivial substructure within parameter space, 
one that is obscured by standard likelihood-based 
 inference.
Equitability, Mutual Information, and the 
Maximal Information Coefﬁ cient
[This work was done in collaboration with J. Kinney, 
Cold Spring Harbor Laboratory]
How should one quantify the strength of association 
between two random variables without bias for rela-
tionships of a specifi c form? Despite its conceptual 
simplicity, this notion of statistical “equitability” has 
yet to receive a defi nitive mathematical formalization. 
Here, we argue that equitability is properly formalized 
by a self-consistency condition closely related to data 
processing inequality. Mutual information, a funda-
mental quantity in information theory, is shown to 
satisfy this equitability criterion. These fi ndings are 
at odds with the recent work of Reshef et al. (Science 
334: 1518 [2011]), which proposed an alternative defi -
nition of equitability and introduced a new statistic, 
the “maximal information coeffi cient” (MIC), said 
to satisfy equitability in contradistinction to mutual 
information. These conclusions, however, were sup-
ported only with limited simulation evidence, not 
with mathematical arguments. Upon revisiting these 
claims, we proved that the mathematical defi nition of 
equitability proposed by Reshef et al. cannot be satis-
fi ed by any (nontrivial) dependence measure. We also 
identify artifacts in the reported simulation evidence. 
When these artifacts are removed, estimates of mutual 
information are found to be more equitable than esti-
mates of MIC. Mutual information is also observed to 
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have consistently higher statistical power than MIC. 
We conclude that estimating mutual information pro-
vides a natural (and often practical) way to equitably 
quantify statistical associations in large data sets.
Modeling Morphogenesis in Leaf Polarity 
and tasiRNA Regulation of ARF in Moss
[This work was done in collaboration with the 
Timmermans lab, Cold Spring Harbor Laboratory]
Adaxial–abaxial polarity is essential for leaf function-
ing in plants. The polarity is sharply defi ned by a pre-
cise establishment of gene expression patterns with 
cells across the adaxial–abaxial axis. Previous work 
in the Timmermans lab has shown that two short 
RNAs—miR166 and trans-acting short interfering 
(tasiR-ARF) may act as morphogens in establishing 
leaf polarity. However, it is not clear if these two op-
posite gradients of small RNA are suffi cient to explain 
the sharp spatial expression pattern in leaves. We fi rst 
modeled the dynamic behavior of the morphogen 
using a minimal network of the relevant genes, where-
by tasiR-ARF inhibits ARF3/4 and miR166 inhibits 
HD-ZIPIII. A fi xed-point analysis indicated that the 
system is stable with respect to small perturbations, 
although the infl uence of stochastic noise has yet to be 
determined. We next investigated the positional infor-
mation carried by the morphogens using tools from 
information theory in an effort to determine how a 
cell optimally predicts its position in the adaxial–ab-
axial axis using the two opposing morphogens. The 
analysis from simulations of the stochastic concentra-
tion gradients indicated that the two RNA gradients 
were indeed suffi cient to convey enough information 
to induce two cell fates. Further work remains to sup-
plement the simulations with actual RNA-Seq data 
from each cell layer.
Analysis of Physcomitrella patens mutants perturbed 
in tasiRNA biogenesis reveals defects in the fi lamentous 
stage of moss development. These defects are the result 
of a spatial misregulation of the evolutionarily conserved 
targets of the tasiRNA pathway, the auxin response fac-
tors (ARFs). The similarity between these phenotypes 
and those of moss mutants defective in auxin signaling 
suggest that tasiRNAs may modulate plants’ response 
to this ancient hormone. Yevgeniy Plavskin modeled 
the effect of tasiRNA regulation of ARF levels on the 
output of the auxin response gene regulatory network 
in the context of network topology differences identi-
fi ed between Arabidopsis and Physcomitrella. The model 
predicts that tasiRNAs sensitize cells to auxin and may 
have a complex effect on the robustness of the auxin 
response to noisy signals. This suggests that the robust 
yet sensitive auxin response that results from the struc-
ture of the auxin response network and its regulation by 
tasiRNAs may have favored its repeated cooption over 
the course of evolution.
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DE NOVO MUTATION IN AUTISM
I. Iossifov E. Dalkic
We study the genetics of common diseases in humans 
using two main tools: next-generation sequencing and 
molecular networks representing functional relation-
ship among genetic loci. These tools in combination 
enable the large-scale studies necessary for furthering 
our understanding of the complex etiology of disorders 
such as autism, bipolar disorder, and cancer. We focus 
on both developing new methods (for sequence analy-
sis and for building and using molecular networks) 
and applying them to specifi c biomedical problems.
Exome Sequencing Reveals De Novo 
Gene Disruptions in Children on the 
Autistic Spectrum
The genetic component of autism can be transmitted 
or acquired through de novo mutation. Previous stud-
ies have focused on large-scale de novo copy-number 
events, either deletions or duplications, and have identi-
fi ed a large number of autism candidate genes. Because 
copy-number events often span many genes, discerning 
which of the genes in the target region contribute to the 
disorder requires complex network analysis and infer-
ence. In contrast, with high-throughput DNA sequenc-
ing, we can readily search for de novo single-nucleotide 
and small-insertion or deletion mutations that affect a 
single gene. Such mutation is fairly common, ~100 new 
mutations per child, but with only a few—on the order 
of one per child—falling in coding regions.
We are collaborating in an ongoing large project 
for sequencing the exomes of 2800 families from the 
Simons Simplex Collection (SSC). Our preliminary 
analysis (Iossifov et al., Neuron 74: 285 [2012]) of ~350 
of these families, as well as the reports of three other 
groups, demonstrated the power of identifying de novo 
mutations through exome sequencing to implicate au-
tism genes. Among the major results were (1) strong 
evidence for the role of likely gene-disrupting (LGD) 
mutations (nonsense, splice site, and frame shifts), 
with affecteds having twice as many LGDs compared 
to unaffected siblings; (2) the identifi cation of 127 de 
novo LGD mutations across the four reports with fi ve 
genes (CHD8, DYRK1A, KATNAL2, POGZ, SCN2A) 
having two de novo mutations in unrelated individu-
als (“double hits”); (3) estimation of a total number of 
~400 autism target genes, with a prediction of ~100 
double hits after the whole set of 2800 families has 
been processed; and (4) the discovery of a strong as-
sociation between the target LGD mutations in autism 
and in vivo targets of the RNA-binding translational 
regulator FMRP (encoded by FMR1, which results in 
fragile X syndrome when silenced or mutated).
In the follow-up meta-analysis of four published 
whole-exome sequencing data sets in autism (Rone-
mus et al. 2014), we more than doubled the number of 
recurrently hit genes, clearly demonstrated the role of 
missense mutations and the increased rate of de novo 
LGD mutations in girls with autism compared to boys 
with autism, and established a very important relation 
between de novo LGDs and IQ.
In our work with whole-exome sequencing of the 
SSC, the project comprises 2800 families with one 
child with autism spectrum disorder diagnosis and 
with at least one unaffected child. Such a collection 
is ideally suited for identifi cation of de novo muta-
tions with strong effect on the disorder. The recent 
improvements of the techniques for enrichment of 
coding genomic sequence and of the new-genera-
tion sequencing technology made the whole-exome 
sequencing for large numbers of samples feasible. 
The generated data are of high quality and can be 
used to identify de novo single-nucleotide, short-
indel, and copy-number mutations.
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IN SILICO CANCER GENOMICS
A. Krasnitz M. McGillivray G. Sun
Research in our group is focused on in silico cancer 
genomics. In the last 5 years, there has been explosive 
growth in the volume, as well as quality and detail, 
of cancer-related genomic data available for analysis. 
This development came about through rapid accu-
mulation of public data sets generated by individual 
laboratories worldwide, through large-scale cancer ge-
nome projects such as TCGA and ICGC, and with 
the advent of new experimental methodologies, espe-
cially the next-generation sequencing and single-cell 
genomics. We see our goal as channeling this fl ood of 
data into a number of clinically relevant applications. 
These include pinpointing and prioritizing targets for 
functional analysis; discovery of genomic markers for 
clinical outcome and molecular classifi cation of can-
cer; elucidating the clonal structure of tumors and its 
relation to progression, invasion, metastasis, and re-
sponse to treatment. All of our work is done in close 
coordination with experimental studies performed by 
the Wigler, Hicks, Powers, Lowe (presently at Memo-
rial Sloan-Kettering Cancer Center), and Stillman 
laboratories at CSHL.
Recurrence Analysis of Genomic 
Interval Data
Large collections of intervals commonly arise in high-
throughput genomics. For example, DNA copy-num-
ber analysis yields intervals of the genome correspond-
ing to gains or losses of DNA segments. Likewise, 
chromatin structure is often reported as intervals of 
the genome. In such cases, a common goal is infer-
ence of contiguous genomic target regions, which, 
under certain model assumptions, generates the ob-
served patterns in the data. We call such target regions 
“cores.” The typical evidence for cores is the presence 
of “recurrent” observations, suitably defi ned.
In cancer, genomes display complex patterns of 
DNA copy-number alteration, but recurrent aberra-
tions are observed within a given cancer type. Detec-
tion and quantitative characterization of the cores in 
a given malignancy are potentially benefi cial in two 
ways. First, it is plausible that at least some of the re-
currence owes to selective pressure on regions harbor-
ing cancer-related genes. Focusing on these regions 
may therefore facilitate cancer gene discovery. Second, 
once the cores are known, the genome of a tumor can 
be described in a drastically simplifi ed fashion by in-
dicating the presence or absence of copy-number al-
teration in any given core. This simplifi ed form of the 
data is better suited for further analysis, such as fi nd-
ing subtypes in a given type of cancer or discovering 
associations between genomic properties and clinical 
parameters. Furthermore, differences in core patterns 
among individual tumor cells may be used to explore 
genomic heterogeneity of cancer and examine genea-
logical relationships among tumor cell populations.
We designed and implemented a method for iden-
tifying cores in large collections of genomic interval 
data. A descriptive name for the method is cores of re-
current events (CORE). Central to CORE is the no-
tion of explanatory power. We say that a core explains 
an event and we quantify the explanation provided as 
a number between 0 and 1. The explanation is a mea-
sure of how closely the event is matched by the core. 
We then seek a set of cores that jointly provide the 
best possible explanation of the data, subject to addi-
tional criteria of statistical signifi cance. CORE is now 
available to the community via the Comprehensive R 
Archive Network (CRAN).
Tumor Cell Population Structure
Study of genomic and transcriptional properties 
of individual cells is now the focus of multiple re-
search laboratories around the world. In application 
to cancer, this line of research has revealed the ge-
nomic complexity of the disease and the presence of 
multiple genealogically related cell populations in a 
tumor. Detailed knowledge of the clonal structure of 
a cancer potentially is of high clinical value: Multi-
plicity of clones or of lesions in most advanced clones 
is a possible measure of progression; spatial pattern 
of clone dispersal in a tumor may signal elevated 
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propensity to invade; lesions observed in individual 
clones but not in the bulk tissue may point to targets 
for therapy. DNA copy-number profi ling of cells from 
low-coverage sequencing is an accurate, economically 
feasible technological approach to the study of cancer 
subpopulation structure. Novel multiplex sequencing 
techniques, developed by the Wigler lab at CSHL, 
permit simultaneous sequencing of dozens of single-
cell DNA specimens and their subsequent copy-num-
ber profi ling at up to 50-kb resolution. Optimal use 
of these data for robust reconstruction of cancer cell 
phylogenies is a challenging computational problem 
calling for new and robust informatic and statistical 
tools.
In response, we used CORE to transform copy-
number profi les of single cells into a form suitable for 
phylogeny. As a result of this transformation, each 
profi le is characterized in terms of presence or absence 
of archetypal copy-number events recurrent in the 
single-cell populations. The entire set of copy-number 
profi les of single cells sampled from a tumor is sum-
marized as an incidence table, essentially a matrix 
with cores as columns, single cells as rows, and ele-
ments quantifying, on a scale between 0 and 1, how 
well a given core is matched by a copy-number event 
in a given cell. Distances among cells as rows of this 
matrix can be readily computed and used for distance-
based phylogeny. This methodology has been used to 
reconstruct the cell-population structure in a number 
of samples from prostate cancers. Importantly, this 
study shows that well-defi ned clones of tumor cells 
are likely to exist in prostates of patients with high, 
but not with low, Gleason scores. Furthermore, we 
see evidence that some of the clones spread to mul-
tiple anatomical sites within the affected prostate, 
including sites with less malignant histopathological 
 characteristics.
Prediction of Response to Anthracycline 
Therapy in Breast Cancer
Anthracyclines are a class of chemotherapeutic drugs 
that are effective and widely used in treatment of a 
number of cancers, in particular those of breast. Sen-
sitivity to these agents varies widely across the entire 
population of patients and likely depends on the pat-
tern of genomic alterations in the tumor. Anthracy-
cline administration also causes signifi cant side effects, 
most importantly cardiotoxicity, and should therefore 
be restricted to patient populations for which the ex-
pected benefi ts outweigh these risks. Yet despite more 
than 50 years of use, the anthracycline mechanism of 
action is not fi rmly established, and there are as yet 
no reliable predictive markers. In response, we applied 
CORE to DNA copy-number profi les derived by the 
Hicks laboratory at CSHL from breast tumors of ~250 
patients enrolled in the NEAT/BR9601 clinical trial 
in Britain. The study was conducted in collaboration 
with the Bartlett group at the Ontario Institute for 
Cancer Research. To discover markers of sensitivity to 
anthracyclines, we performed CORE analysis of the 
set of profi les and computed the incidence table. Next, 
we evaluated each core as a prospective marker of sen-
sitivity and found dramatically higher benefi t from 
treatment in patients positive for a narrow amplifi ed 
region of chromosome 8. None of the marker-positive 
patients treated by anthracyclines have suffered a re-
lapse in the 5 years since treatment, whereas the mark-
er-positive patients who were not treated displayed a 
markedly higher rate of relapse than the remainder of 
the cohort. Given these results, a validation study has 
been initiated, with the goal to similarly analyze hun-
dreds of breast tumor samples from the MA.5 clinical 
trial in Canada.
Signiﬁ cantly Distinct Branches 
of Hierarchical Trees
Hierarchical clustering (HC) is widely used as a meth-
od of partitioning data and of identifying meaningful 
data subsets. Most commonly, an application consists 
of visual examination of the dendrogram and intuitive 
identifi cation of subtrees that appear clearly distinct 
from the rest of the tree. Obviously, results of such 
qualitative analysis and conclusions from it may be 
observer-dependent. Quantifying the interpretation 
of hierarchical trees and introducing mathematically 
and statistically well-defi ned criteria for distinctness 
of subtrees would therefore be highly benefi cial.
We formulated and implemented a computational 
method termed tree branches evaluated statistically 
for tightness (TBEST) for identifying signifi cantly 
distinct tree branches in hierarchical clusters. For 
each branch of the tree, a measure of distinctness, or 
tightness, is defi ned as a rational function of heights, 
both of the branch and of its parent. A statistical 
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procedure is then developed to determine the signifi -
cance of the observed values of tightness. We tested 
TBEST as a tool for tree-based data partitioning by 
applying it to four benchmark data sets. These rep-
resent four distinct types of biological data: mRNA 
expression, DNA  copy-number variation, proteomics, 
and fl ow cytometry. In each of the four cases, there is 
a well-defi ned and independently known partition of 
the data into classes. In all cases considered, TBEST 
reproduced these classes on par with or better than 
the existing techniques. The R language implemen-
tation of the method is now available, as an epony-
mous package, from the Comprehensive R Archive 
Network (CRAN).
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COMPUTATIONAL GENETICS
D. Levy
The data-rich environment at CSHL generates a 
wealth of opportunities for the application of mathe-
matics and computation to further our understanding 
of biology and genetics. The primary activities of our 
lab are algorithm development, data analysis, and ge-
netic theory, with a focus on sporadic human diseases 
such as autism, congenital heart disease, and cancer.
Autism Genetics and New Mutation
In collaboration with Michael Wigler and Ivan Ios-
sifov, our efforts in autism attempt to bridge the gap 
between genetic theory and large-scale data analysis. 
In 2007, Zhao et al. (Proc Natl Acad Sci 104: 12831 
[2007]) proposed a genetic theory of autism where 
new (or “de novo”) mutations serve as an entry point 
for highly deleterious genetic lesions. This theory was 
supported by early studies showing an excess of de 
novo copy-number variations (CNVs) in autistic chil-
dren and suggested a strategy for uncovering the set 
of genes whose disruption may result in autism. The 
 Simons Simplex Collection (SSC) includes genetic 
samples and phenotypic data from families with ex-
actly one child affected with an autism spectrum dis-
order (ASD). All 3000 families have samples collected 
from the mother, the father, the affected child, and 
typically at least one unaffected sibling. By identify-
ing mutations that are present in the autistic child but 
absent in the parents and comparing to the observed 
rate in the unaffected siblings, we can infer a con-
tributory rate for new mutations and identify likely 
genetic  targets.
From 2008 to 2011, we generated and analyzed 
thousands of high-resolution CGH (comparative ge-
nome hybridization) arrays with 2.1 million data points 
per individual and, in the process, developed a set of 
tools to reduce system noise and uncover rare and de 
novo CNVs. The resulting study, published in 2011, 
included 1000 SSC families and established a rate of de 
novo CNVs of 8% in autistic children compared to 2% 
in their unaffected siblings. De novo CNVs were more 
frequent and larger in affected girls than affected boys, 
and we found evidence for excess transmission of rare 
variants to the affected children. In collaboration with 
Dorothy Warburton at Columbia University Medical 
Center, we conducted a similar study of 223 children 
with congenital heart disease (CHD) and found strong 
evidence of a causal role for de novo CNVs, with 10% 
of affected children having a de novo variant.
Although copy-number variants provide an excel-
lent signal to background (4:1), even with the high 
resolution of the microarrays and the sophisticated in-
formatics for denoising and analysis, most observable 
CNVs disrupt more than one gene. This necessarily 
complicates the effort to identify causal genetic targets. 
With the availability of low-cost targeted sequencing 
methods, the SSC data analysis effort switched to 
identifying de novo point mutations and small in-
sertion or deletion events (indels) in the exome. Our 
results from the fi rst 350 families, published in Ios-
sifov et al. (Neuron 74: 285 [2012]), are in agreement 
with the results of the other groups studying exomic 
mutation: De novo “loss-of-function” variants, those 
that severely impair gene function, occur in 20% of 
affected children and in only 10% of their siblings. 
Together with groups at University of Washington 
and University of San Francisco, we are in the process 
of fi nishing the data analysis on the entire collection 
of SSC exomes. The latest data set identifi es a strong 
signal for a causative role in missense mutations; how-
ever, the signal to background is small, on the order of 
one causal event against a background of 10 incidental 
ones.
Copy Number from Exome Sequence
Although we are no longer generating copy-number 
microarrays, we now have thousands of families with 
greater than 40× sequence coverage on the exome. 
The principal utility of these data is for its sequence 
content, but there is evidence that we can also ex-
tract copy-number variants. The primary challenge 
in identifying CNVs from exome capture data is that 
the capture process distorts coverage in ways that vary 
228-243_QuantBiol.indb   237 19-08-2014   08:38:12
238  Research
from sample to sample. Our initial expectation was 
that capturing and sequencing the family together 
would result in the same systemic distortion for all 
members in the family. That proved not to be the case. 
Even samples captured together showed variability in 
their coverage distortion, likely resulting from differ-
ences in sample handling prior to applying the capture 
protocol (sample acquisition, DNA extraction, etc.). 
What is more, the entirety of the SSC exome project 
involves several different centers, each using their own 
protocols for capture and sequencing.
Fortunately, the variability expressed in an individ-
ual sample is often recapitulated on a population level, 
and thus, we can use our library of samples to identify 
the major elements of systemic noise. Our normaliza-
tion procedure is coupled to a hidden Markov model 
(HMM) that integrates over all the copy-number pos-
sibilities for a given sample and returns a probability 
for each copy state for each region of the genome. We 
then modify the expected coverage based on the re-
sults of the HMM, repeat our normalization proce-
dure, and iterate until the results are unchanged. After 
identifying likely regions of CNV, we apply statisti-
cal tests over the segmented events in each family to 
determine the plausibility of the CNV. These results 
include tests for goodness of fi t, rarity of the event in 
the population, and its pattern of inheritance.
There are four objectives to our present copy-
number study. The fi rst is to increase the number of 
de novo copy-number variants associated with ASD. 
The second is to look for an imbalance in small de 
novo CNVs, events that were too small to detect using 
CGH technology but might be within our reach using 
the sequence data. The third is to test the claims with 
respect to rare inherited copy-number events and 
their unequal distribution to autistic children. Fi-
nally, we would like to combine the CNV analysis 
in the larger context of sequence data, for example, 
identifying SNPs that occur opposite a deletion and 
establishing parent of origin for de novo copy-number 
changes. The data analysis and algorithm implemen-
tations have been performed by Kith Pradhan and in 
collaboration with Chris Yoon, who has an alternative 
method for calling copy-number events.
From our current analysis, it appears that large de 
novo and transmitted events are easily identifi able in 
the exome data; however, fi nding small events con-
tinues to present a challenge. If our thresholds are too 
high, we fail to identify anything; if they are too low, 
we obtain many false events. Together with Zihua 
Wang in the Wigler lab, we are developing bench pro-
tocols that could test copy number at targeted posi-
tions in the genome using high-throughput sequencing 
methods. Such a protocol would provide an excellent 
screen for validating our calls on small events.
Insertions and Deletions by Exact Match
We are also developing, together with Peter Andrews 
at CSHL, an algorithm for identifying large genomic 
rearrangements—deletions, insertions, translocations, 
and inversions—by cataloging discontinuities in the 
mapping of reads against the reference genome. The 
majority of existing methods for fi nding such events 
approach the problem one read at a time, typically 
identifying a target region by anchoring a mate-pair 
and then fi tting the misaligned read using a scoring 
algorithm with a mismatch/gap penalty. Elaborations 
on this method make a secondary correction to obtain 
consensus among gapped mappings per sample. These 
methods are reasonably good—provided the event is 
small and occurs in an uncomplicated region.
Our algorithm uses all the reads over the whole 
population to make inferences about genomic rear-
rangements. Thanks to Moore’s law, computational 
methods that were impractical at the dawn of genomic 
analysis are now feasible, fast, and useful. Suffi x arrays 
require vast amounts of memory but perform very fast 
lookups for a query sequence of all its unique maxi-
mal exact matches (MEMs) to the human genome. By 
cataloging and indexing all reads in a sample by their 
MEMs, in particular those with two distinct matches 
into the reference genome, we identify and label recur-
rently observed discontinuities. Integrating this infor-
mation across all samples, we can recognize common 
events, spurious rearrangements resulting from se-
quence homology, and global discrepancies within the 
reference. With all reads indexed and anchored to the 
reference genome, we reassemble rare and de novo dis-
continuities within an individual or family. Early ver-
sions of this method using fi xed-width exact match-
ing and applied to the SSC exome data successfully 
identifi ed large deletions, inversions, and insertions, 
and small indels, as well as rare and de novo pseudo-
genes. Our latest efforts show that the statistical signal 
is easily discernible even with just one distinct match 
into the reference genome, which should facilitate the 
identifi cation of events that involve regions with mul-
tiple mappings in the genome.
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Genetic Models of Autism
Autism is often described as the most highly heritable 
neurological disorder. Concordance for autism among 
identical twins is as high as 90%. There are several 
other interesting statistics in the epidemiology of au-
tism that are less often noted. If a family has a single 
child with autism, the risk to the next born male child 
is ~20%. This elevated risk has led to an explanation 
that autism is a multifactorial disorder and that sev-
eral gene disruptions are needed to produce an autism 
phenotype. That claim, however, is belied by another 
statistic: Given two children in the family with au-
tism, the risk to a third-born male child is 50%.
One model that fi ts these data is to postulate two 
risk classes for autism: Nearly all families have a very 
low risk of having a child with autism, whereas a small 
percentage of families have a very high risk. Together 
with Michael Wigler and Swagatam Mukhopadhyay, 
we have been exploring simple genetic models that re-
capitulate the observed risk statistics, both for boys 
and girls, as well as observations that stem from ge-
netic analyses of ASD families. Our model includes 
parameters such as de novo mutation rates, variability 
of penetrance, assortative mating, and the number 
and type of genetic targets.
Combinatorics allow for fast simulations of infi nite 
populations, providing a means for quickly exploring 
the space of possible models consistent with the ob-
servable measures. We fi nd that a simple model with 
two gene classes and different selection profi les for 
males and females is suffi cient to match observable 
risk and mutation rates. This model also makes pre-
dictions about gender ratios as a function of severity, 
the role of transmitted mutation, and the genetic load 
in the population.
In Press
Ronemus M, Iossifov I, Levy D, Wigler M. 2014. The role of de novo 
mutations in the genetics of autism spectrum disorders. Nat Rev 
Genet 15: 133–141.
Warburton D, Ronemus M, Kline J, Jobanputra V, Williams I, Any-
ane-Yeboa K, Chung W, Yu L, Wong N, Awad D, Yu CY, Leotta 
A, Kendall J, Yamrom B, Lee YH, Wigler M, Levy D. 2014. The 
contribution of de novo and rare inherited copy number changes 
to congenital heart disease in an unselected sample of children 
with conotruncal defects or hypoplastic left heart disease. Human 
Genet 133: 11–27.
228-243_QuantBiol.indb   239 19-08-2014   08:38:12
240
COMPUTATIONAL SEQUENCE ANALYSIS
M. Schatz T. Garvin H. Lee S. Ramakrishnan
 A. Gupta S. Marcus A.H. Wences
 R. Gupta G. Narzisi G. Vurture
 J. Gurtowski D. Nettem
Our lab develops novel computational analysis meth-
ods to study the information content in biological 
sequences and the dynamics of biological processes. 
These include methods for assembling sequence data 
into complete genomes, for aligning sequences to dis-
cover variations or measure transcription levels, and 
for mining these data to discover relationships be-
tween an organism’s genome and its traits. We then 
apply these methods to study several biological sys-
tems, for example, to discover mutations associated 
with human diseases such as cancer and autism or 
to reconstruct the genomes of important agricultural 
crops and biofuels.
In the past year, our lab has grown by several new 
members. Tyler Garvin is a new student from the Wat-
son School of Biological Sciences. Tyler completed his 
undergraduate education in Biomedical Engineering 
at the University of Southern California. Throughout 
his dissertation, Tyler will be researching novel meth-
ods for single-cell DNA and RNA analysis with appli-
cations to cancer and other complex diseases. Srividya 
Ramakrishnan joined the lab as a Computational Sci-
entifi c Analyst after completing her Master’s degree 
in Bioinformatics from the New Jersey Institute of 
Technology. Srividya is working on building ultra-
large-scale sequence analysis pipelines for KBase, the 
Department of Energy Systems Biology Knowledge-
base. During the summer, Greg Vurture joined the lab 
through the undergraduate research program to devel-
op new computational and mathematical approaches 
to infer the properties of genomes from unassembled 
sequencing reads. Avijit Gupta, Rushil Gupta, and 
Deepak Nettem completed their Master’s degrees in 
Computer Science and have gone on to accept soft-
ware engineering positions at Microsoft and TuneIn.
In the past year, our lab continued working on sev-
eral funded projects studying the genetics of autism 
and of several important agricultural- and bioenergy-
related plant species and developing algorithms for 
genome assembly and large-scale sequence analysis. 
In the last year, I have been interviewed by editors of 
the journals Nature, Nature Biotechnology, and Nature 
Methods as well as Wired Magazine and The New York 
Times, especially to describe my work applying third-
generation sequencing technology from Pacifi c Biosci-
ences to human and plant genetics.
Assemblathon 2: Evaluating De Novo 
Methods of Genome Assembly 
in Three Vertebrate Species
The process of generating raw genome sequence data 
continues to become cheaper, faster, and more accu-
rate. However, assembly of such data into high-quality, 
fi nished genome sequences remains challenging. Many 
genome assembly tools are available, but they differ 
greatly in terms of their performance (speed, scalabil-
ity, hardware requirements, acceptance of newer read 
technologies) and in their fi nal output (composition 
of assembled sequence). More importantly, it remains 
largely unclear how to best assess the quality of as-
sembled genome sequences. The Assemblathon com-
petitions are intended to assess current state-of-the-art 
methods in genome assembly.
In Assemblathon 2, sequence data were provided 
for three vertebrate species (a bird, a fi sh, and a snake). 
This resulted in a total of 43 submitted assemblies 
from 21 participating teams. The assemblies were 
evaluated using a combination of optical map data, 
Fosmid sequences, and several statistical methods. 
From more than 100 different metrics, we chose 10 
key measures by which to assess the overall quality 
of the assemblies. Our assembly of the fi sh genome 
placed second in the overall contest, using a new 
method prototyped by a former undergraduate re-
search program (URP) participant in my lab, Paul 
Baranay.
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Genome of the Long-Living Sacred 
Lotus Nelumbo nucifera (Gaertn.)
Sacred lotus is a basal eudicot of agricultural, medici-
nal, cultural, and religious importance. It was domes-
ticated in Asia ~7000 years ago and cultivated for its 
rhizomes and seeds as a food crop. It is particularly 
noted for its 1300-year seed longevity and exceptional 
water repellency, known as the lotus effect. The latter 
property is due to the nanoscopic closely packed pro-
tuberances of its self-cleaning leaf surface, which have 
been adapted for the manufacture of a self-cleaning 
industrial paint, Lotusan.
The genome of the China Antique variety of the 
sacred lotus was sequenced with Illumina and 454 
technologies, at respective depths of 101× and 5.2×. 
We assembled these data and achieved a contig N50 
of 38.8 kbp and a scaffold N50 of 3.4 Mbp, which 
covers 86.5% of the estimated 929 Mbp total genome 
size. The genome notably lacks the paleotriplication 
observed in other eudicots, but it does reveal a lin-
eage-specifi c duplication. The genome has evidence 
of slow evolution, with a 30% slower nucleotide mu-
tation rate than observed in grape. Comparisons of 
the available sequenced genomes suggest a minimum 
gene set for vascular plants of 4223 genes. Strikingly, 
the sacred lotus has 16 COG2132 multicopper oxi-
dase family proteins with root-specifi c expression; 
these are involved in root meristem phosphate starva-
tion, refl ecting adaptation to limited nutrient avail-
ability in an aquatic environment. The slow nucleo-
tide substitution rate makes the sacred lotus a better 
resource than the current standard, grape, for recon-
structing the pan-eudicot genome and should there-
fore accelerate comparative analysis between eudicots 
and monocots.
Cultivation and Complete Genome 
Sequencing of Gloeobacter kilaueensis 
sp. nov. from a Lava Cave in Kı-lauea 
Caldera, Hawai’i
The ancestor of Gloeobacter violaceus PCC 7421T 
is believed to have diverged from that of all known 
cyanobacteria before the evolution of thylakoid mem-
branes and plant plastids. The long and largely inde-
pendent evolutionary history of G. violaceus presents 
an organism retaining ancestral features of early oxy-
genic photoautotrophs, and in whom cyanobacteria 
evolution can be investigated. No other Gloeobacter 
species has been described since the genus was estab-
lished in 1974. Gloeobacter-affi liated ribosomal gene 
sequences have been reported in environmental DNA 
libraries, but only the type strain’s genome has been 
sequenced. However, we report here the cultivation of 
a new Gloeobacter species, G. kilaueensis JS1T, from 
an epilithic biofi lm in a lava cave in Kı-lauea Caldera, 
Hawai’i. The strain’s genome was sequenced from 
an enriched culture resembling a low-complexity 
metagenomic sample, using 9-kb paired-end 454 py-
rosequences and 400-bp paired-end Illumina reads. 
The JS1T and G. violaceus PCC 7421T genomes have 
little gene synteny despite sharing 2842 orthologous 
genes; a comparison of the genomes shows they do 
not belong to the same species. Our results support 
establishing a new species to accommodate JS1T, for 
which we propose the name Gloeobacter kilaueensis sp. 
nov. Strain JS1T has been deposited in the American 
Type Culture Collection (BAA-2537), the Scottish 
Marine Institute’s Culture Collection of Algae and 
Protozoa (CCAP 1431/1), and the Belgian Coordi-
nated Collections of Microorganisms (ULC0316). 
The G. kilaueensis holotype has been deposited in 
the Algal Collection of the U.S. National Herbari-
um (US# 217948). The JS1T genome sequence has 
been deposited in GenBank under accession number 
CP003587. The complete genome sequence of G. 
kilaueensis JS1T may further the understanding of cy-
anobacteria evolution and the shift from anoxygenic 
to oxygenic photosynthesis.
The Advantages of SMRT Sequencing
Of the current next-generation sequencing technol-
ogies, single-molecule real-time (SMRT) sequenc-
ing from Pacifi c Biosciences is sometimes overlooked. 
However, attributes such as long reads, modifi ed base 
detection, and high accuracy make SMRT a useful 
technology and an ideal approach to the complete 
sequencing of small and large genomes. The advan-
tages the platform provides relate to the possibility of 
sequencing small and large genomes, with long non-
amplifi ed single-molecule sequencing, and on the ca-
pability of detecting methylated nucleotides.
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Aluminum Tolerance in Maize Is Associated 
with Higher MATE1 Gene Copy Number
Genome structure variation, including copy-number 
variation (CNV) and presence/absence variation, con-
tributes greatly to maize genetic diversity; however, 
its effect on phenotypes remains largely unexplored. 
Here, we describe how CNV underlies a rare allele 
that contributes to maize aluminum (Al) tolerance. 
Al toxicity is the primary limitation for crop produc-
tion on acid soils, which make up 50% of the world’s 
potentially arable lands. In a recombinant inbred line 
mapping population, copy-number variation of the Al 
tolerance gene multidrug and toxic compound extru-
sion 1 (MATE1) is the basis for the quantitative trait 
locus of largest effect on phenotypic variation. This 
expansion in MATE1 copy number is associated with 
higher MATE1 expression, which in turn results in 
superior Al tolerance. The three MATE1 copies are 
identical and are part of a tandem triplication, which 
we were able to resolve using PacBio SMRT long-read 
sequencing. Only three maize inbred lines carrying 
the three-copy allele were identifi ed from maize and 
teosinte diversity panels, indicating that CNV for 
MATE1 is a rare, and quite likely recent, event. These 
maize lines with higher MATE1 copy number are 
also Al-tolerant, have high MATE1 expression, and 
originate from regions of highly acidic soils. Our fi nd-
ings show a role for CNV in the adaptation of maize 
to acidic soils in the tropics and suggest that genome 
structural changes may be a rapid evolutionary re-
sponse to new environments.
The DNA Data Deluge
In June 2000, a press conference was held in the 
White House to announce an extraordinary feat: 
the completion of a draft of the human genome. For 
the fi rst time, researchers had read all three billion of 
the chemical “letters” that make up a human DNA 
molecule, which would allow geneticists to investi-
gate how that chemical sequence codes for a human 
being. In his remarks, President Bill Clinton recalled 
the moment nearly 50 years prior when Francis Crick 
and James Watson fi rst discovered the double-helix 
structure of DNA. “How far we have come since that 
day,” Clinton said.
But the president’s comment applies equally well to 
what has happened in the ensuing years. In little more 
than a decade, the cost of sequencing one human ge-
nome has dropped from hundreds of millions of dollars 
to just a few thousand dollars. Instead of taking years 
to sequence a single human genome, it now takes ~10 
days to sequence a half dozen at a time using a high-
capacity sequencing machine. Scientists have built rich 
catalogs of genomes from people around the world and 
have studied the genomes of individuals suffering from 
diseases; they are also making inventories of the ge-
nomes of microbes, plants, and animals. Sequencing is 
no longer something only wealthy companies and in-
ternational consortia can afford to do. Now, thousands 
of benchtop sequencers sit in laboratories and hospitals 
across the globe. Discussed here is the state of the art 
in sequencing and analysis  methods.
Sixty Years of Genome Biology
Sixty years after Watson and Crick published the 
double helix model of DNA’s structure, 13 members 
of Genome Biology’s Editorial Board selected key ad-
vances in the fi eld of genome biology subsequent to 
that discovery. My response follows.
The most signifi cant development in genome bi-
ology since 25 April 1953 has been the rise of large-
scale DNA sequencing, pioneered by Fred Sanger 
in 1977 and refi ned over the last several decades in 
fi rst-, second-, and now third-generation automated 
sequencing technologies. Determining the structure 
of DNA in 1953 was incredibly signifi cant for deter-
mining the molecular framework for so many aspects 
of biology, including the frameworks for replication, 
transcription, inheritance, mutation and evolution, to 
name but a few. However, determining the structure 
of DNA is analogous to determining the structure of 
a piece of paper void of any literature or mathematics 
written upon it. Now, with the rise of high-through-
put sequencing, we have the capability of reading the 
genetic messages written on those molecular pages. 
This capability has unlocked not only the human ge-
nome, but also those of thousands of other species, re-
vealing their genes, regulatory sequences, and overall 
structures, which has in turn led to many important 
advances in biology and medicine. The next frontier 
in genome biology is to apply these technologies, and 
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the related molecular assays empowered by DNA se-
quencing, over large populations of species, individ-
uals, and cells to compare, model, and predict how 
these systems behave.
The DNA60IFX Contest
In honor of the 60th anniversary of the publication 
of the structure of DNA, we organized a contest re-
lated to DNA and its applications in current research. 
The contest began on April 20 and ended on April 25, 
the anniversary itself, and popularly known as “DNA 
Day.” The contest drew nearly 1000 participants from 
across the world. Refl ecting the transition from genet-
ics to genomics in the 60 years since the discovery, 
the contest was presented as a series of bioinformat-
ics challenges in which participants would assemble, 
align, or otherwise analyze nucleic acid sequences to 
identify a message hidden in the data.
The contest consisted of fi ve stages, ordered so that 
the solution to one stage unlocked access to the next 
by completing its URL. There were no timing require-
ments for the fi rst four stages since they were released 
at a predefi ned time for all participants, although the 
overall winners were determined by how quickly they 
could correctly solve the fi nal stage. The top prize 
was an iPad, and the second and third place entries 
had their choice of a one-year subscription to Genome 
 Biology or registration to the Beyond the Genome 
conference. In addition to celebrating the discovery, 
we hoped to reach out to students and postdoctoral 
researchers around the world to motivate them to 
learn a few new techniques and a few new concepts 
of molecular biology. This appears to have been quite 
successful, and several students outside of biology par-
ticipated in the contest. We hope and anticipate hold-
ing similar contests in the years to come.
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QUANTITATIVE BIOLOGY FELLOW
Quantitative Biology Fellows are independent researchers who enter this position soon after re-
ceiving a PhD. They come from the fi elds of mathematics, physics, engineering, or computer 
science and spend 3–5 years at CSHL applying techniques from these disciplines to important 
questions in biology.
Justin Kinney completed his PhD in Physics at Princeton University in 2008 and began his 
term as a Quantitative Biology Fellow in 2010. His research focuses on developing next-generation 
DNA sequencing as a tool for dissecting the structure and function of large macromolecular com-
plexes. Of particular interest to his lab is the biophysical basis of transcriptional regulation—how 
simple interactions between proteins and DNA allow promoters and enhancers to modulate genes 
in response to physiological signals.
In 2010, Kinney and colleagues published a paper demonstrating Sort-Seq, a novel sequencing-
based method that can measure the functional activity of hundreds of thousands of slightly mu-
tated versions of a specifi c DNA sequence of interest. Using a novel information-theoretic analysis 
of the resulting data, Kinney et al. were able to quantitatively measure, in living cells, the protein–
DNA and protein–protein interactions controlling mRNA transcription at a chosen promoter.
Kinney continues to develop this approach using a combination of theory, computation, and 
experiment. From a biological standpoint, Sort-Seq allows researchers to investigate important 
but previously inaccessible biological systems. Kinney’s lab is currently using Sort-Seq to address 
open problems in transcriptional regulation, DNA replication, and immunology. These experi-
ments also present new challenges for the fi eld of machine learning, and a substantial fraction of 
Kinney’s efforts are devoted to addressing the theoretical and computational problems relevant to 
the analysis of Sort-Seq data.
Transcriptional Regulation, Biophysics, 
and Machine Learning
J. Kinney
My research combines theory, computation, and ex-
periment in an effort to better understand sequence-
function relationships in biology.
My experimental work focuses primarily on the 
biophysics of transcriptional regulation in the gut 
bacterium Escherichia coli. In graduate school and as 
a postdoctoral researcher, I developed an experimen-
tal method called Sort-Seq that allows the transcrip-
tional activities of hundreds of thousands of different 
E. coli promoters to be measured in a single experi-
ment. These data can be used to build quantitative 
biophysical models for how elementary protein–DNA 
and protein–protein interactions combine to regulate 
gene expression. I continue to use Sort-Seq to study 
transcriptional regulation in E. coli, but am also using 
similar techniques to study both DNA replication ini-
tiation and antibody–antigen interactions.
The analysis of Sort-Seq data also highlights in-
teresting problems in statistics and machine learning 
that have yet to be fully addressed. Approximately half 
of my research effort is devoted to these theoretical 
and computational questions.
Probability Density Estimation Using 
Scale-Free Field Theories
Analyzing Sort-Seq data requires the accurate esti-
mation of continuous probability distributions, also 
known as “probability densities.” Motivated by this 
need, I developed a method called density estimation 
using fi eld theory (DEFT) to rapidly and accurately 
estimate probability densities using mathematical 
methods from theoretical physics (Fig. 1) (Kinney 
2013). Unlike other density estimation approaches, 
this method has essentially no free tunable param-
eters. In particular, the length scale characterizing the 
smoothness of the underlying distribution is not set by 
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the user, but is rather learned directly from the data 
themselves. My hope is that DEFT will be applicable 
to a wide range of statistical problems across many dis-
ciplines as well as to “Big Data” problems in industry.
Parametric Inference in the Large Data Limit 
Using Maximally Informative Models
Kinney and Atwal (2014a) describe a basic problem in 
statistical inference. Our work was initially motivated 
by my analysis of Sort-Seq data, but it is also relevant 
to the measurement of neuron receptive fi elds in sen-
sory neuroscience.
Consider an experiment that produces an unlim-
ited supply of data, for example, activity measure-
ments for many different mutants of a bacterial pro-
moter. In addition, assume, however, that the precise 
quantitative form of the experimental noise pollut-
ing these measurements is unknown. Such situations 
are common in Sort-Seq and other high-throughput 
biology experiments. However, not knowing how to 
model experimental noise causes problems for the 
standard statistical methods used to fi t models to 
such data. The reason is that standard statistics re-
quires that one compute “likelihood,” and comput-
ing this requires an explicit quantitative model of 
experimental noise.
Atwal and I show that using a quantity from infor-
mation theory called “mutual information” in place 
of likelihood circumvents the problem of not know-
ing the details of the experimental noise (Fig. 2). 
We also introduce the concept of “diffeomorphic 
modes”—directions in parameter space that mutual 
information cannot pin down. This work therefore 
reveals that different model parameters respond in 
qualitatively different ways to data. This is a general 
mathematical fi nding applicable to all statistical re-
gression problems.
Equitability, Mutual Information, and the 
Maximal Information Coefﬁ cient
In Kinney and Atwal (2014b), we introduce a rigor-
ous formulation of statistical “equitability,” a heuristic 
criterion for measures of dependence that was recently 
advocated by Reshef et al. (Science 334: 1518 [2011]). 
We show that this formal criterion is a closely related 
core concept in information theory called the “Data 
Processing Inequality.” We also show that this equita-
bility criterion is naturally satisfi ed by the well-known 
mutual information measure and that estimates of 
mutual information made on fi nite data adhere well 
to this notion of equitability in practice.
Although the heuristic concept of statistical equi-
tability is indeed valuable, we also fi nd that the pri-
mary claims of Reshef et al. regarding equitability are 
incorrect. In particular, we show that the “maximal 
information coeffi cient” (MIC), a new statistic that 
Reshef et al. introduced in order to satisfy equitabil-
ity, does not actually have this mathematical property. 
This fi nding is important because the paper by Reshef 
et al. has become one of the most highly cited statistics 
papers of the last few years, and MIC appears to have 
gained widespread use. We hope that our paper will 
motivate scientists in need of an equitable measure of 
dependence to use mutual information instead.
Ongoing Projects
A Biophysical Code for Transcriptional Regulation in E. coli
I have established a long-term collaboration with Rob 
Phillips (California Institute of Technology), the goal 
of which is to build a full biophysical model of the 
transcriptional regulatory code of E. coli. We are fo-
cusing on this bacterium for two reasons. First, the 
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Figure 1. DEFT probability density estimation in two dimen-
sions. Shown is a simulated probability density Qtrue (composed 
of two Gaussian distributions), raw data sets R (of various size N) 
drawn from Qtrue, and density estimates computed from R using 
either DEFT (with constrained derivative of order α = 2, 3, or 4), 
kernel density estimation, or Gaussian mixture modeling.
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underlying molecular biology of transcriptional regu-
lation is understood well enough in E. coli to allow for 
mechanistic interpretations of Sort-Seq data. Second, 
transcription in E. coli is regulated in a hierarchical 
manner, with only a small number of proteins control-
ling a large number of promoters. Using in vitro single-
molecule techniques together with in vivo Sort-Seq as-
says, we aim to systematically build a full sequence-de-
pendent biophysical model for how regulatory proteins 
bind DNA, interact with one another, and modulate 
the rate of mRNA transcription. Initial work on this 
project has been pursued by Daniel Jones (California 
Institute of Technology), a graduate student who has 
spent his last four summers at CSHL doing experi-
ments and computational work in my lab.
Sequence-Function Relationships 
in Antibody–Antigen Recognition
Despite the central role that antibodies have in the 
adaptive immune system and in biotechnology, sur-
prisingly little is known about how antibody–antigen 
affi nity depends on antibody sequence. For instance, 
how many possible antibodies can specifi cally bind an 
antigen of interest with 1 nM affi nity, or with 1 pM 
affi nity? Is the sequence-affi nity landscape “convex” 
or “glassy”? Do the sequence-affi nity landscapes for 
different antibody–antigen pairs exhibit any general 
features, for example, a universal “density of states.” 
In collaboration with Aleksandra Walczak (ENS, 
Paris) and Thierry Mora (ENS, Paris), I am pursuing 
a combination of theory, computation, and experi-
ment aimed at making progress on these important 
problems.
During the last year, Rhys Adams, a postdoctoral 
researcher working with Walczak, Mora, and myself, 
has been performing and analyzing Sort-Seq experi-
ments designed to address these questions. Using yeast 
display technology, he is able to measure the binding 
affi nities of thousands of mutant antibodies to a spe-
cifi c antigen of interest. Our hope is that these data 
will allow us to build quantitative models of the se-
quence-affi nity landscape of this system, explore this 
landscape computationally, and look for features that 
might generalize to other antibody–antigen pairs.
Figure 2. Schematic illustration of constraints 
placed on diffeomorphic and nondiffeomorphic 
modes in parameter space by different objective 
functions. The closed circle in each panel repre-
sents the correct model θ*; shades of gray rep-
resent the posterior distribution p(θ|data). (A,B) 
Likelihood places tight constraints along both dif-
feomorphic and nondiffeomorphic directions in 
parameter space. (A) θ* will typically lie within 
error bars if the correct noise function π* is used 
to compute likelihood L. (B) However, if an incor-
rect noise function π′ is used, θ* will generally 
violate inferred constraints along both diffeomor-
phic and nondiffeomorphic modes. (C) Alterna-
tively, if uncertainties in the noise functions are 
explicitly accounted for in the computation of 
p(θ|data), one will ﬁ nd tight constraints on non-
diffeomorphic modes but only weak constraints 
along diffeomorphic modes. (D) Mutual informa-
tion places tight constraints on nondiffeomorphic 
modes but provides no constraints whatsoever 
on diffeomorphic modes. (Figure from Kinney 
and Atwal 2014a.)
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The Biophysical Mechanisms 
of DNA Replication Initiation
I am collaborating with Bruce Stillman (CSHL) and 
Leemor Joshua-Tor (CSHL) on a project investigat-
ing the biophysical mechanisms of DNA replication 
initiation, both in vivo and in vitro. In collaboration 
with Bruce Stillman, I have developed a plasmid re-
tention assay in the yeast Saccharomyces cerevisiae that 
produces Sort-Seq-like data probing the sequence 
dependence of DNA replication initiation. In paral-
lel, the Joshua-Tor lab is performing in vitro binding 
assays of replication proteins to DNA replication ori-
gins. The primary goal of this project is to determine 
whether the in vitro sequence dependence of pro-
tein–DNA binding recapitulates the in vivo sequence 
dependence of replication initiation. My hope is that 
this approach will eventually produce insight into the 
biophysical mechanisms leading from protein–DNA 
binding to origin activation.
Formal Diagrammatic Methods 
for Biochemical Systems
All of my experimental projects require quantitative 
biophysical modeling of molecular interactions. How-
ever, the only systematic way to currently represent 
models of such interactions is to explicitly list all the 
possible states of a system, a task that becomes expo-
nentially more diffi cult as system size increases. For 
this reason, I am developing a formal diagrammatic 
method for concisely and rigorously defi ning thermo-
dynamic models of biochemical systems. This method 
allows equilibrium partition functions to be calculat-
ed systematically, and it should eventually facilitate 
nonequilibrium calculations as well. This approach 
can be applied to a wide range of processes in systems 
biology. My hope is that such methods will serve a 
purpose much like Feynman diagrams do in physics, 
bridging the gap between one’s intuitive visual under-
standing of a system and rigorous quantitative models 
thereof.
PUBLICATIONS
Weirauch MT, Cote A, Norel R, Annala M, Zhao Y, Riley TR, Saez-
Rodriguez J, Cokelaer T, Vedenko A, Talukder S, DREAM5 Con-
sortium, et al. 2013. Evaluation of methods for modeling tran-
scription factor sequence specifi city. Nat Biotechnol 31: 126–134.
In Press
Kinney JB, Atwal GS. 2014a. Parametric inference in the large data 
limit using maximally informative models. Neural Comput (in 
press).
Kinney JB, Atwal GS. 2014b. Equitability, mutual information, and 
the maximal information coeffi cient. Proc Natl Acad Sci (in press).
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SCIENCES DEAN’S REPORT
After a number of changes to the administrative staff at the WSBS last year, there was only one 
change in 2013. An Associate Dean, Dr. Carrie Cowan, joined the WSBS in July to help direct 
the long-term vision of the School. Carrie trained as a cell and developmental biologist at Welles-
ley College and University of California, Berkeley, where she obtained her PhD with Dr. Zac 
Cande. She performed postdoctoral work with Dr. Tony Hyman at the Max Planck Institute in 
Dresden, Germany, and then established an independent research group at the Research Institute 
of Molecular Pathology (IMP) in Vienna, Austria, studying cell polarity in Caenorhabditis elegans 
embryos. After mentoring several PhD and MS students in her lab and helping to restructure the 
PhD program in Vienna, Carrie comes to Cold Spring Harbor Laboratory to pursue her inter-
est in graduate education and to help ensure that the Watson School continues to be a successful 
enterprise for both students and faculty.
NYS Accreditation
Carrie’s fi rst major project for the School was to prepare a lengthy self-study for the School’s reac-
creditation from the New York State Board of Regents. New York State conducted a site visit on 
October 31st and November 1st, meeting with senior laboratory administration, faculty, and stu-
dents and exploring the Laboratory’s facilities. Joining Department of Education representative Paul 
Thompson on the visit were biologists from other New York State institutions: James Boroweic (New 
York University), Ron Prywes (Columbia University), Wes Gruber (Columbia University), and Greg 
DeAngelis (University of Rochester). The site visitors will prepare a report of their fi ndings that we 
should receive in early 2014. The Board of Regents will make the accreditation decision later in the 
year. We are confi dent that the visit went well and that accreditation will indeed be renewed.
The 10th WSBS Graduation
On April 28, 2013, we celebrated the Watson School’s 10th graduation ceremony. Eight students 
were awarded PhD degrees: Eyal Gruntman from the Entering Class of 2006, Megan Bodnar, 
 Joseph Calarco, Saya Ebbesen, Paloma Guzzardo, Maria Pineda, and Peter Znamenskiy from the 
Entering Class of 2007, and Felix Schlesinger from the Entering Class of 2008. Ralph Burgess from 
the Entering Class of 2007 was awarded a Master’s degree, but he did not attend the ceremony. Hon-
orary degrees were bestowed upon Jack Dixon and Brigid Hogan. Dr. Jack E. Dixon is a professor 
at the University of California, San Diego, and Vice President and Chief Scientifi c Offi cer of the 
Howard Hughes Medical Institute (HHMI). Since 2007, he has directed HHMI’s fl agship investi-
gator program. Dr. Dixon was also responsible for identifying new opportunities that capitalize on 
the HHMI’s expertise in biomedical research and science education. Dr. Brigid Hogan, who gave an 
inspirational commencement address, is the George Barth Geller Professor and Chair of the Depart-
ment of Cell Biology, Duke University Medical Center. In 1983, she initiated the CSHL course “Mo-
lecular Embryology of the Mouse,” one of the most infl uential courses in the Lab’s history. Through 
this course and her lead role in writing and editing the CSHL Press manual that it spawned (Manipu-
lating the Mouse Embryo, considered the “Bible” of mammalian embryo manipulation techniques), 
Dr. Hogan made the techniques of mammalian developmental genetics and experimental embryol-
ogy widely available to the broader scientifi c community, greatly enhancing the work of others.
As with each graduation, we extended a special welcome to the family members and friends of 
our students who attend the ceremony.
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2013 WSBS graduates: (Left to right) CSHL President Bruce Stillman, Paloma Guzzardo, Petr Znamenskiy, Megan Bodnar, Saya Ebbesen, 
Maria Pineda, Joseph Calarco, Felix Schlesinger, WSBS Dean Alexander Gann
2013 WSBS DOCTORAL RECIPIENTS
Student
Thesis 
advisor
Academic 
mentor
Current 
position
Megan Bodnar David L. Spector Nicholas Tonks Postdoctoral Fellow, Mount Sinai School of Medicine 
(Advisor: Thomas Zwaka)
Joseph Calarco Robert Martienssen David Jackson Postdoctoral Fellow, Stanford University (Advisor: 
Gerald Crabtree)
Saya Ebbesen Scott Lowe David Stewart Postdoctoral Fellow, Memorial Sloan-Kettering Cancer 
Center (Advisor: Scott Lowe)
Paloma Guzzardo Gregory Hannon Adrian R. Krainer Program Evaluation Consultant, Damon Runyon Cancer 
Research Foundation. Graduate Student Post, CSHL 
(Advisor: Gregory Hannon)
Marek Kudla Gregory Hannon David Jackson Graduate Student Post, CSHL (Advisor: Gregory Hannon)
Hassana Oyibo Anthony Zador Hiro Furukawa Graduate Student Post, CSHL (Advisor: Anthony Zador)
Michael Pautler David Jackson Robert Lucito Research Associate, Trait Development, Vineland 
Research and Innovation Centre, Canada
Eugene Plavskin Marja Timmermans Jan A. Witkowski Postdoctoral Fellow, New York University (Advisor: 
Mark Siegal)
Joshua Sanders Adam Kepecs Bruce Stillman Graduate Student Post, CSHL (Advisor: Adam Kepecs)
Felix Schlesinger Thomas Gingeras Gregory Hannon Bioinformatic Scientist, Illumina, Inc. San Diego, CA
Petr Znamenskiy Anthony Zador Terri Grodzicker Postdoctoral Fellow, Biozentrum, University of Basel, 
Switzerland (Advisor: Thomas Mrsic-Flogel)
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2013 THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2007
Megan Bodnar, March 29, 2013
The dynamics of pluripotency genes upon differentiation of 
mouse embryonic stem cells.
Thesis Examining Committee
Chair: Alea A. Mills
Research Mentor: David L. Spector
Academic Mentor: Nicholas Tonks
Committee Member: Bruce Stillman
External Examiner: Jane Skok,
  New York University
Joseph Calarco, January 18, 2013
A system to study chromatin dynamics through pollen 
development.
Thesis Examining Committee
Chair: Gregory Hannon
Research Mentor: Robert Martienssen
Academic Mentor: David Jackson
Committee Member: Leemor Joshua-Tor
Committee Member: Adrian R. Krainer
Committee Member:  Danesh Moazed, 
 Harvard University
External Examiner:  Craig Pikaard,
 Indiana University
Saya Ebbesen, March 6, 2013
RNAi mouse models of breast cancer tumor suppressor genes.
Thesis Examining Committee
Chair: Lloyd Trotman
Research Mentor: Scott Lowe
Academic Mentor: David J. Stewart
Committee Member: Gregory Hannon
Committee Member: Scott Powers
External Examiner:  Ramon E. Parsons,
 Columbia University
Paloma Guzzardo, February 12, 2013
Identifi cation and characterization of novel components of 
the Drosophila piRNA pathway.
Thesis Examining Committee
Chair: Zachary Lippman
Research Mentor: Gregory Hannon
Academic Mentor: Adrian R. Krainer
Committee Member: Leemor Joshua-Tor
Committee Member:  Emily Bernstein,
 Mount Sinai Hospital
External Examiner:  Victor Corces,
 Emory University
Marek Kudla, July 23, 2013
Identifi cation of miRNA target sites in mouse embryonic stem 
cells and derived cells of neuronal lineage.
Thesis Examining Committee
Chair: W. Richard McCombie
Research Mentor: Gregory Hannon
Academic Mentor: David Jackson
Committee Member: Adrian R. Krainer
Committee Member: Molly Hammell
Committee Member: Marja Timmermans
External Examiner:  Ihor Lemischka,
 Mount Sinai Hospital
Hassana Oyibo, June 3, 2013
A high-throughput sequencing approach to mapping synaptic 
connectivity in the brain.
Thesis Examining Committee
Chair: Pavel Osten
Research Mentor: Anthony Zador
Academic Mentor: Hiro Furukawa
Committee Member: Gregory Hannon
Committee Member: Josh Dubnau
External Examiner:  Lynn Enquist,
 Princeton University
Michael Pautler, June 18, 2013
Meristem size and determinacy in maize: How stem cell 
activity shapes plant architecture.
Thesis Examining Committee
Chair: Robert Martienssen
Research Mentor: David Jackson
Academic Mentor: Zachary Lippman
Committee Member:  Hajime Sakai,
 University of Delaware
External Examiner:  Erik W. Vollbrecht,
 Iowa State University
Eugene Plavskin, June 25, 2013
The story of an evolutionary hijacking: Regulation of the 
auxin response by an ancient small RNA pathway.
Thesis Examining Committee
Chair: Gregory Hannon
Research Mentor: Marja Timmermans
Academic Mentor: Jan A. Witkowski
Committee Member: David Jackson
Committee Member:  Ralph Quatrano, 
  Washington University, 
St. Louis
External Examiner:  Michael Scanlon,
 Cornell University
Joshua Sanders, September 17, 2013
A framework for understanding decision confi dence.
Thesis Examining Committee
Chair: Glenn Turner
Research Mentor: Adam Kepecs
Academic Mentor: Bruce Stillman
Committee Member: Anthony Zador
Committee Member:  Carlos Brody
External Examiner:  Nathaniel Daw,
 New York University
Petr Znamenskiy, March 19, 2013
Role of corticostriatal projections in auditory 
discrimination.
(continued )
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Teaching Award
At the graduation ceremony this year, Mickey Atwal was presented with the eighth annual  Winship 
Herr Faculty Teaching Award, named in honor of the School’s founding dean. Mickey, the lead 
instructor in the Specialized Disciplines course in Quantitative 
Biology, was chosen by the students for this award, based on his 
enthusiasm, excellence, and creativity in teaching. The winner of 
this award is nominated and voted on by the students. Here is some 
of what they had to say about Mickey:
 “Mickey was responsible for teaching subject matter that most of 
the class had little to no experience in and did so in such a way that 
engaged the class.”
 “He had no problem deviating from his scheduled lesson to go into 
detail about any topic that our class was either confused about or 
took specifi c interest in.”
 “Most of all, Mickey made quantitative biology fun and accessible 
to novices while still challenging us.”
2013 THESIS DISSERTATION DEFENSES (continued)
Thesis Examining Committee
Chair: Adam Kepecs
Research Mentor: Anthony Zador
Academic Mentor: Terri Grodzicker
Committee Member: Anne Churchland
Committee Member:  Pavel Osten
External Examiner:  J. Anthony Movshon,
 New York University
ENTERING CLASS OF 2008
Melanie Eckersley-Maslin, October 23, 2013
Characteristics of random monoallelic gene expression during 
embryonic stem cell differentiation.
Thesis Examining Committee
Chair: Thomas Gingeras
Research Mentor: David L. Spector
Academic Mentor: Gregory Hannon
Committee Member: Robert Martienssen
Committee Member:  Christopher Vakoc
External Examiner:  Marisa Bartolomei,
 University of Pennsylvania
Katie Liberatore, December 3, 2013
Mechanisms of plant reproductive success: Gene dosage, 
stem cell maintenance, and the regulation of shoot 
architecture.
Thesis Examining Committee
Chair: David Jackson
Research Mentor: Zachary Lippman
Academic Mentor: Adrian R. Krainer
Committee Member: Marja Timmermans
Committee Member:  Doreen Ware
External Examiner:  Rüdiger Simon,
  Heinrich Heine University,
Düsseldorf, Germany
Zinaida Perova, August 13, 2013
Synaptic changes in the medial prefrontal cortex in resilience 
and susceptibility to stress.
Thesis Examining Committee
Chair: Stephen Shea
Research Mentor: Bo Li
Academic Mentor: Linda Van Aelst
Committee Member: Fritz Henn
Committee Member: Z. Josh Huang
Committee Member:  Pavel Osten
External Examiner:  Ming-Hu Han,
  Mount Sinai School 
of Medicine
Felix Schlesinger, January 14, 2013
Discovery and analysis of transcription at regulatory 
elements.
Thesis Examining Committee
Chair: Mickey Atwal
Research Mentor: Thomas Gingeras
Academic Mentor: Gregory Hannon
Committee Member: Alexander Krasnitz
Committee Member:  David L. Spector
External Examiner:  Manolis Kellis,
  Massachusetts Institute 
of Technology
Alexander Gann (left) and Mickey Atwal
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DOCTORAL THESIS RESEARCH
Student Academic mentor Research mentor Thesis research
ENTERING CLASS OF 2008
Mitchell Bekritsky
Starr Centennial Scholar
W. Richard 
McCombie
Michael Wigler High-throughput microsatellite genotyping.
Dario Bressan
Robert and Teresa Lindsay Fellow
Z. Josh Huang Gregory Hannon A novel technology for the space-specifi c recovery 
of biological molecules.
Sang Geol Koh
George A. and Marjorie H. Anderson 
Fellow
Glenn Turner Anthony Zador Attention-dependent information routing in the 
mouse auditory cortex.
Ozlem Mert
George A. and Marjorie H. Anderson 
Fellow
John R. Inglis Scott Lowe Characterization of the role of E2F7 in oncogene-
induced senescence and tumorigenesis.
Nilgun Tasdemir
Robert and Teresa Lindsay Fellow II
Josh Dubnau Scott Lowe Investigating the molecular overlaps between 
epigenetic reprogramming and transformation.
Elvin Wagenblast
Starr Centennial Scholar 
Boehringer Ingelheim Fellow
Jan A. Witkowski Gregory Hannon Role of stem/progenitor cells in mammary gland 
and breast tumors.
Susann Weissmueller
Annette Kade Fellow
Gregory Hannon Scott Lowe In vivo identifi cation and characterization of tumor 
suppressor genes in hepatocellular carcinoma.
ENTERING CLASS OF 2009
Stephane Castel
Cashin Fellow NSERC Scholar
Lloyd Trotman Robert 
Martienssen
RNAi-mediated heterochromatin in S. pombe.
Kristen Delevich
NIH Predoctoral Trainee
Stephen Shea Bo Li Elucidating the role of disrupted-in-schizophrenia-1 
in development of prefrontal cortical circuits.
Silvia Fenoglio
Elisabeth Sloan Livingston Fellow
Linda Van Aelst Gregory Hannon RNAi screening to identify putative therapeutic 
targets for the treatment of pancreatic cancer.
Wee Siong Goh
A*STAR Fellow Delbrück Fellow
Hiro Furukawa Gregory Hannon Determining piRNA primary biogenesis and 
MIWI and late piRNA function in mice using 
Caenorhabditis elegans as a model system for 
genetic screening.
Ian Peikon
Dr. John and Consuelo Phelan Student
Mickey Atwal Anthony Zador Reverse engineering the brain.
Kaja Wasik
George A. and Marjorie H. Anderson 
Fellow
Jan A. Witkowski Gregory Hannon A screen for novel components of the piRNA 
pathway in Drosophila melanogaster.
Cinthya Zepeda Mendoza
Gonzalo Rio Arronte Fellow
Thomas Gingeras David L. Spector Analysis of higher-order chromatin organization 
at the mouse syntenic region of human 1p36 upon 
genomic copy-number changes.
ENTERING CLASS OF 2010
Arkarup Bandyopadhyay
Goldberg Lindsay Fellow
Zachary Lippman Florin Albeanu Identity and intensity encoding of odors in 
rodents.
Colleen Carlston
John and Amy Phelan Student
Hiro Furukawa Christopher 
Hammell
Identifi cation and characterization of noise-
suppressor genes that act via microRNAs in 
Caenorhabditis elegans larval development.
Matthew Koh
George A. and Marjorie H. Anderson 
Fellow
Bo Li Florin Albeanu Roles of olfactory bulb inhibitory microcircuits 
in shaping the temporal response properties of 
mitral cells.
Lisa Krug
NIH Predoctoral Trainee
Stephen Shea Josh Dubnau Mechanisms of transposon regulation in the 
central nervous system.
(continued )
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DOCTORAL THESIS RESEARCH (continued)
Student Academic mentor Research mentor Thesis research
John Sheppard
Bristol Myers Squibb/NIH 
Predoctoral Trainee
Josh Dubnau Anne Churchland Neural mechanisms of multisensory decision 
making.
Jack Walleshauser
Barbara McClintock/NIH 
Predoctoral Trainee
Christopher 
Hammell
Leemor Joshua-Tor Structural basis for TUT4 uridylation of the 
pre-let-7/lin28 complex.
ENTERING CLASS OF 2011
Robert Aboukhalil
NIH Predoctoral Trainee 
Starr Centennial Scholar
Josh Dubnau Mickey Atwal 
Michael Wigler
Using single-cell RNA-Seq to investigate tumor 
heterogeneity and evolution.
Brittany Cazakoff
Edward and Martha Gerry Fellow
Christopher 
Hammell
Stephen Shea Dynamic granule cell processing of odor 
information.
Joaquina Delas Vives
La Caixa Fellow
Nicholas Tonks Gregory Hannon Functional role of long noncoding RNAs in 
hematopoiesis.
Anja Hohmann
David H. Koch Fellow
John Inglis Christopher Vakoc Exploring the role of bromodomain-containing 
protein 9 (Brd9) in the maintenance of acute 
myeloid leukemia.
Justus Kebschull
David and Fanny Luke Fellow 
Genentech Foundation Fellow
Marja Timmermans Anthony Zador Grasping the brain.
Fred Marbach
Farish-Gerry Fellow
Josh Dubnau Anthony Zador A study of auditory corticostriatal cells in the 
behaving mouse.
Onyekachi Odoemene
NIH Predoctoral Trainee 
William Randolph Hearst Scholar
Stephen Shea Anne Churchland The role of neural inhibition in perceptual decision 
making.
Sophie Thomain
George A. and Marjorie H. Anderson 
Fellow
Josh Dubnau Zachary Lippman Characterization of a new meristem maintenance 
pathway in tomato and Arabidopsis thaliana and its 
relation to pollen tube growth.
Charles Underwood
William R. Miller Fellow
Michael Schatz Robert 
Martienssen
Epigenetic inheritance through mitosis and meiosis 
in Arabidopsis thaliana.
ENTERING CLASS OF 2012
William Donovan
NIH Predoctoral Trainee
Christopher 
Hammell
Josh Dubnau/ 
Anthony Zador
Transposons on the mind: Characterizing 
transposable element activity in TDP-43-
pathology neurodegenerative disorders.
Talitha Forcier
NIH Predoctoral Trainee 
William Randolph Hearst Scholar
Nicholas Tonks Michael Wigler Determining the chance of transcriptional events 
from single-cell RNA analysis.
Tyler Garvin 
NIH Predoctoral Trainee/Dr.
John and Consuelo Phelan Student
Zachary Lippman Michael Schatz Structural variants and gene networks underlying 
complex human disease.
Yu-Jui (Ray) Ho 
David and Fanny Luke Fellow
Michael Schatz Molly Hammell Methods development for low-input RNA-Seq 
analysis.
Paul Masset 
Florence Luke Fellow
Jan A. Witkowski Adam Kepecs Representations of decision confi dence in the 
brain: From Bayes’ rule to channel rhodopsin.
Annabel Romero Hernandez
Genentech Foundation Fellow
Adrian R. Krainer Hiro Furukawa Molecular mechanisms of inhibition in NMDA 
receptors.
Abram Santana
William Randolph Hearst Scholar
Lloyd Trotman David Tuveson Pancreatic tumor biology and therapy.
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Admissions 2013
The School received 274 applications for the 2013/2014 academic year and is deeply indebted to 
its Admissions Committee, which reviewed, interviewed, and selected candidates for our doc-
toral program. The Admissions Committee for the 2013 entering class comprised myself, Gregory 
Hannon (chair), Mickey Atwal, Anne Churchland, Adrian R. Krainer, Zachary Lippman, W. 
Richard McCombie, Stephen Shea, Nicholas Tonks, and Linda Van Aelst.
Entering Class of 2013
On August 26, 2013, the Watson School welcomed a new class of 10 students: Giorgia Battistoni, 
Lital Chartarifsky, Sanchari Ghosh, Michael Giangrasso, Michael Gutbrod, Daniel Kepple, Laura 
Maiorino, Maria Nattestad, Kim Palacios, and Georgi Yordanov.
ENTERING CLASS OF 2013
Giorgia Battistoni, University of Pisa; MS Awarded: University 
of Pisa (2013); Scuola Normale Superiore Scholarship 
Recipient (2008)
Academic Mentor: Christopher Hammell
Lital Chartarifsky, Hebrew University of Jerusalem; MS Awarded: 
Hebrew University of Jerusalem (2012); Rector Prize Academic 
Excellence Award for MSc Studies: Hebrew University (2012); 
Dean’s List Awarded: Hebrew University (2009–2011)
Academic Mentor: John Inglis
Sanchari Ghosh, Presidency College; Master of Biotechnology 
Awarded: All India Institute of Medical Sciences (2008); 
Ranked Second: All India Institute of Medical Sciences, 
Master of Biotechnology; Master of Biotechnology Student 
Fellowship, Department of Biotechnology, Ministry of Science 
and Technology (2006–2008); National Eligibility Test for 
Junior Research Fellowship (JRF) and Lectureship, Council 
for Scientifi c and Industrial Research Fellowship Scheme 
(2008); DBT-JRF Program, National Level Biotechnology 
Entrance Test (BET), Department of Biotechnology, Ministry 
of Science and Technology (2008); Junior Research Fellowship 
and Lectureship, National Entrance Test, University Grant 
Commission Fellowship Scheme (2007)
Academic Mentor: Josh Dubnau
Michael Giangrasso, Tulane University; Tulane University 
Distinguished Scholar (2009–2013); David H. Ledbetter 
Undergraduate Scholar (2010–2013); Dean’s List Awarded: 
Tulane University (2010–2013); CELT Research Grant for 
Cellular Electrophysiology (2012–2013); Tulane University 
Neuroscience Department’s Summer Research Program (2012)
Academic Mentor: Bo Li
Michael Gutbrod, University of Illinois at Urbana-Champaign; 
Dean’s List Awarded: University of Illinois at Urbana-
Champaign; Research Intern, Baxter Healthcare, Biochemistry 
and Cell Biology Group (Summer 2008, 2009)
Academic Mentor: Florin Albeanu
Daniel Kepple, Syracuse University; Harvard University NSF 
REU Summer Fellowship (2012); Harvard University 
Leadership Alliance Summer Research Early Identifi cation 
Program Fellowship (2011); Gilman Scholarship, U.S. 
Department of State, Bureau of Educational and Cultural 
Affairs (2012); Syracuse University Anthony Yeh Scholarship 
(2012); Syracuse University Remembrance Scholarship (2011); 
Syracuse University Crown-Wise Award (2011); Syracuse 
University Sharon and Peter Kissel Endowed Scholarship 
(2009–2012)
Academic Mentor: David Stewart
Laura Maiorino, Università Vita-Salute San Raffaele; MS 
Awarded: Università Vita-Salute San Raffaele (2011); 
Postgraduate Research Fellow, Leukocyte Biology Unit, DiBit, 
San Raffaele Scientifi c Institute (2011–2013)
Academic Mentor: Nicholas Tonks
Maria Nattestad, University of the Pacifi c; University of the 
Pacifi c Honors Program; University of the Pacifi c Regents 
Scholar; Phi Beta Kappa; Phi Kappa Phi; The Rockefeller 
University Summer Undergraduate Research Fellowship 
(2012); Thomas J. Long Scholarship for Excellence in 
General Education; Raymond College Alumni Essay 
Competition Outstanding Entry; Mortar Board National 
Senior Honor Society; Alpha Lambda Delta Freshman 
Honor Society
Academic Mentor: Michael Schatz
Kim Palacios, Universidad Nacional Autonoma de Mexico; 
Universidad Nacional Autonoma de Mexico Honorifi c Award 
(2010–2011); Universidad Nacional Autonoma de Mexico 
Honorifi c Award, High Ranking (2010)
Academic Mentor: Bruce Stillman
Georgi Yordanov, University of Liverpool; University of Liverpool 
Sir Henry Wade Deacon Scholarship (2009–2013)
Academic Mentor: David Tuveson
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Academic Mentoring
The Watson School takes great pride in the level of mentoring that it offers its students. One ex-
ample is our two-tiered mentoring approach whereby each student receives an academic mentor 
and a research mentor. Because WSBS students select a research mentor only in June right before 
their qualifying exam, the academic mentor is critical for monitoring students—and offering 
advice—during the intensive coursework of the fi rst term, during student rotations, and when 
identifying a suitable research mentor. The academic mentors continue to follow the students 
throughout their doctoral experience, often serving as important advocates. Entering students se-
lect by mutual agreement a member of the research or nonresearch faculty to serve as an academic 
mentor. This program continues to receive much support from the faculty, who volunteer to be 
academic mentors, and it has rightfully become a vital ingredient in our success. The following are 
the Academic Mentors for the Entering Class of 2013.
STUDENT MENTOR STUDENT MENTOR
Giorgia Battistoni Christopher Hammell Daniel Kepple David Stewart
Lital Charatifsky John Inglis Laura Maiorino Nicholas Tonks
Sanchari Ghosh Josh Dubnau Maria Nattestad Michael Schatz
Michael Giangrasso Bo Li Kim Palacios Bruce Stillman
Michael Gutbrod Florin Albeanu Georgi Yordanov David Tuveson
2013 Entering Class: (Top row, left to right) Kim Palacios, Lital Chartarifsky, Laura Maiorino, Sanchari Ghosh. 
(Bottom row, left to right) Georgi Yordanov, Daniel Kepple, Giorgia Battistoni, Maria Nattestad, Michael 
Giangrasso, Michael Gutbrod
251-282_WSBS.indb   260 8/28/2014   10:45:15 AM
Dean’s Report  261
The Fall Term Curriculum
Our faculty continues to do an outstanding job developing and delivering the curriculum. We are 
extremely grateful for their considerable time and effort in maintaining the high-quality course-
work. The Curriculum Development and Integration Committee (CDIC)—Adrian Krainer 
(Chair), David Jackson, Nicholas Tonks, and Glenn Turner—continues to oversee development 
of the curriculum. In addition to the outstanding course instructors and guest lecturers from 
within the Laboratory, our courses also continue to attract an impressive array of guest lecturers 
from other institutions.
Recruiting Efforts
This year, we introduced some minor changes with regard to campus recruitment visits. Instead 
of visiting individual college campuses, we primarily focused on targeted visits to graduate fairs 
and minority conferences. In addition to these visits, the WSBS generated new mailing lists for the 
distribution of information to top undergraduate science departments around the world. A new 
poster and trifold pamphlet were designed for this recruitment season. A Quick Response (QR) 
barcode was created and added to printed materials, which when scanned sends interested stu-
dents directly to the School’s website. Additionally, emails were sent to personalized contacts and 
to an electronic mailing list of more than 50,000 individuals who receive information from the 
Cold Spring Harbor Laboratory Press or who have attended Meetings & Courses and Banbury. 
We are grateful to these departments for sharing their contact lists.
2013 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Event Location Date
Cold Spring Harbor Laboratory Open House Cold Spring Harbor Laboratory March 23
American Association of Cancer Research Annual Meeting Washington, D.C. April 6–10
Molloy College Visit and Information Session Cold Spring Harbor Laboratory April 12
Brookhaven National Laboratory Graduate School Fair and Undergraduate 
Research Program Symposium
Brookhaven, New York August 7
UMDNJ–NJ Medical School, PHRI Visit and Information Session Cold Spring Harbor Laboratory August 12
Binghamton University Graduate School Fair Binghamton, New York October 1
Cornell University Graduate School Day Ithaca, New York October 2
Society for Advancement of Chicanos and Native Americans in Science 
(SACNAS) National Conference
San Antonio, Texas October 3–5
Atlanta University Center Consortium Graduate and Professional School Fair Atlanta, Georgia October 3
Princeton University Graduate and Professional School Fair Princeton, New Jersey October 4
Stanford University Graduate School Fair Palo Alto, California October 14
University of California, Santa Cruz Graduate and Professional School Fair Santa Cruz, California October 16
University of California, Berkeley Graduate School Fair Berkeley, California October 16
University of Cambridge Information Session Cambridge, England October 17
Columbia University Information Session New York October 17
Big 10+ Graduate School Exposition (Purdue University) West Lafayette, Indiana October 20–21
American Society for Human Genetics Annual Meeting Boston, Massachusetts October 22–26
California Forum for Diversity in Graduate Education Graduate School Fair Moraga, California October 26
Colby/Bates/Bowdoin Graduate School Fair Tour Maine October 28–29
University of Massachusetts Five College Graduate and Professionals Schools 
Information Day
Amherst, Massachusetts October 30
Rutgers University Graduate & Professional School Fair Rutgers, New Jersey October 30
Society for Neuroscience Annual Meeting Graduate School Fair New Orleans, Louisiana October 14–15
Annual Biomedical Research Conference for Minority Students Nashville, Tennessee November 12–16
American Society for Cell Biology Annual Meeting New Orleans, Louisiana December 14–18
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Interinstitutional Academic Interactions
WSBS students account for approximately half of the total graduate students at CSHL. The other half 
is visiting graduate students from other universities who have decided to conduct some or all of their 
thesis research in CSHL faculty members’ laboratories. A large percentage of students are from Stony 
Brook University (SBU), via a program established between CSHL and SBU more than 30 years ago.
Over the years, we have also established relationships with institutions around the world, there-
by enabling their students to conduct research at CSHL. Currently, we have visiting students from 
institutions in Germany, France, and Spain, to name a few. The Watson School provides a contact 
person for the students and maintains relationships with administrations from their home institu-
tions. These students are fully integrated into the CSHL community and receive all of the neces-
sary assistance as they navigate the complexities of performing doctoral research away from their 
home institutions. The following students, listed in the table below, joined us from SBU this year.
STUDENT CSHL RESEARCH MENTOR AFFILIATION AND PROGRAM
Brinda Alagesan David Tuveson Stony Brook, Molecular Genetics and Microbiology
Kung-Chi Chang David L. Spector Stony Brook, Molecular and Cellular Biology
Michael E. Klingener Gholson Lyon Stony Brook, Genetics
Jesse M. Levine Z. Josh Huang Stony Brook, Neuroscience
Tobiloba Oni David Tuveson Stony Brook, Molecular and Cellular Biology
Justin Snider Darryl Pappin Stony Brook, Molecular and Cellular Biology
Yali Xu Christopher Vakoc Stony Brook, Molecular and Cellular Biology
Graduate Student Symposium
Each year, the students participate in three Graduate Student Symposia held at the Laborato-
ry’s Genome Research Center in Woodbury: one in January, one in May, and one in October. 
Each Symposium consisted of fi ve sessions, where all of the presenters (senior students) each gave 
15-minute talks. Coffee breaks, lunch, and a wine and cheese reception at the end of the day 
rounded out the program and provided opportunities for more informal interactions. We are 
grateful to the two student chairs of the Symposium, Nitin Shirole (SBU) and Lisa Krug (WSBS), 
and to Kimberley Geer for providing administrative oversight.
Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also departures. The following graduate students 
and postdoctoral fellows departed the Laboratory during 2013:
Postdoctoral Fellows
Katharine Borges Santiago Jaramillo Mukesh Lodha Stephanie Shaw
Andres Canela Rodriguez Marie Javelle Martine Mirrione Frederic Van Ex
Nabanita Chatterjee Mads Aaboe Jensen Hysell Oviedo Angelina Vaseva
Muhan Chen Ted Karginov Jae-Hyun Park Lang Son Vi
Ertugrul Dalkic Tim Kees Jennifer Parla Fang Yang
Bernard Fendler Brian Kolterman Shilpi Paul Jianchao Yao
Yael Galon-Wolfenson Tali Lavy Hongtao Qin Zhu Zhu
Justyna Janas Darrin Lewis Kentaro Sahashi
Graduate Students
Joseph Calarco Jong Jin Han Deepak Nettem Areekul Sodsiri
Lorenza Calcaterra Kyle Honegger Jessica Oberheim Ruei-Ying Tzeng
Li-An Chu Canan Kuscu Michael Pautler Jie Wu
Laura Desban Wangzhi Li Megha Rajaram Bin Xu
Saya Ebbesen Willey Liao Vincent Robert Petr Znamenskiy
Eyal Gruntman Elena Lum Frederick Rollins Giulia Zunino
Rushil Gupta Antoine Molaro Felix Schlesinger
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Executive Committee
The School’s Executive Committee, in its monthly meetings, provides year-round direction for the 
School and its students through its invaluable policy recommendations. I wish to thank faculty 
members Mickey Atwal, Mikala Egeblad, Adrian Krainer, David Spector, David Stewart, Linda 
Van Aelst, and Bo Li. Bo joined the committee in October, replacing Linda Van Aelst, who had 
completed her second consecutive 3-year term. Ioana Rus served until October, when she was 
replaced by Mathangi Ramesh. Colleen Carlston was the WSBS representative. We are thankful 
to Ioana, Mathangi, and Colleen, who contributed to discussions and provided useful suggestions 
and feedback.
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (named after the energetic and charismatic publisher of 
Molecular Biology of the Cell, who died of cancer in 1991) brings to CSHL an eminent researcher 
and educator to give the Gavin Borden Lecture, which is aimed primarily at the graduate students 
at the laboratory. Dr. Sean Carroll, a professor of molecular biology, genetics, and medical genet-
ics at the University of Wisconsin, Madison, was this year’s Gavin Borden Fellow. He studies the 
evolution of cis-regulation in the context of biological development, using Drosophila as a model 
system. Since 2010, he has also been vice president for science education of the Howard Hughes 
Medical Institute. His lecture, “Brave genius: A scientist’s journey from the French resistance to 
the Nobel Prize,” described the role of chance and circumstance in the life of the French scientist 
Jacques Monod. In addition, the students joined Dr. Carroll during a roundtable lunch and dis-
cussion at which he shared insights into his personal scientifi c journey with a discussion on “Sci-
ence, education, and storytelling.”
The Watson School Continues to Beneﬁ t from Generous Benefactors
We are extremely grateful for the generous donors, whose one-time gifts or continued sup-
port made our 2013 programs possible, including the Annenberg Foundation, Lita Annenberg 
Hazen Foundation, Bristol-Myers Squibb Corporation, Mr. and Mrs. Richard M. Cashin, Mr. 
and Mrs. Landon Clay, Lester Crown, the Dana Foundation, Henriette and Norris Darrell, the 
Samuel Freeman Charitable Trust, the William Stamps Farish Fund, the Genentech Foundation, 
Mr. and Mrs. Alan Goldberg, Florence Gould Foundation, Gonzalo Río Arronte Foundation, 
William Randolph Hearst Foundation, Dr. Mark Hoffman, Annette Kade Charitable Trust, Mr. 
David H. Koch, Mr. and Mrs. Robert D. Lindsay and Family, Mr. and Mrs. David Luke III, 
Marjorie A. Matheson, Mr. and Mrs. William R. Miller, OSI Pharmaceuticals Foundation, Estate 
of Edward L. Palmer, Mr. and Mrs. John C. Phelan, the Quick Family, Estate of Elisabeth Sloan 
Livingston, the Starr Foundation, and the Roy J. Zuckerberg Family Foundation.
We are also very fortunate to hold a prestigious National Research Service Award Predoctoral 
Training Grant from the National Institutes of Health, National Institute of General Medical Sci-
ences. The School successfully competed for renewal of this award in 2013.
Student Achievements
The WSBS students continue to impress us all with their accomplishments. They publish their 
research fi ndings in prestigious international journals—more than 240 to date—and obtain fel-
lowships to pursue their research interests. In addition, our current students and alumni have been 
successful in receiving prestigious awards and fellowships. In 2013,
• WSBS student Brittany Cazakoff was awarded the 2012 Golden Key Graduate Scholar Award 
and a Graduate Scholarship from the Natural Sciences and Engineering Research Council of 
Canada (NSERC).
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• WSBS graduates Ji-Joon Song and Zachary Lippman were promoted to Associate Professor.
• WSBS Student Melanie Eckersley-Maslin was awarded the poster prize at the EMBL meeting 
on Chromatin and Epigenetics, EMBO, Heidelberg.
• WSBS graduate Monica Dus received a National Institutes of Health K99/R00 Pathway to 
Independence Award.
• Three WSBS students, Joaquina Delas Vives, Anja Hohmann, and Justus Kebschull, were 
awarded predoctoral fellowships from Boehringer Ingelheim Fonds.
2013 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS
Aboukhalil R, Fendler B, Atwal G. 2013. Kerfuffl e: A web tool for multi-species gene colocalization analysis. BMC 
Bioinformatics 14: 22.
Batut P, Gingeras TR. 2013. RAMPAGE: Promoter activity profi ling by paired-end sequencing of 5′-complete cDNAs. 
Curr Protoc Mol Biol 104: 25B.11.1–25B.11.16.
Batut PJ, Dobin A, Plessy C, Carninci P, Gingeras TR. 2013. High-fi delity promoter profi ling reveals widespread 
alternative promoter usage and transposon-driven developmental gene expression. Genome Res 23: 169–180.
Bodnar MS, Spector DL. 2013. Chromatin meets its organizers. Cell 153: 1187–1189. Review.
Campbell RAA, Honegger KS, Qin H, Li W, Demir E, Turner GC. 2013. Imaging a population code for odor identity 
in the Drosophila mushroom body. J Neurosci 33: 10568–10581.
Castel SE, Martienssen RA. 2013. RNA interference in the nucleus: Roles for small RNAs in transcription, epigenetics 
and beyond. Nat Rev Genet 14: 100–112. Review.
Das S, Fregoso OI, Krainer AR. 2013. A new path to oncogene-induced senescence: At the cross-roads of splicing and 
translation. Cell Cycle 12: 1477–1479.
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras, TR. 2013. STAR: 
Ultrafast universal RNA-seq aligner. Bioinformatics 29: 15–21.
Eckersley-Maslin MA, Bergmann JH, Lazar Z, Spector DL. 2013. Lamin A/C is expressed in pluripotent mouse 
embryonic stem cells. Nucleus 4: 53–60.
Eveland AL, Goldshmidt A, Pautler M, Morohashi K, Liseron-Monfi ls C, Lewis MW, Kumari S, Hiraga S, Yang F, 
Unger-Wallace E, Olson A, Hake S, Vollbrecht E, Grotewold E, Ware D, Jackson D. 2013. Regulatory modules 
controlling maize infl orescence architecture. Genome Res 24: 431–443.
Fregoso OI, Das S, Akerman M, Krainer AR. 2013. Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and 
induces cellular senescence. Mol Cell 50: 56–66.
Gruntman E, Turner GC. 2013. Integration of the olfactory code across dendritic claws of single mushroom body 
neurons. Nat Neurosci 16: 1821–1829.
Guzzardo PM, Muerdter F, Hannon GJ. 2013. The piRNA pathway in fl ies: Highlights and future directions. Curr 
Opin Genet Dev 23: 44–52. Review.
Hübner MR, Eckersley-Maslin MA, Spector DL. 2013. Chromatin organization and transcriptional regulation. Curr 
Opin Genet Dev 23: 89–95.
Jiang K, Liberatore KL, Park SJ, Alvarez JP, Lippman ZB. 2013. Tomato yield heterosis is triggered by a dosage 
sensitivity of the fl origen pathway that fi ne-tunes shoot architecture. PLoS Genet 9: e1004043.
Li W, Prazak L, Chatterjee N, Grüninger S, Krug L, Theodorou D, Dubnau J. 2013. Activation of transposable 
elements during aging and neuronal decline in Drosophila. Nat Neurosci 16: 529–531.
Lu X, Wontakal SN, Kavi H, Kim BJ, Guzzardo PM, Emelyanov AV, Xu N, Hannon GJ, Zavadil J, Fyodorov DV, 
Skoultchi AI. 2013. Drosophila H1 regulates the genetic activity of heterochromatin by recruitment of Su(var)3-9. 
Science 340: 78–81.
Muerdter F, Guzzardo PM, Gillis J, Luo Y, Yu Y, Chen C, Fekete R, Hannon GJ. 2013. A genome-wide RNAi screen 
draws a genetic framework for transposon control and primary piRNA biogenesis in Drosophila. Mol Cell 50: 736–748.
Nakasone ES, Askautrud HA, Egeblad M. 2013. Live imaging of drug responses in the tumor microenvironment in 
mouse models of breast cancer. JVis Exp 73: e50088.
Pautler M, Tanaka W, Hirano HY, Jackson D. 2013. Grass meristems I: Shoot apical meristem maintenance, axillary 
meristem determinacy, and the fl oral transition. Plant Cell Physiol 54: 302–312. Review.
Pi HJ, Hangya B, Kvitsiani D, Sanders JI, Huang ZJ, Kepecs A. 2013. Cortical interneurons that specialize in 
disinhibitory control. Nature 503: 521–524.
Raddatz G, Guzzardo PM, Olova N, Fantappié MR, Rampp M, Schaefer M, Reik W, Hannon GJ, Lyko F. 2013. 
Dnmt2-dependent methylomes lack defi ned DNA methylation patterns. Proc Natl Acad Sci 110: 8627–8631.
Sabin LR, Delás MJ, Hannon GJ. 2013. Dogma derailed: The many infl uences of RNA on the genome. Mol Cell 
49: 783–794. Review.
(continued )
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Alumni in Faculty and Senior Positions
To date, 66 students have received their PhD degree from the WSBS. Of these graduates, 15 cur-
rently hold tenure-track faculty positions and one holds an independent research position. Thirty-
fi ve of our former students are pursuing postdoctoral research, and 11 of our alumni completed 
their postdoctoral studies and have moved into positions in administration, education, industry, 
management consulting, and journal editing. Two are pursuing additional degrees.
2013 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS (continued)
Schlesinger F, Smith AD, Gingeras TR, Hannon GJ, Hodges E. 2013. De novo DNA demethylation and non-coding 
transcription defi ne active intergenic regulatory elements. Genome Res 23: 1601–1614.
Sheppard JP, Raposo D, Churchland AK. 2013. Dynamic weighting of multisensory stimuli shapes decision-making in 
rats and humans. J Vis 13: 1–19.
Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS, Minder JL, Mercan F, Wang E, Eckersley-Maslin 
MA, et al. 2013. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 
27: 2648–2662.
Tanaka W, Pautler M, Jackson D, Hirano, HY. 2013. Grass meristems II: Infl orescence architecture, fl ower 
development and meristem fate. Plant Cell Physiol 54: 313–324.
Tasdemir N, Lowe SW. 2013. Senescent cells spread the word: Non-cell autonomous propagation of cellular senescence. 
EMBO J 32: 1975–1976. Review.
Vagin VV, Yu Y, Jankowska A, Luo Y, Wasik KA, Malone CD, Harrison E, Rosebrock A, Wakimoto BT, Fagegaltier D, 
Muerdter F, Hannon GJ. 2013. Minotaur is critical for primary piRNA biogenesis. RNA 19: 1064–1077.
Vu TM, Nakamura M, Calarco JP, Susaki D, Lim PQ, Kinoshita T, Higashiyama T, Martienssen RA, Berger F. 2013. 
RNA-directed DNA methylation regulates parental genomic imprinting at several loci in Arabidopsis. Development 
140: 2953–2960.
Znamenskiy P, Zador AM. 2013. Corticostriatal neurons in auditory cortex drive decisions during auditory 
discrimination. Nature 497: 482–485.
Watson School student
WSBS GRADUATES IN FACULTY AND SENIOR POSITIONS
Name Current position
François Bolduc Assistant Professor, University of Alberta, Canada
Darren Burgess Associate Editor, Nature Reviews Cancer and Nature Reviews Genetics, United Kingdom
Amy Caudy Assistant Professor, University of Toronto, Canada
Daniel Chitwood Assistant Professor, Donald Danforth Plant Science Center, St. Louis
Michelle Cilia Research Molecular Biologist, U.S. Dept. of Agriculture, The Boyce Thompson Institute; 
Adjunct Assistant Professor, Cornell University
Catherine Cormier Scientifi c Liaison, Arizona State University
Yaniv Erlich Whitehead Fellow, Whitehead Institute
Rebecca Ewald Project Manager, Roche Diagnostics, Inc.
Elena Ezhkova Assistant Professor, Mount Sinai School of Medicine
Ira Hall Assistant Professor, University of Virginia School of Medicine
Christopher Harvey Assistant Professor, Harvard University
Keisha John Assistant Dean, Florida State University
Zachary Lippman Associate Professor, Cold Spring Harbor Laboratory
Marco Mangone Assistant Professor, Arizona State University
Elizabeth Murchison Reader, Cambridge University; Fellow, Kings College, United Kingdom
(continued )
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WSBS GRADUATES IN FACULTY AND SENIOR POSITIONS  (continued)
Name Current position
Patrick Paddison Assistant Member, Fred Hutchinson Cancer Research Center
Emiliano Rial-Verde Associate Principal, McKinsey & Co., Inc., Geneva, Switzerland
Ji-Joon Song Associate Professor, Korea Advanced Institute of Science and Technology (KAIST), 
South Korea
Niraj Tolia Assistant Professor, School of Medicine, Washington University, St. Louis
Wei Wei Assistant Professor, University of Chicago
Jeremy Wilusz Assistant Professor, University of Pennsylvania (Feb. 2014)
Alexander Gann
WSBS Professor and Dean
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SPRING CURRICULUM
Topics in Biology
ARRANGED BY Alyson Kass-Eisler and Jan A. Witkowski
FUNDED IN PART BY  The Daniel E. Koshland, Jr. Visiting Lectureship; the David Pall Visiting Lectureship; 
the Fairchild Martindale Visiting Lectureship; the Lucy and Mark Ptashne Visiting 
Lectureship; the Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference 
Center to explore specialized topics outside the expertise of the Cold Spring Harbor Labora-
tory faculty. These courses include morning or evening lectures as well as afternoon sessions 
during which students read assigned papers. These intensive courses are modeled on the Cold 
Spring Harbor Laboratory Lecture Courses held each summer at the Banbury Conference 
Center. In Spring 2013 there were two such courses: Microbial Pathogenesis and Physical 
Biology of the Cell.
Microbial Pathogenesis
Attended by the entering classes of 2009 and 2012
INSTRUCTORS Stanley Maloy, Center for Microbial Sciences, San Diego
 Ronald K. Taylor, Dartmouth Medical School
VISITING LECTURERS Nicholas Biais, CUNY Brooklyn College, New York
 Lisa Craig, Simon Fraser University
 Heran Darwin, New York University
 Nancy Freitag, University of Illinois, Chicago
Throughout recorded history, microbial pathogens have been a major cause of human disease 
and mortality. However, with the advent of effective antibiotics, it seemed like the war on mi-
crobes had been won. Hence, for several decades, health-related research shifted to topics such as 
cancer, heart disease, and genetic diseases. Although research in microbial pathogenesis slowed, 
the microbes demonstrated the effi cacy of evolution. Microbial resistance to antibiotics devel-
oped faster than new antibiotics could be made available, and the resistance spread throughout 
the microbial world. The global expansion of food distribution networks has increased the in-
cidence of common microbial pathogens. Simultaneously, emerging microbial pathogens fi lled 
new ecological niches, such as indwelling medical devices that provide a surface for biofi lms and 
the growing population of patients who are immunocompromised due to primary infections 
such as HIV or due to therapies for chronic diseases. Furthermore, recent discoveries have dem-
onstrated that some diseases (e.g., ulcers) previously believed to be caused by a genetic predis-
position or environmental conditions are actually caused by microbes. This microbial offensive 
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has summoned a renewed counterattack on microbial pathogens that has intensifi ed during the 
last several years. Meanwhile, a variety of new tools have become available that make it possible 
to dissect the molecular basis of pathogenesis from both the microbial and host perspectives. 
Recently, the complete DNA sequence of bacterial pathogens has provided valuable insights 
into how microbial pathogens evolve and the extent of gene transfer between pathogens. These 
advances have revealed new ways to control infection, including the identifi cation of novel tar-
gets for antimicrobials and novel approaches for vaccine development. Nevertheless, many more 
questions remain unanswered and many pathogens are still poorly understood.
Understanding bacterial pathogenesis demands a detailed knowledge of the host response as 
well as the pathogen itself. Both of these perspectives provide potential strategies for solving im-
portant clinical problems. To elucidate these distinct aspects of microbial pathogenesis requires 
an interdisciplinary approach, integrating the fi elds of microbiology, eukaryotic cell biology, im-
munology, and genomics.
This course focused on mechanisms of microbial pathogenesis and the host response, as well 
as the scientifi c approaches that are used to investigate these mechanisms. How do microbes 
adhere to host cells? How do environmental cues direct the response of microbial pathogens? 
How do microbial pathogens modulate host cells to expedite virulence? How do host cells 
respond to microbial pathogens? How does the host immune system react to microbial patho-
gens? What does genomics tells us about how microbial pathogens evolve? How do emerging 
pathogens take advantage of new ecological niches? Although there are numerous microbial 
pathogens, the answers to these questions indicate that many pathogens use similar approaches 
to solve common problems. The course integrated lectures by the instructors, directed readings 
of research papers, and seminars by the instructors plus three invited speakers who specialize in 
various aspects of bacterial pathogenesis. The course ran from Saturday, February 10, through 
Sunday, February 16.
Topics in Biology: Microbial Pathogenesis, 2013. (Left to right) Ronald Taylor, Lisa Craig, Nicolas Biais, Tyler 
Garvin, Silvia Fenoglio, Sho Goh, Nitin Chouhan, Ray Ho, Annabel Romero Hernandez, Will Donovan, Irene Liao, 
Paul Masset, Cinthya Zepeda Mendoza, Talitha Forcier, Charles Underwood, Ozlem Aksoy, Abram Santana, Kaja 
Wasik, Ian Peikon, Kristin Delevich, Stephane Castel, Sophie Thomain, Stanley Maloy
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Physical Biology of the Cell
Attended by the entering classes of 2010 and 2011
INSTRUCTOR Rob Phillips, California Institute of Technology
VISITING LECTURERS Joseph Blitzstein, Harvard University
 Eva-Maria S. Collins, University of California, San Diego
 Thomas Gregor, Princeton University
 Greg Huber, University of California, Santa Barbara
 Jané Kondev, Brandeis University
 Sanjoy Mahajan, Franklin W. Olin College of Engineering
TEACHING FELLOWS James Boedicker, California Institute of Technology
 Franz Weinert, California Institute of Technology
The aim of this course was to provide a hands-on experience in the use of quantitative models as a 
way to view biological problems. It began with “order of magnitude biology,” showing how simple 
estimates can be exploited in biology. Simple models of a variety of different biological problems 
were constructed, primarily using the tools of statistical mechanics. One of the key themes of the 
course was to show how physical biology unites and organizes topics in a fundamentally different 
way, often revealing that topics which are nearby in physical biology seem to be unrelated when 
viewed from the vantage point of molecular or cell biology. The instructors guided the students 
from start to fi nish on several modeling case studies. The course ran from Saturday, March 10, to 
Friday, March 16.
Topics in Biology: Physical Biology of the Cell 2013. (Left to right) Jané Kondev, Franz Weinert, Joe Blitzstein, 
Sanjoy Mahajan, James Boedicker, Joaquina Delas Vives, Robert Aboukhalil, Anja Hohmann, Fred Marbach, Kachi 
Odoemene, Justus Kebschull, Rob Phillips, Greg Huber, Colleen Carlston, John Sheppard, Brittany Cazakoff, Matt 
Koh, Arka Bandyopadhyay, Lisa Krug, Sophie Thomain, Jack Walleshauser
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Teaching Experience at the DNA Learning Center
DIRECTOR David A. Micklos
INSTRUCTORS Amanda McBrien (Lead)
 Jennifer Galasso
 Elna Gottlieb
 Erin McKechnie
 Bruce Nash
 Jermel Watkins
Science has an increasing role in society, and there is an increasing need for biologists to educate 
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral pro-
gram offers its students unique teaching experiences through the Laboratory’s DNA Learning 
Center, where students teach laboratory courses to high school and middle school students. From 
these teaching experiences, they learn how to communicate with nonbiologists and to inspire and 
educate creative young minds. The teaching module entailed pairs of students teaching one morn-
ing or afternoon a week for 12 weeks. In the initial weeks, the DNA Learning Center instructors 
taught the Watson School students the didactic process; it was not until the fi fth week that the 
graduate students taught on their own. At the end of the 12 weeks, the students were very excited 
about their teaching experiences.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research 
that leads to a unique contribution to human knowledge. After the fall course term, students par-
ticipate in laboratory rotations. These rotations provide students and faculty the opportunity to 
get to know each other and to explore possibilities for doctoral thesis research. At the end of each 
rotation, students make short presentations of their studies to the other students and their rotation 
advisors. These talks give students an opportunity to share their laboratory experiences and to 
learn how to give a scientifi c presentation. With this latter goal in mind, in addition to the research 
mentors, the instructors of the Scientifi c Exposition and Ethics core course and members of the 
School’s Executive Committee attend the talks and give individual feedback to students on their 
presentations. This year, 18 WSBS faculty members served as rotation mentors, some mentoring 
more than one student.
ROTATION MENTORS Florin Albeanu Christopher Hammell Robert Martienssen
 Mickey Atwal Molly Hammell Michael Schatz
 Anne Churchland Leemor Joshua-Tor Stephen Shea
 Josh Dubnau Adam Kepecs David Tuveson
 Mikala Egeblad Adrian R. Krainer Michael Wigler
 Hiro Furukawa Zachary Lippman Anthony Zador
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FALL CURRICULUM
In the Fall of 2013, the major curriculum change was the introduction of a Molecular and Cell 
Biology “boot camp” at the start of the semester. The goal of this 3-day course was to introduce 
the students to the techniques and terminology of molecular biology that they will encounter 
in their subsequent courses. The boot camp featured six lectures from faculty members: Hiro 
Furukawa, W. Richard McCombie, David Spector, Lloyd Trotman, Christopher Vakoc, and 
Linda Van Aelst.
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientiﬁ c
Reasoning and Logic
INSTRUCTORS Gregory Hannon (Lead) Leemor Joshua-Tor
 Linda Van Aelst (Co-lead) Bo Li
 Alexander Gann Nicholas Tonks
 Christopher Hammell 
GUEST LECTURERS Hiro Furukawa Senthil Muthuswamy
 Molly Hammell David Tuveson
 Justin Kinney Christopher Vakoc
 Robert Martienssen
VISITING LECTURER Songhai Shi, Memorial Sloan-Kettering Cancer Center
A fundamental aspect of earning the PhD is training in the pursuit of knowledge. In this core course, 
which forms the heart of the curriculum, students (1) acquire a broad base of knowledge about the 
biological sciences, (2) learn the scientifi c method, and (3) learn how to think critically. The begin-
ning of the course is divided into four to fi ve modules, each of which has a different general theme, 
and proceeds with the goal of considering an open, still unanswered, scientifi c question. For each 
module, students read an assigned set of research articles (generally, four articles), and at the end of 
the module, they provide written answers to a problem set that guides them through several of the 
articles.
Twice weekly, students attend lectures related to the module’s topic that include concepts and 
fundamental information as well as experimental methods. During each week, the students meet 
among themselves to discuss the assigned papers not covered by the problem set. Each week, stu-
dents spent an evening discussing the assigned articles with faculty. In a special module in the 
course, students participated in a mock study-section in which real National Institutes of Health 
R01 grants were reviewed and critiqued. This allows the students to evaluate the questions before 
the answers are known, evaluate routes toward discovery before knowing where they will end, and 
make critical judgments about how to proceed in the face of an uncertain outcome. The module 
topics for this course were as follows:
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Topic Instructor(s)
Mechanism and Structure of Gene Regulation Alex Gann 
Leemor Joshua-Tor
Gene Regulatory Logic and the Construction of Multicellular 
Organisms: Insights from Flies, Plants, and Worms
Christopher Hammell
Signal Transduction and the Search for Novel Therapeutics Nicholas Tonks
Study Section Gregory Hannon 
Linda Van Aelst
The Brain: Wiring, Plasticity, and Maladaptation Bo Li
The Darrell Core Course on Scientiﬁ c Exposition and Ethics
INSTRUCTORS David J. Stewart (Lead)
 Mikala Egeblad
 Arne Stenlund
GUEST LECTURERS Lisa Bianco
 Diane Esposito
 Peter Tarr
VISITING LECTURERS Olga Akselrod, The Innocence Project
 Keith Baggerly, University of Texas, M.D. Anderson Cancer Center
 Michael Beilski, The Center for Biotechnology
 Robert Charrow, Greenberg Traurig, LLC
 Yaniv Erlich, The Whitehead Institute
 Avner Hershlag, North Shore University Hospital
 Amy Harmon, The New York Times
 Boyana Konforti, Editor, Nature Structural & Molecular Biology
 Ivan Oransky, Retraction Watch
 Tung-Tien (Henry) Sun, New York University
The 2013 Scientifi c Exposition and Ethics (SEE) core course was led by David Stewart. He was 
joined by Arne Stenlund and a new addition to the course, Mikala Egeblad. As usual, the course 
hosted expert guest lecturers who covered topics including scientifi c presentations, the editorial 
review process, the ethical and legal responsibilities of scientists, DNA profi ling and postconvic-
tion appeals, and reproductive genetics.
This core course offered instruction in the fundamental elements of scientifi c exposition—
writing skills and public speaking—and ethics. The ability to communicate effectively and to 
appreciate the intricacies of ethical issues are essential skills for biologists; both subjects were 
taught in a series of example-based lectures and discussion groups. Writing skills included the fun-
damentals of modern scientifi c English and the organization and preparation of papers, research 
abstracts, and grant applications. Oral presentation skills were taught by instructors with different 
modes of presentation. Together with instructors, students critiqued formal seminar presentations 
at the Laboratory. Instruction and discussions about ethics included the ethical implications of 
biological discovery on society as well as the nature and boundaries of ethical behavior of scientists 
and their rights and responsibilities. A primary objective of the course was that students consider 
exposition and ethics integral aspects of scientifi c research.
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Research Topics
ORGANIZERS Kimberley Geer
 Alyson Kass-Eisler
This core course provided students with an in-depth introduction to the fi elds of research that the 
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, 
at which faculty members and CSHL fellows presented their current research topics and methods 
of investigation each Wednesday evening over dinner. The students learned how to approach im-
portant problems in biology. These seminars, together with the annual fall Laboratory In-House 
symposium, provided students with a basis for selecting laboratories in which to do rotations.
Specialized Disciplines Courses
The students in the Entering Class of 2013 took a total of three Specialized Disciplines courses 
this fall: Genetics and Genomics, Systems Neuroscience, and Quantitative Biology. They will take the 
Cellular Structure and Function course at the start of 2014.
Genetics and Genomics
INSTRUCTORS Thomas Gingeras (Lead)
 Zachary Lippman
GUEST LECTURERS Josh Dubnau
 Marja Timmermans
This course placed modern genetics and genomics into the context of classical genetics. History, 
technique, and perspective of genetic inference were described around four levels of analysis: forward 
genetics, natural genetic variants, gene interaction, and genomics. Emphasis was on integrating clas-
sical with modern questions of genetic analysis: How are genes mapped and “cloned”? How do gene 
mutations help to defi ne biological processes? How are more complex traits genetically dissected into 
simpler (underlying) components? What concepts and techniques are used to organize genes into 
pathways and networks? What defi nes a gene and what gene variation exists in natural populations? 
What are the functional consequences of gene variation, and how is it detected? How are genomes 
organized and coordinately regulated? How can genomic information be catalogued, organized, and 
mined? These questions and concepts were fl eshed out using examples from the literature.
Systems Neuroscience
INSTRUCTORS Adam Kepecs (Lead)
 Glenn Turner
GUEST INSTRUCTORS Anne Churchland
 Alexei Koulakov
 Stephen Shea
 Anthony Zador
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This course introduced students to neuroscience, with a focus on learning and plasticity from its 
cellular basis, through development, to systems and behavior. Both experimental and theoretical 
viewpoints were explored. The course started with the basics of electrical signaling in neurons: ion 
channels, action potentials, and synaptic transmission. The cellular basis of learning, including 
Hebb’s postulates, LTP (long-term synaptic potentiation), was discussed. The course explored the 
consequences of synaptic learning rules by examining how experience shapes the wiring of the ner-
vous system during development and investigated how such building blocks translate into whole-
organism behavior. The course then examined classical conditioning and asked how changes in 
synaptic transmission could underlie such behavior. Associative learning computational models of 
the learning process were discussed.
From behaviors that focus on simple memories, the course turned to behaviors that require 
making perceptual decisions. This was accomplished by covering some basic concepts of percep-
tual neuroscience, such as neuronal “receptive fi elds,” and using these to discuss current results 
and models of perceptual decision making. Finally, the course turned to the learning of behaviors 
through reward and punishment, what is known as reinforcement learning. The course concluded 
with a discussion of the role of dopamine in reward and learning, the theory of reinforcement 
learning, and pathologies of reward-seeking behavior.
Quantitative Biology
INSTRUCTORS Mickey Atwal (Lead)
 Michael Schatz
GUEST LECTURERS Ivan Iossifov
 Justin Kinney (CSHL Fellow)
 Alexander Krasnitz
With the advent of high-throughput technologies in biology, it has become necessary for biologi-
cal researchers to be able to analyze and interpret high-dimensional data and frame hypotheses 
mathematically. To this end, the aim of this course was to equip the students with a basic training 
in modern statistical methods. By the end of the course, the students were able not only to answer 
many of the simple statistical questions that arise in data analyses, but also to become familiar 
with the more complex techniques used by fellow computational biologists. Topics covered includ-
ed error fl uctuations, calculating the signifi cance of an experimental result, Bayesian inference, 
information theory, power calculations, dimensional reduction, and DNA sequence analyses. In 
addition, this course introduced mathematical modeling motivated by the classic examples in 
quantitative biology such as the Delbrück-Luria experiment, Hopfi eld’s kinetic proofreading, and 
Kimura’s neutral theory of population genetics. For the fi rst time, a 2-day Quantitative Biology 
boot camp, in which students were provided with the quantitative skills useful to their other 
coursework, was given at the very beginning of the fall semester.
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POSTDOCTORAL PROGRAM
PROGRAM DIRECTOR Nicholas Tonks
PROGRAM ADMINISTRATOR Alyson Kass-Eisler
Cold Spring Harbor Laboratory (CSHL) is proud of its rich tradition in postdoctoral education 
and has a deep commitment to the postdoctoral experience. CSHL has long been recognized as 
a place for nurturing young scientists, with postdoctoral researchers being an integral part of the 
discovery process. Current fi elds of research expertise include genetics; molecular, cellular, and 
structural biology; neuroscience; cancer; plant biology; genomics; and quantitative biology. The 
postdoctoral community at CSHL is diverse and international, arriving at the Laboratory with 
many different backgrounds and with needs that change during the course of the postdoctoral 
years. The Postdoctoral Program Offi ce works closely with the fellows and the Laboratory’s ad-
ministration to coordinate and organize educational and career development activities. Alyson 
Kass-Eisler, the Postdoctoral Program Offi cer, and Nicholas Tonks, the Scientifi c Director of 
the Postdoctoral Program, provide the day-to-day support for the postdoctoral program, which 
is overseen by the Dean of the Watson School of Biological Sciences (WSBS), Alexander Gann.
The Postdoctoral Liaison Committee (PDLC)—an elected group of postdocs who help share 
information and ideas between the administration and the postdoctoral community—continues to 
help enhance the postdoctoral experience at CSHL. The PDLC is the voice of the community and 
has regular meetings with CSHL President Bruce Stillman. In 2013, new member Saikat Nandi 
joined returning members Kate Creasey, Jonathan Ipsaro, Santiago Jaramillo, Dawid Nowak, and 
Benjamin Roche. The PDLC was been hard at work organizing two successful retreats this year 
aimed at fostering networking and collaboration. The day-long retreats took place at the Banbury 
Conference Center and included research talks, chalk talks, and discussions sessions. The PDLC 
also oversees and distributes funds to two career development groups as described below. These 
groups are primarily composed of postdoctoral fellows, but they also include graduate students. 
Today’s postdocs face a number of challenges, including a very diffi cult job market. CSHL works 
hard to give its postdocs the upper hand when it comes to competing for the scarce jobs that are 
available. More and more, it has become our responsibility to introduce a diversity of career oppor-
tunities that are available and to provide the tools to our postdocs to prepare for these positions. 
Thanks to the assistance from PDLC and these career development groups, a number of fantastic 
events were organized.
The Career Development Program (CDP) is interested in providing programming geared 
toward careers in academia. They continued the successful “Conversations with Faculty” series in 
which the postdocs were given career insights in an informal and interpersonal format. Sessions 
included First Year as a P.I., led by CSHL Assistant Professors Michael Schatz and Anne Church-
land, and Going on the Job Market: Applicant Perspective, led by two current postdocs Martine 
Mirrione, from Bo Li’s laboratory, and Santiago Jaramillo, from Tony Zador’s laboratory who 
were successful in their academic job search this year.
The CDP also hosted another extremely well-received workshop on preparing for the Chalk 
Talk, an integral part of the academic job search. In this session, Muhan Chen, a postdoctoral 
researcher in Lloyd Trotman’s laboratory, presented her future research plans in front of Adrian 
Krainer, Alea Mills, and Hongwu Zheng, who served as the mock hiring panel.
Together, we have also been working on building connections with local colleges and uni-
versities to provide teaching experience opportunities for interested postdocs. The fi rst of these 
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connections has been made with Molloy College. There are plans in place to expand this program 
in 2014. In addition, selected postdoctoral fellows participate in the Watson School as tutors ei-
ther one-on-one or in the classroom setting, thus providing the postdocs with good experience in 
teaching and mentoring.
Finally, the CDP also has a series called “Getting to Know Your Faculty” where CSHL faculty 
members share stories of their journey throughout their career and highlight the person behind 
the scientifi c concepts and publications. The guests this year were Leemor Joshua-Tor and Michael 
Wigler.
The Bioscience Enterprise Club (BEC) is most interested in providing information for non-
academic careers, and they have also been organizing a series of seminars and workshops. The 
areas of interest include biotechnology, intellectual property, law, regulatory affairs, and venture 
capitalism. This year’s guests included Jennifer Henry, Director of Life Sciences at the New York 
Academy of Sciences; Gustavo Stolovitzky, manager of the IBM System Biology Group; David 
Frendewey, Sr. Director from Regeneron Pharmaceuticals, Inc.; Jing Li, Senior Scientist, Merck 
& Co.; John H. Friedman, Founding and Managing Partner of Easton Capital Group; Daniel 
Nolan, Director of Research, Angiocrine; and Matthew Kaplan, Managing Director, Ladenbury 
Thalman & Co. Through BEC, CSHL postdocs have also been invited to networking events and 
lectures sponsored by Topspin Partners, Canrock Ventures, and Accelerate Long Island, three 
local organizations.
The postdoc and student leaders of BEC—Dawid Nowak, Assaf Vestin, and Robert 
Aboukhalil—successfully applied for funding from the American Society for Cell Biology to 
fund their inaugural “Beyond the Bench” symposium for alternative careers in academia. The 
Symposium consisted of talks, live Q&As, and panels about career opportunities for PhDs in-
terested in careers in biotechnology, entrepreneurship, publishing, science writing, and IP/law. 
The keynote speakers were Dr. Herb Boyer, cofounder of Genentech and 1996 recipient of the 
Lemelson-MIT Prize, and Dr. Colin Goddard, Chairman & CEO of Coferon and former CEO 
of OSI Pharmaceuticals.
As a core component of the laboratory’s National Cancer Institute–funded postdoctoral train-
ing grant, a course on the Fundamentals of Cancer was held at the Banbury Conference Center. 
The 3-day course was co-organized by Program Director and CSHL faculty member Alea Mills 
and Hannes Vogel from Stanford University. The course included lectures from CSHL faculty 
and a hands-on workshop for discussing case studies of actual cancer patients.
To celebrate National Postdoc Appreciation week, we held a faculty/postdoc volleyball game, 
barbeque, and events fair highlighting the career development initiatives. It was a great opportu-
nity for the community to get together not only for some fun (particularly when the postdocs won 
the match), but also to network and fi nd out about the ongoing programs we have been running.
Through the Laboratory’s Human Resources department, the postdocs have had access to free 
jobseeker webinars hosted by the Higher Education Research Consortium. The 2013 webinars 
included Succeeding at the Academic Job Search in the Sciences, Academic Careers in America’s 
Two-Year Colleges, How to Get Published, Publishing Ethics, Interviewing!, and Making Your 
Case: Writing Cover Letters for Nonacademic Jobs.
To make the most of their experience here, CSHL Director of Research David Spector has 
been hosting quarterly talks with recently arrived postdocs to provide them with an orientation 
highlighting the opportunities available to them at CSHL. It is also a nice opportunity to get to 
know the new postdocs and for them to meet one another.
Each year, during the Laboratory’s annual In-House Symposium, a prize is awarded by the 
Watson School for the best poster by a postdoctoral fellow and the best poster by a graduate stu-
dent. In addition to providing a forum for the postdoctoral fellows to show off their research, and 
potentially win a prize, the poster session gives the entire scientifi c community a chance to come 
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together and share ideas beyond the walls of their individual laboratories. It has been a great suc-
cess for both the presenters and the Laboratory community as a whole. This year, the postdoctoral 
prize was shared between Dannielle Engle from David Tuveson’s laboratory and Yichun Shuai 
from Yi Zhong’s laboratory.
Demystifying Science, which started in 2011, enlists postdoctoral fellows who bring their ex-
pertise and teaching interests to the educationally diverse staff of the Laboratory. In the 2013 ses-
sions, geared toward a general audience, postdocs have talked about the following: From CSHL 
to CVS: How Discoveries in the Lab May Turn into Drugs, by Jackie Novatt; Seeing Is Believing: 
Advancing Whole Brain Imaging, by Arun Narasimhan; Follow Your Nose: Social Memory For-
mation in Mice, by Dennis Eckmeier; Mind the Gap: Brain Cells under the Magnifying Glass, 
by Francesca Anselmi; The Social Brain: Autism and Brain Activity Maps, by Yongsoo Kim; and 
Understanding Cancer, One Cell at a Time, by Robert Aboukhalil.
Since 2003, all postdoctoral fellows and graduate students at the Laboratory have been enrolled 
in a special initiative of the New York Academy of Science (NYAS), the Science Alliance. The 
Science Alliance for graduate students and postdoctoral fellows is a consortium of universities, 
teaching hospitals, and independent research facilities in the New York City metro area that have 
formed a partnership with NYAS. The aim of the Alliance is to provide career and professional de-
velopment monitoring for postdoctoral fellows and graduate students in science and engineering, 
through a series of live events and a dedicated web portal. In addition, the Science Alliance gives 
graduate students and postdoctoral fellows the opportunity to network with their peers across in-
stitutions and with key leaders in academia and industry. This year, the Science Alliance meetings 
and workshops included Writing for Biomedical Publication; From Idea to IPO; The Nonaca-
demic Job Search: Target the Job, Tailor the Approach; Introduction to Scientifi c Teaching; Risky 
Business: A Pharmaceutical Industry Strategy Workshop; PepsiCo Journey through Science Day; 
From Scientist to CSO: A Leadership Prep Course for Scientists in Business, Academia, Govern-
ment, and Research Institutes; Powerful Teaching Statements for STEM Educators: An Interac-
tive Workshop for Scientists and Teachers; and Scientists Teaching Science. In addition, the bian-
nual symposium What Can You Be with a PhD? was held November 2–3 at New York University.
On November 14, the Offi ce of Sponsored Programs, the Development Department, and the 
Postdoc Program Offi ce held a very popular course on grant writing. The sessions included In-
troduction to Grants and External Funding; The Grant Application; The Grant Abstract/Pub-
lic Summary; Peer Review Panel Discussion; Effective Writing Skills; and Fellowships: Career 
 Development Awards and Resources for Postdocs.
Postdoctoral fellows at CSHL compete successfully for awards and fellowships. Of note this 
year, Emily Hodges, a postdoctoral fellow in Gregory Hannon’s laboratory, was a fi nalist for the 
prestigious Blavatnik Award from the NYAS. In addition, four postdocs—Sandra Ahrens from 
Bo Li’s lab, Guy Horev from Alea Mills’ lab, Yongsoo Kim from Pavel Osten’s lab, and Keerthi 
Krishnan from Josh Huang’s lab—received Young Investigator grants from the National Alliance 
for Research on Schizophrenia and Depression (NARSAD).
Finally, a most important measure of our postdoctoral program’s success is the ability of post-
doctoral fellows to secure positions at the end of their training. In 2013, the Laboratory’s depart-
ing postdoctoral fellows went on to positions at Bayer CropScience, City College of New York, 
Oncotest (Germany), Hunan University (China), inGenious Targeting Laboratory, Merck & Co., 
Quinnipiac University, Santaris Pharma (Denmark), University of California at Riverside, and 
the University of Oregon, just to name a few.
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UNDERGRADUATE RESEARCH PROGRAM
PROGRAM DIRECTORS Anne Churchland
 Michael Schatz
PROGRAM ADMINISTRATOR Kimberly Creteur
Established more than 50 years ago, the CSHL Undergraduate Research Program (URP) plays 
a major role in providing and setting the standard for meaningful hands-on undergraduate 
research training in biology. The 10-week program begins the fi rst week of June. During the 
fi rst week, the students are oriented to the campus, receiving a guided historical tour of campus 
and a tour of all facilities and resources available to them; this ensures a smooth transition into 
the Laboratory community and research. The URPs work, live, eat, and play among CSHL 
scientists, and they have a very busy academic and social calendar throughout the remaining 
9 weeks of the summer. The students receive training in Scientifi c Research, Science Communi-
cation, Career Preparation, and Bioinformatics and Computational Biology, all while interact-
ing socially with fellow program participants and members of the CSHL community at large 
in formal and informal activities. Some of these activities in 2013 were a pizza party with Dr. 
and Mrs. Watson, dinner with Dr. and Mrs. Stillman, BBQ and pool parties, volleyball games, 
designing the URP T-shirt, competing in the annual Scavenger Hunt, and the ever-famous 
URP vs. PI volleyball match.
The students’ scientifi c development is the most important component of the program; there-
fore, in the beginning of the summer, the URPs write an abstract and present a talk on their 
proposed research. The URP participants work alongside scientists and become increasingly inde-
pendent throughout the summer. Concluding the program in August, the URPs prepare a fi nal 
report and present their results in a 15-minute talk at the URP Symposium. As in previous years, 
the program directors and faculty mentors were highly impressed with the accomplishments of 
the URP students.
The 2013 URP participants on Blackford Lawn.
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The following 27 students, selected from 738 applicants, took part in the 2013 program:
Lauren Choate, Truman State University
Advisor: Marja Timmermans
Funding: Dorcus Cumming Scholar
Mapping and characterization of a leaf polarity mutant in 
maize: rld-5409.
Amy Danson, University of Cambridge
Advisor: David Tuveson
Funding: Genetics Society of the United Kingdom
Optimizing growth conditions of normal and diseased pancreatic 
organoids to study and identify pancreatic cancer biomarkers.
Abhishek Dev, Bard College
Advisor: Adam Kepecs
Funding: Thirtieth Anniversary URP Scholar
Effect of morphine on decision making.
Maria Eguiluz, Hope College
Advisor: Gregory Hannon
Funding: Student selected by HHMI-EXROP
Characterization of nuclear protein CG13741 in the germline 
piRNA pathway.
Michael Fishman, Swarthmore College
Advisor: Pavel Osten
Funding: Alfred L. Goldberg Fellowship
The role of the medial amygdala and ventromedial 
hypothalamus circuit in mouse social behavior.
Emily Flynn, Smith College
Advisor: Thomas Gingeras
Funding: National Science Foundation Scholar
Examining RNA annotation and quantifi cation by 
RAMPAGEL comparison with RNA-Seq and Pol II.
Gregory Fuller, Johns Hopkins University
Advisor: Z. Josh Huang
Funding: Burroughs Wellcome Fellowship
Chandelier cells and apoptosis.
Heather Fuller, University College London
Advisor: Josh Dubnau
Funding: Genetics Society of the United Kingdom
Gypsy virus and neurodegenerative disorders.
Michael Jacobs, Oberlin College
Advisor: Leemor Joshua-Tor
Funding: James D. Watson Fellow
CG3893 and the piRNA pathway.
Victoria Jones, North Carolina Central University
Advisor: Alea A. Mills
Funding: National Science Foundation Scholar
The role of plant homeodomains (PHDs) of chromodomain 
helicase DNA-binding protein 5 in neural stem cells.
David Kleinman, University of Toronto
Advisor: Lloyd Trotman
Funding: Robert H.P. Olney Fellow; Garfi eld Fellowship
STAT3 inhibition and prostate cancer.
Ricki Korff, Cornell University
Advisor: Mickey Atwal
Funding: National Science Foundation Scholar
Germline genes and cancer.
Prashant Kota, Rensselaer Polytechnic Institute
Advisor: Gholson Lyon
Funding: Howard Hughes Medical Institute Scholar
Investigation of protein—protein interactions in the amino-
terminal acetyltransferase complex.
Therese LaRue, Skidmore College
Advisor: David Jackson
Funding: Former URP Fund Scholar
Identifying direct targets of FEA4, a master regulator of 
meristem size in maize.
Yitong Li, Cornell University
Advisor: Hiro Furukawa
Funding: Libby Fellowship
New approach aided the study of human SPPL2b in 
oligomerization and protease activity.
Abigail Lin, Duke University
Advisor: W. Richard McCombie
Funding: National Science Foundation Scholar
Classifying epistasis in the DISC1 interactome.
Michael MacGillivray, University of Notre Dame
Advisor: Alexander Krasnitz
Funding: University of Notre Dame URP Scholar
Mathematical inference of tumor phylogeny.
Pascal Maguin, Hunter College, SUNY
Advisor: Mikala Egeblad
Funding: Hunter College Scholar
Exploration of LOXL2 expression in pancreatic cancer.
Uju Momah, Amherst College
Advisor: Bruce Stillman
Funding: National Science Foundation Scholar
Nucleosome disassembly ahead of the DNA replication fork: 
In vivo studies.
Marjorie Morales, Stony Brook University
Advisor: Leemor Joshua-Tor
Funding: Student selected by HHMI-EXROP
Argonautes and GW182 proteins in microRNA-mediated 
gene silencing.
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Holly Rees, University of Cambridge
Advisor: Adrian R. Krainer
Funding: James D. Watson Undergraduate Scholar
Investigating the effect of SRSF1 on nonsense-mediated 
mRNA decay (NMD).
Benjamin Schuman, State University of New York at 
Geneseo
Advisor: Stephen Shea
Funding: Von Stade Fellowship
Locus coeruleus activity in response to social stimuli.
Daniel Starer-Stor, Oberlin College
Advisor: Anthony Zador
Funding: William Townsend Porter Foundation Scholar
Generation of random barcodes for in vivo cell identifi cation.
Alexis Tchaconas, Columbia University
Advisor: Michael Wigler
Funding: National Science Foundation Scholar
Looking beyond the nucleus: Mitochondrial DNA 
transmission in autism spectrum disorder.
Akash Umakantha, Vanderbilt University
Advisor: Partha Mitra
Funding: William Shakespeare Fellowship
Addition of high-resolution Nissl histology to Waxholm 
space.
Gregory Vurture, New York University
Advisor: Michael Schatz
Funding: National Science Foundation Scholar
Mathematics of genome architecture.
Alissa Williams, Wofford College
Advisor: Gregory Hannon
Funding: National Science Foundation Scholar
Viral barcode tracking on clonal tumor formation.
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PARTNERS FOR THE FUTURE
PROGRAM DIRECTOR David Jackson
PROGRAM ADMINISTRATOR Michele Borriello
The Partners for the Future Program, established by Dr. James Watson in 1990, provides an op-
portunity for talented Long Island high school students to have hands-on experience in biomedical 
research at Cold Spring Harbor Laboratory. This highly competitive program is open to Long Island 
high school students in their junior year. Each high school science chairperson may nominate up 
to three students. The top candidates are interviewed by CSHL scientists. Students selected to the 
program are paired with a scientist mentor and spend a minimum of 10 hours per week, September 
through March of their senior year, conducting original research. At the conclusion, the students 
present their projects to an enthusiastic audience of the students, scientifi c mentors and colleagues, 
CSHL administrators, parents, and teachers. Although the students learn a great deal about modern 
biology and state-of-the-art research techniques, the main advantage of the program is that they are 
exposed to day-to-day life in a lab. Interacting with scientists and support staff, the students learn 
to defi ne and pursue a research goal while solving problems that may occur along the way. The 
2013–2014 Partners for the Future were chosen from among 54 nominations. They are listed below.
Partner High School Laboratory CSHL Mentor
Yohance Basdeo Valley Stream South High School Adrian R. Krainer Tomoki Nomakuchi
Nathaniel Hogg Friends Academy Adam Kepecs Hyun Jae Pi
Priyanka Kumar Syosset High School Mikala Egeblad Mario Shields
Rebecca Layne Oyster Bay High School Robert Martienssen Kate Creasey
Sarah Lee Mineola High School David Jackson Qingyu Wu
Ann Lin Farmingdale High School Robert Martienssen Rowan Herridge
Marissa Mathew Commack High School Doreen Ware Lifang Zhang
Paige Varney Hicksville Senior High School Alea Mills Alea Mills
Lindsey Stevens East Hampton High School David Tuveson Vincenzo Corbo
Katherine Vera Farmingdale High School David Jackson Huyen Bui
Dylan Wadler Harborfi elds High School Adrian R. Krainer Isabel Aznarez Da Silva
George Wang Syosset High School Leemor Joshua-Tor Ante Tocilj
Partners for the Future participants
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ACADEMIC AFFAIRS
The Cold Spring Harbor Laboratory Meetings & Courses Program attracts scientists from all over 
the world to communicate, learn, and critique the latest ideas and approaches in the biological 
sciences. The program consists of advanced laboratory and lecture courses, as well as large meet-
ings and biotechnology conferences that are held almost year ’round. The Meetings & Courses 
Program at the Laboratory attracted strong attendance with more than 7300 meeting participants 
and almost 1300 course participants (trainees, teaching, and support faculty). The Cold Spring 
Harbor Asia Program, including 17 conferences and one summer school, has to date attracted 
more than 3000 participants, bringing the anticipated year-end total for both the United States- 
and China-based programs to almost 11,600.
The Laboratory held 27 academic meetings this year, which brought together scientists from 
around the world to discuss their latest research. The 78th Symposium in this historic series ad-
dressed Immunity and Tolerance and attracted almost 400 participants, including notable im-
munologists James Allison, Frederick Alt, David Baltimore, Michel Nussenzweig, Anne O’Garra, 
William Paul, Hidde Ploegh, Fiona Powrie, Lalita Ramakrishnan, Stephen Smale, Tadatsugu 
Taniguchi, Craig Thompson, and Irving Weissman.
Cold Spring Harbor Laboratory meetings are unique in assembling a program with very few 
invited speakers. Instead, meeting organizers are encouraged to select talks from abstracts that 
are submitted on the basis of scientifi c merit, ensuring that the latest fi ndings will be presented 
and that young scientists will have the chance to describe their work. The introduction of several 
successful new meetings occurred in 2013 with Wiring the Brain, Metabolic Signaling, Disease: 
From Cell to Organism, and Behavior and Neurogenetics of Nonhuman Primates. The annual 
meetings on the Biology of Genomes and Retroviruses were again oversubscribed, and many oth-
ers attracted strong attendance despite the funding climate. Many of these meetings have become 
essential for those in the fi eld and are held on a biannual basis. Two special meetings on Genes 
and Diagnostics: A Myriad of Issues in Biotech IP and the History of Restriction Enzymes drew 
a rather different audience, respectively, of lawyers and historians. Partial support for individual 
meetings is provided by grants from the National Institutes of Health (NIH), the National Sci-
ence Foundation (NSF), and other foundations and companies. Core support for the meetings 
program is provided by the Laboratory’s Corporate Sponsor Program.
Symposium Wine and Cheese
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The Courses program covers a diverse array of topics in molecular biology, neurobiology, struc-
tural studies, and bioinformatics. The primary aim of the courses remains to teach advanced 
students cutting-edge science that can be immediately applied to their own research. Courses are 
always being evaluated and updated to include the latest concepts and approaches. Increasingly, 
many courses feature a strong computational component as biology grows ever more interdisci-
plinary, incorporating methodologies from computer science, physics, and mathematics. Instruc-
tors, lecturers, and assistants come from universities, medical schools, research institutes, and 
companies around the world to teach at Cold Spring Harbor.
A new 2-week laboratory course on Synthetic Biology was taught by young and dynamic fac-
ulty in the recently opened Hershey Laboratory. This emerging discipline takes inspiration from 
our ever-expanding ability to measure and manipulate biological systems, and the philosophical 
refl ections of Schrodinger and Feynman that physical laws can be used to describe and rationally 
engineer biology to accomplish useful goals.
Instructors, course assistants, and course lecturers come from universities, medical schools, 
research institutes, and companies around the world to teach at Cold Spring Harbor. Their excel-
lence and dedication make the course program work exceptionally well. We would especially like 
to thank Drs. Richard Burgess (with more than 20 years of teaching protein chemistry at CSHL), 
Naomi Altman, David DiGregorio, Stacey Harmer, Sue Jaspersen, Lee Kraus, Rusty Lansford, 
Robert Last, Julin Maloof, Kelsey Martin, Jennifer Raymond, and Michael Zody, who all retired 
after many years of service.
Grants from a variety of sources support the courses. The core support provided through the re-
cently renewed grant from the Howard Hughes Medical Institute remains critical to our course pro-
gram. The courses are further supported by multiple awards from the NIH and NSF, and additional 
support for individual courses is provided from various foundations and other sources. The courses 
also depend on equipment and reagents that are loaned or donated by a large number of companies, 
partnerships that are invaluable in ensuring that the courses offer training in the latest technologies.
Now in its fourth year of operation, the Cold Spring Harbor Asia (CSHA) program, under the 
direction of Dr. Maoyen Chi, is headquartered at the Suzhou Dushu Lake Conference Center, a 
purpose-built academic conference center on the outskirts of old Suzhou, within a high-technology 
suburb (SIP). CSHA’s scientifi c program includes large symposia and meetings, training workshops, 
and Banbury-style discussion meetings. It is a wholly owned subsidiary of CSHL and is not beholden 
to outside partners in terms of our scientifi c programming. In 2013, 17 scientifi c conferences and 
one summer school were held in Suzhou, predominantly attracting scientists from the Asia/Pacifi c 
region. Attendance by junior Asian scientists continues to be one of the challenges faced by the pro-
gram, but the 50% growth in attendance between the fi rst and fourth year of operations bodes well 
for the future. This program is described in more detail in a separate Annual Report.
Alumni Notes: The 2013 Nobel Prize in Physiology or Medicine was awarded to Randy Schek-
man, Jim Rothman (both alumni of the CSHL yeast course), and Tom Sudhof, a regular attendee at 
CSHL meetings and founding organizer of the Channels, Receptors, & Synapses meeting in 2004.
The Meetings & Courses Program staff comprises a lean team of talented professionals who 
handle the complexities of database design, programming, web and multimedia design, educa-
tional grants management, marketing and recruitment, conference and course administration, 
audiovisual services, and other activities.
Terri Grodzicker
Dean of Academic Affairs
David Stewart
Executive Director, 
Meetings & Courses Program/ 
President, Cold Spring Harbor Asia
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78TH COLD SPRING HARBOR LABORATORY 
SYMPOSIUM ON QUANTITATIVE BIOLOGY
Immunity and Tolerance
May 29–June 3 382 Participants
ARRANGED BY Michel Nussenzweig, HHMI/The Rockefeller University
 Anne O’Garra, MRC National Institute for Medical Research
 Stephen Smale, University of California School of Medicine
 David Stewart and Bruce Stillman, Cold Spring Harbor Laboratory
The Cold Spring Harbor Symposia on Quantitative 
 Biology bring together scientists from all over the world to 
present and evaluate new data and ideas in rapidly moving 
areas of biological research. Each year, a topic is chosen that 
appears to be at a stage where general and intensive scru-
tiny and review are needed. There are numerous criteria 
for selection of topics, including the rate of progress in a 
given fi eld, how recent research is highlighting connections 
between fundamental biological mechanisms, and the po-
tential applications of the new discoveries to human health 
and disease. Cold Spring Harbor Laboratory selected the 
theme of Immunity and Tolerance for the historic 78th 
Symposium in the series.
The immune system evolved to defend individuals against invading pathogens. However, be-
cause exaggerated responses to pathogens or commensals can result in damage to the host, mecha-
nisms of immune regulation have developed to inhibit pathology. These mechanisms also inhibit 
the immune response to self-antigens and so prevent autoimmune disease. Advanced molecular 
techniques to perturb gene function in experimental mouse models as well as the identifi cation of 
genetic mutations in human diseases have provided conclusive evidence toward the role of particu-
lar molecules and pathways in vivo, in the development and function of the immune system. The 
genomic era has contributed to signifi cant advances in our understanding of mechanisms underly-
ing human disease. During the past decades, immunology research has been revolutionized by the 
rapid identifi cation of molecules, pathways, and cells contributing to innate and adaptive immune 
responses. In addition, this has furthered our understanding of how failures in immunoregulation 
during immune responses to pathogens, commensals, or self can result in disease and inaugurated 
the era of biologics as therapeutic agents. Major advances have been made toward our understand-
ing of the regulatory mechanisms in place to prevent infl ammatory and autoimmune diseases. 
In turn, immunologists and clinicians are attempting to exploit this knowledge to harness these 
pathways in order to eradicate cancer.
The decision to focus the 2013 Symposium on immunity and tolerance refl ected the enormous 
research progress achieved in recent years. The plan was to provide a broad synthesis of the current 
state of the fi eld, setting the stage for future discoveries and application and to introduce research 
topics on mechanisms of human disease, extending beyond the more basic molecular research of 
past years. The Symposium spanned a broad range of areas of investigation including molecular 
mechanisms of B- and T-lymphocyte development in experimental models, at levels ranging from 
the single cell to the entire organism and from single genes to genomes. There was a good cover of 
D. Littman, A. O’Garra
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development and function of innate cells, including myeloid cells, NK cells, and a more recently 
defi ned innate lymphoid cell (ILC); ILC resembles T cells in producing effector molecules such 
as cytokines but lacks an antigen receptor and plays an early role like other innate cells in the 
immune response. In keeping with Cold Spring Harbor tradition, the program included talks on 
in-depth molecular mechanisms of transcriptional regulation of key immune pathways in innate 
and adaptive cells of the immune system. Emerging areas of research were also covered includ-
ing how metabolic pathways affect immune responses and conversely how immune cells may 
affect cell and tissue physiology outside the immune response, as well as how commensal bacteria 
can affect the immune response contributing to protection against pathogens or disease. Diverse 
immune mechanisms underlying the events leading to chronic infection or immune control in 
HIV and tuberculosis in addition to mechanisms underlying auto-
immune diseases were introduced, which have potential to lead to 
new clinical therapies.
In arranging the Symposium, immunologists interacted with 
Cold Spring Harbor organizers to introduce more on the mecha-
nisms of the immune response underlying human disease. Open-
ing night speakers included Anjana Rao, Jean-Laurent Casanova, 
Fiona Powrie, and James Allison. Of special excitement with respect 
to human disease was the progress that Jim Allison presented on 
“Immune Checkpoint Blockade in Cancer Therapy,” having ad-
vanced this area by combining fi ndings from experimental models 
and human disease to expedite treatments of cancer. Hidde Ploegh 
delivered a compelling Dorcas Cummings Lecture on “The Logic of 
Your Immune System” to Laboratory friends, neighbors, and Sym-
posium participants in advance of the annual dinner parties.
This Symposium was attended by almost 385 scientists from 
more than 20 countries, and the program included 67 invited pre-
sentations and 200 poster presentations. To disseminate the latest 
results and discussion of the Symposium to a wider audience, at-
tendees were able to share many of the Symposium talks with their 
colleagues who were unable to attend using the Leading Strand 
video archive. In addition, interviews by Laurie Dempsey, Karin 
G. Natoli, S. Smale J.D. Watson, M. Nussenzweig, W. Yokoyama
B. Stillman, J. Allison
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Dumstrel, John Inglis, Richard Sever, Liz Thompson, and Jan Witkowski with leading experts in 
the fi eld were arranged during the Symposium and distributed as free video from the Cold Spring 
Harbor Symposium interviews website.
Funds to support this meeting were obtained from the National Institute of Allergy and Infec-
tious Diseases, a branch of the National Institutes of Health, and Merck. Financial support from 
the corporate sponsors of our meetings program is essential for these Symposia to remain a success, 
and we are most grateful for their continued support.
PROGRAM
Introduction
B. Stillman, Cold Spring Harbor Laboratory
Development and Antigen Receptor Gene Assembly
Chairperson: S. Ghosh, Columbia University College of 
Physicians & Surgeons, New York
Gene Regulation
Chairperson: E. Rothenberg, California Institute of 
Technology, Pasadena
Microbial Immunity
Chairperson: P. Cresswell, HHMI/Yale University School of 
Medicine, New Haven, Connecticut
Anti-HIV Immunity and Vaccination
Chairperson: D. Mathis, Harvard Medical School, Boston, 
Massachusetts
NK Cells and Innate Lymphoid Cells
Chairperson: P. Marrack, HHMI/National Jewish Center, 
Denver, Colorado
Autoimmunity
Chairperson: K. Murphy, HHMI/Washington University, 
St. Louis, Missouri
Dorcas Cummings Lecture: The Logic of Your Immune 
System
H. Ploegh, Whitehead Institute for Biomedical Research, 
Massachusetts Institute of Technology, Cambridge
Development and Function of Myeloid Subsets
Chairperson: C. Vinuesa, Australian National University, 
Canberra
Short Talks from Submitted Abstracts
Chairperson: S. Pierce, NIAID/National Institutes of Health, 
Rockville, Maryland
Tolerance, Tregs, and Infl ammasome
Chairperson: R. Grosschedl, Max-Planck Institute of 
Immunobiology and Epigenetics, Freiburg, Germany
Tumor Immunology and Genome Stability
Chairperson: M. Davis, HHMI/Stanford University, 
California
T-Cell Differentiation and Function
Chairperson: P. Bjorkman, HHMI/California Institute of 
Technology, Pasadena
Summary
W. Paul, NIAID/National Institutes of Health, Rockville, 
Maryland
R. Medzhitov, Y. Belkaid L. Ramakrishnan H. von Boehmer, I. Weissman
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From Base Pair to Body Plan: 60th Anniversary of DNA
February 28–March 3 195 Participants
ARRANGED BY Alex Gann, Cold Spring Harbor Laboratory
 Rob Martienssen, Cold Spring Harbor Laboratory
February 28, 1953, was an important day for biology. It was not the day 
(2 months later) that the structure of DNA was published in the jour-
nal Nature, nor the day (more than 10 years later) that James D. Watson, 
 Francis Crick, and Maurice Wilkins won the Nobel Prize for perhaps the 
most important biological discovery of the 20th century. Rather, February 
28, 1953, was the day when Watson and Crick discovered the base pair, the 
key chemical structure that underlies the interpretation and transmission of 
genetic information. On that day in 1953, the pair famously announced in 
the Eagle (a Cambridge pub frequented by members of the University) that 
they had discovered the secret of life. In celebration of the 60th anniversary 
of this momentous occasion, the Laboratory hosted a 4-day symposium, 
organized by Alex Gann and Rob Martienssen, focused on the role that the 
base pair has had in our understanding of developmental biology and gene 
regulation. Attended by six Nobel laureates and 26 speakers from around 
the world, the symposium included sessions on gene regulation, genome 
surveillance, pluripotency, stem cells, pattern formation, and evolution, 
chaired by such luminaries as Tom Maniatis and Brigid Hogan. The open-
ing session (chaired by Bruce Stillman) included some fi ghting words from 
Mark Ptashne on genetic and epigenetic inheritance, as well as seminal talks 
on stem cells (from Nobel laureate Sir John Gurdon), and pattern forma-
tion (from Nobel laureate Christiane Nusslein Volhart). Blackford Bar was retrofi tted to resemble 
the Eagle pub, complete with a mock ceiling from the “RAF bar,” the original signed by United 
States and United Kingdom servicemen during WWII. The Cold Spring Harbor version is now 
signed by several meeting participants, including Michael Ashburner (Genetics, Cambridge). 
Other highlights included a session devoted to anecdotes surrounding that day in 1953, from 
Matthew Meselson and Nobel laureates Walter Gilbert, Sydney Brenner, and Jim Watson himself, 
prompted by his ironic remark in Nature “It has not escaped our notice that the specifi c pairing 
we have postulated immediately suggests a possible copying mechanism for the genetic material.” 
Meeting participants were summoned to dinner by an alpine horn, courtesy of Walter Schaffner, 
and the symposium was topped off with a gala banquet at Oheka Castle, presided over by Robert 
Tjian, president of the Howard Hughes Medical Institute and Cold Spring Harbor alumnus, as 
well as many current and former employees and friends of the laboratory.
Funding for this meeting was provided by Life Technologies.
M. Levine, M. Ashburner
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PROGRAM
Introduction
R. Tjian, HHMI/University of California, Berkeley
Gene Regulation
Chairperson: T. Maniatis, Columbia University Medical 
Center, New York
Renewal and Differentiation
Chairperson: C. Greider, Johns Hopkins University, Baltimore, 
Maryland
Special Talk
R. Tjian, HHMI/University of California, Berkeley
Specifi cation and Pattern Formation
Chairperson: W. Schaffner, University of Zurich, Switzerland
Genome Surveillance
Chairperson: R. Martienssen, HHMI/Cold Spring Harbor 
Laboratory
Panel Discussion
S. Brenner, Salk Institute for Biological Studies
W. Gilbert, Cambridge, Massachusetts
M. Meselson, Harvard University
J.D. Watson, Cold Spring Harbor Laboratory
Evolution and Adaptation
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
L. Caporale, J.D. Watson S. Brenner. J.L. Sikorav, Y. Wu T. Pederson, M. Meselson
B. Stillman, H. Ptashne J. Gurdon, R. Tjian
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Single-Cell Analyses
March 6–9 114 Participants
ARRANGED BY Nancy Allbritton, University of North Carolina
 James Eberwine, University of Pennsylvania Medical School
 Scott Fraser, California Institute of Technology
The goal of this third workshop was to bring together scientists who work with single cells using 
different experimental paradigms to discuss the progress that is being made. Nearly 112 scien-
tists convened with 31 talks and 22 posters. Many cell types were discussed, including  bacteria, 
C.  elegans, and mammalian cells. Discussions centered around techniques used to investigate 
 single-cell biology, including single-cell dissection and transcriptomics, single-cell genomic DNA 
sequencing, proteomics, and metabolomics, all at single-cell resolution. A common theme from 
many of the talks and posters was individual cell-to-cell variability in mRNA abundances, DNA 
sequence, and protein expression. Several presenters discussed particular progress in the single-cell 
analysis of human cells. An important component of the meeting was discussion of various imag-
ing modalities, including light sheet and SPIM. The importance of, and necessity for, microfabri-
cation and nanotechnology was highlighted in several talks. Finally, the multidisciplinary nature 
of single-cell analyses was demonstrated by the discussion of many novel single-cell-resolving 
biosensors that combined the expertise of molecular biologists, chemists, engineers, and biopho-
tonics experts. The need for quantitative analysis of biological properties/processes in live cells in 
their natural microenvironment was a consistent theme. The analysis of single-cell biology will 
undoubtedly lead to a better understanding of disease states, better production of biofuels, and 
insight into evolutionary mechanics that is unachievable using pooled cells.
This meeting was funded in part by Clontech Laboratories.
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PROGRAM
Keynote Speaker
M. Chalfi e, Columbia University
Single-Cell Transcriptomics/Genomics I
Chairperson: J. Eberwine, University of Pennsylvania 
Perelman School of Medicine, Philadelphia
Single-Cell Transcriptomics/Genomics II
Chairperson: M. McConnell, University of Virginia School of 
Medicine, Charlottesville
Single-Cell Proteomics
Chairperson: A. Vertes, George Washington University, 
Washington, DC
Microfl uidics Applied to Single Cells I
Chairperson: N. Allbritton, University of North Carolina, 
Chapel Hill
Microfl uidics Applied to Single Cells II
Chairperson: P. Dittrich, ETH Zurich, Switzerland
Imaging Advances in Analysis of Single-Cell Biology
Chairperson: S. Fraser, University of Southern California, 
Los Angeles
M. Chalﬁ e, S. Fraser
J Eberwine, J. Morrison
A. Vertes, N. Allbritton T. Masujima, B. Ray
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Genes and Diagnostics: A Myriad of Issues in Biotech IP
March 10–13 47 Participants
ARRANGED BY Salim Mamajiwalla, In(sci)te IP, Markham, Canada
 Rochelle K. Seide, RKS Consulting, Boca Raton, Florida
The year 1980 was transformative for biotechnology. By a narrow deci-
sion of fi ve to four, the United States Supreme Court, in Diamond versus 
Chakrabarty, found that Ananda Chakrabarty’s patent application cov-
ering oil-digesting bacteria constituted patentable subject matter under 
United States patent law and paved the way for the commercialization 
of biotechnology to the highly dynamic industry it is today. Other coun-
tries, such as Australia, Canada, and the United Kingdom, soon followed 
suit and found microorganisms patentable subject matter. No one could 
have foreseen then the breakneck speed at which biotechnology would 
advance and the accompanying patents that would be granted. The 
 Supreme Court’s statement in Chakrabarty that “anything under the sun 
made by man” is patentable subject matter gave the USPTO license to 
broaden the boundaries of patentable subject matter in the life sciences 
and grant patents with respect to a wide variety of biotechnological in-
novations. Entrepreneurial scientists and patent lawyers have, in turn, 
tested the limits of these boundaries. Although “anything under the sun 
made by man” may be patentable subject matter, recent cases challenging 
the patentability of genes and diagnostic methods clearly suggest that the 
patentability of biotechnological inventions related to this subject mat-
ter is not a settled point of law, not just in the United States, but also in 
other jurisdictions, most notably in Europe and Australia. In the United 
States, the Association for Molecular Pathology versus Myriad Genetics and 
Mayo versus Prometheus cases rekindled the debate on the patentability 
of biotechnological inventions, primarily genes and diagnostic methods. 
Similar challenges to biotechnology patents in Europe and Australia have 
also reignited the debate on the patentability of such inventions in these 
jurisdictions.
This special Cold Spring Harbor conference was organized to explore the legal, ethical, and 
social issues related to the patenting of biotechnological inventions and how, if at all, these issues 
might infl uence the patentability of such inventions, and ultimately the future of the biotechnol-
ogy industry as a commercial endeavor. The conference attracted prominent judges, patent law-
yers, CEOs, and ethicists from all over the world. Attendees debated the impact of recent judicial 
decisions and future direction the judiciary in the United States, Europe, and Australia might take 
and how this may impact the future of the industry. Sessions addressing a variety of issues at the 
meeting are listed below.
The conference was funded, in part, by the generous support of Bereskin & Parr LLP, Baker 
Botts LLP, Jones Day LLP, Biotechnology Industry Organization (BIO), and Genentech.
R. Seide
S. Mamajiwalla
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PROGRAM
Pre-Conference Workshops
IP 101: Aimed at scientists, entrepreneurs, venture 
capitalists, and investors
BIOTECH 101: Aimed at patent practitioners, venture 
capitalists, and investors
Introduction and Overview
S. Mamajiwalla, In(sci)te IP, Markham, Canada
R.K. Seide, RKS Consulting, Boca Raton, Florida
Keynote Speaker
T. Caulfi eld, Faculty of Law, University of Alberta, Edmonton, 
Canada
Patenting Genes and Diagnostics: The Judiciary’s View
Chairperson: R. Seide, RKS Consulting, Boca Raton, Florida
A Global Perspective on Patentable Subject Matter, Patent-
ability, Validity, and Enforceability
Chairperson: L. Coruzzi, Jones Day, New York
Patenting and Biotechnology at Cold Spring Harbor 
Laboratory
Chairperson: S. Mamajiwalla, In(sci)te IP, Markham, 
Canada
Are Gene and Diagnostic Patents a Hindrance or Help to 
Industry?
Chairperson: M. Wales, Human Genome Sciences, Rockville, 
Maryland
The Impact of Prometheus on Personalized Medicine
Chairperson: W. Woessner, Schwegman Lundberg Woessner 
LLP, Minneapolis, Minnesota
Patenting Genes and Diagnostics: Policy and Ethics
Where to Next?
Meeting Review and Summary
R. Seide, M. Malathi L. Parla, D. Kadiri
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Systems Biology: Networks
March 13–16 151 Participants
ARRANGED BY Patrick Aloy, Institute for Research in Biomedicine, Spain
 Suzanne Gaudet, Dana-Farber Cancer Institute
 Trey Ideker, University of California, San Diego
 Chad Myers, University of Minnesota
With a growing appreciation of the complexity of biological systems, 
the fi eld of network biology has come to the forefront of life sciences 
in the past decade. The science of biological networks spans both de-
scriptive work, with the systematic characterization of various inter-
action networks, and mechanistic investigations, probing the funda-
mental principles governing molecular and cellular behaviors in both 
health and disease. As in previous editions, this conference gathered 
together a growing community, with many repeat attendees and also 
newcomers, a group of leading minds in the world of cell networks 
and systems biology who presented the most promising recent ad-
vances and discussed how future developments will unfold.
This year, the program was organized into six main topics as 
listed below. The program opened on Tuesday with the fi rst of two 
keynote addresses from Eric Schadt. His presentation beautifully 
highlighted the power of not just systematic, but also comprehensive characterization of a pa-
tient’s biological status in the fi eld of individualized medicine. In the following days, the program 
continued with 17 invited presentations and 19 short talks selected from submitted abstracts, all 
of them of outstanding quality. The presentations covered many aspects of network and systems 
biology, from methodology development, to characterization of the topology of various types of 
networks, to interrogation of dynamic network behaviors after genetic interventions or sponta-
neous mutations. Some presentations highlighted how much better we are getting at predicting 
the behavior of certain biological systems, and others were eye opening specifi cally because they 
emphasized how much we still have to learn.
S. Gaudet
B. Raphael, C. Myers H. Pedersen, V. Gudmundsdottir
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More than 70 abstracts were accepted for poster presentations, and the posters were divided 
into two groups and displayed on Wednesday and Thursday evenings, in a very relaxed atmo-
sphere during wine and cheese mixers. These sessions were great opportunities for attendees with 
different skills and expertise to discuss network science and exchange ideas.
Late Saturday morning, we had the pleasure to hear the second keynote address from Arthur 
Lander. Dr. Lander gave what he dubbed a “Sticky Note Talk,” a truly thought-provoking pre-
sentation, challenging us to remember as we move forward to think not only about the “how” of 
biological systems, but also about the “why.” Only once we identify the objectives of biological 
systems—the “why”—will we be able to derive a deep mechanistic, and predictive, understanding 
of that system’s behavior.
This meeting was funded, in part, by the National Cancer Institute and the National Human 
Genome Research Institute, branches of the National Institutes of Health.
PROGRAM
Keynote Speaker
E. Schadt, Mount Sinai Medical Center, New York
Gene Regulatory Networks
Chairperson: B. Andrews, University of Toronto, Canada
Chemical–Genetics Networks
Chairperson: C. Myers, University of Minnesota, Minneapolis
Signaling Networks
Chairperson: S. Gaudet, Dana-Farber Cancer Institute, 
Harvard Medical School, Boston, Massachusetts
Protein–Protein Interaction Networks I
Chairperson: P. Aloy, Institute for Research in Biomedicine, 
Barcelona, Spain
Protein–Protein Interaction Networks II
Chairperson: P. Braun, Technical University of Munich, 
Germany
Metabolic and Synthetic Networks
Chairperson: M. Walhout, University of Massachusetts 
Medical School, Worcester
Networks and Disease
Chairperson: T. Ideker, University of California, San Diego
Keynote Speaker
A. Lander, University of California, Irvine
P. Braun, E. Klipp R. Edwards, N. Sahni
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Computational Cell Biology: The Interplay between 
Modeling and Experimentation
March 19–22 88 Participants
ARRANGED BY Galit Lahav, Harvard Medical School
 Wallace Marshall, University of California, San Francisco
 Ed Munro, University of Chicago
 Vito Quaranta, Vanderbilt University
This 2013 meeting marked the exit from the organizing committee of Leslie Loew and John 
Tyson, the original founding members. Thank you Les and John for your foresight in creating this 
compelling scientifi c forum! To follow in their tracks, the basic format of the meeting was main-
tained: The opening talk of a session was given by an established leader, who also functions as 
chairperson, and the remaining slots are fi lled with speakers chosen from the submitted abstracts. 
To select these oral presentations, organizers and session chairs entertained lively discussion in the 
preceding weeks, ensuring coverage of the latest, most exciting science. As expected of a meeting 
tracing the interplay of experiments and modeling, all presentations intertwined computational 
and experimental approaches. Poster sessions were also animated by vibrant discussions around 
the work presented.
Two keynote addresses were delivered, respectively, by Jennifer Lippincott-Schwartz, who de-
scribed advances in fl uorescent reporters and super-resolution microscopy ushering a new era in 
structural cell biology, and by Michael Elowitz, who eloquently spoke about lessons from synthetic 
gene circuits. Marileen Dogterom chaired a session on Cell Mechanics, presenting work to study 
organization of and force generation by the cytoskeleton in cell free systems. This year, a new 
emphasis on disease was introduced to the meeting: A cancer systems biology theme was covered 
in two sessions, respectively, chaired by Vito Quaranta (substituting for a suddenly indisposed 
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Michael Yaffe, MIT), who spoke about tumor cell heterogeneity captured by targeted drug-in-
duced proliferation rates, and Sylvia Plevritis, who described computational tools to characterize 
differentiation-based breast cancer heterogeneity. Covered cancer topics included p53 oscillations 
in single cells, and control of G1/S transition. Wendell Lim and Orion Weiner chaired the session 
on Synthetic Biology, with talks on maintenance of cell polarity, molecular dynamics within cells, 
and molecular circuitry regulating cell states. The session on Development, chaired by Angela 
DePace, covered fl y, zebrafi sh, and mouse model organisms, focusing on computational models 
for gene regulation. The Noise and Statistical Physics session, cochaired by Guron Suel and Rob 
Phillips, reported on molecular and mathematical approaches to study stochastic processes in cells. 
Organizing Principles of Biological Systems was chaired by James Ferrell, who described feedback 
circuits controlling the cell cycle. Noise control in cells, as well as principles of microbial colony 
organization, was also discussed in this session. Imaging and Computer Vision was chaired by 
Richard Murphy, speaking on useful “features” for segmenting and classifying cell images in au-
tomated fashion. The session included description of computational methods to classify iPS and 
heterogeneity of growing cell size. A session on Signal Processing was opened by its chair, Boris 
Kolodenko, with a comprehensive recap of the underlying features of the EGFR network. Homeo-
static controlling motifs and models for bacterial sporulation were covered as well in this session.
A steady feature of this meeting has become the improvisational theater to build a social con-
text for conversations among scientists, cleverly led by the gifted Raquel Holmes. After some 
understandable hesitation, all scientists participated fervently, and a splendid time was had by all.
The meeting was supported by a grant from the National Science Foundation as well as ad-
ditional contributions from various companies. The meeting will observe its biennial schedule 
(March/April 2015). NSF representative Gregory W. Warr enthusiastically participated at the 
meeting and confi rmed that it is among the NSF’s priorities for continued support.
PROGRAM
Keynote Speaker
J. Lippincott-Schwartz, National Institutes of Health
Cell Mechanics: Shape, Motility, and Cytoskeleton
Chairperson: M. Dogterom, FOM Institute AMOLF, 
Amsterdam, The Netherlands
Cancer Systems Biology I
Chairperson: M. Yaffe, MIT, Broad Institute, Cambridge, 
Massachusetts
J. Lippincott-Schwartz, G. Lahav, J. Liu E. Munro, G. Gaglia
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Synthetic Biology
Chairpersons: W. Lim and O. Weiner, University of 
California, San Francisco
ImprovScience Session
Chairperson: R. Holmes, University of Connecticut Health 
Center, Farmington
Keynote Speaker
M. Elowitz, California Institute of Technology, Pasadena
Development
Chairperson: A. DePace, Harvard Medical School, Boston, 
Massachusetts
Noise and Statistical Physics in Cells
Chairpersons: G. Suel, University of California, San Diego;
R. Phillips, California Institute of Technology, Pasadena
Organizing Principles of Biological Systems
Chairperson: J. Ferrell, Stanford University, California
Imaging and Computer Vision of Cells
Chairperson: R. Murphy, Carnegie Mellon University, 
Pittsburgh, Pennsylvania
Signal Processing, Circuit Design, and Decision Making
Chairperson: B. Kholodenko, Systems Biology Institute, 
Dublin, Ireland
Cancer Systems Biology II
Chairperson: S. Plevritis, Stanford University School of 
Medicine, California
C. Carmona-Fontaine, O. Marchenko, W. Marshall E. Stukalin, C. Lopez
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RNA and Oligonucleotide Therapeutics
April 10–13 120 Participants
ARRANGED BY Ryszard Kole, Sarepta Therapeutics
 Adrian Krainer, Cold Spring Harbor Laboratory
 Arthur Krieg, RaNA Therapeutics
 Bruce Sullenger, Duke University
This inaugural Cold Spring Harbor conference was focused on clinical 
trials and development of oligonucleotides as drugs, but it brought to-
gether top scientists from academia and industry interested in a variety 
of RNA-based therapeutics, not only oligonucleotides. The theme “from 
the bench to the bedside” made it unique among CSHL meeting series. 
Covered approaches ranged from antisense oligonucleotides and aptamers 
through modulation of splicing, targeting expanded triplet repeats and 
immunostimulation to small interfering RNAs and microRNAs as poten-
tial drugs and targets. The all-important issue of RNA therapeutics de-
livery by a variety of methods was also covered. The applications of these 
varied technologies included rare diseases, cancer, cardiovascular diseases, 
and bacterial and viral infections.
The participants came from 11 companies and from universities and re-
search institutions from the United States and abroad. The seven scientifi c 
sessions featured 37 platform talks and 20 posters and included 90 registered attendees. Animated 
and insightful exchanges during the sessions continued throughout. A number of participants 
expressed interest in attending this conference next year.
The meeting opened with a keynote address by Nobel laureate Dr. Sydney Altman. The sessions 
addressed modulation of RNA splicing, antisense oligonucleotides, posttranscriptional  control of 
gene expression, siRNA, miRNA, and aptamers as therapeutics, delivery of RNA therapeutics, 
and immunomodulating oligonucleotides.
The topic of the meeting attracted funding from several companies; the main sponsor: AVI Bio-
pharma. This meeting was funded, in part, by the National Institute of Neurological Disorders and 
Stroke, a branch of the National Institutes of Health; Isis Pharmaceuticals; and Sarepta Therapeutics.
R. Kole
A. Krainer, S. Dowdy T. Haraguchi, A. Krieg
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PROGRAM
Keynote Speakers
J. Lee, Massachusetts General Hospital, Boston;
V.J. Dzau, Duke University, Durham, North Carolina
Aptamers
Chairperson: L. Gold, SomaLogic, Inc., Boulder, Colorado
Clinical Development of ASOs and SSOs
Chairperson: G. Campion, Prosensa, Leiden, The Netherlands
Therapeutic Modulation of RNA Processing
Chairperson: R. Kole, Sarepta Therapeutics, Bothell, 
Washington
Immunomodulatory Oligos/RNAs
Chairperson: E. Gilboa, University of Miami, Florida
Noncoding RNAs
Chairperson: A. Krieg, RaNA Therapeutics, Cambridge, 
Massachusetts
Delivery
Chairperson: L. Sepp-Lorenzino, Merck, West Point, 
Pennsylvania
A. Aartsma-Rus M. Huang, A. Fiorillo E. Phimister
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Synapses: From Molecules to Circuits and Behavior
April 17–20 159 Participants
ARRANGED BY Hollis Cline, The Scripps Research Institute
 Michale Fee, Massachusetts Institute of Technology
The brain consists of a vast network of specialized cells, neurons, and glia, which communicate 
with each other through specialized contacts, called synapses. The nervous system processes and 
stores information encoded as patterns of electrical activity. As master regulators of neuronal excit-
ability and synaptic communication, ion channels and receptors lie at the heart of neurobiology. 
All aspects of nervous system function, including perception, cognition, and action, depend on 
accurate information processing by synapses, neurons, and networks. In recent years, the mo-
lecular and cell biological analysis of neuronal ion channels and receptors has revolutionized our 
understanding of the basic mechanisms that control electrical signaling and synaptic function 
in the nervous system. The convergence of advances in biochemistry, molecular genetics, micro-
scopic imaging, and electrophysiology has made the study of neuronal and circuit plasticity one of 
the most rapidly growing in neuroscience. In contrast to previous years, scientists seeking under-
standing of mechanisms of circuit and behavioral plasticity in healthy or neuropathophysiological 
conditions are expanding their range of vision past the previous focus of synaptic pathologies to 
examine network modifi cations arising from epigenetic and synergistic effects on multiple nodal 
points within brain machinery. This year’s meeting saw a more diverse representation of experi-
mental animals in use to investigate brain plasticity, which represents increased appreciation of the 
lessons that evolution can contribute to neuroscience.
This fi fth very successful meeting brought together nearly 200 participants from the United 
States, Europe, and Asia in an atmosphere of social and scientifi c exchange. A wide range of topics 
(listed below) were discussed, with an emphasis on the biophysics and cell biology of synapses and 
neurons, the integration of neurons and circuits, as well as pathophysiological aspects of nervous 
system functions. More than 50 attendees were selected to give oral presentations of their work. 
The two poster sessions were sites of active discussion of data and concepts. The meeting was 
opened by an outstanding plenary lecture given by Dr. Richard Tsien.
K. Haas, E. Ruthazer, H. Cline A. Banerjee
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The overall response to the meeting was extremely positive, continuing to cement the reputa-
tion of this Cold Spring Harbor conference in the fi eld. Attendees enjoyed the breadth of subjects 
covered and the chance to interact with investigators in related but distinct fi elds. The unusual 
opportunity for junior investigators (including postdocs and students) to present their own work 
was welcomed.
The meeting was supported with funds from the National Institute on Drug Abuse and the 
National Institute of Mental Health, branches of the National Institutes of Health.
PROGRAM
Keynote Speaker
R. Tsien, Stanford University, California
Ion Channels, Receptors, and Transporters
Chairpersons: P. Garrity, Brandeis University, Waltham, 
Massachusetts;
L. Looger, Howard Hughes Medical Institute, Ashburn, 
Virginia
Synapse Formation
Chairpersons: S.-H. Shi, Memorial Sloan-Kettering Cancer 
Center, New York;
Y. Dan, University of California, Berkeley
Synaptic Plasticity
Chairpersons: R. Yasuda, Max-Planck Florida Institute for 
Neuroscience, Jupiter;
A. Barth, Carnegie Mellon University, Pittsburgh, 
Pennsylvania
R. Tsien, G. Popescu T. Venkatesh, P. Garrity
F. Albeanu, K. Podgorski D. Beacham, S. Herlitze
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Circuit Development
Chairpersons: C. Aizenman, Brown University, Providence, 
Rhode Island;
T. Mrsic-Flogel, University College London, United 
Kingdom
Neuronal and Circuit Plasticity
Chairpersons: J. Wang, University of California, 
San Diego;
S. Herlitze, University of Bochum, Germany
Circuit and Behavior Plasticity
Chairpersons: F. Engert, Harvard University, Cambridge, 
Massachusetts;
L. Stowers, Scripps Research Institute, La Jolla, California
Behavioral Plasticity
Chairpersons: G. Feng, Massachusetts Institute of Technology, 
Cambridge;
C. Murphy, Princeton University, New Jersey
Diseases of Synapses and Circuits
Chairpersons: A. Muotri, University of California, San Diego;
H. Song, Johns Hopkins University, Baltimore, Maryland
l. Miracourt, E. Pastrana T. Kennedy, C. Cho
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Cancer Biology and Therapeutics
April 23–27 244 Participants
ARRANGED BY Senthil Muthuswamy, Ontario Cancer Institute
 Kornelia Polyak, Dana-Farber Cancer Institute
 David Tuveson, Cambridge Research Institute
Cancer is now recognized as an abnormal organ where 
multiple signals and cell types cooperate during cancer 
initiation and metastatic progression. Signifi cant progress 
is being made on identifying and characterizing different 
cell types, understanding the mechanisms by which these 
cell types interact with each other, developing ways to 
image the changes in a tumor, and exploring therapeutic 
opportunities that take into account the noncancer cells. 
Thus, there is an emergence of a need for an integrative 
approach for controlling cancer. This meeting brought 
together molecular and computational biologists who are 
decoding the cancer genome and epigenome; biochemists 
studying cell metabolism; physicists developing ways to 
image cells and tumors; immunologists developing ways 
to harness the immune system; cell biologists identifying new ways to stop the growth and spread 
of tumor cells; mouse modelers developing models to study human cancers; and medical oncolo-
gists using all of this information to best treat patients. Including the keynote speaker Bill Kaelin, 
several prominent cancer researchers who are pioneers and thought leaders in their fi elds presented 
and participated in the meeting. In addition, we held a lively panel discussion titled “Will the 
ineffectiveness of oncology trials be rescued by personalized medicine?” In this provocative ses-
sion chaired by clinicians and scientists, we attempted to identify the real barriers to implement-
ing superior cancer care, including scientifi c, fi scal, and logistical limitations. The meeting, as a 
whole, was received very well, and the participants enjoyed both the diversity and the depth of 
topics covered.
J. Allison, S. Muthuswamy
R. Jain, S. Mohla, D. Tuveson A. Giannakou, N. Rosen
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This meeting was funded, in part, by the National Cancer Institute, a branch of the National 
Institutes of Health; and Astellas Pharma.
PROGRAM
Keynote Speaker
W.G. Kaelin, HHMI/Dana-Farber Cancer Institute, Boston, 
Massachusetts; Brigham & Women’s Hospital, Boston, 
Massachusetts.
Tumor Heterogeneity I: Genetic
Chairpersons: E. Mardis, Washington University School of 
Medicine, St. Louis;
M. Wigler, Cold Spring Harbor Laboratory
Diagnostic Imaging and Drug Delivery
Chairpersons: R. Jain, Massachusetts General Hospital, Boston;
K. Brindle, University of Cambridge, United Kingdom
Immunotherapy
Chairpersons: J. Allison, University of Texas MD Anderson 
Cancer Center, Houston;
B. Vonderheide, Abramson Family Cancer Research Institute, 
Philadelphia, Pennsylvania
Translational Trial/Personalized Cancer Therapy
Chairpersons: L. Siu, Princess Margaret Hospital, Toronto, 
Canada;
L. Norton, Memorial Sloan-Kettering Cancer Center 
New York
Panel Discussion
Will the Ineffectiveness of Oncology Trials Be Rescued 
by “Personalized Medicine”? Does This Mean Better 
Integration with Preclinical Studies, Better Trial 
Designs, Better Training for Caregivers, and Safer 
Drugs?
Tumor Heterogeneity II: Epigenetic
Chairperson: M. Brown, Dana-Farber Cancer Institute, 
Boston, Massachusetts
Tumor Cell Plasticity and Microenvironment
Chairpersons: B. Stanger, University of Pennsylvania, 
Philadelphia;
V. Weaver, University of California, San Francisco
Metabolism
Chairperson: J. Brugge, Harvard Medical School, Boston, 
Massachusetts
Signaling Networks and Therapeutics
Chairpersons: N. Rosen, Memorial Sloan-Kettering Cancer 
Center, New York;
L. Cantley, Weill Cornell Medical College/New York 
Presbyterian Hospital, New York
S.-C. Bae, Y. Ito R. Parmigiani, C. Attwooll
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Telomeres and Telomerase
April 30–May 4 331 Participants
ARRANGED BY Titia de Lange, The Rockefeller University
 Roger Reddel, Children’s Medical Research Institute
 Virginia Zakian, Princeton University
The conference consisted of eight talk sessions and two poster sessions. As in 1999, 2001, 2003, 
2005, 2007, and 2009, the format was to invite two chairs per session, who were a mix of estab-
lished scientists in the fi eld and younger scientists who had already made their mark by publishing 
as independent investigators. Session chairs were given the choice between giving a 12-min pre-
sentation themselves or having a member of their lab give a talk. The rest of the presentations (also 
12 min) were chosen from submitted abstracts, allowing as many presentations as possible. These 
presentations were primarily by graduate students and postdoctoral fellows. Attendance exceeded 
300 participants, a high fraction of whom presented the 161 posters and 82 talks.
The talks and posters covered many aspects of telomere and telomerase biology, including 
telomerase structure, enzymology, and regulation; telomere length regulation; protection and pro-
cessing of chromosome ends, the consequences of telomere dysfunction, diseases associated with 
short telomeres; telomerase-independent telomere maintenance; telomeric RNA; and effects of 
telomere dysfunction on mitochondria.
The scientifi c content was very high throughout the conference in both the talks and the post-
ers. Most of the presented data were unpublished and extensively discussed in an open fashion. 
Formal and informal discussions were lively and informative. The conference was judged to be 
highly successful based on verbal and email communications to the organizers. There is strong 
enthusiasm for another meeting on the same topic in 2015.
This meeting was funded, in part, by the National Institute on Aging, a branch of the National 
Institutes of Health.
D. Frescas, A Sfeir, N. Bosco, I. Schmutz, S. Kabir, Y. Doksani
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PROGRAM
Yeast Telomere Function/CST Structure and Function
Chairpersons: J. Cooper, Cancer Research, London, United 
Kingdom;
T. Nakamura, University of Chicago, Illinois
ALT and Telomerase Structure/Biochemistry
Chairpersons: R. Wellinger, Université de Sherbrooke, Canada;
T. Cech, HHMI/University of Colorado, Boulder
Telomerase Structure and Biochemistry
Chairpersons: K. Collins, University of California, Berkeley;
M. Blasco, CNIO, Madrid, Spain
Telomerase Recruitment and Regulation
Chairpersons: C. Price, University of Cincinnati, Ohio;
C. Greider, Johns Hopkins University, Baltimore, Maryland
Consequences of Telomere Dysfunction
Chairpersons: L. Harrington, Institut de Recherche en 
Immunologie et Cancérologie, Montréal, Canada; M. Godinho 
Ferreira, Instituto Gulbenkian de Ciência, Oeiras, Portugal
Terra and Mammalian Telomere Function I
Chairpersons: W. Wright, University of Texas Southwestern 
Medical Center, Dallas;
C. Azzalin, ETH, Zurich, Switzerland
Mammalian Telomere Function II
Chairpersons: D. Shippen, Texas A&M University, 
College Station;
J. Karlseder, The Salk Institute, La Jolla, California
Telomeres and Disease
Chairpersons: S. Savage, National Cancer Institute, Rockville, 
Maryland;
E. Gilson, University of Nice, France
C. Nelson, S. Bailey
C. Wagner, S. Stanley D. Shore, B. Luke J. Alder, A. Garbuzo
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The Biology of Genomes
May 7–11 558 Participants
ARRANGED BY Ewan Birney, EBI/EMBL
 Carlos Bustamante, Stanford University
 Joel Hirschhorn, The Broad Institute of Harvard/MIT
 Elaine Mardis, Washington University School of Medicine
This meeting marked the 26th annual gathering of genome scientists at Cold Spring Harbor 
Laboratory. A total of 558 investigators from around the world attended the meeting, with more 
than 385 abstracts presented describing a broad array of topics relating to the production, analy-
sis, and interpretation of genomes from diverse organisms. The meeting built upon the remark-
able progress in the sequencing, functional annotation, and analysis of genomes from many 
human individuals, “model organisms,” other animals including new genomic studies of deer 
mice,  Drosophila, and the very challenging large conifer genomes. There were talks from the 
1000 Genomes Project and other genome projects. Many investigators reported on their ap-
plication of the most recent generation of DNA sequencing technologies to determine sequence 
variants within populations that convey differences in molecular function and organismal phe-
notype, and in susceptibility to disease, including cancer and complex disease. The new data are 
also providing important insights into functional genomic elements and population structure for 
humans, as well as other species. Many groups are generating transcriptome, transcription-fac-
tor-binding site and epigenomic maps to understand transcriptional complexity and regulation. 
There were interesting talks on the history of humans, both more recent history (e.g., in Africa) 
and early human history (e.g., population inference of early hominid populations).
All sessions (listed below) were well attended, stretching the capacity of the CSHL facilities. 
Andrew Fire and Eric Lander gave the keynote presentations.
The ELSI (Ethical, Legal, and Social Implications) panel was moderated by Hank Greely; 
the area of discussion was “Ethical Issues in Noninvasive Prenatal Testing (NIPT) and Other 
 Advances in Prenatal Testing Technology.”
This meeting was funded, in part, by the National Human Genome Research Institute, a 
branch of the National Institutes of Health; Complete Genomics, Fluidigm, Illumina, Ingenuity 
Systems, and Sunrise Scientifi c.
M. Kellis, E. Lander F. Yu, K. Vaydylevich M. Cullen, D. Kural
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PROGRAM
High-Throughput Genomics and Genetics
Chairpersons: M. Blaxter, University of Edinburgh, 
United Kingdom;
M. Snyder, Stanford University, California
Genetics of Complex Traits
Chairpersons: M. Daly, Massachusetts General Hospital/Broad 
Institute, Boston;
C. Willer, University of Michigan, Ann Arbor
ENCODE Tutorial
Chairpersons: M. Snyder, Stanford University, California;
M. Pazin, NHGRI; J. Stamatoyannopoulos, University of 
Washington
Functional and Cancer Genomics
Chairpersons: L. Pennaccio, Lawrence Berkeley National 
Laboratory, California; B. Wold, California Institute of 
Technology, Pasadena
Computational Genomics
Chairpersons: J. Korbel, European Molecular Biology 
Laboratory, Heidelberg, Germany;
Y. Song, University of California, Berkeley
ELSI Panel and Discussion: Ethical Issues in Noninvasive 
Prenatal Testing (NIPT) and Other Advances in Prenatal 
Testing Technology
Moderator: H. Greely, Stanford University Panelists:
R. Wapner, Columbia University Medical Center;
B. Berkman, National Human Genome Research Institute;
M. Cho, Stanford University;
S. Chandrasekharan, Duke University
Evolutionary Genomics
Chairpersons: D. Kingsley, Stanford University, 
California;
H. Hoekstra, Harvard University, Cambridge, 
Massachusetts
Genetics and Genomics of Nonhuman Species
Chairpersons: M. Przeworski, University of Chicago, 
Illinois;
M. Nordborg, Gregor Mendel Institute of Molecular Plant 
Biology, Vienna, Austria
Keynote Speakers
Chairpersons: A. Fire, Stanford University School of Medicine; 
E. Lander, The Broad Institute of MIT and Harvard
Population Genomic Variation
Chairpersons: A. Siepel, Cornell University, Ithaca, 
New York;
J. Kidd, University of Michigan Medical School, Ann Arbor
M. Blaxter, K. Worley
N. Yutin, T. Hubbard
M. Nordborg, D. Schwartz
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The Ubiquitin Family
May 14–18 247 Participants
ARRANGED BY Ronald Hay, University of Dundee
 Ron Kopito, Stanford University
 Brenda Schulman, St. Jude Children’s Research Hospital
This fi fth meeting following the successful inauguration 
of this series in 2003 focused on ubiquitin and a group of 
structurally related “ubiquitin-like” proteins and their roles 
in regulation of various cellular processes. Major questions 
in the fi eld include how specifi city in ubiquitin and ubiq-
uitin-like protein conjugation reactions is maintained, the 
molecular mechanisms by which specifi c ubiquitin chain 
linkages are recognized and regulate distinctive pathways, 
roles of the ubiquitin system in physiology and disease, 
and opportunities and mechanisms for therapeutically 
targeting the ubiquitin system. These questions are being 
elegantly addressed using structural biology, sophisticated 
kinetic studies, systematic library screening, and quantita-
tive proteomics technologies by an increasing number of 
investigators in the fi eld. In addition, important advances continue to be made in understanding 
how ubiquitin and its family members contribute to the operation of diverse cellular pathways, 
and how these functions are perturbed in diseases ranging from viral infections to cancers. Ex-
citing progress is also being made in the development of small-molecule inhibitors of a range of 
enzymes involved in ubiquitin and ubiquitin-like protein pathways.
The meeting this year attracted 247 scientists who engaged in lively discussions concerning the 
roles of ubiquitin in protein turnover, the structure and mechanism of a large multisubunit prote-
ase called the proteasome, which catalyzes the degradation of ubiquitinated proteins, highlighted 
by recent cryo-EM structures of the 26S proteasome in action. There have been tremendous ad-
vances in understanding the involvement of ubiquitin quality control mechanisms used by cells 
to eliminate otherwise toxic misfolded proteins, in terms of characterizing disease-related ubiqui-
tination machineries such as the Parkin E3 ligase, and a wide range of distinctive quality control 
pathways converging on ubiquitin. There is also a growing understanding of nonproteolytic roles 
of ubiquitin and ubiquitin-like proteins. A wide array of experimental systems, including fungi, 
plants, and mammals. were used to probe functions of ubiquitin and ubiquitin-like proteins in 
diverse physiological processes ranging from control of stem cell division to DNA repair and path-
ways associated with diseases such as neurological disorders and cancers. Other highlights of the 
meeting this year concerned progress on use of mass spectrometry both to defi ne the ubiquitin 
and SUMO-modifi ed proteomes and to understand how these vary in cellular responses to dif-
ferent signals. Signifi cant advances were also reported in terms of the structures and mechanisms 
of enzymes that function in ubiquitin conjugation and deconjugation. Fascinating new structural 
mechanisms were reported that explain how different types of ubiquitin chains and ubiquitin-
like protein modifi cations—and their dynamic properties—impart new functionalities to target 
proteins; this includes the fi rst presentation of structures of RBR E3 ligases as well as autoin-
hibited conformations of Parkin and mechanisms underlying ubiquitin ligation by HECT E3s. 
From a technology standpoint, a new “ubiquitin chain sequencing” methodology, through use of 
DUBs in the OTU pathway with distinctive specifi cities, will greatly enable the fi eld. There was 
R. Ray, B. Shulman, R. Kopito
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also a great increase in understanding assembly and 
functions of linear ubiquitin chains and other forms 
of pro tein amino-terminal ubiquitination. Finally, 
mechanism and physiology converged in several 
presentations describing exciting new ways in which 
small molecules can target the ubiquitin proteasome 
at virtually every level of the pathway. In summary, 
this meeting has continued to be a unifying forum 
that helps us understand the regulatory mechanisms 
by which ubiquitin and ubiquitin-like proteins func-
tion, their ever-growing roles in cellular physiology 
and disease, and development of therapeutics target-
ing the ubiquitin family.
This meeting was funded, in part, by the 
 National Cancer Institute, the National Institute of 
Child Health and Human Development, and the National Institute of General Medical Sciences, branches of 
the National Institutes of Health; Boston Biochem; and Ubiquigent.
PROGRAM
Conjugation, Removal, and Recognition of Ubiquitin and 
Ubiquitin-Like Proteins I
Chairpersons: D. Komander, MRC Laboratory of Molecular 
Biology, Cambridge, United Kingdom; R. Klevit, University 
of Washington, Seattle
Keynote Speaker
M. Hochstrasser, Yale University, New Haven, Connecticut
Conjugation, Removal, and Recognition of Ubiquitin and 
Ubiquitin-Like Proteins II
Chairpersons: C. Lima, Memorial Sloan-Kettering Cancer 
Institute, New York;
M. Rape, University of California, Berkeley
Substrate Targeting and Degradation
Chairpersons: D. Finley, Harvard Medical School, Boston, 
Massachusetts;
A. Martin, University of California, Berkeley
Quality Control
Chairpersons: C. Joazeiro, The Scripps Research Institute, 
La Jolla, California;
R. Hampton, University of California, San Diego
UBLs in Signaling I: Receptors, Plasma 
Membrane/Endosomal Traffi cking
Chairpersons: S. Polo, European Institute of Oncology, 
Milan, Italy;
R. Tomko, Jr.
J. Kowalski, C. Dahlberg A. Fox F. Melchior, C. Lima
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I. Dikic, Goethe University Medical School, Frankfurt, Germany
Nuclear Functions of Ubiquitin-like Proteins
Chairpersons: C. Wolberger, HHMI/Johns Hopkins University 
School of Medicine, Baltimore, Maryland; F. Melchior, 
University of Heidelberg, Germany
Regulation of Intracellular Pathways
Chairpersons: J. Huibregtse, University of Texas, Austin;
H. Ulrich, Cancer Research UK, London Research Institute
Keynote Speaker
J.W. Harper, Harvard Medical School, Boston, 
Massachusetts
UBLs in Signaling II: Intracellular Communication and 
Regulation of Organismal Biology
Chairpersons: R. Deshaies, HHMI/California Institute of 
Technology, Pasadena;
T. Sixma, Netherlands Cancer Institute, Amsterdam
J. Corn, L. Frappier
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Retroviruses
May 20–25 396 Participants
ARRANGED BY Frank Kirchhoff, Ulm University Medical Center, Germany
 Reuben Harris, University of Minnesota
A total of 396 scientists from 23 countries attended this 5-day 2013 Cold Spring Harbor meeting, 
which featured 120 talks and 179 poster presentations covering a broad range of topics. More than 
38% of the participants were female scientists, and 229 (57.8%) were junior trainees (graduate or 
postdoctoral level). Like many retrovirologists, the organizers have contributed to this meeting for 
many years. This meeting is highly interactive and forms the basis for many long-term friendships 
and collaborations.
The fi rst keynote lecture was given by Dr. Warner Greene, who has made key contributions 
to our understanding of the transmission and pathogenesis of HIV/AIDS. Dr. Greene’s talk ad-
dressed the long-standing question of how HIV-1 induces the depletion of CD4+ T cells that 
represents a key feature of AIDS. He reported the surprising fi nding that most T cells in ex vivo 
HIV-infected human lymphoid tissues are abortively infected and that cell death is induced by 
caspase 1 and due to pyroptosis, a process associated with high levels of infl ammation. Dr. Greene 
also suggested that available caspase-1 inhibitors may help to reduce the immune damage caused 
by HIV-1, which could be an adjuvant line of treatment in addition to combinatorial antiretroviral 
therapy (ART). His presentation resulted in lively discussions and numerous questions that kept 
him on stage long after the allotted hour.
The second keynote speaker was Dr. Ben Berkhout, who has long-standing expertise in retrovi-
ral transcription, RNA structure, and antiretroviral agents. His presentation touched upon many 
issues, among others on the striking fi nding that HIV-1 can actually become dependent on a drug, 
that is, the entry inhibitor T20. Furthermore, Dr. Berkhout reminded us that the HIV-1 genome 
has a very unusual composition characterized by a high percentage of “A” nucleotide. He also pre-
sented results suggesting that inducible live-attenuated SIV constructs exert protective effects in 
the rhesus macaque model and may offer a novel avenue for the development of an AIDS vaccine.
A. Hulme, J. Sastr, Z. Lukic
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The meeting was organized into 10 oral and three poster sessions 
covering the various steps of the viral life cycle, mechanisms of virus 
adaptation to different hosts, as well as viral immune evasion and per-
sistence. Most presentations dealt with HIV with a particular focus on 
host restriction factors and their viral antagonists. As usual for this meet-
ing, mainly novel unpublished data were presented, and suffi cient time 
was allowed for discussion between sessions. Three prizes were awarded 
at this meeting: Sharon Schlesinger received the Andy Kaplan young 
faculty prize for her studies on proviral silencing; Judd F. Hultquist was 
decorated with the Ute von Schwendler prize for the best Ph.D. research 
in retrovirology and reported his results on the role of CBFβ in counter-
action of APOBEC3G by the viral Vif protein. Finally, Siddarth Ven-
katesh received the best poster award for his studies on the mechanisms 
of HIV-1 entrapment by tetherin.
Several presentations described how HIV and SIV adapt to their re-
spective hosts. One report described strong selective sweeps in HIV-1- 
infected individuals that are most likely driven by the immune response. 
Others indicated that both TRIM-5α and APOBEC3 proteins drive 
species-specifi c adaptations that increase viral fi tness in primate lentivi-
ruses. Furthermore, it was reported that the creation of SIVcpz resulted 
in the loss of the vpx gene and that vpu-containing SIVs may cause disease in their natural simian 
hosts. Several talks focused on the regulation of viral latency, and one highlight was the fi nding 
that Yin Yang 1 may induce proviral silencing in embryonic cells.
Restriction factors were once again a major topic in several sessions. Emerging evidence sug-
gests that some of these antiviral factors, such as tetherin and TRIM5, also have important roles 
in viral immune sensing, and the underlying mechanisms were discussed in several talks. Fur-
thermore, some novel potential restriction factors, for example, MxB, IFITMs, and Schlafen 1, 
were presented. Three oral presentations reported that the antiretroviral activity of SAMHD1 
is regulated by phosphorylation. Two studies in mouse models support that SAMHD1 exerts 
antiviral and anti-infl ammatory activity in vivo. Another report showed that Vpr and Vpx have 
evolved multiple means to target SAMHD1, once again highlighting the complexity and plasticity 
of virus–host interactions. Notably, several studies suggested that inhibition of reverse transcrip-
tion activity by reduction of intracellular dNTP levels may not be the only mode of SAMHD1-
dependent retroviral restriction.
J. Lingappa, E. Arts
L. Mansky, S. Goff S. Hughes, V. Kewal Ramani
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The APOBEC/Vif axis fi gured prominently at the meeting with the largest number of ab-
stracts of any category (refl ected as cover of the symposium abstract book). Highlights on this 
topic included in vivo data from humanized and transgenic mice, cats, and monkeys, as well as 
cell-based studies on mechanisms of RNA binding, virion encapsidation, and deamination target 
site selection. A high-resolution structure of APOBEC3F catalytic domain was presented, as was a 
low-resolution structure of the Vif ubiquitin ligase complex, with optimism for higher-resolution 
larger complexes in the near future. APOBEC3F was also shown to have the surprising capacity to 
ride with the viral core from budding, through entry and reverse transcription, and even into the 
nuclear compartment. More work will be necessary to tie this unexpected property to mechanism, 
but APOBEC3F may still be a powerful tool for cell biology of the early steps of virus replication.
The last session of the meeting focused on nuclear entry and integration. Highlights included 
the unexpected observation that several integration-blocking compounds also cause a late-stage 
maturation defect. Several talks also focused on the integrity of the viral capsid during reverse 
transcription up to the stage of nuclear import. Other presentations described the pathway(s) of 
nuclear import, with several studies highlighting CPSF6, TNPO3, and nuclear pore components. 
A TNPO3 structure was reported with RAN-GDP and GTP. Participants were very optimistic 
that the stages of virus replication related to integration are good targets for additional antiretro-
viral drug development.
This meeting was funded, in part, by the National Institute of Allergy and Infectious Diseases, 
a branch of the National Institutes of Health; and Gilead Sciences.
PROGRAM
Latency and Evolution
Chairpersons: S. Goff, Columbia University, New York; 
S. Sawyer, University of Texas, Austin
Seventh Annual Andy Kaplan Prize
Awarded by: A. Telesnitsky, University of Michigan, Ann 
Arbor
To: S. Schlesinger, Columbia University, New York
Virus and Host Gene Expression
Chairpersons: E. Browne, Massachusetts Institute of 
Technology, Cambridge;
J.-C. Paillart, CNRS-Université de Strasbourg, France
Assembly and RNA Packaging
Chairpersons: M. Johnson, University of Missouri, Columbia;
R. Craven, Pennsylvania State University College of Medicine, 
Hershey
Keynote Speaker
W. Greene, Gladstone Institute, University of California, 
San Francisco
Budding, Maturation, and BST2/Tetherin
Chairpersons: T. Hatziioannou, Aaron Diamond AIDS 
Research Center, New York;
Z. Williams B. Liu, A. Cheatham, T. Turner, H. Taylor
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D. Evans, Harvard Medical School, Southborough, 
Massachusetts
Transmission and Entry
Chairpersons: W. Mothes, Yale University, New Haven, 
Connecticut;
A. Finzi, Centre de Recherche du CHUM, Université de 
Montréal, Canada
RT, Mutagenesis, and APOBECs
Chairpersons: M.-A. Langlois, University of Ottawa, Canada;
V. Simon, Icahn School of Medicine at Mount Sinai, New York
Second Annual Ute Von Schwedler Prize for Retrovirology
Awarded by: V. Vogt, Cornell University
To: J.F. Hultquist, University of Minnesota, Twin Cities
RT, dNTPs, and SAMHD1
Chairpersons: N. Laguette, CNRS UPR1142, Montpellier, 
France;
F. Diaz-Griffero, Albert Einstein College of Medicine, Bronx, 
New York
Keynote Speaker
B. Berkhout, University of Amsterdam, The Netherlands
RT, Uncoating, Trim5, and Novel Host Factors
Chairpersons: K. Bishop, MRC National Institute for Medical 
Research, London, United Kingdom; E. Campbell, Loyola 
University, Chicago, Illinois
PICs, Nuclear Entry, and More Restriction Factors
Chairpersons: V. Kewal Ramani, National Cancer Institute, 
Frederick, Maryland;
W. Johnson, Boston College, Chestnut Hill, Massachusetts
Third Annual Daniel Wolf Prize
Awarded by: Stephen Goff, Columbia University, New York
To: Jury-selected poster presenter at the 2013 Retroviruses 
meeting
Integration
Chairpersons: P. Cherepanov, Cancer Research UK/Imperial 
College London, United Kingdom;
J. Luban, University of Massachusetts Medical School, Worcester
J. Stoye, J. Luban D. Evans, J. Guatelli
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Wiring the Brain
July 18–22 195 Participants
ARRANGED BY Catalina Betancur, INSERM, Paris
 Ed Bullmore, Cambridge University
 Josh Huang, Cold Spring Harbor Laboratory
 Helen Mayberg, Emory University
 Kevin Mitchell, Trinity College Dublin, Ireland
This was the fi rst Wiring the Brain conference hosted at Cold Spring Harbor, following two pre-
vious meetings in this series held in Ireland in 2009 and 2011. The main goal of this meeting is 
to bring together researchers from diverse fi elds to explore how brain connectivity is established, 
how genetic variation can affect these processes, how circuit and network function are affected 
by defects in neural development, and how this can lead to psychiatric and neurological disease. 
The program was designed with a particular focus on neurodevelopmental disorders and covered 
a wide range of areas relevant to this theme.
Session topics are listed below. There were 28 invited talks from world leaders in diverse fi elds 
and an additional 20 talks selected from submitted abstracts. These talks highlighted cutting-edge 
research in specifi c fi elds, and it was also notable how many of them were integrating across levels 
of analysis, using new technologies to transition smoothly from cells to circuits to systems, from 
development to function or dysfunction, and between animals and humans.
Two stimulating keynote lectures set an excellent tone for the meeting. The fi rst, by Huda 
Zoghbi, described her long-running work on Rett syndrome, a single-gene disorder manifesting 
as autism. This was an inspirational talk, going from careful clinical observation and defi nition 
of the syndrome to gene discovery, to elucidation of molecular and neurobiological pathogenic 
mechanisms, and ultimately to the design and development of therapies now in clinical trials. The 
second talk was by Edmund Rolls, who presented a computational perspective on brain wiring, 
asking what neural circuits are designed to do and how their anatomy and connectivity is con-
strained by these functional imperatives.
There were also 87 posters, which were similarly outstanding in the quality of research present-
ed, again across very diverse fi elds. Poster sessions were very well attended, lively, and stimulating.
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The meeting was characterized by a very open attitude and wide-ranging discussions centered 
on big questions, rather than focused on technical details. As such, it provided a unique forum 
for the integration of research from developmental neurobiology, psychiatric genetics, molecular, 
cellular, and systems neuroscience, cognitive science, and psychology. These kinds of interactions 
will help build an integrative explanatory framework in neuroscience, especially in our under-
standing of the nature and causes of brain disorders.
This meeting was funded, in part, by the National Institute of Neurological Disorders and 
Stroke, a branch of the National Institutes of Health; and Forest Laboratories.
PROGRAM
Genetically Programmed Development
Chairpersons: K. Mitchell, Trinity College Dublin, 
Ireland;
Z.J. Huang, Cold Spring Harbor Laboratory
Activity-Dependent Development
Chairpersons: Z.J. Huang, Cold Spring Harbor Laboratory;
H. Mayberg, Emory University, Atlanta, Georgia
Genetics of Neurodevelopmental Disorders
Chairpersons: C. Betancur, INSERM, Paris, France;
K. Mitchell, Trinity College Dublin, Ireland
Keynote Speakers
H.Y. Zoghbi, HHMI/Baylor College of Medicine; 
E. Rolls, Jan and Duncan Neurological Research Institute, 
Texas Children’s Hospital
G. Marcus, K. Mitchell, E. Viding, S. Fisher A. Zuko, M. Kas, K. Kleijer
O. Bibollet-Bahena, D. Shanley D. Geschwind, J. Korenberg
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Modeling Neurodevelopmental Disorders
Chairpersons: Z.J. Huang, Cold Spring Harbor Laboratory;
C. Betancur, INSERM, Paris, France
Connectivity: From Synapses to Systems
Chairpersons: E. Bullmore, University of Cambridge, 
United Kingdom;
H. Mayberg, Emory University, Atlanta, Georgia
Circuits: Function and Dysfunction
Chairpersons: Z.J. Huang, Cold Spring Harbor Laboratory;
H. Mayberg, Emory University, Atlanta, Georgia
Wiring the Human Brain
Chairpersons: C. Betancur, INSERM, Paris, France;
E. Bullmore, University of Cambridge, United Kingdom
Keynote Speaker
E. Rolls, Oxford Centre for Computational Neuroscience; 
University of Warwick, Coventry
Cognitive Development: The Emergence of the Mind
Chairpersons: H. Mayberg, Emory University, Atlanta, 
Georgia;
K. Mitchell, Trinity College Dublin, Ireland
C. Ross, D. Lewis
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Metabolic Signaling and Disease: From Cell to Organism
August 13–17 209 Participants
ARRANGED BY Daniel Kelly, Sanford-Burnham Medical Research Institute, Lake Nona
 Mitchell Lazar, University of Pennsylvania
 Susanne Mandrup, University of Southern Denmark
This meeting was conceived following a highly successful 
Symposium on Quantitative Biology 2 years earlier. The 
main goal of the meeting was to bring together researchers 
from diverse fi elds to explore how principles of cellular me-
tabolism manifest in different cell types, including cancer; 
how differences in metabolic regulation underlie the func-
tions of differentiated tissues; and how these differences 
impact on organismal physiology and disease. The meet-
ing was subtitled “From Cell to Organism” to highlight 
these objectives.
The 26 invited speakers were leaders in the various as-
pects of metabolic research from all over the world. A key-
note address by Nobel laureate Michael Brown set a superb 
tone on the opening evening. A total of 10 sessions followed, 
all highlighting unpublished research. Eight sessions featured oral presentations. Of these, two fo-
cused on metabolic cells and their role in storing, converting, and sharing metabolites; three sessions 
emphasized signaling mechanisms, metabolic networks, and organ–organ cross-talk. An additional 
session concentrated on the physiology and pathophysiology of energy metabolism, whereas the fi nal 
two sessions focused on altered metabolism in aging and disease states including cancer, obesity and 
diabetes. Short talks were chosen from abstracts to increase the exposure of younger investigators and 
to highlight hot topics that complemented and extended the exciting program.
The total number of abstracts was 153, including 127 posters that were presented in two ses-
sions. All 10 sessions were characterized by open and wide-ranging discussions, and the meeting 
provided a unique forum for the exploration of the commonalities and differences in metabolic 
principles and details across different laboratories, systems, and diseases. Indeed, a great success 
M. Lazar, S. Mandrup, D. Kelly
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of the meeting was that attendees gained in-depth expo-
sure to the amazing cell, organ, and disease specifi city of 
metabolic fl ux and its regulation.
This meeting was funded, in part, by the National 
Institute of Diabetes and Digestive and Kidney Diseases, 
a branch of the National Institutes of Health.
PROGRAM
Keynote Speaker
M. Brown, University of Texas Southwestern Medical School, 
Dallas
Professional Metabolic Cells I: Storing Metabolites
Chairperson: T. Osborne, Sanford-Burnham Medical Research 
Institute at Lake Nona, Orlando, Florida
Professional Metabolic Cells II: Converting and Sharing 
Metabolites
Chairperson: B. Kahn, Beth-Israel Deaconess Medical Center, 
Boston, Massachusetts
Signaling Metabolism I: Cellular Signaling Networks
Chairperson: D. Muoio, Duke University, Durham, North 
Carolina
Signaling Metabolism II: Metabolite Signals
Chairperson: M. Birnbaum, University of Pennsylvania, 
Philadelphia
Signaling Metabolism III: Organ-Organ Cross-Talk
Chairperson: R. Evans, Salk Institute for Biological Studies, 
La Jolla, California
Burning Metabolites: Energy and Heat
Chairperson: K. Schoonjans, Ecole Polytechnique Federale de 
Lausanne, Switzerland
Cellular Proliferation and Metabolic Adaptation: Cancer
Chairperson: D. Moore, Baylor College of Medicine, Houston, 
Texas
Metabolic Failure: Aging and Metabolic Disease
Chairperson: C. Thompson, Memorial Sloan-Kettering 
Cancer Center, New York
G. Hardie, J.D. Watson
R. Evans, N. Hah N. Prior, S. Borrego
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Eukaryotic mRNA Processing
August 20–24 336 Participants
ARRANGED BY Tom Blumenthal, University of Colorado
 Kristen Lynch, University of Pennsylvania
 Karla Neugebauer, Yale University
This meeting was held in order to present and discuss recent 
developments in mRNA metabolism. As in the past, the 
regulation of alternative pre-mRNA splicing was a focus, as 
was the mechanism of spliceosome assembly and catalysis. 
Additional areas included mRNA 3′-end formation, mRNA 
decay, mRNA traffi cking, and the coupling of RNA pro-
cessing to transcription and export. Structural, live-cell im-
aging, and genome-wide approaches were interwoven into 
the sessions, refl ecting state-of-the-art techniques currently 
applied to understanding how mRNA is processed in vivo 
and in vitro. Following on our aim to include all aspects of 
RNA biology, reports on miRNA, RNAi, and noncoding 
RNA were encouraged and well represented.
In addition to our traditional splicing mechanisms ses-
sion, this topic was further visited in our kick-off session on RNA–protein interactions as well as 
a session on RNP assembly and functions. One highlight among splicing mechanisms was the 
presentation of a high-resolution structure of the yeast PRP24 protein bound to the U6 snRNA, 
revealing extensive interfaces of the protein chaperone with the RNA that promote RNA rear-
rangements en route to mature U6 snRNP formation. These phenomena contrasted with energy-
dependent rearrangements carried out by, for example, Prp5 and Prp16 in the spliceosome, as well 
as a study on the role of U6 snRNA at the catalytic center.
This year, an overwhelming number of abstracts on alternative splicing regulation were 
 received, refl ecting the development of approaches to studying transcript isoforms in model organ-
K. Neugebauer, T. Blumenthal, K. Lynch
Crossing Airslie lawn
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isms and tissues. This also refl ects the momentum the fi eld has 
gained in identifying RNA–protein interactions, thanks largely to 
in vivo cross-linking approaches such as CLIP. Therefore, many ab-
stracts on alternative splicing also appeared in the sessions on RNA–
protein interactions and RNP assembly and functions, in addition 
to the session on RNA processing and disease and global analyses. 
These included the development of splicing targeted therapeutics.
Several presentations on alternative 3′-end formation established 
that poly(A) site choice is highly regulated and a major source of 
transcript variability, linking polyadenylation, transcription, and 
quality control. A major advance in the fi eld, namely, the discovery 
of triple-helix formation at 3′ ends, providing resistance to mRNA 
decay mechanisms, was described in the last session. In the RNA 
decay session, the nonsense-mediated decay (NMD) pathway was a 
particular focus, including work showing that NMD sculpts the cel-
lular transcriptome, disconnecting transcript abundance from tran-
scriptional output, by altering the stability of specifi c transcripts. 
Several studies homed in on the activity of Staufen, a double- stranded 
RNA-binding protein implicated in Staufen-mediated decay 
(SMCD), in order to understand how target specifi city is achieved.
The RNA Cell Biology and Cotranscriptional RNA-processing sessions focused on genome-
wide approaches to RNA–protein interactions that infl uence RNA localization, live-cell imag-
ing, NGS approaches to measuring the kinetics of transcription and splicing in living cells, and 
changes in processing due to cell signaling and progression through the cell cycle.
This meeting was funded, in part, by the National Cancer Institute, a branch of the National 
Institutes of Health; and the National Science Foundation.
PROGRAM
RNA–Protein Interactions
Chairpersons: J. Doudna, HHMI/University of 
California, Berkeley; A. Zahler, University of California, 
Santa Cruz
RNP Assembly and Functions
Chairpersons: R. Lührmann, Max-Planck Institute of 
Biophysical Chemistry, Göttingen, Germany; M. Jurica, 
University of California, Santa Cruz
L. Guilgur, M. Gonzalez-Porta
B. Graveley, B. Blencowe J. Witkowski, J. Wiluz
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Cotranscriptional RNA Processing
Chairpersons: N. Proudfoot, University of Oxford, United 
Kingdom; T. Johnson, University of California, San Diego
Mechanisms of RNA Splicing/Global Analyses and 
 Evolution
Chairpersons: M. Sattler, Helmholtz Zentrum München, 
Neugerberg, Germany; C. Guthrie, University of California, 
San Francisco
RNA Cell Biology
Chairpersons: A.G. Matera, University of North Carolina, 
Chapel Hill; M. Carmo-Fonseca, University of Lisbon, Portugal
Translational Control/Decay Mechanisms
Chairpersons: R. Parker, HHMI/University of Colorado, 
Boulder; N. Conrad, University of Texas Southwestern 
Medical Center, Dallas
RNA Processing in Development and Disease
Chairpersons: M. Ares, University of California, Santa Cruz; 
A. Krainer, Cold Spring Harbor Laboratory
miRNA Biogenesis and Function/ncRNA Processing
Chairpersons: F. Gebauer, Center for Genomic Regulation, 
Barcelona, Spain; E. Lund, University of Wisconsin, 
Madison
H. Lou, E. Lasda S. Sharma, M. Peterson
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Mechanisms of Eukaryotic Transmission
August 27–31 367 Participants
ARRANGED BY Stephen Buratowski, Harvard Medical School
 Katherine A. Jones, The Salk Institute for Biological Studies
 John Lis, Cornell University
Regulation of gene transcription has a central role in the 
growth and development of eukaryotic organisms. Tran-
scriptional responses occur as a consequence of cell signal-
ing, environmental stresses, and developmental cues. The 
fi eld of transcription encompasses a broad range of study 
from structural biology to developmental biology and ge-
nomics. This 13th Cold Spring Harbor meeting appropri-
ately covered many aspects of the fi eld and brought togeth-
er a diverse group of scientists. It consisted of eight plenary 
sessions, two poster sessions, and one breakout session.
The meeting began with a session that included exciting 
new insights derived from structure and imaging studies of 
mammalian, yeast, and archaeal RNA polymerase preini-
tiation complexes. The second session covered new mecha-
nisms that control factor targeting and activation of transcription initiation. The next plenary ses-
sion described mechanisms that activate chromatin remodeling and actin-containing complexes 
during transcription, and new mechanisms that regulate transcription in response to phosphoryla-
tion, signaling or differentiation. The fourth session introduced several new factors and complexes 
that regulate RNAPII elongation and coupled events, such as cotranscriptional splicing, nucleo-
some modifi cation, termination, and mRNA export. The next plenary session continued with the 
elongation theme but was primarily focused on enzymatic complexes that modify the RNAPII 
carboxy-terminal domain (CTD). Additional topics covered in this session include transcrip-
tional control by mRNA capping enzymes, gene looping, and a role for alternative termination 
J. Lis, K. Jones, S. Buratowski
Y. Ghavi-Helm, M. Werner C. Engel, F. Werner
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complexes in premature termination at specifi c genes. The sixth and seventh sessions described the 
role of histone chaperones, variant histones, noncoding RNAs and novel complexes that read his-
tone marks in regulating transcription and establishing euchromatin or heterochromatin domains 
in development and disease. The fi nal session included genome-wide approaches for understand-
ing how gene networks are organized and regulated through superenhancers, promoter structure, 
and long-range chromatin interactions and for understanding how chromatin and dynamics are 
interrelated.
Interspersed with these oral presentations were the two poster sessions where a wide variety of 
exciting unpublished transcriptional research was presented. The meeting also including a break-
out session, initiated at the previous meeting and focused on complexes that recognize distinct 
phosphorylation patterns of the RNAPII CTD. Breakout sessions provide a unique forum to focus 
on rapidly evolving topics, and this one was well attended. The organizers plan to continue this 
session organization in future meetings on topics yet to be determined.
This meeting was funded, in part, by the National Science Foundation.
PROGRAM
Initiation Complexes
Chairperson: P. Cramer, Gene Center LMU Munich, 
Germany
Activators and Co-Activators
Chairperson: J. Conaway, Stowers Institute for Medical 
Research, Kansas City, Missouri
Signaling and Regulatory Complexes
Chairperson: K. Arndt, University of Pittsburgh, 
Pennsylvania
Elongation, Pausing, and Termination
Chairperson: W. Bickmore, MRC Human Genetics Unit, 
Edinburgh, United Kingdom
The CTD and Postinitiation Events
Chairperson: R. Young, Whitehead Institute, MIT, 
Cambridge, Massachusetts
Transcriptionally Active Chromatin
Chairperson: A. Shilatifard, Stowers Institute for Medical 
Research, Kansas City, Missouri
Repressive Chromatin
Chairperson: K. Luger, HHMI/Colorado State University, 
Fort Collins
Genomics and Systems Biological Approaches
Chairperson: B. Cairns, Huntsman Cancer Institute, 
University of Utah, Salt Lake City
N. Fuda, R. Young A. Ansari, D. Reinberg
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Behavior and Neurogenetics of Nonhuman Primates
September 6–9 54 Participants
ARRANGED BY Nelson Freimer, University of California, Los Angeles
 Jeffrey Rogers, Baylor College of Medicine
This inaugural meeting provided an opportunity to bring 
 together investigators from different fi elds marked by rapid 
recent progress, including genetics, genomics, and neuroim-
aging. The meeting sessions all related clearly to the overall 
topic, but emphasized distinct aspects of this broad fi eld.
The fi rst session introduced topics related to the genomics 
of brain function and behavior. The second session focused on 
primate brain evolution, incorporating perspectives ranging 
from neuroanatomy to comparative gene expression. The key-
note address, by Svante Pääbo, was a tour de force presentation. 
He used a comprehensive genomic comparison between extinct 
human species and modern humans, including exciting unpub-
lished data, as a framework for understanding the evolution of 
the primate brain and behavior. The keynote provided an excellent bridge to the third session, which 
focused on the genetics of behavior in free-ranging or wild primates. As in other areas of biology, 
technology developments promise to transform investigations of primate brain and behavior. Inte-
grating new technologies into various aspects of primate research, including studies of wild or free-
ranging animals, was a recurrent theme of the conference. The presentations in session four showed 
the value of novel methods in primate research clearly. They described a series of approaches that 
are not feasible in humans or where non-human primates provide better models for human disease 
than do rodents. These talks included the use of transgenic technologies to model human diseases 
in monkeys, the introduction of optogenetics in non-human primate species, and the application of 
functional and structural brain imaging in a primate model of anxiety. Session fi ve focused on brain 
N. Freimer, J. Rogers
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development, continued the theme of non-human primate models, focusing on 
regional differences in gene function at critical developmental time points, the 
role of microRNAs, and interspecies differences as assessed through transcrip-
tional network analyses. The fi nal session focused on non-human primate models 
of disease-related processes including stress response, temperament, and activity 
patterns. The poster session covered a diverse set of topics and stimulated consid-
erable discussion. A principal goal of the meeting was to provide a unique venue 
for investigators who do not overlap at other meetings to make new acquaintances 
and initiate communications. In an open-discussion session that ended the meet-
ing, attendees enthusiastically reported that this goal had been achieved, and they 
endorsed the view that the CSHL conference format had played an important 
part in this achievement. In this discussion, the attendees voiced strong support 
for future CSHL meetings on the topics covered in this meeting.
This meeting was funded, in part, by the National Institutes of Health.
PROGRAM
Introductory Session
Chairpersons: J. Rogers, Baylor College of Medicine; 
N. Friemer, University of California, Los Angeles
Genome Structure and Brain Function
Chairpersons: E. Eichler, University of Washington, Seattle; 
L. Stubbs, University of Illinois, Urbana
Comparative Evolution of the Brain
Chairpersons: P. Khaitovich, CAS-MPG Partner Institute for 
Computational Biology, Shanghai, China; E. Lein, Allen 
Institute for Brain Science, Seattle, Washington
Keynote Speaker
S. Pääbo, Max-Planck Institute for Evolutionary Anthropology 
and Biology, Leipzig, Germany
Evolution and Behavior
Chairpersons: S. Alberts, Duke University, Durham, 
North Carolina; A. Varki, University of California, 
San Diego
New Technologies
Chairpersons: K. Deisseroth, Stanford University, California; 
E. Sasaki, Keio University, Tokyo, Japan
Neurodevelopment and Stem Cell Biology
Chairpersons: C. Dehay, INSERM, Bron, France; 
D. Geschwind, University of California, Los Angeles
Genetics of Primate Behavior
Chairpersons: J. Cameron, University of Pittsburgh, 
Pennsylvania; J. Rogers, Baylor College of Medicine, 
Houston, Texas
Concluding Remarks and Discussion
J. Rogers, Baylor College of Medicine, Houston; N. Freimer, 
University of California, Los Angeles
C. Dehay, K. Kosik, M. Arcila
U. Borello, T. Nowakowski
283-422_Meetings & Courses.indb   330 8/28/2014   10:50:55 AM
331
Eukaryotic DNA Replication and Genome Maintenance
September 9–13 297 Participants
ARRANGED BY Anindya Dutta, University of Virginia
 Joachim Li, University of California, San Francisco
 Johannes Walter, Harvard Medical School
This fourth biannual meeting refl ected the remarkable 
progress that has been made in the past 2 years and serves 
an important role in bringing together researchers studying 
eukaryotic DNA replication, repair, and their interactions 
to maintain genome stability. As in the past, this meeting 
brought together an international cadre of researchers who 
presented exciting new advances, upholding the tradition 
that this is the most important meeting in the DNA replica-
tion fi eld. A total of 80 investigators participated in the 10 
scientifi c sessions, with a total of 249 platform and poster 
presentations. The eight platform sessions were marked by 
spirited and enthusiastic exchanges of new results. The post-
er sessions were of very high quality and were overcrowded 
with interested attendees delving into the fi ndings presented.
Sessions and their chairs at the meeting are listed below. The presentations confi rmed the 
power of biochemical reconstitution and structural studies in dissecting the mechanisms of cel-
lular DNA replication initiation and repair. Genome-wide and replication-fork-specifi c assays 
are beginning to reveal that origin selection in metazoan cells is probably not sequence specifi c, 
whereas replication timing is determined signifi cantly by the status of the chromatin. Novel ac-
tivities involved in termination of DNA replication were described. The abundance of specifi c 
replication proteins was shown to be important for mid-blastula transition during development. 
The connection between loss of replication control and gene amplifi cation was highlighted. In 
addition, the presentations illustrated our increasing understanding of the close coordination be-
tween the DNA repair and cell cycle checkpoints and DNA replication initiation and elongation.
Essential funding for the meeting was provided by the National Cancer Institute, a branch of 
the National Institutes of Health, and travel support for two European investigators was provided 
by EMBO.
PROGRAM
New Approaches and Perspectives
Chairpersons: A. van Oijen, University of Groningen, The 
Netherlands; K. Labib, Cancer Research UK, University of 
Manchester, United Kingdom
Origin Selection and Licensing
Chairpersons: M. Aladjem, NCI, National Institutes of Health, 
Bethesda, Maryland; S. Bell, HHMI/Massachusetts Institute 
of Technology, Cambridge
Chromatin and Replication
Chairpersons: A. Groth, BRIC, University of Copenhagen, 
Denmark; Z. Zhang, Mayo Clinic, Rochester, Minnesota
Origin Activation and Timing
Chairpersons: H. Araki, National Institute of Genetics, 
Mishima, Japan; H. Masukata, Osaka University, 
Japan
Replisome Activities and Functions
Chairpersons: L. Bloom, University of Florida, Gainesville; 
A. Donaldson, University of Aberdeen, United Kingdom
Dealing with Blocks and Lesions
Chairpersons: W. Yang, NIDDK, National Institutes of 
Health, Bethesda, Maryland; P. Burgers, Washington 
University School of Medicine, St. Louis, Missouri
A. Dutta, J. Walker, J. Li
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Development, Cell Cycle, and Cancer
Chairpersons: B. Calvi, Indiana University, Bloomington; 
V. Gorgoulis, University of Athens Medical School, 
Greece
Replication Stress and Damage Signaling
Chairpersons: D. Cortez, Vanderbilt University School of 
Medicine, Nashville, Tennessee; J. Lukas, University of 
Copenhagen, Denmark
G. Alvino, C. Muller B. Stillman, C. Speck J. Sequeira-Mendes, J.-C. Cadoret
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Microbial Pathogenesis and Host Response
September 17–21 264 Participants
ARRANGED BY Andrew Camilli, Tufts University School of Medicine
 Lalita Ramakrishnan, University of Washington
 Malcolm Whiteway, Concordia University
Despite advances in modern health care, infectious diseases 
continue to be major causes of human morbidity and mor-
tality. The evolution of microbial pathogens with humans 
has resulted in complex interactions that impact the strug-
gle between the infectious invader and the susceptible host. 
Increased understanding of these interactions with the goal 
of developing new therapeutics and preventive strategies 
requires collaborative and interdisciplinary scientifi c ap-
proaches. This meeting brought together a diverse group of 
international scientists who approach the study of bacterial 
and fungal pathogens from a broad range of perspectives. 
Investigators from the disciplines of molecular microbiol-
ogy, eukaryotic cell biology, immunology, and genomics, 
and representing academia, industry, and the public health 
sector, shared recent fi ndings concerning microbial and host aspects of infectious diseases.
The meeting focused on bacterial and fungal pathogens and the host response and defense 
to these invading microbes. Oral sessions were topic-based and included studies of multiple and 
diverse organisms. Areas covered included the microbial–host interactions; genetic approaches to 
studying microbial pathogenesis; regulation of commensalism and pathogenesis; the host infl am-
matory response; microbial communication and biofi lms in infection; immune killing; chemical 
genetic approaches to studying pathogenesis; development of new antibiotics; and role of the gut 
microbiota in human health and disease. Speakers for each session were a mixture of established 
M. Whiteway, L. Ramakrishnan, A. Camilli
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leaders in the fi eld and young investigators. Half of the speakers, including postdoctoral fellows 
and graduate students, were chosen from submitted abstracts. Dr. Jeffrey I. Gordon, the Dr. Rob-
ert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences 
& Systems Biology at Washington University, presented the keynote address. Dr. Gordon is an in-
ternationally recognized leader in the fi eld of biomedical research. His presentation, “The Human 
Microbiome in Health and Disease,” addressed how the gut microbiota is established, the factors 
that affect the species composition of the microbiota, the diversity between individuals but stabil-
ity within individuals, and the causal role of the gut microbiota in human health.
The informal atmosphere, combined with the broad perspectives of the meeting participants, 
resulted in a free fl ow of novel and refreshing ideas on pathogenesis and clinical treatment, with 
the atmosphere of a small meeting. Active questioning and discussion followed all oral presen-
tations, was evident throughout the posters sessions, and continued during a wine and cheese 
reception and other social gatherings. We strongly encouraged submission of abstracts by junior 
researchers in the fi eld, and many young investigators were in attendance. Some of these interac-
tions have already produced fruitful scientifi c collaborations.
This meeting was partly supported by funds from the National Institute of Dental and Cranio-
facial Research and the National Institute of Allergy and Infectious Diseases.
PROGRAM
Host Cell/Pathogen Interactions
Chairperson: C. Roy, Yale University, New Haven, 
Connecticut
Antibiotics, Chemical Genetics, and Immune Killing
Chairperson: G. Wright, McMaster University, Hamilton, 
Canada
Regulation of Commensalism/Pathogenesis
Chairperson: T. Koehler, University of Texas Health Science 
Center, Houston
Genetic Approaches to Pathogenesis
Chairperson: R. Valdivia, Duke University Medical Center, 
Durham, North Carolina
Biofi lms, Quorum Sensing, and Disease
Chairperson: P. Singh, University of Washington, Seattle
Keynote Speaker
J. Gordon, Washington University, St. Louis
L. Burrows, M. Machner A. Arbues, C. Astarie-Dequeker A. Guzman, J. Barroso-Batista
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Stem Cell Biology
September 24–28 203 Participants
ARRANGED BY Konrad Hochedlinger, Harvard Medical School
 Fiona Watt, King’s College London
 Ting Xie, Stowers Institute for Medical Research
This third biannual CSHL conference was organized in 
thematic topics, including somatic stem cells and regen-
eration, stem cell niches and asymmetric cell division, plu-
ripotency and transdifferentiation, lineage differentiation, 
stem cells and therapy, cancer and stem cells, and stem 
cells in model organisms. There were 203 participants, 
which is comparable to previous years (190 in 2011 and 
240 in 2009). About 20% of participants were Ph.D. stu-
dents, and 30% were postdocs from 23 different countries 
(64% from the United States), documenting the infl uence 
of the meeting on trainees from around the world. More-
over, representatives from major publishing houses such as 
Cell and Nature were present. Speakers comprised a mix of 
internationally known leaders in the individual disciplines 
as well as emerging junior researchers, who presented ex-
citing unpublished work or work that had recently appeared in print. In addition, each section 
had one short talk that was picked from abstracts by the organizers. It was decided to increase 
the short talks for the next meeting (2015) to give more trainees the opportunity to present their 
work. Main talks were 20–25 min plus 5–10 min of discussion (28 speakers), and the short 
talks were 15 min plus 5 min of discussion (seven speakers). The keynote lecture was given by 
Rudolf Jaenisch, who presented recent work by his lab on CRISPR/Cas genome engineering in 
stem cells and studies on MECP2 and Rett syndrome. Discussions were very stimulating and 
long and often continued at poster sessions and during lunch, dinner, or at the bar. Preliminary 
(informal) feedback by students, postdocs, speakers, and journal editors was uniformly positive. 
Attendees liked the mixed topics of sessions and the inclusion of presentations on the therapeutic 
F. Watt, K. Hochedlinger
I. Jordens, M. Khurgel C. Lillyhook, E. Ezhkova
283-422_Meetings & Courses.indb   335 8/28/2014   10:51:02 AM
336  Meetings
potential of stem cells (e.g., a talk by a Pfi zer researcher) and model organisms in some sessions 
(e.g., C. elegans, Drosophila), which distinguish this meeting from other, more focused stem cell 
conferences.
This meeting was funded, in part, by Fluidigm.
PROGRAM
Somatic Stem Cells and Tissue Regeneration
Chairperson: F. Watt, King’s College London, United Kingdom
Stem Cell Niches/Asymmetric Stem Cell Division
Chairperson: C. Blanpain, Université Libre de Bruxelles, 
Brussels, Belgium
Stem Cells in Model Organisms
Chairperson: T. Xie, Stowers Institute for Medical Research, 
Kansas City, Missouri
Pluripotency and Cellular Plasticity
Chairperson: K. Hochedlinger, Harvard Medical School, 
Boston, Massachusetts
Stem Cells in Disease Modeling and Therapy
Chairperson: R. Jaenisch, Whitehead Institute for Biomedical 
Research, Cambridge, Massachusetts
Lineage Determination
Chairperson: J. Rajagopal, Harvard Stem Cell Institute, 
Massachusetts General Hospital, Boston
Keynote Speaker
R. Jaenisch, Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts
Cancer and Stem Cells
Chairperson: J. Wysocka, Stanford University, California
J. Kimble, E. Matunis, B. Ohlstein S. Wood, J. Knoblich
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Neurobiology of Drosophila
October 1–5 427 Participants
ARRANGED BY Tom Clandinin, Stanford University
 Linda Restifo, University of Arizona
As in previous years, the goal of this meeting was to foster com-
munication of ideas, techniques, and new discoveries within the 
fi eld of Drosophila neurobiology. The meeting was structured with 
platform and poster presentations by a variety of researchers in-
cluding graduate students, postdoctoral fellows, and junior and 
senior faculty. The topics for the platform sessions were chosen to 
refl ect the areas of Drosophila neurobiology in which cutting-edge 
advances are being made: neural development, neural circuits and 
function, simple and complex behaviors, disease models, synaptic 
structure and function, and emerging technologies. A small frac-
tion of abstracts submitted in each of these areas was selected by 
the respective session chairs and the meeting organizers for plat-
form presentations, and the rest were presented as posters. The 
research reported used a wide range of techniques, including ge-
netic, molecular, cellular, biochemical, physiological, and behavioral approaches to address basic 
questions of nervous system development and function. Among the highlights of the meeting were 
the creative ways in which researchers are using Drosophila to understand the molecular and cel-
lular underpinnings of many different physiological and pathological processes. A focal point in 
the meeting was the keynote address, the Benzer Lecture, by S. Lawrence (Larry) Zipursky. Dr. 
Zipursky, a prominent leader in the fi eld of Drosophila neurobiology and genetics, presented an 
historical perspective on Drosophila visual system development, describing his many contributions 
starting with his work with Seymour Benzer. In addition, the meeting included reports of im-
portant advances in the development of the nervous system, the perception of external stimuli, in 
particular olfactory cues, by the fl y, and the design of new technology. A signifi cant shift was clear 
T. Clandinin, L. Restifo
Banquet toast
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in that many of the talks concerned circuits and behavior, rather than development and studies of 
sensory systems. The Elkins Award plenary lecture was presented by Dr. Jan Melom (now at Stan-
ford University) based on her extraordinary doctoral dissertation research at MIT in the lab of Troy 
Littleton. The environment of the meeting allowed many opportunities for informal discussions 
among all participants. The high quality of the presentations, the ongoing development of novel 
techniques, and the exciting new directions of Drosophila research toward circuits and behavior, as 
well as disease models, demonstrate the vitality of this interdisciplinary research area. Discussions 
at the meeting led to cross-fostering of ideas that was valuable to everyone in the fi eld.
This meeting was funded, in part, by the National Institute of Neurological Disorders and 
Stroke, a branch of the National Institutes of Health.
PROGRAM
Brain, Behavior, and Evolution
Chairperson: K. Siwicki, Swarthmore College, Pennsylvania
Neural Circuits
Chairperson: G. Turner, Cold Spring Harbor Laboratory
Synapses
Chairperson: N. Reist, Colorado State University, Fort Collins
Elkins Memorial Lecture: Visualizing Calcium: Insights 
into Quantal Synaptic Transmission and Cortex Glial 
Function
J. Melom, Massachusetts Institute of Technology, Cambridge
Neural Development
Chairperson: W. Grueber, Columbia University, New York
Neuroscience Medley
Chairperson: L. Restifo, University of Arizona, Tucson
Seymour Benzer Lecture
L. Zipursky, HHMI/University of California, Los Angeles
Higher-Order Brain Function
Chairperson: U. Heberlein, HHMI/Janelia Farm Research 
Campus, Ashburn, Virginia
Disease Models
Chairperson: A. Schenk, Radboud University Nijmegen, 
The Netherlands
Technology
Chairperson: M. Nitabach, Yale University School of Medicine, 
New Haven, Connecticut
L. Zipursky, J. Simpson
E. Storkebaum, H. Scholz, A. Schenck
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Cell Death
October 8–12 246 Participants
ARRANGED BY Douglas Green, St. Jude Children’s Research Hospital
 Sally Kornbluth, Duke University
 Scott Lowe, Memorial Sloan-Kettering Cancer Center
This 10th meeting was regarded by many present as perhaps 
the best cell death meeting in years. More than 50 outstand-
ing presentations and lively discussions centered on topics in 
the fi eld of cell death (see list below).
The keynote lectures were given by Karen Vousden, who 
spoke on p53 and the control of metabolic stress in cell death 
and survival, and David Andrews, who presented cutting-
edge research on the function of Bcl-2 proteins in controlling 
the mitochondrial pathway of apoptosis. Other highlights: 
Shige Nagata presented on the mechanisms of phosphati-
dylserine externalization in response to calcium and during 
apoptosis; Vishva Dixit spoke on the unexpected lethal ef-
fects of a kinase-dead RIPK3 mutation that promotes apo-
ptosis via caspase-8; Guy Salvesen presented on the protease 
clan that includes the caspases, and how related biochemistry interfaces with cell death pathways; 
Loren Walensky spoke on the design of therapeutic peptides controlling Bcl-2 interactions not 
only in cell death, but also glucokinase control in diabetes; Andreas Strasser presented stunning 
developmental analysis of defects caused by the elimination of the three pro-apoptotic effectors, 
Bax, Bak, and Bok, and how these contribute, or not, to different tissues; Tony Letai talked 
about the application of detection of mitochondrial “priming” for apoptosis as a biomarker for 
cancer therapy; Junying Yuan presented new data on inhibitors of necroptosis via blockade of 
RIPK1; and Peter Sorger presented systems analysis of single-
cell studies on caspase activation leading, or not, to cell death. 
Many other talks explored extensive progress in interrogating 
the functions of the Bcl-2 proteins, the interface of metabo-
lism and cell death, and the functions of cell death in develop-
ment, cancer, and immunity, among other topics. By limiting 
the total number of talks, discussion remained lively and did 
not have to be curtailed, and sessions were completed more or 
less on time. Many commented that this made the meeting 
less stressful than previous meetings, and more productive in 
terms of exploration of new ideas.
A total of 140 posters were also presented in two sessions, 
one held traditionally in the afternoon prior to the wine and 
cheese reception, and another held during the morning. The 
morning session attracted very active discussion and essential-
ly complete attendance, suggesting that this approach might 
be continued in future meetings.
In retrospect, it should not be surprising that the fi eld of cell 
death remains enormously exciting and vibrant more than 20 years after its “rebirth” in the early 
1990s. Cell death is a fundamental biological process, and as we gain insights into its mechanisms, 
D. Green, S. Kornbluth
L. Bouchier-Hayes, B. Murphy
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we unveil new processes and phenomena with deep implications. The therapeutic control of cell 
death, as presented at the meeting, has entered the clinic with striking effects, and we suspect this 
is just the beginning. The next meeting will be even better, we are sure.
This meeting was funded, in part, by the National Cancer Institute and the National Institute 
on Aging, branches of the National Institutes of Health.
PROGRAM
Keynote Speakers
D. Green, St. Jude Children’s Research Hospital, Memphis, 
Tennessee; K. Vousden, Beatson Institute for Cancer Research, 
Bearsden, United Kingdom; D. Andrews, Sunnybrook 
Research Institute, University of Toronto, Canada
Infl ammation/Immunity
Chairpersons: V. Dixit, Genentech Inc., South San Francisco, 
California; S. Nagata, Kyoto University, Japan
Molecular Mechanisms I
Chairperson: H. Wu, Boston Children’s Hospital, Harvard 
Medical School, Massachusetts
Metabolism
Chairpersons: T. Mak, Ontario Cancer Institute, Toronto, 
Canada; J. Opferman, St. Jude Children’s Research Hospital, 
Memphis, Tennessee
V. Dixit, T. Mak
K. Lindblom, K. Cocce S. Joshi, G. Liccardi
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BCL-2 Family Get-Together I
Chairperson: L. Walensky, Dana-Farber Cancer Institute, 
Boston, Massachusetts
BCL-2 Family Get-Together II
Chairperson: A. Strasser, Walter & Eliza Hall Institute of 
Medical Research, Parkville, Australia
Model Organisms
Chairpersons: J.M. Hardwick, Johns Hopkins University, 
Baltimore, Maryland; K. White, Massachusetts General 
Hospital, Harvard Medical School, Boston
Cancer
Chairpersons: J. Abrams, University of Texas Southwestern 
Medical School, Dallas; S. Kornbluth, Duke University 
School of Medicine, Durham, North Carolina
Targets and Therapies
Chairpersons: S. Lowe, Memorial Sloan-Kettering Cancer 
Center, New York; E. White, Rutgers University/The Cancer 
Institute of New Jersey, New Brunswick
Nonapoptotic Cell Death
Chairpersons: D. Green, St. Jude Children’s Research Hospital, 
Memphis, Tennessee; J. Yuan, Harvard Medical School, 
Boston, Massachusetts
Molecular Mechanisms II
Chairperson: G. Salvesen, Sanford-Burnham Medical Research 
Institute, La Jolla, California
Survival Strategies
Chairpersons: S. Martin, Trinity College Dublin, Ireland; 
R. Youle, NINDS, National Institutes of Health, Bethesda, 
Maryland
A. Dbrot, M. Miura
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History of Restriction Enzymes
October 19–21 99 Participants
ARRANGED BY Herbert Boyer, University of California, San Francisco
 Stuart Linn, University of California, Berkeley
 Mila Pollock, Cold Spring Harbor Laboratory
 Richard Roberts, New England BioLabs
This lively and productive meeting was organized by Herb Boyer, Stu Linn, Rich Roberts, and 
Mila Pollock. Herb Boyer is a restriction enzyme and recombinant DNA pioneer and cofounder of 
Genentech; Stu Linn is a restriction enzyme pioneer and professor at the University of California 
at Berkeley; Rich Roberts is a restriction enzyme and gene splicing pioneer, Nobel laureate, and 
chief scientifi c offi cer of New England BioLabs; and Mila Pollock is the executive director of the 
CSHL Library & Archives. This was the fi fth international meeting on the history of science co-
organized by the CSHL Library & Archives. It was the fi rst to bring together the scientists who 
were involved with the discoveries and research on restriction enzymes dating back to the 1950s 
and covering developments to the present time.
The meeting was attended by more than 150 scientists, history of science scholars/authors, edu-
cators, students, and members of the CSHL community. It included sessions on the beginnings 
of the fi eld, the growth of the restriction enzyme fi eld, the development of restriction enzymes 
into commercial reagents, cloning and sequencing of restriction modifi cation (RM) systems, the 
biochemistry of restriction enzymes, and structural studies of restriction enzymes.
A highlight of the meeting was a special toast to meeting co-organizer Rich Roberts, a presen-
tation titled, Restriction Enzymes: Between Nature, Culture, and Politics, by historian of science 
and medicine and author Bruno Strasser. Other highlights included a poster session with poster 
presentations by nine restriction enzyme research groups and one historian of science/author; 
short contributions, including reminiscences of life in the restriction enzymes research commu-
nity, by Robert Yuan, Lise Raleigh, David Dryden, Ichizo Kobayashi, and others; and a summa-
rization of the meeting by Stu Linn, which included commentary on the importance of meetings, 
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collaborations, and short visits to other labs; the importance of “small science;” and “some hot and 
future items” for restriction and modifi cation studies.
What are restriction enzymes? Discovered in 1970, restriction enzymes cleave DNA at specifi c 
recognition sites and have many uses in molecular biology, genetics, and biotechnology. More 
than 4000 restriction enzymes are known today, of which more than 620 are commercially avail-
able. The 1978 Nobel Prize in Physiology or Medicine was awarded jointly to Werner Arber, Dan 
Nathans, and Hamilton Smith for the discovery of “restriction enzymes and their application 
to problems of molecular genetics.” Werner Arber and Hamilton Smith both participated in the 
CSHL meeting. (Dan Nathans passed away in 1999.)
Major support for this meeting was provided by Life Technologies, New England BioLabs, 
and ThermoFisher. Signifi cant support was provided by Genentech, Nippon, Promega, and 
 TAKARA/Clontech. Additional support was provided by Molecular Biology Resources.
PROGRAM
The Beginnings of the Field
Chairperson: S. Linn, University of California, Berkeley
The Restriction Enzyme Field Begins to Grow
Chairperson: D. Dryden, University of Edinburgh, 
United Kingdom
Restriction Enzymes Become Commercial Reagents
Chairperson: S. Chandrasegaran, Johns Hopkins University, 
Baltimore
B. Stillman, H. Smith S. Linn, M. Meselson B. Strasser, J.D. Watson
A. Creager, B. Ames J. Josephsen, D. Dryden
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Conversations: Commercialization
Cloning and Sequencing of RM Systems
Chairperson: H. Smith, J. Craig Venter Institute, La Jolla, 
California
The Biochemistry of Restriction Enzymes
Chairperson: V. Nagaraja, Indian Institute of Science, 
Bangalore, India
Structural Studies
Chairperson: Herb Boyer, University of California, 
San Francisco
Short Contributions and Summary
Chairperson: R. Roberts, New England BioLabs, Ipswich
M. Pollock, J. Rosenberg, H. Boyer R. Roberts, T. Kelly
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Genome Informatics
October 30–November 2 305 Participants
ARRANGED BY Jennifer Harrow, Wellcome Trust Sanger Institute
 Michael Schatz, Cold Spring Harbor Laboratory
 James Taylor, Emory University
This 13th Cold Spring Harbor Laboratory/
Wellcome Trust conference was held at Cold 
Spring Harbor, New York. The conference series 
continues to demonstrate a robust attendance, 
both from the United States and from abroad. 
It attracted more than 300 registrants present-
ing 208 abstracts and offered a snapshot of the 
latest developments in the fi eld. There were 12 
invited talks and two keynote addresses. The 
remaining 36 talks were all selected for presen-
tation by session chairs from openly submitted 
abstracts.
This year, abstracts covered a wide variety 
of genomic analyses, with a special emphasis 
on population-wide analysis across multiple 
cell types, individuals, and species driven by 
the massively increased availability of sequence 
data. There was also a focus on emerging biotechnologies for single-molecule analysis and other 
biochemical assays. The sessions in the conference are listed below.
The fi rst keynote address was delivered by Dr. Michael Snyder, who focused on the possibilities 
enabled by detailed longitudinal multiomics assays of individuals, exemplifi ed by his own medical 
records that he calls the “Synderome.” He described how he has regularly had his transcriptional 
and metabolic profi les recorded for several years, leading him to adjust his diet and lifestyle to 
J. Harrow, M. Schatz, J. Taylor
B. Rao, K. Rao (father and son) S. Pai, E. Mukamel, L. Carmel
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combat the prediabetic state that he was developing. The second keynote was delivered by Dr. 
Lior Pachter, whose keynote address, titled “Stories from the Supplement,” emphasized the need 
for rigorous computational and analytic methods for analyzing genomic data, with an emphasis 
on the challenges in transcriptome profi ling. Both talks were extremely well regarded, with much 
follow-up discussion.
This meeting was also one of the fi rst CSHL meetings to be completely open on Twitter (using 
hashtag #gi2013). More than 2000 messages were broadcasted by users around the world to dis-
cuss and debate the ideas presented.
This meeting was funded, in part, by the National Human Genome Research Institute, a 
branch of the National Institutes of Health.
PROGRAM
Databases, Data Mining, Visualization, and Curation
Chairpersons: C. Bult, The Jackson Laboratory, Bar Harbor, 
Maine; M. Fiume, University of Toronto, Canada
Keynote Speaker I
M. Snyder, Stanford University School of Medicine, 
California
Transcriptomics, Alternative Splicing, and Gene 
 Predictions
Chairpersons: C. Burge, Massachusetts Institute of Technology, 
Cambridge; M. Stanke, University of Greifswald, Germany
Sequencing Pipelines and Assembly
Chairpersons: I. Korf, University of California, Davis; 
A. Quinlan, University of Virginia, Charlottesville
Comparative and Evolutionary Genomics
Chairpersons: J. Ma, University of Illinois, Urbana-
Champaign; H. Roest Crollius, Ecole Normale Supérieure, 
Paris, France
Epigenomics and Noncoding Genome
Chairpersons: R. Lister, University of Western Australia, Perth; 
A. Marques, University of Oxford, United Kingdom
Keynote Speaker II
L. Pachter, University of California, Berkeley
Population and Personal Genomics
Chairpersons: Y. Erlich, Whitehead Institute, Cambridge, 
Massachusetts; D. MacArthur, Massachusetts General 
Hospital, Boston
J. Trinh, N. Pearson J. Davila, H. Fang
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Cell Biology of Yeasts
November 5–9 178 Participants
ARRANGED BY Martha Cyert, Stanford University
 Daniel Lew, Duke University
 Kenneth Sawin, University of Edinburgh
This inaugural conference is a direct descendant of the 
Yeast Cell Biology meeting, and it can be considered the 
15th biannual international meeting devoted to diverse as-
pects of cell biology in yeasts. However, the slight name 
change refl ects a new emphasis on expanding beyond the 
traditional focus on baker’s yeast to include other ascomy-
cetes, particularly fi ssion yeast. Recruitment of Ken Sawin, 
an accomplished researcher working on the fi ssion yeast cy-
toskeleton, as a meeting organizer helped us to recruit an 
impressive panel of session chairs including Sir Paul Nurse 
(Nobel Prize winner for cell cycle studies in fi ssion yeast), 
representing many fi elds of cell biology in both yeasts. The 
resulting meeting had an exciting mix of research from the 
two systems, which highlighted both deep conservation 
(e.g., of Tor nutrient signaling, or kinetochore and spindle checkpoint pathways in the two sys-
tems) and remarkable differences in the way that the different systems use conserved pathways 
(e.g., the mechanisms of polarization).
Among this year’s many highlights, diverse presentations featured new cutting-edge biophysi-
cal approaches using advances in single-particle tracking methodologies to address the mecha-
nisms of septin fi lament assembly (Amy Gladfelter), endocytosis (Marko Kaksonen), and ultra-
slow diffusion in yeast plasma membranes (Frans Bianchi). In a technical tour de force, Paul 
Nurse presented single-molecule DNA combing studies that analyzed enormous (up to 5 MB) 
DNA molecules, revealing hitherto unappreciated large-scale clustering in the pattern of DNA 
replication origin fi ring during S phase. And creative and ingenious approaches were presented 
to measure rare “escape events” from chromatin silencing (Jasper Rine’s lab), to reveal unex-
pected aspects of the pheromone signaling pathway using periodic stimulation (Tim Elston and 
Beverly Errede labs), and to map the order of chaperone actions during protein folding (Michael 
 McMurray lab).
Several presentations solved long-standing puzzles. For example, Peter Pryciak revealed the 
detailed mechanism whereby the mating pathway actually blocks cell cycle progression; Yoshi 
Watanabe in fi ssion yeast and Sue Biggins in budding yeast revealed the detailed mechanism 
whereby checkpoint components are recruited to kinetochores. Others identifi ed new cell bio-
logical phenomena—for example, mega-autophagy during meiosis and sporulation, from Marc 
Meneghini’s lab, and mother-daughter differences in pH regulation leading to aging, from Dan 
Gottschling. And yet others discovered new kinds of mutant phenotypes revealing intriguing new 
puzzles in systems that we thought we understood (e.g., on the role of the nuclear envelope in 
maintaining the integrity of the microtubule-organizing center). In some areas, different experi-
ments provoked a stimulating clash of models (e.g., on size control in fi ssion yeast, or pheromone 
gradient tracking in budding yeast). And in all areas, presentations and posters led to enthusiastic 
questions and discussions.
K. Sawin, M. Cyert, D. Lew
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Although funding constraints and other factors 
relating to the November timing reduced atten-
dance at this year’s meeting, the combined yeasts 
meeting drew in many researchers who had never 
attended a Cold Spring Harbor meeting before, and 
attendees were very enthusiastic about the high level 
of the science at the meeting as well as its egalitarian 
format and intimate setting.
This meeting was funded, in part, by the Nation-
al Institute of General Medical Sciences, a branch of 
the National Institutes of Health; the National Sci-
ence Foundation; and Sunrise  Scientifi c.
PROGRAM
Cytoskeleton and Cytokinesis
Chairpersons: K. Gould, HHMI/Vanderbilt University, 
Nashville, Tennessee; M. Balasubramanian, Temasek Life 
Sciences Laboratory, Singapore
Membranes, Organelles, and Traffi c
Chairpersons: S. Lemmon, University of Miami, Florida; 
M. Kaksonen, EMBL Heidelberg, Germany
Polarity and Morphogenesis
Chairpersons: A. Gladfelter, Dartmouth College, Hanover, 
New Hampshire; D. Kovar, University of Chicago, Illinois
Stress Responses and Signaling
Chairpersons: K. Shiozaki, Nara Institute of Science & 
Technology, Japan; J. Frydman, Stanford University, California
Mating and Meiosis
Chairpersons: P. Pryciak, University of Massachusetts Medical 
School, Worcester; J. Thorner, University of California, 
Berkeley
Chromosomes and Mitosis
Chairpersons: S. Biggins, Fred Hutchinson Cancer Research 
Center, Seattle, Washington; Y. Watanabe, University of 
Tokyo, Japan
Cell Cycle Control and Proteolysis
Chairpersons: S. Emr, Cornell University, Ithaca, New York; 
P. Nurse, Francis Crick Institute, London, United Kingdom
Nuclear Structure and Function
Chairpersons: T. Davis, University of Washington, Seattle; 
J. Rine, University of California, Berkeley
D. Gottschling, A. Selmecki
J. Rine, A. Kachroo
P. Nurse, J. Pringle
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Precision Medicine: Personal Genomes and Pharmacogenomics
November 13–16 171 Participants
ARRANGED BY Ann Daly, Newcastle University Medical School, United Kingdom
 Nicholas Katsanis, Duke University
 Deanna Kroetz, University of California, San Francisco
 Jim Lupski, Baylor College of Medicine
This sixth meeting on Personal Genomes again combined 
both the content of the Personal Genomes Meeting and 
that of the Pharmacogenomics Meeting to bring together 
scientifi c communities interested in gleaning medically 
actionable information from individual personal genomes. 
The meeting was titled “Precision Medicine: Personal 
 Genomes and Pharmacogenomics” as a further step to-
wards precision medicine that utilizes genomic information 
to guide differential diagnoses and potentially optimizing 
and directing therapeutic interventions based on individ-
ual genetic/genomic variation. The meeting was initiated 
with an outstanding and personal presentation from Hugh 
Rienhoff, who spoke about his quest to fi nd the underly-
ing genetic susceptibility/contribution(s) to his daughter’s 
phenotype—highlighting the challenges his family faced seeking a diagnosis for a condition not 
known to exist. Hugh’s struggles as a parent were paralleled by his struggles as a scientist and 
medical geneticist who identifi es a novel gene and is faced with the burden of proof for causality. 
The keynote speaker was both heartening and humbling in that the power of defi ning disease at 
the molecular level was apparent, yet our ignorance was further revealed. The keynote address 
was followed by a terrifi c Opening Session with a series of talks on genomics to guide differential 
diagnosis and therapy in which it became obvious that personal genomes are being used around 
the world at the leading medical institutions by thought leaders in genomics who are trying to 
leverage the clinical utility of information that can be gleaned from personal genomes. It ended 
with a powerful description of the United Kingdom 100,000 clinical genomes project. The sec-
ond session dealt with somatic cell genomics 
and cancer, and the third on germline genom-
ics emphasizing Mendelizing traits and locus 
heterogeneity. Three other sessions included 
genomic variation and common traits/dis-
ease, clinical integration of genomic variation 
with particular reference to recent advances 
in pharmacogenomics and evolving genomic 
technologies. An obvious change over last 
year’s meeting was the sheer amount of data 
and talks that discussed 1000 clinical exomes 
or 1000 trio analyses of exomes from chil-
dren with developmental disabilities! A lively 
and informative ethics panel was presented 
in which challenges of incidental or second-
ary fi ndings were discussed in the context of 
N. Katsanis, A. Daly, D. Kroetz, J. Lupski
E. Kiruluta, M. Reese, E. Mardis, M. Singleton
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whether these were something to fear or clinical opportunities to help both physicians and pa-
tients contextualize their genetic susceptibilities. Finally, a keynote address was given by Richard 
Durbin on human genome sequencing from reference to populations to individuals that discussed 
some of the remarkable progress during this journey. The insights from an individual who has had 
a large role in leading us down some of the paths were indeed thought provoking. Overall, the 
meeting was a celebration of the advances of genomic technologies as they transition to personal 
application, but it also served as a sobering reminder of the magnitude of the task ahead with 
regard to interpretation and the fundamental, largely unsolved, challenges in distilling clinically 
actionable items from personal genomes.
This meeting was funded, in part, by the National Institute of General Medical Sciences, 
a branch of the National Institutes of Health; Life Technologies; Real Time Genomics; and 
 Illumina.
PROGRAM
Genomics to Guide Differential Diagnosis and Therapy
Chairperson: J. Lupski, Baylor College of Medicine, Houston, 
Texas
Keynote Speaker
H.Y. Rienhoff, Jr., Children’s Hospital Oakland Research 
Institute, San Carlos, California
Somatic Cell Genomics and Cancer
Chairperson: D. Kroetz, University of California, 
San Francisco
Germline Genomics, Mendelizing Traits, and Locus 
 Heterogeneity
Chairperson: L. Biesecker, NHGRI, National Institutes of 
Health, Bethesda, Maryland
Genomic Variation in Common Traits/Disease
Chairperson: R. Durbin, Wellcome Trust Sanger Institute, 
Hinxton, United Kingdom
Clinical Integration of Genomic Variation
Chairperson: A. Daly, Newcastle University Medical School, 
United Kingdom
Ethics Panel: Incidental Findings or Good Medical 
 Practice?
Moderator: N. Katsanis, Duke University, Durham, 
North Carolina
Evolving Genomic Technologies
Chairperson: R. Gibbs, Baylor College of Medicine, Houston, 
Texas
Keynote Speaker
R. Durbin, Wellcome Trust Sanger Institute, Hinxton, 
United Kingdom
S. Santos, R. Karni H. Fang, G. Highnam S. Jhangiani, C. Van Diemen
283-422_Meetings & Courses.indb   350 8/28/2014   10:51:54 AM
351
Harnessing Immunity to Prevent and Treat Disease
November 20–23 107 Participants
ARRANGED BY Susan Kaech, HHMI/Yale University
 Robert Seder, Vaccine Research Center, NIAID, National Institutes of Health
 Susan Swain, University of Massachusetts Medical School
Participants at this broad-based meeting explored the design of novel vaccines, the immune re-
sponse, and delivery systems. Three keynote addresses were delivered by internationally renowned 
scientists Michel Nussenzweig, Rafi  Ahmed, and Antonio Lanzavecchia.
The focal points of the scientifi c sessions are listed below. There were 32 talks and 41 post-
ers of largely unpublished work presented on these topics, with a signifi cant amount of lively 
discussion. The 2013 conference was the last of a long series of meetings. The participating sci-
entists in this fi eld look forward to the incorporation of these issues into related CSHL meetings 
in the future.
This meeting was funded, in part, by the National Institute of Allergy and Infectious Diseases, 
a branch of the National Institutes of Health.
PROGRAM
Keynote Address: Harnessing Immunity to Prevent and 
Treat HIV Infection
M. Nussenzweig, HHMI/The Rockefeller University
Innate Programming of Adaptive Immunity
Chairperson: K. Fitzgerald, University of Massachusetts 
Medical School, Worcester
Organ-Specifi c Immunity I
Chairperson: S. Kaech, HHMI/Yale University, New Haven, 
Connecticut
Keynote Address: Human Immune Memory to Vaccination
R. Ahmed, Emory University School of Medicine
Transcriptional and Metabolic Control of Adaptive 
 Immunity
Chairperson: E.J. Wherry, University of Pennsylvania School of 
Medicine, Philadelphia
Organ-Specifi c Immunity II
Chairperson: Y. Belkaid, NIAID, National Institutes of 
Health, Bethesda, Maryland
R. Lier, S. Kaech S. Nedospasov, L. Delamarre
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The Impact of Age on Immunity
Chairperson: J. Goronzy, Stanford University School of 
Medicine, California
Keynote Address: Analytic Vaccinology
A. Lanzavecchia, Institute for Research in Biomedicine, 
Switzerland
The Immunological Ascent of Man
Chairperson: R. Seder, Vaccine Research Center, NIAID, 
National Institutes of Health, Bethesda, Maryland
K. Vora, R. Ahmed K. Yadava J. Yu, A. Lanzavecchia
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Plant Genomes and Biotechnology: From Genes to Networks
December 4–7 124 Participants
ARRANGED BY Mary Lou Guerinot, Dartmouth College
 Todd Mockler, Donald Danforth Plants Science Center
 Detlef Weigel, Max-Planck Institute for Developmental Biology
This eighth Cold Spring Harbor Laboratory conference 
continued to demonstrate a robust attendance, both from 
the United States and from abroad. It attracted more than 
120 registrants, presenting over 94 abstracts, offering a 
snapshot of the latest developments in the fi elds of plant 
genomics, biotechnology, and systems biology. There were 
35 invited talks and one keynote address. The remaining 
59 talks were all selected for presentation by the organizers 
from openly submitted abstracts.
This year, abstracts covered a wide variety of topics in 
modern plant biology, including gene regulatory networks, 
in vivo imaging technologies, plant genome analysis, ge-
nome assembly, epigenetics/epigenomics, natural variation, 
diurnal and circadian rhythms, synthetic pathway engi-
neering, plant hormone signaling, and developmental reg-
ulation. There was also an emphasis on emerging high-throughput controlled-environment and 
fi eld-based phenotyping systems complementary to parallel developments in ‘omics technologies 
that together enable genotype–phenotype associations. There were also talks of broad interest to 
the plant science community, including presentations on the Bill & Melinda Gates Foundation’s 
investments in agricultural research and development and the iPlant Collaborative’s unifi ed cyber-
infrastructure for plant science. The sessions in the conference are listed below.
The keynote address was delivered by Dr. Joseph Ecker, who discussed the layering of multiple 
levels of ‘omics assays in Arabidopsis to understand the system underlying gene regulation and the 
interactions of gene network components with the genome itself. Dr. Ecker’s talk emphasized a 
number of technologies for whole-genome analysis in Arabidopsis that were pioneered in his lab 
and emphasized the need for a holistic view involving multiple ‘omics approaches coupled with 
T. Mockler, D. Weigel, M.L. Guerinot
D. Ware, G. Giuliano J. Nemhauser, R. Simon
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genetics to understand the plant cell as a system. This talk was extremely well received and gener-
ated an active follow-up discussion.
This meeting was also the fi rst CSHL Plant Genomes and Biotechnology conference to be 
completely open on Twitter (using hashtag #cshlplant13).
PROGRAM
New Frontiers
Chairperson: D. Weigel, Max-Planck Institute for 
Developmental Biology, Tübingen, Germany
Synthetic Biology and Networks
Chairperson: I. Lee, Yonsei University, Seoul, Korea
Abiotic and Biotic Signals
Chairperson: M.L. Guerinot, Dartmouth College, Hanover, 
New Hampshire
Epigenetics
Chairperson: J. Parker, Max-Planck Institute for Plant 
Breeding Research, Cologne, Germany
Biodiversity and Adaptation
Chairperson: L. Hererra-Estrella, National Polytechnic 
Institute, Irapuato, Mexico
Hormones and Development
Chairperson: S. Mackenzie, University of Nebraska, 
Lincoln
Keynote Speaker
J. Ecker, HHMI/The Salk Institute, San Diego, California
Genotype–Phenotype Map
Chairperson: J. Nemhauser, University of Washington, 
Seattle
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Rat Genomics and Models
December 11–14 133 Participants
ARRANGED BY Edwin Cuppen, Hubrecht Institute, The Netherlands
 Aron Geurts, Medical College of Wisconsin
 Michael Gould, University of Wisconsin, Madison
 Bina Joe, University of Toledo College of Medicine
This eighth winter biotechnology conference has been held biannually since 1999 at Cold Spring 
Harbor Laboratory and is the fi rst in the United States to focus exclusively on the unique physi-
ological and genetic relevance of the rat as a model organism for biomedical research into the 
molecular origins of human diseases. A complementary meeting outside of the United States is 
held in the alternating years, with the most recent meetings being held in Cambridge, United 
Kingdom (2012), Kyoto, Japan (2010), Hinxton, United Kingdom (2008), and Melbourne, Aus-
tralia (2006). The primary goals of this meeting were to (1) promote interactions among biomedi-
cal researchers who use rat models in the study of emerging technology, genomics, physiology, 
pathophysiology, metabolism, neuroscience, and oncology; (2) provide young investigators and 
trainees an opportunity to network with leaders in the rat genomics community; and (3) provide 
an interface between the research community and the entities that support biomedical research in 
which rat models are used.
The meeting was organized into six sessions featuring both invited speakers and those selected 
from submitted abstracts. An opening keynote lecture featured Dr. Ross Hardison, who described 
his ongoing interest in the rat as a means to understand the impact of genomics and epigenetic 
analysis to dissect out causative variants and uncover mechanistic insights into physiology and 
pathology.
Chairpersons and sessions are listed below. Invited speakers featured for each session were Dr. 
Tomoji Mashimo (Session 1); Drs. Timothy Aitman, Paul Flicek, and Norbert Hübner (Session 
2); Drs. James Shull and David Samuelson (Session 3); Drs. Percio Gulko, Steve Britton, and 
E. Cuppen, A. Geurts, B. Joe, M. Gould
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Elizabeth Blankenhorn (Session 4); Drs. Mingyu Liang and Ted Kurtz (Session 5); and Drs. Boris 
Tabakoff and Fabio Cruz (Session 6).
The closing keynote address featured Dr. Howard Jacob, who was the original founder of 
the conference series and longtime champion of rat genomics. He discussed strategies for the rat 
community to move successfully and collaboratively forward in a diffi cult funding environment 
by capitalizing on human genetics and the excellent physiological and disease models that the 
rat community has developed. In sum, it is clear that this conference serves an important role in 
meeting the needs of those in the biomedical research community who use rat models in genetics 
and genomics-based research. The organizers and attendees expressed high enthusiasm for con-
tinuing the present biannual meeting format at Cold Spring Harbor Laboratory and other sites in 
the intervening years.
PROGRAM
Keynote Speaker
R. Hardison, Pennsylvania State University, State College
Emerging Technologies: Stem Cells and Genome 
 Manipulation
Chairperson: A. Geurts, Medical College of Wisconsin, 
Milwaukee
Genomics, Epigenetics, and Integrative Biology
Chairperson: E. Cuppen, Hubrecht Institute, Utrecht, 
The Netherlands
Tumor Biology
Chairperson: M. Gould, University of Wisconsin, Madison
Metabolism, Infl ammation, and Exercise Physiology
Chairperson: A. Kwitek, University of Iowa, Iowa City
Cardiovascular Diseases
Chairperson: B. Joe, University of Toledo College of Medicine, 
Ohio
Neurobiology, Behavior, and Addiction
Chairperson: A. Geurts, Medical College of Wisconsin, 
Milwaukee
Keynote Speaker
H. Jacob, Medical College of Wisconsin, Milwaukee
H. Jacob, N. Hubner O. Hummel, C. Mieth, K. Saar P. Gellar
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POSTGRADUATE COURSES
Workshop on Leadership in Bioscience
February 22–25
INSTRUCTORS C.M. Cohen, Science Management Associates
 D. Kennedy, Workshop Cofacilitator
This was a highly interactive 3.5-day workshop in which participants developed the skills nec-
essary to lead and interact effectively with others, in both one-on-one and group settings. The 
workshop focused on techniques, situations, and challenges that relate specifi cally to leading and 
managing in the scientifi c workplace. It emphasized learning by doing and involved role playing, 
giving and receiving feedback, and group problem solving. Much of the learning was peer-to-peer. 
Participants were expected to discuss their own experiences and listen to others as they discuss 
theirs. The workshop helped participants identify areas where they need guidance and growth, 
as well as how to capitalize on areas of strength. Participants had the opportunity to share their 
experiences and challenges with others and to receive feedback and guidance from others with 
experience in leading scientists in a variety of settings. At the end of the course, participants were 
linked through a unique on-line community in which they continued learning from one another 
and from the course instructors.
This course was supported with generous support from American Express Philanthropy.
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PARTICIPANTS
Ahmari, S., Ph.D., Columbia University, New York
Carter, M., Ph.D., Center for Disease Control and 
Prevention, Atlanta, Georgia
Chen, P., Ph.D., Kessler Foundation, West Orange, 
New Jersey
Crowder, R., Ph.D., Penn State, Milton S. Hershey Medical 
Center, Hershey, Pennsylvania
Fantana, A., Ph.D., Bowling Green State University, Ohio
Gutteling, E., Ph.D., Rijik Zwaan Breeding BV, 
The Netherlands
Hamerlik, P., M.D., Danish Cancer Society Research Center, 
Denmark
Hanlon, C., Ph.D., Medical University of South Carolina, 
Charleston
Kain, J., Ph.D., Harvard University, Cambridge, 
Massachusetts
Karst, A., Ph.D., Dana-Farber Cancer Institute, Boston, 
Massachusetts
Krause, S., Ph.D., Boston Children’s Hospital, Boston, 
Massachusetts
Kvaskoff, M., Ph.D., Harvard Medical School, Cambridge, 
Massachusetts
Lee, J., Ph.D., ArQule, Woburn, Massachusetts
Marie, C., Ph.D., University of Virginia, Charlottesville
McKay, S., M.S., University of Vermont, Burlington
Norholm, M., Ph.D., Technical University of Denmark
Noustos, C., Ph.D., Cold Spring Harbor Laboratory
Ray, R., Ph.D., Baylor College of Medicine, Houston, 
Texas
Reis, T., Ph.D., University of Colorado Medical School, 
Aurora
Schweizer B.A., Ph.D., University of Pennsylvania, 
Philadelphia
Seib, P., Ph.D., University of Strathclyde, Glasgow, 
Germany
Timmes, A., B.S., Rocky Mountain Laboratories, Hamilton, 
Montana
Tseng, K., Ph.D., University of Nevada, Las Vegas
Ulrich, T., Ph.D., Massachusetts Institute of Technology, 
Cambridge
Wang, Kai, Ph.D., University of Southern California, Los 
Angeles
White, E., Ph.D., Harvard Medical School, Cambridge, 
Massachusetts
SEMINAR
Miller, K. Brown University, Providence, Rhode Island: 
Science in the public eye.
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Protein Puriﬁ cation and Characterization
April 3–16
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
 A. Courey, University of California, Los Angeles
 S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
 M. Marr, Brandeis University, Waltham, Massachusetts
ASSISTANTS S. Callaci, University of Wisconsin, Madison
 M. Donovan, Brandeis University, Waltham, Massachusetts
 P. Kwong, University of California, Los Angeles
 Y.-C. Lee, M.D. Anderson Cancer Center/University of Texas, Houston
 M. Spellberg, Brandeis University, Waltham, Massachusetts
 N. Thompson, University of Wisconsin, Madison
 W. Turki-Judeh, University of California, Los Angeles
This course was for scientists who were unfamiliar with techniques of protein isolation and char-
acterization. The course was extremely rigorous and included laboratory work during the days, as 
well as lectures with discussions and student talks in the evenings. Students are typically graduate 
students, postdoctoral scholars, staff scientists, and professors with specialized scientifi c expertise 
who now need to learn about protein purifi cation and characterization. The course emphasized 
laboratory strategies and current best practices in the fi eld.
Each student in the course became familiar with major techniques in protein purifi cation by 
performing four separate isolations: (1) a regulatory protein (calmodulin) from muscle tissue 
(chicken gizzards), (2) a sequence-specifi c DNA-binding protein (transcription factor AP1) from 
HeLa cell nuclei, (3) a recombinant protein overexpressed as inclusion bodies in E. coli, and (4) a 
membrane-bound protein (insulin receptor) from rat liver.
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Students were divided into four groups of four and spent three days in each of the above four 
modules. In addition to the primary purifi cation in a given module, a number of relevant char-
acterizations were performed on each protein, giving students experience with immunological 
and biochemical assays, peptide mapping, protein sequencing, and mass spectrometry. Students 
learned bulk fractionation and electrophoretic and chromatographic techniques, including pre-
cipitation by salts, pH, and ionic polymers; ion exchange, gel fi ltration, hydrophobic interaction, 
and reverse-phase chromatography; lectin affi nity, ligand affi nity, oligonucleotide affi nity, and 
immunoaffi nity chromatography; polyacrylamide gel electrophoresis and electroblotting; and 
high- performance liquid chromatography. Students also learned procedures for solubilizing pro-
teins from inclusion bodies and refolding them into active monomeric forms. Evenings in the 
course involved lectures about topics that complement the laboratory curriculum: protein struc-
ture; modifi cation of proteins; methodologies for protein purifi cation, stabilization, and charac-
terization; and applications of protein biochemistry to molecular cell biology and cancer research.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Barrio, G.C., B.S., Gene Center, Munich, Germany
Basu, J., Ph.D., Lebanon Hospital Center, Bronx, New York
Chuang, C., Ph.D., M.D. Anderson Cancer Center, 
Houston, Texas
Fredens, J., M.S., University of Southern Denmark, Odense
Gomes, A., M.S., University of Copenhagen, Denmark
Jay, S., Ph.D., Brigham and Women’s Hospital, Cambridge, 
Massachusetts
Johnson, M., B.S., Texas A&M University, College Station
Manna, J., B.A., Vanderbilt University Medical Center, 
Nashville, Tennessee
McCoy, F., B.Sc., St. Jude Children’s Research Hospital, 
Memphis, Tennessee
Nelson, J., M.S., University of Amsterdam, The Netherlands
Quijada, J., B.S., Northeastern University, Boston, 
Massachusetts
Sami, F., Ph.D., Howard University, Washington, DC
Tsai, Y.C., Ph.D., National Cancer Institute, Frederick, 
Maryland
Wall, E., B.S., Virginia Commonwealth University, 
Richmond
Wylie, C.S., Ph.D., Brown University, Providence, 
Rhode Island
Yi, J. (Eva), Ph.D., University of Oklahoma, Norman
SEMINARS
Burgess, R., University of Wisconsin, Madison: Introduction 
to protein purifi cation. Doing protein purifi cation in the 
mid-60s and 1-second purifi cation today.
Courey, A., University of California, Los Angeles: System-
wide analyses of Groucho and SUMO in Drosophila.
Lazic, A., Nano Temper Technologies, San Francisco, 
California: Some like it hot: Biomolecule analytics using 
microscale, thermophoresis MST.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas: 
Secretome analysis of prostate cancer bone metastasis.
Marr, M., Brandeis University, Boston, Massachusetts: 
Multilevel control of gene expression in response to cellular 
stress.
Pappin, D., Cold Spring Harbor Laboratory: Introduction to 
mass spectrometry of proteins.
Thompson, N., University of Wisconsin, Madison: 
Monoclonal antibodies and gentle immunoaffi nity 
chromatography.
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Quantitative Imaging: From Cells to Molecules
April 3–16
INSTRUCTORS J. Waters, Harvard Medical School, Boston, Massachusetts
 T. Wittmann, University of California, San Francisco
CO-INSTRUCTORS L. Cameron, Dana-Farber Cancer Institute, Boston, Massachusetts
 B. Huang, University of California, San Francisco
 M. Krummel, University of California, San Francisco
ASSISTANTS R. Citron, University of California, San Francisco
 K. Corbin, University of California, San Francisco
 A. Ettinger, University of California, San Francisco
 T. Lambert, Washington State University, Pullman
 H. Pemble, University of California, San Francisco
This course focused on advanced quantitative fl uorescence microscopy techniques used for imag-
ing a range of biological specimens, from cells to single molecules. The course was designed for 
cell and molecular biologists, with little or no microscopy experience, who wish to begin using mi-
croscopy in their own research. Students gained a theoretical understanding of, and hands-on ex-
perience with, state-of-the-art equipment used in quantitative fl uorescence microscopy, including 
laser scanning and spinning disk confocal microscopy, deconvolution methods, total internal fl uo-
rescence microscopy (TIRF), super-resolution methods (structured illumination, STORM, and 
PALM), and digital image processing and analysis. Students learned how to design and implement 
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a wide range of imaging experiments using these techniques. They used the techniques to address 
specifi c quantitative questions and then discussed the results as a group, learning to troubleshoot 
the common problems that occurred in the course of a quantitative imaging experiment. Among 
the lectures presented were microscopy basics, CCD cameras, confocal microscopy, multiphoton 
microscopy, deconvolution, TIRF, single-molecule imaging, imaging ratiometric “biosensors” (in-
cluding FRET), and super-resolution techniques. Students also learned specimen preparation for 
microscopy, including fi xation and immunofl uorescence in tissue culture cells, choosing fl uores-
cent proteins, working with live samples requiring environmental control, and more.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Collu, G., Mount Sinai School of Medicine, New York
Das, A., Ph.D., National Heart, Lung, and Blood Institute, 
Bethesda, Maryland
Durham, N., B.Sc., Mount Sinai School of Medicine, 
New York
Evans, D., B.S., Mayo Clinic, Rochester, Minnesota
Githaka, J., B.Sc., University of Alberta, Edmonton, 
Canada
Ionescu, I., Ph.D., Max-Planck Institute of Psychiatry, 
Munich, Germany
Magadan, J., Ph.D., National Institutes of Health, Bethesda, 
Maryland
Montero, L., Paula, Ph.D., Harvard Medical School, Boston, 
Massachusetts
Pease, S., B.S., Harvard University, Cambridge, 
Massachusetts
Peters, N., Ph.D., Harvard Medical School, Boston, 
Massachusetts
Rino, J., Ph.D., Instituto de Medicina Molecular, Lisbon, 
Portugal
Salter, A., B.Sc., University of Manchester, United Kingdom
Spelke, D., B.S., University of California, Berkeley
Titov, D., Ph.D., Massachusetts General Hospital, Boston
Tyler, J., B.S., University of North Carolina, Chapel Hill
SEMINARS
Betzig, E., Janelia Farm Research Campus, Ashburn, 
Virginia: Improving the spatiotemporal resolution of 
fl uorescence microscopy.
Cameron, L., Dana-Farber Cancer Institute, Boston, 
Massachusetts: Confocal microscopy.
Huang, B., University of California, San Francisco: Super-
resolution microscopy: STORM/PALM. Super-resolution 
microscopy: Structured illumination. Life inside the cell.
Goodwin, P.l., Applied Precision, Inc., Issaquah, 
Washington: Deconvolution.
Krummel, M., University of California, San Francisco: 
TIRF. Principles, benefi ts, and application of multiphoton 
microscopy. Live imaging of immune cell dynamics in 
viable tissues.
Patterson, G., National Institutes of Health, Bethesda, 
Maryland: Fluorescent proteins.
Waters, J., Harvard Medical School, Boston, Massachusetts: 
Quantitative microscopy basics. Objective lenses. 
Transmitted light microscopy. Digital cameras. 
Quantitative digital imaging. Ratio imaging and FRET.
Wittmann, T., University of California, San Francisco: Live-
cell imaging. Live confocal, FRAP, and photoactivation. 
CLASP-mediated local exocytosis facilitates extracellular 
matrix degradation and focal adhesion turnover. Sample 
preparation for fl uorescence microscopy. Fluorescence 
microscopy.
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Cell and Developmental Biology of Xenopus
April 5–16
INSTRUCTORS A. Sater, University of Houston, Texas
 G. Thomsen, Stony Brook University, New York
ASSISTANTS T. Nakayama, University of Virginia, Charlottesville
 J. Oomen-Halagos, Stony Brook University, New York
 K. Pfi ster, University of Virginia, Charlottesville
Xenopus is the leading vertebrate model for the analysis of gene function in development. The 
combination of lineage analysis, gene-knockout strategies, experimental manipulation of the em-
bryo, and genomic/bioinformatic techniques makes it ideal for studies on the molecular control 
of embryo patterning, morphogenesis, and organogenesis. Moreover, recent advances in Xenopus 
genomics offer new opportunities to integrate computational strategies with experimental ap-
proaches. The course combined intensive laboratory training with daily lectures from recognized 
experts in the fi eld. Students learned both emerging technologies and classical techniques to study 
gene function in Xenopus development. An important element was the informal interaction be-
tween students and course faculty.
Technologies covered included oocyte and embryo culture, lineage analysis and experimen-
tal manipulation of embryos, time-lapse imaging of morphogenesis, gain- and loss-of-function 
analysis using mRNAs and antisense oligonucleotides, whole-mount in situ hybridization, im-
munocytochemistry, genomics and bioinformatics, chromatin immunoprecipitation, preparation 
of transgenic embryos, and use of Xenopus tropicalis for genetic analyses. This course was designed 
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for those new to the Xenopus fi eld, as well as for those wanting a refresher course in the emerging 
technologies. The course was open to investigators from all countries.
This course was supported with funds provided by the National Institute of Child Health and 
Human Development.
PARTICIPANTS
Barber, A., Ph.D., The University of East Anglia, Norwich, 
United Kingdom
Chowanadisai, W., Ph.D., University of California, Davis
De Domenico, E., Ph.D., MRC-National Institute for 
Medical Research, London, United Kingdom
Jevtic, P., B.S., University of Wyoming, Laramie
Kwon, T., Ph.D., Center for Systems and Synthetic Biology, 
Austin, Texas
O’Connell, L., Ph.D., Harvard University, Cambridge, 
Massachusetts
Petridou, N., B.Sc., University of Cyprus, Nicosia, Cyprus
Pickett, M., B.S., North Carolina State University, Raleigh
Reis, R.A., M.S., Federal University of Rio de Janeiro, 
Brazil
Reyes, C., B.S., University of Michigan, Ann Arbor
Schuh-Herta, S., Ph.D., Stanford University, Palo Alto, 
California
Shah, V., B.S., University of Houston, Texas
Smith, H., M.S., University of Texas, Austin
Speer, K., B.A., Perelman School of Medicine, Philadelphia, 
Pennsylvania
Tisler, M., Diplom., University of Hohenheim, Stuttgart, 
Germany
Zhu, K., B.S., Leiden University, The Netherlands
SEMINARS
El-Hodiri, H., Ohio State University, Columbus; The retinal 
homeobox (Rx) gene plays essential roles in the regenerating 
retina.
Gilchrist, M., National Institute for Medical Research, 
London, United Kingdom: Using high-resolution RNA-Seq 
data to untangle mechanisms of gene activation in early 
development.
Grainger, R., University of Virginia, Charlottesville: Analysis 
of eye formation in Xenopus: Model system for genetic 
and genomic studies of determination, induction, and 
organogenesis.
Hannon, G., Cold Spring Harbor Laboratory: A small RNA-
based immune system defends the germline against mobile 
elements.
Harland, R., University of California, Berkeley: Spemann’s 
organizer.
Keller, R., University of Virginia, Charlottesville: 
Gastrulation and morphogenesis.
Khokha, M., Yale University, New Haven, Connecticut: 
Modeling congenital heart disease genes in Xenopus.
Klein, P., University of Pennsylvania School of Medicine, 
Philadelphia: Mechanisms of Wnt signaling in early 
development.
Nakayama, T., University of Virginia, Charlottesville: 
Transgenic approaches for manipulating gene expression in 
Xenopus.
Peshkin, L., Harvard Medical School, Boston, Massachusetts: 
Quantitative molecular embryology: Coupled proteomic-
transcriptomic analysis reveals developmental strategies.
Shindo, A., HHMI/University of Texas, Austin: In vivo 
imaging of cellular and subcellular behaviors during 
morphogenesis.
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Workshop on Autism Spectrum Disorders
June 5–11
INSTRUCTORS D. Geschwind, University of California Center for Autism Research, Los Angeles
 P. Levitt, University of Southern California, Los Angeles
 S. Spence, Children’s Hospital Boston/Harvard University, Massachusetts
ASSISTANT N. Parikshak, University of California, Los Angeles
Autism spectrum disorders (ASD) are developmental disorders with complex phenotypes defi ned 
by a triad of symptoms that include disrupted social abilities, verbal and nonverbal communi-
cation skills, and restricted interests with repetitive behaviors. Co-occurring neurological and 
medical conditions are common in the disorder. The underlying etiology remains a mystery, but 
ASD is one of the most highly heritable of neuropsychiatric disorders. This workshop examined 
the dimensions of ASD on various levels, which included sessions on characteristics of the clinical 
syndrome, the neuropathology, imaging, and cognitive neuroscience studies that implicate cir-
cuits and systems involved in ASD, the current state of fi ndings from human genetics, concepts 
regarding the developmental neurobiological basis, the use of experimental models, and current 
etiological theories and hypotheses of ASD.
In addition to hearing about the most recent research in these areas, this course explored and 
debated controversial topics and challenges to basic assumptions in the fi eld. An exceptional 
faculty with diverse interests brought the most up-to-date results and theories to the students, 
making this workshop a valuable resource for young researchers starting out in this fast-moving 
and expansive fi eld. Not only did it help them build the foundation for their future research, it 
also introduced them to many potential collaborators working to understand ASD from different 
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disciplines. The workshop had hands-on exercises to complement the featured intense lecture ses-
sions. Importantly, students also had free time for reading, informal discussions, and recreation 
on the beautiful Banbury Center campus.
This course was supported with funds provided by the Nancy Lurie Marks Family  Foundation.
PARTICIPANTS
Albers Prock, L., M.D., Boston Children’s Hospital, Boston, 
Massachusetts
Barak, B., Ph.D., Massachusetts Institute of Technology, 
Cambridge
Boin Choi, A., M.Ed., Harvard Graduate School of 
Education, Cambridge, Massachusetts
Brimberg, L., Ph.D., Feinstein Institute for Medical 
Research, Manhasset, New York
Brumback, A., M.D., Ph.D., University of California, 
San Francisco
Burrows, E., Ph.D., Florey Institute of Neuroscience and 
Mental Health, Parkville, Victoria, Australia
Karhson, D., Ph.D., Tulane University, New Orleans, Louisiana
Kim, S., Ph.D., Stanford University, California
Kouser, M., Ph.D., University of Texas Southwestern Medical 
Center, Dallas
Levin, A., M.D., Boston Children’s Hospital, Boston, 
Massachusetts
Makhlouf, M., Ph.D., Diderot University, Paris, 
France
Miodovnik, A., M.D., Boston Children’s Hospital, 
Massachusetts
Morin Duchesne, X., M.S., Université de Montréal, 
Montreal, QC, Canada
Sidorov, M., Ph.D., Massachusetts Institute of Technology, 
Cambridge
Speed, H., Ph.D., University of Texas Southwestern Medical 
Center, Dallas
Swarup, V., Ph.D., University of California, Los Angeles
Yau, S., Ph.D., ARC Centre of Excellence in Cognition and 
Its Disorders, Sydney, Australia
Zermeño, A., Ph.D., Universidad de Salamanca, Spain
SEMINARS
Akbarian, S., Mount Sinai School of Medicine, New York: 
Epigenetics.
Bird, G., King’s College London, United Kingdom: Mirror 
neurons, theory of mind, and social behavior.
Fombonne, E., Oregon Health and Science University, 
Portland: Epidemiology of ASD.
Geshwind, D., University of California, Los Angeles: 
Introduction to human genetics and genomics/gene 
expression fi ndings in ASD.
Geschwind, D., University of California, Los Angeles; Levitt, 
P., University of Southern California; Spence, S., Boston 
Children’s Hospital, Massachusetts; Introduction to the 
course and student assignments.
Hensch, T., Harvard University, Boston, Massachusetts: 
Clinical period plasticity.
Iversen, P., Co-Founder of Cure Autism Now: Autism close 
up and personal.
Kasari, C., University of California, Los Angeles: Engaging 
autism: Active ingredients for early interventions. Social 
skills: Methods, models, and mediating agents.
Levitt, P., University of Southern California, Los Angeles: 
Basics of neural development, cellular and molecular 
neuropathology, infl ammation.
Nelson, C., Boston Children’s Hospital, Massachusetts: 
Electrophysiological imaging methods in ASD. Early 
identifi cation in ASD.
Pasca, S., Stanford University, California: Cellular models for 
ASD in humans.
Pelphrey, K., Yale University, New Haven, Connecticut: 
Searching for neuroendophenotypes of autism.
Powell, C., University of Texas, Austin: Interpreting animal 
models of ASD.
Rapin, I., Albert Einstein School of Medicine, Bronx, New 
York: Autism2013: 60 Years of personal experience.
Spence, S., Boston Children’s Hospital, Massachusetts: 
Informal discussion of clinical assessments. Medical 
comorbidities.
Stevens, B., Harvard Medical School, Boston, Massachusetts: 
Synaptic physiology.
Stone, W., University of Washington, Seattle: Clinical 
presentation and phenotypic variation. An SD phenotypic 
variability outcome.
Suomi, S., NICHD, National Institutes of Health, 
Bethesda, Maryland: Evolutionary perspectives on social 
behavior.
Tsien, R., New York University, New York: Circuits and 
functional physiology: Oxytocin.
Veenstra-Vander Weele, J., Vanderbilt University, Nashville, 
Tennessee: From mouse to man: The Path to new 
treatments in ASD.
Weisskopf, M., Harvard School of Public Health, Longwood, 
Massachusetts: Environmental contributions.
Young, L., Emory University, Atlanta, Georgia: Oxytocin 
and social cognition: Implications for novel therapies for 
autism.
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Single-Cell Analysis
June 5–18
INSTRUCTORS J. Eberwine, University of Pennsylvania Perelman School of Medicine, Philadelphia
 C. McMurray, University of California, Berkeley/Lawrence Berkeley Laboratory
ASSISTANTS T. Ball, NDRI Resource, Philadelphia, Pennsylvania
 P. Buckley, Janssen Research & Development, Spring House, Pennsylvania
 H. Budworth, Lawrence Berkeley National Laboratory, Berkeley, California
 C. Canaria, Lawrence Berkeley National Laboratory, Berkeley, California
 K. Frankel, Lawrence Berkeley National Laboratory, Berkeley, California
 D.-Y. Lee, Lawrence Berkeley Laboratory, Seoul, Korea
 J. Morris, University of Pennsylvania School of Medicine, Philadelphia
The goal of this new 2-week course was to familiarize students with the most recent cutting-edge 
technologies for characterization of cells. Important in this process was highlighting the advan-
tages to analysis of single cells in isolation and in their natural microenvironment. Sections of the 
course were taught by scientists who are experts in particular areas of single-cell analysis. Topics 
that were covered included quantitative single-cell analysis by RNA-Seq, genomic DNA analysis, 
epigenetics, RNA localization analysis, proteomics, protein translation, and metabolomics. The 
techniques that were taught included real-time live cell quantifi cation where appropriate. Multiple 
techniques to isolate specifi c cell populations and individual cells were also taught. The course 
included the use of model systems such as mouse, Drosophila, C. elegans, Aplysia, and Planaria.
This course was generously supported with funds provided by the Howard Hughes Medical 
Institute.
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PARTICIPANTS
Brosnahan, M., Ph.D., Woods Hole Oceanographic 
Institution, Massachusetts
Carre, G.-A., Ph.D., MRC, Harwell, United Kingdom
Gini, B., Ph.D., University of California, San Diego, La Jolla
Guibentif, C., B.Sc., Lund University, Sweden
Han, M.-E., Ph.D., Pusan National University, Yangsan, 
South Korea
Hill, C., Ph.D., Burke-Cornell Medical Research Institute, 
White Plains, New York
Jouhilahti, E.-M., Ph.D., Karolinska Institutet, Huddinge, 
Sweden
Kolesnikova, A., M.S., Institute of Cell Biophysics, 
Pushchino, Russia
Kudryavtseva, A., Ph.D., Engelhardt Institute of Molecular 
Biology RAS, Moscow, Russia
Lundin, E., M.S., Stockholm University, Sweden
Madsen, J., B.Sc., University of Southern Denmark, Odense
Mande, K., Ph.D., King Abdullah University of Science & 
Technology, Jeddah, Saudi Arabia
Oka, Y., B.S., Nara Institute of Science and Technology, 
Ikoma-shi, Japan
Proctor, A., Ph.D., University of North Carolina, Chapel Hill
Roberts, K., Ph.D., St. Jude Children’s Research Hospital, 
Memphis, Tennessee
Shakur, R., M.D., University of Cambridge, United 
Kingdom
Vermehren-Schmaedick, A., Ph.D., Oregon Health and 
Science University, Portland
SEMINARS
Albritton, N., University of North Carolina, Chapel Hill: 
Separating the one from the many.
Botvinick, E., University of California, Irvine: 3-D 
durataxis: Laser microbeams and mechanobiology.
Eberwine, J., University of Pennsylvania, Philadelphia: 
The secret lives of single cells.
Kim, J., University of Pennsylvania, Philadelphia: The single-
cell RNA landscape and its computational analysis.
Larabell, C., Lawrence Berkeley Laboratory, California: 
Nanoscale CT scans of single cells.
McMurray, C., Lawrence Berkeley Laboratory, California: Cell 
type alterations in the brains of Huntington’s disease mice.
Montell, D., University of California, Santa Barbara: Life, 
death, and resurrection at the cellular level.
Roberts, R., University of Southern California, Los Angeles: 
Using mRNA display to design intrabodies.
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Advanced Bacterial Genetics
June 5–25
INSTRUCTORS D. Hughes, Uppsala University, Sweden
 B. Lazazzera, University of California, Los Angeles
 F. Yildiz, University of California, Santa Cruz
ASSISTANTS G. Brandis, Uppsala University, Sweden
 N. Howitz, University of California, Los Angeles
 L. Townsley, University of California, Santa Cruz
This course presented logic and methods used in the genetic dissection of complex biological pro-
cesses in diverse bacteria. Laboratory methods included classical mutagenesis using transposons, 
and mutator strains, recombineering with single- and double-stranded DNA; detection of gene 
expression changes using various reporter genes; the mapping of mutations using genetic and 
physical techniques; modern approaches to the generation and analysis of targeted gene disrup-
tions and fusions using PCR and cloning methods; epitope insertion mutagenesis; site-directed 
mutagenesis; and fl uorescence microscopy. Key components of the course were the use of sophis-
ticated genetic methods in the analysis of model bacteria (including E. coli, Salmonella, Bacillus 
subtilis, and Vibrio cholerae), and the use of the wealth of new genomic sequence information to 
motivate these methods.
Invited lecturers presented various genetic approaches to study bacterial mechanisms of me-
tabolism, development, and pathogenesis.
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The course admitted 18 students, both foreign and US residents, from diverse backgrounds and 
career levels for intensive (but fun) instruction in microbial genetics.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Angst, D., M.S., ETH Zurich, Switzerland
Barnes, S., B.S., California Institute of Technology, Pasadena
Daughtry, K., Ph.D., National Institute of Environmental 
Health Science, Research Triangle Park, North Carolina
Goemans, C., M.S., De Duve Institute, Belgium
Hernandez, C., Ph.D., Cornell University, Ithaca, New York
Holwerda, E., M.S., Dartmouth College, Hanover, New 
Hampshire
Lang, K., B.S., University of Minnesota, St. Paul
Los, J., Ph.D., University of Gdansk, Poland
Murray, S., Ph.D., John Innes Centre, United Kingdom
Noobakhsh, J., B.S., Boston University, Massachusetts
Simari, R., B.S., The Ohio State University, Columbus
Rocio Suarez-Moreno, Z., Ph.D., Instituto de 
Biotechnologia-Universidad Nacional, Colombia
Stokes, E., B.S., City College, City University of New York
Sysoeva, T., Ph.D., Harvard University, Cambridge, 
Massachusetts
Tran, C., M.D., University of California, San Francisco
Uehling, J., M.S., Duke University, Durham, North Carolina
Ursell, T., Ph.D., Stanford University, California
Zampieri, M., Ph.D., ETH Zurich, Switzerland
SEMINARS
Darwin, H., New York University, New York: Using genetics 
to understand mycobacterium tuberculosis pathogenesis.
Grossman, A., Massachusetts Institute of Technology, 
Cambridge: Horizontal gene transfer: Functions of 
integrative and conjugative elements.
Kirby, J., University of Iowa, Iowa City: Chemosensory 
regulation of multicellularity in bacteria.
Levin, B., Emory University, Atlanta, Georgia: Modeling 
the population and evolutionary dynamics of bacteria for 
people who prefer to hum equations than solve them. The 
population biology and evolution of adaptive immunity in 
bacterial, CRISPR, and too much fun. 
Lovett, S., Brandeis University, Waltham, Massachusetts: 
Replication during starvation: The stringent response.
Schmid, M., Tech Coast Angels, Claremont, California: Use 
of bacterial genetics in the drug discovery process.
Schweizer, H., Colorado State University, Fort Collins: The 
mini-Tn7 systems for gram-negative bacteria: A versatile 
and user-friendly genetic toolbox.
Silhavy, T., Princeton University, New Jersey: Divide and 
conquer: Genetic dissection of the β-barrel assembly 
machine.
Snitkin, E., National Institutes of Health, Bethesda, Maryland: 
Overview of bioinformatics tools for bacterial genetics.
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Mouse Development, Stem Cells, and Cancer
June 5–25
INSTRUCTORS R. Johnson, M.D. Anderson Cancer Center, Houston, Texas
 X. Sun, University of Wisconsin, Madison
CO-INSTRUCTORS M. Lewandoski, National Cancer Institute, Frederick, Maryland
 D. Wellik, University of Michigan Medical Center, Ann Arbor
ASSISTANTS H. Adams, M.D. Anderson Cancer Center, Houston, Texas
 K. Branchfi eld, University of Wisconsin, Madison
 Y. Furuta, RIKEN, Center for Developmental Biology, Kobe, Japan
 R. Kadzik, University of Pennsylvania, Perleman School of Medicine, Philadelphia
 B. Larsen, University of Michigan Medical Center, Ann Arbor
 R. Poche, Baylor College of Medicine, Houston, Texas
 N. Schrode, Memorial Sloan-Kettering Cancer Institute, New York
This intensive laboratory and lecture course was designed for biologists interested in using mouse 
models to study mammalian development, stem cells, and cancer. Lectures provided the conceptual 
basis for contemporary research in embryogenesis, organogenesis, embryonic, adult and induced 
pluripotent stem cells, and cancer biology. Laboratory practicals provided an extensive hands-on 
introduction to engineering of mouse models, phenotyping, and stem cell technologies. Experi-
mental techniques covered included isolation, in vitro culture and manipulation of pre- and post-
implantation embryos, embryo transfer, genetic manipulation of embryonic stem cells, production 
of chimeras by embryo aggregation and by embryonic stem cell injection, and transgenesis by 
pronuclear microinjection. The course also introduced the generation and differentiation of embry-
onic stem cells as well as induced pluripotent stem cells, isolation of mouse embryonic fi broblasts, 
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focus formation assay, teratoma formation assay, time-lapse microscopy of early embryos, and organ 
cultures. In addition, this year’s practicals featured increased emphasis on phenotypic analysis of 
mutants, including vibratome and cryosectioning, in situ hybridization, immunostaining, skeletal 
preparation, tissue recombination, and confocal and ultrasound imaging.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Alberton, P., Ph.D., Ludwig-Maximilians University, 
Munich, Germany
Dominguez, M.I., Ph.D., Boston University School of 
Medicine, Massachusetts
Fontanet, P., B.S., Institute of Cellular Biology and 
Neuroscience, Argentina
Funk, M., M.S., University Medical Center Freiburg, 
Germany
Gama, V., Ph.D., University of North Carolina, Chapel Hill
Garces, J., B.A., University of Pennsylvania, Philadelphia
Han, L., B.S., University of Cincinnati, Ohio
Koutelou, E., Ph.D., University of Texas M.D. Anderson 
Cancer Center, Smithville
Rooney, T., B.S., University of Massachusetts Medical 
School, Worcester
Sahai-Hernandez, P., B.S., University of California, 
San Francisco
Wainwright, E., B.S., University of Queensland, Brisbane, 
Australia
Wu, P.-H., Ph.D., HHMI/University of Massachusetts, 
Worcester
Zhang, C., Ph.D., Columbia University, New York
Zong, C., Ph.D., Harvard University, Cambridge, 
Massachusetts
SEMINARS
Behringer, R., M.D. Anderson Cancer Center, Houston, 
Texas: Mouse transgenics and reproduction.
Capecchi, M., University of Utah School of Medicine, Salt 
Lake City: Homologous recombination and knockout mice.
Cleaver, O., University of Texas Southwestern Medical 
Center, Dallas: Mouse pancreas development and disease. 
Mouse blood vessel development.
DePinho, R., M.D. Anderson Cancer Center, Houston, 
Texas: GEMs in cancer and aging.
Egeblad, M., Cold Spring Harbor Laboratory: Live imaging 
in mouse models of cancer.
Johnson, R., M.D. Anderson Cancer Center, Houston, Texas: 
Mouse liver development and cancer.
Li, L., Stowers Institute for Medical Research, Kansas City, 
Missouri: Mouse hematopoiesis.
Lewandoski, M., National Cancer Institute, Frederick, 
Maryland: Mouse conditional knockout technologies. 
Mouse somitogenesis.
Looney, M., University of California, San Francisco: Lung 
imaging in mice.
Lovell-Badge, R., MRC National Institute for Medical, 
United Kingdom: Sex determination.
Lowe, S., Memorial Sloan-Kettering Cancer Center, New 
York: Probing cancer drivers and dependencies using mouse 
models and RNAi.
Morrisey, E., University of Pennsylvania, Philadelphia: 
Mouse heart development and diseases.
Rivera, J., University of Massachusetts Medical School, 
Worcester: Mouse postimplantation.
Rossant, J., The Hospital for Sick Children, Toronto, 
Ontario, Canada: Early mouse embryonic and 
extraembryonic cell lineage.
Solter, D., Institute of Medical Biology, Singapore: Mouse 
preimplantation. Preimplantation development.
Sun, X., University of Wisconsin, Madison: Mouse lung 
development and disease.
Takahashi, J., University of Texas Southwestern Medical 
Center, Dallas: Mouse circadian clocks and behavior.
Tam, P., Children’s Medical Research Institute, Australia: 
Mouse gastrulation. Mouse neural induction.
Threadgill, D., North Carolina State University, Raleigh: 
Quantitative trait analysis in mice.
Trainor, P., Stowers Institute for Medical Research, Kansas 
City, Missouri: Mouse craniofacial development and the 
neural crest.
Tuveson, D., Cold Spring Harbor Laboratory: Pancreatic 
cancer.
Wellik, D., University of Michigan Medical Center, Ann 
Arbor: Hox genes, development, and cancer.
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Ion Channels and Synaptic Transmission
June 5–25
INSTRUCTORS S. Brenowitz, NIDCD, National Institutes of Health, Bethesda, Maryland
 I. Duguid, University of Edinburgh, United Kingdom
 P. Kammermeier, University of Rochester Medical Center, New York
ASSISTANTS C. Bladen, University of Calgary, Alberta, Canada
 J. Grundemann, Friedrich Miescher Institute, Basel, Switzerland
 V. Lu, NIH/NIAAA/LMP, Rockville, Maryland
 J. Lueck, University of Iowa Carver College of Medicine, Iowa City
 M. Rigby, University College London, United Kingdom
 J. Schiemann, University of Edinburgh, United Kingdom
 N. Wanaverbecq, Aix-Marseille University, Marseille, France
The primary goal of this course was to investigate, through lectures and laboratory work, the 
properties of ion channels that allow neurons to carry out their unique physiological functions in 
a variety of neural systems. Areas of particular interest included channels that (1) were activated 
by neurotransmitter at central and peripheral synapses, (2) were activated by voltage changes in 
axons and dendrites, (3) responded to neuromodulators with changes in functional properties, (4) 
are developmentally required and regulated, or (5) are light-gated and engineered to express in 
specifi c neural subtypes. The research interests of guest lecturers refl ected these areas of emphasis.
The laboratory component of the course introduced students to state-of-the-art electrophysi-
ological approaches for the study of ion channels in their native environments. Hands-on exercises 
included patch-clamp recording of ion channel activity in acutely isolated or cultured cells or 
neurons in brain slice preparations. Different recording confi gurations were used (e.g., whole-cell, 
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cell-attached, dendritic patches, and voltage- and current-clamp confi gurations) to examine mac-
roscopic or single-channel activity. Similarly, various methods of ligand and drug application were 
demonstrated. The advantages and disadvantages of each method, preparation, and recording 
technique were considered in relation to the specifi c scientifi c questions being asked. Admissions 
priority was given to students and postdocs with a demonstrated interest, specifi c plans, and a sup-
portive environment to apply these techniques to a defi ned problem.
This course was supported by the Howard Hughes Medical Institute.
PARTICIPANTS
Chiu, I., Ph.D., Boston Children’s Hospital, Massachusetts
Cummings, K., B.A., University at Buffalo, New York
Engl, E., B.A., M.S., University College London, United 
Kingdom
Furth, K., B.S., National Institutes of Health, Bethesda, 
Maryland
Harde, E., Diploma, Buchmann Institute for Molecular Life 
Sciences, Germany
Kim, C., Ph.D., Howard Hughes Medical Institute at Janelia 
Farm, Ashburn, Virginia
Lazzerini Ospri, L., M.S., Johns Hopkins School of 
Medicine, Baltimore, Maryland
Murali, S., B.Sc., McMaster University, Hamilton, Canada
Pablo, J.L., B.S., Duke University, Durham, North 
Carolina
Ruckh, T., Ph.D., Northeastern University, Boston, 
Massachusetts
Steinberg, E., B.A., University of California, San Francisco
Wei, Q, (Eric), B.S.E, Duke University, Durham, North 
Carolina
SEMINARS
Boyden, E., Massachusetts Institute of Technology, 
Cambridge: Optogenetics, in vivo robotics, and other 
neural circuits tools.
Carandini, M., University College London, United 
Kingdom: Probing the roles of inhibition in vivo.
Clapham, D., Children’s Hospital Boston/Harvard Medical 
School, Massachusetts: Measuring ion channels in tough 
places.
Colquhoun, D., University College London, United 
Kingdom: Is “allosteric” a useful word? What single ion 
channel measurements say.
Hausser, M., University College London, United Kingdom: 
Dendritic integration.
Hull, C., Duke University, Durham, North Carolina: Functional 
properties of fast synaptic inhibitory circuits in the CNS.
Ikeda, S., National Institute on Alcohol Abuse & Alcoholism, 
Rockville, Maryland: Nutrient substrates, channel 
modulation, and human genomics: GPR41/FFAR3 in the 
sympathetic nervous system.
Isom, L.L., University of Michigan, Ann Arbor: Role 
of sodium channel SCN1A and SCN1B in inherited 
epilepsy.
Larsson, P., University of Miami, Florida: Molecular 
mechanism of voltage-gated proton channels.
Lee, A., University of Iowa, Iowa City: Decalmodulation of 
voltage-gated Ca2+ channels.
Nolan, M., University of Edinburgh, United Kingdom: 
Synaptic mechanisms for computation of location.
Plested, A., Leibnitz Institute for Molecular Pharmacology, 
Berlin, Germany: Glutamate receptor activation 
mechanisms.
Shepherd, G., Northwestern University, Chicago, Illinois: 
Circuit analysis in the neocortex.
Sjostrom, J., McGill University, Montreal Quebec, Canada: 
Synaptic plasticity and LTP. Spike-timing-dependent 
plasticity in neocortex.
Xu-Friedman, M., University of Buffalo, SUNY, New York: 
Synaptic transmission and short-term plasticity.
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Vision: A Platform for Linking Circuits, Perception, and Behavior
June 12–25
INSTRUCTORS F. Briggs, Geisel School of Medicine, Dartmouth, New Hampshire
 A. Huberman, University of California, San Diego
ASSISTANT O. Dhande, University of California, San Diego
The purpose of this course was to bring together students and faculty for in-depth and high-level 
discussions of modern approaches for probing how specifi c cell types and circuits give rise to de-
fi ned categories of perception and action. It was also designed to address novel strategies aimed at 
overcoming diseases that compromise sensory function.
The visual system is the most widely studied sensory modality. Recently, three major shifts 
have occurred in the fi eld of neuroscience. First, because of the large array of genetic techniques 
available in mice and the relative ease of imaging and recording from the cortex of small rodents, 
the mouse visual system has become a premiere venue for attacking the fundamental unresolved 
question of how specifi c cells and circuits relate to visual performance at the receptive fi eld and 
whole-animal level. Second, genetic and viral methods have evolved to the point where neuro-
physiologists can directly probe the role of defi ned circuits in species such as macaque monkeys, 
thus bridging the mechanism-cognition gap. Third, the fi eld of visual neuroscience is rapidly pav-
ing the way for widespread clinical application of stem cell, gene therapy, and prosthetic devices to 
restore sensory function in humans.
The time is ripe to build on the classic paradigms and discoveries of visual system structure, 
function, and disease to achieve a deep, mechanistic understanding of how receptive fi elds are 
organized and fi lter sensory information, how that information is handled at progressively higher 
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levels of neural processing, and how different circuits can induce defi ned categories of percepts 
and behaviors in the healthy and diseased brain.
This course was supported by the Howard Hughes Medical Institute.
PARTICIPANTS
Baragli, C., B.S., University College London, United 
Kingdom
Bos, R., Ph.D., University of California, Berkeley
Burbridge, T., M.Phil., Yale University, New Haven, 
Connecticut
Daum, J., M.S., Friedrich Miescher Institute, Basel, 
Switzerland
Denman, D., Ph.D., University of Pennsylvania, Philadelphia
Fransen, J., Ph.D., University of Louisville School of 
Medicine, Kentucky
Garner, A., Ph.D., Allen Institute for Brain Science, Seattle, 
Washington
Hasse, J., Ph.D., Geisel School of Medicine at Dartmouth, 
Lebanon, New Hampshire
Hoy, J., Ph.D., University of Oregon, Eugene
Jeurissen, D., Ph.D., Netherlands Institute for Neuroscience, 
Amsterdam
Kandler, S., Ph.D., IMEC-NERF, Leuven, Belgium
Liberman, A., Ph.D., University of California, Berkeley
Marques, T., Ph.D., Champalimaud Foundation, Lisbon, 
Portugal
Mock, V., B.A., Geisel School of Medicine at Dartmouth, 
Lebanon, New Hampshire
Pinto-Teixeira Sousa, F., Ph.D., New York University, New 
York
Ribic, A., Ph.D., Yale University, New Haven, Connecticut
Rudiger, P., Ph.D., University of Edinburgh, United 
Kingdom
Stevens, J.-L., M.S./Ph.D., University of Edinburgh, United 
Kingdom
Tschetter, W., Ph.D., University of Oregon, Eugene
Vaiceliunaite, A., Ph.D., University of Tuebingen, Germany
Wilk, M., Ph.D., Medical College of Wisconsin, Milwaukee
Zhou, Y., M.S., Columbia University, New York
SEMINARS
Berson, D., Brown University, Providence, Rhode Island: 
Retinal output channels.
Briggman, K., National Institutes of Health, Bethesda, 
Maryland: Retinal circuitry.
Briggs, F., Geisel School of Medicine at Dartmouth, 
Lebanon, New Hampshire: Introduction: V1 and beyond.
Callaway, E., The Salk Institute for Biological Studies, San 
Diego, California: Circuits and functions of cell types and 
visual areas in mice and monkeys.
Cang, J., Northwestern University, Evanston, Illinois: 
Critical period plasticity and binocular matching in the 
mouse visual cortex.
Carandini, M., University College London, United Kingdom: 
Probing circuits and computations in primary visual cortex.
Chichilnisky, E.J., The Salk Institute, San Diego, California: 
Visual signaling in primate retina and design of retinal 
prostheses.
Churchland, A., Cold Spring Harbor Laboratory: Integrating 
visual information across time and with other modalities.
Clandinin, T., Stanford University, California: Dissecting the 
circuit mechanisms of visual computation in fruit fl ies.
Fitzpatrick, D., Max-Planck Florida Institute, Jupiter: 
Building cortical representations with experience: Insights 
from visual cortex.
Gandhi, S., National Biological Standards Laboratory, United 
Kingdom: The mechanisms of critical period plasticity.
Guido, W., University of Louisville, Kentucky: Mouse visual 
thalamus: Structure, function, and circuitry.
Horwitz, G., University of Washington, Seattle: Cortex II 
(coding and processing).
Huberman, A., University of California, San Diego: 
Introduction: Retina to V1.
Maunsell, J., Harvard Medical School, Boston, 
Massachusetts: Cortical mechanisms of attention.
Movshon, J.A., New York University, New York: Elements 
of form and motion processing in early visual cortex.
Neitz, M., University of Washington, Seattle: Cone opsin 
genetics and the cure and prevention of eye disease.
Niell, C., University of Oregon, Eugene: Cell types and 
receptive fi elds in the mouse visual system.
Nielsen, K., Johns Hopkins University, Baltimore, Maryland: 
Cortex I (mapping circuits/alternate pathways).
Pearson, R., University College London, United Kingdom: 
Retinal repair.
Roska, B., Friedrich Miescher Institute, Basel, Switzerland: 
Cell-type-specifi c computations in retina and cortex: 
Understanding and repair.
Tsao, D., California Institute of Technology, Pasadena: The 
ventral stream.
Ursey, W.M., University of California, Davis: Functional 
properties of neural circuits for vision.
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Statistical Methods for Functional Genomics
June 21–July 3
INSTRUCTORS N. Altman, Penn State University, University Park, Pennsylvania
 H. Bussemaker, Columbia University, New York
 S. Davis, National Institutes of Health, Bethesda, Maryland
 O. Elemento, Weill Cornell Medical College, New York
ASSISTANTS V. FitzPatrick, Columbia University, New York
 P. Kuruppumullage Don, Penn State University, State College, Pennsylvania
 Y. Lee, Penn State University, University Park, Pennsylvania
 T. Riley, Columbia University, New York
During the past decade, high-throughput assays have become pervasive in biological research 
due to both rapid technological advances and decreases in overall cost. To properly analyze the 
large data sets generated by such assays and thus make meaningful biological inferences, both 
experimental and computational biologists must understand the fundamental statistical principles 
underlying analysis methods. This course was designed to build competence in statistical methods 
for analyzing high-throughput data in genomics and molecular biology.
Detailed lectures and presentations by instructors and guest speakers were combined with 
hands-on computer tutorials. The methods covered in the lectures were applied to example high-
throughput data sets.
This course was supported with funds provided by National Institute of General Medical Sciences.
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PARTICIPANTS
Chaudhuri, R., Ph.D., Garvan Institute for Medical 
Research, Darlinghurst, Australia
Demel, C., M.S., Ludwig-Maximilians-Universtat, Munich, 
Germany
Dose, M., Ph.D., National Institutes of Health, Bethesda, 
Maryland
Durresi, E., M.S., Harvard University, Boston, Massachusetts
Francescatto, M., M.S., German Center for 
Neurodegenerative Diseases, Tuebingen, Germany
Franco, L., M.D., Baylor College of Medicine, Houston, 
Texas
Fufa, T., Ph.D., National Institutes of Health, Bethesda, 
Maryland
Gearhart, M., Ph.D., University of Minnesota, Minneapolis
He, X., Ph.D., National Cancer Institute, NIH, Bethesda, 
Maryland
Jaksik, R., M.S., Silesian University of Technology, Gliwice, 
Poland
Jeselsohn, R., M.D., Dana-Farber Cancer Institute, Boston, 
Massachusetts
Liu, X.-Y., Ph.D., University of Wisconsin, Madison
Lopez-Anido, C., B.A., University of Wisconsin, Madison
Mehta, N., B.S., Northwestern University, Chicago, Illinois
Mitchell, A., Ph.D., Mount Sinai School of Medicine, 
New York
Sawicka, A., M.S., Medical University of Vienna, MFPL, 
Austria
Shetty, A., M.S., University of Baltimore, Maryland
Sun, W., M.S., University of Rochester Medical Center, 
New York
Sweet-Cordero, E.A., M.D., Stanford University, California
Williams, K., B.A., Washington University, St. Louis, 
Missouri
Wirthlin, M., B.A., Oregon Health & Science University, 
Portland
Zhao, G., Ph.D., SUNY, Stony Brook, New York
Zimmers, T., Ph.D., Thomas Jefferson University, 
Philadelphia, Pennsylvania
Zou, Y., B.S., Memorial Sloan-Kettering Cancer Center, 
New York
SEMINARS
Carlson, M., Fred Hutchinson Cancer Research Center, 
Seattle, Washington: Bioconductor annotation and data 
resources.
Davis, S., National Institutes of Health, Bethesda, Maryland: 
R precourse.
Gerstein, M., Yale University, New Haven, Connecticut: 
Grappling with a big data blizzard in genomics: Reproducible 
and open annotation, networks, models, and tools.
Hodges, E., Cold Spring Harbor Laboratory: Domains of 
DNA hypomethylation are pockets of activity for genome 
regulation and organization.
Horvath, S., University of California, Los Angeles: Empirical 
evaluation of prediction and correlation network methods 
applied to genomic data.
Ingolia, N., Carnegie Institution, Baltimore, Maryland: 
Genome-wide profi ling of translation initiation and 
protein.
Leslie, C., Memorial Sloan-Kettering Cancer Center, New 
York: New insights into “regulatory transcriptomics” with 
CLIP-Seq and 3′-Seq.
Reimers, M., VCU School of Medicine, Richmond, Virginia: 
Genomics of the human brain.
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Workshop on Pancreatic Cancer
June 26–July 2
INSTRUCTORS D. Bar-Sagi, New York University Medical Center, New York
 S. Leach, Johns Hopkins University School of Medicine, Baltimore, Maryland
 D. Tuveson, Cold Spring Harbor Laboratory
ASSISTANT J. Bailey, Johns Hopkins University, Baltimore, Maryland
Pancreatic cancer is one of the deadliest cancers; tumors are often diagnosed at advanced stages 
of the disease and metastasize rapidly. This 1-week discussion course provided a comprehensive 
overview of clinical and biological aspects of pancreatic cancer with special emphasis on disease 
diagnosis and management, molecular pathways involved in tumor development and progression, 
mechanism-based therapeutic strategies, advanced research tools, and ethical concerns. Attendees 
were able to interact with senior investigators on a one-on-one basis in an informal environment. 
Nonfaculty students were eligible for partial stipends, depending on stated need. Applications 
were invited from medical and graduate students, postdoctoral fellows, and faculty.
This course was supported equally by the Lustgarten Foundation and the Pancreatic Cancer 
Action Network.
PARTICIPANTS
Badgley, M., B.A., Columbia University, New York
Bartholin, L., Ph.D., Cancer Research Center of Lyon 
(CRCL), Lyon, France
Bien, H., Ph.D., Stony Brook University, Stony Brook, New York
Egeblad, M., Ph.D., Cold Spring Harbor Laboratory
Gomes-DaGama, E.G., Ph.D., Memorial Sloan-Kettering 
Cancer Center, New York
Gore, J., Ph.D., Indiana University, Indianapolis
283-422_Meetings & Courses.indb   379 8/28/2014   10:52:52 AM
380  Postgraduate Courses
Handler, J., Ph.D., New York University School of Medicine, 
New York
Hendley, A., Ph.D., Johns Hopkins University, Baltimore, 
Maryland
Houghton, J., Ph.D., Memorial Sloan-Kettering Cancer 
Center, New York
Kim, M., M.D., University of Texas M.D. Anderson Cancer 
Center, Houston
Liu, X., Ph.D., Eppley Institute, University of Nebraska 
Medical Center, Omaha
Park, J., Ph.D., Seoul National University Hospital, South Korea
Quinn, B., M.S., Virginia Commonwealth University, 
Richmond
Sherman, M., Ph.D., Salk Institute, La Jolla, California
Schmid, M., Ph.D., Lecturer and Research Group Leader, 
Liverpool, United Kingdom
Shields, M., Ph.D., Cold Spring Harbor Laboratory
Smith, K., Ph.D., Mayo Clinic, Jacksonville, Florida
Sugumar, A., M.Ph., University of Kansas, Kansas City
Takahashi, R., B.S., The University of Tokyo, Japan
Takeuchi, K., Ph.D., Mayo Clinic, Jacksonville, Florida
Waghray, M., Ph.D., University of Michigan, Ann Arbor
Yoon, S., Ph.D., Beckman Research Institute of City of 
Hope, Duarte, California
SEMINARS
Bar-Sagi, D., New York University Medical Center, New 
York; Leach, S., Johns Hopkins University School of 
Medicine, Baltimore, Maryland; Tuveson, D., Cold Spring 
Harbor Laboratory: In vivo and in vitro models.
Baylin, S., Johns Hopkins University School of Medicine, 
Baltimore, Maryland: Genetics I.
Crawford, H., Mayo Clinical Cancer Center, Rochester, 
Minnesota: Animal models of pancreatitis and the 
epithelial contributions and responses.
Der, C., University of North Carolina, Chapel Hill: 
Targeting K-Ras for pancreatic cancer treatment.
Hollingsworth, T., University of Nebraska, Omaha: Clinical 
trials.
Iacobuzio-Donahue, C., Johns Hopkins University School 
of Medicine, Baltimore, Maryland: Current concepts in 
pancreatic cancer genetics.
Kelly, K., University of Virginia, Charlottesville: Molecular 
imaging and biomarker discovery in PDAC.
Kimmelman, A., Dana-Farber Cancer Institute, Boston, 
Massachusetts: Pancreatic cancer metabolism.
Klimstra, D., Memorial Sloan-Kettering Cancer Center, New 
York: Pathology of pancreatic ductal carcinoma and other 
solid neoplasms.
Klimstra, D., Memorial Sloan-Kettering Cancer Center, New 
York: Pathology of cystic and intraductal neoplasms.
Leach, S., Johns Hopkins University School of Medicine, 
Baltimore, Maryland: Developmental biology and PDA.
Megibow, A., New York University, New York: Imaging 
pancreatic cysts.
Megibow, A., New York University, New York: The altered 
metabolism of pancreatic cancer.
Miller, G., New York University Langone Medical Center, 
New York: Pancreatic infl ammation: A historical 
and clinical perspective. Cellular and biochemical 
mediators of stromal infl ammation from pancreatitis to 
carcinogenesis.
Murtaugh, C., Harvard Medical School, Cambridge, 
Massachusetts: A cellular “identity crisis” in pancreatic 
cancer initiation.
Olive, K., Columbia University, New York: Preclinical 
therapeutics in genetically engineered models of pancreatic 
cancer.
Simeone, D., University of Michigan Medical Center, 
Ann Arbor: Clinical evaluation. Surgical management of 
pancreatic cancer.
Ting, D., Massachusetts General Hospital/Harvard Medical 
School, Boston: Early detection biomarkers for pancreatic 
cancer.
Vander Heiden, M., Massachusetts Institute of Technology, 
Cambridge: Metabolomics: Role of metabolism in 
pancreatic cancer.
Vonderheide, R., University of Pennsylvania, Philadelphia: 
Immunobiology of pancreatic cancer.
Watson, J., Cancer Biology, National Cancer Institute, 
Bethesda, Maryland: Funding opportunities; training 
opportunities.
Yu, K., Memorial Sloan-Kettering Cancer Center, New York: 
Clinical trials in pancreatic cancer.
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Drosophila Neurobiology: Genes, Circuits, and Behavior
June 28–July 16
INSTRUCTORS G. Macleod, University of Texas Health Science Center, San Antonio
 K. O’Connor-Giles, University of Wisconsin, Madison
 A. Rothenfl uh, University of Texas Southwestern, Dallas
ASSISTANTS J. Bruckner, University of Wisconsin, Madison
 S. Gratz, University of Wisconsin, Madison
 J. Jin, University of Texas Southwestern, Dallas
 A. Rossano, University of Texas Health Science Center, San Antonio
This laboratory/lecture course was intended for researchers at all levels, from beginning graduate 
students through established primary investigators who want to use Drosophila as an experimen-
tal system for nervous system investigation. The two and a half-week course was designed to 
introduce students to a wide variety of topics and techniques, including the latest approaches in 
studying nervous system development, activity, and connectivity, as well as complex behaviors and 
disease models. Daily research seminars presented comprehensive overviews of specifi c subfi elds of 
nervous system function or focused on specifi c techniques and approaches to study fl y neurobiol-
ogy. Expert guest lecturers discussed their fi ndings and approaches, and brought along their own 
assays and techniques for students to learn in the laboratory part of the course. The hands-on por-
tion of the course was centered around student-led projects, where gene mutants were discovered 
and analyzed throughout the course using the different morphological and physiological measure-
ments and behavioral paradigms at hand. This included electrophysiological and in vivo calcium 
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recordings and anatomical examination and circuit mapping, as well as numerous quantitative 
behavioral measures. Collectively, the course provided a comprehensive and practical introduction 
to modern experimental methods for studying the Drosophila nervous system.
This course was supported with funds provided by the National Institute on Drug Abuse, the 
National Institute of Neurological Disorders and Stroke, and the National Science Foundation.
PARTICIPANTS
Allo, M., Ph.D., European Molecular Biology, Heidelberg, 
Germany
Clark, M., B.S., University of Oregon, Eugene
Imler, E., Ph.D., University of Arizona, Tucson
Kreko, T., B.S., University of Texas Health Science Center, 
San Antonio
Lembke, K., B.A., Oregon Health and Science University 
School of Dentistry, Portland
Macara, A.M., B.S., University of Michigan, Ann Arbor
Muenzel, J., Ph.D., University of Edinburgh, United 
Kingdom
Namiki, S., Ph.D., Howard Hughes Medical Institute, 
Ashburn Virginia
Pankova, K., B.Sc., Max-Planck Institute of Neurobiology, 
Martinsried, Germany
Shields, M., B.S., Colorado State University, Fort Collins
Titlow, J., M.S., University of Kentucky, Lexington
Yang, L., B.Sc., University of Oxford, United Kingdom
SEMINARS
Daniels, R., University of Wisconsin, Madison: NMJ 
physiology.
Dubnau, J., Cold Spring Harbor Laboratory: Learning and 
memory.
Kaun, K., HHMI/Janelia Farm Research Campus, Ashburn, 
Virginia: Flies and ethanol.
Keene, A., University of Reno, Nevada: Circadian rhythms/
sleep.
Kravitz, E., Harvard Medical School, Boston, Massachusetts: 
Aggression.
Lee, C.-H., NICHD, National Institutes of Health, 
Bethesda, Maryland: Visual system development.
Levitan, E., University of Pittsburgh, Pennsylvania: Imaging 
dense core vesicles and neurosecretion.
MacLeod, G., University of Texas Health Science Center, San 
Antonio: Ca++ and pHluorin imaging.
McKellar, C., HHMI/Janelia Farm Research Campus, 
Ashburn, Virginia: Genetic tools for mapping circuits 
underlying behavior.
Nitabach, M., Yale School of Medicine, New Haven, 
Connecticut: Genetically encoded voltage indicators.
O’Connor-Giles, K., University of Wisconsin, Madison: 
Synaptogenesis.
Pulver, S., Janelia Farms, Ashburn Virginia: CNS 
physiology.
Rolls, M., Penn State, University Park, Pennsylvania: 
Neuronal polarity.
Rothenfl uh, A., University of Texas Southwestern, Dallas: 
Studying behavior in Drosophila.
Simpson, J., HHMI/Janelia Farm Research Campus, 
Ashburn, Virginia: Genetic tools for mapping circuits 
underlying behavior.
Simpson, J., HHMI/Janelia Farm Research Campus, 
Ashburn, Virginia: Genetic tools for mapping circuits 
underlying behavior.
Strausfeld, N., University of Arizona, Tucson: Comparative 
neuroanatomy.
Turner, G., Cold Spring Harbor Laboratory: Studying neural 
activity in the CNS.
White, B., National Institute of Mental Health, Bethesda, 
Maryland: Circuit mapping complex behaviors.
Yoshihara, M., University of Massachusetts Medical School, 
Worcester: Drosophila feeding circuit.
Zwart, M., University of Cambridge, United Kingdom: CNS 
physiology.
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Frontiers of Techniques in Plant Science
June 28–July 18
INSTRUCTORS S. Harmer, University of California, Davis
 M. Johnson, Brown University, Providence, Rhode Island
 R. Last, Michigan State University, E. Lansing
 J. Maloof, University of California, Davis
 S.-H. Shiu, Michigan State University, East Lansing
ASSISTANTS A. Burkhardt, Michigan State University, East Lansing
 A. Leydon, Brown University, Providence, Rhode Island
 G. Moghe, Michigan State University, East Lansing
 S. Uygun, Michigan State University, East Lansing
 H. Van Houtte, KU Leuven, Heverlee, Belgium
This course provided an intensive overview of topics in plant physiology, biochemistry, and devel-
opment, focusing on genomic, analytical, computational, and other high-throughput approaches 
to understanding plant biology. It emphasized recent results from model organisms including 
Arabidopsis, maize, and tomato as well as a variety of other plants, and provided an introduction 
to current methods used in basic and applied plant biology. It was designed for scientists with 
some experience in molecular techniques or in plant biology who wish to work with plants using 
the latest molecular, genomic, and computational technologies. The course consisted of a vigorous 
lecture series, a hands-on laboratory, and informal discussions. The instructors and a stellar group 
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of invited speakers, acknowledged leaders in their fi elds, presented up-to-the-moment research on 
a wide range of topics in plant research.
These seminars included plant evolution, morphology, and anatomy; various topics in plant de-
velopment (including development of meristems, gametophytes, and roots); light perception and 
photomorphogenesis; cell wall biosynthesis and biofuels; function and perception of hormones; 
small RNAs; biotic and abiotic interactions; and applications addressing current agronomic prob-
lems. Lectures describing bioinformatics tools available to the plant community and the resources 
provided by plant genome projects were also included. Speakers provided expert overviews of their 
fi elds, followed by in-depth discussions of their own work. The laboratory sessions provided expo-
sure to cutting-edge techniques currently used in plant research. These included studies of plant 
development and genome evolution, transient gene expression, applications of fl uorescent pro-
teins, automated phenotyping, analysis of polysomal mRNA, analysis of global gene expression 
data (microarray and short-read sequencing), construction of genetic networks, and metabolome 
analysis. Students were introduced to leading computational environments and programs includ-
ing R, Bioconductor, and ImageJ. The course also included several short workshops on important 
themes in plant research.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Atkins, P., B.A., University of Minnesota, St. Paul
Englhart, M., M.S., University of Regensburg, Germany
Gentzel, I., Ph.D., Ohio State University, Columbus
Gonzalez, T., B.S., University of California, Berkeley
Jahnsen, M., M.A., University of Copenhagen, Denmark
Jawahir, V., Ph.D., University of Missouri, St. Louis
Munoz Sanhueza, L.G., Lic., Norwegian University of Life 
Sciences, Ås, Norway
Noble, J., B.S., University of Arizona, Tucson
Pater, D., Ph.D., University of San Diego, La Jolla, California
Schroeder, S., Ph.D., University of Oklahoma, Norman
Seraj, Z., Ph.D., University of Dhaka, Bangladesh
Siler, E., B.S., Michigan State University, E. Lansing
Stonoha, C., B.S., University of Massachusetts, Amherst
Tulin, F., Ph.D., The Rockefeller University, New York
Zimmerman, N., Ph.D., Stanford University, California
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SEMINARS
Brady, S., University of California, Davis: Root 
development.
Dinesh-Kumar, S., University of California, Davis: Plant 
immune response.
Gehring, M., Whitehead Institute, Cambridge, 
Massachusetts: Epigenetics.
Geitmann, A., University of Montreal, Canada: Overview 
of the use of modeling in plant science. Size, speed, and 
power: How the male gametophyte delivers the sperm cells 
in the fl owering plants.
Grossniklaus, U., University of Zurich, Switzerland: 
Reproductive development.
Harmer, S., University of California, Davis: Circadian 
rhythm.
Johnson, M., Brown University, Providence, Rhode Island: 
Overview of genetic approaches in plant. Analysis of male 
reproductive development and function. Imaging and plant 
biology.
Kellogg, E., University of Missouri, St. Louis: Molecular 
systematics and developmental genetics.
Last, R., Michigan State University, E. Lansing: Specialized 
metabolites. Large-scale genetics/phenomics.
Maloof, J., University of California, Davis: Light signaling. 
Quantitative trait loci.
McSteen, P., University of Missouri, Columbia: Meristem 
development.
Noel, J., HHMI/Salk Institute for Biological Sciences, 
La Jolla, California: Plant metabolism.
Oldroyd, G., John Innes Center, Norwich, United Kingdom: 
Plant symbiotic associations.
Osborn, T., Monsanto, Chesterfi eld, Missouri: Genetic 
variation we should care about, and why?
Pappin, D., Cold Spring Harbor Laboratory: Mass 
spectrometry.
Provart, N., University of Toronto, Ontario, Canada: 
Bioinformatic tools in plant research.
Raikhel, N., University of California, Riverside: The 
secretory system.
Shiu, S.-H., Michigan State University, E. Lansing: 
Evolutionary genomics.
Sinha, N., University of California, Davis: Introduction to 
plant anatomical development.
Spalding, E., University of Wisconsin, Madison: 
Kinematics.
Tiffi n, P., University of Minnesota, Minneapolis: Population 
genetics/genomics.
Timmermans, M., Cold Spring Harbor Laboratory: RNA 
interference.
Voytas, D., University of Minnesota, Minneapolis: Precise 
genome engineering with sequence-specifi c nucleases.
Walling, L., University of California, Riverside: Plant-insect 
interaction.
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Advanced Techniques in Molecular Neuroscience
July 2–18
INSTRUCTORS C. Lai, Indiana University, Bloomington
 R. Lansford, California Institute of Technology, Pasadena
 J. Loturco, University of Connecticut, Storrs
ASSOCIATE 
INSTRUCTORS J. Dougherty, Washington University, St. Louis, Missouri
 K. Haas, University of British Columbia, Canada
 B. Maher, Johns Hopkins Medical School, Baltimore, Maryland
 J. Singh, University of Pennsylvania, Philadelphia
TEACHING 
ASSISTANTS F. Chen, University of Connecticut, Storrs
 J. Dalal, Washington University, St. Louis, Missouri
 M. Girgenti, University of Connecticut, Storrs
 D. Huss, California Institute of Technology, Pasadena
 H. Kang, Harvard University, Cambridge, Massachusetts
 A. Kaur, Indiana University, Bloomington
 S. Maloney, Washington University School of Medicine, St. Louis, Missouri
 J. Morris, University of Pennsylvania, Philadelphia
 K. Podorski, University of British Columbia, Canada
 M. Rannals, Lieber Institute for Brain Development, Baltimore, Maryland
 A. Zybura, Indiana University, Bloomington
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This laboratory and lecture course was designed to provide neuroscientists at all levels with a con-
ceptual and practical understanding of several of the most advanced techniques in molecular neu-
roscience. The course curriculum was divided into three sections: an extensive and up-to-date set 
of laboratory exercises, daily lectures covering the theoretical and practical aspects of the various 
methods used in the laboratory, and a series of evening research seminars. The informal and in-
teractive evening lectures were given by leading molecular neuroscientists and served to illustrate 
the ways in which the various experimental approaches have been used to advance specifi c areas of 
neurobiology. In this year’s course, the laboratory portion included topics such as an introduction 
to the design and use of animal virus vectors in neurobiology; the use of small interfering RNAs 
(siRNA) for regulating the expression of specifi c genes in neurons; practical exercises in gene 
delivery systems including mammalian cell transfection protocols and single-cell electroporation 
techniques for targeted gene transfer in vivo; an introduction to overall strategies, use and design 
of BAC transgenic vectors; quantitative real time PCR analyses from small numbers of cells (RNA 
purifi cation, PCR optimization, interpretation of results); and application of RNA amplifi ca-
tion (aRNA) for single-cell analysis. Each laboratory module was followed by presentations and 
discussions focused on data interpretation, protocol troubleshooting, and ways to modify and 
potentially improve existing techniques.
This course was supported with major funding provided by the Howard Hughes Medical 
 Institute.
PARTICIPANTS
Akahori Stroud, H., B.A., Harvard Medical School, Boston, 
Massachusetts
Bundo, M., Ph.D., The University of Tokyo, Japan
Coles, C., Ph.D., German Centre for Neurodegenerative 
Disease-DZNE, Bonn, Germany
Cruz, E., B.S., Ponce School of Medicine & Health Sciences, 
Ponce, Puerto Rico
Franquinho, F., B.Sc., Instituto de Biologia Molecular 
e Cellular, Porto, Portugal
Fuchs, C., M.S., University of Bologna, Italy
Gabreski, N., B.S., University of Michigan, Ann Arbor
Gustafsen, C., Ph.D., Aarhus University, Denmark
Huang, X., B.S., Vanderbilt University, Nashville, 
Tennessee
Inoue, W., Ph.D., University of Calgary, Canada
Kopec, A., B.S., New York University, New York
Lang, J., Ph.D., University of California, Davis/Shriners’ 
Hospital, Sacramento
Sabo, J., Ph.D., University of California, San Francisco
Schank, J., B.A., National Institute for Alcohol Abuse & 
Alcoholism, Bethesda, Maryland
Sloan, S., B.S., Stanford University, California
Yu, J., B.A., Max-Planck Florida Institute, Jupiter
SEMINARS
Darnell, R., The Rockefeller University, New York: Next-
generation sequencing and RNA genomics.
Eberwine, J., University of Pennsylvania, Philadelphia: 
Single-cell neurogenomics: Insights into neuronal 
functioning.
Haas, K., University of British Columbia, Vancouver, 
Canada: Distinguished ATMN Alumnus Lecture: 
In vivo imaging of developmental brain plasticity 
and metaplasticity.
Huang, J., Cold Spring Harbor Laboratory: Genetic dissection 
of neural circuits in neocortex: Chandeliers light up the path.
Josselyn, S., University of Toronto, Canada: Making, 
breaking, and linking fear memories in mice.
Lichtman, J., Harvard University, Cambridge, 
Massachusetts: Talking about Science. Connectomics.
Zhang, F., Massachusetts Institute of Technology, 
Cambridge: Neuroengineering: Molecular and optical axes 
of control.
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Proteomics
July 9–24
INSTRUCTORS M. Bereman, University of Washington, Seattle
 M. Cilia, USDA-ARS, Ithaca, New York
 I. Cristea, Princeton University, New Jersey
 D. Pappin, Cold Spring Harbor Laboratory
ASSISTANTS S. DeBlasio, USDA-ARS, Ithaca, New York
 H. Budayeva, Princeton University, New Jersey
 B. Diner, Princeton University, New Jersey
 T. Greco, Princeton University, New Jersey
 D. Igwe, USDA-ARS, Ithaca, New York
 A. Kliot, The Volcani Institute, Jerusalem, Israel
 M. Sweeney, Boyce Thompson Institute, Ithaca, New York
This intensive laboratory and lecture course focused on cutting-edge proteomic approaches and 
technologies. Students gained practical experience purifying and identifying protein complexes 
and posttranslational modifi cations. In a section focused on quantitative whole-proteome analyses 
or top-down proteomics, students gained hands-on experience using two-dimensional gel electro-
phoresis and mass spectrometry analysis. Students used differential in-gel electrophoresis (DIGE) 
for gel-based protein quantifi cation. Differentially expressed proteins were recognized by statisti-
cal methods using advanced gel analysis software and identifi ed using MALDI mass spectrom-
etry. For shotgun proteomic analysis sections or bottom-up proteomics, students used label-free 
and covalent isotopic-labeling quantitative approaches to differentially profi le changes in protein 
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complexes and whole proteomes. Students were trained in high-sensitivity microcapillary liquid 
chromatography coupled with nanospray-ESI and tandem mass spectrometry analysis. Students 
learned both single-dimension and multidimensional separation methods. In a section focused on 
targeted proteomics, students learned to analyze and process shotgun proteomic data for the de-
velopment of SRM/MRM assays that accurately identify and quantify targeted proteins. Students 
designed transitions for selected peptides and performed SRM/MRM mass spectrometry assays. 
They learned to process and interpret the acquired data to measure changing quantities of targeted 
proteins in a variety of biological samples. For all sections of the course, a strong emphasis was 
placed on data analysis. A series of outside lecturers discussed various proteomics topics including 
imaging by mass spectrometry, de novo sequence analysis, advanced mass spectrometry methods, 
protein arrays, and functional proteomics. The aim of the course was to provide each student with 
the fundamental knowledge and hands-on experience necessary for performing and analyzing 
proteomic experiments. The overall goal was to train students to identify new opportunities and 
applications for proteomic approaches in their biological research.
This course was supported with funds provided by the National Institute of Child Health and 
Human Development.
PARTICIPANTS
Balasubramani, A., Ph.D., La Jolla Institute for Allergy and 
Immunology, California
Bantysh, O., M.S., Institute of Gene Biology RAS, Moscow, 
Russia
Chai, H., B.A., University of California. Los Angeles
Colpan, M., B.S., Washington State University, Pullman
Cook, C., Ph.D., Colorado State University, Fort Collins
Daniels, C., Ph.D., Johns Hopkins Bloomberg School of 
Public Health, Baltimore, Maryland
Duncombe, T., B.S., University of California, Berkeley
Gallo MacFarlane, E., Ph.D., Johns Hopkins University, 
Baltimore, Maryland
Huang, H., Ph.D., Wilmer Eye Institute, Baltimore, 
Maryland
Johnson, E., Ph.D., Washington University, St. Louis, 
Missouri
Kong, L., M.S., McGill University, Montreal, Canada
Patel, A., B.Sc., McGill University, Ste. Anne de Bellevue, 
Canada
Polanco, G., B.S., University of Texas. El Paso
Tong, Z., B.S., Cornell University, Ithaca, New York
Womble,T., Ph.D., Florida A&M University, Tallahassee
SEMINARS
Bereman, M., University of Washington, Seattle: 
Introduction to MS.
Bruce, J., University of Washington, Seattle: Protein 
interaction topologies.
Cilia, M., USDA-ARS, Ithaca, New York: Applications of 
2-D DIGE technology.
Clauser, K., Broad Institute/Massachusetts Institute of 
Technology, Cambridge: Manual de novo peptide MS/MS 
interpretation for evaluating database search results.
Colon, F., University of North Carolina, Chapel Hill: 
Isolation of endogenous protein complexes from early 
mouse embryos.
Cristea, I., Princeton University, New Jersey: Protein 
interactions.
MacCoss, M., University of Washington, Seattle: 
Introduction to peptide quantifi cation. Introduction to 
targeted method refi nement with Skyline. Removing the 
subjectivity of peptide list.
Medzihradsky, K., University of California, San Francisco: 
How to interpret/evaluate MS/MS spectra: Focus on PTM 
assignments–I. How to interpret/evaluate MS/MS spectra: 
Focus on PTM assignments–II.
Muddiman, D., North Carolina State University, Raleigh: 
ESI MALDI and hybrids of the two. Labeling with 
isotopic glycan hydrazide tugs (INLIGHT): A novel 
glycan relative quantifi cation strategy, development, and 
application. Mass spectrometry-based absolute protein 
quantifi cation.
Pappin, D., Cold Spring Harbor Laboratory: Tandem MS 
identifi cation of proteins.
Smolka, M., Cornell University, Ithaca, New York: Signaling 
networks.
Wolf-Yadlin, A., University of Washington, Seattle: 
Phosphoproteomics and cell signaling.
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Biology and Disorders of Learning and Memory
July 20–August 2
INSTRUCTORS A. Duarte, Georgia Institute of Technology, Atlanta
 F. Froemke, New York University School of Medicine, New York
 K. Martin, University of California, Los Angeles
 J. Raymond, Stanford University, California
ASSISTANTS N. Amin, University of California, Berkeley
 I. Carcea, New York University, New York
This lecture course provided an introduction to cellular, molecular, and systems approaches to 
learning and memory. It was suited for graduate students and postdoctoral fellows in molecular 
biology, neurobiology, and psychology, as well as research workers who are interested in an intro-
duction to this fi eld. The course covered topics ranging from behavioral considerations of learning 
and memory to gene regulation in the nervous system. The lectures provided an intensive coverage 
of modern behavioral studies of learning and memory, the cell and molecular biology of neuronal 
plasticity, cellular and molecular mechanisms of simple forms of learning and memory, and sys-
tems approaches to learning in vertebrates and humans. Lectures were complemented by exercises 
in which students worked in small groups with lecturers to discuss topical issues in learning and 
memory, to evaluate recent studies, and to identify and formulate new research questions and ap-
proaches. The course was thus designed not only to introduce students to the fi eld of learning and 
memory, but also to provide an intellectual framework upon which future studies can be built.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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PARTICIPANTS
An, L., Ph.D., Xidian University, Xi’an, Shaanxi Province, 
China
McCue, M., B.A., Research Foundation for Mental Hygiene/ 
Nathan Kline Institute, Orangeburg, New York
Baj, G., Ph.D., Ph.D., University of Trieste, Italy
Pastuzyn, E., Ph.D., University of Utah, Salt Lake City
DiMauro, A., M.D./Ph.D., Boston University, Massachusetts
Robinson, N., Ph.D., Boston University, Massachusetts
Dulas, M., M.S., Georgia Institute of Technology, Atlanta
Sukhanova, A., Ph.D., Kurchatov NBIC Center, Moscow, 
Russia
Guo, W., Ph.D., Massachusetts Eye and Ear Infi rmary, 
Boston
Tamtè, M., M.Sc., Lund University, Sweden
Ibrahim, M.S., King Abdullah for Science and Technology, 
Thuwal, Saudi Arabia
Templer, V., Ph.D., Emory University, Atlanta, Georgia
Kau Escalante, M., M.S., Pierre-and-Marie-Curie University, 
Paris, France
Turney, I., Ph.D., Pennsylvania State University, University 
Park
Kim, J., B.A., Nathan Kline Institute, Orangeburg, New York
Waller, H., M.S., Montana State University, Bozeman
Lebois, E., Ph.D., Emory University, Atlanta, Georgia
Zalcman, G., M.S., IFIByNE-CONICET, Buenos Aires, 
Argentina
Wei-Jye, L., Ph.D., Icahn School of Medicine at Mount Sinai, 
New York
SEMINARS
Barth, A., Carnegie Mellon University, Pittsburgh, 
Pennsylvania: Cumulative experience-dependent plasticity 
in neocortical circuits.
Duarte, A., Georgia Institute of Technology, Atlanta: What 
can neuroimaging contribute to our understanding of age-
related memory changes?
Eichenbaum, H., Boston University, Massachusetts: Memory 
mechanisms and the hippocampus.
Hensch, T., Harvard University, Boston, Massachusetts: 
Biological constraints on brain plasticity.
Josselyn, S., Hospital for Sick Children/University of 
Toronto, Canada: Molecular, cellular, and systems basis of 
fear learning,
Levey, A., Emory University School of Medicine, Atlanta, 
Georgia: Alzheimer’s disease research and discovery.
Martin, K., University of California, Los Angeles: Regulating 
gene expression in neurons during synapse formation and 
synaptic plasticity.
Moscovitch, M., University of Toronto, Canada: Recent and 
remote memory in humans and rodents.
Raymond, J., Stanford University, Massachusetts; Froemke, 
R., New York University School of Medicine: Synaptic 
plasticity in vitro and in vivo.
Squire, L., University of California/Veterans Affairs 
Medicine Center, San Diego; Neuroscience of 
memory in historical perspective: 1881–2005. 
Conscious and unconscious memory systems of 
the mammalian brain.
Turner, G., California Institute of Technology, Pasadena: 
Pavlovian learning in Drosophila.
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Computational Cell Biology
July 23–August 12
INSTRUCTORS R. Albert, Pennsylvania State University, University Park
 L. Loew, University of Connecticut Health Center, Farmington
 G. Smith, The College of William and Mary, Williamsburg, Virginia
ASSISTANTS S.-A. Brown, Mayo Clinic, Rochester, New York
 K. Hardcastle, William and Mary College, Williamsburg, Virginia
 L. Harris, University of Pittsburgh School of Medicine, Pennsylvania
 S. Jalil, University of Texas Health Center, Houston
 O. Marchenko, University of Connecticut Health Center, Farmington
 X. Wang, The College of William and Mary, Williamsburg, Virginia
 S. Weinberg, The College of William and Mary, Williamsburg, Virginia
Computational cell biology was the fi eld of study that applied the mathematics of dynamical sys-
tems together with computer simulation techniques to the study of cellular processes. The fi eld 
encompassed several topics that have been studied long enough to be well established in their own 
right, such as calcium signaling, molecular motors and cell motility, the cell cycle, and gene expres-
sion during development. In addition to providing a recognizable larger community for topics such 
as these, this course provided a base for the development of newer areas of inquiry, e.g., the dynam-
ics of intracellular second-messenger signaling, of programmed cell death, of mitotic chromosome 
movements, and of synthetic gene networks. Unlike computational genomics or bioinformatics, 
computational cell biology is focused on simulation of the molecular machinery (genes-proteins-
metabolites) that underlies the physiological behavior (input-output characteristics) of living cells.
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This 3-week course incorporated a series of didactic lectures on the mathematics of dynami-
cal systems, computational simulation techniques, cell biology, and molecular biology. Practicing 
theoreticians and experimentalists rotated in for 1–3-day visits during the course to give lectures 
and interact with the students. Midway through the course, students selected an area for indepen-
dent study, and the focus of the last week of the course was largely on these projects, supplemented 
by continued visiting lecturers.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Chen, Y., B.S., West Virginia University, Morgantown
Connolly, N., B.E., Royal College of Surgeons, Dublin, 
Ireland
Daneshjou, N., B.S., University of Illinois, Chicago
Ding, Q., A.B.S, University of Pittsburgh, Pennsylvania
Dolatshahi, S., B.S., Georgia Institute of Technology, Atlanta
Ghochani, M., B.S., NICHD, National Institutes of Health, 
Bethesda, Maryland
Grande, A., B.A., CONICET-UBA, Ciudad Autonoma de 
Buenos Aires, Argentina
Imran Alsous, J., M.S., Princeton University, New Jersey
Lee, W., Ph.D., Johns Hopkins University School of 
Medicine, Baltimore, Maryland
Matthews, M., B.S., North Carolina State University, 
Raleigh
Morin, M., B.A., LISBP, Toulouse, France
Norman, R., B.S., University of Connecticut Health Center, 
Farmington
Ravi, B., B.Tech., CSIR-Institute of Genomics & Integrative 
Biology, New Delhi, India
Suarez, I., M.A., University of Miami Miller School of 
Medicine, Florida
van Mourik, T., M.Sc., Utrecht University, The 
Netherlands
Yang, Y., Ph.D., Emporia State University, Emporia, 
Kansas
SEMINARS
Albert, R., Pennsylvania State University, University Park: 
Graph theoretical analysis of intracellular networks. 
Linking the structure and dynamics of intracellular 
networks. Discrete dynamic modeling of signal 
transduction networks.
Chen, T., Stanford University, California: Cell cycle 
modeling.
Cohens, D.; Samant, A., Mathworks, Inc., Natick, 
Massachusetts: Matlab Overview. Matlab sim biology.
DeVries, G., University of Alberta, Edmonton, Canada: Enzyme 
kinetics I: Michaelis-Menten kinetics. Enzyme kinetics II: 
Cooperativity and the Hill equation. Modeling a biochemical 
network (resulting in a sharp threshold). Modeling a genetic 
network (resulting in a switch with memory).
Feinberg, M., Ohio State University, Columbus; Chemical 
reaction network theory.
Harris, L., University of Pittsburgh School of Medicine, 
Pennsylvania: Rule-based modeling.
Hasty, J., University of California, San Diego, La Jolla: Gene 
networks.
Hucka, M., California Institute of Technology, Pasadena: 
Sbml, model databases, and translation.
Keener, J., University of Utah, Salt Lake City; Cardiac 
models.
Loew, L, University of Connecticut Health Center, Farmington: 
Virtual cell and ODEs. Actin dendritic nucleation.
Mendes, P., University of Manchester, United Kingdom: 
Copasi and parameter estimation.
Moraru, I., University of Connecticut Health Center, 
Farmington: Model building with virtual cells. Virtual cell 
stochastic reactions.
Phair, R., Integrative Bioinformatics, Sunnyvale, California: 
Fluorescent protein kinetics and model diagrams.
Sachs, K.; Chen, T., Stanford University, California: 
Bayesian analysis of reaction networks. Machine learning/
network analysis.
Schaff, J., University of Connecticut Health Center, 
Farmington: Virtual cells and PDEs. Virtual cell spatial 
stochastic.
Smith, G.D., The College of William and Mary, 
Williamsburg, Virginia: Cellular biophysics and ODEs. 
Molecular cell biology and ODEs. Random walks/
diffusion. Stochastic modeling.
Sobie, E., Icahn School of Medicine at Mount Sinai, New 
York: Local control.
Terman, D., Ohio State University, Columbus: Dynamical 
systems.
Tyson, J., Virginia Tech, Blacksburg: Cell cycle.
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Eukaryotic Gene Expression
July 23–August 12
INSTRUCTORS K. Adelman, NIH/NIEHS, Research Triangle Park, North Carolina
 W. L. Kraus, University of Texas Southwestern Medical Center, Dallas
 A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
 D. Taatjes, University of Colorado, Boulder
ASSISTANTS B. Gibson, University of Texas Southwestern Medical Center, Dallas
 D. Gilchrist, NIEHS, Research Triangle Park, North Carolina
 G. Fromm, NIH/NIEHS, Research Triangle Park, North Carolina
 K. Liang, Stowers Institute for Medical Research, Kansas City, Missouri
 Z. Poss, University of Colorado, Boulder
This course was designed for students, postdocs, and principal investigators who have recently 
ventured into the exciting area of gene regulation. The course focused on state-of-the-art strategies 
and techniques used in the fi eld. Emphasis was placed both on in vitro and in vivo protein–DNA 
interactions and on novel methodologies to study gene regulation. Students made nuclear extracts, 
performed in vitro transcription reactions, and measured RNA levels using primer extension. 
They isolated transcription factor complexes and assessed their activity in functional assays. In ad-
dition, students learned techniques for the assembly and analysis of chromatin in vitro, including 
transcription assays, chromatin footprinting, and chromatin remodeling assays.
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During the past few years, the gene regulation fi eld has developed in vivo approaches to study 
gene regulation. Students learned widely used techniques such as qRT-PCR and chromatin im-
munoprecipitation (ChIP). They also used RNAi for specifi c knock-down experiments. Deter-
mining cellular gene expression profi les has been accelerated tremendously by microarray and se-
quencing technology. Students received hands-on training in performing and interpreting results 
from microarrays, ChIP-Seq, and RNA-Seq data sets.
Experience with basic recombinant DNA techniques was a prerequisite for admission to this 
course. Lectures by the instructors covered the current status of the gene expression fi eld, theo-
retical aspects of the methodology, and broader issues regarding strategies for investigating the 
regulation of gene expression in eukaryotes. Emphasis was placed on advantages and limitations 
of specifi c techniques and data interpretation. The students were encouraged and expected to 
actively participate in these discussions. Guest lecturers discussed contemporary problems in eu-
karyotic gene regulation and technical approaches to their solution. From the guest lectures and 
discussions, students learned to design effective experiments, properly interpret their own data, 
and critically evaluate the gene expression literature.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Alzrigat, M., M.Sc., Uppsala University, Sweden
Au, E., B.S., Thomas Jefferson University, Philadelphia, 
Pennsylvania
Audetat, K., B.S., University of Colorado, Boulder
Ben Chaabane, S., M.S., University of Copenhagen, 
Frederiksberg C, Denmark
Chottekalapanda, R., Ph.D., The Rockefeller University, 
New York
Mokube Ekumi, K.M., M.S., University of Helsinki, 
Finland
Fusby, B., B.S., University of Colorado Anschutz Medical 
Campus, Aurora
Garcia-Molinero, V., M.S., Prince Felipe Research Center, 
Valencia, Spain
Hanley, M., B.A., Harvard University, Cambridge, 
Massachusetts
Hill, C., Ph.D., Burke-Cornell Medical Research Institute, 
White Plains, New York
Malavazi, I., Ph.D., Universidade Federal de Sao Carlos, 
Sao Paulo, Brazil
Rutledge, E., B.A., Baylor College of Medicine, Houston, 
Texas
Sapochnik, D., B.S., LFBM-IFIByNE-UBA-CONICET, 
Buenos Aires, Argentina
Strandjord, D., B.A., University of Minnesota, Minneapolis
Sun, Y., B.S., Mount Sinai School of Medicine, New York
Viadiu, H., Ph.D., University of California, San Diego, 
La Jolla
SEMINARS
Akhtar, A., Max-Planck Institute of Immunobiology and 
Epigenetics, Freiburg, Baden-Wuerttemberg, Germany: Dosage 
compensation: A paradigm to study epigenetic regulation.
Almouzni, G., Institut Curie, Paris, France: Chromatin 
assembly: Stay tuned!
Espinosa, J.M., HHMI/University of Colorado at Boulder, 
Denver: Harnessing the p53 transcriptional network for 
cancer therapeutics.
Furlong, E., European Molecular Biology Laboratory, 
Heidelberg, Germany: Enhancers: cis-Regulatory 
elements that control the timing and location of gene 
expression.
Gilmour, D., Penn State University, University Park, 
Pennsylvania: RNA polymerase II dynamics and promoter 
proximal pausing.
Johnston, M., University of Colorado, Denver: Feasting, 
fasting, and fermenting: How yeasts sense glucose.
Kadonaga, J., University of California, San Diego, La Jolla: 
Peculiarities of promoters, prenucleosomes, and other 
planetary phenomena.
Kingston, R., Massachusetts General Hospital/Harvard 
Medical School, Boston: Epigenetic mechanisms: 
Mapping long noncoding RNAs and modulating 
chromatin structure.
Levine, M., University of California, Berkeley: The metazoan 
promoter as a developmental. 
Manley, J.; Prives, C., Columbia University, New York: 
Factors linking gene expression pathways and neurological 
disease (Manley). The two faces of p53: Tumor suppressor 
and oncogene (Prives).
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Pugh, F., Penn State University, University Park, 
Pennsylvania: Subnucleosomal chromatin architecture.
Rinn, J., Harvard University, Cambridge, Massachusetts: 
Through the genome and into noncodarnia.
Roy, A., Tufts University School of Medicine, Boston, 
Massachusetts: Growth regulatory functions of the 
transcription factor TFII-I.
Smale, S., University of California School of Medicine, 
Los Angeles: Transcriptional cascades induced by 
infl ammatory stimuli.
Tyler, J., University of Texas/M.D. Anderson Cancer Center, 
Houston: Regulation of gene expression by chromatin 
assembly and disassembly.
Whetstine, J., Massachusetts General Hospital and Harvard 
University, Charlestown: Looking at cancer through the 
eyes of histone demethylases.
283-422_Meetings & Courses.indb   396 8/28/2014   10:53:09 AM
397
Yeast Genetics and Genomics
July 23–August 12
INSTRUCTORS M. Dunham, University of Washington, Seattle
 M. Gartenberg, Robert Wood Johnson Medical School, Piscataway, New Jersey
 S. Jaspersen, Stowers Institute for Medical Research, Kansas City, Missouri
ASSISTANTS S. Burns, Stowers Institute for Medical Research, Kansas City, Missouri
 M. Chen, Robert Wood Johnson Medical School, Piscataway, New Jersey
 C. Payen, University of Washington, Seattle
This course was a modern, state-of-the-art laboratory course designed to teach students the full 
repertoire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces 
cerevisiae. Combinations of classical and modern genetic approaches were emphasized, including 
the isolation and characterization of mutants, tetrad analysis, complementation, and mitotic re-
combination, as well as array-, next-generation sequencing, and genome-based methods of analysis 
facilitated by the yeast genome, the deletion collection, and other genomic resources available 
to the community. Molecular genetic techniques, including yeast transformation, gene replace-
ment by PCR, construction and analysis of gene fusions, and generation of mutations were also 
emphasized. Students used classical approaches and modern whole-genome sequencing to gain 
experience in identifying and interpreting various kinds of genetic interactions including sup-
pression and synthetic lethality as well as synthetic genetic array (SGA). Students were immersed 
in yeast genomics and performed and interpreted experiments using DNA arrays and multiplex 
sequencing. Students gained fi rst-hand experience in modern cytological approaches such as epi-
tope tagging and imaging yeast cells using indirect immunofl uorescence, GFP-protein fusions, 
and a variety of fl uorescent indicators for various subcellular organelles. Lectures on fundamental 
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aspects of yeast genetics were presented along with seminars given by prominent experts in the 
fi eld on topics of current interest.
This course was supported with funds provided by a generous gift from Dr. David Botstein.
PARTICIPANTS
Aviran, S., Ph.D., University of California, Berkeley
Becker-Kettern, J., M.Sc., University of Luxembourg, 
Esch-sur-Alzette, Luxembourg
Carvunis, A.-R., Ph.D., University of California, 
San Diego
Dorrity, M., B.S., University of Washington, Seattle
Garabedian, M., B.S., Brandeis University, Waltham, 
Massachusetts
Garcia, D., Ph.D., Stanford University School of Medicine, 
California
Gray, V., B.S., University of Washington, Seattle
Grinberg, G., B.Sc., Tel Aviv University, Israel
Halimi, M., B.S., Brandeis University, Waltham, 
Massachusetts
Jiang, S., B.S., Tsinghua University, Beijing, China
Ledesma-Fernandez, M.-E., B.Sc., MRC National Institute 
for Medical Research, London, United Kingdom
Lyon, G., Ph.D., Cold Spring Harbor Laboratory
Morlot, S., Ph.D., University of Geneva, Switzerland
Sanchez de Groot, N., Ph.D., Medical Research Council, 
Cambridge, United Kingdom
Schwartz, B., Ph.D., Columbus State University, Columbus, 
Georgia
Strope, P., Ph.D., Duke University, Durham, North Carolina
SEMINARS
Biggins, S., Fred Hutchinson Cancer Research Center, 
Seattle, Washington: How do cells get the right 
chromosomes?
Bloom, K., University of North Carolina at Chapel Hill: 
Dissecting the function of a chromatin spring.
Boeke, J., Johns Hopkins University, Baltimore, Maryland: 
Synthesizing and scrambling Sc2.0, a designer yeast 
genome.
Boone, C., University of Toronto, Canada: The genetic 
landscape of a cell.
Fink, G., Whitehead Institute for Biomedical Research/
MIT, Chestnut Hill, Massachusetts: From genotype to 
phenotype—An inconvenient truth.
Gasch, A., University of Wisconsin. Madison: Genomic 
analysis of yeast environmental stress responses.
Johnston, M., University of Colorado School of Medicine, 
Denver: Feasting, fasting, and fermenting: Glucose 
sensing by yeasts.
Klar, A., National Cancer Institute, Frederick, Maryland: 
Schizosaccharomyces japonicus yeast poised to become a 
favorite organism for eukaryotic research and other yeast 
stories.
Koshland, D., University of California, Berkeley: Stress: 
From within afar.
Murray, A., Harvard University, Cambridge, Massachusetts: 
Checkpoint and mitosis/experimental evolution.
Nash, R., Stanford University, Palo Alto, California: Using 
SGD.
Smith, J., University of Virginia Health System, 
Charlottesville: Yeast as a model system for aging 
research.
Toczyski, D., University of California, San Francisco: 
Identifying ubiquitin ligase substrates.
Winston, F., Harvard Medical School, Boston, 
Massachusetts: Analysis of transcription and chromatin 
structure in S. cerevisiae and S. pombe.
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Imaging Structure and Function in the Nervous System
July 24–August 13
INSTRUCTORS D. DiGregorio, Institut Pasteur, Paris, France
 J. Waters, Allen Institute for Brain Sciences, Seattle, Washington
 K. Zito, University of California, Davis
ASSISTANTS G. Moneron, Institut Pasteur, Paris, France
 F. Munoz-Cuevas, University of California, San Francisco
 W. Oh, University of California, Davis
 A. Scimemi, National Institutes of Health, Bethesda, Maryland
 K. Smith, Northwestern University, Chicago, Illinois
 A. Tran-Van-Minh, Institut Pasteur, Paris, France
Advances in light microscopy and digital image processing and the development of a variety of 
powerful fl uorescent probes present expanding opportunities for investigating the nervous sys-
tem, from synaptic spines to networks in the brain. This intensive laboratory and lecture course 
provided participants with the theoretical and practical knowledge to utilize emerging imaging 
technologies. The primary emphasis of the course was on basic optics. Students learned the prin-
ciples of light microscopy, as well as the use of different types of electronic cameras, laser-scanning 
systems, illumination holographics, functional fl uorophores, delivery techniques, and digital im-
age-processing software. In addition to transmitted light microscopy for viewing cellular motility, 
the course examined a variety of molecular probes of cell function, including calcium-sensitive 
dyes, voltage-sensitive dyes, and photo-activated (“caged”) compounds. Issues raised in imag-
ing with electrophysiological methods were covered. Particular weight was given to multiphoton 
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laser-scanning microscopy and to genetically encoded fl uorophores, especially green fl uorescent 
protein (GFP) and its variants. A spectrum of neural and cell biological systems was used, includ-
ing living animals and brain slices.
Applicants had a strong background in the neurosciences or in cell biology. In their personal 
statements, applicants specifi ed (1) their experience with optical techniques, (2) how they will 
apply optical methods in their current projects, (3) the microscope systems available to them, and 
(4) their long-term goals in learning more about optical methods.
This course was supported by the Howard Hughes Medical Institute, with additional funding 
from the Burroughs Wellcome Fund.
PARTICIPANTS
Alvina, K., Ph.D., Albert Einstein College of Medicine, 
Bronx, New York
Chae, H.G., Ph.D., Cold Spring Harbor Laboratory
Chesler, A., Ph.D., University of California, San Francisco
Chevy, Q., M.S., Pierre & Marie Curie University, Paris, 
France
Gao, Y., B.S., Pennsylvania State University, State College
Haider, B., Ph.D., UCL Institute of Ophthalmology, 
London, United Kingdom
Hoffman, E., M.D., Yale University, New Haven, 
Connecticut
Koukouli, F., M.S., Pasteur Institute Paris France
Lavi, K., B.A., Friedrich Miescher Institute, Basel, 
Switzerland
Lu, J., Ph.D., Cold Spring Harbor Laboratory
Odstrcil, I., B.A., Harvard University, Cambridge, 
Massachusetts
Oliveira Martins, A.R., Ph.D., New York University 
SOM/BEB, New York
Picardo, M., Ph.D., New York University Medical Center, 
New York
Slezak, M., Ph.D., VIB, Leuven, Belgium
SEMINARS
Albeanu, F., Harvard University, Cambridge, Massachusetts: 
Intrinsic imaging.
De Grand, A., Olympus America, Inc., Center Valley, 
Pennsylvania: BX51 optics and objective cleaning.
Deisseroth, K., Stanford University, California: 
Optogenetics.
Denk, W., Max-Planck-Institute for Medical Research, 
Heidelberg, Germany: Extended 2P imaging and 
block-fa.
DiGregorio, D., Institut Pasteur, Paris, France: Point spreads: 
Intro to lab. Fast Imaging, including VSDs. Practical guide 
to neurotransmitter uncaging.
DiGregorio, D., Institut Pasteur, Paris, France; Zito, K., 
University of California, Davis: Flash photolysis.
Dittman, J., Weill Cornell Medical College, New York; 
Photoactivatable XFPs.
Dombeck, D., Northwestern University, Evanston, Illinois: 
Awake imaging in hippocampus.
Emiliani, V., CNRS, INSERM, University Paris Descartes, 
Paris, France: Digital holography.
Engert, F., Harvard University, Cambridge, Massachusetts: 
Shot noise and intro to noise measurement lab. Two-photon 
microscopy.
Glickfeld, L., Duke University, Durham, North Carolina: 
Imaging presynaptic function.
Griesbeck, O., Max-Planck Institute of Neurobiology, 
Martinsried, Germany: XFP calcium indicators.
Kilborn, K., Intelligent Imaging Innovations, Inc., Denver, 
Colorado: Image analysis deconvolution. 
Kleinfeld, D., University of California, San Diego, La Jolla: 
Image analysis ICA, PCA, and denoising. Wavefront 
aberration, aberration correction.
Lanni, F., Carnegie-Mellon University, Pittsburgh, 
Pennsylvania: Basic microscopy.
Lichtman, J., Harvard University, Cambridge Massachusetts: 
Confocal microscopy.
Mertz, J., Boston University, Massachusetts: Phase-contrast 
microscopy.
Moneron, G., Institut Pasteur, Paris, France: Super-resolution.
Tsai, P., University of California, San Diego, La Jolla: 
Scanning and fl uorescence. Cameras and PMTs. Saturation. 
Optics bench lab exercises: Confocal.
Waters, J., Allen Institute for Brain Science, Seattle, 
Washington: Organic calcium indicators. Homebrew 
microscope including laser safety.
Weninger, K., North Carolina State University, Raleigh: 
FRET.
Wilbrecht, L., University of California, San Francisco; 
Munoz-Cuevas, F., University of California, Emeryville: 
Image analysis dendrite and spine morphology.
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Synthetic Biology
July 30–August 12
INSTRUCTORS K. Haynes, Arizona State University, Tempe
 J. Lucks, Cornell University, Ithaca, New York
 D. Savage, University of California, Berkeley
 J. Tabor, Rice University, Houston, Texas
ASSISTANTS R. Davis, Arizona State University, Tempe
 D. Nadler, University of California, Berkeley
 E. Olson, Rice University, Houston, Texas
 M. Takahashi, Cornell University, Ithaca, New York
The goal of synthetic biology is to enable the predictable reprogramming of cells to execute com-
plex physiological activities. It takes inspiration from our ever-expanding ability to measure and 
perturb biological systems and the philosophical refl ections of Schrodinger and Feynman that 
rational physical laws can be used to describe and engineer biology to accomplish useful things. 
However, biological systems are noisy, massively interconnected, and nonlinear. The grand chal-
lenge for synthetic biology was therefore how to reconcile the desire for a predictable, formalized 
design process with the inherent “squishiness” of biology.
This course focused on how the complexity of biological systems, combined with traditional 
engineering approaches, results in the emergence of new design principles for synthetic biology. 
In the lab, students were introduced to the design–build–test cycle, in which libraries of bio-
logical parts are composed into larger modules and evaluated using a variety of high-throughput 
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techniques. Students worked in teams to solve challenges introduced by the instructors and 
learned how bacterial and eukaryotic regulation of all forms—transcriptional, translational, post-
translational, and epigenetic—can be used to engineer cells to do useful things. In addition, inter-
nationally recognized invited speakers gave students a broad overview of applications for synthetic 
biology, including renewable chemical production and therapeutics, and the current state-of-the-
art techniques for both bottom-up and top-down design.
Synthetic biology is an inherently interdisciplinary fi eld. We encouraged students of all back-
grounds, whether the very biological or very theoretical, to apply.
This course was equally supported by the U.S. Offi ce of Naval Research and the Howard 
Hughes Medical Institute.
PARTICIPANTS
Alexander, W., Ph.D., University of Wisconsin, Madison
Al-Khabouri, S., M.Sc., University of Montreal, Canada
Fall, C., Ph.D., Offi ce of Naval Research, Arlington, Virginia
Herd, H., Ph.D., University of Utah, Salt Lake City
Jusiak, B., Ph.D., Baylor College of Medicine, Houston, 
Texas
Kan, A., M.Phys., University of Cambridge, United Kingdom
MacEachran, D., Ph.D., Logos Technologies, Ashburn, 
Virginia
Neofotis, P., B.A., City of New York and Brooklyn College, 
New York
Nygard, Y., M.Sc., VTT Technical Research Centre of 
Finland, Espoo, Finland
Sander, K., B.S., Bredesen Center Interdiscip., Knoxville, 
Tennessee
Savitskaya, J., M.Phil., Cambridge University, United 
Kingdom
Singhal, V., B.Eng., California Institute of Technology, 
Pasadena
Spring, K., Ph.D., University of Texas Health Science Center, 
Houston
Vogl, T., M.Sc., Graz University of Technology, Austria
Ward, J., Ph.D., Middlebury College, Middlebury, 
Vermont
Wells, D., B.A., Northwestern University, Evanston, 
Illinois
SEMINARS
Arkin, A., University of California, Berkeley: Context effects 
and predictability in gene expression.
Chang, M., University of California, Berkeley: Engineering 
microbes for chemical synthesis.
Ellington, A., University of Texas, Austin: Synthetic biology: 
An alternative view.
Gallivan, J., Emory University, Atlanta, Georgia:
Reprogramming bacteria with small molecules and RNA.
Gibson, D., J. Craig Venter Institute, San Diego, California: 
Building a synthetic cell and advancing synthetic 
genomics.
Jewett, M., Northwestern University, Evanston, Illinois: 
Establishing cell-free synthetic biology for materials.
Klavins, E., University of Washington, Seattle: Control of 
cellular state and decision making in synthetic. 
Murray, R., California Institute of Technology, Pasadena: 
Biomolecular breadboards for prototyping and debugging.
Palmer, M., University of California, Berkeley: Practicing 
synthetic biology: (How) can we be responsible?
Silver, P., Harvard Medical School, Boston, Massachusetts: 
How to think about designing biological systems.
Wang, H., Columbia University, New York: Multiplexed 
genome engineering methods and applications.
Weiss, R., Massachusetts Institute of Technology, 
Cambridge: From parts to modules to therapeutic systems 
in mammalian.
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Cellular Biology of Addiction
August 6–12
INSTRUCTORS A. Bonci, National Institute on Drug Abuse, Baltimore, Maryland
 C. Evans, University of California, Los Angeles
 B. Kieffer, IGBMC, Cedex, France
 R. Maldonado, Pompeu Fabra University, Barcelona, Spain
 M. Von Zastrow, University of California, San Francisco
ASSISTANTS P. Chu Sin Chung, IGBMC, Cedex, France
 A. Taylor, University of California, Los Angeles
Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and re-
peated exposure to drugs produces neuroadaptation and long-term memory of the experience, but 
the cellular and molecular processes involved are only partially understood. The primary objective 
of the proposed workshop was to provide an intense dialog of the fundamentals, state-of-the-art ad-
vances, and major gaps in the cell and molecular biology of drug addiction. Targeted to new or ex-
perienced investigators, the workshop combined formal presentations and informal discussions to 
convey the merits and excitement of cellular and molecular approaches to drug addiction research. 
With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop 
comprehensive models of neuroadaptive processes fundamental to addiction, withdrawal, craving, 
and relapse to drug use and to brain function, in general. A range of disciplines and topics were 
represented, including noninvasive brain imaging to identify drug targets and adaptive processes; 
neuroadaptive processes at the molecular and cellular level; neural networks and their modulation; 
the relevance of genotype to susceptibility and drug response; tolerance and adaptation at the cel-
lular level; and approaches to exploiting the daunting volume generated by neuroinformatics. This 
283-422_Meetings & Courses.indb   403 8/28/2014   10:53:15 AM
404  Postgraduate Courses
workshop provided an integrated view of current and novel research on neuroadaptive responses 
to addiction, fostered discussion on collaboration and integration, provided critical information 
needed to construct a model of addiction as a disease and novel molecular targets for biological 
treatments. Beyond the plane of scientifi c endeavor, the information is vital for formulating public 
policy and for enlightening the public on the neurobiological consequences of drug use and ad-
diction. The workshop was designed to generate interest in this level of analysis, open conduits for 
collaborations, and present novel routes to investigating the neurobiology of addictive drugs.
This course was supported with funds provided by the National Institute on Drug Abuse.
PARTICIPANTS
Ables, J., Ph.D., The Rockefeller University, New York
Abraham, A., Ph.D., Oregon Health & Science University, 
Portland
Aydin, C., Ph.D., University of Michigan, Ann Arbor
Banghart, M., Ph.D., Harvard Medical School, Boston, 
Massachusetts
Barr, J., Ph.D., Temple University, Philadelphia, 
Pennsylvania
Bocarsly, M., B.A., Princeton University, New Jersey
Brown, J., Ph.D., University of Missouri, Columbia
Brown, R., Ph.D., Medical University of South Carolina, 
Charleston
Damez Werno, D., M.S., Icahn School of Medicine at Mount 
Sinai, New York
Frohmader, K., Ph.D., University of Michigan, Ann Arbor
Graham, D., B.S., Vanderbilt University Medical Center, 
Nashville, Tennessee
Hancock, D., B.S., RTI International, Research Triangle 
Park, North Carolina
Ko, J., Ph.D., Seton Hall University, South Orange, New Jersey
McIver, S., Ph.D., Tufts University, Boston, Massachusetts
Orsini, C., Ph.D., University of Florida, Gainesville
Panarsky, R., Ph.D., NIAAA/LNG, National Institutes of 
Health, Rockville, Maryland 
Parker, R., Ph.D., California Institute of Technology, 
Pasadena
Pick, J., Ph.D., New York University Medical Center, New 
York
Ramaker, M., B.S., Oregon Health & Science University, 
Portland
Spencer, S., Ph.D., Medical University of South Carolina, 
Charleston
Yeo, S., Ph.D., National Institute on Alcohol Abuse and 
Alcoholism, Bethesda, Maryland
SEMINARS
Belin, D., INSERM, Lyon, France: Corticostriatal substrates 
of incentive habits: Relevance for the pathophysiology of 
addictions.
Bonci, National Institute on Drug Abuse/NIDA, Rockville, 
Maryland: Optogenetics and synaptic plasticity: 
Implications of substance abuse.
Chavkin, C., University of Washington, Seattle: 
Understanding stress as a risk factor for addiction.
Edwards, R., University of California, San Francisco: The 
corelease of glutamate with monoamines.
Goldman, D., NIAAA/LNG, National Institutes of Health, 
Rockville, Maryland: Genetics of addiction: Alleles, 
mechanisms, and contexts.
Kalivas, P., Medical University of South Carolina, 
Charleston: Curing addiction with synaptic plasticity.
Kenny, P., The Scripps Research Institute, La Jolla, 
California: Mechanisms by which hypocretin (orexin) 
regulates drug intake.
Kieffer, B., IGBMC, Cedex, France: Opioid receptor 
function in addiction and mood disorders: Mouse genetic 
approaches.
Koob, G., The Scripps Research Institute, La Jolla, California: 
Neurobiology of addiction: View from the dark side.
Mason, B., The Scripps Research Institute, La Jolla, 
California: Predictive validity of human laboratory models 
for medication development in alcohol dependence.
Nairn, A., Yale University School of Medicine, New Haven, 
Connecticut: Signal transduction mechanisms beyond the 
dopamine receptor.
Nestler, E., Mount Sinai University, New York: 
Transcriptional and epigenetic mechanisms of addiction.
Picciotto, M., Yale University, New Haven, Connecticut: 
Molecular basis of nicotine addiction.
Pierce, C., University of Pennsylvania, Philadelphia: 
Forgiving the sins of the father: Epigenetic inheritance of 
addiction phenotypes.
Pollock, J., National Institute on Drug Abuse/NIH/DHHS, 
Rockville, Maryland: The genetics program at NIDA.
Sinha, R., Yale University, New Haven, Connecticut: 
Clinical neurobiology of stress and addiction.
Volkow, N., National Institutes of Drug Addiction, 
Rockville, Maryland: Progress and priorities in drug abuse 
and addiction research.
Yang, W., University of California, Los Angeles: Genetic 
dissection of basal ganglia circuitry: Novel mechanistic 
insights into opiate reward.
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X-Ray Methods in Structural Biology
October 14–29
INSTRUCTORS W. Furey, V.A. Medical Center/University of Pittsburgh, Pennsylvania
 G. Gilliland, Janssen R&D, LLC/Johnson & Johnson, Radnor, Pennsylvania
 A. McPherson, University of California, Irvine
 J. Pfl ugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT M.J. Whitley, University of Pittsburgh, Pennsylvania
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable 
through other methods. This intensifi ed laboratory/computational course focused on the major 
techniques used to determine the three-dimensional structures of macromolecules. It was designed 
for scientists with a working knowledge of protein structure and function, but who are new to 
macromolecular crystallography. Topics covered included basic diffraction theory, crystallization 
(proteins, nucleic acids, and complexes), crystal characterization, X-ray sources and optics, synchro-
trons, crystal freezing, data collection, data reduction, crystal twinnings, multiple isomorphous 
replacement, multiwavelength anomalous diffraction, molecular replacement, solvent fl attening, 
noncrystallographic symmetry averaging, electron density interpretation, molecular graphics, 
structure refi nement, structure validation, coordinate deposition, and structure presentation. Par-
ticipants learned through extensive hands-on experiments. One or more proteins were crystallized 
and the structure(s) determined by several methods, in parallel with lectures on the theory and 
informal discussions behind the techniques. Applicants were familiar with the creation and editing 
of simple text fi les on Linux workstations using a screen-based editor (either vi or emacs).
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This course was supported with funds provided by the National Institute of General Medical 
Sciences.
PARTICIPANTS
Barajas, J., B.S., University of California, Irvine
Benning, F., B.Sc., University of Basel, Switzerland
Chen, P.-H., B.S., Northwestern University Feinberg School 
of Medicine, Chicago, Illinois
Galicia, C., B.S., Instituto de Quimica, UNAM, Mexico
Griffi th, E., Pharm., St. Jude Children’s Research Hospital, 
Memphis, Tennessee
Jackson, R., Ph.D., Montana State University, Bozeman 
Karr, E., Ph.D., University of Oklahoma, Norman
Kuiper, E., B.S., Emory University, Atlanta, Georgia
Lansky, S., B.S., The Hebrew University of Jerusalem, Israel
Meekins, D., B.S., University of Kentucky, Lexington
Michel, S., Ph.D., University of Maryland School of 
Pharmacy, Baltimore
Musselman, C., Ph.D., University of Iowa, Iowa City
Ragland, D., B.S., University of Massachusetts Medical 
School, Worcester
Ron, D., M.D., University of Cambridge, United Kingdom
Vasiliauskaite, I., B.S., The Pasteur Institute, Paris, France
Wu, P., M.S., Genentech, Inc., S. San Francisco, California
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, California: 
Structure refi nement. PHENIX overview.
Caffrey, M., Trinity College Dublin, Ireland: Crystallizing 
membrane proteins for structure-function studies using 
lipidic mesophases.
Calero, G., University of Pittsburgh School of Medicine, 
Pennsylvania: Nano crystals and nano seeds.
Emsley, P., University of Glasgow, Oxford, United Kingdom: 
Model-building tools in coot. 
Furey, W., V.A. Medical Center/University of Pittsburgh, 
Pennsylvania: Patterson group therapy. Anomalous data 
collection considerations. Isomorphous replacement 
and anomalous scattering. Solvent fl attening/phase 
combination. MAD phasing: A classical approach. The 
role of direct methods in macromolecular crystallography. 
Noncrystallographic symmetry averaging.
Gilliland, G., Janssen R&D, LLC/Johnson & Johnson, 
Radnor, Pennsylvania: Course overview: The structure 
determination of biological macromolecules. Maximizing 
crystallization success through seeding.
Hendrickson, W., Columbia University, New York: MAD 
and SAD phasing.
Kleywegt, G., European Bioinformatics Institute, Cambridge, 
United Kingdom: Just because it’s in Nature, doesn’t mean 
it’s true (macromolecular structure validation).
McPherson, A., University of California, Irvine: 
Crystallization of macromolecules I. Crystallization of 
macromolecules II. Symmetry, periodicity, unit cells, space 
groups, Miller planes, and lattices. Waves, vectors, and 
complex numbers. Fundamental diffraction relationships, 
and Bragg’s law. Diffraction patterns, reciprocal space, and 
Ewald’s sphere. Fourier transforms and the electron density 
equation. Patterson methods. The art of capillary crystal 
mounting. Heavy atoms and anomalous scatters.
Perrakis, A., Netherlands Cancer Institute, Amsterdam, 
The Netherlands: Automated model building and 
rebuilding: From ARP/WARP to PDB_REDO. 
Macromolecular animation.
Pfl ugrath, J., Rigaku Americas Corporation, The 
Woodlands, Texas: Data collection: Design and setup. 
Cryocrystallography. Scaling and merging synchrotron 
data.
Ready, R., University of Cambridge, United Kingdom: 
Using SAD data in Phaser. Molecular replacement: New 
structures from old.
Richardson, J., Duke University Medical Center, Durham, 
North Carolina: Headd, J., Lawrence Berkeley Laboratory, 
California: Detection and repair of model errors using 
MolProbity.
Richardson, J., Duke University Medical Center, Durham, 
North Carolina: Structure presentation.
Smith, C., Stanford University, California: Synchrotron data 
collection and femtosecond crystallography.
Sweet, R., Brookhaven National Laboratory, Upton, 
New York: A slightly different view of fundamental 
crystallography. X-ray sources and optics.
Terwilliger, T., Los Alamos National Laboratory, New 
Mexico: Automated structure solution and model 
building.
Thorn, A., MRC Laboratory of Molecular Biology, 
Cambridge, United Kingdom: An introduction to 
SHELXC/D/E. The basics of twinning in crystals of 
macromolecules.
Tronrud, D., Oregon State University, Corvalis: 
Macromolecular refi nement I. Macromolecular refi nement 
II. Electron density maps.
Westbrook, J., Rutgers University, Piscataway, New Jersey: 
Automating PDB deposition.
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Programming for Biology
October 14–29
INSTRUCTOR S. Prochnik, DOE–Joint Genome Institute, Walnut Creek, California
CO-INSTRUCTOR S. Robb, University of California, Riverside
ASSISTANTS S. Ahrendt, University of California, Riverside
 J. Bredeson, University of California, Berkeley
 D. Messina, Cofactor Genomics, St. Louis, Missouri
 E. Ross, Howard Hughes Medical Institute, Kansas City, Missouri
 D. Triant, University of Virginia, Charlottesville
A computer is already an indispensable tool for database searches, but the use of web-based tools 
alone is not enough for today’s biologist who needs to access and work with data from myriad 
sources in disparate formats. This need will become ever more important as new technologies 
increase the already exponential rate at which biological data is generated. Designed for students 
and researchers with little or no prior programming experience, this 2-week course gave biologists 
the bioinformatics skills necessary to exploit this abundance of biological data.
The course was based around the Perl scripting language because of its ease of learning and 
incredible wealth of ready-built modules, such as Bioperl, that was designed to solve common 
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biological problems. Starting with introductory coding and continuing with a survey of avail-
able biological libraries and practical topics in bioinformatics, students ended by learning how to 
construct and run powerful and extensible analysis pipelines in a straightforward manner. The 
course combined formal lectures with hands-on sessions in which students work to solve problem 
sets covering common scenarios in the acquisition, validation, integration, analysis, and visualiza-
tion of biological data. For their fi nal projects, which ran during the second week of the course, 
students posed problems using their own data and worked with each other and the faculty to solve 
them. Final projects have formed the basis of publications as well as public biological websites.
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Adeogun, S., B.S., Fisk University, Nashville, Tennessee
Ameziane, N., Ph.D., Vrije Universitet Medical Center, 
Amsterdam, The Netherlands
Blaby, I., Ph.D., University of California, Los Angeles
Boyle, J., B.S., Harvard University, Cambridge, 
Massachusetts
Chevrier, N., Ph.D., Harvard University, Cambridge, 
Massachusetts
Clark, V., B.A., Yale University School of Medicine, New 
Haven, Connecticut
Duggan, A., M.S., Max-Planck Institute for Evolutionary 
Anthropology, Leipzig, Germany
Franke, K., Ph.D., University of Delaware, Newark
Gallaher, S., Ph.D., University of California, Los Angeles
Glover-Cutter, K., B.Sc., U.S. Department of Agriculture, 
Corvallis
Goldmann, J., Ph.D., Whitehead Institute/MIT, Cambridge, 
Massachusetts
Guo, L., B.S., Stowers Institute for Medical Research, Kansas 
City, Missouri
Jones, K., B.Sc., University of Waterloo, Canada
Kantar, M., Ph.D., University of Minnesota, St. Paul
Keasey, S., B.S., U.S. Army Medical Research Institute of 
Infectious Diseases, Fort Detrick, Maryland
Landau, D., M.D., Dana-Farber Cancer Institute, Boston, 
Massachusetts
MacHugh, D., Ph.D., University College of Dublin, Ireland
Malone, C., Ph.D., New York University Medical School, 
Skirball Institute, New York
McDevitt, S., B.A., Children’s Hospital Oakland Research 
Institute, Oakland, California
Paul, A., Ph.D., Cold Spring Harbor Laboratory
Rehan, S., Ph.D., University of Pennsylvania, Philadelphia
Ruiz, N., M.S., University of Utah, Salt Lake City
Turner, J., Ph.D., University of Pennsylvania, Philadelphia
Wang, H.-L., B.S., University of Missouri, Kansas City
SEMINARS
Cain, S., Ontario Institute for Cancer Research, Medina, 
OH: GBrowse. 
Haas, B., Broad Institute, Cambridge, Massachusetts: 
RNA-Seq expression analysis. RNA-Seq expression. 
HTML.
Marques-Bonet, T., University of Pompeu Fabra/CSIC, 
Barcelona, Spain: Structural variant analysis.
Moore, B., University of Utah, Salt Lake City: Genome 
annotation with MAKER. VAAST variant analysis 
pipeline.
Pearson, W., University of Virginia, Charlottesville: Sequence 
similarity searches.
Prochnik, S., DOE–Joint Genome Institute, Walnut Creek, 
California: CGI.
Robb, S., University of California, Riverside: Bioperl.
Schatz, M., Cold Spring Harbor Laboratory: Genome 
assembly with ALLPATHS–LG.
Stajich, J., University of California, Riverside: Introduction 
to next-generation sequencing and SNP calling.
Tisdall, J., Baltimore, Maryland: Scientifi c computing.
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Computational and Comparative Genomics
November 6–12
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
 L. Stubbs, University of Illinois, Urbana
ASSISTANT L. Mills, University of Virginia, Charlottesville
This course presented a comprehensive overview of the theory and practice of computational 
methods for the identifi cation and characterization of functional elements from DNA sequence 
data. The course focused on approaches for extracting the maximum amount of information 
from protein and DNA sequence similarity through sequence database searches, statistical anal-
ysis, and multiple sequence alignment. Additional topics included alignment and analysis of 
“next-gen” sequencing data, with applications from metagenomic, RNA-Seq, and CHiP-Seq 
experiments; the Galaxy environment for high-throughput analysis; regulatory element and 
motif identifi cation from conserved signals in aligned and unaligned sequences; integration of 
genetic and sequence information in biological databases; the ENSEMBL genome browser; and 
BioMart.
The course combined lectures with hands-on exercises; students were encouraged to pose chal-
lenging sequence analysis problems using their own data. The course was designed for biologists 
seeking advanced training in biological sequence and genome analysis, computational biology 
core resource directors and staff, and individuals in other disciplines (e.g., computer science) who 
wished to survey current research problems in biological sequence analysis. Advanced program-
ming skills were not required.
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The primary focus of this course was the theory and practice of algorithms in computational 
biology, with the goals of using current methods more effectively for biological discovery and 
developing new algorithms.
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Auble, D., Ph.D., University of Virginia Health System, 
Charlottesville
Baldridge, D., M.D., Ph.D., St. Louis Children’s Hospital, 
Missouri
Brukhin, V., Ph.D., St. Petersburg State University, Russia
Buckner, B., Ph.D., Truman State University, Kirksville, 
Missouri
Carey, W., Ph.D., Intertrust Corp., Sunnyvale, California
Doss, J., Ph.D., Duke University, Durham, North Carolina
Dupont, P.-Y., Ph.D., Massey University, Palmerston North, 
New Zealand
Elgin, S., Ph.D., Washington University, St. Louis, Missouri
Guler, G., Ph.D., Genentech, S. San Francisco, California
Hapala, J., M.Sc., Masaryk University, Brno, Czech 
Republic
Hopper, K., Ph.D., USDA-Agricultural Research Service, 
Newark, Delaware
Kozel, B., M.D., Ph.D., Washington University School of 
Medicine, St. Louis, Missouri
Miller, D., B.A., Stowers Institute for Medical Research, 
Kansas City, Missouri
Mitchell, D., Ph.D., Texas Tech University Health Sciences 
Center, El Paso
Palmer, S., Ph.D., University of Florida, Gainesville
Paudel, Y., M.S., Wageningen University, Wageningen, 
The Netherlands 
Renn, S., Ph.D., Reed College, Portland, Oregon
Theisen, J., M.D., Ph.D., St. Louis Children’s Hospital, 
St. Louis, Missouri
Ziegler, K., B.Sc., University of Alberta, Edmonton, Canada
SEMINARS
Mackey, A., University of Virginia, Charlottesville: 
Genome annotation I (HMM basics). Annotation 
review Yandell. Sequencing technologies/tools. SNP 
discovery and variation. RNA-Seq. From gene lists to 
pathways. 
Mills, L., University of Virginia, Charlottesville: The UCSC 
genome browser. Open helix UCSC browser intro UCSC 
exercises. Review/Panel Discussion–Ensembl/UCSC–
which browser when?
Overduin, B., EMBL–European Bioinformatics Institute, 
Hinxton, Cambridgeshire, United Kingdom: The 
Ensembl database of genomes I. Ensembl/BioMart; 
BioMart/API Demos. Ensembl API.
Pearson, W., University of Virginia, Charlottesville; 
Stubbs, L., University of Illinois, Urbana: Introduction 
and overview. Protein evolution and sequence similarity 
sequencing. Practical sequence similarity searching. 
Alignment algorithms and scoring matrices. PSSMs, 
HMMs, and Pfam. Multiple sequence alignment and 
phenotype prediction. PolyPhen/SIFT.
Stormo, G., Washington University School of Medicine, 
St. Louis, Missouri: Modeling motifs: Collecting data. 
From motifs to regulatory networks.
Stubbs, L, University of Illinois, Urbana: Introduction 
to genome biology. Using the ECR browser. zPicture/
MULAN chromosome alignment. MEME motif funding. 
Cisfi nder. DAVID exercise. DAVID gene list. DAVID 
paper. Integrating genomics data sets for biological 
inference. Comparative epigenomics demo. Epigenome 
browser from UCSC. WashU epigenome browser.
Taylor, J., Emory University, Atlanta, Georgia: Galaxy for 
high-throughput analysis.
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Antibody, Engineering, and Phage Display
November 6–19
INSTRUCTORS C. Barbas, Scripps Research Institute, La Jolla, California
 D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
 G. Silverman, New York University School of Medicine, New York
ASSISTANTS S. Gilgunn, Dublin City University, Ireland
 S. Kacir, University of Pennsylvania, Philadelphia
 M.A. Pohl, Albert Einstein College of Medicine, Bronx, New York
Recent advances in the generation and selection of antibodies from combinatorial libraries allow 
for the rapid production of antibodies from immune and nonimmune sources. This intensive lab-
oratory/lecture course focused on the construction of combinatorial antibody libraries expressed 
on the surface of phage and selection of desired antibodies from the library. Students learned the 
theoretical and practical aspects of constructing combinatorial libraries from immune and nonim-
mune sources as well as the construction of synthetic antibody libraries. Antibodies were selected 
from the library by panning. Production, purifi cation, and characterization of antibody fragments 
expressed in E. coli were also covered. Epitopes were selected from peptide libraries and character-
ized.
The lecture series, presented by the course instructors and invited speakers, emphasized anti-
body structure and function, alternative display technologies and scaffolds, the immunobiology of 
the antibody response, and the use of antibodies and antibody conjugates for therapy.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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PARTICIPANTS
Aguilar, J., Ph.D., Albert Einstein College of Medicine, 
Bronx, New York
Bethke, A., Ph.D., Cornell University, Ithaca, New York
Chirichella, M., M.S., Scuola Normale Superiore, Pisa, Italy
Dobrenkov, K., M.D., Memorial Sloan-Kettering Cancer 
Center, New York
Fleetwood, F., B.S., Royal Institute of Technology, 
Stockholm, Sweden
Fofana, I., Ph.D., Boston College, Chestnut Hill, 
Massachusetts
Hatahet, F., B.Sc., Harvard Medical School, Boston, 
Massachusetts
Heinen, R., M.D., Institute of Molecular Biology, Vienna, 
Austria
Juncker, D., Diplom., McGill University, Montreal, Canada
Kanter, J., Ph.D., Medimmune, Frederick, Maryland
Lin, C.-W., M.S., Academia Sinica, Taipei, Japan
Lopez Albaitero, A., M.D., Memorial Sloan-Kettering Cancer 
Center, New York
Mercan, F., Ph.D., Cold Spring Harbor Laboratory
Roberts, S., B.S., Duke University, Durham, North Carolina
Viadiu, H., Ph.D., University of California, San Diego, 
La Jolla
Vuong, C., B.S., Texas A&M University, College Station
SEMINARS
Boyd, S., Stanford University, California: High-throughput 
sequencing of human antibody repertoires.
Crowe, Jr., J., Vanderbilt University Medical Center, Nashville, 
Tennessee: Integrated human B-cell repertoire studies using 
hybridoma and next-generation sequence analysis.
Noren, C.; Noreen, K., New York England Biolabs, Beverly, 
Massachusetts: Phage peptide libraries: The PhD for 
peptides.
Rader, C., The Scripps Research Institute-Florida, Jupiter, 
Florida: Antibody engineering and conjugation technologies 
for cancer therapy.
Siegel, D., University of Pennsylvania Medical Center, 
Philadelphia: Human phage display libraries, cell surface 
panning, and translational medicine applications.
Silverman, G.J., New York University Medical Center, 
New York: Superantigens and immune repertoires.
Stahl, S., AlbaNova University Center, Stockholm, Sweden: 
Selecting affi body molecules for applications in cancer and 
Alzheimer’s disease.
Wilson, I., The Scripps Research Institute, La Jolla, 
California: Broadly neutralizing antibodies to HIV and 
infl uenza viruses.
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Advanced Sequencing Technologies and Applications
November 12–24
INSTRUCTORS E. Mardis, Washington University School of Medicine, St. Louis, Missouri
 G. Marth, Boston College, Chestnut Hill, Massachusetts
 W. McCombie, Cold Spring Harbor Laboratory
 A. Quinlan, University of Virginia, Charlottesville
 M. Zody, Broad Institute, Cambridge, Massachusetts
ASSISTANTS A. Farrell, Boston College, Chestnut Hill, Massachusetts
 E. Garrison, Boston College, Chestnut Hill, Massachusetts
 E. Ghiban, Cold Spring Harbor Laboratory
 S. Goodwin, Cold Spring Harbor Laboratory
 M. Griffi th, Washington University School of Medicine, St. Louis, Missouri
 O. Griffi th, Washington University School of Medicine, St. Louis, Missouri
 V. Magrini, Washington University School of Medicine, St. Louis, Missouri
 S. McGrath, Washington University School of Medicine, St. Louis, Missouri
 C. Miller, Boston College, Chestnut Hill, Massachusetts
 J. Walker, Washington University School of Medicine, St. Louis, Missouri
 A. Ward, Boston College, Chestnut Hill, Massachusetts
During the last decade, large-scale DNA sequencing has markedly impacted the practice of mod-
ern biology and is beginning to affect the practice of medicine. With the recent introduction of 
several advanced sequencing technologies, costs and timelines have been reduced by orders of 
magnitude, enabling investigators to conceptualize and perform sequencing-based projects that 
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heretofore were prohibitive. Furthermore, the application of these technologies to answer ques-
tions previously not experimentally approachable is broadening their impact and application.
This intensive 2-week course explored applications of next-generation sequencing technolo-
gies, with a focus on commercially available methods. Students were instructed in the detailed 
operation of several revolutionary sequencing platforms, including sample preparation procedures, 
general data handling through pipelines, and in-depth data analysis. A diverse range of biological 
questions were explored, including DNA resequencing of human genomic regions (using cancer 
samples as a test case), de novo DNA sequencing of bacterial genomes, and the use of these tech-
nologies in studying small RNAs, among others. Guest lecturers highlighted their own applica-
tions of these revolutionary technologies.
We encouraged applicants from a diversity of scientifi c backgrounds including molecular evo-
lution, development, neuroscience, cancer, plant biology, and microbiology.
This course was supported by the National Human Genome Research Institute, with major 
equipment provided by Illumina & Life Technologies.
PARTICIPANTS
Allam, B., Ph.D., Stony Brook University, Stony Brook, NY
Apparsundaram, A., Ph.D., HySynth Biotechnologies, North 
Caldwell, NJ
Beeler, J.S., Ph.D., Vanderbilt University School of Medicine, 
Nashville, TN
Coban Akdemir, Z., Ph.D., M.D. Anderson Cancer Center, 
Houston, TX
Dermawan, K.T., Ph.D., Cleveland Clinic Lerner Research 
Institute, Ohio
Engle, E., Ph.D., Washington University, St. Louis, Missouri
Espitia, H., M.Sc., Colombian Sugarcane Research Center, 
Cali, Colombia
Goldlust, I., Ph.D., National Institutes of Health, Rockville, 
Maryland
Hapala, J., M.Sc., Masaryk University, Brno, Czech Republic
Higgins, G., Ph.D., Mayo Clinic, Assure Rx Health, Inc., 
Mason, Ohio
Jeukens, J., Ph.D., University Laval, Quebec, Canada
Masamha, C., Ph.D., University of Texas Health Science 
Center, Houston
Melas, P., Ph.D., Karolinska Institute, Stockholm, Sweden
O’ Brien, E., Ph.D., University of Cambridge, United Kingdom
Oh, Y.-S., Ph.D., The Rockefeller University, New York
Oppenheim, S., Ph.D., American Museum of Natural 
History, New York
Schafer, M., Ph.D., New York University, New York
Stadler, Z., M.D., Memorial Sloan-Kettering Cancer Center, 
New York
Tihon, E., Ph.D., Institute of Tropical Medicine, Antwerp, 
Belgium
Uyar, A., Ph.D., Yale School of Medicine, New Haven, 
Connecticut
SEMINARS
Baslan, T., Cold Spring Harbor Laboratory: Single cancer cell 
sequencing.
Dewar, K., McGill University and Genome QC Innovation 
Centre, Montreal, Canada: Clinical sequencing of 
Clostridium diffi cile isolates with Illumina and PacBio 
hybrid assembly.
Griffi th, M., Washington University School of Medicine, 
St. Louis, Missouri: RNA-Seq introduction.
Hall, I., University of Virginia, Charlottesville: Background 
talk: Structural variation prevalence, mechanisms, 
biological impact. Structural variant detection and cancer-
specifi c aspects. Practical exercise on structural variant 
detection.
Hodges, E., Cold Spring Harbor Laboratory; Methylation 
and ChIP-Seq: Methods and analysis.
Kramer, M., Cold Spring Harbor Laboratory: Illumina PE 
and ion torrent read processing, base-calling pipeline, 
interpreting results.
Magrini, V.; McGrath, S., Washington University School 
of Medicine, St. Louis, Missouri: Overview of next-
generation sequencing technologies and sample prep 
methods.
Mardis, M., Washington University School of Medicine, 
St. Louis, Missouri: NGS in cancer genomics studies.
Marth, G., Boston College, Chestnut Hill, Massachusetts; 
SNP callers and other downstream analytical processing.
Quinlan, A., University of Virginia, Charlottesville; Yandell, 
M., University of Utah, Salt Lake City: Variant interpretation: 
Interactive interrogation of variants with Aaron’s GEMINI, 
and disease gene hunting with Mark Yandell’s VAAST.
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Schatz, M., Cold Spring Harbor Laboratory: Hybrid 
assembly of NGS data.
Walker, J.; Griffi th, O.; Griffi th, M., Washington 
University School of Medicine, St. Louis, Missouri: 
Introduction to Unix commands and fi le system 
organization. Continue Unix commands, BASH, Perl, 
R, etc. RNA-Seq alignment and visualization. RNA-Seq 
expression and differential expression. RNA-Seq isoform 
discovery and alternative expression. RNA-Seq fi nale.
Walker, J.; Griffi th, O., Washington University School of 
Medicine, St. Louis, Missouri: RNA-Seq tuxedo suite.
Zody, M., Broad Institute, Cambridge, Massachusetts: 
Introduction to IGV viewer. RNA-Seq de novo assembly.
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The Genome Access Course
The Genome Access Course (TGAC) is an intensive 2-day introduction to bioinformatics that 
was held three times in 2013 and trained more than 110 participants in total. Registration for 
the course is open to all on a fi rst-come, fi rst-served basis subject to basic eligibility requirements. 
The core of TGAC covers the manipulation and analysis of sequence data using publicly available 
tools. The course is broken into modules designed to give a broad overview of a given topic, with 
ample time for hands-on exercises chosen by the instructors. Each module includes three parts: 
(1) a discussion of theory and methods, (2) coverage of software and Web resources, and (3) use 
of selected tools in practice. The modular design allows the instructors to tailor the curriculum 
to the interests of the students. Modules in 2013 included Genome Sequencing and Assembly, 
Gene Prediction, the UCSC Genome Browser, Ensembl, Comparative Genome Analysis, Gene 
Set Enrichment and Pathway Analysis, High-Throughput Sequence Analysis, the Galaxy Project, 
and RNA-Seq Analysis Using R. Students were encouraged to bring questions and data from their 
own research projects to the course, and they were also encouraged to contact instructors with 
additional questions once they returned to their home institutions.
In April and July, TGAC was held in CSHL’s newly renovated Hershey Laboratory, which 
opened in the summer of 2012.
INSTRUCTORS C. Lambert, Cold Spring Harbor Laboratory
 G. Howell, The Jackson Laboratory
 B. King, Mount Desert Island Biological Laboratories
 J. Ward, Middlebury College
LECTURERS A. Gordon, Cold Spring Harbor Laboratory
 E. Hodges, Cold Spring Harbor Laboratory
 M. Schatz, Cold Spring Harbor Laboratory
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April 21–23
Students: 30
PARTICIPANTS
Bacanamwo, M., Morehouse School of Medicine
Carmona, M., Yale University
Ciarleglio, C., Brown University
D’Alessandro, L., The Hospital for Sick Children
Diaz, P., University of Connecticut Health Center
Guallar, D., Mount Sinai School of Medicine
Higgins, G., Mayo Clinic; AssureRx Health, Inc.
Higgins, M., Roswell Park Cancer Institute
Janha, R., Medical Research Council Unit The Gambia
Jin, K., University of Medicine & Dentistry of New Jersey
Kasmar, A., Harvard Medical School
Leda, A. R., The Aaron Diamond AIDS Research Center
Lucs, A., Feinstein Institute for Medical Research
Marsh, J., University of Pittsburgh
Moss, W., Yale University/HHMI
Mustapha, M., University of Pittsburgh
Newsome, C., Child Health Institute of New Jersey 
(UMDNJ/RWJMS)
Novatt, J., Cold Spring Harbor Laboratory
O’Rawe, J., Cold Spring Harbor Laboratory
Schneyer, A., University of Massachusetts, Amherst
Seth, R., Yale School of Medicine
Shakur, R., University of Cambridge
Stansell, E., Harvard Medical School/NEPRC
Tian, Y., University of Pennsylvania
Wang, C.-L., Cold Spring Harbor Laboratory
Wang, J., Mount Sinai School of Medicine
Watson, P., Memorial Sloan-Kettering Cancer Center
Wong, J., Mount Sinai School of Medicine
Zuber, M., SUNY Upstate Medical University
Zukher, I., Institute of Gene Biology
July 18–20
Students: 35
PARTICIPANTS
Klingener, M., Cold Spring Harbor Laboratory
Knowlton, D., RaNA Therapeutics
Lo, J., Harvard/MGH
Maze, I., The Rockefeller University
Nemeth, K., University of Minnesota Medical School, 
Duluth
Pena, C., Mount Sinai School of Medicine
Reshmi, S., Nationwide Children’s Hospital
Rezza, A., Black Family Stem Cell Institute. Mount Sinai
Ruan, T., Stony Brook University
Santiago, J., Rosalind Franklin University
Schnyder, S., Boston Medical Center
Sennett, R., Mount Sinai School of Medicine
Simien, C., University of Texas M.D. Anderson Cancer 
Center
Sintov, E., Tel-Aviv University
Sokolow, S., University of California, Los Angeles
Stundon, J., Princeton University
Todd, J., Children’s Hospital Boston
Toussaint, V., Agriculture and Agri-Food Canada
Turner, J., University of Pennsylvania
Veronneau, P.-Y., 
Villani, S., Cornell University
Walker, D., Mount Sinai School of Medicine
Westby, G., Memorial Sloan-Kettering Cancer Center
Zhan, H., James J. Peters VA Medical Center
Zhang, Y., Stony Brook University
Zuo, L., Yale University
The November course was held in Manhattan at the brand-new facilities of the New York Ge-
nome Center, and it marked the fi rst collaborative training project with the New York Genome 
Center, for which CSHL is an institutional founding member. The November course had a record 
high enrollment of 48 students with more than 20 on a waiting list, a majority of who were from 
institutions in the New York City area. CSHL plans to offer the Manhattan course again in July 
2014 in collaboration with the New York Genome Center, and annually thereafter as long as de-
mand for the course continues.
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November 17–19
Students: 48
INSTRUCTORS G. Howell, The Jackson Laboratory
 B. King, Mount Desert Island Biological Laboratories
 C. Lambert, Cold Spring Harbor Laboratory
 B. Overduin, EMBL-European Bioinformatics Institute
 J. Ward, Middlebury College
LECTURERS D. Church, DHHS/NIH/NLM/NCBI
 E. Hodges, Cold Spring Harbor Laboratory
PARTICIPANTS
Aggarwal, A., Mount Sinai School of Medicine
Alshafai, K., Imperial College of London
Banaszynski, L., The Rockefeller University
Barton, G., University of California, Berkeley
Benazet, J.-D., Weill Cornell Medical College
Carmona-Fontaine, C., Memorial Sloan-Kettering Cancer 
Center
Cattani, V., New York University
Cerdeira, L.T., Fleury, South America
Chheda, M., Memorial Sloan-Kettering Cancer Center
Coux, R., New York University School of Medicine/Skirball 
Institute
D’Angelo, C.S., University of Sao Paulo
Fariello, D., Fordham University
Garabedian, M., New York University School of Medicine
Griffi ths, B., University of Massachusetts
Hafner, M., The Rockefeller University
Hsu, Y.-C., The Rockefeller University
Huebner, M., Cold Spring Harbor Laboratory
Jain, A., Systems Biology Center, New York
Jarvis, J., University at Buffalo
Knapp, R., University of Oklahoma
Kutluay, S., Aaron Diamond AIDS Research Center
Loughran. O., Virginia Commonwealth University
Matov, A., Weill Cornell Medical College
Miura, P., Memorial Sloan-Kettering Cancer Center
Moore, M., Stony Brook University
Pande, P., Boehringer Ingelheim Pharmaceuticals
Park, H.Y., Albert Einstein College of Medicine
Patel, J., Janssen Pharmaceuticals (Johnson & Johnson)
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Pavlicev, M., Cincinnati Children’s Hospital
Pelton, S., Boston University School of Medicine
Petros, T., New York University
Rosa Fernandes, L., Fundação Faculdade de Medicina
Sabari, B., The Rockefeller University
Sabharwal, V., Boston University Medical Center
Sanfi lippo, P., Gerstner Sloan-Kettering Graduate School of 
Biomed
Schneiderman, J., Memorial Sloan-Kettering Cancer Center
Sheng, Q., Novartis
Sohn, J., Yonsei Cancer Center
Tahtinen, P., Boston University
Tang, L., Memorial Sloan-Kettering Cancer Center
Veerappan, R., SiParadigm Diagnostics Informatics
Wamsley, B., New York University Langone Medical Center
Will, B., Albert Einstein College of Medicine
Wontakal, S., Columbia University
Xu, W., Synthetic Genomics, Inc.
Yazbeck, V., Massey Cancer Center
Yu, L., The Ohio State University
Zhao, Y.,(Jeffrey), Memorial Sloan-Kettering Cancer 
Center
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The Laboratory acknowledges the generosity of the following companies that loaned equipment and 
supplied free or discounted reagents to the various courses:
ASI Imaging
Agilent Technologies Inc.
Andor Technology
Applied Biosystems
Applied Precision
Art Robbins Institute
Astro-Med Inc.
BD Biosciences
Berthold Technologies USA, 
LLC
Bioline USA
Bio-Rad Laboratories
Bitplane
Cairn Research LTD
Caliper Life Sciences
Carl Zeiss Inc.
Chroma Technology 
Corporation
Clontech
Coherent Laser
ConOptics
CoolLED
Corning Inc.
Covaris, Inc.
CrystaLaser
Dage-MTI
Doric Lenses
Drummond Scientifi c 
Company
Epicentre
Eppendorf North America
Fludigm
Fotodyne Inc.
Forte Bio
GE Life Sciences
Hamamatsu Photonic 
Systems
Hamilton Thorne 
Biosciences
Hampton Research
Harvard Apparatus Inc.
Heka Instruments
Illumina Inc.
Intelligent Imaging 
Innovations Inc.
Integrated DNA 
Technologies
Invitrogen
Jackson Immunoresearch 
Laboratories
Kinetic Systems Inc.
Kopf Instruments
Leica Microsystems Inc.
Life Technologies
LI-COR
Luigs & Neumann
Mightex
Millipore Corporation
Miltenyi Biotec Inc.
Molecular Devices
Nanodrop Technologies
NanoTemper Technologies
Narishige International USA 
Inc.
Nasco
New England Biolabs Inc.
Nikon Inc.
Nonlinear Dynamics
NuGEN
Olympus America Inc.
Pel-Freez, Inc.
PerkinElmer Life and 
Analytical Sciences
Photometrics
Prairie Technologies
Prior Scientifi c
Promega Corporation
Qiagen Inc.
RC Testing Services
Rapp Optoelectronic 
GmbH
Roche Applied Science
Roche Nimblegen
Sage Science Inc.
Scientifi ca Ltd.
SciGene
Semrock, Inc.
Singer Instruments
Spectra-Physics Lasers Inc.
Spectral Applied Research
Sutter Instruments
Taconic Farms
Tecan US, Inc.
Thermo Fisher Scientifi c
Thor Labs
Tokai Hit
Warner Instruments
Waters Corporation
World Precision 
Instruments
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Title Host
January
James Eberwine, University of Pennsylvania Single-cell mRNA variation—Why? Adrian Krainer
Tim Stearns, Stanford University School of 
Medicine
Centrosomes, cilia, and cell signaling. Bruce Stillman
Nadrian Seeman. New York University DNA is not merely the secret of life: Using 
molecular information for the control of 
3D structure.
Leemor Joshua-Tor
February
Anne Brunet, Stanford University School of 
Medicine
Epigenetic regulation of aging. Lloyd Trotman
Iannis Aifantis, New York University School 
of Medicine
Regulation of cancer stem cell function by the 
ubiquitin/proteasome system.
Scott Powers
Michael Rosbash, Brandeis University Genome-wide approaches provide new insights 
into circadian regulation. 
Christopher Hammell
Carol Prives, Columbia University Lessons learned from studying the p53 network. Terri Grodzicker
March
John Lis, Cornell University New views of transcription and its regulation. Christopher Hammell
Robert Singer, Albert Einstein College of 
Medicine of Yeshiva University
Following single mRNAs in living cells and 
tissues.
David Spector
April
Yang Shi, Harvard Medical School A histone methylation network regulates 
transgenerational epigenetic inheritance in 
C. elegans.
Hongwu Zheng
Miguel Nicolelis, Duke University Medical 
Center
Principles of neural ensemble physiology and 
brain–machine interfaces.
Hassana Oyibo
October
Stuart Schreiber, Broad Institute of MIT and 
Harvard
Toward a chemistry-enabled patient-based drug 
discovery.
Scott Powers
Jean Zhao, Dana Farber Cancer Institute P13 K isoforms in signaling and cancer: 
Mechanistic and therapeutic insights from 
GEM models.
Lloyd Trotman
November
Dana Pe’er, Columbia University On the road to personalized therapy: Dealing 
with heterogeneity within and between tumors.
Scott Powers
Brian Shoichet, University of Toronto The metabolic code. Leemor Joshua-Tor
Sean Morrison, University of Texas 
Southwestern Medical Center
Stem cell self-renewal and leukemogenesis. Grigori Enikolopov
December
Takao Hensch, Harvard University Shaping neural circuits by early experience. Stephen Shea
Elaine Fuchs, The Rockefeller University Skin stem cells in silence, action and cancer. Terri Grodzicker
SEMINARS
INVITED SPEAKERS PROGRAM (“CSHL SEMINAR SERIES”)
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present 
their fi ndings. These weekly seminars keep the CSHL staff current on the latest scientifi c devel-
opments and broaden their perspectives. Graduate students and postdoctoral fellows meet with 
the seminar speakers for lunch immediately after the seminar, providing an opportunity for the 
exchange of ideas in an informal setting.
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Speaker Title
January
Jesse Gillis Network-based interpretation of gene function from postsynaptic protein interaction to 
schizophrenia coexpression.
Greg Hannon A small RNA-based innate immune system guards germ cell genomes.
Mikala Egeblad Innate immune cells as villains and heroes in the host response to cancer.
James D. Watson Oxidants, antioxidants, and the current incurability of metastatic cancers.
February
Bo Li Brain mechanisms of fear in health and disease.
Wangzhi Li (Mills Lab) A gift package from Dad: Chd5 orchestrates rewrapping of the sperm genome.
March
Jim Hicks Where’s Waldo? Can rare circulating tumor cells help direct cancer treatment in 
real time?
Hongwu Zheng Understanding malignant glioma pathogenesis.
Shane McCarthy (McCombie Lab) Harvesting rare variation in schizophrenia.
Junwei Shi (Vakoc Lab) Cooperation between chromatin readers and remodelers in the pathogenesis of cancer.
April
Martin Akerman (Krainer Lab) A deep dive into high-throughput data: Analysis of alternative splicing using RNA-Seq.
Anne Churchland Optimal weighting of sensory information for decision-making.
Andrea Eveland (Jackson Lab) Defi ning developmental mechanisms in maize using an integrative genomics approach.
October
Michael Schatz Algorithms for the analysis of complex genomes.
Duda Kvitsiani (Kepecs Lab) Foraging decisions revealed by cell-type-specifi c recordings in anterior cingulate cortex.
November
Qiaojie Xiong (Zador Lab) Corticostriatal synaptic weights encode arbitrary associations between stimuli and motor 
responses.
Simon Knott (Hannon Lab) Applying functional genomics to a mouse model of tumor heterogeneity and metastasis.
Michael Huebner (Spector Lab) The role of the histone demethylase JMJD3/KDM6B in transcriptional induction.
Grisha Enikolopov Stem cells of the adult brain.
December
Glenn Turner Input-output transformation in the mushroom body.
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor Laboratory’s In-House Seminars were initiated to provide a semiformal  venue 
for communication among the various research groups at the Laboratory. The seminars also af-
ford a necessary opportunity for graduate students and postgraduate staff to develop their skills in 
organizing, presenting, and defending their research.
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EXECUTIVE DIRECTOR’S REPORT
It was just over a year ago that our region was devastated by Superstorm Sandy, and I am glad to 
say that there is little, if any, evidence left of its impact on Banbury. The Robertson House roof 
was speedily repaired, the debris cleared up, and the fallen trees reduced to chips. The weather 
continued to be interesting with a major snowstorm in February, 2013, but fortunately Banbury 
was occupied by the Watson School of Biological Sciences’ course on microbial pathogenesis. The 
participants in the course did not have far to travel to get here.
One lingering effect of the storm was that meetings which were to have been held in 2012 were 
moved to 2013, so that the year was rather busy. We held 23 meetings with more than 700 partici-
pants, in addition to three Watson School courses and six Cold Spring Harbor Laboratory courses. 
Altogether, the Center was used on 37 occasions in 2013. Participants in the meetings were drawn 
from no fewer than 40 states, probably a record, although, as usual, four states—California, 
Maryland, Massachusetts, and New York—accounted for 51% of participants. Twenty-nine per-
cent of participants were female, a proportion that has doubled over the years since 1988, and 50% 
of the 2013 meetings had at least one female organizer. Banbury meetings continue to have strong 
international participation with 18% of participants coming from 20 countries.
One of the postponed meetings was on Redesigning Photosynthesis—Identifying Opportunities 
and Novel Ideas, organized by Donald Ort (University of Illinois) and Sabeeha Merchant (Uni-
versity of California, Los Angeles). Nearly all other biological processes on earth depend on the 
ability of photosynthesis to convert solar energy into chemical energy. There is a great deal of in-
terest in the effi ciency with which photosynthesis can accomplish this as it is the basis of the yield 
potential of both our food and bioenergy crops. In fact, photosynthesis is rather ineffi cient when 
all the costs are factored in; in the world’s best agricultural regions, ~1% of the total solar energy 
that falls on the fi eld during the growing season is stored as chemical energy in the plant materials 
at the end of the season. Participants discussed whether the effi ciency of solar energy capture by 
photosynthesis could be improved even though evolution has provided very little genetic variation 
in the component mechanisms of photosynthesis.
Conference Room, Fall 2013
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The second plant science meeting in 2013 also dealt with metabolism. Organized by Toni 
Kutchan (Danforth Center, St. Louis), Robert Last (Michigan State University), and Anne 
Osborn (John Innes Centre, United Kingdom), Evolution of Plant Metabolic Diversity focused 
on the evolution of specialized metabolism in plants. Most classes of specialized compounds are 
taxonomically restricted, making their analysis less accessible to some of the traditional tools of 
biology. However, studies of diverse plants, including “nonmodel” species, are benefi ting greatly 
from recent advances in genomics, metabolomics, reverse genetics, and synthetic biology. These 
tools are allowing rapid enzyme discovery and pathway identifi cation, and the abundance of 
data across and within taxa creates unprecedented opportunities for comparative analysis. The 
meeting brought together leaders in studies of these biosynthetic pathways and their functions, 
along with researchers at the forefront of comparative genomics, evolution, systems, and syn-
thetic biology.
The Banbury Center is known for having meetings on what might be called “emerging top-
ics,” and four such meetings took place in 2013. The fi rst was organized by Joshua Dubnau (Cold 
Spring Harbor Laboratory) and Fred Gage (Salk Institute for Biological Studies). Transposable 
elements are mobile genetic elements that constitute approximately 50% of the human genome. 
Some transposable elements have been shown to cause neurodegenerative diseases by insertional 
mutagenesis, but very recently there have been reports that transposable elements are active during 
normal neurogenesis. This suggests that mobilization of transposable elements in the developing 
brain might contribute to neuronal diversifi cation. If transposable element mobilization is impor-
tant in normal brain development, we may need to revise the way we think about the brain.
The involvement of telomeres in aging and aging-related disorders has been known since 
Carol Greider and Bruce Futcher here at CSHL, together with Calvin Harley at McMaster 
University, showed that telomeres shorten as human diploid fi broblasts age in cell culture. More 
recently, a growing body of evidence is implicating telomeres in the pathogenesis of several im-
portant degenerative disorders including pulmonary fi brosis, bone marrow failure, and diabetes. 
However, the underlying role of telomeres in these diverse disorders is not well understood. Is 
the role of shortened telomere length in these disorders due to effects on stem cells? What is 
the relationship between telomeres, mitochondria, and cell death? Can measurement of telo-
mere length be a useful diagnostic tool? Will an understanding of the role of telomeres in these 
disorders point to new therapeutic strategies? Organized by Mary Armanios (Johns Hopkins 
Meier House, Winter 2013
423-486_Education.indb   426 22-08-2014   13:50:22
Executive Director’s Report  427
University) and Peter Lansdorp (University of Groningen), the meeting brought together sci-
entists and clinicians to review and critically assess current data on how telomere dysfunction 
contributes to these diseases.
Enhancers—transcriptional regulatory elements that, as their name suggests, enhance gene 
expression—have been studied for many years. In recent years, there has been rapid progress 
in identifying transcriptional regulatory elements and the factors that occupy them. In particu-
lar,  “superenhancers,” large clusters of transcriptional enhancers, have been identifi ed. Disease- 
associated sequence variation occurs in some of these regulatory elements and in the factors that 
bind them. Enhancer Biology in Health and Disease, organized by James Bradner (Dana Farber 
Cancer Institute), Joanna Wysocka (Stanford University), and Richard Young (Whitehead 
 Institute), brought together experts in enhancer biology to discuss the roles of superenhancers in 
controlling gene expression and their impact on human health and disease. Topics included basic 
biology of enhancers (enhancers and chromatin folding, and enhancer dynamics), reviews of the 
evidence for enhancer involvement in diseases, and how to perform large-scale functional analysis 
of enhancers identifi ed by sequencing.
Finally, it was a pleasure to have a former Watson School of Biological Sciences student become 
an organizer of a Banbury Center meeting. Yaniv Erlich left the WSBS with a PhD in 2010 and is 
now at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts. Yaniv and 
his colleagues caused something of a sensation in early 2013, when they published a paper showing 
that it was possible to recover surnames associated with supposedly anonymized sequence data, 
using public, freely accessible Internet resources. One concern is whether the ability to do this, 
even on a limited scale, might lead to restrictions on the availability of genome data. The goals 
of Accelerate Genomic Research with Privacy Protections, organized by Yaniv, Arvind Narayanan 
(Princeton University), and Robert Kain (Illumina Inc.), were to discuss technical strategies for 
maintaining privacy of genetic and –omics data sets so that future research would not be com-
promised. Participants were drawn from an especially wide range of disciplines—human genetics, 
bioinformatics, cryptography, and ethics.
The continuing success of the Banbury Center program is due to the efforts of many people. 
Janice Tozzo and Pat Iannotti in the Banbury offi ce, Basia Polakowski at Robertson House, 
and Jose Pena Corvera, Fredy Vasquez, and Joe McCoy looking after the grounds, all worked 
Sammis, Winter 2013
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very hard to keep the Center running smoothly. Culinary Services, Facilities, and the Meet-
ings  Offi ce played key roles in the operation of the Center. The meetings could not take place 
without the hard work of the organizers, the generosity of the Laboratory’s Corporate Sponsors 
and the other donors who funded our meetings, and the Laboratory’s scientists who continue 
to support the Center.
Jan Witkowski
Executive Director
Cocktails at the Robertson House
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BANBURY CENTER MEETINGS
Title Organizer(s)
February 3–6 Oxidants and Antioxidants in Cancer Genesis 
and Treatment
Toren Finkel, Nicholas Tonks, 
David Tuveson
February 19–22 Interdisciplinary Approaches to Idiopathic Lung 
Fibrosis
Brigid Hogan, Maria Padilla
February 28–March 3 Grand Challenges in Organismal Biology: 
Walking the Tightrope between Stability and 
Change
Dianna Padilla, Billie Swalla, 
Brian Tsukimura
March 3–6 Evolution of Plant Metabolic Diversity  Toni Kutchan, Robert Last, 
Anne Osbourn
March 31–April 2 Transposable Elements in the Brain and Other 
Tissues: Prevalence and Function
Joshua Dubnau, Fred Gage
April 14–16 Development and Evolution of the Human 
Motor System in Relation to ALS and FTD 
Lucie Bruijn, Jeffrey Macklis, 
Martin Turner
April 19–24 Communicating Science Sandra Schedler, Claudia Walther
April 28–30 Developing a Neuroscience Consortium Larry Alphs, Arthur Holden
May 13–16 Redesigning Photosynthesis: Identifying 
Opportunities and Novel Ideas
Sabeeha Merchant, Donald Ort
July 14–16 The Emerging Intersection between Physical 
Sciences and Oncology
David Agus, Danny Hillis, Parag 
Mallick,
September 8–11 Telomeres and Disease Mary Armanios, Peter Lansdorp
September 15–18 Neurobiology and Clinical Study of Rapid-
Acting Antidepressants
Ronald Duman, Carlos Zarate
September 22–25 Plant Reproduction Robert Martienssen, Robert Meeley
September 29–
October 1
Science of Pancreatic Cancer Ronald Evans, William Isacoff, 
David Tuveson
October 6–9 Biguanides and Neoplasia Michael Pollak, Kevin Struhl
October 21–22 Lustgarten Foundation Scientifi c Meeting Mila McCurrach
October 23–25 Ovarian Cancer: Developing Research-Based 
Public Messaging on Early Detection and 
Screening
Jeffrey Boyd, Audra Moran, 
Michael Seiden
October 27–30 Enhancer Biology in Health and Disease James Bradner, Joanna Wysocka, 
Richard Young
November 12–15 INK4a/ARF Network David Beach, Norman Sharpless. 
Charles J. Sherr
December 3–5 The Adolescent Brain Jay Giedd, Hakon Heimer, Edward 
Lein, Nenad Sestan
December 8–11 Psychiatric Genomics: Current Status, Future 
Strategies
W. Richard McCombie, 
Aarno Palotie
December 11–13 Accelerate Genomic Research with Privacy 
Protections
Yaniv Erlich, Robert Kain, 
Arvind Narayanan
December 15–17 Phelan-McDermid Syndrome: Autism Due to 
Shank3 Mutations/Deletions
Geraldine Bliss, Ricardo Dolmetsch, 
Craig Powell
423-486_Education.indb   429 22-08-2014   13:50:23
430
BANBURY CENTER MEETINGS
Oxidants and Antioxidants in Cancer Genesis and Treatment
February 3–6
FUNDED BY John K. Castle, Oliver Grace Cancer Fund
ARRANGED BY T. Finkel, National Heart, Lung, and Blood Institute/NIH, Bethesda, Maryland
 N. Tonks, Cold Spring Harbor Laboratory
 D. Tuveson, Cold Spring Harbor Laboratory
Increased production of reactive oxygen species (ROS) has been functionally linked to aging and 
cancer. It is now clear that the cellular antioxidant machinery can be up-regulated in response to 
oncogenes and may confer drug resistance and “stemness.” Such observations suggest that redox 
modulation may offer a new approach for selective targeting of cancer cells. Participants in this 
meeting explored the chemical, biochemical, and genetic facets of ROS biology in relation to 
cancer, with the goal of determining whether ROS can be manipulated in vivo to alter cancer 
pathogenesis and the response of cancer cells to therapy.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Pathways and Redox
Chairperson: T. Finkel, National Heart, Lung, and Blood 
 Institute/NIH, Bethesda, Maryland
T. Finkel, National Heart, Lung, and Blood Institute/NIH, 
Bethesda, Maryland: Oxidants as signaling molecules.
B. Burgering, University Medical Center Utrecht, The Nether-
lands: Redox control of FOXO transcription factors to bal-
ance life span with disease.
B. Wouters, Ontario Cancer Institute, Toronto, Canada: The 
role of unfolded protein response on autophagy and ROS 
 during hypoxia.
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SESSION 2: Redox Biology
Chairperson: P. Schumacker, Northwestern University, Chi-
cago, Illinois
P. Huang, MD Anderson Cancer Center, Houston, Texas: 
ROS stress in cancer: Mechanisms and therapeutic implica-
tions.
M. Espey, National Cancer Institute/NIH, Bethesda, Mary-
land: Interplay between mechanobiology, NO, and O2 in 
tumors.
SESSION 3: ROS Biology and Chemistry
Chairperson: M. Murphy, University of Cambridge, United 
Kingdom
M. Murphy, MRC Mitochondrial Biology Unit, Cambridge, 
United Kingdom: Exploring mitochondrial ROS with tar-
geted molecules.
P. Schumacker, Northwestern University, Chicago, Illinois: 
Mitochondrial oxidant signals trigger stress responses
N. Chandel, Northwestern University, Chicago, Illinois: 
 Mitochondria regulate cancer.
SESSION 4: ROS Methods and Therapeutic Development
Chairperson: J. Held, Buck Institute for Age Research, Nov-
ato, California
J. Held, Buck Institute for Age Research, Novato, Califor-
nia: Mass spectrometric approaches to characterize oxidized 
cysteines.
T. Dick, German Cancer Research Center, Heidelberg, Germany: 
In vivo ROS imaging: Concepts, limitations, future directions.
M. Adorno, Institute for Stem Cell Biology & Regenerative 
Medicine, Stanford University, California: Trisomy of Usp16 
contributes to senescence and stem cell defects in somatic tis-
sues of Down syndrome and is associated with breast cancer 
protection.
Summary Discussion, T. Finkel, National Heart, Lung, and 
Blood Institute/NIH, Bethesda, Maryland
SESSION 5: Exogenous and Endogenous Antioxidants and 
Cancer
Chairperson: A. Holmgren, Karolinska Institute, Stockholm, 
Sweden
A. Holmgren, Karolinska Institute, Stockholm, Sweden: Thio-
redoxin and glutaredoxin systems in DNA synthesis and 
control of cell death.
T. Mak, Princess Margaret Hospital, Toronto, Canada: Regu-
lation of oxidants and antioxidants in oncogenic metabolic 
adaption.
G. Buettner, University of Iowa, Iowa City: Applying quanti-
tative redox biology to understand mechanisms of pharma-
cological ascorbate in cancer treatment.
SESSION 6: NRF2 and ROS Regulation
Chairperson: J. Hayes, Ninewells Hospital and Medical 
School, Dundee, United Kingdom
J. Hayes, Ninewells Hospital and Medical School, Dundee, 
United Kingdom: Roles of transcription factor Nrf2 in ad-
aptation to oxidative stress and tumor growth.
S. Biswal, Johns Hopkins School of Public Health, Baltimore, 
Maryland: Nrf2 at the crossroad of redox and energy me-
tabolism and therapeutic resistance.
M. Sporn, Dartmouth Medical School, Hanover, New Hamp-
shire: Nrf2: Good or bad for cancer?
SESSION 7: ROS Signaling
Chairperson: S.G. Rhee, Ewha Womans University, Seoul, 
Korea
S.G. Rhee, Ewha Womans University, Seoul, Korea: Centro-
somal accumulation of H2O2 through Peroxiredoxin I inac-
tivation is required for mitotic entry.
A. Ostman, Karolinska Institute, Stockholm, Sweden: ROS-
mediated regulation of cell signaling through oxidation of 
tyrosine phosphatases.
S. Muthuswamy, Ontario Cancer Institute, University of 
 Toronto, Canada: Cell polarity, protein scribble, and ROS.
SESSION 8: ROS and p53
Chairperson: K. Vousden, Beatson Institute, Glasgow, United 
Kingdom
K. Vousden, Beatson Institute, Glasgow, United Kingdom: 
The role of p53 in regulation of ROS.
R. Sordella, Cold Spring Harbor Laboratory: p53 mutation or 
splice forms cause mitochondrial ROS.
Summary Discussion: A. Holmgren, Karolinska Institute, 
Stockholm, Sweden
SESSION 9: ROS and Therapies I
Chairperson: A. Letai, Dana-Farber Cancer Institute, Boston, 
Massachusetts
I. Blair, University of Pennsylvania, Philadelphia: Serum bio-
markers of oxidative stress.
A. Letai, Dana-Farber Cancer Institute, Boston, Massachu-
setts: Mitochondrial fi tness and response to anticancer 
therapy.
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G. Wondrak, University of Arizona, Tucson: Teaching old 
dogs new tricks: Drug repurposing for redox-directed cancer 
chemotherapy.
D. Spitz, University of Iowa, Iowa City: Metabolic oxidative 
stress in cancer biology and therapy.
SESSION 10: ROS and Therapies II
Chairperson: B. Stockwell, Columbia University, New York
B. Stockwell, Columbia University, New York: Ferroptosis: An 
iron-dependent, oxidative form of nonapoptotic cell death.
Final Meeting Summary: D. Tuveson and N. Tonks, Cold 
Spring Harbor Laboratory
R. Sordella, J. Schlessinger K. Vousden
D. Tuveson, N. Chandel
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Interdisciplinary Approaches to Idiopathic Lung Fibrosis
February 19–22
FUNDED BY Elizabeth Livingston Estate
ARRANGED BY B. Hogan, Duke University Medical Center, Durham, North Carolina
 M. Padilla, Mount Sinai School of Medicine, New York
Idiopathic pulmonary fi brosis (IPF) is a devastating clini-
cal condition for which there is no effective therapy. This 
meeting brought together an eclectic mix of clinical and 
basic scientists with the goal of stimulating ideas about 
the origin and progression of fi brotic lesions in IPF and 
how new research tools and experimental paradigms can 
be developed to test them and to move basic studies into 
the clinic. Sessions followed the traditional Banbury for-
mat of short talks and discussion and focused extended dis-
cussions. Topics covered included clinical progression and 
heterogeneity of IPF; genetic and genomic approaches; de-
velopment of the peripheral lung, including lineage tracing 
and new mouse models; stem cells and their regeneration 
in relation to fi brosis; new discoveries related to fi brosis in 
different organ systems; role of oxidative and ER stress and senescence; the molecular biology of 
myofi broblasts, pericytes, and other mesenchymal cells; complexities of the extracellular matrix 
and signaling pathways; the role of immune cells; and progress of clinical trials.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: B. Hogan, Duke University Medical Center, Durham, North Carolina
M. Padilla, B. Hogan
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SESSION 1: Overviews of Clinical Impact, Pathology, and 
Classifi cation of Idiopathic Pulmonary Fibrosis
M. Padilla, Mount Sinai School of Medicine, New York: 
Overview of idiopathic pulmonary fi brosis and other fi bros-
ing interstitial pneumonias: Clinical challenges.
K. Leslie, Mayo Clinic, Scottsdale, Arizona: The pathology 
of idiopathic pulmonary fi brosis, what have we learned in 
50 years?
P. Noble, Duke University School of Medicine, Durham, 
North Carolina: Overview of pathologic heterogeneity in 
idiopathic pulmonary fi brosis.
Issues to Consider for Meeting
SESSION 2: Genetics and Genomic Approaches to Lung 
Fibrosis
C. K. Garcia, University of Texas Southwestern Medical Cen-
ter, Dallas: Genetic heterogeneity of idiopathic pulmonary 
fi brosis.
S. Guttentag, University of Pennsylvania, Philadelphia: Pul-
monary fi brosis in Hermansky Pudlak syndrome
N. Kaminski, University of Pittsburgh Medical Center, 
 Pennsylvania: Novel biomarkers for idiopathic pulmonary 
fi brosis.
General Discussion
SESSION 3: Cellular Stress, Senescence, and Epithelia-
Mesenchymal Interactions in Relation to Fibrosis
M. Armanios, Johns Hopkins University, Baltimore, Mary-
land: Telomerase and idiopathic pulmonary fi brosis.
S. Savage, National Cancer Institute, Bethesda, Maryland: 
Dyskeratosis congenita as a model for understanding pul-
monary fi brosis.
S. Friedman, Mount Sinai Hospital, New York: Autophagy 
drives fi brogenic cell activation in tissue injury?
SESSION 4: Fibrosis in Multiple Organ Systems
J. Duffi eld, University of Washington, Seattle: Kidney, peri-
cytes, and lung fi brosis.
L. Sakai, Shriners Hospital for Children, Portland, Oregon: 
Fibrosis due to mutations in fi brillin-1.
SESSION 5: Embryonic Development of the Alveolar Regions 
of the Lung, Lung Stem Cells, and Alveolar Cell Interac-
tions
E. Morrisey, University of Pennsylvania, Philadelphia: Con-
tribution of Wnt2+ mesoderm progenitors to the developing 
and adult lung.
B. Hogan, Duke University Medical Center, Durham, North 
Carolina: Alveolar stem cells and fi brosis in the mouse lung.
B. Hinz, University of Toronto, Canada: Myofi broblast me-
chanics.
R. Chambers, Centre for Respiratory Research, Rayne Insti-
tute, London, England: Coagulation cascade and pulmo-
nary fi brosis.
SESSION 6: Proliferation and Differentiation of Myo fi b-
roblasts and Other Mesenchymal Cells (Pericytes, Vascular 
Smooth Muscle, Lipofi broblasts, Fibrocytes) and Matrix
P. Noble, Duke University School of Medicine, Durham, 
North Carolina: Regulation of severe pulmonary fi brosis: 
Roles of the ECM.
L. Olson, Oklahoma Medical Research Foundation, Okla-
homa City: PDGF signaling and fi brosis.
K. Leslie, P. Ward, B. Stillman
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SESSION 7: Immune System and Lymphatics
I. Rosas, Brigham and Women’s Hospital, Boston, Massachu-
setts: NLRP3 infl ammasome activation and experimental 
pulmonary fi brosis.
C. Becker, Mount Sinai School of Medicine, New York: The 
role of dendritic cells in idiopathic pulmonary fi brosis.
W. Bradford, InterMune, Inc., Brisbane, California: Idio-
pa thic pulmonary fi brosis clinical trial effi ciency.
P.A. Ward, University of Michigan, Ann Arbor: Regulation of 
the lung infl ammatory response by the adrenergic and cho-
linergic nervous systems.
C. Hogaboam, University of Michigan, Ann Arbor: Innate 
immune signaling and fi brosis.
D. Wilkes, Indiana University School of Medicine, Indianap-
olis: Autoimmunity to type V collagen in idiopathic pulmo-
nary fi brosis pathogenesis.
General Discussion
SESSION 8: Clinical Trials
S. Violette, Biogen Idec, Cambridge, Massachusetts: Develop-
ing a biomarker strategy to support the early clinical devel-
opment of STX-100 in IPF patients.
S. Friedman, Mount Sinai Hospital, New York: Defi ning thera-
peutic targets for antifi brotic therapies: Challenges and oppor-
tunities.
General Discussion and Wrap Up, Potential Areas for Future 
Collaboration
Impromptu seminar
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Grand Challenges in Organismal Biology: Walking the Tightrope 
between Stability and Change
February 28–March 3
FUNDED BY Stony Brook University through a grant from the National Science Foundation
ARRANGED BY D. Padilla, Stony Brook University, New York
 B. Swalla, University of Washington, Seattle
 B. Tsukimura, California State University, Fresno
A central paradox in biology is that animals must maintain the integration of complex develop-
mental and functional systems while simultaneously responding and adapting to continuously 
changing internal and external environments. Understanding how animals maintain the balance 
between integrated stability and fl exibility (both short-term accommodation and long-term evolu-
tionary adaptation) is of growing importance. However, we do not understand the functional and 
system-level attributes of animals that make them resilient or robust to internal or external envi-
ronmental perturbation or, conversely, sensitive or fragile. In particular, we need to understand 
mechanisms that mediate phenotypic responses to environmental inputs across different scales 
and to develop quantitative frameworks for analyzing these phenomena. Participants identifi ed 
critical areas and questions that require new information or approaches, and priorities for new 
research agendas to address this grand challenge.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
 I. Introduction of the Grand Challenge of Organismal 
Biology
 a. History from NSF to this meeting
 i. GCOB in general
 ii. Selection of walking a tightrope as a fi rst effort
 b.  Discussion of Steering Meeting: Goals and 
challenges
 c. Vision Statement: Transformation of community
 d.  Guidelines and deliverables from this big 
meeting
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 II. Question and Answer Session
 III. What Have Other Communities Done That Are 
Successful?
 a.  NCEAS example: Building the next generation of 
scientist
 b. iPlant
 IV. Tutorial: Control Theory (T. Daniel and N. Cowan)
 a.  A control theorist’s view on organismal biology 
(stability): A tutorial
 b.  How can control theory be used to answer this 
GCOB?
 c. How do dynamics interact among scales?
 V. Instructions and Ground Rules for Breakout Sessions
 VI. First Breakout Session 
  What are the most important, burning questions 
explicitly across temporal, spatial, and organizational 
scales related to stability and change?
  What new approaches can/should we use to address 
these questions?
 VII. Second Breakout Session 
  What are the major challenges or impediments to 
addressing the burning questions beyond capacity 
building or just more funding in general?
   Are there specifi c needs or approaches that would 
jump-start making progress (e.g., specifi c national 
opportunities to facilitate and amplify interactions, 
targeted research centers)? What they would target, 
RCNs for mining existing data, and what areas would 
be most profi table?
  What would your wish list be for solving these 
questions?
 VIII. Third Breakout Session
   What are the mutual benefi ts and deliverables of a new 
set of approaches for organismal biology, recognizing 
that the dynamics occurring on all levels of biological 
organization are inextricably linked?
 IX. Fourth Breakout Session
   Given steering committee recommendations, what 
are the short-term and long-term best ways to move 
forward to answering this GCOB?
  What are the most easily accomplished (low-hanging 
fruit) and targeted funding priorities?
 X. Grand Synthesis of What We Have Accomplished
 XI. Next Steps
D. Plachetzki, D. Grunbaum, Z. Cheviron, J. Marden, M. Hale
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Evolution of Plant Metabolic Diversity
March 3–6
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY T. Kutchan, Danforth Center, St. Louis, Missouri
 R. Last, Michigan State University, East Lansing
 A. Osbourn, John Innes Centre, Norwich, United Kingdom
This is an exciting time for investigation of specialized (secondary) metabolism in plants. Most of 
these specialized compounds are taxonomically restricted, making their analysis less accessible to 
some of the traditional tools of biology. However, studies of diverse plants are benefi ting greatly 
from recent advances in genomics, metabolomics, reverse genetics, and synthetic biology. The 
abundance of data across and within taxa is creating unprecedented opportunities for compara-
tive analysis. Given the important ecological functions of these molecules, it is not surprising that 
examples of evolutionary plasticity and strong phenotypic diversity are being uncovered for a 
 variety of biosynthetic pathways. This meeting focused on the evolution of specialized metabolism 
in plants. Participants included leaders in studies of biosynthetic pathways and researchers at the 
forefront of comparative genomics, evolution, systems, and synthetic biology.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: R. Last, Michigan State University, East Lansing
SESSION 1: Metabolite Diversity in an Evolutionary/Functional Context
Chairperson: T. Kutchan, Danforth Center, St. Louis, Mis-
souri
R. Last, Michigan State University, East Lansing: Signatures 
of evolution in glandular trichomes of Solanum.
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K. Saito, Riken Plant Science Center, Chiba University, Japan: 
Origin of metabolomic diversity.
M. Simmonds, Royal Botanic Gardens, Kew, London, Eng-
land: Plant chemosystematics: New opportunities for select-
ing plants.
E. Kellogg, University of Missouri, St. Louis: Secondary me-
tabolism in the Poaceae (grasses).
T. Mitchell-Olds, Duke University, Durham, North Carolina: 
Metabolism and complex traits.
General Discussion
SESSION 2: Regulation of Metabolism
Chairperson: A. Osbourn, John Innes Centre, Norwich, Unit-
ed Kingdom
N. Doudareva, Purdue University, West Lafayette, Indiana: 
An alternate microbial pathway contributes to phenylalanine 
biosynthesis in plants.
D.J. Kliebenstein, University of California, Davis: Evolu-
tion of regulatory links between primary and secondary 
metabolism.
H. Klee, University of Florida, Gainesville: Regulation of 
fl avor-associated chemical accumulation in the tomato 
fruit.
M. Lange, Washington State University, Pullman: Evolution 
of specialized plant tissues and cell types for the synthesis 
and accumulation of terpenoids.
V. DeLuca, Brock University, Ontario, Canada: Specialized 
metabolism and the recruitment of multiple cell types for 
functional pathway organization.
General Discussion
SESSION 3: Pathway Evolution
Chairperson: R. Last, Michigan State University, East Lansing
A. Osbourn, John Innes Centre, Norwich, United Kingdom: 
Pathway evolution.
E. Pichersky, University of Michigan, Ann Arbor: Terpene 
gene evolution, evolution of functional gene clusters.
D. Werck-Reichhart, Institute of Plant Molecular Biology, 
Strasbourg, France: Cytochromes P450 as landmarks of 
plant metabolism evolution.
E. Wurtzel, City University of New York–Lehman College, 
Bronx, New York: Enzyme evolution and topological control 
of carotenoid biosynthesis in plants.
E. Cahoon, University of Nebraska, Lincoln: Evolution of un-
usual fatty acid synthesis: The case of acetylenic fatty acids 
and polyacetylenes.
General Discussion
SESSION 4: Omics Approaches to Studies of Pathway and 
Genome Evolution
Chairperson: H. Klee, University of Florida, Gainesville
S.-H. Shiu, Michigan State University, East Lansing: Meta-
bolic gene duplication and functional divergence/conver-
gence.
S. Rhee, Carnegie Institution of Washington, Stanford, Cali-
fornia: Genomic signatures of specialized metabolism evolu-
tion in plants.
T. Mockler, Donald Danforth Plant Science Center, St. Louis, 
Missouri: Informing metabolic studies using transcriptome 
profi ling.
T. Kutchan, Danforth Plant Science Center, St. Louis, Mis-
souri: Using genomics to elucidate biochemical pathways.
General Discussion
SESSION 5: Applying Evolutionary Principles to Pathway 
Engineering
T. Mitchell-Olds C. Paddon, E. Wurtzel
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Chairperson: K. Saito, Riken Plant Science Center, Chiba 
University, Japan
I. Abe, University of Tokyo, Japan: Engineered biosynthesis of 
plant polyphenols.
C. Paddon, Amyris, Inc., Emeryville, California: Semisyn-
thetic Artemisinin: Using synthetic biology to increase the 
supply of a crucial antimalarial drug.
R. Peters, Iowa State University, Ames: To gibberellins and 
beyond! The evolution of (Di)terpenoid metabolism.
J. Noel, Salk Institute for Biological Studies, La Jolla, Califor-
nia: The remarkable pliability and promiscuity of specialized 
metabolism.
Summary Discussion
Conference Room, Winter 2013
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Transposable Elements in the Brain and Other Tissues: 
Prevalence and Function
March 31–April 2
FUNDED BY Dart NeuroScience and the Marie Robertson Research Fund
ARRANGED BY J. Dubnau, Cold Spring Harbor Laboratory
 F. Gage, Salk Institute for Biological Studies, San Diego, California
The functions, if any, of transposable elements (TEs) in 
the human genome are largely unknown. However, they 
do cause disease by insertional mutagenesis and have been 
linked to neurodegenerative diseases. These include trans-
missible prion disorders, amyotrophic lateral sclerosis, 
frontotemporal lobar degeneration, macular degeneration, 
fragile-X-tremor ataxia, and normal aging. There are recent 
reports that several types of TEs are active during normal 
neurogenesis in mammals and invertebrates. It has been 
suggested that active mobilization of transposable elements 
in the developing brain can produce somatic neuronal ge-
netic heterogeneity and that this somatic variation may 
contribute to neuronal diversifi cation. Participants criti-
cally reviewed the state of the fi eld, and the meeting con-
cluded with a session devoted to considering future lines of 
research, discussing how to promote this area of research, 
and how to encourage funding by foundations and NIH.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
F. Gage, H. Kazazian, A. Ferguson-Smith
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Introduction:  J. Dubnau, Cold Spring Harbor Laboratory
SESSION 1: Transposons and Genome Evolution
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
R. Martienssen, Cold Spring Harbor Laboratory: Transposons 
at Cold Spring Harbor Laboratory
P. Batut, Cold Spring Harbor Laboratory: Transposons and 
evolution of transcriptional regulation in the Drosophila 
clade.
A. Ferguson-Smith, University of Cambridge, United King-
dom: Large clusters of LINE1 repeats: Functional or junk?
K. Kosik, University of California, Santa Barbara: The emer-
gence of brain noncoding RNAs at the Catarrhini Branch.
K. Burns, Johns Hopkins University School of Medicine, 
Baltimore, Maryland: Mapping and functional analysis of 
transposable element insertions.
M.C. Marchetto, Salk Institute for Biological Studies, La Jolla, 
California: Differential LINE-1 retrotransposition in in-
duced pluripotent stem cells between humans and great apes.
SESSION 2: Functional Roles and Regulatory Mechanisms
Chairperson: F. Gage, Salk Institute for Biological Studies, 
San Diego, California
O. Voinnet, Swiss Federal Institute of Technology Zurich, 
Switzerland: RNAi-dependent and -independent control of 
LINE1 mobility and accumulation in mouse ES cells.
K. Creasey, Cold Spring Harbor Laboratory: Plants catch 
transposons in the act: Control when methylation fails.
S. Waddell, University of Oxford, England: Transposition-
driven genomic heterogeneity in the Drosophila brain.
C. Walsh, Boston Children’s Hospital, Cambridge, Massa-
chusetts: Single-neuron, whole-genome analysis of L1 ret-
rotransposition in the human brain.
A. Muotri, University of California, San Diego, La Jolla: Im-
pact of L1 retrotransposition in the nervous system.
J. Moran, University of Michigan Medical School, Ann Arbor: 
Studies of a human retrotransposon.
SESSION 3: Dysfunction and Disease
Chairperson: S. Martin, University of Colorado, Aurora
J. Dubnau, Cold Spring Harbor Laboratory, Cold Spring Har-
bor, New York: Jumping into neurodegeneration.
R. Hunter, Rockefeller University, New York: Stress and hip-
pocampal transposable element expression.
P. Jin, Emory University School of Medicine, Atlanta, Geor-
gia: Transposable elements in neurodegeneration.
H. Kazazian, Johns Hopkins University, Institute of Genetic 
Medicine, Baltimore, Maryland: Extensive somatic L1 ret-
rotransposition in colon cancer.
A. Nath, National Institutes of Health, Bethesda, Maryland: 
Human endogenous retroviruses in ALS.
Summary, Discussion, and Future Research
P. Batut photographing Barbara McClintock’s corn cobs
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Development and Evolution of the Human Motor System 
in Relation to ALS and FTD
April 14–16
FUNDED BY Greater New York Chapter of the ALS Association
ARRANGED BY L. Bruijn, ALS Association, Washington, DC
 J. Macklis, Harvard University, Cambridge, Massachusetts
 M. Turner, University of Oxford, United Kingdom
The neurodegenerative process characteristic of amyotrophic lateral sclerosis (ALS) may be regarded 
as a system failure on several levels. The mechanisms of spread and of the variable penetrance of 
pathology within extramotor, upper and lower motor neuronal populations (and supporting cells) 
remain uncertain, but they are critical to hopes of therapeutic intervention. Data suggest that wider 
cortical organization, local circuits, and developmental factors may be important in defi ning vulner-
ability to neurodegenerative disorders. The neocortical evolutionary changes involved in bipedalism 
with opposable thumbs, and the relative athleticism observed premorbidly among patients, have 
been postulated to hold particular relevance for ALS. An understanding of the development and evo-
lution of the motor system and its frontotemporal connections has the potential to re-frame think-
ing on the pathogenesis of both ALS and FTD. This symposium was the fi rst to draw together a 
multidisciplinary group of internationally leading neuroscientists who might not otherwise interact.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction:  L. Bruijn, ALS Association, Washington, DC
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SESSION I
Chairperson: J. Macklis, Harvard University, Cambridge, 
Massachusetts
M. Turner, University of Oxford, John Radcliffe Hospital, 
United Kingdom: Introduction: From Charcot to C90rf72.
K. Talbot, University of Oxford, John Radcliffe Hospital, 
United Kingdom: The clinical spectrum of disorders affect-
ing the motor neuron.
V.R. Edgerton, University of California, Los Angeles: Evolu-
tionary organization of motor control circuitry.
A. Eisen, University of British Columbia, Canada: Evolution-
ary considerations in the pathogenesis of ALS: A clinical 
perspective.
SESSION II
Chairperson: J. Rothstein, Johns Hopkins University School 
of Medicine, Baltimore, Maryland
J. Martin, City College of New York, New York: Circuit func-
tion: Corticospinal and descending systems.
J. Macklis, Harvard University, Cambridge, Massachusetts: 
Molecular logic of corticospinal motor neuron development 
and broader neuron class evolution.
W. Seeley, University of California, San Francisco: Selective 
neuronal and network-based vulnerability in frontotemporal 
dementia.
SESSION III
Chairperson: J. Ravits, University of California, San Diego
Z. Molnár, University of Oxford, United Kingdom: The earli-
est cortical circuits.
S. Pfaff, Salk Institute for Biological Studies, La Jolla, Califor-
nia: Spinal motor neuron development.
J. Rothstein, Johns Hopkins University School of Medicine, 
Baltimore, Maryland: Cell vulnerability and the role of non-
neuronal cells and interneurons in MND.
G. Miles, University of St. Andrews, Fife, Scotland, United 
Kingdom: Physiology and pathology of spinal motor cir-
cuitry.
R. Brownstone, Dalhousie University, Halifax, Nova Scotia, 
Canada: Control of spinomuscular circuits.
M. Hallett, National Institute of Neurological Disorders, 
Bethesda, Maryland: Spinal cord circuitry and function.
SESSION IV
Chairperson: A. Al Chalabi, Kings College, Institute of 
 Psychiatry, London, England
A. Al Chalabi, Kings College, Institute of Psychiatry, London, 
England: Introductory remarks to tie the session together.
D.W. Dickson, Mayo Clinic, Jacksonville, Florida: The emerg-
ing neuropathological taxonomy of ALS and FTD. The 
range of ALS and FTD phenotypes and their overlap: A 
pathological view.
M. Strong, Schulich School of Medicine & Dentistry, On-
tario, Canada: The emerging neuropsychological spectrum 
of frontotemporal dysfunction in ALS.
SESSION V
Chairperson: M. Benatar, University of Miami Hospital, 
Miller School of Medicine, Florida
J. Ravits, University of California, San Diego: Clinicopatho-
logical observations on spread in ALS.
A. Eisen S. Pfaff, J. Rothstein
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J. Shefner, State University of New York, Upstate Medical 
University, Syracuse: Lower motor neuron studies evaluat-
ing spread of disease burden.
G. Fishell, New York University Medical Center, New York: 
Interneuron development.
E. Azim, Columbia University, New York: Genetic manipula-
tion of circuits for skilled forelimb movement in mice.
SESSION VI
Chairperson: T. Maniatis, Columbia University Medical Cen-
ter, New York
M. Kiernan, Institute of Neurological Sciences, Neuroscience 
Research of Australia, Sydney: Cortical excitability in ALS.
T. Siddique, Northwestern University, Feinberg School of 
Medicine, Chicago, Illinois: Is neurodegeneration a conse-
quence of protein in evolutionary confl ict?
General Discussion
Closing Remarks
Conference Room
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April 19–24
FUNDED BY Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine
ARRANGED BY S. Schedler, Boehringer Ingelheim Fonds, Mainz, Germany
 C. Walther, Boehringer Ingelheim Fonds, Mainz, Germany
The Boehringer Ingelheim Fonds (BIF) has an international program of support for PhD fellow-
ship, and it fi rst brought its fellows to the Banbury Center for their annual North American retreat 
in 2005. It has been a great pleasure to have them return, and their 2013 stay at Banbury was the 
sixth occasion on which they have been here. At Banbury, the fellows receive intensive instruction 
in matters such as giving presentations and writing papers—topics usually learned by default (and 
often poorly) during graduate research.
Opening Remarks and All About BIF
C. Walther, Boehringer Ingelheim Fonds, Mainz, Germany
Communication in General
N. LeBrasseur, DNA Medical Communications, New York, 
New York
Writing techniques and how to structure papers
Preparing and Delivering a Scientifi c Talk
B. Tansey, Vanderbilt University Medical Center, Nashville, 
Tennessee
How to Measure Success in Science
R. Lehmann, New York University School of Medicine, New 
York, New York
How to Design Figures
K. Ris-Vicari, Katie Ris-Vicari Graphic Design, Levittown, 
New York and Matt Hansen, Nature Publishing Group, New 
York, New York
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Developing a Neuroscience Consortium
April 28–30
FUNDED BY ISCTM and Individual Participants
ARRANGED BY L. Alphs, Janssen Pharmaceuticals, Titusville, New Jersey
 A. Holden, Pharmaceutical Biomedical Research, Chicago, Illinois
There has been considerable support for developing a con-
sortium to combine existing industry databases (with the 
goal of including quality data from other sources as well). 
Given the level of interest and support, this meeting was 
convened to discuss the practical issues involved and what 
can be done to move the project forward. The topics that 
were reviewed included the goals for the Neuroscience 
Consortium; what might be the organizational structure 
of the Consortium and how might it relate to or even be 
integrated into existing organizations; the legal and intel-
lectual hurdles that must be overcome to make this orga-
nization successful; the possible fi nancial models for this 
organization; and the major milestones and timeline for 
the successful development of this consortium.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction and Outline of the Meeting:  L. Alphs, Janssen Pharmaceuticals, Titusville, New Jersey and 
A. Holden, Pharmaceutical Biomedical Research, Chicago, Illinois
L. Alphs, M. Burke
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SESSION 1: Rationale for Consortium: The Value of Big 
Neuroscience Clinical Data
Goal: Brainstorming on What the Precompetitive Neurosci-
ence Data-Sharing Consortium Might Do
Brief presentations followed by brief discussions that sum-
marize a variety of potential different uses of consortium 
data.
W. Potter, National Institute of Mental Health, Bethesda, 
Maryland: The value of big neuroscience clinical data: A 
perspective from NIH.
Discussion
J. Dudley, Mount Sinai School of Medicine, New York: The 
value of big neuroscience clinical data: A computational bi-
ologist’s perspective.
Discussion
A. Cross, AstraZeneca Pharmaceuticals, Cambridge, Massa-
chusetts: The value of big neuroscience clinical data: A drug 
developer’s perspective.
Discussion
H. Geerts, Silico Biosciences, Philadelphia, Pennsylvania: The 
value of big neuroscience clinical data: A disease modeler’s 
perspective.
Discussion
M. Arrighi, Janssen Research and Development, South San 
Francisco, California: (presented by Larry Alphs)
The value of big neuroscience clinical data: An epidemiolo-
gist’s perspective.
Discussion
D. Meltzer, University of Chicago, Illinois: The value of big 
neuroscience clinical data: An economist’s perspective.
Discussion
W.R. McCombie, Cold Spring Harbor Laboratory: The val-
ue of big neuroscience clinical data: A geneticist’s perspec-
tive.
Discussion
S. Potkin, University of California, Irvine: The value of big 
neuroscience clinical data: A neuroimager’s perspective.
Discussion
SESSION 2: Breakout Groups
Goal: Discuss What This Precompetitive Neuroscience Data-
Sharing Consortium Might Do
Builds on ideas from the morning session and other ideas that 
participants may have.
Breakout Group I
Leader: R. Conley, Eli Lilly & Company, Indianapolis, Indiana
Rapporteur: H. Heimer, Schizophrenia Research Forum, 
Providence, Rhode Island
Breakout Group II
Leader: S. Potkin, University of California, Irvine
Rapporteur: M. Schatz, Cold Spring Harbor Laboratory
Breakout Group III
Leader: S. Romano, Pfi zer, New York
Rapporteur: J. Sum, First Manhattan Company, New York
SESSION 3: Breakout Groups
Goal: Prioritize in Small Groups What This Precompetitive 
Neuroscience Data-Sharing Consortium Might Do Priori-
tization should be based on value and doability of the idea.
Switch Groups: Discuss and Build on Ideas from Other 
Groups
Leaders: R. Conley, S. Potkin, S. Romano
Rapporteurs: H. Heimer, M. Schatz, Joseph Sum
A. Holden, Pharmaceutical Biomedical Research, Chicago, 
Illinois: Ongoing Consortium Initiatives: Goals, Successes, 
Hurdles, Solutions, and Failures: Lessons from the Serious 
Adverse Event Consortium
Group Discussion
PLENARY SESSION 4: Presentation of Final Ideas and 
Voting on Priorities of Ideas Consortium
Chairperson: A. Vogt, Hoffmann La-Roche, Basel, Switzerland
Goal: Agree as a Plenary Group on Priorities for What This 
Precompetitive Neuroscience Data-Sharing Consortium 
Might Do
Rapporteur: H. Heimer, E. Garofalo, A. Satlin
Group Discussion and Consensus on Objectives for Direc-
tion of Consortium
PLENARY SESSION 5: Identifying and Addressing Hurdles 
to the Development of a Neuroscience Consortium
Goal: Learn from Persons Who Have Led Other Consortia 
Experienced in Bringing Similar Databases Together
D. Stephenson, Critical Path Institute, Tucson, Arizona: On-
going consortium initiatives: Goals, successes, hurdles, solu-
tions and failures: Lessons from CAMD.
Group Discussion
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J. Rabinowitz, Bar-Ilan University, Ramat-Gan, Israel: Ongo-
ing consortium initiatives: Goals, successes, hurdles, solu-
tions and failures: Lessons from IMI New Med.
Group Discussion
Goal: Focus on Specifi c Important Hurdles and Their Solu-
tions for Developing This Precompetitive Neuroscience 
Data-Sharing Consortium
J. Contreras, American University, Washington, DC: Hurdles 
and solutions: Legal considerations/fi nancial models.
Group Discussion
M. Schatz, Cold Spring Harbor Laboratory: Hurdles and solu-
tions: IT considerations.
Group Discussion
PLENARY SESSION 6
Goal: Review and Build on Ideas from April 29 on the Pre-
competitive Neuroscience Data-Sharing Consortium. Firm-
ly determine if there will be further work on this effort and, 
if so, what the next steps will be.
L. Alphs, Janssen Pharmaceuticals, Titusville, New Jersey: 
 Review of Day 1.
Identifi cation of Key Consideration for Development of 
 Precompetitive Neuroscience Data-Sharing Consortium
Mission Statement and Primary Goals
J. Sum, First Manhattan Co., New York: Financial consider-
ations and solutions.
Next Steps
Group Discussion
Organizational Structure and Governance Considerations and 
Solutions
Receipt and Safety of Data
Analysis of Data
Interpretation of Data
Access to Data
Group Discussion: Identifi cation of outstanding issues and 
new ideas
Immediate Next Steps and Final Summarization
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Redesigning Photosynthesis: Identifying Opportunities and Novel Ideas
May 13–16
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY S. Merchant, University of California, Los Angeles
 D. Ort, University of Illinois, Urbana
Nearly all other biological processes on earth depend on the 
ability of photosynthesis to convert solar energy into chemi-
cal energy. There is a great deal of interest in the effi ciency 
with which photosynthesis can accomplish this as it is the 
basis of the yield potential of both our food and bioenergy 
crops. Sometimes it is stated that photosynthesis is nearly 
100% effi cient because under ideal conditions, one photon 
of light can result in one photosynthetic charge separation. 
But in the world’s best agricultural regions, only about 1% 
of the total solar energy that falls on the fi eld during the 
growing season is stored as chemical energy in the plant ma-
terials at the end of the season. The key question discussed 
at this meeting was Can the effi ciency of solar energy cap-
tured by photosynthesis be improved even though evolution 
has provided very little genetic variation in the component mechanisms of photosynthesis?
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Workshop Introduction: D. Ort, University of Illinois, Institute for Genomic Biology, Urbana
D. Ort, S. Merchant
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S. von Caemmerer, B. Stillman
The purpose of the short (10-min, four-slide) presentations was for the participants to introduce 
their relevant expertise to the other participants and provide a sense of their research questions, as 
well as their initial thoughts or ideas toward redesigning photosynthesis. Participants were asked 
to focus on their work and ideas that were relevant to the workshop and its goals.
Participant Presentations I
J. Alric, CEA Cadarache, Saint-Paul-les-Durance, France
A. Barkan, University of Oregon, Eugene
R. Croce, VU University Amsterdam, The Netherlands
M. Hanson, Cornell University, Ithaca, New York
J. Hibberd, University of Cambridge, England
D. Lindstrom, Agilent Laboratories, Santa Clara, California
Participant Presentations II
S. Merchant, University of California, Los Angeles
T. Moore, Arizona State University, Tempe
J. Moroney, Louisiana State University, Baton Rouge
K. Niyogi, University of California, Berkeley
D. Ort, University of Illinois, Institute for Genomic Biology, 
Urbana
M. Parry, Rothamsted Research Ltd., Hertfordshire, United 
Kingdom
P. Peralta-Yahya, Georgia Institute of Technology, Atlanta, 
Georgia
R. Prince, Exxon Mobil Research and Engineering Co., An-
nandale, New Jersey
K. Redding, Arizona State University, Tempe
M. Spalding, Iowa State University, Ames
Participant Presentations III
K. Van Wijk, Cornell University, Ithaca, New York
W. Vermaas, Arizona State University, Tempe
T. Yeates, University of California, Los Angeles
J. Yuan, Texas A&M University, College Station
X. Zhu, Chinese Academy of Sciences, Shanghai, China
Sectional Topic Overviews
These longer (25-min) presentations were intended to intro-
duce and give an overview of the opportunities in the differ-
ent subprocesses or components of photosynthesis.
S. Long, University of Illinois at Urbana-Champaign, Urbana, 
Illinois: Identifying limitations.
R. Blankenship, Washington University, St. Louis, Missouri: 
Optimizing/redesigning light capture.
S. von Caemmerer, Australian National University, Canberra: 
Optimizing/redesigning carbon reduction.
A. Weber, Heinrich–Heine University, Dusseldorf, Germany: 
Defeating oxygenation/improving photorespiration.
R. Bock, Max-Planck Institute of Molecular Plant, Potsdam-
Golm, Germany: Synthetic biology and new tools.
Breakout Groups
Synthesis Session I: Report Back from Breakouts on Priorities 
for Each Goal. Reorganize breakout groups.
Synthesis Session II: Report Back from Breakouts on Priori-
ties for Each Goal. Discussion of meeting outcomes.
Perspective from a Funding Source
K. Kahn, Bill & Melinda Gates Foundation, Seattle, Wash-
ington
Discussion of Next Steps (e.g., Publication, Proposal Ini-
tiatives)
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The Emerging Intersection between Physical Sciences and Oncology
July 14–16
FUNDED BY USC NCI Physical Sciences in Oncology Center
ARRANGED BY D. Agus, University of Southern California, Los Angeles
 D. Hillis, Applied Minds, Inc., Glendale, California
 P. Mallick, Stanford School of Medicine, California
This was the second occasion on which the Physical Sciences in Oncology Center came to Ban-
bury Center to report on progress and to stimulate ideas about the challenges and solutions in the 
detection and treatment of cancer. As before, participants were not restricted to cancer research 
but included some of the foremost leaders and emerging scientists in clinical care, cancer biology, 
engineering, and physics. The meeting was structured to promote interactions between members 
of different research areas by classifying participants into two groups: Group A had a  biological/
clinical focus and Group B had a technology/engineering focus. Members of each group were 
paired with a member of the other group to identify a research project of mutual interest and a 
potential approach for solving it. One objective was to give junior investigators an opportunity to 
work with more senior investigators and get direct mentorship on how to overcome the challenges 
associated with working in this highly interdisciplinary fi eld.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Teams
1. J. Iwasa, D. Ruderman, C. Behroozi
2. J. Sachs, A. Sharif, P. Newton
3. P. Bhatnagar, P. Macklin
4. S. Mumenthaler, M. Said, M. Padi
5. H. Karnofsky, V. Stodden, A. Naeim
6. R. Dror, D. Felsher
7. R. Judson, J. LaBaer
8. J. Mogil, P. Mallick, M. Gross
SESSION 1: Presentation of Team 1
SESSION 2: Presentations of Teams 2 and 3
SESSION 3: Presentations of Teams 4 and 5
SESSION 4: Presentations of Teams 6, 7, and 8
SESSION 5: Presentations by Teams 1 and 2
SESSION 6: Presentations by Teams 3 and 4
SESSION 7: Presentations by Teams 5, 6, 7, and 8
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Telomeres and Disease
September 8–11
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M. Armanios, Johns Hopkins University, Baltimore, Maryland
  P. Lansdorp, University of Groningen, University Medical Centre Groningen, The Netherlands
A growing body of evidence is implicating telomeres in the pathogenesis of several important and 
common disorders, including pulmonary fi brosis, bone marrow failure, and diabetes. However, 
the underlying role of telomeres in these diverse disorders is not fully understood. This discussion 
meeting brought scientists and clinicians together to review and critically assess current data on 
how telomere dysfunction contributes to disease. Participants included scientists working on telo-
mere biology as well as in other areas that are relevant to the study of these disorders. The goal was 
to forge new links between fundamental biology and telomere-mediated disorders.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Overviews:  M. Armanios, Johns Hopkins University, Baltimore, Maryland;
P. Lansdorp, University of Groningen, University Medical Centre Groningen, The Netherlands
SESSION 1: Telomerase, Dyskeratosis Congenita, and Mouse 
Models
Chairperson: L. Harrington, University of Montreal,  Quebec, 
Canada
C. Greider, Johns Hopkins University School of Medicine, 
Baltimore, Maryland: Short telomeres and mouse models of 
telomere-mediated disease.
I. Dokal, Barts & The London School of Medicine & Den-
tistry, London, United Kingdom: Dyskeratosis congenita 
and related diseases.
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M. Bessler, Children’s Hospital of Philadelphia, Pennsylvania: 
Using IPCs for the investigation of X-linked dyskeratosis 
congenita.
SESSION 2: Telomerase Structure, Function, and Biogenesis
Chairperson: S. Artandi, Stanford University Medical  Center, 
California
K. Collins, University of California, Berkeley: Telomerase 
 holoenzyme regulation.
P. Baumann, Stowers Institute for Medical Research, Kansas 
City, Missouri: Telomerase RNA biogenesis.
J. Chen, Arizona State University, Tempe: New mechanistic 
insights into the telomerase catalytic cycle.
SESSION 3: Telomere End-Protection, CST, and Disease
Chairperson: A. Bertuch, Baylor College of Medicine, Hous-
ton, Texas
V. Lundblad, Salk Institute for Biological Studies, La Jolla, 
California: Faithful replication of duplex telomeric DNA is 
necessary for telomere homeostasis.
T. Linnankivi, University of Helsinki, Finland: The clinical 
phenotype of Coats plus (CRMCC) syndrome.
E. Jenkinson, University of Manchester, England: Mutations 
in CTC1, encoding conserved telomere maintenance com-
ponent 1, cause Coats plus.
C. Price, University of Cincinnati, Ohio: The multiple roles 
of human CST and how they may relate to human disease.
SESSION 4: DC and Bone Marrow Failure Syndromes II
Chairperson: K. Collins, University of California, Berkeley
A. Bertuch, Baylor College of Medicine, Houston, Texas: Mu-
tations associated with very short leukocyte telomere length 
and early childhood disease presentation.
S. Savage, National Cancer Institute, Rockville, Maryland: 
Clinical and epidemiological considerations in telomere bi-
ology disorders.
J. Tolar, University of Minnesota, Minneapolis: Refi ning he-
matopoietic cell transplantation in dyskeratosis congenita: 
Where now, and where next?
A. Smogorzewska, Rockefeller University, New York: Fanconi 
anemia: DNA repair and bone marrow failure syndrome.
SESSION 5: Telomeres and Pulmonary Fibrosis
Chair: C. Price, University of Cincinnati, Cincinnati, Ohio
M. Armanios, Johns Hopkins University, Baltimore, Mary-
land: Telomeres and age-related lung disease.
B. Hogan, Duke University Medical Center, Durham, North 
Carolina: Stem cells in the adult lung and models of pulmo-
nary fi brosis.
SESSION 6: Telomeres and Stem Cells
Chairperson: J. Sedivy, Brown University, Providence, Rhode 
Island
P. Lansdorp, University of Groningen, University Medical 
Centre, The Netherlands: Mortal and immortal stem cells.
S. Artandi, Stanford University Medical Center, California: 
Telomerase in stem cells and disease.
R. Reddel, Children’s Medical Research Institute, Westmead, 
Australia: Functional role of ATRX defi ciency in ALT
SESSION 7: Senescence and the DNA-Damage Response
Chairperson: A. Smogorzewska, Rockefeller University, New 
York
J. Sedivy, Brown University, Providence, Rhode Island: How 
are telomeres, cellular senescence, transposable elements and 
aging connected?
V. Lundblad, L. Harrington M. Bessler, I. Dokal
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F. D’Adda Di Fagagna, IFOM Foundation–FIRC Institute of 
Molecular Oncology Foundation, Milan, Italy: Telomeres in 
aging and cancer.
E. Hendrickson, University of Minnesota Medical School, 
Minneapolis: Escape from telomere-driven crisis is DNA 
 ligase III-dependent.
L. Harrington, University of Montreal, Quebec, Canada: 
 Latent implications of critically short telomeres on cellular 
differentiation in aging and disease.
E. Lazzerini Denchi, Scripps Research Institute, La Jolla, Cali-
fornia: Shelterin complex mutations and genomic instability.
Conference Room
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Neurobiology and Clinical Study of Rapid-Acting Antidepressants
September 15–18
FUNDED BY Janssen Pharmaceutical Research and Development, Johnson & Johnson 
ARRANGED BY R. Duman, Yale University, New Haven, Connecticut
 C. Zarate, National Institute of Mental Health, Bethesda, Maryland
Mood disorders affect millions of people worldwide, but a major limitation of existing phar-
macotherapies is that they take weeks or months to show therapeutic effects. This lag exerts a 
toll on patients’ well-being and ability to function and increases the already high risk of suicide. 
Therefore, rapid-onset pharmacological strategies with pronounced and sustained effects would 
have an enormous impact on public health. Recent studies have found that the drug ketamine 
produces antidepressant and antisuicidal effects within hours in treatment-resistant depressed 
patients. However, ketamine also produces psychotic-like symptoms, which limits its therapeutic 
use. A vigorous effort, both preclinical and clinical, has arisen to explore ketamine’s mechanism 
of action, with an eye toward developing safer alternatives. This meeting provided an oppor-
tunity to examine the critical questions and outline the steps to developing safe rapid-acting 
antidepressants.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction:  R. Duman, Yale University, New Haven, Connecticut
C. Zarate, National Institute of Mental Health, Bethesda, Maryland
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SESSION 1: Rapid Antidepressant Actions of NMDA 
Receptor Antagonists
Chairperson: H. Mayberg, Emory University School of Medi-
cine, Atlanta, Georgia
J. Krystal, Yale University School of Medicine, New Haven, 
Connecticut: Overview of the clinical actions of ketamine 
and glutamate neurobiology.
D. Charney, Icahn School of Medicine at Mount Sinai, New 
York: Rapid clinical actions of ketamine.
S. Mathew, Baylor College of Medicine, Houston, Texas: Im-
pact of ketamine on suicidality in patients with treatment-
resistant depression.
C. Zarate, National Institute of Mental Health, Bethesda, 
Maryland: Clinical effects of ketamine and biomarkers of 
treatment response.
W. Drevets, Janssen Research & Development, Titusville, 
New Jersey: NR2B antagonists as rapid acting antidepres-
sants.
General Discussion
SESSION 2: Rapid Actions of Muscarinic Receptor Antag-
onists: Mechanisms for Scopolamine and Ketamine
Chairperson: J. Krystal, Yale University School of Medicine, 
New Haven, Connecticut
M. Furey, National Institute of Mental Health, Bethesda, 
Maryland: Clinical actions of scopolamine and biomarkers 
of response.
C. Jones, Vanderbilt University, Nashville, Tennessee: Neuro-
biology and pharmacology of muscarinic receptors.
G. Sanacora, Yale University School of Medicine, New Haven, 
Connecticut: Regulation of glutamate/GABA metabolism 
by rapid antidepressants.
R. Duman, Yale University School of Medicine, New Haven, 
Connecticut: Synaptogenic actions of rapid-acting antide-
pressants.
General Discussion
SESSION 3: Neurobiology and Circuitry of Depression 
and Potential Rapid Antidepressant Targets
Chairperson: R. Duman, Yale University School of Medicine, 
New Haven, Connecticut
E. Nestler, Icahn School of Medicine at Mount Sinai, New 
York: Transcriptional and epigenetic mechanisms of depres-
sion.
R. Hen, College of Physicians & Surgeons, New York: Hip-
pocampal-amygdala and related circuits in depression and 
anxiety.
M.-H. Han, Icahn School of Medicine at Mount Sinai, New 
York: VTA dopamine system and depression.
E. Castren, University of Helsinki, Finland: Isofl urane as a 
rapid-acting antidepressant.
G. Chen, Johnson & Johnson Pharmaceutical Research and 
Development, San Diego, California: Preclinical models of 
depression and drug development.
General Discussion
SESSION 4: Novel Rapid Antidepressant Approaches I: 
Glutamatergic Mechanisms and Targets
Chairperson: E. Nestler, Icahn School of Medicine at Mount 
Sinai, New York
D. Bredt, Johnson & Johnson Pharmaceutical Research & 
 Development, San Diego, California: Overview of glutama-
tergic receptor synaptic mechanisms.
J. Witkin, Lilly Research Laboratories, Indianapolis, Indiana: 
AMPA receptor potentiation: Potential impact on TRD.
E. Nestler
H. Mayberg
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J. Moskal, Northwestern University, Evanston, Illinois: 
GLYX-13, a novel NMDA receptor modulator with rapid 
onset and long-lasting antidepressant effects in humans 
without ketamine-like side effects.
S. Chaki, Taisho Pharmaceutical Co, Ltd., Saitama, Japan: 
mGlu2/3 receptor antagonists as antidepressants.
P. Skolnick, National Institute on Drug Abuse, Bethesda, 
Maryland: AMPA receptor potentiators as antidepressants.
General Discussion
SESSION 5: Novel Rapid Antidepressant Approaches II: 
Drug Development and Clinical Study Design
Chairperson: C. Zarate, National Institute of Mental Health, 
Bethesda, Maryland
H. Mayberg, Emory University School of Medicine, Atlanta, 
Georgia: DBS as a rapid antidepressant treatment and neu-
robiological mechanisms.
W. Bunney, University of California, Irvine: Circadian rhythms, 
clock genes, and sleep deprivation therapy in depression.
J. Heemskerk, National Institute of Mental Health, Bethesda, 
Maryland: Funding drug development.
M.R. Trivedi, University of Texas Southwestern Medical Cen-
ter, Dallas: Integrating biomarkers in clinical research.
M. Fava, Massachusetts General Hospital, Boston: Study de-
sign and outcome measures for the NIMH RAPID studies.
Closing Discussion and Summary
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Plant Reproduction
September 22–25
FUNDED BY CSHL/DuPont Pioneer Joint Collaborative
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory
 R. Meeley, DuPont Pioneer, Johnston, Iowa
This was the annual meeting of the collaborative project between the plant science group at Cold 
Spring Harbor Laboratory and scientists at DuPont Pioneer. The goals of this meeting were to 
explore the latest advances in our understanding of sexual and asexual reproduction in crop and 
model plant species and to drive discussions on current research addressing genetic, epigenetic, 
and population-based approaches to manipulating key mechanisms in plant reproductive biology. 
As usual, one day was devoted to presentations from speakers outside the collaboration.
Welcoming Remarks: J.A Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: R. Meeley, DuPont Pioneer, Johnston, Iowa
  R. Martienssen, Cold Spring Harbor Laboratory
SESSION 1: Data Mining in Expression Networks
Chairperson: R. Meeley, DuPont Pioneer, Johnston, Iowa
Y.K. Lee, Cold Spring Harbor Laboratory: The Arabidopsis 
root miRNA regulatory network supports functional char-
acterization of transcription factors involved in develop-
ment and environmental response.
C. Liseron-Monfi ls, Cold Spring Harbor Laboratory: The dynam-
ic of gene coexpression within Arabidopsis miRNA-based genet-
ic network during plant development and response to stresses.
A. Eveland, Cold Spring Harbor Laboratory: Systems ap-
proaches in maize infl orescence architecture and drought.
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SESSION 2: Somatic Patterning and Small RNA
Chairperson: M. Cigan, Pioneer Hi-Bred International, John-
ston, Iowa
K. Petsch, Cold Spring Harbor Laboratory: Hierarchical 
DICER activity in maize triggers alternate processing of 
 tasiARF target transcripts.
M. Timmermans, Cold Spring Harbor Laboratory: Patterning 
properties of mobile small RNAs.
Y. Plavskin, Cold Spring Harbor Laboratory: Regulation of 
the auxin response by an ancient small RNA pathway.
SESSION 3: Genetic Dissection of Infl orescence 
Development
Chairperson: L. Perugini, DuPont Pioneer, Johnston, Iowa
B. ll Je, Cold Spring Harbor Laboratory: Finding the function 
of fasciated ear3.
M. Pautler, Cold Spring Harbor Laboratory: FASCIATED 
EAR4: Function and targets.
D. Jackson, Cold Spring Harbor Laboratory: Update on 
 RAMOSA3 in maize and Arabidopsis.
SESSION 4: Targeted Molecular and Genetic Strategies
Chairperson: D. Jackson, Cold Spring Harbor Laboratory
L. Perugini, DuPont Pioneer, Johnston, Iowa: Characteriza-
tion of ear trait mutants for increasing yield in elite maize 
germplasm.
B. Li, DuPont Experimental Station, Wilmington, Delaware: 
Understanding the molecular mechanisms of gene–back-
ground interactions: Two case studies.
M. Cigan, Pioneer Hi-Bred International, Johnston, Iowa: 
Targeted genome modifi cation of plant fertility genes using 
double-strand-break reagents.
M. Williams, DuPont Experimental Station, Wilmington, 
Delaware: The interaction of genetics and mutagenesis.
SESSION 5: A Landscape of Reproductive Strategies
Chairperson: S. Lawit, DuPont Pioneer, Johnston, Iowa
M. Singh, DuPont Pioneer, Johnston, Iowa: Genetic and epi-
genetics of apomixis in maize.
A. Schnittger, Institut de Biologie Moleculaire des Plantes, 
Strasbourg, France: Control of germline entry in Arabidopsis.
T. Dresselhaus, Universitat Regensburg, Germany: Fertiliza-
tion mechanisms and early embryogenesis in maize.
SESSION 6: Developmental and Reproductive Outcomes of 
Auxin Signaling
Chairperson: B. Li, DuPont Pioneer, Wilmington, Delaware
P. McSteen, University of Missouri, Columbia: Role of auxin 
in maize infl orescence development.
M. Evans, Carnegie Institution for Science, Stanford, Cali-
fornia: Mutant analysis of maize antipodal cells and auxin 
signaling.
SESSION 7: Epigenetics that Pattern Reproductive Boundaries
Chairperson: M. Singh, DuPont Pioneer, Johnston, Iowa
C. Kohler, Swedish University of Agriculture Science, Uppsala, 
Sweden: Epigenetic mechanisms establishing interploidy 
and interspecies hybridization barriers in the endosperm.
R. Martienssen, Cold Spring Harbor Laboratory: Reprogram-
ming heterochromatin in the germline and its consequences.
SESSION 8: Technical Approaches to Recombination
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
G. May, DuPont Pioneer, Johnston, Iowa: Genomic appro-
aches to recombination.
W. Pawlowski, Cornell University, Ithaca, New York: The 
landscape of meiotic recombination in maize.
A. Eveland B. Li, D. Jackson
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R. Mercier, INRA Centre de Versailles-Grignon, Versailles, 
France: What limits meiotic recombination?
SESSION 9: Genetic and Epigenetic Pathways in Flowering 
and Reproductive Success
Chairperson: M. Komatsu, DuPont Pioneer, Wilmington, 
Delaware
Z. Lippman, Cold Spring Harbor Laboratory: Fine-tuning 
fl owering to boost yield.
C. Xu, Cold Spring Harbor Laboratory: The TMF-BOP com-
plex directs infl orescence architecture in tomato.
C. MacAlister, Cold Spring Harbor Laboratory: From meri-
stems to pollen tubes to protonema: An unknown gene fam-
ily with diverse functions in plant development.
F. de Sousa Borges, Cold Spring Harbor Laboratory: The pol-
len methylome and implications for epiallele formation.
SESSION 10: Development of Apomictic Strategies
Chairperson: M. Timmermans, Cold Spring Harbor Laboratory
R. Herridge, Cold Spring Harbor Laboratory: The role of 
 argonautes in reproductive strategies in Arabidopsis.
S. Lawit, DuPont Pioneer, Johnston, Iowa: Research frontiers 
of plant female reproductive strategies in Arabidopsis.
M. Williams, DuPont Stine-Haskell Research Center, New-
ark, Delaware: Self-reproducing hybrid technology in 
maize.
Meeting Wrap-Up
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Science of Pancreatic Cancer
September 29–October 1
FUNDED BY MCJ Amelior Foundation and Kotumba Capital Management LLC
ARRANGED BY R. Evans, Salk Institute for Biological Studies, La Jolla, California
 W. Isacoff, University of California, Los Angeles
 D. Tuveson, Cold Spring Harbor Laboratory
Recent fi ndings in pancreatic cancer science and medicine demonstrate that both neoplastic cell 
genetic changes and distinct features of the tumor microenvironment may serve as therapeutic 
vulnerabilities in this malignancy. This meeting focused on the role of the stroma in modulating 
therapeutic responses and the development of new dependency pathways. Topics reviewed included 
vitamin D and pancreatic stellate cell activation; survival cues in the tumor microenvironment 
as major causes of drug resistance; methods to develop a tissue bank of the tumor microenviron-
ment and cancer cells; and the role of genomics in addressing this disease. The meeting concluded 
with a discussion intended to help identify one or two important areas worthy of large-scale 
 additional investigation.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Pancreatic Stromal Cells and Opportunities
Chairperson: D. Tuveson, Cold Spring Harbor Laboratory
R. Kalluri, University of Texas, MD Anderson Cancer Center, 
Houston: Stromal biology in PDAC.
D. Fearon, CRUK Cambridge Institute, United Kingdom: 
FAP+ cells and immune suppression.
M. Egeblad, Cold Spring Harbor Laboratory: Imaging the 
PDAC stroma.
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SESSION 2: Pancreatic Stroma and Manipulation
Chairperson: D. Tuveson, Cold Spring Harbor Laboratory
R. Evans, Salk Institute for Biological Studies, La Jolla, Cali-
fornia: PSCs and vitamin D.
M. Hollingsworth, University of Nebraska Medical Center, 
Omaha: The best targets in PDAC.
G. Wahl, Salk Institute for Biological Studies, La Jolla, Califor-
nia: Stromal and epithelial approaches to pancreatic cancer.
General Discussion
SESSION 3: Neoplastic Cells and Therapeutic Opportunities 
in PDAC
Chairperson: R. Evans, Salk Institute for Biological Studies, 
La Jolla, California
T. Hunter, Salk Institute for Biological Studies, La Jolla, Cali-
fornia: Secreted proteins that mediate cross-talk between 
stellate cells and tumor cells.
A. Maitra, University of Texas, MD Anderson Cancer Center, 
Houston: Triple metabolism therapy in PDAC.
K. Olive, Columbia University, New York: Targeting ROS 
 detoxifi cation in pancreatic cancer.
SESSION 4: Neoplastic Cells and Therapeutic Opportunities
Chairperson: R. Evans, Salk Institute for Biological Studies, 
La Jolla, California
A. Lowy, University of California, San Diego, Moores Cancer 
Center, La Jolla, California: Targeting RON in PDAC.
H. Crawford, Mayo Clinic Florida, Jacksonville, Florida: Sig-
naling cascades as targets in PDAC.
S. Muthuswamy, University of Toronto, Ontario, Canada: A 
new model system for PDAC.
Summary Discussion, What Have We Heard?
P. Philip, Karmanos Cancer Center, Detroit, Michigan
B. Stillman, Cold Spring Harbor Laboratory
SESSION 5: Additional Opportunities in PDAC
Chairperson: W. Isacoff, University of California, Los  Angeles
C. Iacobuzio-Donahue, Johns Hopkins University, Baltimore, 
Maryland: Moving genetic targets in PDAC.
N. Bardeesy, Massachusetts General Hospital Cancer Center, 
Boston: Role of MiT proteins in metabolic reprogramming 
in pancreatic cancer.
S. Leach, Johns Hopkins University, Baltimore, Maryland: 
Targeting PanIN initiation and progression.
SESSION 6: Final Discussion and Next Steps
Chairperson: W. Isacoff, University of California, Los Angeles
P. Philip, Karmanos Cancer Institute, Detroit, Michigan: Sta-
tus of clinical trials.
T. Donahue, David Geffen School of Medicine, Los Angeles, 
California: Translational PET imaging to guide chemother-
apy in human pancreatic cancer.
Final Meeting Summary: Is the Science Ready for Transfor-
mative Clinical Efforts?
W. Isacoff, University of California, Los Angeles
R. Evans, Salk Institute for Biological Studies, La Jolla, Cali-
fornia
D. Tuveson, Cold Spring Harbor Laboratory
T. Hunter
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Biguanides and Neoplasia
October 6–9
FUNDED BY Oliver Grace Cancer Fund
ARRANGED BY M. Pollak, McGill University, Montreal, Quebec, Canada
 K. Struhl, Harvard Medical School, Boston, Massachusetts
Interest in potential roles of biguanides such as metformin in treatment and/or prevention of 
neoplastic disease continues to increase since the topic was last discussed at Banbury in 2011. Par-
ticipants in the 2013 meeting discussed the nature of the primary site of action in mitochondria, 
the alterations in cellular energetics and metabolism caused by biguanides, and the genetic factors 
that infl uence these effects. Additionally, the effects of biguanides at the whole-organism level 
were reviewed, including modulation of both infl ammatory responses and the endocrine environ-
ment. An important discussion centered on strategies for optimizing drug exposure to target tis-
sues, which may differ from those important in diabetes treatment. Finally, the use of preclinical 
fi ndings to optimize the design of future trials was reviewed.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: K. Struhl, Harvard Medical School, Boston, Massachusetts
Overview of Progress Since Last Meeting: M. Pollak, McGill University, Montreal, Quebec, Canada
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SESSION 1
Chairperson: M. Pollak, McGill University, Montreal, 
 Quebec, Canada
J. Hirst, The Medical Research Council, The Wellcome Trust/
MRC Building, Cambridge, United Kingdom: Effects of 
 biguanides on mitochondrial complex I.
M. Schwab, University Hospital of Tuebingen, Stuttgart, 
 Germany: Metformin and drug disposition: Update and 
 future perspectives.
B. Kahn, Beth Israel Deaconess Medical Center, Boston, Mas-
sachusetts: AMPK and the regulation of food intake, body 
weight, and metabolism.
SESSION 2
Chairperson: K. Struhl, Harvard Medical School, Boston, 
Massachusetts
L. Cantley, Weill Cornell Medical College, New York: AMPK 
and cancer.
R. Shaw, Salk Institute for Biological Studies, La Jolla, Cali-
fornia: LKB1/STK11 genotype dictates therapeutic response 
to phenformin.
J. Pouyssegur, University of Nice, France: Targeting glycolysis 
(lactate transporters) sensitizes tumor cells to phenformin.
M. Pollak, McGill University, Montreal, Canada: Serine defi -
ciency sensitizes neoplastic cells to phenformin.
K. Birsoy, Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts: Metabolic liabilities of cancer 
cells to nutrient limitation.
SESSION 3
Chairperson: R. Shaw, Salk Institute for Biological Studies, 
La Jolla, California
M. Stampfer, Harvard University, Brigham and Women’s 
Hospital, Boston, Massachusetts: Metformin and prostate 
cancer prevention.
N. Fleshner, Princess Margaret Hospital, Toronto, Canada: 
Rationale for metformin in prostate cancer.
C. Dang, University of Pennsylvania, Philadelphia: Activities 
of biguanides and metabolic inhibitors in human pancreatic 
cancer xenografts.
N. Hay, University of Illinois, Chicago: Targeting glucose 
 metabolism for cancer therapy
P. Puigserver, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: Therapeutic implications of metabolic and energy 
fl exibility in melanoma tumors.
M. Keiser, SeaChange Pharmaceuticals, Inc. San Francisco, 
California: Prediction and testing of a new target for metfor-
min with a potential role in neoplasia.
H. Udono, Okayama University, Japan: Metformin-induced 
reversion of immune-exhaustion in tumor microenvironment.
SESSION 4
Chairperson: R. Jones, McGill University, Montreal, Quebec, 
Canada
J. Schlessinger, Yale University, New Haven, Connecticut: 
Targeting receptor tyrosine kinases.
K. Struhl, David Geffen School of Medicine, Los Angeles, 
California: Metformin mediates anticancer effects by inhib-
iting the infl ammatory pathway.
J.D. Watson, Cold Spring Harbor Laboratory: Exercise vs. 
metformin.
K. Vousden, Beatson Institute, Glasgow, United Kingdom: 
Regulation of metabolism through the p53 pathway.
G. Thomas, University of Cincinnati, Ohio: Metformin in the 
treatment of HCC?
N. Sonenberg, McGill University, Montreal, Quebec, Canada: 
Translational control of mitochondria function via mTOR.
M. Pollak, F. Cabreiro, N. Sonenberg, K. Vousden J. Hirst
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R. Kalluri, MD Anderson Cancer Center, Houston, Texas: 
Designing rational preclinical combination trials for pancre-
atic cancer (PDAC).
SESSION 5
Chairperson: K. Vousden, Beatson Institute, Glasgow, United 
Kingdom
P. Dennis, Johns Hopkins Bayview Medical Center, Baltimore, 
Maryland: Mechanisms of chemoprevention by metformin.
B. Zheng, Harvard Medical School, Charlestown, Massachu-
setts: Targeting AMPK signaling in melanoma.
G. Ferbeyre, University of Montreal, Canada: Metformin and 
the NF-κB pathway.
M. VanderHeiden, Massachusetts Institute of Technology, 
Cambridge: Understanding tumor metabolism in vivo: Impli-
cations for use of metformin to treat cancer.
F. Cabreiro, University College London, United Kingdom: 
Biguanides regulate microbial function to modulate host 
health and lifespan.
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Lustgarten Foundation Scientiﬁ c Meeting
October 21–22
FUNDED BY Lustgarten Foundation for Pancreatic Cancer, Bethpage, New York
ARRANGED BY M. McCurragh, Lustgarten Foundation for Pancreatic Cancer, Bethpage, New York
This meeting provided an opportunity for investigators supported by the Lustgarten Foundation 
to meet and to present and discuss their research. The goals of the meeting were to update the 
Lustgarten Foundation research community of progress in the laboratory, to evaluate performance 
and provide feedback for improvement, and to establish and strengthen collaborations between 
groups and brainstorm new ideas to push the fi eld forward.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction:  R. Vizza, Lustgarten Foundation for Pancreatic Cancer, Bethpage, New York
D. Tuveson, Cold Spring Harbor Laboratory
Key Note Speaker: B. Vogelstein, Johns Hopkins University 
School of Medicine, Baltimore, Maryland
PRECLINICAL GROUP
H.C. Manning, Vanderbilt University Institute of Imaging 
Science, Nashville, Tennessee
Q. Nguyen, University of California, San Diego, La Jolla
S. Thorne, University of Pittsburgh, Pennsylvania
S. Hingorani, Fred Hutchinson Cancer Research Center, 
 Seattle, Washington
General Discussion
Keynote Speaker: Cold Spring Harbor Laboratory
CONSORTIUM PANEL 1
S. Lowe, Memorial Sloan-Kettering Cancer Center, New York
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C. Castro, Harvard University Medical School, Boston, Mas-
sachusetts
B. Wolpin, Dana Farber Cancer Institute, Boston, Massachu-
setts
General Discussion
BASIC GROUP 1
D. Fearon, CRUK Cambridge Institute, United Kingdom
G. Miller, New York University Langone Medical Center
E. O’Reilly, Memorial Sloan-Kettering Cancer Center, New 
York
General Discussion
BASIC GROUP 2
D. Bar-Sagi, New York University School of Medicine, New 
York
A. Kimmelman, Dana-Farber Cancer Institute, Boston, Mas-
sachusetts
M. Egeblad, Cold Spring Harbor Laboratory
General Discussion
BASIC GROUP 3
J.J. Yeh, University of North Carolina, Chapel Hill
T. Wang, Columbia University, New York
General Discussion
CLINICAL GROUP
H. Degani, Weizmann Institute of Science, Rehovot Israel
J. Fleming, MD Anderson Cancer Center, Houston, Texas
General Discussion
CONSORTIUM PANEL 2
C. Der, University of North Carolina, Chapel Hill
T. Van Dyke, Frederick National Laboratory for Cancer, Fred-
erick, Maryland
S. Fesik, Vanderbilt University School of Medicine, Nashville, 
Tennessee
General Discussion
Meeting Summary and Future Goals
D. Tuveson, Cold Spring Harbor Laboratory
J. Watson, D. Tuveson, R. Vizza Q. Nguyen
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Ovarian Cancer: Developing Research-Based Public Messaging 
on Early Detection and Screening
October 23–25
FUNDED BY Ovarian Cancer Research Fund
ARRANGED BY J. Boyd, Fox Chase Cancer Center, Philadelphia, Pennsylvania
 A. Moran, Ovarian Cancer Research Fund, New York
 M. Seiden, McKesson Specialty Health, Woodlands, Texas
Messages to the public about ovarian cancer should accu-
rately refl ect what research results currently demonstrate, as 
well as what might reasonably be expected in the near term. 
When the public talks about ovarian cancer and ovarian can-
cer research, much emphasis is placed on early detection of 
the disease, as well as symptoms as a means of saving lives. 
In practice, the matter is more complicated, depending on 
the type of cancer, the effi cacy of the screening, and the con-
sequences of false positives. The UK Collaborative Trial of 
Ovarian Cancer Screening is under way, designed to provide 
fi rm data that can be used as the basis for assessing the value 
of current methods of early detection of ovarian cancer. The 
fi ndings of these trials will have a major impact on the ovar-
ian cancer community. This meeting was held to review the 
current status of ovarian cancer screening, to discuss action that might be taken for either positive 
or negative results of the UKCTOCS study, and to use these discussions as the basis for developing 
clearly defi ned messages that can help lay public understand the implications of the fi ndings.
Welcoming Remarks:  J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
A. Moran, Ovarian Cancer Research Fund, New York
M. Seiden, A. Moran
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Introduction: Defi ning the Problem, What We Hope to 
Accomplish
J. Boyd, Fox Chase Cancer Center, Philadelphia, Pennsylvania
M. Seiden, McKesson Specialty Health, Woodlands, Texas
SESSION 1: State of Science
J. Boyd, Fox Chase Cancer Center, Philadelphia, Pennsylva-
nia: Whence epithelial ovarian carcinoma?
N. Urban, Fred Hutchinson Cancer Research Center, Seattle, 
Washington: Symptoms index and multimodal screening: 
Using novel markers to improve screening performance.
K. Lu, MD Anderson Cancer Center, Houston, Texas: MD 
Anderson Study: A stage-2 Ovarian cancer screening strat-
egy using the risk of ovarian cancer algorithm (ROCA) 
identifi es early-stage incident cancers and demonstrates high 
positive predictive value.
I. Jacobs, University of Manchester, United Kingdom: UKC-
TOCS update.
U. Menon, University College London, United Kingdom: 
Time series algorithms: What can we learn from UKCTOCS.
S. Skates, Massachusetts General Hospital, Boston: ROCA: 
Development and implementation in screening trials.
S. Narod, Women’s College Research Institute, Toronto, 
 Canada: Perspectives for screening for ovarian cancer.
SESSION 2: Defi ning Benefi t
K. Trivers, Centers for Disease Control, Atlanta, Georgia: 
A public health approach to understanding ovarian cancer.
M. Ebell, University of Georgia, Athen, Georgia: The US Pre-
ventive Services Task Force and Ovarian Cancer Screening
Group Discussion: Provocative Questions
Moderators: J. Boyd, Fox Chase Cancer Center, Philadelphia, 
Pennsylvania
M. Seiden, McKesson Specialty Health, Woodlands, Texas
Day-One Recap: Group Discussion
Moderators:
J. Boyd, Fox Chase Cancer Center, Philadelphia, Pennsyl-
vania
M. Seiden, McKesson Specialty Health, Woodlands, Texas
Concluding Discussion
U. Menon, S. Skates
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Enhancer Biology in Health and Disease
October 27–30
FUNDED BY Oliver Grace Cancer Fund
ARRANGED BY J. Bradner, Dana-Farber Cancer Institute, Boston, Massachusetts
 J. Wysocka, Stanford School of Medicine, California
 R. Young, Whitehead Institute, MIT, Cambridge, Massachusetts
There has been rapid progress in identifying transcriptional regulatory elements and the factors 
that occupy them. Disease-associated sequence variation occurs in some of these regulatory ele-
ments and in the factors that bind them. This meeting brought together experts in enhancer biol-
ogy to discuss the roles of regulatory elements and factors in control of gene expression programs 
and their impact on human health and disease.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Enhancers and Chromatin Folding
Chairperson: J. Bradner, Dana-Farber Cancer Institute, Bos-
ton, Massachusetts
R. Young, Whitehead Institute, MIT, Cambridge, Massachu-
setts: Super-enhancers.
B. Ren, University of California, San Diego: Functional re-
lationship between DNA looping and enhancer activities.
J. Dekker, University of Massachusetts, Worcester: Chromo-
some folding and long-range gene regulation.
M. Merkenschlager, MRC Clinical Sciences Centre, Imperial 
College London, United Kingdom: Cohesin and the regula-
tion of gene expression.
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V. Corces, Emory University, Atlanta, Georgia: The role of 
architectural proteins in organizing the 3D architecture of 
the genome.
W. Bickmore, University of Edinburgh, Scotland: Do enhanc-
ers function in compact chromatin domains?
General Discussion
SESSION 2: Enhancer Dynamics
Chairperson: E. Furlong, EMBL, Heidelberg, Germany
M. Levine, University of California, Berkeley: Enhancer dy-
namics in the Drosophila embryo.
J. Wysocka, Stanford School of Medicine, California: En-
hancer regulation in development.
K. Zaret, Perelman School of Medicine, Philadelphia, Penn-
sylvania: Creating active enhancers.
SESSION 3: Enhancers in Disease Part 1: Genomic Variation
Chairperson: J. Bradner, Dana-Farber Cancer Institute, Bos-
ton, Massachusetts
M. Maurano, University of Washington, Seattle: Regulatory 
variation and human disease.
S. Parker, National Institutes of Health, Bethesda, Maryland: 
Stretch enhancers drive cell-specifi c gene regulation and har-
bor human disease variants.
P. Scacheri, Case Western Reserve University School of Medi-
cine, Cleveland, Ohio: Combinatorial effects of multiple 
 enhancer variants in common disease.
General Discussion
SESSION 4: Enhancers in Disease Part II: Coactivator 
Function
Chairperson: R. Young, Whitehead Institute, MIT, Cam-
bridge, Massachusetts
J. Bradner, Dana-Farber Cancer Institute, Boston, Massachu-
setts: Disrupting enhancer function to discover and down-
regulate cancer dependencies.
C. Vakoc, Cold Spring Harbor Laboratory: Targeting coacti-
vator proteins in acute myeloid leukemia.
SESSION 5: Large-Scale Functional Analysis
Chairperson: B. Ren, University of California, San Diego
A. Stark, Research Institute of Molecular Pathology, Vienna, 
Austria: Decoding transcriptional regulatory sequences.
M. Bulyk, Brigham & Women’s Hospital, Boston, Massachu-
setts: Highly parallel enhancer assays in whole Drosophila 
embryos.
B. Bernstein, Broad Institute, Charlestown, Massachusetts: 
Manipulating cis-element landscapes in human cells.
General Discussion
SESSION 6: Enhancer Factors And Function
Chairperson: M. Levine, University of California, Berkeley
J. Zeitlinger, Stowers Institute for Medical Research, Kansas 
City, Missouri: Dissecting transcription factor binding at 
Drosophila enhancers using ChIP-exo.
G. Crabtree, Stanford University School of Medicine, Cali-
fornia: ATP-dependent chromatin remodeling and enhancer 
function.
J. Dekker, K. Zaret M. Levine
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D. Odom, University of Cambridge, United Kingdom: In-
sights into mammalian enhancers from comparative func-
tional genomics.
SESSION 7: Developmental Mechanisms
Chairperson: J. Wysocka, Stanford School of Medicine, Cali-
fornia
E. Furlong, EMBL, Heidelberg, Germany: Temporal proper-
ties of enhancer activity during development.
T. Maniatis, Columbia University Medical Center, New York: 
Generation of cell surface diversity through stochastic en-
hancer/promoter interactions.
S. Lomvardas, University of California, San Francisco: Syner-
gistic action of distant enhancers specifi es singular olfactory 
receptor expression.
General Discussion
SESSION 8: Enhancers and Noncoding RNA
Chairperson: M. Bulyk, Brigham & Women’s Hospital, Bos-
ton, Massachusetts
R. Shiekhattar, Wistar Institute, Philadelphia, Pennsylvania: 
Biogenesis and mechanism of action of enhancer RNAs.
M.G. Rosenfeld, University of California, San Diego: Nuclear 
receptor and IncRNA regulation of enhancer function.
J. Rinn, Broad Institute of MIT and Harvard, Cambridge, 
Massachusetts: Linking RNA to nuclear architecture.
Concluding Discussion: Challenges to Developing Therapies 
That Target Enhancer Function in Disease
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INK4/ARF Network
November 12–15
FUNDED BY Pfi zer, Inc.
ARRANGED BY D. Beach, University of London, United Kingdom
 N.E. Sharpless, University of North Carolina, Chapel Hill
 C.J. Sherr, St. Jude Children’s Research Hospital, Memphis, Tennessee
This meeting celebrated the 20th anniversary of the discov-
ery of the INK4/ARF locus encoding three tumor suppres-
sor proteins that coordinate signaling of the CDK4/6-reti-
noblastoma (RB) and MDM2-p53 pathways. Disruption of 
this circuitry, frequently by deletion or silencing of INK4/
ARF, is a hallmark of many cancers. The INK4/ARF locus 
may have evolved to physiologically restrict the self-renewal 
capacities and numbers of stem and progenitor cells with 
the attendant consequence of limiting tissue regenerative 
capacity, particularly as animals age. In accord with this 
concept, altered regulation of the INK4/ARF locus has been 
implicated in age-associated diseases in humans by unbi-
ased, genome-wide analyses. Participants in the meeting re-
viewed a wide-ranging set of issues relating to the evolution 
and biology of the locus, and its implications for therapies.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Historical Overview: C. Sherr, St. Jude Children’s Research Hospital, Memphis, Tennessee
J. Watson, D. Beach, K. Knudsen
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SESSION 1: Signaling through the RB Pathway
Chairperson: G. Peters, CRUK London Research Institute, 
United Kingdom
J. Lees, Koch Institute, MIT, Cambridge, Massachusetts: Are 
Ink4, CycD/K4, and Rb mutations synonymous in tumori-
genesis?
J. Sage, Stanford University Medical Center, California: The 
RB gene family in cell cycle control and cancer.
J.A. Diehl, University of Pennsylvania, Philadelphia: Dysreg-
ulation of D-type cyclins in cancer.
J. Bartek, Danish Cancer Society, Copenhagen, Demark: 
INK4/ARF and the DNA-damage response as a barrier to 
cancer progression.
General Discussion
SESSION 2: New Approaches to Cancer Treatment
Chairperson: N. Sharpless, Lineberger Comprehensive Cen-
ter, Chapel Hill, North Carolina
K. Knudsen, Thomas Jefferson University, Philadelphia, Penn-
sylvania: Translating alterations of the p16/RB locus to the 
clinic: Prostate cancer.
M. Gillison, Ohio State University, Columbus: p16 and prog-
nosis of head and neck cancer.
G. Shapiro, Harvard Medical School, Boston, Massachusetts: 
Clinical development of selective CDK4/6 inhibitors.
K. Arndt, Pfi zer Worldwide Research & Development, Pearl 
River, New York: Palbociclib inhibition of CDK4/6 as a 
treatment for cancer.
General Discussion
SESSION 3: INK4/ARF and Aging
Chairperson: M. Serrano, Spanish National Cancer Research 
Center, Madrid, Spain
N. Sharpless, University of North Carolina, Chapel Hill: p16, 
aging, and cancer.
C. Bishop, Barts & The London School of Medicine, London, 
United Kingdom: p16 and senescence.
J.D. Watson, Cold Spring Harbor Laboratory: RAS, ROS, 
PTEN, and senescence.
C. Burd, Ohio State University, Columbus: Reporter model 
for p16 regulation.
J. van Deursen, Mayo Clinic, Rochester, Minnesota: p16-posi-
tive senescent cells in aging and age-related disease
SESSION 4: Senescence Networks and Development
Chairperson: J. Sage, Stanford University Medical Center, 
California
M. Serrano, Spanish National Cancer Research Center, Ma-
drid, Spain: INK4/ARF locus: Developmental senescence 
and in vivo reprogramming.
S. Lowe, Memorial Sloan-Kettering Cancer Center, New 
York: New insights into the p53 tumor suppressor networks.
D. Peeper, Netherlands Cancer Institute, Amsterdam, The 
Netherlands: p16: A smoking gun in melanoma senescence.
S. Skapek, University of Texas Southwestern Medical Cen-
ter, Dallas: Insights into Arf biology from studying blind 
mice.
General Discussion
SESSION 5: Regulation of INK4/ARF Gene Expression
Chairperson: J. Lees, Koch Institute, MIT, Cambridge, Mas-
sachusetts
G. Peters, CRUK London Research Institute, London, United 
Kingdom: Polycomb regulation of INK4a.
A. Bracken, Trinity College, Dublin, Ireland: Polycomb regu-
lation of the INK4/ARF locus.
G. Shapiro
J. Lees
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J. Gil, MRC Clinical Sciences Centre, London, United King-
dom: Regulation of INK4/ARF by SWI/SNF and other 
chromatin modifi ers.
A. Mills, Cold Spring Harbor Laboratory: Chd5-mediated 
regulation of the Ink4/Arf tumor suppressor network.
Y. Xiong, University of North Carolina, Chapel Hill: Epig e-
netic regulation of p16 and Arf.
Closing Remarks
Sammis, Winter 2013
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The Adolescent Brain
December 3–5
FUNDED BY  The Allen Institute for Brain Science, the Lieber Institute for Brain Development, the 
National Institute on Alcohol Abuse and Alcoholism, and the National Institute of 
Mental Health
ARRANGED BY J. Giedd, National Institute of Mental Health, Bethesda, Maryland
 H. Heimer, Schizophrenia Research Forum, Providence, Rhode Island
 E. Lein, Allen Institute for Brain Science, Seattle, Washington
 N. Sestan, Yale University School of Medicine, New Haven, Connecticut
It has long been noted that many psychiatric disorders fi rst make their appearance in adoles-
cence and the transition to adulthood. Adolescence is a time of great developmental change in the 
human brain, and it is becoming clear that the origins of at least some of these disorders lie in the 
failure of normal brain development. Modern neuroscience has revealed a great deal about prena-
tal and early postnatal human brain development, but it has not provided much detail about later 
stages of neurodevelopment. This meeting surveyed the state of knowledge about normal adoles-
cent brain and behavior and the apparent special vulnerability of the adolescent brain to mental 
disorders. The most recent data were critically reviewed with the aim of producing an integrated 
account that will point out the signifi cant gaps in our knowledge.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Workshop Introduction: H. Heimer, Schizophrenia Research Forum, Providence, Rhode Island
SESSION 1: Overviews
Chairperson: H. Heimer, Schizophrenia Research Forum, 
Providence, Rhode Island
T. Paus, Rotman Research Institute, University of Toronto, 
Ontario, Canada: Adolescent brain development.
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B.J. Casey, Sackler Institute, Weill Cornell Medical College, 
New York; Adolescent behavioral development.
J. Giedd, National Institute of Mental Health, Bethesda, 
Maryland: Mental illness in adolescence.
D. Weinberger, Lieber Institute for Brain Development, 
 Baltimore, Maryland: Developmental biology and psycho-
pathology.
SESSION 2: Short Presentations A
Chairperson: N. Sestan, Yale University School of Medicine, 
New Haven, Connecticut
P. Schmidt, National Institute of Mental Health, Bethesda, 
Maryland
E. Sowell, University of Southern California, Los Angeles
J. Tollkuhn, University of California, San Francisco
B. Luna, University of Pittsburgh, Pennsylvania
N. Tottenham, University of California, Los Angeles
Z.J. Huang, Cold Spring Harbor Laboratory
Key Issues
SESSION 3: Short Presentations B
Chairperson: E. Lein, Allen Institute for Brain Science, Se-
attle, Washington
C. Sisk, Michigan State University, East Lansing
R. Gur, Perelman School of Medicine, Philadelphia, Pennsyl-
vania
L. Spear, Binghamton University, New York
I. Gotlib, Stanford University, California
F. Lee, Weill Cornell Medical College, New York
Key Issues
SESSION 4: Short Presentations C
Chairperson: J. Giedd, National Institute of Mental Health, 
Bethesda, Maryland
P. Rakic, Yale University School of Medicine, New Haven, 
Connecticut
K. Mirnics, Vanderbilt University, Nashville, Tennessee
C. Colantuoni, Lieber Institute for Brain Development, Bal-
timore, Maryland
E. Lein, Allen Institute for Brain Science, Seattle, Washington
N. Sestan, Yale University School of Medicine, New Haven, 
Connecticut
P. Mitra, Cold Spring Harbor Laboratory
Key Issues
SESSION 5: Revisiting Key Issues
Chairperson: J. Giedd, National Institute of Mental Health, 
Bethesda, Maryland
SESSION 6: Discussion of Next Steps (e.g., Publication, 
Proposal Initiatives)
Chairperson: N. Sestan, Yale University School of Medicine, 
New Haven, Connecticut
K. Mirnics, P. Rakic C. Colantuoni, D. Weinberger
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Psychiatric Genomics: Current Status, Future Strategies
December 8–11
FUNDED BY The Stanley Research Fund
ARRANGED BY W.R. McCombie, Cold Spring Harbor Laboratory
 A. Palotie, University of Helsinki, Finland
It has been diffi cult to fi nd the genes and gene loci underlying psychiatric and other complex dis-
orders. However, recent GWA studies and new high-throughput DNA sequencing techniques have 
provided new promise. Although there are good standards and practices to analyze GWAS data, the 
interpretation and analysis of sequence data are still in their infancy. This meeting brought together 
experts to critically assess current strategies and to outline how genome-scale sequencing can be used 
most effectively and effi ciently. Topics covered included the following: How can high-throughput 
sequencing build on GWA studies? How should candidate rare risk alleles be validated? How will 
we ensure that data will be accessible to the community at large, while protecting the legitimate 
intellectual concerns of primary investigators, not to mention the privacy concerns of study subjects?
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction:  W.R. McCombie, Cold Spring Harbor Laboratory
A. Palotie, University of Helsinki, Finland
SESSION 1: What Can We Learn from Genotype-Based 
Association Studies?
Chairperson: J. Knowles, University of Southern California, 
Los Angeles
P. Sullivan, University of North Carolina, Chapel Hill: PGC, 
update on the schizophrenia GWAS.
B. Neale, Harvard University, Boston, Massachusetts: Statis-
tics, and why we need them.
T. Pers, Harvard University, Boston, Massachusetts: Select-
ing likely causal genes and pathways from GWAS by data 
integration.
T. Lencz, North Shore LIJ Health System, Glen Oaks, New 
York: Genetic studies in schizophrenia: Expanding the scope 
by narrowing the focus.
General Discussion
SESSION 2: What Can We Learn from Sequence-Based 
Association Studies?
Chairperson: D. Porteous, University of Edinburgh, United 
Kingdom
S. Purcell, Mount Sinai School of Medicine, New York: 
Schizophrenia case control exome sequencing association.
M. Daly, Harvard University, Boston, Massachusetts: Exome 
sequencing and the genetic architecture of autism spectrum 
disorders.
L. Scott, University of Michigan, Ann Arbor: Whole-genome 
and -exome sequencing of bipolar disorder.
D. Goldstein, Duke University, Durham, North Carolina: 
Lessons from Mendelian genetics in complex neuropsychi-
atric disease.
General Discussion
D. Porteous
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SESSION 3: What Can We Learn from Sequencing Families?
Chairperson: D. Goldstein, Duke University, Durham, North 
Carolina
J. Knowles, University of Southern California, Los Angeles: 
RNA-Seq: BrainSpan, CNON, and single cells.
D. Porteous, University of Edinburgh, United Kingdom: Gen-
eration Scotland GWAS for major depressive disorder and 
related traits.
A. Corvin, Trinity College, Dublin, Ireland: Common and 
rare variants implicate PAK signaling in psychosis suscep-
tibility.
M. Wigler, Cold Spring Harbor Laboratory: Gene target dis-
covery in autism by family exome sequencing.
M.-C. King, University of Washington, Seattle: Damaging de 
novo mutations in schizophrenia: Identifi cation and map-
ping to prefrontal cortex.
J. McClellan, University of Washington, Seattle: Damaging 
de novo mutations in schizophrenia: Insights from gene 
function.
General Discussion
SESSION 4: What Can We Learn from More Detailed 
Analysis of the Phenotype and the Environment?
Chairperson: P. Sullivan, University of North Carolina, Cha-
pel Hill
N. Freimer, University of California, Los Angeles: Genetics of 
brain and behavior: What is the right phenotype?
A. McIntosh, University of Edinburgh, United Kingdom: Quan-
tifi cation and stratifi cation of depression for gene discovery.
M. Burmeister, University of Michigan, Ann Arbor: Gene x 
environment interactions play a role in human behavior and 
psychiatric disorders.
J. Smoller, Harvard Medical School, Boston, Massachusetts: 
DSM and beyond: Leveraging alternative phenotypic strategies.
General Discussion
SESSION 5: What Can We Learn from Using Alternative 
Approaches?
Chairperson: W.R. McCombie, Cold Spring Harbor Laboratory
A. Need, Imperial College, London, United Kingdom: Whole-
genome sequencing in childhood psychiatric illness.
A. Palotie, University of Helsinki, Finland: Use of population 
isolates in disease genetics.
SESSION 6: How to Proceed to Understanding More About 
the Function
Chairperson: N. Freimer, University of California, Los  Angeles
K. Brennand, Mount Sinai School of Medicine, New York: 
Validating genetic fi ndings using human iPSCs.
W.R. McCombie, Cold Spring Harbor Laboratory: Heteroge-
neity and strategy: Ways to move to function.
Final Discussion: What Next?
Coffee break discussion
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Accelerate Genomic Research with Privacy Protections
December 11–13
FUNDED BY Illumina, Inc.
ARRANGED BY Y. Erlich, Whitehead Institute, Cambridge, Massachusetts
 R. Kain, Illumina, Inc., San Diego, California
 A. Narayanan, Princeton University, New Jersey
In a decade, we have gone from sequencing megabases of DNA at great cost, to sequencing gigabases 
at low cost. Projects on a scale unimaginable a few years ago are now possible. The data from these 
projects, coupled with the healthcare records and other details of the life histories of the individuals, 
will be the foundation for a revolution in healthcare. One particular challenge is the personal privacy 
and the ultimate security of personal genome information. Even if the information is used in a de-
identifi ed manner for large-scale health studies, there is no guarantee that the information will not be 
traced back to the individual. There is a danger that the dialogue about the security of an individual’s 
genome information will be driven by anecdotes and ill-considered reporting in scientifi c journals, 
the mainstream press, and social networks. We hope to minimize this risk by initiating a public 
discussion of these issues, recognizing the ethical and technical challenges of managing genomic 
information and suggesting possible solutions. To do so, we are bringing together scientists from the 
fi elds of human genetics, bioinformatics, cryptography, and privacy scholarship.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
What the Meeting Is About: Y. Erlich, Whitehead Institute, Cambridge, Massachusetts
Introduction:  Genomics and the Value of Data Dissemination
T. Manolio, National Human Genome Research Institute, Rockville, Maryland
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SESSION 1: Anatomy of Hacks: Vulnerability Points and 
Areas of Vulnerability
Chairperson: R. Kain, Illumina, Inc., San Diego, California
B. Malin, Vanderbilt University, Nashville, Tennessee: Ge-
nomics and the wonderful world of re-identifi cation.
Y. Erlich, Whitehead Institute, Cambridge, Massachusetts: 
Identifying personal genomics by surname inference.
General Discussion
SESSION 2: Current State of Ecosystem: Summary of Ethi-
cal and Policy Considerations
Chairperson: R. Kain, Illumina, Inc., San Diego, California
N. Farahany, Duke University, Durham, North Carolina: US 
and EU privacy frameworks for genomics.
SESSION 3: Approaches to Risk Analysis: Future 
Vulnerability and Impact
Chairperson: R. Kain, Illumina, Inc., San Diego, California
S. Brenner, University of California, Berkeley: Premises in 
 genome privacy.
D. Glazer, Google, Mountain View, California: Google’s pri-
vacy principles.
General Discussion
SESSION 4: The Sandbox Model and Access Control
Chairperson: Y. Erlich, Whitehead Institute, Cambridge, Mass-
achusetts
S. Sherry, National Library of Medicine, Bethesda, Maryland: 
An overview of DBGap, content, format, and access.
R. Shelton, Private Access, Inc., Irvine, California: Consumer-
controlled empowered tools for harmonizing privacy and 
 access to confi dential information.
A. Philippakis, Broad Institute, Boston, Massachusetts: Ge-
nome Bridge, a cloud-based platform for genome-scale anal-
ysis: How it works, how is privacy managed.
General Discussion
SESSION 5: Differential Privacy: Quantitative Methods 
for Data Perturbation or Restricting Queries to Ensure 
Privacy
Chairperson: Y. Erlich, Whitehead Institute, Cambridge, 
Massachusetts
A. Narayanan, Princeton University, New Jersey: Introduction 
and framing: Cryptography and differential privacy (why it’s 
included).
V. Shmatikov, University of Texas, Austin: Attempting to apply 
differential privacy to genome-wide association studies.
General Discussion
SESSION 6: Cryptographic Approaches for Data 
Dissemination
Chairperson: Y. Erlich, Whitehead Institute, Cambridge, 
Massachusetts
E. Eskin, University of California, Los Angeles: Identifying 
genetic relatives without compromising privacy.
J. Witkowski, S. Turner, M. Olson, T. Hunkapiller R. Shelton, Y. Erlich, and T. Manolio list topics for discussion
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G. Tsudik, University of California, Irvine: How medical pre-
dictions can be made from DNA data using homomorphic 
encryption.
General Discussion
SESSION 7: Interdependencies: Technology Solutions vs. 
Ethics and Public Policy/Legislation
Chairperson: A. Narayanan, Princeton University, New Jersey
T. Callaghan, Federal Bureau of Investigation, Quantico, Vir-
ginia: Law enforcement databases: Tensions between foren-
sic analysis and genetic privacy.
C. Ball, Ancestry DNA, San Francisco, California: DTC test-
ing and the consumer’s attitude toward genetic privacy.
L. Rodriguez, National Human Genome Research Institute, 
Bethesda, Maryland: Moving forward: Evolving policy con-
siderations regarding genomic privacy.
General Discussion
SESSION 8: Summaries and Proposed Outcomes
White paper: Which fi ve key points to include?
Summary and Concluding Remarks
L. Stein, C. Ball
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Phelan-McDermid Syndrome: Autism due to Shank3 
Mutations/Deletions
December 15–17
FUNDED BY Phelan-McDermid Syndrome Foundation
ARRANGED BY G. Bliss, Phelan-McDermid Syndrome Foundation, Houston, Texas
 R. Dolmetsch, Allen Brain Institute, Stanford, California
 C. Powell, University of Texas Southwestern, Dallas
The goals of this discussion meeting were to share the most current re-
search on Shank3-related neurodevelopmental disorders and to design a 
plan for near-term and long-term research aimed at understanding and 
treating Shank3-related symptoms. A carefully selected group of scien-
tists and clinicians from diverse backgrounds and interests discussed 
their most recent data and their candid thoughts on the most promising 
future avenues of research. Participants shared unpublished data, future 
research plans, and constructive criticism of published data in the fi eld. 
Discussion sessions with appointed leaders were interleaved among the 
talks to encourage goal-directed brainstorming that was hoped would 
lead to clear future objectives. It was expected that at the conclusion of 
the meeting, participants would come away with a clear picture of the 
challenges that lie ahead and strategies to overcome them.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Toward a Natural History of PMS
G. Bliss, Phelan-McDermid Syndrome Foundation, Houston, 
Texas: Registry.
C. Betancur, INSERM-CNRS, Paris, France: Clinical ge-
netics.
K. Phelan, Tulane University School of Medicine, New Or-
leans, Louisiana: PMS in adolescents and adults.
A. Kolevzon, Icahn School of Medicine at Mt. Sinai, New 
York: Natural history.
Session Discussion: How to Proceed to Obtaining Informa-
tion about Natural History?
Moderator: A. Hardan, Stanford University, California
SESSION 2: Toward Clinical Trial Design in PMS
J. Buxbaum and A. Kolevzon, Icahn School of Medicine at 
Mt. Sinai, New York: PMS clinical trial: Rationale, design, 
outcome measures.
J. Neul, Baylor College of Medicine, Houston, Texas: Rett 
syndrome clinical trial outcome measures.
R. Carpenter, Seaside Therapeutics, Cambridge, Massachu-
setts, and M. Bear, Massachusetts Institute of Technology: 
Fragile X clinical trial outcome measures.
M. Sahin, Children’s Hospital, Boston, Massachusetts: TSC 
clinical trial outcome measures; Mechanisms of neurocogni-
tive dysfunction and treatment trials in TSC.
Session Discussion: How to Discover and Defi ne Most 
 Appropriate Outcome Measures for Clinical Trials in PMS?
Moderator: J. Veenstra-Vanderweele, Vanderbilt University, 
Nashville, Tennessee
SESSION 3: Therapeutic Target Identifi cation for PMS in 
Model Systems: Study, Replicate, Repeat
R. Dolmetsch, Novartis Institute for BioMedical Research, 
Inc., Cambridge, Massachusetts: Human neuronal cultures.
K. Phelan
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C. Sala, CNR: Institute of Neuroscience, Milan, Italy: Animal 
neuronal cultures.
Z. Yan, State University of New York, Buffalo: Shank3 de-
fi ciency causes synaptic and behavioral impairment via an 
actin-dependent mechanism.
Session Discussion: In Vitro Models: How Best to Use 
Them?
Moderator: W. Spooren, F. Hoffmann-LaRoche Ltd., Basel, 
Switzerland
Do the cultures and animal models overlap?
How can we move rationally to high-throughput screening 
that is meaningful?
Consensus on how targets should be preclinically validated?
SESSION 3 (continued): Therapeutic Target Identifi cation 
for PMS in Model Systems
J. Buxbaum, Icahn School of Medicine at Mt. Sinai, New 
York: Animal models 1: Exon 4–9 (Ankryin repeat domain).
C. Powell, University of Texas, Dallas: Animal models 3: 
Exon 21 (Homer-binding domain).
Y.-H. Jiang, Duke Institute for Brain Sciences, Durham, 
North Carolina: Animal models 4: Complete deletion.
J. Holder, Baylor College of Medicine, Houston, Texas: Ani-
mal models 5: SHANK3 overexpression; Overexpression of 
Shank3 causes a unique neuropsychiatric disorder.
Session Discussion: Animal Models: How Best to Use Them?
Moderator: T. Boeckers, Universität Ulm, Germany
What replicates, what does not, why?
What convergence is there if any?
What brain regions are most critical?
What treatments should be studied next in the models?
What are the key issues for future research?
SESSION 4: Goal-Directed Group Discussion
D. Bredt, Johnson & Johnson Pharmaceutical R&D, San 
Diego, California: Preclinical studies.
W. Kaufmann, Boston Children’s Hospital, Massachusetts: 
Clinical studies and outcome measures.
C. Powell, University of Texas, Dallas: Therapeutic targets 
and screening.
W. Spooren, F. Hoffmann-LaRoche Ltd., Basel, Switzerland: 
EU-AIMS.
Final Discussion: What Are the Key Issues, What to Do 
Next?
• Toward a natural history of PMS
• Toward clinical trial design in PMS
• Therapeutic target identifi cation for PMS in model systems
• Funding
• Dissemination
C. Powell, G. Bliss R. Dolmetsch
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DNA LEARNING CENTER
EXECUTIVE DIRECTOR’S REPORT
ADMINISTRATION INSTRUCTION BIOMEDIA
Lauren Correri Elna Carrasco Mohammed Khalfan
Mary Lamont Heather Cosel-Pieper Susan Lauter
Valerie Meszaros Antonia Florio Amy Nisselle
David Micklos Jennifer Galasso Jason Williams
Carolyn Reid Natalia Hanson Chun-hua Yang
 Melissa Lee
 Christine Marizzi
 Kathleen McAuley
 Amanda McBrien
 Erin McKechnie
 Bruce Nash
 Brooke Roeper
 Jermel Watkins
 Xiaoqun Catherine Zhang
The DNALC originated the concept of providing lab experiences in genetics and biotechnology to 
large numbers of biology students. During the year, we touched base with 13 programs worldwide 
that were developed under licensing agreements with the DNALC, were initiated by DNALC staff 
or kick-off events, or that claimed to be directly modeled after us. Together with us, these programs 
provide hands-on experiments to more than 150,000 students per year. In addition, 25 kits devel-
oped with Carolina Biological Supply Company are used by 200,000 students annually. Likely 
a similar number of students do labs based on our three textbooks and eight experiment websites.
Worldwide Genetics and Biotech Lab Exposures at Programs Modeled on the DNALC
Program Location
Year 
founded
Number of 
labs
Yearly 
student 
exposure
Cumulative 
student 
exposure
DNA Learning Center, Cold Spring Harbor Laboratory Cold Spring Harbor, NY 1988 6 31,900 475,580
Biotechnology Teaching Center at Stony Brook University Stony Brook, NY 1995 3 4,610 75,950
Bay Area Biotechnology Education Consortium (BABEC) San Francisco Bay, CA 1996 Distributed 45,500 200,000
Ecole de I’ADN (“DNA School”), Museum of Nimes Nimes, France 1998 9 35,000
Glasemes Labor (“Visible Lab”), GmbH Campus Berlin-Buch Berlin-Buch, Germany 1999 3 10,045 122,000
Gene Technology Access Centre (GTAC) Melbourne, Australia 2000 2 11,020 61,430
Life Learning Center, University of Bologna Bologna, Italy 2000 4 12,910 103,230
Biogen-Idec Community Laboratory Cambridge, MA 2002 2 2,480 25,430
Lifelab, Life Science Centre Newcastle upon Tyne, UK 2002 1 3,320 42,430
DNA Learning Lab, Science Centre, Singapore Singapore 2003 3 24,140 214,270
South Carolina DNA Learning Centre, Clemson University Clemson, SC 2006 2 1,560 11,740
Vienna Open Lab Vienna, Austria 2006 1 5,050 29,790
Sackler Educational Lab, American Museum of Natural History New York, NY 2007 1 3,800 21,330
College of Science, University of Notre Dame South Bend, IN 2013 1
38 156,335 1,418,180
DNALC Kits, Carolina Biological Supply Company Burlington, NC 1986 200,000
356,335
In 2008, we collaborated with the New York City (NYC) Department of Education (DOE) to 
open the Harlem DNA Lab, which is located in the John S. Roberts Educational Complex on 1st 
Avenue and 120th Street, owned by the DOE. During its 5 years of operation, Harlem DNA Lab 
has fulfi lled our goal of providing underserved schools in NYC enrichment opportunities identical 
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to those that we offer Long Island’s affl uent schools. More than 15,400 students have done hands-
on experiments at the facility; 75% were Hispanic or African American. The same proportion 
of students were from Title 1 schools, at which 40% or more of students are designated as low 
income. Harlem DNA Lab was the site of a Howard Hughes Medical Institute (HHMI) teacher-
training program that we administered in collaboration with the NYC DOE. During the 5-year 
term of the grant, 835 NYC teachers completed an average of 15 hours of training.
The success of Harlem DNA Lab has proven that we can fi nd our way in the megalithic NYC 
school system, draw signifi cant numbers of underrepresented minority (URM) students, and 
have a measurable impact on student achievement. With no long-term contract with the DOE, 
use of the Harlem DNA Lab continues on a year-to-year basis. Evening, weekend, or holiday ac-
cess requires permits for each activity. Furthermore, in the last 2 years, there have been several 
instances of gun violence in the neighborhood that have caused the facility to be “locked down” 
and have discouraged some schools from attending labs there.
DNA Center NYC
Emboldened by our success, but sobered by the limitations in Harlem, in 2013 we took major steps 
toward achieving our long-held goal of having our own dedicated center in Manhattan. DNA 
Center NYC will further extend the DNALC “brand” to NYC, using a successful educational 
formula perfected over 25 years:  academic year lab fi eld trips for 5th through 12th grade students, 
in-school instruction with mobile experiment “footlockers,” intensive summer DNA camps, and 
teacher training and follow-up support for effective hands-on science learning.
DNA Center NYC will be a 7,000–10,000-square-foot facility, administering a full program 
of student enrichment for 5th–12th grade students from the fi ve boroughs of NYC. Its mission is 
to be the “go-to” place for DNA education and information from the world’s top-rated molecular 
biology and genetics research institution. DNA Center NYC will be a vibrant hub of hands-on ex-
plorations of the DNA world and its relationship to inheritance and health. DNA Center NYC envi-
sions a day when all NYC students will have the opportunity to look at their own DNA—to better 
understand their uniqueness, the implications of personalized medicine, and the genetic heritage 
Concept illustrations (see also next page) of DNA Center NYC provided by Centerbrook Architects and Planners.
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they share with other people in America’s 
melting pot. DNA Center NYC will leverage 
the DNALC’s leadership to create a unique 
environment in which students can ask ques-
tions and do hands-on science experiments.
Each year, we anticipate providing 
hands-on labs for 27,500 students and sup-
porting a network of 200 students and men-
tors involved in extended research projects 
in DNA barcoding, microbiomes, and ge-
nome sequencing. We also plan to train 100 
5th- through 12th-grade teachers and pro-
vide equipment footlockers to support 2000 
in-school student labs. We will continue to 
encourage participation of URM. To aid re-
cruitment, we will deepen relationships with leaders and programs serving these populations and 
have budgeted funds to provide scholarships to 50% of all students attending programs at DNA 
Center NYC who are URM and/or from Title I schools.
Because Harlem DNA Lab is convenient to students commuting from northern Manhattan and 
the Bronx, we intend to continue to operate this facility along with the new DNA Center NYC. The 
two facilities will offer the same lab programs, allowing us to serve the broadest possible population. 
We anticipate that a proportion of Harlem DNA Lab’s natural clientele, for example, some schools 
in the Bronx, will opt to travel to the larger DNA Center NYC. However, our 10 years of experience 
with an analogous situation on Long Island with the Dolan DNALC and DNALC West shows 
that a smaller satellite facility can operate at capacity due to the strong demand for our programs.
Building out and equipping three teaching labs, an exhibit, a bioinformatics/multimedia class-
room, a lunchroom, and staff offi ces will cost $2.7 million. Annual operating costs, including 
salaries for three administrative staff, six instructional staff, and two interns, are estimated at $2 
million. Expected revenues from student labs, interpretive programs, teacher training, and mem-
berships can only generate about half of this amount. Federal and private foundation grants cur-
rently supply the difference between operating income and total DNALC operating costs. In light 
of the decreasing availability of grants and increased funding gaps caused by vagaries of the federal 
budget process, we have adopted a plan to cover additional operating costs from endowment.
The Cold Spring Harbor Laboratory (CSHL) Board of Trustees has included $25 million for 
DNA Center NYC in its $250 million capital campaign to commemorate the institution’s 125th 
anniversary in 2015. Building on a lead gift of $6 million from CSHL Trustee Laurie Landeau, 
the campaign gained momentum in the fall. In October, we received a $10 million gift from the 
Thompson Family Foundation whose namesake, Wade Thompson, founded Thor Industries as 
one of the world’s largest manufacturers of recreational vehicles, including the fl agship Airstream. 
This was followed by a $3 million grant from the Alfred P. Sloan Foundation, prompting CSHL 
President Bruce Stillman to offi cially announce the project at the annual Double Helix Award 
dinner on November 4.
The Sloan Foundation grant provided start-up funds to initiate a three-phase development 
timetable. By year’s end, we had launched Phase I. Working with Cushman & Wakefi eld Real-
tors, we began our search for a suitable lease property with good street visibility and ready access 
to the NYC subway. At the same time, members of a newly formed DNA Center NYC Council are 
introducing the project to companies, foundations, and individuals capable of making major gifts 
to close out the $25 million capital campaign. We intend to begin Phase II facility development 
in summer 2014, with design and construction complete in 2015. We have developed a fi nancial 
plan in which the Sloan grant will fund renovation and staff recruitment in Phases I and II. Then, 
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income from a $22 million endowment will supplement tuition income in Phase III, producing a 
sustainable, balanced budget. During Phase III, we will open DNA Center NYC and scale up to 
full operation in 2016.
DNALC Licensing
Beginning with a 2002 agreement with the North Shore–Long Island Jewish Health System that 
founded DNALC West, the licensing program has provided an effi cient mechanism for institu-
tions to develop science centers based on the DNALC model. This formal relationship provides 
transparent access to teaching methods and intellectual property (“know-how”) developed over a 
25-year period at a cost of more than $40 million.
On September 28, the DNALC at the University of Notre Dame was dedicated, becoming the 
sixth licensed DNALC operation. The collaboration was made possible by CSHL friend and Notre 
Dame Alumnus John Passarelli. A 36-seat lab, which makes use of the DNALC’s distinctive lab 
“islands,” will be located in the new Jordan Hall of Science. The facility was blessed by a Notre 
Dame priest—but the football team had no such help when they lost to Oklahoma that afternoon.
By year’s end, we also had a draft licensing agreement with Beijing No. 166 High School, a 
public school with 2000 students in grades 7–12. Beijing No. 166 is the top rated of ~30 high 
schools in the Dongcheng District in the heart of old Beijing, just one mile from the Forbidden 
City and Tiananmen Square. Founded in 1864 as China’s most prestigious girls’ school, Beijing 
No. 166 became coeducational after the Cultural Revolution. With training in biology, Principal 
Wang Lei has recently developed Beijing No. 166 as the only designated high school of biology in 
the capital. The school has major partnerships with the Genetics Society of China and the Beijing 
Genomics Institute (BGI), whose Chairman, Henry Yang, introduced DNALC Executive Direc-
tor Dave Micklos to China in 2003.
Our collaboration began in 2011, with 20 stu-
dents attending a 3-week summer workshop at the 
DNALC. We continued summer workshops in 2012 
and 2013 and added a winter internship for select-
ed students. We were lucky to catch the beginning 
of the wave of precollege Chinese students visiting 
the  United States, driven by the desire of many top 
 Chinese students to attend U.S. universities and af-
fl uent parents who are able to focus resources on a 
single child. Travel visas have become easier to ob-
tain, and travel agencies are catering to the demand.
The formal collaboration will begin in spring 
2014 with funding from the Dongcheng District. 
Under terms of the agreement, we will create a co-
branded DNALC at Beijing No. 166 as a resource for 
Dongcheng public schools, which serve 100,000 stu-
dents. A well-equipped biology lab, completed during 
the renovation of the school in 2013, will be dedicated 
to providing academic-year fi eld trips and summer camps. The DNALC will provide 260 student-
weeks of workshops at Cold Spring Harbor, as well as 4 weeks of student/faculty training in Beijing.
New Program on Next-Generation Sequencing
Since the advent of so-called “next-generation sequencing” (NGS) in 2005, the cost of DNA 
sequencing has decreased 10,000-fold (imagine anything in your lifetime that has decreased by 
even twofold!). Coupled with free online analysis tools, NGS offers the promise to make genome 
Beijing No. 166 students pose with DNALC instructional staff following 
summer workshops.
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analysis an egalitarian pursuit open to virtually anyone. Indeed, recent DNALC surveys of attend-
ees at scientifi c meetings and training workshops suggest that 98% of researchers are currently, or 
soon will be, using large sequence data sets.
Raw DNA and RNA sequences are becoming the currency of modern biology, and easy access 
to genome information is leading a paradigm shift in the fi eld. Throughout history, biologists have 
worked lifetimes attempting to amass enough data to support their ideas, with the effect that hy-
potheses were usually undersupported by data. Today, NGS has created a virtually data-unlimited 
paradigm in which hypotheses are often derived from sequence data itself. This whole-genome 
paradigm will dominate the biological landscape for students seeking future careers in biomedical 
and agricultural research.
Against this backdrop, in the fall, the DNALC was awarded a $537,000 grant from the  National 
Science Foundation (NSF) to develop “Infrastructure and Training to Bring NGS  Analysis into 
Undergraduate Education.” This 3-year project will assist undergraduate faculty in integrating 
NGS analysis into course-based and independent student research. Participating  faculty will de-
velop a total of 30 RNA sequence (RNA-Seq) data sets that bear on novel research problems 
in eukaryotic genomics. Following refi nement of a biochemical and bioinformatics workfl ow by 
project staff, a Working Group retreat will be conducted at CSHL in June 2014 with 11 faculty. In 
subsequent years, regional and virtual workshops will be held for 80 faculty representing diverse 
institutions and areas of the country. Approximately 25% of faculty will be from minority-serving 
institutions with the objective of reaching African American, Hispanic, and Native American 
faculty and students.
Analysis will use large-scale data storage and bioinformatics workfl ows provided by the iPlant 
Collaborative, an NSF-supported cyberinfrastructure for biological research. The project will pro-
vide faculty at predominately undergraduate institutions (PUI) the fi rst easy access to high-perfor-
mance computing through the NSF’s Extreme Science and Engineering Discovery Environment 
(XSEDE). Advanced applications, including command line customization, are supported in the 
research-grade Discovery Environment.
Using the visual metaphor of a subway map, the DNA Subway educational platform bundles 
research-grade bioinformatics tools and databases into intuitive workfl ows and presents them in 
an easy-to-use interface. Each of four DNA Subway lines focuses on different problems in genome 
analysis, organizing bioinformatics tools at stops along branches off a main track. The Green Line 
is an educational workfl ow specifi cally designed to support student analysis of RNA-Seq data sets. 
It integrates all tools needed to assemble millions of RNA sequences into a transcriptome—the 
entire set of genes active under different conditions or in different cell types (such as normal vs. 
tumor cells). The Green Line articulates directly with high-performance clusters at the Texas 
Advanced Computing Center, providing what we believe to be the fi rst easy biological on-ramp 
to the national supercomputing highway. This infrastructure will make it possible to broadly dis-
seminate on-demand experiments using RNA-Seq in undergraduate settings.
During the grant, training will transition from in-person workshops to online webinars and 
self-paced learning via a dedicated Internet microsite, providing a sustainable method to intro-
duce large numbers of faculty to NGS analysis. Participants will also share instructional strategies 
and solve analysis problems during regular webinars and video conferences broadcast from the 
DNALC’s Laurie J. Landeau Multimedia Studio. A multifaceted evaluation program will assess 
effects on student learning, interests, and attitudes across a variety of classroom and student re-
search settings.
This project operates on the continuum of biology research and education. It recognizes that 
many college faculty would like to bring NGS to bear on a problem of their own interest and 
invite students to become coinvestigators of class-based and independent projects. The program 
will prepare faculty to operate in the new, sequence-driven paradigm and empower them to guide 
students in novel genome explorations.
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iPlant Collaborative
In September, we learned that the NSF had approved an additional 5 years of funding for the 
iPlant Collaborative. The renewal proposal received an extremely rigorous review, including 
an anonymous panel of peers, a “reverse” site visit with NSF program offi cials, and approval 
by NSF division directors, culminating in a fi nal nod from the National Science Board, NSF’s 
governing body. Considering the federal sequester and general uncertainty of research funding, 
the renewal of this project for $50 million was a vote of confi dence in this collaboration among 
CSHL, the University of Texas, and the University of Arizona.
During the fi rst 5 years of the project, the DNALC successfully expanded its role to become 
the leader of Education, Outreach, and Training (EOT). This 
ramped up funding to nearly $800,000 per year, or about one 
quarter of the DNALC’s $3.2 million operating budget. So we 
heaved a sigh of relief at the renewal. Notably, iPlant support al-
lowed the DNALC to recruit two high-level computer program-
mers, who worked to consolidate our leadership in educational 
bioinformatics. We focused much effort on DNA Subway, fi nal-
izing the Green Line in time for the NGS program. With nearly 
6000 registered users, DNA Subway continues to fulfi ll our mis-
sion of bringing cyberinfrastructure into the classroom, making 
it easy for students to work with the same data and bioinformat-
ics tools as high-level researchers. The Blue Line articulates with 
a complete set of lab materials for DNA barcoding and is the 
basis of the successful Urban Barcode Project (UBP), which has 
involved more than 400 students in examining biodiversity in 
(Top) The iPlant Collaborative website was redesigned during the year and is set to launch in early 2014. Junior designer Chris 
Weidler created the look of the new site. (Bottom) The Tools & Services Workshop at CSHL in December was also broadcast 
using Adobe Connect and Livestream. Watch it here: http://new.livestream.com/cshl-dnalc/cshl-tsw.
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NYC. Students analyze and compare DNA barcode sequences and construct phylogenetic trees. 
An export feature simplifi es barcode sequence submissions to GenBank and has been used to pub-
lish more than 100 novel DNA sequences, with students as authors.
We are currently upgrading the existing Red Line annotation workfl ow to incorporate JBrowse 
and WebApollo, a user-friendly rewrite of the Apollo annotation editor. The Red Line will enable 
an easy annotation “round trip” as locally generated RNA-Seq data are automatically transferred 
from the Green Line as annotation evidence. The workfl ow will readily accept any type of GFF 
(general feature format) fi le, including output from Maker and evidence from other genome re-
sources. This seamless integration will create a “power desktop” that allows faculty and students to 
explore large-scale variation in gene expression and genome structure on their personal computers. 
We believe that the Green and Red Lines of DNA Subway will be the most user-friendly workfl ows 
available to support distributed annotation of newly sequenced and re-sequenced genomes. The 
maize genome is specifi cally being developed as the fi rst use case.
Also in light of the renewal, we designed a refreshed iPlant website that features the variety of 
iPlant platforms and tools and user success stories to highlight the research problems that iPlant 
can help solve. The DNALC will also continue the development of the iPlant Learning Center, 
where users can access Quick Start or in-depth tutorials online.
Throughout 2013, we continued to deliver iPlant workshops for researchers and faculty. We 
trained 283 researchers at eight Tools & Services Workshops and 38 faculty at Genomics in Educa-
tion Workshops. Workshops and conferences continued to be an important component of reach-
ing and training new iPlant users, and thus we anticipated reaching many more people virtually. 
In 2013, we launched a series of webinars, described further in our BioMedia section below. We 
can achieve an extended reach through webinars; for example, a workshop attended by 27 re-
searchers at CSHL had 316 “virtual” webinar attendees! In total, we reached an additional 405 
researchers and faculty virtually.
Longitudinal evaluation continues to guide and inform EOT efforts and document our suc-
cess in reaching our intermediate audience of biological researchers who do not have special-
ized expertise in computation. Workshop follow-up surveys show that 60% of Tools & Services 
Workshop attendees actively use the iPlant platform to analyze their data, and 72% say that they 
introduced their colleagues to iPlant. Genomics in Education Workshops also had signifi cant 
impact, with faculty reporting more than 24,000 student exposures to iPlant bioinformatics 
exercises as a result.
Genomic Approaches in BioSciences
This year was the fi nal year of our NSF Advanced Technological Education (ATE) grant, which 
reached 258 biotechnology educators at 12-week-long workshops conducted at community col-
leges nationwide. The curriculum covers four key technologies: polymerase chain reaction (PCR), 
DNA sequencing, RNA interference (RNAi), and bioinformatics. In 2013, the last fi ve workshops 
were held at Tulsa Community College (Tulsa, OK), City College San Francisco (San Francisco, 
CA), Minneapolis Community and Technical College (Minneapolis, MN), Seminole State Col-
lege (Sanford, FL), and Nassau Community College (Garden City, NY). Of 103 participants in 
2013, 53% were from 2-year colleges, 18% from 4-year colleges or universities, and 28% from 
high schools, with 30% URM. We conducted follow-up workshops in the spring for 21 educators 
who attended workshops in 2012.
The workshops consistently increased educator knowledge and confi dence to teach labs and 
bioinformatics. Preworkshop (n = 260) and postworkshop (n = 245) survey data showed that be-
fore the workshop, only 10% of participants knew “a lot” about the key genomic concepts com-
pared with 37% afterward. Participants also felt more confi dent in teaching the genomics labs 
(16% to 41%) and bioinformatics (8% to 32%). In long-term follow-up surveys (n = 98), 89% 
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of workshop alumni had implemented course materials at schools with an average of 35% URM 
students. Educators taught DNA barcoding (52%), PCR (54%), RNAi (25%), bioinformatics 
(50%), and careers modules (70%), with an annual student exposure of 9768 wet labs, 5582 bio-
informatics exercises, and 5304 biotech careers activities.
In January, four case studies were conducted with 2011 workshop alumni. The case studies 
involved classroom observation of PCR and DNA barcoding (n = 64 students, 22% URM), stu-
dent focus groups (n = 28; 25% URM), and educator interviews (n = 5) at a rural high school and 
at suburban 2- and 4-year colleges. College faculty discussed using the curricula as an “enabler” 
to link subjects, make best use of faculty expertise and equipment, and increase student interest. 
For example, biotechnology students used DNA barcoding to help ecology students map campus 
biodiversity. Two courses were implemented as a direct result of our training program. The aim 
of the ATE program is to “prepare tomorrow’s biotechnology workforce,” and this was illustrated 
by one case study participant: “We’ve had a lot of interesting classes but Biotech is the only one where 
we’ve learned stuff that we can apply when we got a job. . . where I feel a little more confi dent. . . I could 
be without supervision.”
Our evaluation data consistently show that bioinformatics is challenging to teach and learn. 
Both educators and students feel more comfortable and engaged when bioinformatics exercises 
are incorporated into relevant, personalized curricula, such as our human mitochondrial DNA, 
DNA barcoding, and RNAi labs. At the least complex end of the spectrum, students use their 
own mitochondrial DNA sequences to discover principles of human evolution through database 
searches for similar sequences and alignment to the sequences of other people, primates, and even 
extinct hominid ancestors. Of medium complexity, DNA barcoding allows students to conduct 
fi eld work and then use DNA sequences to search databases and build phylogenetic trees to answer 
questions about species diversity and conservation. In more complex experiments, students use 
bioinformatics to identify homologs of human disease genes in Caenorhabditis elegans and then 
design targeting vectors to disrupt these genes using RNAi.
In 2013, we secured additional funding to extend the NSF ATE grant and test our “train-the-
trainer” model of instruction. Community college cohosts from the original 2011–2013 grant now 
instruct Genomic Approaches in BioSciences Workshops at their colleges. The fi rst “extension” work-
shop was held at Madison Area Technical College (Madison, Wisconsin), with local faculty teach-
ing the program to 10 participants under DNALC supervision. These workshops will continue in 
2014, and we will compare outcomes for extension workshop participants with the original cohort.
Professional Meetings
The DNALC delivered fi ve presentations at the 2013 National Association of Biology Teachers 
(NABT) conference in Atlanta, Georgia, continuing our partnership with Carolina Biological 
Supply Company (CBSC) to signifi cantly expand our presence at teacher professional meetings. 
CBSC has distributed DNALC experiment kits to science teachers since 1986, and this year, we 
cosponsored a DNA barcoding workshop, based on the CBSC kit, demonstrating all facets from 
sample collection, DNA isolation and amplifi cation, and gel electrophoresis, through sequencing 
and bioinformatic analysis. We presented on the power of DNA barcodes and the use of DNA 
barcoding to drive independent research in the classroom, and we promoted the new DNALC 
Genome Science textbook and laboratory manual for advanced secondary and postsecondary 
education. The textbook combines approachable narrative with extensively tested lab exercises 
that illustrate key concepts of genome biology in humans, invertebrates, and plants. Attendees 
learned about human mitochondrial DNA sequencing, detecting epigenetic DNA methylation in 
 Arabidopsis thaliana, and using DNA Subway. The presentations emphasized how Genome Science 
provides a historical and conceptual framework to enhance existing courses, start new courses, 
and support student research projects.
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DNA Barcoding
The second year of the UBP came to a successful conclusion in June. This year, 53 teams com-
peted: 144 students from 12 public and seven private high schools across NYC, with 24% URM. 
Teachers and students attended 20 Open Lab sessions at the Harlem DNA Lab after school and 
on weekends, equipment footlockers were used by an additional 93 students, and DNALC staff 
conducted fi ve school visits to help teams with their experiments and phylogenetic analyses on 
DNA Subway. Students collected more than 1000 samples for DNA sequencing, with more than 
2500 single sequences provided by GENEWIZ. Importantly, teams discovered 35 novel DNA 
sequences, which are being published to GenBank with student authors, making the data freely 
available for use by other researchers.
Forty-one teams presented research posters at the American Museum of Natural History (AMNH) 
on May 29. The projects mapped NYC wildlife, detected food fraud, determined biodiversity of 
traded species, identifi ed exotic and/or invasive species, and explored the effects of biodiversity on 
human health. A jury of 27 experts selected the top six fi nalist teams (15 students), who gave oral 
presentations at the AMNH on June 5th. George Amato, Director of the Sackler Institute for Com-
parative Genomics at AMNH, gave the keynote address: “DNA Barcoding of Endangered Species, 
From Central African Forests to Restaurants in Man-
hattan.” The grand prize winners were Hostos-Lin-
coln Academy of Science students Kavita Bhikhi and 
Hillary Ramirez. Their project, Using DNA Barcodes 
to Identify Ant Biodiversity in St. Mary’s Park, Bronx, 
New York, identifi ed seven ant species and found evi-
dence for population structure within the ant species 
Tetramorium caespitum. Kavita and Hillary built on 
their research from the 2012 UBP, for which they 
earned fourth prize. This was also mentor Allison 
Granberry’s second UBP victory, and her experience 
is featured in the February 2014 Carolina Tips.
(Top) Hostos-Lincoln Academy of Science students Hillary Ramirez and Kavita Bhikhi, pictured with 
Allison Granberry (center), won the grand prize. (Bottom) UBP participants presented research results in 
a poster session.
487-516_DNALCe.indd   497 19-08-2014   08:09:54
498  DNA Learning Center
Program evaluation highlighted two main barriers to students completing their UBP projects: 
Some teachers were limited in their ability to mentor students through all phases of their  research, 
and students lacked  specifi c training. Therefore, we expanded the program to offer select students 
a more in-depth experience and direct student-scientist mentoring. We partnered with the Pinker-
ton Foundation to establish the Urban Barcode Research Program (UBRP). All UBRP  students 
take introductory courses on DNA barcoding, conservation biology or genetics, proposal writ-
ing, and laboratory safety, and an expert scientifi c mentor works directly with each team. UBRP 
students commit 100+ hours to the program, half of which is directed research with their 
 scientist mentor.
In 2013, 126 NYC students completed preparatory UBRP workshops at the Harlem DNA Lab, 
AMNH, and the Gateway Institute for Pre-College Science Education at Benjamin N. Cardozo 
High School in Queens, New York. Students were recruited from DNALC summer camps at 
Harlem DNA Lab in collaboration with the NYC DOE and through the Gateway Institute. At 
the beginning of the 2013–2014 academic year, 40 of these students were accepted into the fi rst 
UBRP cohort, with 50% URM or disadvantaged students. Teams of two students were paired 
with scientist mentors from collaborating institutes, such as the Rockefeller University, Columbia 
University, and the New York Botanical Garden, to guide them through the research process: 
Antonia Florio (top left photo, far left) leads DNA Barcoding Research Workshop students on a specimen collection trip on the CSHL 
campus.
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preparing a proposal, collecting samples, extracting and amplifying DNA, analyzing data, and 
preparing a scientifi c poster. As with the UBP, projects will culminate in presentations at a re-
search symposium.
Both cycles of the UBP and UBRP continue into 2014, with a total of 55 student teams par-
ticipating: 153 students, 20 teachers, and 20 scientists from 33 different NYC high schools and 
institutions. The students will present their fi ndings at symposia in spring 2014.
To assess the impact of our NYC barcoding research programs, all students complete pre- and 
postsurveys, and we interview a subcohort of students and teachers. When asked to compare 
DNA barcoding with other research experiences, UBP students felt that the DNA barcoding 
programs provided more “real world” science (81% of students), more chance for hands-on expe-
rience (69%) and to learn science (76%), more opportunity to develop critical thinking (83%) 
and independent inquiry skills (70%), and more understanding of the scientifi c process (68%). 
DNA barcoding increased the students’ interest in studying science or pursuing a career in science 
(83%), while still being more fun than other research experiences (84%).
In line with the primary mission of the DNALC, students consistently cited hands-on lab ex-
periences as the most unique, rewarding, and inspiring aspect of the DNA barcoding programs. 
As one student commented,
It really shows you what everyday scientists actually do. They take an unanswered question, they 
get their hypothesis and they test it and they come up with an answer that nobody knows. Whereas 
previous projects that I’ve done. . .you usually know the expected outcome because so many people 
have done this experiment over and over again.
Victoria, 10th grade
We held several DNA barcoding summer camps this year, including basic and advanced re-
search workshops. We expanded DNA barcoding to middle school students with great success: 48 
students attended the new Backyard Barcoding camp. The students worked in groups to identify 
plants and fi llets of fi sh. Thirty-nine local and international students completed the advanced high 
school workshop, DNA Barcoding Research. Students explored the biodiversity of the intertidal 
zone of Cold Spring Harbor and compared DNA isolation methods to identify the effi ciency of in-
house DNA isolations. Students collected and analyzed more than 150 samples that produced 43 
novel sequences to be published to GenBank. Most of the barcoding sequences came from small 
aquatic invertebrates—species that are hard to classify using traditional taxonomy—highlighting 
the power of DNA barcoding.
Building on the work of the summer campers, we compared existing and new barcoding 
methods to identify the most robust, cost-effi cient DNA extraction and amplifi cation methods 
equivalent to commercial kits. We determined silica resin is the best medium, being inexpensive 
(<$0.30/sample, which is a fraction of the cost of commercial kits) and reproducible with almost 
any plant, fungus, or animal specimen. For DNA amplifi cation, we found that NEB Taq 2× 
 Master Mix (12.5 μL) is comparable to Ready-To-Go PCR Beads at a much lower cost ($0.55/
sample vs. $1.60/sample), but it requires access to a stable –20°C freezer. Updated protocols with 
information on reagents, primers, and amplifi cation methods are available on our barcoding 
 website, www.dnabarcoding101.org.
The DNA barcoding program also extended beyond Cold Spring Harbor in 2013, when we 
took the curriculum and materials to Africa, Europe, and Asia! In January, Micklos cotaught 
a DNA barcoding course to 10 students at Godfrey Okoye University in Nigeria, identifying 
several novel sequences of dragonfl ies. In March, he presented the curricula at the Genetics 
Education for the 21st Century Workshop in Utrecht, the Netherlands, and then coconvened 
a meeting on DNA barcoding across European science centers at the Wellcome Trust Sanger 
Institute, Cambridge, also facilitating a workshop to 100 students while there. During a trip to 
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China in November, as part of our ongoing collaboration with Beijing No. 166 High School, 
he led students in investigating local Beijing biodiversity. In addition, Oscar Pineda-Catalan 
and Christine Marizzi taught the curriculum to 23 teachers and 80 students in Malaysia and 
Singapore. The bioinformatics analysis of many of these international samples continues back 
at the DNALC.
High School Research Programs
Our partnership with Cold Spring Harbor High School (CSHHS) continued, offering the 
 Molecular and Genomic Biology “capstone” college-level laboratory course. Co-instructed by 
DNALC and CSHHS faculty Jaak Raadsepp, students devote two classes per day to the year-long 
course. The 2012–2013 cohort, our eighth class, focused on hands-on experimentation and inde-
pendent projects across a range of biological systems. The course included units on eugenics, DNA 
barcoding, RNAi, human genome analysis, bioremediation, and protein modeling. Highlights 
were student essays on modern parallels to the eugenics movement of the early 20th century, after 
students visited CSHL Research Archives to examine historical documents; testing the ability of 
bacteria to bioremediate various substrates; and three-dimensional printing of cancer proteins 
with guest lecturer Joan Kiely of Stony Brook University’s Biotechnology Teaching Center. The 
students presented their work during a poster session at the CSHL Cancer Biology and Therapeutics 
meeting on April 24.
We also continued our successful partnership with St. Dominic High School in Oyster Bay, of-
fering a 5-month course for students in Molecular and Genomic Biology. The course capitalized on 
St. Dominic’s new science building, made possible through a parishioner’s generosity. In collabo-
ration with science teacher Teresa Kuehhas, DNALC staff introduced students to experimental 
methods for future independent projects: species diversity using DNA barcoding, gene function 
using RNAi in C. elegans, and human variation using PCR.
In the fall, Long Island’s fi rst regional Doshi Science, Technology, Engineering and Math 
(STEM) high school opened. The Doshi STEM program partnered with Brookhaven National 
Students and faculty of Godfrey Okoye University.
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Laboratory and the DNALC to prepare students for the 
competitive and evolving high-tech science arena. The 
fi rst 20 9th graders were selected by their school districts 
on the basis of academic performance, recommendations, 
and core interest in STEM. The DNALC collaboration 
provided hands-on, inquiry-based science experiments to 
enhance student understanding of the scientifi c method 
while exploring and solving problems. The Doshi stu-
dents applied these new skills on their fi rst independent 
research project, examining biodiversity of Caumsett 
State Historic Park, Garvies Point Museum and Pre-
serve in Glen Cove, a fi eld by Southampton Hospital, a 
cranberry bog in Amagansett, and parks in Greenport 
and Cutchogue. The students collected and analyzed 50 
samples using DNA barcoding, which will culminate in a 
symposium in early 2014.
Student Programs
This year, 20,962 students attended fi eld trips at our three 
facilities: DNALC, DNALC West, and Harlem DNA Lab. 
We reached an additional 10,200 students through in-
school instruction by DNALC staff and 1641 through 
in-school lab exposures by DNALC-trained teachers with 
footlocker kits. GENEWIZ processed a total of 17,632 
sequencing samples (8030 mitochondrial control region 
sequences and 8401 DNA barcodes) from students at 194 high schools and 105 colleges and 
universities.
Of the students who visited the Harlem DNA Lab, 70% received scholarships from the 
William Townsend Porter Foundation. Two schools co-located within the John S. Roberts 
Educational Complex also received instruction: Coalition School for Social Justice students 
participated in three high school biotechnology laboratories, and MS 45 students enjoyed six 
introductory genetics laboratories. Students performed 
DNA extractions at the STEM Careers EXPO Fair for 
English Language Learners in the Armory on the Hudson 
and observed mutant fruit f lies at the New York Public 
Library Youth STEM Fair. Through continued collabo-
ration with the NYC DOE Office of School Programs 
and Partnerships, we held a 5-day DNA Science camp 
during spring break. Twenty-seven budding scientists 
gave up well-deserved vacations to be immersed in the 
lab. The highlight of the week was a visit by  Dennis 
 Walcott (right, center), the former Chancellor of the 
NYC DOE.
The Harlem DNA Lab continued its footlocker kit rental program by providing Howard 
Hughes Medical Institute–trained teachers with equipment and materials for genetics and bio-
technology labs. In 2013, footlocker kits resulted in 1566 total student exposures; 74% of these 
students were URM, and most teachers received the kit free of charge or were charged only 
minimal restocking fees. In addition, the Harlem DNA Lab continued to be the central hub of 
the UBP.
Bruce Nash (top left) meets with Doshi STEM collaborators, and 
Brooke Roeper (bottom left) demonstrates pipetting technique to 
Doshi students.
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Additional grants from Bank of America and National Grid Foundation supported programs 
for more than 3000 underserved students from Long Island school districts including the Brent-
wood, Uniondale, William Floyd, Central Islip, and Valley Stream public schools. As part of 
an ongoing collaboration with Central Islip Union Free School District (UFSD), we provided 
in-school labs for every 6th grader as part of the district’s new Exploration Academy Campus. A 
customized sequence of labs was presented for both the Forensic and Legal Sciences and Health 
and Medical Sciences academies at the Charles Mulligan and Ralph Reed Middle Schools. The 
program culminated with a visit from Bob Keller, Executive Director of the National Grid Foun-
dation, and Craig Carr, Superintendent of the Central Islip UFSD, to celebrate their accomplish-
ments in the lab.
We continued to work with Charter Member schools. The Chapin School introduced an ad-
vanced science elective, Molecular Genetics. The course curriculum, based on DNALC’s Genome 
Science textbook, is implemented with the assistance of DNALC instructors. The Convent of the 
Sacred Heart School in Greenwich, Connecticut, continued fi eld trips to the DNALC, in-school 
instruction, and summer camps, and also expanded its research programs. St. David’s School in 
Manhattan joined this year with a focus on enriching the 5th-grade science curriculum through 
fi eld trips and in-school instruction for a genetics unit that culminates in a DNA barcoding proj-
ect and a school science fair.
This summer, 1241 students participated in 60 week-long camps held at nine locations: 
DNALC, DNALC West, Stony Brook University, and Brookhaven National Laboratory (Long 
Island); Harlem DNA Lab, the Chapin School, and New World Prep Charter School (NYC); 
Convent of the Sacred Heart (CT); and the Roxbury Latin School (MA).
The summer roster was enhanced by the addition of our new BioCoding summer camp. The 
DNALC has a long interest in bringing bioinformatics education to students. Since 1998, students 
have used our websites such as BioServers to analyze their own mitochondrial DNA sequence, 
simulate genetic drift, and investigate other areas of computational biology. With cheap DNA 
sequencing now a reality, bioinformatics skills—the ability to manipulate software and computa-
tional resources to unlock the meaning of sequence—are now the bottleneck to discovery. This 
course was pioneered by DNALC programmers Sheldon McKay and Mohammed Khalfan, along 
with Jason Williams. Although the world of bioinformatics is intimidating (even to many biolo-
gists today), 82% of the students who attended had little or no coding experience. Our summer 
camp increased 91% of students’ interest in coding, with 73% very likely to now take a science or 
computer science elective at school. We are confi dent our camp prepares students for an academic 
world where, to quote one famous CSHL bioinformatician, Lincoln Stein, “if you can’t do bioin-
formatics, you can’t do biology.”
In 2013, the DNALC helped to establish the i2 (“iNVENT and iNSPIRE”) summer camps 
in NYC and Boston. Founded by Ethan Berman, the objective of the i2 camps is to broaden 
students’ exposure to STEM with a wide variety of new, hands-on, and innovative courses not 
seen in traditional middle school science education. As part of i2, the Roxbury Latin School in 
Massachusetts and the Chapin School in Manhattan offered three DNALC middle school pro-
grams: Fun with DNA, World of Enzymes, and Forensic Detectives. Each course was taught by a 
DNALC lead teacher, an associate teacher, and a high school student acting as a “near peer.” Our 
programs reached 73 students and feedback was overwhelmingly positive. i2 plans to continue 
this collaboration by offering DNALC summer camps in additional national and international 
locations next summer.
Each year, we collaborate with the North Shore–Long Island Jewish (NS-LIJ) health sys-
tem to give students the opportunity to step into biotechnology teachers’ shoes. The I.S. 059 
Springfi eld Gardens School in Jamaica, Queens, sends select 8th- through 11th-grade stu-
dents to DNALC West, located in the NS-LIJ core laboratory at Lake Success, to learn the 
latest biotechnology and bioinformatics techniques. Those “seed students” then teach their 
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classmates back at I.S. 059. Since 2008, 125 
students have been through the program, 
with 16 attending in 2013. “We had tons 
of fun—learned, taught. Thanks for giving 
us gifts that will keep on giving” (Marcia 
Young, I.S. 059 science teacher). The larger 
aim of the program is to allow less-fortunate 
students an opportunity to experience the 
laboratory environment and gain exposure 
to a variety of career choices, and we are 
tracking program alumni regarding STEM 
career choices.
Monthly Saturday DNA! sessions drew 
221 participants, with parents and grandpar-
ents joining children to learn about forensics, 
cholesterol, human origins, genetic traits, the 
Romanov family mystery, genes for biolumi-
nescence, and DNA barcoding. An addition-
al 3426 visitors viewed fi lms in the multitorium, including Cablevision’s multimedia presenta-
tion Long Island Discovery, and/or viewed the exhibition The Genes We Share. The annual Great 
Moments in DNA Science seminar series drew 126 top Long Island high school students for three 
presentations by CSHL researchers. Dr. Jaclyn Novatt showed how basic research on nuclear 
pores is improving drug production. Dr. Aman Husbands talked about his research on plant leaf 
architecture and cell differentiation; and Dr. Dennis Eckmeier discussed how mice rely on scent 
during social interactions.
Renovations to our exhibit space continued as we updated “Our Common Origins” to show-
case the latest fossil fi nds, including Ardipithecus ramidus or “Ardi,” which is more than 4 million 
years old. We redesigned the skull wall and displayed a phylogenetic tree behind the skulls, de-
scribing genetic and morphological relationships between species leading to modern man. More 
than 100 classes per year take an instructor-guided tour of our museum, so we updated the ac-
companying booklet that helps them on their journey and that teachers use to extend fi eld trips 
back in the classroom.
Graduate Training
Through our collaboration with the Watson School of Biological Sciences, graduate students de-
velop presentation methods that can be used with any audience. The spring rotation includes 
teaching both middle school and high school students at the DNALC. While under the guid-
ance of experienced DNALC instructors, graduate students work in pairs to complete 12 half-
day teaching sessions, learning how to assess an audience quickly and build quality instruction 
accordingly.
We continue to collaborate with the New York Academy of Sciences (NYAS), one of the oldest 
scientifi c institutions in the United States and a leading organizer of scientifi c meetings. DNALC 
instructors trained 56 mentors in effective strategies to deliver hands-on genetics activities and 
forensics training in after-school settings for the NYAS science mentoring program.
BioMedia Visitation and Projects
We had a record number of visitors to our suite of multimedia resources in 2013. Google Analytics 
counted 4,861,670 visits to 22 DNALC websites. Our YouTube videos received 823,400 views, 
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and the 3D Brain, Weed to Wonder, and Gene Screen apps were downloaded 579,163 times. There-
fore, total website, YouTube, and smartphone/tablet apps visitation was 6.26 million, an 11% 
increase over 2012.
If you blinked or went to the kitchen, you may have missed it, but the DNALC’s 3D Brain 
(see photos above) app was featured in Apple ads that aired during the Academy Awards. Devel-
oped under a grant from the Dana Foundation, the iPhone, iPad, and iPod app has been down-
loaded 1.6 million times and is one of the most highly rated education apps on iTunes.
Since its launch in 2009, 3D Brain has proven to be one of the most successful resources 
we have ever produced, with 2.2 million downloads to date on Apple, Windows, and Android 
devices worldwide! Reviews show that the app is used primarily by teachers and students, as 
intended, but also by health professionals, patients, and the public: As a psych student, this 
info is constantly brought up in lectures and tutorials—it’s great [I can use] this without Internet 
access ! Great on-hand app! and This is a fantastic app, possibly the best medical /anatomy app I 
have seen. As a nurse, it has been very helpful for me when I work with patients with acquired 
brain injuries.
In October, we released an update for the Apple version of the 3D Brain with current infor-
mation for all 29 brain structures. The update was installed on 485,000 devices, showing that 
the 3D Brain was still being used by 29% of people who had downloaded it to an Apple device 
(1,652,638). We took the opportunity to offer users an “in-app” purchase of 3D Brain HQ, 
which includes higher-resolution images and a redesigned user interface for $0.99. Despite an in-
creasing percentage of free apps in app stores, at year’s end, we tallied a respectable 11,322 in-app 
purchases of the HQ version. Proceeds from in-app purchases support the educational programs 
of the DNALC.
In 2013, we moved into live streaming media and webinars to more fully use the DNALC’s 
Laurie J. Landeau Multimedia Studio. We upgraded our capabilities with an all-in-one portable 
live production switcher, called the Livestream HD 500, which is built to television standards. 
This portable PC CPU/monitor enables real-time switching among multiple cameras (e.g., be-
tween a wide shot and close-ups of laboratory bench techniques), the presenter’s computer screen, 
a video clip, and graphics overlay titles. We can simultaneously stream and record high-defi nition 
video, whether in the studio or on the road. The streaming video is distributed to end users via a 
DNALC Adobe Connect “meeting room” for events with less than 50 participants or the DNALC 
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webpage on the Livestream server for larger 
events. Adobe Connect features a custom-
izable meeting space for document down-
loads and live chats. The recorded events 
are then posted to the relevant DNALC 
websites, Livestream page, and YouTube 
channel.
Our fi rst live event was the UBP Award 
Ceremony on June 5th. The event includ-
ed a keynote address by George Amato, 
Director of the Sackler Institute of Com-
parative Genomics; student presentations; 
and awards. On August 9th, we broad-
casted “DNA for Short”: The Story of a Most 
Important Discovery, A Conversation with 
Dr. James D. Watson. Dr. Watson met with 
middle school students attending a Fun 
with DNA summer camp at the DNALC 
and recounted the story of the discovery 
of the structure of DNA. Campers’ par-
ents and invited guests watched from the 
DNALC Multitorium, and 175 people 
viewed the event on Livestream.
In the fall, we presented a series of 
11 webinars. The inaugural webinar was 
follow-up to a high school human mi-
tochondrial DNA laboratory taught by 
Dave Micklos in the Faroe Islands, off 
the northwest coast of Denmark. Dave re-
minded 41 students of the theory behind 
the lab and then walked them through 
their results and analyses using the 
DNALC’s BioServers and DNA Subway 
websites. The next series of webinars were 
targeted at iPlant users and educators doing DNA barcoding and included introductory tutorials 
as well as refresher courses in wet labs and bioinformatics, with 88 participants, many of them 
repeat attendees. In 2014, we will expand our webinars to include “virtual” follow-ups for fi eld 
trips and summer camps.
To promote our expanding international programs, we also produced three videos in Chinese, 
summarizing the history of CSHL and the DNALC and our mission to be a pioneer in genetics 
education, providing case studies of students from Beijing No. 166 High School attending sum-
mer workshops.
Staff and Interns
There were many staff changes in 2013. We are pleased to say that our staff family has grown and 
evolved, but we are also sad to see some of our colleagues move on to other opportunities.
Dr. Oscar Pineda-Catalan joined the DNALC in 2011 as UBP Manager, founding the com-
petition in 2012. He also developed and taught innovative barcoding programs for both teachers 
and high school students at the DNALC and offsite. Oscar moved on in the spring, becoming 
(Top) James Watson and Fun with DNA campers pose following the DNA for Short live 
broadcast. (Bottom) Jermel Watkins demonstrates the updated barcoding silica DNA 
isolation technique during an iPlant webinar. Chun-hua Yang (far right) is manning the 
close-up camera, and the Livestream HD 500 switcher is shown at left.
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Manager of the Science Research Mentoring Program 
(SRMP) at the AMNH.
Oscar recommended his AMNH colleague Dr. Antonia 
Florio as his replacement, and she fi lled the role of Conser-
vation Genetics instructor in March. Growing up, Antonia 
had two mantras: “Animals are cool, and being outside is 
fun,” which spawned her love for biology and the natural 
world. She received her undergraduate degree at Macauley 
Honors College (CUNY City College), doing research in 
the Galapagos, French Guiana, and South Africa. She then 
completed her doctorate in comparative biology of Mada-
gascan chameleon species at the AMNH. Antonia both 
manages and provides instruction for NYC-based DNA 
barcoding projects (the UBP and UBRP) and assists with 
lab instruction at all three DNALC teaching facilities.
Cornel Ghiban, Computer Programmer, left in the 
spring to join Estée Lauder as a Perl programmer. Even be-
fore he was hired in 2006 and came to the United States 
from Romania, he did contract work for us, developing the “back end” of websites. While at the DNALC, he 
developed and maintained the expanding suite of existing DNALC websites and applications and worked on 
DNA Subway. Cornel continues a working relationship with us on development of DNA Subway.
We also bid farewell to computer programmer Sheldon McKay, who joined us in 2011, moving from iPlant 
in Tucson, Arizona. He developed and taught advanced-level bioinformatics and iPlant cyberinfrastructure 
and managed outreach and educational activities. Sheldon is now with former CSHL scientist Lincoln Stein at 
the Ontario Institute for Cancer Research, working with the Reactome database for metabolic pathways and 
biochemical reactions.
A new position was created for Dr. Xiaoquin “Catherine” Zhang as Manager of International Collaborations. 
After receiving her medical degree at Xian Medical University, China, in 1995, she received a Master of Sci-
ence from Johns Hopkins University in Baltimore, Maryland, majoring in biotechnology and bioinformatics. 
Before joining our team, Catherine was an oncology research associate in CSHL Professor Nicholas Tonks’ lab 
and helped to organize the fi rst two Beijing No. 166 High School summer camps in 2011 and 2012. Catherine 
develops collaborations with several groups in China and is also a high school instructor.
In the fall, Tony Biondo, our Junior Programmer, left to go to law school at St. Johns University, New York. Tony 
assisted with the back end of many BioMedia websites and continues to help us occasionally with projects. Also this 
year, one of our longest-serving interns, Christian Weidler, was promoted to Junior Designer in the BioMedia Group 
after receiving his Bachelor of Technology in Visual Communications from Farmingdale State College.
Since opening in 1988, we have successfully integrated high school and college interns into every aspect of 
our day-to-day operations. During the course of a paid internship, students progress from preparing reagents for 
middle school labs to preparing DNA samples for sequencing and maintaining a worldwide catalog of orders 
for RNAi projects. In addition to prep work, interns may take on independent or team projects mentored by 
DNALC staff members, which translate current research into classroom labs. The BioMedia department also 
welcomes interns for summer or longer-term roles. An internship offers students unique opportunities to gain 
real laboratory or design experience in an educational environment.
Interns also conduct external research, such as the study of the environmental management of Alliaria peti-
olata, an invasive species of garlic mustard, conducted by Robert Scott (Sage College). Robert placed third in the 
New York State Science & Engineering Intel Competition. Brittany Coscio (St. Anthony’s High School, Hunting-
ton, New York) completed research on the effect of multitasking on students’ performance. Arielle Bryan (City 
College of New York) also completed an honors thesis analyzing the Drosophila melanogaster cactus protein via 
allele sequencing.
We gathered an amazing group of interns this year and said farewell as others left for college.
2013 new DNALC employees Antonia Florio (left) and  Catherine 
Zhang.
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January 4 Feinstein Institute, “DNA Learning Center” Presentation, Manhasset, New York
January 4–5 Godfrey Okoye University, “DNA Barcoding and DNA Subway” Workshop, Enugu, Nigeria
January 7–8 Lone Star College CyFair, “DNA Barcoding” Workshop, Kingwood, Texas
January 11 International Plant and Animal Genome XXI Conference 2013, pre-PAG Half-Day, NSF iPlant Collaborative 
Tools & Services Workshop, Town and Country Convention Center, San Diego, California
January 12 Saturday DNA! “Bad Cholesterol”! DNALC
January 12 STEM Mentor Training, New York Academy of Sciences, New York, New York
January 19 The New York Academy of Sciences, Fun with DNA and Enzyme Labs for Middle School Instruction Workshops, 
Albany, New York
January 21 “DNA Learning Center” and “DNA Barcoding” Presentations, Singapore Science Center, Jurong East
Jan. 23–Feb. 1 “Nobelist Mindset Program” Workshop, National University of Malaysia, Kuala Lumpur
Jan. 25–Feb. 6 Visiting Student Internships, Beijing No. 166 High School, Beijing, China, DNALC
January 29 Site visit by John Ettinger and Betsy Fader, Helmsley Trust, New York
February 1 Nassau County Science Supervisors Meeting, “DNALC Education Programs” Presentation, Nassau County 
BOCES, Garden City, New York
February 2 Saturday DNA! “CSI Chapters: The Science of Blood Spatter,” DNALC
February 2 Urban Barcode Project Open Lab, Harlem DNA Lab
February 7 Urban Barcode Project Open Lab, Harlem DNA Lab
February 13 Urban Barcode Project Open Lab, Brooklyn Technical High School, New York
February 14 Urban Barcode Project Open Lab, Harlem DNA Lab
February 16 National Biotechnology Education Conference, DNA Barcoding and DNA Subway Workshop, Santa Clara 
University, California
February 19 Site visit by Sir William and Renice Castell, Wellcome Trust Sanger Institute, Hinxton, Cambridge, England
February 21 Urban Barcode Project Open Lab, Harlem DNA Lab
February 23 Human Mitochondrial Sequencing Workshop, Center for Work Education, City University of New York, New York
February 26 Site visit by Jeanne Garbarino, The Rockefeller University, New York
March 2 NSF ATE Professional Development Genomic Approaches in Biosciences Follow-up Workshop, Austin 
Community College, Texas
March 2 Urban Barcode Project Open Lab, Harlem DNA Lab
March 4–12 Visiting Student Internship, Godfrey Okoye University, Enugu, Nigeria, DNALC
March 5 Urban Barcode Project Open Lab, Harlem DNA Lab
New Interns Departing for College
Joseph Babinski, Northeastern University, Chemical Engineering* Matt Angeliadis, University of Connecticut, Molecular and Cell Biology
Kayla Bianco, St. Anthony’s High School Katie Belissimo, College of New Jersey, Biology
Gabriella Blazich, Our Lady of Mercy High School
Kalliopi Chatzis, New York Institute of Technology, Doctor of 
Osteopathy*
Anne Bode, Notre Dame University, Biological Sciences
Brittany Coscio, St. Anthony’s High School Arielle Bryan, City College of New York, Biology
Paul Donat, SUNY Geneseo, Biochemistry*
Kenny Escobar,* Freeport High School* David Dopfel, Stony Brook University, Biomedical Engineering
Nella Hauser, Stony Brook University, Biology
Julie Hemphill, Penn State University, Neuroscience* Magdalene Economou, Georgetown University, Biology
Ashleigh Jackobel, Farmingdale State College, Biosciences
Jungseo (Joe) Kim, Locust Valley High School* Pauline McGlone, University of Delaware, Medical Diagnostics
Michaela Lee, Syosset High School Sophie Podhurst, Northeastern University, Chemical Engineering
William Manolarakis, Chaminade High School*
Jack Manzi, Kings Park High School Daliah Ross, New York University, Neuroscience
Anant Mehrotra, Oyster Bay High School
Giovanni Sanchez, Jericho High School* Robert Scott, Sage College of Albany, Clinical Biology
Shenika Shah, Fordham University, Natural Sciences*
Katherine Villalon, John Jay College of Criminal Justice, Forensics Sulaiman Usman, New York Institute of Technology, Life Sciences
Isabell Whiteley, *Boston University, Neuroscience Lina Marie Varghese, Stony Brook University, Biology
* Summer only. College students in italics.
2013 Workshops, Meetings, Collaborations, and Site Visits
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March 7 Urban Barcode Project Open Lab, Harlem DNA Lab
March 9 Saturday DNA! “Exploring Human Origins –What DNA Says About Our Ancestry,” DNALC
March 9 Saturday DNA! Third Grade Program, CSHL
March 9 Urban Barcode Project Open Lab, Trinity School, New York
March 9 Urban Barcode Project Open Lab, The Chapin School, New York
March 12 Urban Barcode Project Open Lab, Harlem DNA Lab
March 14 Urban Barcode Project Open Lab, Harlem DNA Lab
March 14–17 NSF iPlant Collaborative Tools & Services Workshop, Maize Genetics Conference, St. Charles, Illinois
March 19 Urban Barcode Project Open Lab, Harlem DNA Lab
March 21 Great Moments in DNA Science Honors Seminar, “Learning from Nature: Making Filters by Copying Nature’s 
Nuclear Pore Complex,” Jaclyn Novatt, CSHL, DNALC
March 21 Urban Barcode Project Open Lab, Harlem DNA Lab
March 21–22 Wellcome Trust Sanger Institute, DNA Barcoding and DNA Subway Workshop, Hinxton, Cambridge, England
March 23 New York Public Library Youth STEM Fair, “Fruit Flies” Presentation Booth, Schomburg Center for Research in 
Black Culture, New York
March 25–29 DNA Science Workshop, Harlem DNA Lab
March 29 Site visit by Dennis Walcott, New York City Department of Education, Harlem DNA Lab
April 4 Urban Barcode Project Open Lab, Harlem DNA Lab
April 6 North Carolina Academy of Science, University of North Carolina, “Engineering Society: The American Eugenics 
Movement” Seminar, Pembroke, North Carolina
April 6 North Carolina Academy of Science, University of North Carolina, “iPlant Collaborative Project” Seminar, 
Pembroke, North Carolina
April 6 Urban Barcode Project Open Lab, Harlem DNA Lab
April 8 National Association for Research in Science Teaching, “Bioinformatics Tools and Databases in the Biology 
Classroom” Seminar, Rio Grande, Puerto Rico
April 8–19 Visiting Student Internship, Godfrey Okoye University, Enugu, Nigeria, DNALC
April 9 Urban Barcode Project Open Lab, Harlem DNA Lab
April 10 Site visit by Noah Heller, Math for America, New York, Harlem DNA Lab
April 11 Urban Barcode Project Open Lab, Harlem DNA Lab
April 16 Site visit by Lydia Begley, Nassau County BOCES, Garden City, New York
April 16 Urban Barcode Project Open Lab, Harlem DNA Lab
April 18 Great Moments in DNA Science Honors Seminar, “The Curious Case of Developmental Biology, or Why Do 
Organisms Always Become What They Are Supposed to?” Aman Husbands, CSHL, DNALC
April 18 Urban Barcode Project Open Lab, Harlem DNA Lab
April 19 “DNA Extraction” Workshop, STEM Careers EXPO Fair for English Language Learners, Armory on the 
Hudson, New York
April 20 Saturday DNA! “Mendel, Mendel, How Does Your Garden Grow?” DNALC
April 20 Stony Brook Science and Arts EXPO, “Banana DNA Extraction,” Stony Brook University, Stony Brook, 
New York
April 23 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
April 24 Site visit by Keith W. Jones, Brookhaven National Laboratory, Upton, New York
April 25 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
April 25 “DNA Detectives” Course, Lehman College, New York
April 26 Urban Barcode Project Open Lab, Harlem DNA Lab
April 27 NSF ATE Genomic Approaches in BioSciences Follow-up Workshop, Bluegrass Community and Technical College, 
Lexington, Kentucky
April 27 NSF ATE, Genomic Approaches in BioSciences Follow-up Workshop, Southern Maine Community College, South 
Portland
April 30 Great Moments in DNA Science Honors Seminar, “Learning to Smell Each Other?,” Dennis Eckmeier, CSHL, 
DNALC
April 30 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
April 30 DNA Detectives Course, Lehman College, New York
May 3 Urban Barcode Project Open Lab, Harlem DNA Lab
May 6 Site visit by Sherry Zhang, Medical College of Wisconsin, Milwaukee, Wisconsin
May 9 Site visit by Tatiana Nikolenko, Rusnano, Moscow, Russia
May 10 Site visit by Theodore Muth, Brooklyn College, New York
May 11 Saturday DNA! “DNA: Innocent or Guilty?,” DNALC
May 13 Site visit by Marino Golinelli, Life Learning Center and Fondazione Marino Golinelli, Bologna, Italy
May 13–14 Site visit by Delegation from University of Notre Dame, Indiana
May 13–17 NSF ATE Genomic Approaches in BioSciences Workshop, Tulsa Community College, Oklahoma
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May 16 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
May 16 “DNA Detectives” Course, Lehman College, New York
May 21 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
May 21 DNA Detectives Course, Lehman College, New York
May 23 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
May 23 DNA Detectives Course, Lehman College, New York
May 28 Pinkerton DNA Barcoding Course, American Museum of Natural History, New York
May 28 DNA Detectives Course, Lehman College, New York
May 29 Urban Barcode Project Poster Session, American Museum of Natural History, New York
May 30 Site visit by Alan Siegel, Thompson Family Foundation, Dallas, Texas
May 30 DNA Detectives Course, Lehman College, New York
June 2–3 World Science Festival Presentation, “Pocket Service: Gene Screen and 3-D Brain,” New York
June 4 Bio-Link Summer Fellows Forum, University of California, Berkeley, “DNA Barcoding in the Classroom”
June 4 Site visit by Dr. Christian Anieke, Dr. Christian Okeke, Dr. Obiora Ike, Godfrey Okoye University, Enugu, 
Nigeria
June 4 “DNA Detectives” Course, Lehman College, New York
June 5 Urban Barcode Project Final Symposium and Awards Ceremony, American Museum of Natural History, 
New York
June 6 “DNA Detectives” Course, Lehman College, New York
June 8 Saturday DNA! “The Mystery of Anastasia,” DNALC
June 10 Site visit by David Heller, Allan Morrison, Phil Ferralli, and Beth Paine, Carolina Biological Supply Company, 
Burlington, North Carolina
June 10–14 Fun with DNA Workshop, Convent of the Sacred Heart, Greenwich, Connecticut
Forensics Workshop, Convent of the Sacred Heart, Greenwich, Connecticut
June 11 Site visit by Allan Dobrin, Gillian Small, Iris Weinshall, and Alexandra Logue, City University of New York, 
New York
June 11 20th Annual Golf Outing, Piping Rock Club, Locust Valley, New York
June 17–21 Fun with DNA Workshop, Roxbury Latin School, Boston, Massachusetts
June 17–21 NSF ATE Genomic Approaches in Biosciences Supplemental Workshop, Madison Area Technical College, 
Wisconsin
June 19–25 Fun with DNA Workshop, The Chapin School, New York
June 21 Site visit by Harriett Copel, Long Island Matrix of Science and Technology, Upton, New York; Ken White, 
Brookhaven National Laboratory, Upton, New York; Tom Rogers and Lydia Begley, Nassau BOCES; and Scott 
and Leena Doshi, Doshi Family Foundation
June 24–28 World of Enzymes Workshop, Roxbury Latin School, Boston, Massachusetts
June 24–28 Pinkerton Conservation Genetics Workshop, Harlem DNA Lab
June 24–28 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC
Fun with DNA Workshop, DNA Learning Center West
June 26–July 2 World of Enzymes Workshop, The Chapin School, New York
July 1–5 DNA Barcoding Research Workshop, DNALC
Forensic Detectives Workshop, DNALC
World of Enzymes Workshop, DNALC
World of Enzymes Workshop, DNA Learning Center West
July 8–12 NSF ATE Genomic Approaches in BioSciences Workshop, City College of San Francisco, California
July 8–12 Forensics Workshop, Roxbury Latin School, Boston, Massachusetts
July 8–12 Forensics Workshop, The Chapin School, New York
July 8–12 DNA Barcoding Research Workshop, DNALC
DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNA Learning Center West
July 9 Advanced Placement Biology Institute, Rice University, “Human Evolution and Population Genetics” Workshop, 
Houston, Texas
July 15–19 BioCoding Workshop, DNALC
Fun with DNA Workshop, DNALC
Silencing Genomes Workshop, DNALC
World of Enzymes Workshop, DNALC
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July 16 Advanced Placement Biology Institute, “Human Evolution and Population Genetics” Workshop, West Lake High 
School, Denver, Colorado
Green Genes Workshop, DNA Learning Center West
July 20–24 American Association of Plant Biologists, Plant Biology 2013, “iPlant Collaborative: A Unifi ed 
Cyberinfrastructure for a Unifi ed Research Paradigm” Seminar, Providence, Rhode Island
July 22–26 Pinkerton DNA Barcoding Workshop, Harlem DNA Lab
July 22–26 DNA Barcoding Workshop, The Rockefeller University, New York
July 22–26 DNA Science Workshop, DNALC
Forensic Detectives Workshop, DNALC
Green Genes Workshop, DNALC
Fun with DNA Workshop, DNA Learning Center West
Fun with DNA Workshop, New World Preparatory School, Staten Island, New York
July 28 Botanical Society of America, Botany 2013, Genomics in Education Workshop and NSF iPlant Collaborative 
Tools & Services Workshop, New Orleans, Louisiana
July 29–Aug. 2 Barcoding Workshop, DNALC
Backyard Barcoding Workshop, DNALC
Fun with DNA Workshop, DNALC
World of Enzymes, DNALC
DNA Science Workshop, DNA Learning Center West
August 5–9 Pinkerton Conservation Genetics and DNA Barcoding Workshop, Harlem DNA Lab
August 5–9 DNA Science Workshop, DNALC
Forensic Detectives Workshop, DNALC
Fun with DNA Workshop, DNALC
DNA Science Workshop, Stony Brook University, Stony Brook, New York
August 5–9 NSF ATE Genomic Approaches in BioSciences Workshop, Minneapolis Community and Technical College, 
Minnesota
August 12–16 Backyard Barcoding Workshop, DNALC
DNA Science Workshop, DNALC
World of Enzymes Workshop, DNALC
Genome Science Workshop, DNA Learning Center West
DNA Science Workshop, Harlem DNA Lab
Fun with DNA Workshop, Brookhaven National Laboratory, Upton, New York
August 12–16 NSF ATE Genomic Approaches in Biosciences Workshop, Seminole State College, Sanford, Florida
August 16 Pinkerton Urban Barcode Project Grant Writing Workshop, Harlem DNA Lab
August 19–23 Fun with DNA Workshop, DNALC
Genome Science Workshop, DNALC
Green Genes Workshop, DNALC
Silencing Genomes Workshop, DNALC
World of Enzymes Workshop, DNA Learning Center West
World of Enzymes Workshop, Brookhaven National Laboratory, Upton, New York
August 19–23 NSF ATE Genomic Approaches in Biosciences Workshop, Nassau Community College, Garden City, New York
August 26–30 Backyard Barcoding Workshop, DNALC
DNA Science Workshop, DNALC
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC
Forensic Detectives Workshop, DNA Learning Center West
August 26 Pinkerton Urban Barcode Project Grant Writing Workshop, Harlem DNA Lab
August 27 National University of Malaysia Delegation, “DNA Barcoding: DNA Isolation and PCR” Workshop, DNALC
August 30 National University of Malaysia Delegation, “DNA Barcoding and Bioinformatics” Workshop, New York 
Academy of Sciences, New York
Sept. 17–20 NSF iPlant Collaborative Professional Development Tools and Services Workshop, “Data Mining with iPlant,” 
University of Warwick, Coventry, England
September 18 FarGen Summit, “Human DNA Polymorphisms” Workshop, Torshavn, Faroe Islands, Denmark
September 20 FarGen Summit, “Coming Into the Genome Age: The FarGen Exploration,” Torshavn, Faroe Islands, Denmark
Sept. 23–24 NSF iPlant Collaborative Tools & Services Workshop, Texas A&M University, College Station
Sept. 26–27 NSF iPlant Collaborative Genomics in Education Workshop, Prairie View Texas A&M University
October 1 FarGen Summit “Human DNA Polymorphisms” Follow-up Webinar, DNALC
October 3 NSF iPlant Collaborative Tools & Services Workshop, New York Botanical Garden, Bronx, New York
October 3–4 Site visit by Stanley Xu and Lin Xu, Taurus Education, Shanghai, China
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October 11 NSF iPlant Collaborative Webinar co-taught with Carol Lushbough from University of South Dakota, 
“RNA-Seq & BioExtract,” DNALC
Oct. 16–18 NSF iPlant Collaborative “Reconnecting with iPlant” Webinar Series, DNALC
October 19 Saturday DNA! “Glowing Genes,” DNALC
October 19 Ant Collection Workshop, Pleasantville Community Garden, East Harlem, New York
October 21 Site visit by Bruno Strasser, University of Geneva, Switzerland
October 22 Site visit by Vicky Han, China Service Center for Educational Exchange, Beijing, China
Oct. 23–25 NSF iPlant Collaborative ,”Introduction to iPlant” Webinar Series DNALC
Oct. 28–29 NSF iPlant Collaborative Professional Development Tools & Services Workshop, Colorado State University, Fort 
Collins
Oct. 28–30 NSF iPlant Collaborative “DNA Barcoding for Educators” Webinar Series, DNALC
October 29 Site visit by Sean B. Carroll, Howard Hughes Medical Institute, Chevy Chase, Maryland
November 2 Urban Barcode Project Teacher Training, Harlem DNA Lab
November 4–5 Site visit by Brent Buckner, Truman State University, Kirksville, Missouri
November 8 Site visit by Regeneron Pharmaceuticals, Tarrytown, New York and Laura Woznitski, BioMed Realty, San Diego, 
California
November 9 Saturday DNA! “Botanical Barcoding,” DNALC
November 12 “What DNA Says About Our Human Family” Seminar, Beijing No. 166 High School, China
November 12–14 “Human DNA Polymorphisms, Evolution, and Population Genetics” Workshop, Beijing No. 166 High School, 
China
November 20–23 National Association of Biology Teachers 2013 Professional Development Conference: “Detecting Epigenetic 
DNA Methylation in Arabidopsis thaliana,” “What’s in My Sushi? Unlocking the Power of DNA Barcoding,” 
“DNA Subway: Cutting-edge Bioinformatics for the Classroom,” “Genome Science: Biology in the Post-Genome 
Age,” “DNA Barcoding: Independent Research in the Classroom,” Atlanta, Georgia
December 4 NSF iPlant Collaborative Tools and Services Workshop, Cold Spring Harbor Laboratory
December 4 NSF iPlant Collaborative Seminar, “A Unifi ed Cyberinfrastructure for Plant Science,” Cold Spring Harbor 
Laboratory
December 7 Saturday DNA! “Dust Away Crime: The Truth about Fingerprints,” DNALC
December 18 Site visit by Noah Fuller, New York University, New York
Sites of Major Faculty Workshops
Program Key: Middle School High School College
State Institution Year
ALABAMA University of Alabama, Tuscaloosa 1987–1990
ALASKA University of Alaska, Anchorage 2012
University of Alaska, Fairbanks 1996
ARIZONA Arizona State University, Tempe 2009
Tuba City High School 1988
University of Arizona, Tucson 2011
United States Department of Agriculture, Maricopa 2012
ARKANSAS Henderson State University, Arkadelphia 1992
University of Arkansas, Little Rock 2012
CALIFORNIA California State University, Dominguez Hills 2009
California State University, Fullerton 2000
California Institute of Technology, Pasadena 2007
Canada College, Redwood City 1997
City College of San Francisco 2006
City College of San Francisco 2011, 2013
Contra Costa County Offi ce of Education, Pleasant Hill 2002, 2009
Foothill College, Los Altos Hills 1997
Harbor-UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute (LA Biomed), Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Oxnard Community College, Oxnard 2009
Pasadena City College 2010
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Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001, 2008
San Francisco State University 1991
San Diego State University 2012
San Jose State University 2005
Santa Clara University 2010
Stanford University, Palo Alto 2012
University of California, Berkeley 2010, 2012
University of California, Davis 1986
University of California, Davis 2012
University of California, Northridge 1993
University of California, Riverside 2011
University of California, Riverside 2012
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994, 2007
Colorado State University, Fort Collins 2013
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998, 2009–2010
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University, Washington 1992, 1996, 2009–2010
FLORIDA Armwood Senior High School, Tampa 1991
Florida Agricultural & Mechanical University, Tallahassee 2007–2008
Florida Agricultural & Mechanical University, Tallahassee 2011
North Miami Beach Senior High School 1991
Seminole State College, Sanford 2013
University of Miami School of Medicine 2000
University of Western Florida, Pensacola 1991
GEORGIA Fernbank Science Center, Atlanta 1989, 2007
Gwinnett Technical College, Lawrenceville 2011, 2012
Morehouse College, Atlanta 1991, 1996–1997
Spelman College, Atlanta 2010
HAWAII Kamehameha Secondary School, Honolulu 1990
University of Hawaii at Manoa 2012
ILLINOIS Argonne National Laboratory 1986–1987
iBIO Institute/Harold Washington College, Chicago 2010
Illinois Institute of Technology, Chicago 2009
University of Chicago 1992, 1997, 2010
INDIANA Butler University, Indianapolis 1987
Purdue University, West Lafayette 2012
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Bluegrass Community & Technical College, Lexington 2012–2013
Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Bossier Parish Community College 2009
Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
Southern University at New Orleans 2012
MAINE Bates College, Lewiston 1995
Southern Maine Community College 2012–2013
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Bowie State University 2011
Frederick Cancer Research Center 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990–1992
National Center for Biotechnology Information, Bethesda 2002
St. John’s College, Annapolis 1991
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University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Arnold Arboretum of Harvard University, Roslindale 2011
Beverly High School 1986
Biogen Idec, Cambridge 2002, 2010
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
The Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
Schoolcraft College, Livonia 2012
MINNESOTA Minneapolis Community and Technical College, Madison 2009
Minneapolis Community and Technical College, Madison 2013
University of Minnesota, St. Paul 2005
University of Minnesota, St. Paul 2010
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990–1991
Rust College, Holly Springs 2006–2008, 2010
MISSOURI St. Louis Science Center 2008–2010
Stowers Institute for Medical Research, Kansas City 2002, 2008
University of Missouri, Columbia 2012
Washington University, St. Louis 1989, 1997, 2011
MONTANA Montana State University, Bozeman 2012
NEVADA University of Nevada, Reno 1992
NEW HAMPSHIRE Great Bay Community College, Portsmouth 2009
New Hampshire Community Technical College, Portsmouth 1999
St. Paul’s School, Concord 1986–1987
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
Raritan Valley Community College, Somerville 2009
NEW MEXICO Biolink Southwest Regional Meeting, Albuquerque 2008
NEW YORK Albany High School 1987
American Museum of Natural History, New York 2007
Bronx High School of Science 1987
Canisius College, Buffalo 2007
Canisius College, Buffalo 2011
City College of New York 2012
Cold Spring Harbor High School 1985, 1987
Columbia University, New York 1993
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
Dolan DNA Learning Center 1988–1995, 2001–2004, 2006–2009
Dolan DNA Learning Center 1990, 1992, 1995, 2000–2011
Dolan DNA Learning Center 1990–1992
DNA Learning Center West 2005
Fostertown School, Newburgh 1991
Harlem DNA Lab, East Harlem 2008–2009, 2011–2013
Huntington High School 1986
Irvington High School 1986
John Jay College of Criminal Justice 2009
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mount Sinai School of Medicine, New York 1997
Nassau Community College, Garden City 2013
New York Botanical Garden, Bronx 2013
New York City Department of Education 2007, 2012
New York Institute of Technology, New York 2006
New York Institute of Technology, New York 2006
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
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State University of New York, Stony Brook 1987–1990
Stuyvesant High School, New York 1998–1999
The Rockefeller University, New York 2003
The Rockefeller University, New York 2010
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Saranac Lake 2001
Union College, Schenectady 2004
United States Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Center for Health Research, Triangle Park 2003
North Carolina Agricultural & Technical State University, 
Greensboro
2006–2007, 2009–2011
North Carolina School of Science, Durham 1987
North Carolina State University, Raleigh 2012
NORTH DAKOTA North Dakota State University, Fargo 2012
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
Langston University, Langston 2008
North Westerville High School 1990
OKLAHOMA Oklahoma City Community College 2000
Oklahoma City Community College 2006–2007, 2010
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
Tulsa Community College, Tulsa 2009
Tulsa Community College, Tulsa 2012–2013
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
Kimmel Cancer Center, Philadelphia 2008
RHODE ISLAND Botanical Society of America, Providence 2010
SOUTH CAROLINA Clemson University 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TENNESSEE NABT Professional Development Conference, Memphis 2008
TEXAS Austin Community College–Rio Grande Campus 2000
Austin Community College–Eastview Campus–Roundrock 
Campus
2007–2009, 2013
Austin Community College–Roundrock Campus 2012
Houston Community College Northwest 2009–2010
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
University of Lone Star College, Kingwood 2011
Midland College 2008
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Texas A&M University, College Station, TX 2013
Texas A&M University, Prairie View, TX 2013
Texas A&M, AG Research and Extension Center, Weslaco 2007
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004, 2010, 2012
University of Texas, Brownsville 2010
UTAH Brigham Young University, Provo 2012
University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
Utah Valley State College, Orem 2007
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
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Virginia Polytechnic Institute and State University, Blacksburg 2005, 2008–2009
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001, 2008
Shoreline Community College 2011, 2012
University of Washington, Seattle 1993, 1998, 2010
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999, 2009, 2011–2013
Marquette University, Milwaukee 1986–1987
University of Wisconsin, Madison 1988–1989
University of Wisconsin, Madison 2004, 2012
WYOMING University of Wyoming, Laramie 1991
PUERTO RICO Universidad del Turabo, Gurabo, Puerto Rico 2011, 2012
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
AFRICA Godfrye Okoye University, Enugu, Nigeria 2013
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
AUSTRIA Vienna Open Lab, Vienna 2007, 2012
CANADA Red River Community College, Winnipeg, Manitoba 1989
CHINA Beijing No. 166 High School, Beijing 2013
Ho Yu College, Hong Kong 2009
DENMARK Faroe Genome Project, Torshavn, Faroe Islands 2013
GERMANY Urania Science Center, Berlin 2008
ITALY International Institute of Genetics and Biophysics, Naples 1996
Porto Conte Research and Training Laboratories, Alghero 1993
MEXICO ASPB Plant Biology, Merida 2008
PANAMA University of Panama, Panama City 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001–2005
Singapore Science Center 2013
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University 2000
THE NETHERLANDS International Chromosome Conference, Amsterdam 2007
UNITED KINGDOM Wellcome Trust Conference Center, Hinxton 2012–2013
University of Warwick, Coventry 2013
487-516_DNALCe.indd   515 19-08-2014   08:09:59
487-516_DNALCe.indd   516 19-08-2014   08:09:59
COLD SPRING HARBOR 
LABORATORY PRESS
   
 
517-520_Press.indb   517 01-09-2014   09:02:41
518
2013 PRESS PUBLICATIONS
Serials
Genes & Development, Vol. 27 (www.genesdev.org)
Genome Research, Vol. 23 (www.genome.org)
Learning & Memory, Vol. 20 (www.learnmem.org)
RNA, Vol. 19 (www.rnajournal.org)
Cold Spring Harbor Symposia in Quantitative Biology, Vol. 77:
The Biology of Plants, edited by Terri Grodzicker, 
Robert Martienssen, David Stewart, and Bruce Stillman
Cold Spring Harbor Protocols (www.cshprotocols.org)
Cold Spring Harbor Perspectives in Biology (www.cshperspectives.org)
Cold Spring Harbor Perspectives in Medicine
(www.perspectivesinmedicine.org)
Laboratory Manuals
Antibodies: A Laboratory Manual, Second Edition, edited by 
Edward A. Greenfi eld
Purifying and Culturing Neural Cells: A Laboratory Manual, 
edited by Ben A. Barres and Beth Stevens
Manipulating the Mouse Embryo: A Laboratory Manual, 
Fourth Edition, by Richard Behringer, Marina Gertsenstein, 
Kristina Vintersten Nagy, and Andras Nagy
Calcium Techniques: A Laboratory Manual, edited by Jan B. Parys, 
Martin D. Bootman, David I. Yule, and Geert Bultynck
Mouse Models of Cancer: A Laboratory Manual, edited by 
Cory Abate-Shen, Katerina Politi, Lewis A. Chodosh, and 
Kenneth P. Olive
Textbooks
Introduction to Protein–DNA Interactions: Structure, 
Thermodynamics, and Bioinformatics, by Gary D. Stormo
Molecular Biology of the Gene, Seventh Edition, by James 
D. Watson, Tania A. Baker, Stephen P. Bell, Alexander 
Gann, Michael Levine, and Richard Losick
Mammalian Development: Networks, Switches, and Morphogenetic 
Processes, edited by Patrick P.L. Tam and W. James Nelson
Monographs (Topic Collections from 
Perspectives in Biology and Perspectives 
in Medicine)
The Endoplasmic Reticulum, edited by Susan Ferro-Novick, 
Tom A. Rapoport, and Randy Schekman
DNA Replication, edited by Stephen D. Bell, Marcel Méchali, 
and Melvin L. DePamphilis
Immune Tolerance, edited by Diane J. Mathis and Alexander 
Y. Rudensky
Cystic Fibrosis: A Trilogy of Biochemistry, Physiology, and Therapy, 
edited by John R. Riordan, Richard C. Boucher, and Paul 
M. Quinton
Hemoglobin and Its Diseases, edited by David J. Weatherall, 
Alan N. Schechter, and David G. Nathan
Cell Survival and Cell Death, edited by Eric H. Baehrecke, 
Douglas R. Green, Sally Kornbluth, and Guy S. Salvesen
DNA Repair, Mutagenesis, and Other Responses to DNA Damage, 
edited by Errol C. Friedberg, Stephen J. Elledge, Alan 
R. Lehmann, Tomas Lindahl, and Marco Muzi-Falconi
Mitochondria, edited by Douglas C. Wallace and Richard J. Youle
Signaling by Receptor Tyrosine Kinases, edited by Joseph 
Schlessinger and Mark A. Lemmon
Transplantation, edited by Laurence A. Turka and Katheryn 
J. Wood
Bacterial Pathogenesis, edited by Pascale Cossart and Stanley Maloy
History
The Dawn of Human Genetics, by V.V. Babkov, edited by James 
Schwartz, translated from the Russian by Victor Fet
The Eighth Day of Creation: The Makers of the Revolution in Biology, 
Commemorative Edition, by Horace Freeland Judson
Blue Skies and Bench Space: Adventures in Cancer Research, by 
Kathleen Weston
Other
Lab Math: A Handbook of Measurements, Calculations, and 
Other Quantitative Skills for Use at the Bench, Second Edition, 
by Dany Adams Spencer
CSHL Annual Report 2012, Yearbook Edition
Banbury Center Annual Report 2012
E-books (Kindle editions)
Next-Generation DNA Sequencing Informatics, by Stuart M. Brown
The Eighth Day of Creation: The Makers of the Revolution in Biology, 
Commemorative Edition, by Horace Freeland Judson
Websites
Cold Spring Harbor Monographs Archive Online 
(www.cshmonographs.org)
Cold Spring Harbor Symposium on Quantitative Biology 
Archive (symposium.cshlp.org)
Blues Skies and Bench Space, author’s blog and free download
of the book in PDF format (www.blueskiesbenchspace.org)
Next-Generation DNA Sequencing, resources 
(www.seqinformatics.com)
Services
bioRxiv, the preprint server for biology (www.bioRxiv.org)
BioSupplyNet, scientifi c supply directory (www.biosupplynet.com)
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EXECUTIVE DIRECTOR’S REPORT
Scientists around the world hold the publications of Cold Spring Harbor Laboratory Press in high 
esteem. From its modest beginnings in 1933 with a single volume, the Press has established a pro-
gram consisting of seven journals, 190 books, and online services for research preprints and labo-
ratory products. During the last two decades of extraordinary change in media technologies and 
business models, the Press has continually adapted and become now a fully digital publisher with 
expertise and agility in developing and delivering a variety of publication types. Recent changes 
in Press staffi ng, skills, and organizational structure have enabled this transformation and created 
a foundation for continued growth.
Financially, the past year was one of signifi cant challenges for all publishers, including those 
focused on molecular and cellular biology. In the United States and Europe, budgetary restrictions 
continued to squeeze research departments and the academic libraries that are the most important 
purchasers of scientifi c information. The Press weathered these diffi culties by maintaining the fi rst-
class editorial standards that are its hallmark while fi nding fresh ways of promoting its publications 
to scientists and their institutions worldwide. Aided by the success of three recently launched review 
journals, and the growth of subscriptions in emerging scientifi c communities abroad, the Press was 
able once again to make a signifi cant contribution to the Laboratory’s economy.
Widely cited impact-factor measurements rank two Press journals, Genes & Development and 
Genome Research, in the top three of the world’s genetics journals and in the top 1% overall of 
the 8000 journals in the Science Citation Index. Online usage of these and all the other Press 
journals continues to climb, exceeding 12 million full-text article downloads in 2013, an in-
crease of 25% year-on-year. Cold Spring Harbor Protocols and Learning & Memory continued to 
gain subscriptions and usage. Cold Spring Harbor Perspectives in Biology saw particularly sharp 
growth—a vote of approval for its novel publishing model that integrates journal and book 
publishing. A testament to editorial quality was the award of Nobel Prizes in 2013 to three of 
the scientists who edited recent Perspectives subject collections (Tom Südhof, Randy Schekman, 
and Jim Rothman).
The Press published 24 new book titles in 2013. Several were revised editions of past best sellers 
including Antibodies: A Laboratory Manual and Lab Math: A Handbook of Measurements, Calcula-
tions, and Other Quantitative Skills for Use at the Bench. Eleven books were derived from the two 
online Perspectives review journals.
In November, bioRxiv, a new preprint service for the life sciences, was launched to enable 
distribution of scientifi c manuscripts not yet published in peer-reviewed journals. This service en-
ables scientists to rapidly share the results of their work and to benefi t from the critique of readers 
as manuscripts are honed for publication in a peer-reviewed journal. bioRxiv is the latest example 
of innovation at the Press in its long history of assisting biomedical research and offers another 
new platform on which to build the next generation of valuable services for scientists.
Staff
During the year, we said farewell to Robert Majovski and marked with sadness the retirement 
of three staff members who had given invaluable service to the Laboratory in many different ca-
pacities: Elizabeth Powers after 19 years, Susan Schaefer after 31 years, and Judy Cuddihy after 
35 years. We also welcomed Laura DeMare to the editorial staff of Genome Research, Jacqueline 
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Beggins to Production, and Robert Redmond to Marketing and Sales. A full list of Press staff 
members as of December 31, 2013, is listed elsewhere in this volume.
As an educational division of the Laboratory, the mission of the Press is to create publications 
and services that help scientists succeed. To fulfi ll the mission, we are able to call on many of 
the world’s most accomplished scientists, who respect the Laboratory’s uniqueness and drive for 
excellence in all of its activities. But ultimately, our program relies on the talents of our publish-
ing team. We are fortunate to have skilled and dedicated individuals in all the operations of the 
Press. I am particularly grateful to those who have leadership roles in our ever more diverse activi-
ties: Jan Argentine, Terri Grodzicker, Wayne Manos, Stephen Nussbaum, Richard Sever, Marcie 
Siconolfi , Hillary Sussman, Linda Sussman, and Denise Weiss. And also to my perpetually patient 
and cheerful Executive Assistant, Mala Shwe Mazzullo, who does so much to oil the wheels of the 
organization.
John Inglis
Executive Director 
and Publisher
Press Executive Director John Inglis (fourth from right) during a visit with delegates of China’s National 
Library of Science and Technology, Beijing
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 2013 2012
Assets:
 Cash and cash equivalents $  65,258,594 75,471,404
 Grants receivable 8,506,168 10,012,401
 Contributions receivable, net 110,387,860 145,289,626
 Publications inventory 2,187,157 2,767,427
 Investments 384,070,487 296,611,329
 Restricted use assets 4,504,767 3,597,846
 Other assets 16,226,007 15,891,942
 Land, buildings, and equipment, net  231,988,575 240,625,332
Total assets $   823,129,615 790,267,307
Liabilities and net assets:
 Liabilities:
 Accounts payable and accrued expenses $   10,437,314 10,456,412
 Deferred revenue 5,209,891 5,258,525
 Interest rate swap 18,613,481 35,556,347
 Bonds payable   97,200,000   97,200,000
    Total liabilities  131,460,686 148,471,284
 Net assets:
 Unrestricted 294,223,173 243,281,390
 Temporarily restricted 290,273,304 293,464,158
 Permanently restricted   107,172,452  105,050,475
    Total net assets  691,668,929 641,796,023
Total liabilities and net assets $    823,129,615 790,267,307
FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET 
December 31, 2013
(with comparative ﬁ nancial information as of December 31, 2012)
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  Temporarily Permanently 2013 2012
 Unrestricted Restricted Restricted Total Total
Revenue and other support:
Public support - contributions and 
 nonfederal grant awards $ 19,110,366 23,863,425 2,121,977 45,095,768 60,846,197)
Federal grant awards 26,766,266 –-  ---- –  ---- 26,766,266 28,711,510)
Indirect cost allowances 23,228,697 –   ---- –  ---- 23,228,697 24,445,726)
Investment return utilized 14,837,880 –   ---- –  ---- 14,837,880 23,396,825)
Program fees 7,752,249 –   ---- –  ---- 7,752,249 8,049,856)
Publications sales 10,174,394 –   ---- –  ---- 10,174,394 10,957,863)
Dining services 4,715,566 –   ---- –  ---- 4,715,566 4,614,691)
Rooms and apartments 3,859,785 –   ---- –  ---- 3,859,785 3,770,473)
Miscellaneous 2,579,049 –   ---- –  ---- 2,579,049 2,527,870)
Net assets released from restrictions   50,653,554   (50,653,554)           –  ----               –----                 –----
Total revenue and other support 163,677,806  (26,790,129)     2,121,977   139,009,654   167,321,011)
Expenses:
Research 85,776,617 –   ---- –  ---- 85,776,617 88,821,283)
Educational programs 17,388,667 –   ---- –  ---- 17,388,667 17,815,388)
Publications 9,412,728 –   ---- –  ---- 9,412,728 10,092,372)
Banbury Center conferences 1,571,105 –   ---- –  ---- 1,571,105 1,389,048)
DNA Learning Center programs 1,623,885 –   ---- –  ---- 1,623,885 1,578,211)
Watson School of Biological Sciences 
 programs 3,370,964 –   ---- –  ---- 3,370,964 3,356,033)
General and administrative 18,110,232 –   ---- –  ---- 18,110,232 16,860,891)
Dining services      5,591,701             –   ----            –  ----       5,591,701       5,642,788)
Total expenses 142,845,899             –   ----            –  ----   142,845,899    145,556,014)
Excess (defi ciency) of revenue and other 
support over (under) expenses 20,831,907 (26,790,129) 2,121,977 (3,836,245) 21,764,997)
Other changes in net assets:
Investment return excluding 
amount utilized 13,167,010 23,599,275 –  ---- 36,766,285 9,639,048
Change in fair value of interest 
rate swap   16,942,866            –   ----            –  ----    16,942,866      2,170,350)
Increase (decrease) in net assets 50,941,783 (3,190,854) 2,121,977 49,872,906 33,574,395)
Net assets at beginning of year 243,281,390   293,464,158  105,050,475   641,796,023   608,221,628)
Net assets at end of year $ 294,223,173   290,273,304   107,172,452   691,668,929   641,796,023)
CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2013
(with summarized ﬁ nancial information for the year ended December 31, 2012)
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   2013 2012
Cash fl ows from operating activities:
Increase in net assets  $    49,872,906 33,574,395
Adjustments to reconcile increase in net assets 
 to net cash provided by (used in) operating activities:
Change in fair value of interest rate swap  (16,942,866) (2,170,350)
Depreciation and amortization  14,816,411 15,422,891
Net appreciation in fair value of investments  (47,898,692) (29,325,772)
Contributions restricted for long-term investment  (5,308,027) (10,527,878)
Changes in assets and liabilities:
Grants receivable  1,506,233 (4,279,297)
Contributions receivable, net of fi nancing activities  16,062,486 25,176,987
Publications inventory  580,270 525,471
Other assets  (283,358) (912,934)
Restricted use assets  (906,921) (715,256)
Accounts payable and accrued expenses, net of fi nancing activities  268,487 (139,990)
Deferred revenue           (48,634)      (209,041)
Net cash provided by operating activities     11,718,295 )  26,419,226 )
Cash fl ows from investing activities:
Capital expenditures  (6,179,654) (14,219,427)
Proceeds from sales and maturities of investments  119,019,919 72,539,685
Purchases of investments  (158,580,385) (70,038,915)
Net change in investment in employee residences           (50,707)         48,779 
Net cash used in investing activities    (45,790,827) (11,669,878)
Cash fl ows from fi nancing activities:
Contributions restricted for long-term investment  2,121,977 1,147,593
Contributions restricted for investment in capital  3,186,050 9,380,285
Decrease (increase) in contributions receivable  18,839,280 (7,321,968)
Decrease in accounts payable relating 
 to capital expenditures          (287,585)       (539,182)
Net cash provided by fi nancing activities     23,859,722 )    2,666,728 
Net (decrease) increase in cash and cash equivalents  (10,212,810) 17,416,076
Cash and cash equivalents at beginning of year      75,471,404 )  58,055,329 
Cash and cash equivalents at end of year  $    65,258,594 )   75,471,404 
Supplemental disclosure:
  Interest paid   $       4,016,854 )    3,683,436 
Noncash investing and fi nancing activity:
  Contributed property  $           641,995 )         50,000 
CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2013
(with comparative ﬁ nancial information for the year ended December 31, 2012)
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Grantor Program/Principal Investigator Duration of Grant 2013 Funding1
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Project and Center Support Drs. Hannon/Krainer/Spector/Stillman 05/25/12 12/31/16 $4,101,060.00
Dr. Stillman-Cancer Center Core 08/17/11 07/31/16 4,077,038.00
Cooperative Research Agreement Support 2 Dr. Gingeras 09/21/12 07/31/16 1,884,527.00
Drs. Lowe/Hannon/Hicks/Powers 09/01/09 08/31/14 523,424.00
Drs. Powers/Hannon/Krasnitz/Sordella 05/01/12 04/30/17 971,815.00
Research Support Dr. Albeanu 07/01/13 06/30/18 472,500.00 *
Dr. Churchland 03/01/13 02/28/18 428,000.00 *
Dr. Dubnau 09/15/09 08/31/14 453,742.00
Drs. Enikolopov/Koulakov 09/15/11 05/31/16 379,277.00
Dr. Furukawa 03/01/10 02/28/15 449,064.00
Dr. Hannon 09/01/13 08/31/18 406,350.00 *
Dr. Hannon 04/01/13 03/31/15 243,206.00 *
Dr. Huang 07/01/11 03/31/16 542,447.00
Dr. Huang 07/01/13 06/30/18 866,231.00 *
Drs. Kepecs/Huang 07/01/11 05/31/16 398,968.00
Drs. Koulakov/Enikolopov 07/15/10 02/28/14 342,047.00
Drs. Koulakov/Zador 07/01/13 03/31/18 425,250.00 *
Dr. Krainer 04/01/12 03/31/17 708,654.00
Dr. Krainer 09/01/12 08/31/14 273,578.00
Dr. Li 07/01/10 03/31/15 541,939.00
Dr. Martienssen 09/15/11 08/31/15 333,972.00
Dr. Martienssen 01/20/12 11/30/15 388,223.00
Dr. McCombie 07/23/10 02/28/15 344,653.00
Dr. McCombie 08/16/13 06/30/16 733,183.00 *
Dr. Mitra 09/30/09 03/31/14 813,515.00
Dr. Mitra 03/15/13 01/31/16 249,999.00 *
Dr. Muthuswamy 02/01/09 12/31/14 385,656.00
Dr. Osten 04/01/12 03/31/17 448,320.00
Dr. D. Spector 04/01/11 03/31/15 720,164.00
Dr. Stillman 06/01/12 05/31/16 676,199.00
Dr. Tonks 07/01/10 04/30/15 721,714.00
Dr. Tonks 01/11/10 12/31/14 423,922.00
Dr. Trotman 04/01/10 01/31/14 286,069.00
Dr. Turner 07/15/10 06/30/15 434,511.00
1Includes direct and indirect costs
2Cooperative research agreement funding amounts include only CSHL portion of award
*New or competing renewal grants awarded in 2013
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive 
a substantial portion of their funding through grants from the federal government and through 
grants, capital gifts, and annual contributions from New York State, private foundations, corpo-
rations, and individuals. The following section summarizes funding that occurred during 2013.
GRANTS January 1–December 31, 2013
COLD SPRING HARBOR LABORATORY
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Grantor Program/Principal Investigator Duration of Grant 2013 Funding1
Dr. Vakoc 04/01/13 03/31/18 $ 549,047.00 *
Dr. VanAelst 08/01/13 05/31/18 582,341.00 *
Dr. VanAelst 01/01/09 12/31/14 357,586.00
Dr. VanAelst 04/01/13 03/31/18 481,818.00 *
Dr. Zador 09/27/10 05/31/15 453,742.00
Dr. Zador 09/01/12 08/31/17 381,544.00
Dr. Zador 04/01/13 03/31/15 236,250.00 *
Research Subcontracts
NIH/Certerra, Inc. Consortium 
Agreement
Dr. Koulakov 01/03/13 12/31/13 84,867.00 *
NIH/Cornell University Consortium 
Agreement
Dr. Enikolopov 03/01/13 02/29/16 354,936.00 *
NIH/Georgia Institute of Technology 
Consortium Agreement
Dr. D. Spector 09/30/06 07/31/15 200,000.00
NIH/Johns Hopkins Consortium 
Agreement
Dr. Schatz 09/21/11 08/31/14 98,986.00
NIH/Scripps Research Institute 
Consortium Agreement
Dr. Osten 09/30/12 08/31/17 73,332.00
NIH/Sloan-Kettering Institute for 
Cancer Research Consortium 
Agreement
Dr. Sordella 09/12/12 08/31/17 293,452.00
NIH/University of California–A San 
Francisco Consortium Agreement
Dr. Egeblad 09/01/09 08/31/14 297,562.00
NIH/University of Minnesota 
Consortium Agreement
Dr. Tuveson 07/01/12 06/30/15 190,418.00
07/01/10 06/30/14 100,313.00
NIH/University of Texas Consortium 
Agreement
Dr. Furukawa 09/30/11 05/31/15 18,700.00
Fellowship/Career Development Support Dr. Anczukow 09/01/13 08/31/15 107,088.00 *
Dr. Jansen 01/01/11 10/15/13 12,276.96
S. Kelly 07/16/13 07/15/16 26,232.00 *
J. Tucciarone 09/17/12 09/16/15 26,232.00
Institutional Training Program Support Dr. Gann/Watson School 
of Biological Sciences
07/01/12 06/30/17 267,927.00
Dr. Mills 09/01/11 08/31/16 185,045.00
Course Support Advanced Immunocytochemistry: In Situ 
Hybridization and Live-Cell Imaging
09/01/10 08/31/15 88,154.00
Advanced Sequencing Technologies 
and Applications
04/10/12 03/31/15 66,069.00
Cell and Developmental Biology 
of Xenopus
04/01/09 03/31/14 61,428.00
Cellular Biology of Addiction 03/01/11 02/29/16 78,505.00
Eukaryotic Gene Expression 04/01/12 03/31/17 103,691.96
Mouse Development, Stem Cells, 
and Cancer
04/01/12 03/31/17 119,516.32
Neurobiology of Drosophila 07/15/12 06/30/17 35,000.00
Programming for Biology 09/01/09 08/31/14 63,654.00
Protein Purifi cation and Characterization 04/01/12 03/31/17 96,704.72
Proteomics 08/01/12 04/30/17 107,840.00
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Grantor Program/Principal Investigator Duration of Grant 2013 Funding1
Statistical Methods for Functional 
Genomics
08/05/13 07/31/17 $ 105,657.00 *
X-Ray Methods in Structural Biology 09/01/12 08/31/17 81,540.00
Meeting Support Behavior and Neurogenetics 
of Nonhuman Primates
07/01/13 06/30/14 20,000.00 *
The Biology of Genomes 04/01/13 03/31/14 54,600.00 *
Cancer Biology and Therapeutics 04/15/13 03/31/14 5,000.00 *
Cell Death 09/01/13 08/31/14 29,958.00 *
Eukaryotic DNA Replication 08/01/13 07/31/14 5,000.00 *
Eukaryotic mRNA Processing 08/01/13 07/31/14 4,000.00 *
Gene Expression and Signaling 
in the Immune System
12/15/13 11/30/14 8,000.00 *
Genome Informatics 09/19/13 08/31/14 31,600.00 *
Glia Health and Disease 09/30/13 08/31/14 15,000.00 *
Harnessing Immunity to Prevent 
and Treat Disease
11/12/13 10/31/14 8,000.00 *
Metabolic Signaling and Disease: From 
Cell to Organism
05/22/13 04/30/14 12,000.00 *
Microbial Pathogenesis and Host 
Response
09/01/13 08/31/14 7,000.00 *
Network Biology 04/21/09 02/28/14 5,000.00
Neurobiology of Drosophila 09/01/13 08/31/14 10,000.00 *
Neuronal Circuits 09/30/13 09/29/14 20,000.00 *
Pharmacogenomics and Personalized 
Therapy
09/30/10 08/31/14 10,000.00
Retroviruses 03/15/12 02/28/17 36,645.00
RNA and Oligonucleotide Therapeutics 04/01/13 03/31/14 10,000.00 *
78th Symposium on Quantitative 
Biology: Immunity and Tolerance
04/01/13 03/31/14 5,000.00 *
Synapses: From Molecules to Circuits 
and Behavior
04/01/11 01/31/16 14,400.00
Wiring the Brain 07/17/13 07/16/14 10,000.00 *
Yeast Cell Biology 06/01/11 05/31/16 5,000.00
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Jackson 10/01/10 09/30/15 1,140,498.00 
Drs. Lippman/Schatz 11/01/12 10/31/15 902,602.00 
Dr. Mitra 10/01/13 09/30/16 354,881.00 * 
Dr. Ware 06/01/12 05/31/17 2,350,569.00 
Research Support Dr. Churchland 08/01/11 07/31/14 43,156.00 
Drs. Timmermans/Hammell 05/01/12 04/30/16 305,429.00 
Research Subcontracts
NSF/Cornell University Consortium 
Agreement
Dr. Timmermans 02/01/13 01/31/18 402,885.00 *
Dr. Ware 05/15/13 04/30/18 144,165.00 *
NSF/Iowa State University Consortium 
Agreement
Dr. Jackson 03/01/13 02/28/18 379,668.00 *
NSF/New York University Consortium 
Agreement
Drs. McCombie/Martienssen 08/01/10 07/31/14 419,685.00 
521-552_Finance.indb   527 01-09-2014   07:42:28
528  Finance
1Includes direct and indirect costs
*New or competing renewal grants awarded in 2013
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NSF/North Carolina State University 
Consortium Agreement
Dr. Martienssen 03/01/11 02/29/16 $  451,932.00 
NSF/University of Arizona Consortium 
Agreement
Dr. Ware 08/15/10 07/31/14 597,678.00 
Drs. Ware/Micklos/Schatz 09/01/13 08/31/18 1,890,979.00 *
Drs. Ware/Micklos/Schatz 02/01/12 07/31/13 46,684.06 
Fellowship Support Dr. Carlston 06/01/13 05/31/14 44,000.00 *
Undergraduate Training Program Support Dr. Schatz 04/01/12 03/31/15 116,932.00 
Course Support Advanced Bacterial Genetics 07/01/09 06/30/14 98,081.00 
Computational Cell Biology 08/01/12 07/31/15 70,000.00 
Frontiers and Techniques in Plant 
Science
05/15/12 04/30/15 100,615.00 
Drosophila Neurobiology: Genes, 
Circuits, and Behavior
08/01/12 07/31/14 20,000.00 
Meeting Support Eukaryotic mRNA Processing 07/01/13 06/30/14 5,000.00 *
Computational Cell Biology 04/15/13 03/31/14 14,660.00 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 01/15/11 01/14/15 125,802.00 
Dr. Jackson 12/01/13 11/30/17 118,556.00 *
Dr. McCombie 09/11/09 09/10/14 192,673.00 
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 09/15/12 09/14/17 1,072,791.00 
Drs. Hicks/Trotman 09/30/12 09/29/14 308,554.84 
Fellowship Support Dr. Sheppard 09/01/12 08/31/15 54,927.00 
UNITED STATES DEPARTMENT OF ENERGY
Research Subcontracts
DOE/Brookhaven National Laboratory 
Consortium Agreement
Drs. Ware/Schatz 11/29/11 09/30/16 1,050,000.00 
UNITED STATES DEPARTMENT OF THE NAVY
Course Support Synthetic Biology 07/01/13 06/30/14 45,552.00 *
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
New York State Department 
of Economic Development
Dr. Martienssen 11/01/12 10/31/13 39,765.00
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Program Project Support
Pfi zer Inc. Dr. Stillman 01/01/12 12/31/13 $2,050,000.00
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lippman/Martienssen/ 
Timmermans/Ware
07/01/12 06/30/17 1,600,000.00
The Simons Foundation/Autism Dr. Wigler 01/01/12 12/31/15 4,000,571.00
The Simons Foundation/Center 
for Quantitative Biology
Dr. Wigler 09/01/08 08/31/15 1,500,000.00
The Stanley Medical Institute Drs. Watson/McCombie 06/01/11 05/31/17 5,000,000.00
Research Support
Alex’s Lemonade Stand Dr. Vakoc 01/01/13 12/31/15 125,000.00 *
Rita Allen Foundation Dr. C. Hammell 09/01/12 08/31/17 110,000.00
American Association for Cancer 
Research
Dr. Egeblad 07/01/12 06/30/14 100,000.00
Anonymous Drs. Mitra/Huang 02/01/12 01/31/14 300,000.00
Anonymous Dr. Tonks 12/09/13 12/08/14 162,340.00 *
Babylon Breast Cancer Coalition Inc. Dr. D. Spector 12/30/13 12/29/14 10,000.00 *
Boehringer Ingelheim RCV GmbH 
& Co. KG
Dr. Vakoc 11/01/13 10/31/15 271,804.00 *
The Breast Cancer Research Foundation Drs. Wigler/Hicks 10/01/13 09/30/14 240,000.00 *
Dr. Hicks 10/01/13 09/30/14 154,142.00 *
Burroughs Welcome Fund Dr. Vakoc 09/01/11 08/31/16 151,250.00
Caring for Carcinoid Foundation Dr. Tuveson 07/01/12 06/30/14 255,526.22
Dysautonomia Foundation Inc. Dr. Krainer 07/01/12 06/30/14 90,000.00
Families of S.M.A. Dr. Krainer 07/01/13 06/30/15 75,000.00 *
Find a Cure Today Long Island 
Foundation
Dr. Tonks 01/08/13 01/07/14 5,000.00 *
The Joni Gladowsky Breast Cancer Fund Dr. Tonks 07/01/13 06/30/14 70,000.00 *
Glen Cove C.A.R.E.S., Inc. Dr. Tonks 02/01/13 01/31/14 5,000.00 *
Global Prostate Cancer Research 
Foundation
Dr. Wigler 09/01/13 08/31/14 25,000.00 *
The Griffi n Fund Dr. Tuveson 06/15/13 06/14/14 100,000.00 *
The Irving A. Hansen Memorial Fund Dr. Tonks 08/01/13 07/31/14 25,000.00 *
Hearts for Cancer Dr. Tonks 04/01/13 03/31/14 35,418.68 *
Robert and Cindy Higginson Dr. Mills 02/01/13 01/31/14 2,000.00 *
F. Hoffmann-La Roche Ltd. Dr. Krainer 05/06/13 05/05/15 42,419.00 *
The Hope Foundation Dr. Egeblad 07/01/12 06/30/14 125,000.00
Howard Hughes Medical Institute–
Gordon and Betty Moore Foundation
Dr. Martienssen 12/01/11 11/30/16 333,333.00
Ms. Beatrice Karp Dr. Egeblad 03/01/13 02/28/14 150.00 *
F.M. Kirby Foundation, Inc. Dr. Vakoc 12/16/13 12/15/14 150,000.00 *
The Susan G. Komen Breast Cancer 
Foundation, Inc.
Dr. Hicks 10/22/13 10/21/17 246,829.00 *
The Long Island 2-Day Walk to Fight 
Breast Cancer
Dr. Egeblad 08/15/13 08/14/14 22,500.00 *
Long Island Cruizin’ For a Cure Inc. Drs. Hicks/Trotman 09/01/13 08/31/14 20,000.00 *
The Lustgarten Foundation Dr. Egeblad 01/01/13 12/31/15 162,883.00 *
Dr. Tuveson 06/15/12 06/30/17 52,083.00
Drs. Tuveson/Pappin 09/01/12 08/30/17 1,000,000.00
Carol Marcincuk Fund Dr. Tonks 01/01/13 12/31/13 15,795.00 *
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In Honor of Carissa Maringo Dr. Egeblad 10/01/13 09/30/14 $  5,282.00 *
Breast Cancer Awareness Day in 
Memory of Elizabeth McFarland
Dr. Wigler 01/01/13 12/31/13 77,294.20 *
The McKnight Endowment Fund 
for Neuroscience
Dr. Churchland 07/01/12 06/30/15 75,000.00
The Melanoma Research Alliance Drs. Hannon/Hammell/Vakoc 08/01/11 07/31/14 200,000.00
The John Merck Fund Dr. Churchland 06/01/11 05/31/15 75,000.00
Dr. Kepecs 06/01/10 05/31/14 75,000.00
The Don Monti Memorial Research 
Foundation
Drs. Stillman/Tonks 03/01/08 02/28/16 500,000.00
Louis Morin Charitable Trust Dr. Tuveson 12/01/13 11/30/14 115,000.00 *
National Philanthropic Trust, Inc. Dr. Hannon 10/10/13 10/09/14 325,000.00 *
Pancreatic Cancer UK Dr. Tuveson 10/23/12 10/22/15 65,000.00
The Pew Charitable Trusts Dr. Hannon 01/01/11 12/31/15 354,451.00
Dr. Albeanu 08/01/12 07/31/17 60,000.00
Phi Beta Psi Sorority Dr. Egeblad 08/15/13 08/14/14 58,630.00 *
Pioneer Hi-Bred International, Inc. Dr. Ware 03/15/12 06/30/15 52,308.00
The Hazen Polsky Foundation Dr. Vakoc 01/01/12 12/31/14 50,000.00
The Prostate Cancer Foundation Dr. Hicks 09/01/13 08/31/15 184,325.00 *
Dr. Vakoc 01/20/12 01/19/14 150,000.00
Christina Renna Foundation Inc. Dr. Van Aelst 02/01/13 01/31/14 20,000.00 *
Marie Robertson Memorial Fund CSHL Neuroscience Program Support 01/01/13 12/31/13 137,500.00 *
Diane Emdin Sachs Memorial Fund Dr. Sordella 09/01/12 08/31/14 9,828.00
Eleanor Schwartz Charitable Foundation Dr. Churchland 07/15/11 07/14/14 200,000.00
The Seraph Foundation Dr. Vakoc 12/21/13 12/20/14 125,000.00 *
The Simons Foundation Dr. Mills 08/01/13 07/31/15 208,380.00 *
Drs. Mitra/Huang 12/01/11 11/30/14 300,000.00
Dr. Shea 01/01/13 09/30/13 43,501.00 *
The Sontag Foundation Dr. Zheng 10/01/13 09/30/17 150,000.00 *
Starr Cancer Consortium Dr. Vakoc 08/01/11 07/31/13 22,500.00
Swim Across America Dr. Sordella 12/15/11 12/14/14 70,000.00
Tourette Syndrome Association, Inc. Dr. Lyon 08/01/13 07/31/14 18,454.50 *
Mr. and Mrs. Stanley S. Trotman Dr. Wigler 11/01/13 10/31/14 2,000.00 *
U.S.-Israel Binational Agricultural 
Research and Development Fund
Dr. Krainer 10/01/10 09/30/14 10,000.00
Dr. Shea 12/01/12 11/30/14 60,000.00
Dr. Zador 10/01/10 09/30/14 13,000.00
The V Foundation Dr. Vakoc 11/01/12 10/31/14 100,000.00
West Islip Breast Cancer Coalition for 
Long Island Inc.
Dr. Tonks 11/01/13 10/31/14 10,000.00 *
Whitehall Foundation, Inc. Dr. Albeanu 01/01/12 12/31/14 75,000.00
Dr. Shea 09/01/11 08/31/15 75,000.00
Wodecroft Foundation Dr. Huang 09/27/13 09/26/14 70,000.00 *
Dr. Wigler 09/27/13 09/26/14 20,000.00 *
Women in Science Dr. Joshua-Tor 01/01/12 12/31/13 121,576.35
Elisabeth R. Woods Foundation Inc. Dr. Sordella 09/27/13 09/26/14 15,000.00 *
Yale University/Gilead Sciences Inc. Dr. Sordella 07/16/12 07/15/14 407,656.00
The Bradley Zankel Foundation, Inc. Dr. Zheng 02/22/13 02/21/14 15,000.00 *
Fellowship Support
Agricultural Biotechnology Center Dr. Benkovics 05/01/13 04/30/15 18,862.00 *
American Cancer Society Dr. Ardito 07/01/13 06/30/16 48,000.00 *
Dr. Preall 10/01/11 09/30/14 52,000.00
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Brain and Behavior Research Foundation Dr. Lu 01/15/13 01/14/15 $  30,000.00 *
Dr. Paul 01/15/13 01/14/15 30,000.00 *
Terri Brodeur Breast Cancer Fund Dr. Anczukow 01/01/13 12/31/14 50,000.00 *
Carnegie Institution for Science Dr. Timmermans 09/01/13 08/31/14 30,482.00 *
CSHL Association Fellowship Dr. Mills 01/01/13 12/31/13 35,000.00 *
Dr. Joshua-Tor 01/01/13 12/31/13 245,000.00 *
Marie Curie International Outgoing 
Fellowships for Career Development
Dr. Hangya 01/01/13 12/31/14 120,148.00 *
European Molecular Biology 
Organization
Dr. Anselmi 01/01/13 12/31/13 42,355.52
Dr. Livneh 01/01/13 12/31/13 55,000.00
Genentech Foundation Watson School of Biological Sciences 10/01/12 09/30/15 58,751.00
German Academic Exchange Service Dr. Bergmann 09/01/11 08/31/13 11,000.00
Lola A. Goldring Dr. Stillman 10/01/13 09/30/14 85,000.00 *
Hope Funds for Cancer Research Dr. Knott 07/01/12 06/30/15 46,500.00
Human Frontier Science Program Dr. Chio 04/01/13 09/30/13 25,860.00 *
Dr. Kawaoka 11/01/13 10/31/16 61,080.00 *
Dr. Tam 05/01/13 04/30/14 64,677.50 *
International Rett Syndrome Foundation Dr. He 02/01/13 01/31/15 50,000.00 *
Annette Kade Charitable Trust Watson School of Biological Sciences 10/15/13 10/14/14 25,000.00 *
Life Sciences Research Foundation Dr. MacAlister 08/01/11 07/31/14 56,000.00
Muscular Dystrophy Association Dr. Sahashi 02/01/13 02/28/13 4,869.26 *
Mr. and Mrs. John C. Phelan Watson School of Biological Sciences 09/01/10 08/31/15 100,000.00
Damon Runyon Cancer Research 
Foundation
Dr. Chio 10/01/13 09/30/16 52,000.00 *
Damon Runyon Cancer Research 
Foundation
Dr. Sabin 01/01/12 12/31/14 52,000.00
Sass Foundation for Medical Research 
Inc.
Dr. Roe 06/01/13 05/31/15 50,000.00 *
Lauri Strauss Leukemia Foundation Dr. Mercan 11/15/13 11/14/14 10,000.00 *
The Swartz Foundation Dr. Zador 01/01/13 12/31/13 75,000.00 *
Drs. Koulakov/Ferrante 01/01/13 12/31/13 55,000.00 *
Drs. Churchland/Kaufman 01/01/13 12/31/13 55,000.00 *
Dr. Zador 01/01/13 12/31/13 15,000.00 *
Training Support
Clare College Undergraduate Research Support 06/01/13 05/31/14 6,016.40 *
The Genetics Society Undergraduate Research Support 05/01/13 04/30/14 30,000.00 *
The Lita Annenberg Hazen Foundation Undergraduate Research Support 05/01/08 04/30/18 10,000.00
Howard Hughes Medical Institute Undergraduate Research Support 06/01/13 05/31/14 17,400.00 *
William Townsend Porter Foundation Undergraduate Research Support 04/01/13 03/31/14 12,500.00 *
Research Foundation of the City 
University of NY
Undergraduate Research Support 06/01/13 05/31/14 13,700.00 *
University of Notre Dame Undergraduate Research Support 06/01/13 05/31/14 30,000.00 *
Course Support
American Express Foundation Leadership in Bioscience 11/01/11 10/31/14 50,000.00
Dr. David Botstein Yeast Genetics and Genomics 12/01/13 11/30/14 100,413.67 *
Burroughs Wellcome Fund Imaging Structure and Function 
in the Nervous System
12/01/13 11/30/14 20,000.00 *
The Gatsby Charitable Foundation Vision: A Platform Linking Circuits, 
Perception, and Behavior
06/11/13 06/10/14 10,800.00 *
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1Includes direct and indirect costs
*New or competing renewal grants awarded in 2013
Grantor Program/Principal Investigator Duration of Grant 2013 Funding1
Howard Hughes Medical Institute Course Support 08/01/11 07/31/15 $ 600,000.00
Nancy Lurie Marks Foundation Workshop on Autism Spectrum 
Disorders
07/01/12 06/30/16 25,000.00
The Lustgarten Foundation Workshop on Pancreatic Cancer 01/18/13 01/17/14 15,000.00 *
Pancreatic Cancer Action Network, Inc. Workshop on Pancreatic Cancer 01/18/13 01/17/14 15,000.00 *
Meeting Support
Alfred P. Sloan Foundation New Neuroscience Faculty/
Dr. Goldschmidts
02/01/13 09/01/14 20,000.00 *
Baker Botts L.L.P. Patenting in the Life Sciences 12/03/12 12/02/13 5,000.00
Bereskin & Parr Patenting in the Life Sciences 12/03/12 12/02/13 2,500.00
Biotechnology Industry Organization Patenting in the Life Sciences 12/03/12 12/02/13 10,000.00
Biotechnology Strategy Mobile Genetic Elements 04/15/13 04/14/14 2,000.00 *
ChemGenes Corporation RNA and Oligonucleotide Therapeutics 04/01/13 03/31/14 500.00 *
Dart Neuroscience LLC Mobile Genetic Elements 04/15/13 04/14/14 7,500.00 *
The Ellison Medical Foundation Asia Conference on Molecular Basis 
of Aging and Disease
07/01/13 06/30/14 15,775.00 *
Forest Research Institute, Inc. Wiring the Brain Conference 06/07/13 06/06/14 25,000.00 *
Genentech Inc. History of Restriction Enzymes 07/24/13 07/23/14 10,000.00 *
Patenting in the Life Sciences 12/03/12 12/02/13 10,000.00
Gilead Sciences Inc. Retroviruses 05/01/13 04/30/14 12,500.00 *
GlaxoSmithKline, LLC Asia Meeting Support 09/01/13 08/31/14 10,000.00 *
Glenn Foundation for Medical Research Molecular Genetics of Aging 11/11/13 11/10/14 15,000.00 *
Isis Pharmaceuticals, Inc. RNA and Oligonucleotide Therapeutics 04/01/13 03/31/14 2,000.00 *
Jones Day Patenting in the Life Sciences 12/03/12 12/02/13 5,000.00
Life Technologies Corporation History of Restriction Enzymes 07/24/13 07/23/14 25,000.00 *
60th Anniversary of the Double Helix 
Celebration Gala Dinner
02/08/13 02/07/14 55,000.00 *
Personal Genomes and Medical 
Genomics
12/15/12 10/31/14 10,000.00
Millennium Pharmaceuticals, Inc. The Ubiquitin Family Meeting 06/01/13 05/31/14 12,500.00 *
Molecular Biology Resources, Inc. History of Restriction Enzymes 07/24/13 07/23/14 1,000.00 *
New England Biolabs, Inc. History of Restriction Enzymes 07/24/13 07/23/14 25,000.00 *
Nippon Gene Co., LTD History of Restriction Enzymes 07/24/13 07/23/14 5,000.00 *
OSI Pharmaceuticals, Inc. Cancer Biology and Therapeutics 03/01/13 02/28/14 15,000.00 *
Pioneer Hi-Bred International, Inc. Mobile Genetic Elements 04/15/13 04/14/14 2,500.00 *
Promega Corporation History of Restriction Enzymes 07/24/13 07/23/14 10,000.00 *
RaNA Therapeutics, Inc. RNA and Oligonucleotide Therapeutics 04/01/13 03/31/14 4,000.00 *
Regado Biosciences, Inc. RNA and Oligonucleotide Therapeutics 04/01/13 03/31/14 2,000.00 *
Sarepta Therapeutics, Inc. RNA and Oligonucleotide Therapeutics 04/01/13 03/31/14 10,000.00 *
Takara Bio, Inc. History of Restriction Enzymes 07/24/13 07/23/14 10,000.00 *
Thermo Fischer Scientifi c Inc. History of Restriction Enzymes 07/24/13 07/23/14 25,000.00 *
Ubiquigent LTD The Ubiquitin Family Meeting 02/01/11 01/31/14 1,000.00
Wolf, Greenfi eld & Sacks, P.C. Patenting in the Life Sciences 12/03/12 12/02/13 5,000.00
Library Support
The Ellen Brenner Memorial Fund 12/15/13 12/14/14 2,500.00 *
Ms. Jolanta Fabicka 01/01/13 12/31/13 5,000.00 *
Institute of Museum and Library Services 10/01/13 09/30/14 50,000.00 *
The New York State Education 
Department
07/01/13 06/30/14 3,573.10 *
Wellcome Trust 06/01/11 10/31/13 17,500.00
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DNA LEARNING CENTER GRANTS
Grantor Program
Duration 
of Grant
2013 
 Funding†
FEDERAL GRANTS
National Institutes of Health, 
University of California, 
Berkeley
Enhancing the GMOD suite of genome annotation and 
visualization tools
6/12–5/14 $  39,330
National Science Foundation, 
North Carolina State University
GEPR: Epigenome Dynamics during DNA Replication 3/11–2/13 7,617
National Science Foundation, 
University of Arizona
Educational outreach for iPlant Collaborative: A cyberinfrastructure 
for plant sciences
2/08–7/13 397,011
National Science Foundation, 
University of Arizona
iPlant Collaborative: Cyberinfrastructure for the life sciences 9/13–8/18 363,220
National Science Foundation Infrastructure and training for next-generation sequence (NGS) 
analysis in undergraduate education
9/13–8/16 13,752
National Science Foundation Advanced technology education (ATE) Program: Genomic 
approaches in BioSciences
4/11–3/14 255,955
NONFEDERAL GRANTS
Alfred P. Sloan Foundation DNA Center NYC start-up 12/13–11/16 9,430
The Pinkerton Foundation Urban Barcode Research Program 1/13–12/14 112,315
The following schools and school districts each contributed $1,000 or more for participation in the Curriculum Study program:
Bellmore-Merrick Central High School District $1,500 Massapequa Union Free School District 1,500
East Meadow Union Free School District 1,500 North Shore Central School District 3,000
Elwood Union Free School District 1,500 North Shore Hebrew Academy 3,000
Fordham Preparatory School 1,500 Oceanside Union Free School District 1,500
Garden City Union Free School District 1,500 Oyster Bay-East Norwich Central School District 3,000
Great Neck Union Free School District 1,500 Plainedge Union Free School District 1,500
Green Vale School 3,000 Plainview-Old Bethpage Central School District 1,500
Half Hollow Schools Central School District 1,500 Portledge School 1,500
Harborfi elds Central School District 1,500 Port Washington Union Free School District 1,500
Herricks Union Free School District 1,500 Ramaz Upper School 1,500
Huntington Union Free School District 1,500 Roslyn Union Free School District 3,000
Island Trees Union Free School District 1,500 Syosset Central School District 3,000
Jericho Union Free School District 1,500 West Hempstead Union Free School District 3,000
Levittown Union Free School District 1,500 Yeshiva University High School for Girls 1,500
Locust Valley Central School District 1,500
The following schools and school districts each contributed $1,000 or more for participation in the Genetics as a Model for 
Whole Learning program:
Alpine Public Schools, New Jersey 1,300 JHS 226, Queens 1,193
Bellmore Union Free School District 2,400 Lawrence UFSD 11,100
Bellmore-Merrick Union Free School District 9,875 Locust Valley Central School District 11,841
Bethpage Union Free School District 2,500 Merrick Union Free School District 3,400
Cold Spring Harbor Central School District 14,400 M.S. 447, Brooklyn 1,450
Commack Union Free School District 6,100 North Bellmore Union Free School District 1,900
East Meadow Union Free School District 4,012 North Shore Central School District 1,750
East Williston Union Free School District 2,900 North Shore Hebrew Academy 1,050
Elwood Union Free School District 3,375 Oceanside Union Free School District 1,625
Floral Park-Bellerose Union Free School District 7,800 Oyster Bay-East Norwich Central School District 2,575
Friends Academy 3,300 Passaic Charter School, New Jersey 1,300
Friends Seminary of New York 1,078 Port Washington Union Free School District 5,500
Garden City Union Free School District 10,355 Rockville Centre Union Free School District 6,240
Great Neck Union Free School District 10,150 Roslyn Union Free School District 3,675
Half Hollow Hills Union Free School District 16,450 Saint Dominic Elementary School 4,550
Hebrew Academy of Nassau County 1,700 Scarsdale Union Free School District 12,600
Herricks Union Free School District 2,975 Smithtown Union Free School District 1,680
Hofstra STEP 1,050 Syosset Union Free School District 38,800
Holy Child Academy 3,200 Three Village Central School District 6,300
Huntington Union Free School District 11,600 Trinity School 2,400
Jericho Union Free School District 7,950 Yeshiva Darchei Torah 2,760
†Includes direct and indirect costs.
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BANBURY CENTER GRANTS
Grantor Program
Duration 
of Grant
2013 
Funding
FEDERAL SUPPORT
National Institute on Alcohol Abuse 
and Alcoholism
The Adolescent Brain 2013 $  4,635
National Institute of Mental Health The Adolescent Brain 2013 4,635
NONFEDERAL SUPPORT
Allen Institute for Brain Science The Adolescent Brain 2013 10,500
ALS Association of Greater New York Development and Evolution of the Human Motor System in 
Relation to ALS and FTD
2013 46,367
Boehringer Ingelheim Fonds Science: Get It Across! 2013 58,594
John K. Castle Oxidants and Antioxidants in Cancer Genesis and 
Treatment
2013 20,000
Cold Spring Harbor Laboratory 
Corporate Sponsor Program
Evolution of Plant Metabolic Diversity 2013 43,732
Redesigning Photosynthesis: Identifying Opportunities and 
Novel Ideas
2013 58,988
Telomeres and Disease 2013 48,358
Cold Spring Harbor Laboratory–
DuPont/PioneerCollaborative 
Research Program
Plant Reproduction 2013 50,000
Dart NeuroScience Transposable Elements in the Brain and Other Tissues: 
Prevalence and Function
2013 19,053
Illumina, Inc. Accelerating Genomic Research with Privacy Protections 2013 34,410
Individual participants The Adolescent Brain 2013 6,090
Individual participants Developing a Neuroscience Consortium 2013 23,270
Individual participants The Emerging Intersection between the Physical Sciences 
and Oncology
2013 2,060
Individual participants Grand Challenges in Organismal Biology 2013 1,375
Individual participants The Neurobiology and Clinical Study of Rapid-Acting 
Antidepressants
2013 5,500
ISCTM Developing a Neuroscience Consortium 2013 7,495
Janssen Research & Development The Neurobiology and Clinical Study of Rapid-Acting 
Antidepressants
2013 34,362
Kotumba Capital Management, LLC Science of Pancreatic Cancer 2013 12,572
The Lieber Institute for Brain 
Development
The Adolescent Brain 2013 12,500
Elizabeth Livingston Estate Interdisciplinary Approaches to Idiopathic Lung Fibrosis 2013 43,648
Lustgarten Foundation Lustgarten Foundation Annual Scientifi c Meeting 2013  38,764
MCJ Amelior Foundation Science of Pancreatic Cancer 2013 20,060
Oliver Grace Cancer Fund Oxidants and Antioxidants in Cancer Genesis and 
Treatment
2013  41,233
Oliver Grace Cancer Fund Biguanides and Neoplasia 2013 59,632
Oliver Grace Cancer Fund Enhancer Biology in Health and Disease 2013 51,718
Ovarian Cancer Research Fund Ovarian Cancer: Developing Research-Based Public 
Messaging on Early Detection and Screening
2013 31,544
Pfi zer, Inc. INK4a/ARF Network 2013 56,000
Phelan McDermid Syndrome Autism due to Shank3 Mutations/Deletions Foundation 2013 33,121
Marie Robertson Neuroscience Fund Transposable Elements in the Brain and Other Tissues: 
Prevalence and Function
2013 20,000
The Daniel & Joanna S. Rose 
Foundation
Consciousness and the Brain 2013 10,000
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BANBURY CENTER GRANTS (Continued)
Grantor Program
Duration 
of Grant
2013 
Funding
The Satenik and Adom Ourian 
Educational Foundation
Consciousness and the Brain 2013 $ 1,000
Stanley Research Foundation Psychiatric Genomics: Current Status, Future Strategies 2013 41,335
Stony Brook University through a grant 
from NSF
Grand Challenges in Organismal Biology 2013 42,625
University of Southern California NCI 
Physical Sciences in Oncology Center
The Emerging Intersection between the Physical Sciences 
and Oncology 
2013 27,372
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CORPORATE SPONSOR PROGRAM 
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings 
program held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main 
Laboratory campus or at the Banbury Center. Without the strong foundation provided by the 
Program, we could neither plan with confi dence for the year’s meetings nor introduce new and 
unusual topics.
We are especially grateful to the companies that joined us in 2013 as the economic diffi culties 
began to take effect. The year 2014 is going to be especially challenging as the number of compa-
nies shrinks through takeovers, and companies and foundations adopt austerity measures.
The members of the Program receive special privileges in acknowledgment of their contribu-
tions. We waive all on-site fees for eight representatives of the Corporate Sponsors at our meetings. 
Three scientists from Sponsors may attend meetings at the Banbury Center, where attendance is 
otherwise only by invitation of the organizers. Member companies also receive gratis copies of 
Cold Spring Harbor Laboratory Press publications, including the journals Genes & Development, 
Learning & Memory, CSH Protocols, Genome Research, RNA, and the Perspective series.
We acknowledge our Sponsors in all relevant publications, including the books of abstracts 
given to each of the 7000 participants who come to the meetings each year. The names of the 
sponsoring companies are listed on the poster describing the meetings, and this is mailed to ap-
proximately 17,000 scientists throughout the world. In addition, the companies are listed on the 
Cold Spring Harbor Laboratory website on the Meetings Offi ce and Banbury Center pages. Mem-
bers in 2013 were the following:
CORPORATE BENEFACTORS PLANT CORPORATE SPONSORS
Astellas-OSI Pharmaceuticals, Inc. Monsanto Company
 DuPont-Pioneer International, Inc.
CORPORATE SPONSORS 
Agilent Technologies, Inc. 
Bristol-Myers Squibb Company 
Genentech, Inc.
Life Technologies
New England BioLabs, Inc.
Sanofi  US
521-552_Finance.indb   536 01-09-2014   07:42:29
537
CSHL President Bruce Stillman with NYS Economic Development Rep Andrea Lohneiss, 
NYS Assemblyman Charles Lavine, and LIA President Kevin Law
DEVELOPMENT
Cold Spring Harbor Laboratory (CSHL) is the birthplace of molecular biology and is home to eight 
Nobel Prize winners who have made seminal discoveries in genetics. On the cusp of our 125th 
 anniversary, CSHL is launching the Cancer Therapeutics Initiative to extend this broad genetic ex-
pertise to clinical trials and drug development. To realize this mission, we have recruited new clinical 
scientists such as Dr. David Tuveson, who is an expert in pancreatic cancer and has been involved 
in academic clinical trial development at the University of Cambridge in the United Kingdom. We 
are grateful to the Lustgarten Foundation and Roy Zuckerberg for supporting Dr. Tuveson’s recruit-
ment. It was also essential that we create new infrastructure for this purpose, and through the sup-
port of David Koch, New York State, and an anonymous donor, we broke ground in November on 
the Preclinical Experimental Therapeutics Facility. Together with the planned Center for Cancer & 
Metabolism, these facilities will greatly accelerate our research efforts aimed at developing and test-
ing new therapeutics and diagnostics for cancer and neurological disorders.
As we continue to strengthen, evolve, and expand our research, CSHL is also extending its 
educational reach to urban centers and countries all over the world. We are planning our most 
ambitious public educational undertaking by establishing a fl agship center in Manhattan that will 
serve as the nucleus for DNA learning in New York City. DNA Learning Center NYC will exem-
plify how research institutions and science centers can enhance science education in large cities, by 
providing an environment in which students and the public can ask questions and perform hands-
on experiments. Students and NYC residents will have access to state-of-the-art DNA laboratory 
experiences in order to gain a greater understanding of their own uniqueness, the implications of 
personalized medicine, and the genetic heritage that they share with other people in America’s 
melting pot. The vision for the DNA Learning Center NYC will be realized with great thanks for 
a lead contribution by CSHL Trustee Laurie Landeau and with signifi cant gifts by the Thompson 
Family Foundation and the Alfred P. Sloan Foundation.
These are just some examples of how philanthropy continues to facilitate CSHL in establishing 
and strengthening its advanced genetics-based initiatives. We look forward to continued partner-
ships with friends like you on our 125th anniversary and beyond!
  Charles V. Prizzi, Vice President for Development and Community Relations
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President’s Council
This year’s topic was Infectious Diseases and Viruses. CSHL alumni headlined this year’s intel-
lectual retreat in September for President’s Council members. Nobel laureate and CalTech Presi-
dent Emeritus David Baltimore gave the keynote talk on the latest advances in dealing with the 
AIDS pandemic. Dr. Baltimore was among the Laboratory’s fi rst undergraduate research program 
(URP) students in the summer of 1959. Dr. Niraj Tolia, a member of the fi rst graduating class of 
CSHL’s Watson School of Biological Sciences (2004), described promising developments toward 
a protective malaria vaccine. Members also heard from the Gates Foundation President of Global 
Health, Trevor Mundel, on priority setting; Larry Barrett, Director of the Plum Island Animal 
Disease Center; Stony Brook Distinguished Professor Eckard Wimmer, who solved the genome 
sequence for polio and developed the fi rst synthetic vaccine for poliovirus; and Jonathan Epstein 
of EcoHealth Alliance on his riveting fi eldwork to study the ecology of emerging zoonoses.
Loren Eng and Dinakar Singh also hosted Council members and friends in April at their mag-
nifi cent plaza apartment with sweeping views of Central Park and the Apple store. The lecture, by 
IBM’s Joe Jasinski, focused on the growing role of Internet technology in tracking and preventing 
virus outbreaks.
I am grateful to our many President’s Council members who have, since 1995, helped to sup-
port CSHL fellows with annual gifts of $25,000 or more. CSHL fellows are outstanding young 
scientists who are given the opportunity to pursue a period of independent research soon after 
receiving their Ph.D. or M.D. degrees.
Bruce Stillman, Ph.D., F.R.S.
President and Chief Executive Officer
CSHL president Bruce Stillman (left) with 
Trevor Mundel, Gates Foundation president 
of Global Health, and Eckard Wimmer, 
Stony Brook University
CSHL Trustee Jim Stone with his wife, Cathy Peter Klein, Liz Murray, and Nick Richardson
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Cold Spring Harbor Laboratory Association
With more than 1200 members, the Cold Spring Harbor Laboratory Association continues to 
increase community awareness of CSHL and this year helped to raise more than $6.5 million 
in unrestricted support for the Laboratory. Events spearheaded by Directors of the Association 
included the Women’s Partnership in Science luncheon, where Liz Watson was honored for her 
devotion to CSHL and the community, and the 20th annual golf tournament at Piping Rock 
Club, where Paul Amoruso was the honoree. The Association was also instrumental in the success 
of the Double Helix Medals Dinner in New York City with honorees including newscaster Robin 
Roberts and the founders of the Innocence Project, Barry Sheck and Peter Neufeld.
Special thanks go to Sandy Tytel, President of the CSHL Association, for her support of and 
enthusiasm for Cold Spring Harbor Laboratory.
Directors
Executive Committee Offi cers
Sandy Tytel, President
Frank O’Keefe, Vice President
W. Fifi eld Whitman, Vice 
President
James A. Woods, Treasurer
Charles B. Goodwin, M.D., 
Secretary
Elizabeth Ainslie
Hans E.R. Bosch
Michele Munn Celestino
Edward A. Chernoff
Susan A. Cohen
Maria de Lesseps
Nelson DeMille
Carolyn Gulotta
Nancy Lippman Israeli, M.D.
Joel J. Kassimir, M.D.
Kassahun Kebede
Virginia Knott
Laureen Stanton Knutsen
Suzanne Leeds
Timothy Q. O’Neill
Olga Pharr
Whitney F. Posillico
Charles S. Ryan, J.D., Ph.D.
Tracey DeMatteis Serko
Hope Geier Smith
Debra Parmet Sondock
Heather Lane Spehr
Peter S. Tilles
Lara S. Trafelet
Marjorie J. van de Stouwe, M.D.
2013 CSHLA Directors
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Cold Spring Harbor Laboratory Corporate Advisory Board
The Corporate Advisory Board (CAB) is a vital liaison between Cold Spring Harbor Laboratory 
and the tristate business community. Established more than 20 years ago, the CAB is the driving 
force behind the Laboratory’s annual golf outing at Piping Rock Club; this outing raises critical 
unrestricted funding for research and educational programs. At this year’s 20th annual event, 
CAB Member Paul Amoruso was honored and more than $175,000 was raised.
Special thanks go to Eddie Chernoff, CAB President and Golf Chairman, who continues to 
provide leadership and support. We truly appreciate all of his efforts.
Corporate Advisory Board
Chairperson: Edward A. Chernoff, MARS
Michael Aboff, Aboff ’s Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale 
Sotheby’s International Realty
Christopher Callaghan, GFI Group
Jeffrey Carstens, Capital One
Richard A. Catalano, KPMG, LLP
Jonathan Connors, Wells Fargo
Marian Conway, New York Community 
Bank Foundation
J. Daniel Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall Corporation
Kevin Foley, Fidelity
Brian Fox, McKinsey & Company
Brian Goldstein, M.D.
Lawrence Goodman, Curtis, Mallet-
Prevost, Colt & Mosle LLP
Mary Jane Helenek, Luitpold 
Pharmaceuticals
Diana Hoadley, JP Morgan
Richard W. Humann, H2M
Robert Isaksen, Bank of America
M. Patricia Janco, Wells Fargo
Neil M. Kaufman, Abrams Fensterman
John C. Kean III, Kean Development 
Corporation
Norman Kelker, Enzo Life Sciences
Robert Keller, National Grid Foundation
Amy Koreen, M.D.
Laurie J. Landeau, V.M.D.
Victoria Meagher
Rob Palatnick, DTTC
John G. Passarelli, M.D.
David Peikon
Patricia Petersen, Daniel Gale Sotheby’s 
International Realty
Stephen Ross, Ph.D., Nikon Instruments
Raju Sarwal, M.D.
Nancy Szigethy, NMS Management
Edward Travaglianti, TD Bank
Andrew Whiteley, Enzo Life Sciences
Joseph M. Willen, Advantage Title
Hans Zobel
CAB Chairman Eddie Chernoff (left) with 2013 Golf Tournament 
honoree Paul Amoruso (center) and CSHL President Bruce Stillman
CSHLA Director Whitney Posillico with her three 
sons at CSHL’s golf tournament
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Honor Roll of Donors
Contributions of $5 million+ lifetime
Anonymous
Estate of Donald E. Axinn
The Arnold and Mabel Beckman 
Foundation
Jamie Nicholls and Fran Biondi
Mr. and Mrs. David Boies
The Breast Cancer Research 
Foundation
Mr. and Mrs. Landon T. Clay
The Dana Foundation
Dart Neurosciences LLC
Estate of Kathryn W. Davis
DeMatteis Family Foundation
Mr. and Mrs. Charles F. Dolan 
Dolan Family Foundation
The William Stamps Farish Fund
Estate of Robert B. Gardner, Jr.
GEN*NY*sis grant from New York State 
Dormitory Authority
Howard Hughes Medical Institute
W.M. Keck Foundation
Mr. and Mrs. David H. Koch
Laurie Landeau Foundation
Mr. and Mrs. Robert D. Lindsay 
and Family
The Lustgarten Foundation
Lucille P. Markey Charitable Trust
Nancy Abeles Marks
The Don Monti Memorial Research 
Foundation
New York State Empire State 
Development Corporation
The Honorable and Mrs. Leon B. 
Polsky–Hazen Polsky Foundation
The Quick Family
The Robertson Family–Banbury Fund
Marilyn and Jim Simons
The Simons Foundation
Alfred P. Sloan Foundation
St. Giles Foundation
Theodore R. Stanley–The Stanley Medical 
Research Institute
The Starr Foundation
Thompson Family Foundation
Dr. and Mrs. James D. Watson
Mr. and Mrs. Henry Wendt III
Contributions of $100,000 or 
$1 million+ lifetime
Paul G. Allen Foundation
Angel Foundation
Anonymous (4)
Gonzalo Río Arronte Foundation
Dr. and Mrs. Lalit Bahl
BioBay of Suzhou Venture Capital Group
Drs. Renee Fitts and David Botstein
Bristol-Myers Squibb Company
Burroughs Wellcome Fund
Louise Parent and John Casaly
The Chapman Foundations
Bayard and Virginia Clarkson
Mr. and Mrs. Norris W. Darrell
Michel David-Weill
Ira W. DeCamp Foundation
Edward P. Evans Foundation
Charitable Lead Annuity Trust–
Will of Louis Feil
Samuel Freeman Charitable Trust
Coleman Fung Foundation
Mr. and Mrs. Robert A. Gay
Genentech, Inc.
Kenyon Gillespie
Jacob Goldfi eld
Lola Goldring
The Florence Gould Foundation
The Grace Family
Michael J. Griffi n
Kate Medina and Leo Guthart
The Harrison Foundation and The Mary 
Anderson Harrison Foundation
Thomas Hartman Foundation 
for Parkinson’s Research
Janet Strauss and Jeff Hawkins
Jo-Ellen and Ira Hazan
William Randolph Hearst Foundation
The Karches Foundation
F.M. Kirby Foundation
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. John B. Klingenstein–
The Esther A. and Joseph Klingenstein 
Fund
Elise H. Knight
The Forrest C. and Frances H. Lattner 
Foundation
The Lehrman Institute
Mr. and Mrs. Stephen M. Lessing
Mary D. Lindsay
The Litchfi eld Charitable Trust
Estate of Elisabeth Sloan Livingston
Louis Morin Charitable Trust
Dr. Robert Lourie
Lisa Lourie
Mr. and Mrs. David L. Luke III
Josiah Macy, Jr. Foundation
The G. Harold and Leila Y. Mathers 
Charitable Foundation
Gillian and Eduardo Mestre
Mr. and Mrs. William R. Miller
Dr. and Mrs. Howard L. Morgan
Estate of Thomas C. Nelson
William C. and Joyce C. O’Neil 
Charitable Trust
Deborah Norville, Lee and Elizabeth Ainslie, Bruce Stillman, Terry Lindsay, and Bill and 
Susan Sheeline
Kinematica CEO Andreas Niens (second from 
right), with CSHL researchers accepting an 
autoclave donation
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OSI Pharmaceuticals, LLC
The Pew Charitable Trusts
William and Maude Pritchard 
Charitable Trust
Prostate Cancer Foundation
Fannie E. Rippel Foundation
The Robertson Foundation
Mr. and Mrs. David M. Rubenstein
The Sass Foundation for Medical 
Research
Eleanor Schwartz Charitable 
Foundation
Edith and Alan Seligson
The Seraph Foundation
Mr. and Mrs. Herbert J. Siegel
Mr. and Mrs. Howard Solomon
Mr. and Mrs. Erwin P. Staller
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz–Swartz 
Charitable Trust
Waclaw T. Szybalski, D.Sc.
Mr. and Mrs. Paul J. Taubman
Whitehall Foundation, Inc.
The Roy J. Zuckerberg Family 
Foundation
Contributions of $50,000+
Anonymous (2)
Ellen and Casey Cogut
Joni Gladowsky Breast Cancer 
Foundation
Mr. and Mrs. David M. Knott
Betsy and Bryan H. Lawrence
Life Technologies
Mr. and Mrs. Edward A. Chernoff–MARS
Breast Cancer Awareness Day in Memory 
of Elizabeth McFarland
Pershing Square Foundation
Hope Geier Smith and Theodore 
Smith III
Swim Across America Nassau/Suffolk
Mr. and Mrs. Peter S. Tilles–Peter S. 
and Doris M. Tilles Foundation
Wodecroft Foundation
Contributions of $25,000+ 
Elizabeth and Lee Ainslie
The Bahnik Foundation
Hans and Pien Bosch
Broad Hollow Bioscience Park
The Carson Family Charitable Trust
Julia Coleman
Constance and Yves de Balmann
Mr. and Mrs. Geoffrey de Lesseps–Alpha/
Omega Charitable Foundation, Inc.
Laura and John Desmarais
The Dooley Family
Ike, Molly & Steven Elias Foundation
Claire Friedlander Family Foundation
Mr. and Mrs. Ronald Gottlieb
Mr. and Mrs. Jonathan Gray
The Marc Haas Foundation
The Irving A. Hansen Memorial Foundation
Susan T. Harris
Hearts for Cancer
Drs. Nancy and Ron Israeli
Annette Kade Charitable Trust
Mr. and Mrs. Jeffrey E. Kelter
The Fay J. Lindner Foundation
Marcia Kramer Mayer
Judy and Tom Moore
The Morningside Foundation
University of Notre Dame
Pall Corporation
Pfi zer, Inc.
Amy and John Phelan
William Townsend Porter Foundation
Drs. Maria and Charles S. Ryan–Forest 
Laboratories, Inc.
Susan Wasserstein and George Sard
Loren Eng and Dinakar Singh
Mr. and Mrs. James F. Stebbins
Sandy and Howard Tytel
Leslie and Stuart Weisbrod
Ann Eden Woodward Foundation
Contributions of $10,000+ 
Amy Anthony
Babylon Breast Cancer Coalition
Mr. and Mrs. Louis Moore Bacon
The Bank of America Charitable 
Foundation, Inc.
Blavatnik Family Foundation
Frank Brunckhorst
Mr. and Mrs. Thomas J. Calabrese, Jr.
Mr. and Mrs. George W. Carmany III
Lisa and Dick Cashin
John K. Castle
Centerbrook Architects and Planners, LLC
Arthur and Caroline Monti Saladino, Liz and Jim Watson, and Erin and Richard Monti at the 
Don Monti Memorial Research Foundation Ball
2013 Double Helix honorees Peter Neufeld, Robin Roberts, and Barry Scheck with CSHL President 
Bruce Stillman
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Susan and Glenn Cohen
Cutler Family Education and Animal 
Welfare Fund at the Boston 
Foundation
Eppendorf North America
Pamela Hurst-DellaPietra and Stephen 
DellaPietra
Barbara Amonson and Vincent 
DellaPietra
Disney/ABC Television Group
Fortunato Sons Contracting, Inc.
Mr. and Mrs. Oliver R. Grace Jr.–
OBX, Inc.
Kappa Alpha Order
Dr. and Mrs. Joel J. Kassimir
Mr. and Mrs. Thomas L. Kempner, Jr.
Kinematica, Inc.
Laureen and Ragnar Knutsen
Elaine Langone
Elisabeth Leonard–Elisabeth R. Woods 
Foundation, Inc.
Jennifer and Marc Lipschultz
Long Island 2-Day Walk to Fight 
Breast Cancer
Long Island Cruizin’ for a Cure
Edward E. Matthews
Mirus Bio LLC
National Grid Foundation
Gerry Ohrstrom
Susanne C. Olin
Mr. and Mrs. George D. O’Neill
Wendy O’Neill
Oxford and Simpson Realty Services, Inc.
Dr. and Mrs. John G. Passarelli
Patricia Petersen–Daniel Gale Sotheby’s 
International Realty
Whitney Posillico and Family
Dr. and Mrs. Mark S. Ptashne–The Joe 
Lewis Jefferson Foundation, Inc.
Thomas and Marina Purcell Family 
Foundation
Drs. Marjorie van de Stouwe and Scott 
Ratner
Rauch Foundation, Inc.
Hope and John Reese
Christina Renna Foundation, Inc.
Schwab Family
Constance Silveri
Mr. and Mrs. Harry Slatkin
Deborah K. Solbert
Debra Parmet Sondock and Cliff Sondock
Lauri Strauss Leukemia Foundation
Nancy M. Szigethy–NMS 
Management, Inc.
TD Bank
Joan P. Tilney
Patricia and Edward Travaglianti
Wilhelmus Johannes Van der Goes
Mr. and Mrs. Paul A. Vermylen, Jr.
West Islip Breast Cancer Coalition 
for Long Island
Mr. and Mrs. W. Fifi eld Whitman III
Mr. and Mrs. Richard H. Witmer, Jr.
The Bradley Zankel Foundation
Contributions of $5,000+
Abrams, Fensterman, Fensterman, 
Eisman, Greenberg
Advantage Title Agency, Inc.
Mr. and Mrs. W. Dillaway Ayres, Jr.
Dilworth and Barrese
Lisa and Tim Broadbent
Kimberly Griffi ths and Paul Broder
Mr. and Mrs. James J. Celestino
Clare College
Rita M. Cleary
Samara Cohen
Mr. and Mrs. Jonathan Connors
Marian Conway–New York Community 
Bank Foundation
Milton Cooper
Cottage Pharmacy, Inc.
Ide and David Dangoor
Dau Family Foundation
Sandy and Nelson DeMille
Jolanta Fabicka
Diane and Bob Fagiola
J. Fallon’s Tap Room
F.A.C.T. Long Island Foundation
Michael L. Focazio–Carissa Maringo 
Fund
Jane and John Friedman
The Deane A. and John D. Gilliam 
Foundation
Glen Cove C.A.R.E.S., Inc.
Drs. Amanda and Colin Goddard
H2M Architects and Engineers
Mr. and Mrs. Randall A. Hack
Robin Hadley
The Hastings Foundation
Joan M. Hutchins
J.P. Morgan
Mr. and Mrs. Thomas Campbell Jackson
Paul E. Jefferson
Kean Development Company, Inc.
Kebede Family Foundation
Andrea B. and Peter D. Klein
Kleinknecht Family Foundation
Mr. and Mrs. Gordon E. Lamb
Suzanne and Richard Leeds
Amanda and Tom Lister
Luitpold Pharmaceuticals, Inc.
Mrs. David J. Mahoney
Carol Marcincuk Fund
Robert L. Marcus
The Elena Melius Foundation
Mickie and Jeff Nagel
Ashley and Frank O’Keefe
Lauryl and Robert Palatnick
Panera Breads and Bakery
David P. Pearson
Mrs. Richardson Pratt, Jr. and 
Family–Spionkop Charitable Trust
Nicole and Charlie Prizzi
Mr. and Mrs. Preston V. Pumphrey
Anne and Bernard Reynolds
Pamela and Richard Rubinstein 
Foundation
Diane Emdin Sachs Memorial Walk
Robin and Enrique Senior
Mr. and Mrs. Michael Shoff
Mary F. Smith Family Foundation
Mr. and Mrs. Ian K.W. Snow
Ellen Li and Samuel Stanley, Jr.
Lee A. Steinberg
Grace and Bruce Stillman
UnitedHealthCare
John B. Vermylen
Deedee and Michael Wigler
Barrie and Albert Zesiger
Contributions of $2,500+
Mary Auersperg
Mr. and Mrs. Robert H.B. Baldwin
Banfi  Vintners
Fred H. Baron
Liz and Rodney Berens
Dr. Steven Brenner
Mr. and Mrs. Christopher C. Callaghan
Mr. and Mrs. William J. Candee III
Robert B. Catell
Ann K. Thompson and James C. 
Childress
Olivia Flatto, Karen Ackman, and Kristina 
Davison at the Double Helix Medals dinner
Marilyn Simons, Jamie Nicholls, and Jeanne 
Ashe at the Double Helix Medals dinner
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Jane H. Choate
Mrs. Robert L. Clarkson, Jr.
Pat Covelli Foundation
Dr. Lester Dubnick
Fidelity Investments
Brian Fox
E. Maxwell Geddes, Jr.
Dr. and Mrs. Charles B. Goodwin
James A. Greer II
Niki and Joe Gregory
Dr. and Mrs. Ronald J. Gulotta
Sheila and Gil Henoch
Mr. and Mrs. Joseph Heyenoort
Elizabeth McCaul and Frank 
Ingrassia
Johnston Family Foundation
Mr. and Mrs. Barclay G. Jones III
KPMG LLP
Bridget and John Macaskill
Simone Mailman
Mr. and Mrs. Edward C. Meagher
Merritt Environmental Consulting 
Corporation
Mr. and Mrs. Paul V. Morris
Nikon Instruments, Inc.
Mr. and Mrs. David Peikon
Mr. and Mrs. Simon Pharr
Betsy and Rob Pitts
Louis Rasmussen
Rechler Equity Partners
Mr. and Mrs. David R. Rogol
Mrs. Miriam K. Rothenberg
The Marilyn and Barry Rubenstein 
Family Foundation
Lari and Frank Russo
Mr. and Mrs. Jonathan R. Serko
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. Richard A. Spehr
Mrs. David S. Taylor
Lara and Remy Trafelet
Mr. and Mrs. Stanley S. Trotman, Jr.
Mr. and Mrs. Douglas A. Warner III
Deborah Norville and Karl Wellner
Wells Fargo
Mr. and Mrs. Jeffrey Wilks
Diane and Howard Wohl Family 
Foundation
Mr. and Mrs. Seth Zachary
Contributions of $1,000+ 
Aboff ’s Inc.
Mr. and Mrs. Robert J. Adams
A.L.L. Caring Foundation
Erica and Henry Babcock
Mr. and Mrs. Thomas M. Bancroft, Jr.
Norwood Foundation, Inc.
Joan and Nicholas Bartilucci
Caroline E. Bassett
Edward D. Bean, Jr.
Dr. and Mrs. Arthur M. Bernhang
Kathy and Gene Bernstein
Drs. Giuseppe and L. Elizabeth Bertani
Jan and Don Bettencourt
Dr. William Braden III–Porter Braden 
Endowment Fund
Broadridge Financial Solutions, Inc.
Melissa Brooks
JoAnn and G. Morgan Browne
John Buyko
Peter B. Cannell
Stephen E. Canter
Daniel Carbone–Syosset Limousine 
Service, Inc.
Muffy Carlstrom
Keri and Eric Carlstrom
Mary and Richard Catalano
David C. Clark
Nancy Parmet Cook and Jim Cook
Cosel-Pieper Family Foundation
Cron Family Foundation
Lucy P. Cutting
Duncan Darrow
Kristina and Harry Davison
Debra and Claudio Del Vecchio
Mr. and Mrs. David H. Deming
Meleanor and Donald Deming
Suzanne and Michael DiMaio
Mr. and Mrs. Joseph T. Donohue
Dr. and Mrs. Thomas Dowling
Michael Eisenbud
Electronix Systems Central Station 
Alarms, Inc.
Emily Sky Fashion Inc.
Enzo Life Sciences
Robert J. Feeney
Stephanie and Lawrence Flinn, Jr.
Douglas and Christine Fox
Mr. and Mrs. Roger Fradin
Sydney Gary and Alex Gann
Drs. Joan and Alfred Goldberg
Aimee and Brian Goldstein
Paula and Pierre Gonthier
Mr. and Mrs. John R. Gordon
Dr. Antonio M. Gotto, Jr.–Weill 
Cornell Medical College
Mr. and Mrs. Austen T. Gray, Jr.
Mr. and Mrs. William H. Grover
Mr. and Mrs. Mark W. Hamer
Rev. Linda Peyton Hancock
Margaret M. Hargraves
Harvest Real Estate Services, Inc.
Colleen and Patrick Haskell
Walter Hawrys
Judith G. Hershon
William A. Herzog
James B. Hicks, Ph.D.
Mr. and Mrs. Robert C. Higginson
Mr. and Mrs. Mark Hoffman
Mr. and Mrs. James B. Hoover
Frederic B. Ingraham
Robert R. Israels
Kirill Istomin Inc.
Walter B. James Fund No. 2
Leemor Joshua-Tor
Mr. and Mrs. Gerard Justvig
Dr. Victor Klein
Edward M. Lamont
Nancy Israeli, CSHL scientist Pavel Osten, and 
Ron Israeli at the Spring President’s Council 
reception
Terri Keogh, Lori Bahnik, Peter Keogh, and Roger Bahnik at CSHL’s Summer Solstice party 
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Marsha and Henry Laufer
Lorraine Lew
Georgie W. Lewis
Howard B. Lowell
James R. Lowell III
Mr. and Mrs. Patrick H. Mackay
Mr. and Mrs. Robert G. MacLean
Carla Solomon and Antonio 
Magliocco, Jr.
Mr. and Mrs. Michael G. Mandelker
Claire Mann
Marshs
Mr. and Mrs. Neil T. McGoldrick
Mr. and Mrs. Richard P. Mellon
Miranda Meyer
Mr. and Mrs. Clarence F. Michalis
Dr. and Mrs. Jeffrey H. Miller
Leo Model Foundation, Inc.
Frances S. Moffat
Dr. Kathleen Mooney
Mr. and Mrs. George Braniff Moore
John T. Moore
Agathe David-Weill and Pierre Mordacq
Ann and Steve Munn
Stephen V. and Vicki S. Murphy
Mr. and Mrs. Francis W. Murray III
NorthMarq Capital
Mr. and Mrs. Michael S. O’Brien
Patricia and Hugh O’Kane
One Beacon Charitable Trust
Onyx Management Group, LLC
Optima Charitable Foundation
Mr. and Mrs. Richard S. Overton
Rhoda Parmet
Mr. and Mrs. Michael C. Pascucci
Mr. and Mrs. Jeffrey Pash
Mr. and Mrs. Nicholas B. Paumgarten
David Pennetta
Louise S. Pickart
Mr. and Mrs. Robert Pilkington
Mr. and Mrs. Thomas L. Pulling
Dr. Amy Rappaport Koreen and 
Dr. Judith Rappaport
RBC Capital Markets
Mr. and Mrs. Arthur M. Rogers, Jr.
Ronald K. Rothman
Mr. and Mrs. J. Wright Rumbough, Jr.
Hollis F. Russell, Esq.
George and Jayne Sabbagh
Jacquelyn Samnick
Dr. and Mrs. Raju Sarwal
Mr. and Mrs. Thomas A. Saunders III
Thomas A. Saunders IV
Charles Sawyers
Mr. and Mrs. Peter G. Schiff–The Schiff 
Foundation
Carl Schildkraut
Mr. and Mrs. Richard P. Simmons
Nancy Skala
Mr. and Mrs. Owen T. Smith
Addison Sollog
Mr. and Mrs. Fredric Sosnick
Drs. Mona and David Spector
Mr. and Mrs. James L. Spingarn
Marcia and Myron Stein
Lee Stettner
Dr. Ronald Swanstrom
Judith and Irwin Tantleff
Pamela M. Thye
Mr. and Mrs. Bart T. Tiernan
Mr. and Mrs. Pascal Franchot Tone
Sarah Vermylen Trust and Robert H. Trust
Dr. George F. Vande Woude
Mrs. Helene P. Victor
Waldner’s Business Environments
Jackie and Warren Wasp
Neil Westreich
Gerald I. White
Women’s Financial Group, Inc.
Catherine Zenko
Marilyn Zuckerman
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CORPORATE AND FOUNDATION MATCHING GIFT CONTRIBUTORS
Bank of America Matching Gifts
Bristol-Myers Squibb Foundation
Dow Jones & Company, Inc.
Goldman Sachs & Co. Matching 
Gift Program
Honeywell Matching Gift Program
iStar Financial, Inc.
The J.P. Morgan Chase Foundation
Merck Partnership For Giving
Pfi zer Foundation Matching Gifts 
Program
Wells Fargo Foundation
IN HONOR OF
Gabrielle Bacon
Elinor Bettencourt
Trudy Calabrese
Ed Chernoff
Ellen and Casey Cogut
Susan Cohen
Lee Edwards
Mikala Egeblad
Stephen and Maya Hartley
Arthur Herman
Ben Israeli
Nancy Israeli
Morton and Lois Jaffe
Dr. Louis Lester
Mary D. Lindsay
Robert Lindsay
Cathryn MacInnes
Simone Mailman
Marcia Kramer Mayer
Bob and Sandy Messer
Jamie Nicholls and Fran Biondi
Louise Parent
Justin Rosati
Allen Sachs
Bonnie Sollog
Dr. Bruce Stillman
Glenn and Sandra Sundheimer
Sylvia Thomas
Sandy Tytel
Dr. Marjorie van de Stouwe
Sallie and Alex van Rensselaer
Elizabeth Watson
Dr. James D. Watson
Dr. Michael Wigler
IN MEMORY OF
Shoukre Abdo
TJ Arcati
Pamela S. Banker
Gregory Basmajian
C. A. Beach
Joan Bildner
Howard Borowick
Patricia Boudreau
Ellen Brenner
Helen Brooks
Carol A. Buonaiuto
Laura Campbell
Josephine & Ted Chodkowski
Justine Ciampa
John Paul Cleary
Tina Duque Corbett
August H. Doermann
Donald Dugan
James Eisenman
Mary Fish
Natalie Friedman
Nancy Slaughter Gay
Joni Gladowsky
Dr. Christopher G. Goff
Jessie Guinsburg
Teresa Haire
Charles E. Harris
Walter Hein
Elizabeth Holt
Austin Hudson-Lapore
Dr. Andy Kaplan
Marion Klein
Townsend Knight
Edward C. Kramer
Joan Marie Laube
Lawrence S. Lawrence
Dr. Louis Lester
Dr. Robert Lewis
Allan Lisse
Lisa MacInnes
Carol Marcincuk
Joyce Marcus
Carissa Maringo
Christine R. Mattersdorfer-Amoia
Elizabeth McFarland
Mr. and Mrs. Edward F. McGrath
Rose M. Mooney
Monica Mowery
Howard Olian
Vincent Ortolani
Frank Papa
Donald J. Parmet
Donald Parmet & Eleanor 
Wohlgemuth
Dr. Cecile Pickart
Seamon/Sydney/Milton Pines, 
Castnopol, Kitei
George Rehkamp
Christina Renna
Jack Richards
Marvin Richman
Frank and James Rispoli
Elizabeth Roberts
Susan Rose
Diane Edmin Sachs
Howard Roy Schwartz
Blanche Miller Seelmann
Andrew Seligson
Adelaide Simpson
Elizabeth Jennifer Slack-Merrin
Donald Sondock
Susan Caroline Szigethy
Benjamin Nichols Taylor
Linda Vernam
Steven Vingelis
Maryanne Visconi
Dr. Daniel Wolf
Suzy Geller Wolf
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LABORATORY MANAGEMENT
Bruce W. Stillman, President and Chief Executive Offi cer
James D. Watson, Chancellor Emeritus
W. Dillaway Ayres, Jr., Chief Operating Offi cer
RESEARCH
David L. Spector
Director of Research
Sydney Gary
Director, Research Operations
Walter L. Goldschmidts
Executive Director,
Sponsored Programs
Professors
Thomas Gingeras
Professor and Head,
Functional Genomics
Gregory Hannon*
Program Chair, Genomics
and Plant Biology
Z. Josh Huang
David Jackson
Leemor Joshua-Tor*
Alexei Koulakov
Adrian Krainer
Program Chair, Cancer
and Molecular Biology
Robert Martienssen*
W. Richard McCombie
Alea Mills
Partha Mitra
Marja Timmermans
Nicholas Tonks
Deputy Director, 
CSHL Cancer Center
David Tuveson
Deputy Director, 
CSHL Cancer Center
Linda Van Aelst
Michael Wigler
Anthony Zador
Program Chair, Neuroscience
Yi Zhong
Associate Professors
Joshua Dubnau
Grigori Enikolopov
Hiroyasu Furukawa
Adam Kepecs
Bo Li
Zachary Lippman
Senthil Muthuswamy
Pavel Osten
Darryl Pappin
Scott Powers, 
Associate Professor/Director, 
Human CGC
Raffaella Sordella
Arne Stenlund
Lloyd Trotman
Glenn Turner
Assistant Professors
Dinu Albeanu
Gurinder Atwal
Anne Churchland
Mikala Egeblad
Jesse Gillis
Christopher Hammell
Molly Hammell
Ivan Iossifov
Alexander Krasnitz
Dan Levy
Gholson Lyon
Michael Schatz
Stephen Shea
Christopher Vakoc
Hongwu Zheng
Research Professor
James Hicks
Research Assistant 
Professors
Michael Ronemus
Seungtai Yoon
Senior Computer Scientist
Boris Yamrom
Computer Scientist
Swagatam Mukhopadhyay
Quantitative Biology Fellow
Justin Kinney
Senior Research Investigator
Carrie Davis
Research Investigators
Joan Alexander
Eric Antoniou
Research Investigator/Project 
Manager, CCG
Isabel Aznarez Da Silva
Kenneth Chang
Camila Dos Santos
Emily Hodges
Yimin Hua
Yoon-Ha Lee
Shane Edward McCarthy
Tatyana Michurina
Youngkyu Park
Natalia Peunova
Kandasamy Ravi
Michael Regulski
Yi-Jun Sheu
Adjunct Professors
Scott Lowe
Anil Malhotra
Larry Norton
Adjunct Associate Professor
Doreen Ware
USDA Adjunct 
Associate Professor
Visiting Scientists/
Collaborative Scientists
Gyula Bencze
Ebru Demir
Santiago Jaramillo Escobar
Wei Gao
Hysell Oviedo
Manaswini Sivaramakrishnan
Ting Wu
Zhiming Zhang
Visiting Professors
Fritz Henn
Matthew Ridley
Kathleen Rockland
Stuart Weisbrod
Visiting Scholar
Bhubaneswar Mishra
Director, Antibody and 
Phage Display
Bryce Nelson
Director, Gene Targeting 
Shared Resources
Ping Jiang
Database Manager, 
Genomics
Christopher Zaleski
Senior Fellow
Olga Anczukow-Camarda
Clinical Fellow
Mariano Ponz Sarvise
CSH Fellow
Lingbo Zhang
Postdoctoral Fellows
Sandra Ahrens
Martin Akerman
Francesca Anselmi
Christine Ardito
Gayatri Arun
Lindsey Baker
Rachappa Balkunde
Sara Ballouz
Jan Bergmann
Yael Berstein
Jennifer Beshel
Sonali Bhattacharjee
Huyen Bui
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Alexander Campbell
Hong Goo Chae
Cristina Chen
Iok In Chio
Vincenzo Corbo
Katie Creasey
Benjamin Czech
Filipe de Sousa Borges
Sarah Diermeier
Max Doerfel
Mark Donoghue
Marcela Dotto
Dennis Eckmeier
Cheryl Eifert
Elad Elkayam*
Bradford Elmer
Ela Elyada
Dannielle Engle
Andrea Eveland
Christopher Faehnle
Delphine Fagegaltier
Ilaria Falciatori
Gaofeng Fan
Michael Feigin
Daniel Ferrante
Sara Goodwin
Pascal Grange
Baofeng Guo
Astrid Desiree Haase
Jong-Jin Han
Balazs Hangya
Anna Hangyane Benkovics
Miao He
Rowan Herridge
Toshihide Hige
Junya Hirokawa
Guy Horev
Manzar Hossain
Michael Huebner
Dhananjay Huilgol
Aman Husbands
Change-Il Hwang
Jonathan Ipsaro
Yannick Jacob*
Byoung Il Je
Ke Jiang
Yinping Jiao
Erkan Karakas
Matthew Kaufman
Shimpei Kawaoka
Sukant Khurana
Yongsoo Kim
Stefan Klingler
Simon Knott
Keerthi Krishnan
Navasona Krishnan
Claus-Dieter Kuhn
Duda Kvitsiani
Billy Lau
Seung Cho Lee
Seung-Jae Lee*
Young Koung Lee
Haohong Li
Jinyu Li
Li Li
Christopher Liseron-Monfi ls
Uri Livneh
Jiangteng Lu
Michael Ludwig
Cora MacAlister
Tomas Malinauskas
Shoshana Marcus
Olivia Mendivil Ramos
Faith Mercan
Adaobi Mofunanya
Adam Mohamed Naguib
Almudena Molla-Morales
Amit Mukherjee
Saikat Nandi
Arun Narasimhan
Shuang Ni
Christos Noutsos
Jaclyn Novatt
Dawid Nowak
Erik Olund
Gonzalo Hugo Otazu Aldana
Jean-Sebastien Parent
June Hee Park
Juwon Park
Soonju Park
Mario Penzo
Roberto Perales
Katherine Petsch
Hyun Jae Pi
Ashwin Prakash
Lisa Prazak
Jonathan Preall
Ileng Ramachandran
Sachin Ranade
Clare Rebbeck
Ashlan Reid
Jie Ren
Benjamin Roche
Jae Seok Roe
Nikolay Rozhkov
Elena Rozhkova
Leah Sabin
Ana Margarida Santos 
De Almeida
Juergen Scharner
Andrea Schorn
Serif Senturk
Mario Shields
Meng-Fu Shih
Atsushi Shimada
Yichun Shuai
Damianos Skopelitis
Marcus Stephenson-Jones
Yilin Tai
Nami Tajima
Naoki Takada
Oliver Tam
Julian Taranda
Shaolei Teng
Herve Tiriac
Ante Tocilj
Vasily Vagin
Alexander Vaughan
Wim Verleyen
Bo Wang
Bor-Shuen Wang
Chia-Lin Wang
Minghui Wang
Zihua Wang
Yi Wei
John Wilson
Qingyu Wu
Qiaojie Xiong
Cao Xu
Yu-Ting Yang
Kai Yu
Yang Yu
Huiqing Zhan
Ling Zhang
Graduate Students
Robert Aboukhalil
Ozlem Aksoy
Brinda Alagesan
Pedro Alexandre 
Garcia Da Silva
Naishitha Anaparthy
Deanna Bahel
Arkarup Bandyopadhyay
Timour Baslan
Giorgia Battistoni
Philippe Batut
Mitchell Bekritsky
Fatma Bezirci
Anand Bhagwat
Megan Bodnar
Dario Bressan
Colleen Carlston
Stephane Castel
Brittany Cazakoff
Sudipto Chakrabortty
An-Yun Chang
Kung-Chi Chang
Lital Chartarifsky
Fauzia Chaudhary
Hyejin Cho
Hsiang-Chen Chou
Shipra Das
Maria Joaquina Delas Vives
Kristen Delevich
William Donovan
Melanie Eckersley-Maslin
Helena Ederle
Nicolas Erard
Miriam Fein
Silvia Fenoglio
Liliana Ferreira
Angeliki Field-Pollatou
Talitha Forcier
Tyler Garvin
Sanchari Ghosh
Michael Giangrasso
Siong Wee Goh
Jiaqi Gu
Priyanka Gupta
Michael Gutbrod
Sara Gutierrez Angel
Paloma Tamargo Guzzardo
Abram Handly-Santana
Yu-Jui Ho
Anja Hohmann
Dong-Woo Hwang
Hyun-Yong Jeon
Daniel Jones
Nihan Kara
Justus Kebschull
Sean Kelly
Daniel Kepple
Matthew Koh
Sang-Geol Koh
Lisa Krug
Marek Kudla
Yan Ha Lee
Jesse Levine
Katie Liberatore
Jayon Lihm
Laura Maiorino
Fred Marbach
Paul Masset
Felix Muerdter
Maria Nattestad
Tomoki Nomakuchi
David Raposo Nunes
Onyekachi Odoemene
Tobiloba Oni
Hassana Oyibo
Debjani Pal
Ian Peikon
Zinaida Perova
Yevgeniy Plavskin
Huan Qi
Mathangi Ramesh
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Benjamin Rebouillat
Annabel Hernandez Romero
Christian Ruiz
Ioana Rus
Joshua Sanders
Chen Shen
John Sheppard
Junwei Shi
Nitin Shirole
Liz Snedecor
Justin Snider
Dongyan Song
Mar Soto Ruiz de la Torre
Bingru Sun
Guoli Sun
Eric Szelenyi
Nilgun Tasdemir
Sophie Thomain
Jason Tucciarone
Charles Underwood
Assaf Vestin
Elvin Wagenblast
Jack Walleshauser III
Kaja Wasik
Susann Weissmueller
Yiyang Wu
Youran Wu
Robert Wysocki
Chunsu Xu
Yali Xu
Ming Yang
Georgi Yordanov
Jia-Ray Yu
Cinthya Zepeda Mendoza
Siwei Zhang
Xin Zhou
Computational Science
Peter Andrews
Alexander Dobin
Evan Ernst
Han Fang
Elena Ghiban
Ewa Grabowska
James Gurtowski
Yuan Hao
Gregor Havkin
Ying Jin
Jude Kendall
Melissa Kramer
Sunita Kumari
Anthony Leotta
Zhenyuan Lu
Steven Marks
Ferenc Mechler
Marcela Monaco
Giuseppe Narzisi
Andrew Olson
Eric Paniagua
Shiran Pasternak
Vadim Pinskiy
Kith Pradhan
Srividya Ramakrishnan
Joshua Stein
James Thomason
Kannan Umadevi Venkataraju
Liya Wang
Xuehong Wei
Chenghai Xue
Charles Youens-Clark
Yingbin Zhang
Research Associates
Carmelita Bautista
Barry Burbach
Hilary Cox
Shiqiang Dai
Jorg Drenkow
Cristina Fernandez Marco
Carla Gauss
Diana Gizatullina
Hyun Soo Kim
Lisa Manche
Anirban Paul
Leopold Puzis
Keith Rivera
Linda Rodgers
Patricia Wendel
Caizhi Wu
Scilla Wu
Laboratory Facility 
Managers
Sabrina Boettcher*
Patricia Brady
Robert Gerdes
Stephanie Goldsmith*
Stephen Hearn
Pamela Moody
Timothy Mulligan
Joseph Simorowski*
Spencer Teplin
Jennifer Troge
Ming Wang
Scientiﬁ c IT Support
Peter Van Buren
Scientiﬁ c Administrators
Sadie Arana*
Kristin Armbrecht
Lorraine Baldwin
Christine Bedell
Patricia Bird
Becky Dong
Irene Gill
Carol Gundersen
Jo Leonardo*
Idee Mallardi
Sandra Michelsen
Susan Milham
Sandra Moran
Elizabeth Panagot
Andrea Potopsingh
Dorothy Tsang Hu
Madeline Wisnewski
Laboratory Technicians
Sai Dipikaa Akshinthala
Nabil Azamy
Eleni Boikoglou
Christopher Brooks
Amanda Brown
Jacqueline Cappellani
Yon Chang
Gloria Cheang
Joshua Cohen
Brianna Creighton
Martin Davis
Bethany Delcuze
Anthony DeSantis
Panchajanya Deshpande
Sean D’Italia
Katja Doerfel
Amanda Epstein*
Scott Ethe-Sayers
Margaret Falkowski
Neil Franciotti
Inessa Hakker
Emily Harrison
Tahmid Hassan
Tali Herzka
Ga-Ram Hwang
Meagan Keane
Kendra Lahut
Chantal LeBlanc*
Emily Lee
Jingjing Li
Irene Liao
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